assays_ss_tst_tp,assays_ss_sbclllr_frctn,assays_chmbl_d,assays_src_ss_d,assays_td,assays_ss_tss,assays_b_frmt,assays_ss_rgnsm,assays_tss_d,assays_ss_strn,assays_dscrptn,assays_crtd_b,assays_ss_tx_d,assays_rltnshp_tp,assays_ss_d,assays_src_d,assays_vrnt_d,assays_cnfdnc_scr,assays_ss_tp,assays_ss_cll_tp,assays_cll_d,assays_dc_d,assays_ss_ctgr
In vivo,,CHEMBL618647,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,10116.0,N,7524,1,,1,A,,,9866,
In vivo,,CHEMBL618648,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,Intermediate,10116.0,N,7525,1,,1,A,,,9866,
In vivo,,CHEMBL618649,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,10116.0,N,7526,1,,1,A,,,9866,
In vivo,,CHEMBL618650,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,10116.0,N,7527,1,,1,A,,,9866,
In vivo,,CHEMBL618651,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,Intermediate,10116.0,N,7528,1,,1,A,,,9866,
In vivo,,CHEMBL876497,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,10116.0,N,7529,1,,1,A,,,9866,
In vivo,,CHEMBL618652,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,10116.0,N,7530,1,,1,A,,,9866,
In vivo,,CHEMBL618653,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,Intermediate,10116.0,N,7531,1,,1,A,,,9866,
In vivo,,CHEMBL618654,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,10116.0,N,7532,1,,1,A,,,9866,
,,CHEMBL618655,,50597,,BAO_0000218,Rattus norvegicus,,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,Intermediate,10116.0,N,7533,1,,1,A,,,6351,
,,CHEMBL618656,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for solubility in water,Intermediate,10116.0,N,7534,1,,1,A,,,1465,
,,CHEMBL618657,,22229,,BAO_0000100,,,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),Intermediate,,U,7535,1,,0,P,,,5182,
,,CHEMBL618658,,50597,,BAO_0000218,Rattus norvegicus,,,Solubility was determined,Intermediate,10116.0,N,7536,1,,1,A,,,17847,
,,CHEMBL618659,,50597,,BAO_0000218,Rattus norvegicus,,,solubility in water (ug/mL) at 37 degree C.,Intermediate,10116.0,N,7537,1,,1,A,,,15339,
,,CHEMBL618660,,50597,,BAO_0000218,Rattus norvegicus,,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,Intermediate,10116.0,N,7538,1,,1,A,,,5202,
,,CHEMBL618661,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,Intermediate,10116.0,N,7539,1,,1,A,,,1088,
,,CHEMBL873807,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rats,Intermediate,10116.0,N,7540,1,,1,A,,,3169,
,,CHEMBL618662,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in Dawley rat,Intermediate,10116.0,N,7541,1,,1,A,,,5353,
In vivo,,CHEMBL618663,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period after 3 mg/kg iv administration,Intermediate,10116.0,N,7542,1,,1,A,,,2864,
In vivo,,CHEMBL618664,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period after 3 mg/kg iv administration in rat,Intermediate,10116.0,N,7543,1,,1,A,,,2864,
In vivo,,CHEMBL618665,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period after 3 mg/kg iv administration in the rat,Intermediate,10116.0,N,7544,1,,1,A,,,2864,
,,CHEMBL876498,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in female Sprague-Dawley rats,Intermediate,10116.0,N,7545,1,,1,A,,,6362,
,,CHEMBL618666,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat,Intermediate,10116.0,N,7546,1,,1,A,,,6249,
,,CHEMBL620440,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rats was determined,Intermediate,10116.0,N,7547,1,,1,A,,,3169,
,,CHEMBL620441,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rats with metabolic oxidation,Intermediate,10116.0,N,7548,1,,1,A,,,3169,
,,CHEMBL620442,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rats,Intermediate,10116.0,N,7549,1,,1,A,,,3169,
In vivo,,CHEMBL620443,,50597,,BAO_0000218,Rattus norvegicus,,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,10116.0,N,7550,1,,1,A,,,17260,
In vivo,,CHEMBL620444,,50597,,BAO_0000218,Rattus norvegicus,,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,10116.0,N,7551,1,,1,A,,,17260,
In vivo,,CHEMBL620445,,50597,,BAO_0000218,Rattus norvegicus,,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,10116.0,N,7552,1,,1,A,,,17260,
In vivo,,CHEMBL620446,,50597,,BAO_0000218,Rattus norvegicus,,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,10116.0,N,7553,1,,1,A,,,17260,
,,CHEMBL620447,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biological half-life measured in plasma of rat,Intermediate,10116.0,N,7554,1,,1,A,,,2879,
,,CHEMBL621129,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biological half-life measured in plasma of rat; 22-25,Intermediate,10116.0,N,7555,1,,1,A,,,2879,
,,CHEMBL621130,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biological half-life measured in plasma of rat; 9-16,Intermediate,10116.0,N,7556,1,,1,A,,,2879,
In vivo,,CHEMBL873808,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for its half life when administered intravenously in rat,Intermediate,10116.0,N,7557,1,,1,A,,,3184,
In vivo,,CHEMBL876598,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,Intermediate,10116.0,N,7558,1,,1,A,,,4891,
In vivo,,CHEMBL621131,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,Intermediate,10116.0,N,7559,1,,1,A,,,429,
In vivo,,CHEMBL621132,,50597,,BAO_0000218,Rattus norvegicus,,,Half life (T1/2) after oral administration in rat,Intermediate,10116.0,N,7560,1,,1,A,,,5656,
In vivo,,CHEMBL621133,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound after iv administration of 20 mg/kg dose in rat,Intermediate,10116.0,N,7561,1,,1,A,,,4413,
In vivo,,CHEMBL621312,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,10116.0,N,7562,1,,1,A,,,3598,
,,CHEMBL621313,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound was determined in rat,Intermediate,10116.0,N,7563,1,,1,A,,,17267,
,,CHEMBL621314,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Half life of compound was determined in rat blood,Intermediate,10116.0,N,7564,1,,1,A,,,4727,
In vivo,,CHEMBL621315,,50597,,BAO_0000218,Rattus norvegicus,,,Half life at 1 mg/kg was determined in rat,Intermediate,10116.0,N,7565,1,,1,A,,,17651,
In vivo,,CHEMBL621316,,50597,,BAO_0000218,Rattus norvegicus,,,Half life at 10 mg/kg was determined in rat,Intermediate,10116.0,N,7566,1,,1,A,,,17651,
,,CHEMBL621317,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rats,Intermediate,10116.0,N,7567,1,,1,A,,,401,
,,CHEMBL621318,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rats in hours,Intermediate,10116.0,N,7568,1,,1,A,,,4942,
In vivo,,CHEMBL621319,,50597,,BAO_0000218,Rattus norvegicus,,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,10116.0,N,7569,1,,1,A,,,17735,
In vivo,,CHEMBL621377,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,Intermediate,10116.0,N,7570,1,,1,A,,,6056,
,,CHEMBL621378,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was determined,Intermediate,10116.0,N,7571,1,,1,A,,,5213,
In vivo,,CHEMBL876599,,50597,,BAO_0000218,Rattus norvegicus,,,Half life after i.v. administration,Intermediate,10116.0,N,7572,1,,1,A,,,6616,
In vivo,,CHEMBL621379,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,Intermediate,10116.0,N,7573,1,,1,A,,,5937,
,,CHEMBL621380,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life in rat plasma,Intermediate,10116.0,N,7574,1,,1,A,,,5819,
,,CHEMBL621381,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life in rat plasma; Not detected,Intermediate,10116.0,N,7575,1,,1,A,,,5819,
,,CHEMBL618515,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rats,Intermediate,10116.0,N,7576,1,,1,A,,,6803,
In vivo,,CHEMBL618516,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period of compound was determined after peroral administration,Intermediate,10116.0,N,7577,1,,1,A,,,17804,
In vivo,,CHEMBL618517,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,Intermediate,10116.0,N,7578,1,,1,A,,,17804,
,,CHEMBL618518,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat,Intermediate,10116.0,N,7579,1,,1,A,,,5948,
In vivo,,CHEMBL618519,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,10116.0,N,7580,1,,1,A,,,1916,
In vivo,,CHEMBL618698,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,10116.0,N,7581,1,,1,A,,,1916,
In vivo,,CHEMBL618862,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,Intermediate,10116.0,N,7582,1,,1,A,,,1916,
In vivo,,CHEMBL618863,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,10116.0,N,7583,1,,1,A,,,4890,
In vivo,,CHEMBL618864,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,Intermediate,10116.0,N,7584,1,,1,A,,,17764,
In vivo,,CHEMBL618865,,50597,,BAO_0000218,Rattus norvegicus,,,Half life time in rat the dose of 2 mg/kg,Intermediate,10116.0,N,7585,1,,1,A,,,4727,
In vivo,,CHEMBL618866,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life 24 hr after 10 mg/kg iv administration in rats,Intermediate,10116.0,N,7586,1,,1,A,,,17509,
In vivo,,CHEMBL618867,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life 24 hr after 2 mg/kg iv administration in rats,Intermediate,10116.0,N,7587,1,,1,A,,,17509,
,,CHEMBL875828,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life consistent with the observed metabolic steady state in rats,Intermediate,10116.0,N,7588,1,,1,A,,,6597,
In vivo,,CHEMBL618868,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,10116.0,N,7589,1,,1,A,,,17735,
,,CHEMBL618869,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life for oxidative metabolic stability was determined using male human,Intermediate,10116.0,N,7590,1,,1,A,,,6597,
In vivo,,CHEMBL618870,,50597,,BAO_0000218,Rattus norvegicus,,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,10116.0,N,7591,1,,1,A,,,17670,
,,CHEMBL618871,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in rat plasma,Intermediate,10116.0,N,7592,1,,1,A,,,1696,
,,CHEMBL618872,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in rat plasma was determined,Intermediate,10116.0,N,7593,1,,1,A,,,1742,
,,CHEMBL873816,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rats was determined,Intermediate,10116.0,N,7594,1,,1,A,,,17800,
,,CHEMBL618873,,22224,,BAO_0000218,,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,Autocuration,,U,7595,1,,0,A,,,12923,
,,CHEMBL621602,,22224,,BAO_0000019,,,,Area under curve after oral dose of 0.1 mg//kg,Autocuration,,U,7596,1,,0,A,,,11954,
,,CHEMBL621603,,22224,,BAO_0000218,,,,Area under curve after oral dose of 0.3 mg/kg,Autocuration,,U,7597,1,,0,A,,,11954,
,,CHEMBL621604,,22224,,BAO_0000218,,,,Area under curve after oral dose of 1 mg/kg,Autocuration,,U,7598,1,,0,A,,,11954,
,,CHEMBL621605,,22224,,BAO_0000218,,,,Area under curve after oral dose of 10 mg/kg,Autocuration,,U,7599,1,,0,A,,,11954,
,,CHEMBL621606,,22224,,BAO_0000218,,,,Area under curve after oral dose of 23.4 mg/kg,Autocuration,,U,7600,1,,0,A,,,11954,
,,CHEMBL621607,,22224,,BAO_0000218,,,,Area under curve after oral dose of 3 mg/kg,Autocuration,,U,7601,1,,0,A,,,11954,
,,CHEMBL621608,,22224,,BAO_0000218,,,,Area under curve after oral dose of 3.87 mg/kg,Autocuration,,U,7602,1,,0,A,,,11954,
,,CHEMBL621609,,22224,,BAO_0000019,,,,Area under curve was determined,Autocuration,,U,7603,1,,0,A,,,5237,
,,CHEMBL621610,,22224,,BAO_0000218,,,,Area under curve at a dose of 10 mg/kg,Autocuration,,U,7604,1,,0,A,,,4026,
,,CHEMBL621611,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined; ND=No data,Intermediate,10116.0,N,7605,1,,1,A,,,5237,
,,CHEMBL621612,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,10116.0,N,7606,1,,1,A,,,14793,
,,CHEMBL622308,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Intermediate,10116.0,N,7607,1,,1,A,,,14793,
,,CHEMBL622309,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,10116.0,N,7608,1,,1,A,,,14793,
,,CHEMBL622310,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,Intermediate,10116.0,N,7609,1,,1,A,,,14793,
,,CHEMBL622311,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Intermediate,10116.0,N,7610,1,,1,A,,,14793,
,,CHEMBL622312,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,Intermediate,10116.0,N,7611,1,,1,A,,,14793,
,,CHEMBL622931,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,10116.0,N,7612,1,,1,A,,,14793,
,,CHEMBL622932,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,Intermediate,10116.0,N,7613,1,,1,A,,,14793,
,,CHEMBL622736,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,10116.0,N,7614,1,,1,A,,,14793,
,,CHEMBL622737,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Intermediate,10116.0,N,7615,1,,1,A,,,14793,
,,CHEMBL622738,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,10116.0,N,7616,1,,1,A,,,14793,
,,CHEMBL622739,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,Intermediate,10116.0,N,7617,1,,1,A,,,14793,
,,CHEMBL622740,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Intermediate,10116.0,N,7618,1,,1,A,,,14793,
,,CHEMBL622741,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,Intermediate,10116.0,N,7619,1,,1,A,,,14793,
,,CHEMBL622742,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,10116.0,N,7620,1,,1,A,,,14793,
,,CHEMBL622743,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,Intermediate,10116.0,N,7621,1,,1,A,,,14793,
,,CHEMBL622744,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,AUC in mice,Intermediate,10090.0,N,7622,1,,1,A,,,11637,
,,CHEMBL624134,,22224,,BAO_0000019,,,,Area under curve was measured from the graph obtained from concentration Vs time,Autocuration,,U,7623,1,,0,A,,,11149,
,,CHEMBL624135,,22224,,BAO_0000019,,,,Area under curve value of compound per hour after oral administration,Autocuration,,U,7624,1,,0,A,,,10016,
,,CHEMBL624136,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined after oral administration in rats,Intermediate,10116.0,N,7625,1,,1,A,,,17796,
,,CHEMBL624137,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined after oral administration in rats; No data,Intermediate,10116.0,N,7626,1,,1,A,,,17796,
,,CHEMBL624320,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined after oral administration in rats;No data,Intermediate,10116.0,N,7627,1,,1,A,,,17796,
,,CHEMBL624321,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Intermediate,9615.0,N,7628,1,,1,A,,,12923,
,,CHEMBL624322,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,Intermediate,10116.0,N,7629,1,,1,A,,,15372,
,,CHEMBL624323,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined for the compound after iv dose of 5.06 in rats,Intermediate,10116.0,N,7630,1,,1,A,,,15372,
,,CHEMBL624324,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,Intermediate,10116.0,N,7631,1,,1,A,,,15372,
,,CHEMBL624325,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,Intermediate,10116.0,N,7632,1,,1,A,,,15372,
,,CHEMBL624326,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,Intermediate,10116.0,N,7633,1,,1,A,,,15372,
,,CHEMBL624327,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,Intermediate,10116.0,N,7634,1,,1,A,,,15372,
,,CHEMBL624328,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,Intermediate,10116.0,N,7635,1,,1,A,,,15372,
,,CHEMBL627848,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve was determined in Dogs after peroral administration,Intermediate,9615.0,N,7636,1,,1,A,,,14169,
,,CHEMBL627849,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined in Rats after peroral administration,Intermediate,10116.0,N,7637,1,,1,A,,,14169,
,,CHEMBL627850,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined in carotid blood of rat when administered intradermally,Intermediate,10116.0,N,7638,1,,1,A,,,14258,
,,CHEMBL627851,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined in portal blood of rat when administered intradermally,Intermediate,10116.0,N,7639,1,,1,A,,,14258,
,,CHEMBL627852,,50594,,BAO_0000218,Mus musculus,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,10090.0,N,7640,1,,1,A,,,15011,
,,CHEMBL627853,,50594,,BAO_0000218,Mus musculus,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,10090.0,N,7641,1,,1,A,,,15011,
,,CHEMBL627854,,50594,,BAO_0000218,Mus musculus,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,10090.0,N,7642,1,,1,A,,,15011,
,,CHEMBL627855,,50594,,BAO_0000218,Mus musculus,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,10090.0,N,7643,1,,1,A,,,15011,
,,CHEMBL627856,,50594,,BAO_0000218,Mus musculus,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),Intermediate,10090.0,N,7644,1,,1,A,,,15011,
,,CHEMBL875339,,50594,,BAO_0000218,Mus musculus,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,10090.0,N,7645,1,,1,A,,,15011,
,,CHEMBL627857,,50594,,BAO_0000218,Mus musculus,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),Intermediate,10090.0,N,7646,1,,1,A,,,15011,
In vivo,,CHEMBL627858,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,Intermediate,10116.0,N,7647,1,,1,A,,,11195,
,,CHEMBL627859,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,Intermediate,10116.0,N,7648,1,,1,A,,,10130,
,,CHEMBL627860,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,Intermediate,10116.0,N,7649,1,,1,A,,,10130,
,,CHEMBL627019,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,Intermediate,10116.0,N,7650,1,,1,A,,,10130,
,,CHEMBL627020,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,Intermediate,10116.0,N,7651,1,,1,A,,,10130,
,,CHEMBL627021,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,Intermediate,10116.0,N,7652,1,,1,A,,,10130,
,,CHEMBL627022,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,Intermediate,10116.0,N,7653,1,,1,A,,,10130,
,,CHEMBL627023,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,Intermediate,10116.0,N,7654,1,,1,A,,,10130,
,,CHEMBL627024,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,Intermediate,10116.0,N,7655,1,,1,A,,,10130,
,,CHEMBL627025,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,10116.0,N,7656,1,,1,A,,,10130,
,,CHEMBL627026,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,Intermediate,10116.0,N,7657,1,,1,A,,,10130,
,,CHEMBL627027,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,Intermediate,10116.0,N,7658,1,,1,A,,,10130,
,,CHEMBL627028,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,Intermediate,10116.0,N,7659,1,,1,A,,,10130,
,,CHEMBL627029,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,Intermediate,10116.0,N,7660,1,,1,A,,,10130,
,,CHEMBL627030,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,Intermediate,10116.0,N,7661,1,,1,A,,,10130,
,,CHEMBL627031,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,Intermediate,10116.0,N,7662,1,,1,A,,,10130,
,,CHEMBL627032,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,Intermediate,10116.0,N,7663,1,,1,A,,,10130,
,,CHEMBL627033,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,Intermediate,10116.0,N,7664,1,,1,A,,,10130,
,,CHEMBL627034,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,Intermediate,10116.0,N,7665,1,,1,A,,,10130,
,,CHEMBL627035,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,Intermediate,10116.0,N,7666,1,,1,A,,,10130,
,,CHEMBL627036,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,10116.0,N,7667,1,,1,A,,,10130,
,,CHEMBL875340,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,Intermediate,10116.0,N,7668,1,,1,A,,,10130,
,,CHEMBL627037,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,Intermediate,10116.0,N,7669,1,,1,A,,,10130,
,,CHEMBL627038,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,Intermediate,10116.0,N,7670,1,,1,A,,,10130,
,,CHEMBL627039,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,Intermediate,10116.0,N,7671,1,,1,A,,,10130,
,,CHEMBL627040,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,Intermediate,10116.0,N,7672,1,,1,A,,,10130,
,,CHEMBL624663,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,Intermediate,10116.0,N,7673,1,,1,A,,,10130,
,,CHEMBL625963,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,10116.0,N,7674,1,,1,A,,,10130,
,,CHEMBL876799,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,Intermediate,10116.0,N,7675,1,,1,A,,,10130,
,,CHEMBL626133,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,Intermediate,10116.0,N,7676,1,,1,A,,,10130,
,,CHEMBL626134,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,Intermediate,10116.0,N,7677,1,,1,A,,,10130,
,,CHEMBL626135,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Intermediate,10116.0,N,7678,1,,1,A,,,6295,
,,CHEMBL626136,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Intermediate,10116.0,N,7679,1,,1,A,,,6296,
,,CHEMBL626137,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,Intermediate,10116.0,N,7680,1,,1,A,,,6296,
,,CHEMBL626138,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Intermediate,10116.0,N,7681,1,,1,A,,,6295,
,,CHEMBL626139,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Intermediate,10116.0,N,7682,1,,1,A,,,6296,
In vivo,,CHEMBL626140,,50597,,BAO_0000218,Rattus norvegicus,,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,10116.0,N,7683,1,,1,A,,,17260,
In vivo,,CHEMBL626141,,50597,,BAO_0000218,Rattus norvegicus,,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,10116.0,N,7684,1,,1,A,,,17260,
,,CHEMBL626142,,50597,,BAO_0000218,Rattus norvegicus,,,C24h in rat p.o. at 20 mg/kg concentration,Intermediate,10116.0,N,7685,1,,1,A,,,17686,
In vivo,,CHEMBL627930,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,10116.0,N,7686,1,,1,A,,,9866,
In vivo,,CHEMBL627931,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,Intermediate,10116.0,N,7687,1,,1,A,,,9866,
In vivo,,CHEMBL627932,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,10116.0,N,7688,1,,1,A,,,9866,
In vivo,,CHEMBL627933,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,10116.0,N,7689,1,,1,A,,,9866,
In vivo,,CHEMBL627934,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,Intermediate,10116.0,N,7690,1,,1,A,,,9866,
In vivo,,CHEMBL627935,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,10116.0,N,7691,1,,1,A,,,9866,
In vivo,,CHEMBL627936,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,Intermediate,10116.0,N,7692,1,,1,A,,,9866,
In vivo,,CHEMBL627937,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,Intermediate,10116.0,N,7693,1,,1,A,,,9866,
In vivo,,CHEMBL627938,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,10116.0,N,7694,1,,1,A,,,9866,
In vivo,,CHEMBL627939,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,Intermediate,10116.0,N,7695,1,,1,A,,,9866,
In vivo,,CHEMBL627940,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,Intermediate,10116.0,N,7696,1,,1,A,,,9866,
In vivo,,CHEMBL627941,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,10116.0,N,7697,1,,1,A,,,9866,
In vivo,,CHEMBL876800,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,10116.0,N,7698,1,,1,A,,,9866,
In vivo,,CHEMBL627942,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,Intermediate,10116.0,N,7699,1,,1,A,,,9866,
In vivo,,CHEMBL627943,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,10116.0,N,7700,1,,1,A,,,9866,
In vivo,,CHEMBL627944,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,Intermediate,10116.0,N,7701,1,,1,A,,,9866,
In vivo,,CHEMBL627945,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,Intermediate,10116.0,N,7702,1,,1,A,,,9866,
In vivo,,CHEMBL628584,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,Intermediate,10116.0,N,7703,1,,1,A,,,9866,
In vivo,,CHEMBL628585,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,Intermediate,10116.0,N,7704,1,,1,A,,,9866,
In vivo,,CHEMBL628586,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,Intermediate,10116.0,N,7705,1,,1,A,,,9866,
In vivo,,CHEMBL628587,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,Intermediate,10116.0,N,7706,1,,1,A,,,9866,
In vivo,,CHEMBL628588,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,Intermediate,10116.0,N,7707,1,,1,A,,,9866,
In vivo,,CHEMBL628589,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,Intermediate,10116.0,N,7708,1,,1,A,,,9866,
In vivo,,CHEMBL625304,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,Intermediate,10116.0,N,7709,1,,1,A,,,9866,
In vivo,,CHEMBL625305,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,Intermediate,10116.0,N,7710,1,,1,A,,,9866,
In vivo,,CHEMBL625306,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,Intermediate,10116.0,N,7711,1,,1,A,,,9866,
In vivo,,CHEMBL625307,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,Intermediate,10116.0,N,7712,1,,1,A,,,9866,
In vivo,,CHEMBL625308,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,Intermediate,10116.0,N,7713,1,,1,A,,,9866,
In vivo,,CHEMBL627740,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,Intermediate,10116.0,N,7714,1,,1,A,,,9866,
In vivo,,CHEMBL627741,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,Intermediate,10116.0,N,7715,1,,1,A,,,9866,
In vivo,,CHEMBL627742,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,10116.0,N,7716,1,,1,A,,,9866,
In vivo,,CHEMBL627743,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,Intermediate,10116.0,N,7717,1,,1,A,,,9866,
In vivo,,CHEMBL627744,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,Intermediate,10116.0,N,7718,1,,1,A,,,9866,
In vivo,,CHEMBL627745,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,Intermediate,10116.0,N,7719,1,,1,A,,,9866,
In vivo,,CHEMBL627746,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,10116.0,N,7720,1,,1,A,,,9866,
In vivo,,CHEMBL627747,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,10116.0,N,7721,1,,1,A,,,9866,
In vivo,,CHEMBL876810,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,Intermediate,10116.0,N,7722,1,,1,A,,,9866,
In vivo,,CHEMBL627748,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,Intermediate,10116.0,N,7723,1,,1,A,,,9866,
In vivo,,CHEMBL627749,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,10116.0,N,7724,1,,1,A,,,9866,
In vivo,,CHEMBL627750,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,10116.0,N,7725,1,,1,A,,,9866,
In vivo,,CHEMBL618728,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,Intermediate,10116.0,N,7726,1,,1,A,,,9866,
In vivo,,CHEMBL618729,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,10116.0,N,7727,1,,1,A,,,9866,
In vivo,,CHEMBL618730,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,Intermediate,10116.0,N,7728,1,,1,A,,,9866,
In vivo,,CHEMBL618731,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,Intermediate,10116.0,N,7729,1,,1,A,,,9866,
In vivo,,CHEMBL618732,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,Intermediate,10116.0,N,7730,1,,1,A,,,9866,
In vivo,,CHEMBL618733,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,Intermediate,10116.0,N,7731,1,,1,A,,,9866,
In vivo,,CHEMBL618734,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,Intermediate,10116.0,N,7732,1,,1,A,,,9866,
In vivo,,CHEMBL618735,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,Intermediate,10116.0,N,7733,1,,1,A,,,9866,
In vivo,,CHEMBL876602,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,Intermediate,10116.0,N,7734,1,,1,A,,,9866,
In vivo,,CHEMBL618736,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,Intermediate,10116.0,N,7735,1,,1,A,,,9866,
In vivo,,CHEMBL618737,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,Intermediate,10116.0,N,7736,1,,1,A,,,9866,
In vivo,,CHEMBL618738,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,Intermediate,10116.0,N,7737,1,,1,A,,,9866,
In vivo,,CHEMBL618739,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,Intermediate,10116.0,N,7738,1,,1,A,,,9866,
In vivo,,CHEMBL618740,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,Intermediate,10116.0,N,7739,1,,1,A,,,9866,
In vivo,,CHEMBL618741,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,10116.0,N,7740,1,,1,A,,,9866,
In vivo,,CHEMBL618742,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,Intermediate,10116.0,N,7741,1,,1,A,,,9866,
In vivo,,CHEMBL618743,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,Intermediate,10116.0,N,7742,1,,1,A,,,9866,
In vivo,,CHEMBL618744,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life from rat plasma at a single oral dose of 25 mg/kg,Intermediate,10116.0,N,7743,1,,1,A,,,17752,
,,CHEMBL618745,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in male rat,Intermediate,10116.0,N,7744,1,,1,A,,,5610,
In vivo,,CHEMBL620479,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat after peroral administration at 10 mg/kg concentration,Intermediate,10116.0,N,7745,1,,1,A,,,5939,
In vivo,,CHEMBL620480,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat after peroral administration at 5 mg/kg concentration,Intermediate,10116.0,N,7746,1,,1,A,,,5939,
In vivo,,CHEMBL620481,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat at a dose of 3 mg/kg,Intermediate,10116.0,N,7747,1,,1,A,,,17771,
,,CHEMBL620482,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was evaluated in rats,Intermediate,10116.0,N,7748,1,,1,A,,,1974,
,,CHEMBL876603,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was measured in rat,Intermediate,10116.0,N,7749,1,,1,A,,,4239,
In vivo,,CHEMBL620483,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life period for the compound was determined in rats at 50 mg/kg dose,Intermediate,10116.0,N,7750,1,,1,A,,,6681,
In vivo,,CHEMBL620484,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life period in rats after intravenous administration at 5 mg/kg,Intermediate,10116.0,N,7751,1,,1,A,,,17752,
In vivo,,CHEMBL620485,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life period in rat at 10 mg/kg,Intermediate,10116.0,N,7752,1,,1,A,,,6046,
In vivo,,CHEMBL620486,,50597,,BAO_0000218,Rattus norvegicus,,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",Intermediate,10116.0,N,7753,1,,1,A,,,6685,
In vivo,,CHEMBL620487,,50597,,BAO_0000218,Rattus norvegicus,,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",Intermediate,10116.0,N,7754,1,,1,A,,,6685,
In vivo,,CHEMBL620488,,50597,,BAO_0000218,Rattus norvegicus,,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",Intermediate,10116.0,N,7755,1,,1,A,,,6685,
In vivo,,CHEMBL620489,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life time in rat the dose of 2 mg/kg,Intermediate,10116.0,N,7756,1,,1,A,,,4727,
In vivo,,CHEMBL620490,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,Intermediate,10116.0,N,7757,1,,1,A,,,1088,
In vivo,,CHEMBL620491,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,Intermediate,10116.0,N,7758,1,,1,A,,,5610,
In vivo,,CHEMBL876604,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Intermediate,10116.0,N,7759,1,,1,A,,,3032,
In vivo,,CHEMBL620492,,50597,,BAO_0000218,Rattus norvegicus,,,Oral half life was determined,Intermediate,10116.0,N,7760,1,,1,A,,,5199,
In vivo,,CHEMBL620493,,50597,,BAO_0000218,Rattus norvegicus,,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,10116.0,N,7761,1,,1,A,,,14941,
In vivo,,CHEMBL620494,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (t1/2) in rat,Intermediate,10116.0,N,7762,1,,1,A,,,4408,
,,CHEMBL620495,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma elimination half-life was determined,Intermediate,10116.0,N,7763,1,,1,A,,,2552,
In vivo,,CHEMBL620496,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,10116.0,N,7764,1,,1,A,,,5199,
In vivo,,CHEMBL620497,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half life was observed after intravenous administration in rat,Intermediate,10116.0,N,7765,1,,1,A,,,15662,
,,CHEMBL620498,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life was determined,Intermediate,10116.0,N,7766,1,,1,A,,,1465,
In vivo,,CHEMBL620499,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life following oral administration in Fisher rats,Intermediate,10116.0,N,7767,1,,1,A,,,1446,
,,CHEMBL620500,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life in rat,Intermediate,10116.0,N,7768,1,,1,A,,,6824,
In vivo,,CHEMBL873809,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasmatic Half-life after intravenous administration to rat,Intermediate,10116.0,N,7769,1,,1,A,,,17533,
In vivo,,CHEMBL620501,,50597,,BAO_0000218,Rattus norvegicus,,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Intermediate,10116.0,N,7770,1,,1,A,,,5979,
In vivo,,CHEMBL620502,,50597,,BAO_0000218,Rattus norvegicus,,,Terminal half life after intravenous administration (1 mg/kg) in rat,Intermediate,10116.0,N,7771,1,,1,A,,,4689,
In vivo,,CHEMBL620503,,50597,,BAO_0000218,Rattus norvegicus,,,Terminal half life in Rat at a oral dose of 5 mg/kg,Intermediate,10116.0,N,7772,1,,1,A,,,4689,
In vivo,,CHEMBL620504,,50597,,BAO_0000218,Rattus norvegicus,,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Intermediate,10116.0,N,7773,1,,1,A,,,2463,
In vivo,,CHEMBL876605,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,Intermediate,10116.0,N,7774,1,,1,A,,,4883,
In vivo,,CHEMBL620505,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,Intermediate,10116.0,N,7775,1,,1,A,,,4883,
In vivo,,CHEMBL873811,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,plasma half life was observed after intravenous administration in rat,Intermediate,10116.0,N,7776,1,,1,A,,,15662,
In vivo,,CHEMBL624016,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,10116.0,N,7777,1,,1,A,,,3598,
,,CHEMBL624017,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound determined in rat,Intermediate,10116.0,N,7778,1,,1,A,,,4576,
,,CHEMBL624018,,50597,,BAO_0000218,Rattus norvegicus,,,Mean residence time determined in rat,Intermediate,10116.0,N,7779,1,,1,A,,,4576,
,,CHEMBL624019,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma half life determined in rat,Intermediate,10116.0,N,7780,1,,1,A,,,4576,
In vivo,,CHEMBL624020,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,Intermediate,10116.0,N,7781,1,,1,A,,,4910,
In vivo,,CHEMBL624201,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for pharmacokinetic parameter maximum time period,Intermediate,10116.0,N,7782,1,,1,A,,,4891,
In vivo,,CHEMBL872528,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Intermediate,10116.0,N,7783,1,,1,A,,,429,
In vivo,,CHEMBL624202,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,7784,1,,1,A,,,5974,
In vivo,,CHEMBL624203,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,7785,1,,1,A,,,5974,
In vivo,,CHEMBL624350,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,7786,1,,1,A,,,5974,
In vivo,,CHEMBL621320,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,7787,1,,1,A,,,5974,
In vivo,,CHEMBL621321,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,10116.0,N,7788,1,,1,A,,,17582,
,,CHEMBL621322,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum time (Tmax) required to reach Cmax in rats,Intermediate,10116.0,N,7789,1,,1,A,,,4026,
In vivo,,CHEMBL621323,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,10116.0,N,7790,1,,1,A,,,4890,
In vivo,,CHEMBL621324,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum time of clearance of compound in rats after peroral administration,Intermediate,10116.0,N,7791,1,,1,A,,,6571,
,,CHEMBL621325,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum time at the dose of 2 mg/kg in rat,Intermediate,10116.0,N,7792,1,,1,A,,,4727,
In vivo,,CHEMBL875837,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,Intermediate,10116.0,N,7793,1,,1,A,,,17651,
In vivo,,CHEMBL621326,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,Intermediate,10116.0,N,7794,1,,1,A,,,17651,
In vivo,,CHEMBL621327,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax in Guinea pig (PO dose),Intermediate,10116.0,N,7795,1,,1,A,,,14465,
In vivo,,CHEMBL621328,,50597,,BAO_0000218,Rattus norvegicus,,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,10116.0,N,7796,1,,1,A,,,14941,
In vivo,,CHEMBL621329,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter (Tmax) in rat,Intermediate,10116.0,N,7797,1,,1,A,,,5960,
In vivo,,CHEMBL621330,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter (Tmax) was estimated,Intermediate,10116.0,N,7798,1,,1,A,,,5022,
In vivo,,CHEMBL621331,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Tmax) in rat,Intermediate,10116.0,N,7799,1,,1,A,,,4408,
In vivo,,CHEMBL621332,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,10116.0,N,7800,1,,1,A,,,5983,
In vivo,,CHEMBL621333,,50597,,BAO_0000218,Rattus norvegicus,,,T max in Rat at a oral dose of 5 mg/kg,Intermediate,10116.0,N,7801,1,,1,A,,,4689,
In vivo,,CHEMBL621334,,50597,,BAO_0000218,Rattus norvegicus,,,T max was determined at 10 mg/kg po dose in rats,Intermediate,10116.0,N,7802,1,,1,A,,,2792,
,,CHEMBL621335,,50594,,BAO_0000218,Mus musculus,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),Intermediate,10090.0,N,7803,1,,1,A,,,15011,
,,CHEMBL621336,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,Intermediate,9615.0,N,7804,1,,1,A,,,14180,
,,CHEMBL621337,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,Intermediate,10116.0,N,7805,1,,1,A,,,14180,
,,CHEMBL621338,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve was measured after i.v. administration into Beagle dog.,Intermediate,9615.0,N,7806,1,,1,A,,,14599,
,,CHEMBL875838,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve was measured after iv administration into Beagle dog,Intermediate,9615.0,N,7807,1,,1,A,,,14599,
,,CHEMBL621339,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve was measured after po administration into Beagle dog,Intermediate,9615.0,N,7808,1,,1,A,,,14599,
,,CHEMBL621340,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve was measured after po administration into Beagle dog.,Intermediate,9615.0,N,7809,1,,1,A,,,14599,
,,CHEMBL621341,,22224,,BAO_0000218,,,,Area under curve was measured at peroral dose of 3 mg/kg,Autocuration,,U,7810,1,,0,A,,,15675,
,,CHEMBL621342,,22224,,BAO_0000019,,,,Area under curve was measured by using concentration Vs time,Autocuration,,U,7811,1,,0,A,,,12706,
,,CHEMBL621343,,22224,,BAO_0000019,,,,Area under curve was measured by using concentration Vs time; not tested,Autocuration,,U,7812,1,,0,A,,,12706,
,,CHEMBL621344,,50594,,BAO_0000218,Mus musculus,,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),Intermediate,10090.0,N,7813,1,,1,A,,,9750,
,,CHEMBL621345,,50594,,BAO_0000218,Mus musculus,,,Area under curve(AUC) was measured in mice after oral administration.,Intermediate,10090.0,N,7814,1,,1,A,,,9750,
,,CHEMBL621346,,22224,,BAO_0000019,,,,Area under curve(AUC) value of the compound,Autocuration,,U,7815,1,,0,A,,,14691,
,,CHEMBL621347,,22224,,BAO_0000218,,,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,Autocuration,,U,7816,1,,0,A,,,14691,
,,CHEMBL621348,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,Intermediate,9615.0,N,7817,1,,1,A,,,14691,
,,CHEMBL621349,,22224,Blood,BAO_0000019,,178.0,,Area under curve(carotid artery) was determined by the availability in blood,Autocuration,,U,7818,1,,0,A,,,2939,
,,CHEMBL621350,,22224,Blood,BAO_0000019,,178.0,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,Autocuration,,U,7819,1,,0,A,,,2939,
,,CHEMBL875839,,22224,Blood,BAO_0000019,,178.0,,Area under curve(carotid artery) was determined by the availability in blood; No data,Autocuration,,U,7820,1,,0,A,,,2939,
,,CHEMBL620211,,22224,Blood,BAO_0000019,,178.0,,Area under curve(portal vein) was determined by the availability in blood,Autocuration,,U,7821,1,,0,A,,,2939,
,,CHEMBL620212,,22224,Blood,BAO_0000019,,178.0,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,Autocuration,,U,7822,1,,0,A,,,2939,
,,CHEMBL620213,,22224,Blood,BAO_0000019,,178.0,,Area under curve(portal vein) was determined by the availability in blood; No data,Autocuration,,U,7823,1,,0,A,,,2939,
,,CHEMBL620214,,50797,Plasma,BAO_0000218,Macaca mulatta,1969.0,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Intermediate,9544.0,N,7824,1,,1,A,,,9552,
,,CHEMBL620215,,50797,Plasma,BAO_0000218,Macaca mulatta,1969.0,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Intermediate,9544.0,N,7825,1,,1,A,,,9552,
,,CHEMBL620216,,50797,Plasma,BAO_0000218,Macaca mulatta,1969.0,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,Intermediate,9544.0,N,7826,1,,1,A,,,9552,
,,CHEMBL620888,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",Intermediate,9615.0,N,7827,1,,1,A,,,9552,
,,CHEMBL620889,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",Intermediate,9615.0,N,7828,1,,1,A,,,9552,
,,CHEMBL620890,,22224,Plasma,BAO_0000019,,1969.0,,Area under plasma concentration vs time curve observed in rats for 0-3 h,Autocuration,,U,7829,1,,0,A,,,9552,
,,CHEMBL620891,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under plasma time curve determined in male rat,Intermediate,10116.0,N,7830,1,,1,A,,,11911,
,,CHEMBL620892,,22224,,BAO_0000019,,,,Area under the MAP curve measured over 5 min.,Autocuration,,U,7831,1,,0,A,,,16618,
,,CHEMBL621079,,50594,,BAO_0000218,Mus musculus,,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,Intermediate,10090.0,N,7832,1,,1,A,,,14387,
,,CHEMBL621080,,50594,,BAO_0000218,Mus musculus,,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,Intermediate,10090.0,N,7833,1,,1,A,,,14387,
,,CHEMBL621081,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,Intermediate,9615.0,N,7834,1,,1,A,,,12836,
,,CHEMBL621082,,100712,,BAO_0000218,Cricetinae,,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,Intermediate,10026.0,N,7835,1,,1,A,,,12836,
,,CHEMBL621083,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,Intermediate,10116.0,N,7836,1,,1,A,,,12836,
,,CHEMBL621084,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,Intermediate,9615.0,N,7837,1,,1,A,,,14339,
,,CHEMBL621085,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,Intermediate,9615.0,N,7838,1,,1,A,,,14339,
,,CHEMBL621086,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,Intermediate,9615.0,N,7839,1,,1,A,,,14339,
,,CHEMBL621087,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Intermediate,9615.0,N,7840,1,,1,A,,,10524,
,,CHEMBL622607,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),Intermediate,9615.0,N,7841,1,,1,A,,,9994,
,,CHEMBL622608,,50588,,BAO_0000218,Canis lupus familiaris,,,Serum AUC in marmosets (IV dose),Intermediate,9615.0,N,7842,1,,1,A,,,11325,
,,CHEMBL624481,,22224,,BAO_0000019,,,,Area under the curve after intravenous administration at a dose of 10 umol/kg,Autocuration,,U,7843,1,,0,A,,,12536,
,,CHEMBL624482,,22224,,BAO_0000019,,,,Area under the curve after intravenous administration at a dose of 2 umol/kg,Autocuration,,U,7844,1,,0,A,,,12536,
,,CHEMBL624483,,22224,,BAO_0000019,,,,Area under the curve after intravenous administration at a dose of 4 umol/kg,Autocuration,,U,7845,1,,0,A,,,12536,
,,CHEMBL624484,,22224,,BAO_0000019,,,,Area under the curve after intravenous administration at a dose of 40 umol/kg,Autocuration,,U,7846,1,,0,A,,,12536,
,,CHEMBL624485,,22224,,BAO_0000019,,,,Area under the curve after intravenous administration at a dose of 5 umol/kg,Autocuration,,U,7847,1,,0,A,,,12536,
,,CHEMBL624486,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve for fumarate salt was evaluated in F344 Rats.,Intermediate,10116.0,N,7848,1,,1,A,,,15556,
,,CHEMBL624487,,22224,,BAO_0000019,,,,Area under the curve for the compound was calculated.,Autocuration,,U,7849,1,,0,A,,,2809,
,,CHEMBL624488,,22224,,BAO_0000019,,,,Area under the curve in concentration/ time,Autocuration,,U,7850,1,,0,A,,,9511,
,,CHEMBL624489,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve administered intraintestinal in rats.,Intermediate,10116.0,N,7851,1,,1,A,,,12818,
,,CHEMBL625184,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve administered intravenously in rats.,Intermediate,10116.0,N,7852,1,,1,A,,,12818,
,,CHEMBL625185,,22224,,BAO_0000019,,,,Area under the curve during intravenous administration,Autocuration,,U,7853,1,,0,A,,,15118,
,,CHEMBL875954,,22224,,BAO_0000019,,,,Area under the curve during intravenous administration; Not determined,Autocuration,,U,7854,1,,0,A,,,15118,
,,CHEMBL625186,,22224,,BAO_0000019,,,,Area under the curve during systemic administration,Autocuration,,U,7855,1,,0,A,,,15118,
,,CHEMBL625187,,22224,,BAO_0000019,,,,Area under the curve during systemic administration; Not determined,Autocuration,,U,7856,1,,0,A,,,15118,
,,CHEMBL625188,,22224,,BAO_0000019,,,,Area under the curve was calculated for the compound.,Autocuration,,U,7857,1,,0,A,,,2632,
,,CHEMBL625189,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,Intermediate,9615.0,N,7858,1,,1,A,,,14346,
,,CHEMBL625190,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,Intermediate,9615.0,N,7859,1,,1,A,,,14346,
,,CHEMBL621733,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,Intermediate,10116.0,N,7860,1,,1,A,,,14346,
,,CHEMBL621734,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,Intermediate,10116.0,N,7861,1,,1,A,,,14346,
,,CHEMBL621735,,50597,,BAO_0000218,Rattus norvegicus,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,Intermediate,10116.0,N,7862,1,,1,A,,,11149,
,,CHEMBL621736,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Clearance of the drug was measured in the plasma of rat; No data,Intermediate,10116.0,N,7863,1,,1,A,,,17796,
,,CHEMBL621737,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The pharmacokinetic parameter plasma clearance in vivo in rats,Intermediate,10116.0,N,7864,1,,1,A,,,5247,
,,CHEMBL621738,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance at the dose of 2 mg/kg in rat,Intermediate,10116.0,N,7865,1,,1,A,,,4727,
In vivo,,CHEMBL622806,,50597,,BAO_0000218,Rattus norvegicus,,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,10116.0,N,7866,1,,1,A,,,5654,
In vivo,,CHEMBL623519,,50597,,BAO_0000218,Rattus norvegicus,,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,10116.0,N,7867,1,,1,A,,,5654,
In vivo,,CHEMBL623520,,50597,,BAO_0000218,Rattus norvegicus,,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,10116.0,N,7868,1,,1,A,,,17260,
In vivo,,CHEMBL623521,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,10116.0,N,7869,1,,1,A,,,17065,
In vivo,,CHEMBL623522,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,10116.0,N,7870,1,,1,A,,,17671,
In vivo,,CHEMBL623523,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance rate in rat,Intermediate,10116.0,N,7871,1,,1,A,,,6672,
In vivo,,CHEMBL623690,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance rate in rat,Intermediate,10116.0,N,7872,1,,1,A,,,6673,
In vivo,,CHEMBL623691,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,7873,1,,1,A,,,5978,
In vivo,,CHEMBL623692,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,7874,1,,1,A,,,5978,
In vivo,,CHEMBL623693,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,7875,1,,1,A,,,5978,
In vivo,,CHEMBL623694,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,7876,1,,1,A,,,5978,
In vivo,,CHEMBL623695,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance of compound after iv administration of 20 mg/kg dose in rat,Intermediate,10116.0,N,7877,1,,1,A,,,4413,
In vivo,,CHEMBL623696,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,10116.0,N,7878,1,,1,A,,,2661,
In vivo,,CHEMBL623697,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,10116.0,N,7879,1,,1,A,,,2661,
In vivo,,CHEMBL623698,,22224,Plasma,BAO_0000218,Macaca mulatta,1969.0,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Intermediate,9544.0,U,7880,1,,0,A,,,5005,
In vivo,,CHEMBL623699,,22224,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,Intermediate,10116.0,U,7881,1,,0,A,,,5005,
In vivo,,CHEMBL623700,,50597,,BAO_0000218,Rattus norvegicus,,,Mean (%CV) PK parameters for CL(mL/min/kg).,Intermediate,10116.0,N,7882,1,,1,A,,,15765,
In vivo,,CHEMBL623701,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,Intermediate,10116.0,N,7883,1,,1,A,,,3747,
In vivo,,CHEMBL623702,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,Intermediate,10116.0,N,7884,1,,1,A,,,16366,
In vivo,,CHEMBL623703,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,Intermediate,10116.0,N,7885,1,,1,A,,,4199,
In vivo,,CHEMBL623704,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat was determined,Intermediate,10116.0,N,7886,1,,1,A,,,17267,
In vivo,,CHEMBL623705,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat after administration of 2 mg/kg iv,Intermediate,10116.0,N,7887,1,,1,A,,,6535,
In vivo,,CHEMBL623706,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat after administration of 2 mg/kg iv,Intermediate,10116.0,N,7888,1,,1,A,,,6535,
In vivo,,CHEMBL623707,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was determined,Intermediate,10116.0,N,7889,1,,1,A,,,5041,
In vivo,,CHEMBL623708,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat,Intermediate,10116.0,N,7890,1,,1,A,,,5960,
In vivo,,CHEMBL623709,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,Intermediate,10116.0,N,7891,1,,1,A,,,5937,
In vivo,,CHEMBL623710,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat by iv administration,Intermediate,10116.0,N,7892,1,,1,A,,,5871,
In vivo,,CHEMBL623711,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,Intermediate,10116.0,N,7893,1,,1,A,,,5874,
In vivo,,CHEMBL623712,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat p.o.,Intermediate,10116.0,N,7894,1,,1,A,,,6504,
In vivo,,CHEMBL623713,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rats,Intermediate,10116.0,N,7895,1,,1,A,,,6803,
In vivo,,CHEMBL623714,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was determined; ND denotes no data,Intermediate,10116.0,N,7896,1,,1,A,,,5041,
In vivo,,CHEMBL623715,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was determined; ND denotes not determined,Intermediate,10116.0,N,7897,1,,1,A,,,5041,
In vivo,,CHEMBL623716,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,10116.0,N,7898,1,,1,A,,,1916,
In vivo,,CHEMBL622980,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,10116.0,N,7899,1,,1,A,,,5199,
In vivo,,CHEMBL622981,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma administration to rats,Intermediate,10116.0,N,7900,1,,1,A,,,16367,
In vivo,,CHEMBL622982,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance of the compound in female Sprague-Dawley rats,Intermediate,10116.0,N,7901,1,,1,A,,,6362,
In vivo,,CHEMBL622983,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was observed after intravenous administration in rat,Intermediate,10116.0,N,7902,1,,1,A,,,15662,
In vivo,,CHEMBL622984,,50597,,BAO_0000218,Rattus norvegicus,,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,10116.0,N,7903,1,,1,A,,,6215,
In vivo,,CHEMBL622985,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,10116.0,N,7904,1,,1,A,,,1466,
In vivo,,CHEMBL623631,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,plasma clearance was observed after intravenous administration in rat,Intermediate,10116.0,N,7905,1,,1,A,,,15662,
In vivo,,CHEMBL623632,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo CL/F determined,Intermediate,10116.0,N,7906,1,,1,A,,,4723,
In vivo,,CHEMBL623633,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,Intermediate,10116.0,N,7907,1,,1,A,,,2792,
In vivo,,CHEMBL623634,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,Intermediate,10116.0,N,7908,1,,1,A,,,2792,
In vivo,,CHEMBL623635,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for the lower blood clearance in rat,Intermediate,10116.0,N,7909,1,,1,A,,,5213,
In vivo,,CHEMBL621195,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for the low clearance in rat (in vivo),Intermediate,10116.0,N,7910,1,,1,A,,,4687,
In vivo,,CHEMBL621196,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (CLb)of the compound was determined in rat,Intermediate,10116.0,N,7911,1,,1,A,,,3371,
In vivo,,CHEMBL875287,,50597,,BAO_0000218,Rattus norvegicus,,,Rapid clearance after intravenous administration in rat was determined,Intermediate,10116.0,N,7912,1,,1,A,,,4690,
In vivo,,CHEMBL621197,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance measured in rat,Intermediate,10116.0,N,7913,1,,1,A,,,5702,
In vivo,,CHEMBL621198,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was evaluated for plasma clearance in rat,Intermediate,10116.0,N,7914,1,,1,A,,,740,
In vivo,,CHEMBL621199,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Low plasma clearance was calculated in rat,Intermediate,10116.0,N,7915,1,,1,A,,,4853,
In vivo,,CHEMBL621200,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Clp) in rat,Intermediate,10116.0,N,7916,1,,1,A,,,5789,
In vivo,,CHEMBL621201,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,Intermediate,10116.0,N,7917,1,,1,A,,,4527,
In vivo,,CHEMBL621202,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,Intermediate,10116.0,N,7918,1,,1,A,,,4527,
In vivo,,CHEMBL621203,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,Intermediate,10116.0,N,7919,1,,1,A,,,6518,
In vivo,,CHEMBL621204,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance after IV dosing at 1 mg/kg in rat,Intermediate,10116.0,N,7920,1,,1,A,,,6518,
In vivo,,CHEMBL621205,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,Intermediate,10116.0,N,7921,1,,1,A,,,9866,
In vivo,,CHEMBL621206,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,Intermediate,10116.0,N,7922,1,,1,A,,,9866,
In vivo,,CHEMBL621207,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,10116.0,N,7923,1,,1,A,,,9866,
In vivo,,CHEMBL621208,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,Intermediate,10116.0,N,7924,1,,1,A,,,9866,
In vivo,,CHEMBL621209,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,Intermediate,10116.0,N,7925,1,,1,A,,,9866,
In vivo,,CHEMBL876484,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,Intermediate,10116.0,N,7926,1,,1,A,,,9866,
In vivo,,CHEMBL621210,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,10116.0,N,7927,1,,1,A,,,9866,
In vivo,,CHEMBL621211,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,Intermediate,10116.0,N,7928,1,,1,A,,,9866,
In vivo,,CHEMBL621212,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,10116.0,N,7929,1,,1,A,,,9866,
In vivo,,CHEMBL621213,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,Intermediate,10116.0,N,7930,1,,1,A,,,9866,
In vivo,,CHEMBL621214,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,Intermediate,10116.0,N,7931,1,,1,A,,,9866,
In vivo,,CHEMBL621215,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,Intermediate,10116.0,N,7932,1,,1,A,,,9866,
In vivo,,CHEMBL621216,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,Intermediate,10116.0,N,7933,1,,1,A,,,9866,
In vivo,,CHEMBL621217,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,Intermediate,10116.0,N,7934,1,,1,A,,,9866,
In vivo,,CHEMBL621218,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,Intermediate,10116.0,N,7935,1,,1,A,,,9866,
In vivo,,CHEMBL621219,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,Intermediate,10116.0,N,7936,1,,1,A,,,9866,
In vivo,,CHEMBL621220,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,Intermediate,10116.0,N,7937,1,,1,A,,,9866,
In vivo,,CHEMBL621221,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,Intermediate,10116.0,N,7938,1,,1,A,,,9866,
In vivo,,CHEMBL621222,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,Intermediate,10116.0,N,7939,1,,1,A,,,9866,
In vivo,,CHEMBL621223,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,Intermediate,10116.0,N,7940,1,,1,A,,,9866,
In vivo,,CHEMBL876485,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,Intermediate,10116.0,N,7941,1,,1,A,,,9866,
In vivo,,CHEMBL621224,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,10116.0,N,7942,1,,1,A,,,9866,
In vivo,,CHEMBL621225,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,Intermediate,10116.0,N,7943,1,,1,A,,,9866,
In vivo,,CHEMBL621226,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,Intermediate,10116.0,N,7944,1,,1,A,,,9866,
In vivo,,CHEMBL621227,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,Intermediate,10116.0,N,7945,1,,1,A,,,9866,
In vivo,,CHEMBL621228,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,10116.0,N,7946,1,,1,A,,,9866,
In vivo,,CHEMBL621229,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,10116.0,N,7947,1,,1,A,,,9866,
In vivo,,CHEMBL621230,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,Intermediate,10116.0,N,7948,1,,1,A,,,9866,
In vivo,,CHEMBL621231,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,Intermediate,10116.0,N,7949,1,,1,A,,,9866,
In vivo,,CHEMBL621232,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,10116.0,N,7950,1,,1,A,,,9866,
In vivo,,CHEMBL621233,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,10116.0,N,7951,1,,1,A,,,9866,
In vivo,,CHEMBL621234,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,Intermediate,10116.0,N,7952,1,,1,A,,,9866,
In vivo,,CHEMBL621235,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Intermediate,10116.0,N,7953,1,,1,A,,,9866,
In vivo,,CHEMBL621236,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,10116.0,N,7954,1,,1,A,,,9866,
In vivo,,CHEMBL621237,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,Intermediate,10116.0,N,7955,1,,1,A,,,9866,
In vivo,,CHEMBL876486,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,Intermediate,10116.0,N,7956,1,,1,A,,,9866,
In vivo,,CHEMBL622436,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,Intermediate,10116.0,N,7957,1,,1,A,,,9866,
In vivo,,CHEMBL622437,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,Intermediate,10116.0,N,7958,1,,1,A,,,9866,
In vivo,,CHEMBL622438,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,Intermediate,10116.0,N,7959,1,,1,A,,,9866,
In vivo,,CHEMBL622439,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,Intermediate,10116.0,N,7960,1,,1,A,,,9866,
In vivo,,CHEMBL622440,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,Intermediate,10116.0,N,7961,1,,1,A,,,9866,
In vivo,,CHEMBL622441,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,Intermediate,10116.0,N,7962,1,,1,A,,,9866,
In vivo,,CHEMBL622442,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,Intermediate,10116.0,N,7963,1,,1,A,,,9866,
In vivo,,CHEMBL622443,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,Intermediate,10116.0,N,7964,1,,1,A,,,9866,
In vivo,,CHEMBL622444,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,10116.0,N,7965,1,,1,A,,,9866,
In vivo,,CHEMBL622445,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,Intermediate,10116.0,N,7966,1,,1,A,,,9866,
In vivo,,CHEMBL622446,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,10116.0,N,7967,1,,1,A,,,9866,
In vivo,,CHEMBL622447,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,10116.0,N,7968,1,,1,A,,,9866,
In vivo,,CHEMBL622448,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,Intermediate,10116.0,N,7969,1,,1,A,,,9866,
In vivo,,CHEMBL622449,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Intermediate,10116.0,N,7970,1,,1,A,,,9866,
In vivo,,CHEMBL622450,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,Intermediate,10116.0,N,7971,1,,1,A,,,9866,
In vivo,,CHEMBL622451,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,Intermediate,10116.0,N,7972,1,,1,A,,,9866,
In vivo,,CHEMBL622452,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,Intermediate,10116.0,N,7973,1,,1,A,,,9866,
In vivo,,CHEMBL622453,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,Intermediate,10116.0,N,7974,1,,1,A,,,9866,
In vivo,,CHEMBL622454,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,Intermediate,10116.0,N,7975,1,,1,A,,,9866,
In vivo,,CHEMBL622455,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,Intermediate,10116.0,N,7976,1,,1,A,,,9866,
In vivo,,CHEMBL876024,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,Intermediate,10116.0,N,7977,1,,1,A,,,9866,
In vivo,,CHEMBL622456,,50597,,BAO_0000218,Rattus norvegicus,,,T max was determined at 3 mg/kg po dose in rats,Intermediate,10116.0,N,7978,1,,1,A,,,2792,
In vivo,,CHEMBL622457,,50597,,BAO_0000218,Rattus norvegicus,,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,7979,1,,1,A,,,15078,
In vivo,,CHEMBL622458,,50597,,BAO_0000218,Rattus norvegicus,,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,7980,1,,1,A,,,15078,
,,CHEMBL622459,,50597,,BAO_0000218,Rattus norvegicus,,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,Intermediate,10116.0,N,7981,1,,1,A,,,15022,
,,CHEMBL873343,,50597,,BAO_0000218,Rattus norvegicus,,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,Intermediate,10116.0,N,7982,1,,1,A,,,15022,
,,CHEMBL622460,,50597,,BAO_0000218,Rattus norvegicus,,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,Intermediate,10116.0,N,7983,1,,1,A,,,15022,
,,CHEMBL622461,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Time for maximum plasma concentration determined in rat,Intermediate,10116.0,N,7984,1,,1,A,,,4576,
In vivo,,CHEMBL622462,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Intermediate,10116.0,N,7985,1,,1,A,,,6681,
In vivo,,CHEMBL622463,,50597,,BAO_0000218,Rattus norvegicus,,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,Intermediate,10116.0,N,7986,1,,1,A,,,16365,
In vivo,,CHEMBL622464,,50597,,BAO_0000218,Rattus norvegicus,,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,Intermediate,10116.0,N,7987,1,,1,A,,,16365,
In vivo,,CHEMBL622465,,50597,,BAO_0000218,Rattus norvegicus,,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,Intermediate,10116.0,N,7988,1,,1,A,,,16365,
In vivo,,CHEMBL622466,,50597,,BAO_0000218,Rattus norvegicus,,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,Intermediate,10116.0,N,7989,1,,1,A,,,16365,
In vivo,,CHEMBL622467,,50597,,BAO_0000218,Rattus norvegicus,,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,Intermediate,10116.0,N,7990,1,,1,A,,,16365,
,,CHEMBL622468,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Time of maximum plasma concentration in rat,Intermediate,10116.0,N,7991,1,,1,A,,,6824,
,,CHEMBL876025,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Intermediate,10116.0,N,7992,1,,1,A,,,6685,
,,CHEMBL622469,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Intermediate,10116.0,N,7993,1,,1,A,,,6685,
,,CHEMBL622470,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,10116.0,N,7994,1,,1,A,,,6685,
In vivo,,CHEMBL622471,,50597,,BAO_0000218,Rattus norvegicus,,,Time required to reach maximum concentration (Cmax) after oral administration in rat,Intermediate,10116.0,N,7995,1,,1,A,,,15662,
,,CHEMBL622472,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Time required to reach maximum concentration in rat plasma,Intermediate,10116.0,N,7996,1,,1,A,,,1742,
In vivo,,CHEMBL622473,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Intermediate,10116.0,N,7997,1,,1,A,,,2774,
In vivo,,CHEMBL624282,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Intermediate,10116.0,N,7998,1,,1,A,,,5199,
In vivo,,CHEMBL624283,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,10116.0,N,7999,1,,1,A,,,12873,
In vivo,,CHEMBL624284,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,10116.0,N,8000,1,,1,A,,,12873,
In vivo,,CHEMBL624285,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,10116.0,N,8001,1,,1,A,,,1916,
In vivo,,CHEMBL624286,,50597,,BAO_0000218,Rattus norvegicus,,,Time to reach Cmax after oral administration to rats,Intermediate,10116.0,N,8002,1,,1,A,,,16367,
In vivo,,CHEMBL624287,,50597,,BAO_0000218,Rattus norvegicus,,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,Intermediate,10116.0,N,8003,1,,1,A,,,16366,
,,CHEMBL624288,,50597,,BAO_0000218,Rattus norvegicus,,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,Intermediate,10116.0,N,8004,1,,1,A,,,216,
In vivo,,CHEMBL624289,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,10116.0,N,8005,1,,1,A,,,6410,
In vivo,,CHEMBL873344,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,Intermediate,10116.0,N,8006,1,,1,A,,,6410,
In vivo,,CHEMBL619623,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax after peroral administration (10 mg/kg) was determined in rat,Intermediate,10116.0,N,8007,1,,1,A,,,6215,
In vivo,,CHEMBL621399,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,10116.0,N,8008,1,,1,A,,,3598,
In vivo,,CHEMBL621400,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,10116.0,N,8009,1,,1,A,,,4527,
In vivo,,CHEMBL621401,,50597,,BAO_0000218,Rattus norvegicus,,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,10116.0,N,8010,1,,1,A,,,17670,
,,CHEMBL621402,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax was determined,Intermediate,10116.0,N,8011,1,,1,A,,,1465,
,,CHEMBL621403,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax was determined,Intermediate,10116.0,N,8012,1,,1,A,,,2552,
In vivo,,CHEMBL621121,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax after oral administration in rat,Intermediate,10116.0,N,8013,1,,1,A,,,5656,
In vivo,,CHEMBL872525,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax after peroral administration in rats at 2.4 uM/kg,Intermediate,10116.0,N,8014,1,,1,A,,,17764,
,,CHEMBL621122,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax in male rat,Intermediate,10116.0,N,8015,1,,1,A,,,5610,
In vivo,,CHEMBL621123,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax in rat at 10 mg/kg,Intermediate,10116.0,N,8016,1,,1,A,,,6046,
In vivo,,CHEMBL621124,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax in rat by po administration at a dose of 40 mg/kg,Intermediate,10116.0,N,8017,1,,1,A,,,5874,
,,CHEMBL621125,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax in rats,Intermediate,10116.0,N,8018,1,,1,A,,,17596,
In vivo,,CHEMBL621126,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax was measured in rats after peroral administration at 5 mg/kg,Intermediate,10116.0,N,8019,1,,1,A,,,17804,
In vivo,,CHEMBL621127,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,10116.0,N,8020,1,,1,A,,,1908,
In vivo,,CHEMBL621128,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax value after administration of 20 mg/Kg oral dose in rat,Intermediate,10116.0,N,8021,1,,1,A,,,2959,
In vivo,,CHEMBL618263,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax value at a dose of 10 mg/kg in male SD rats,Intermediate,10116.0,N,8022,1,,1,A,,,6757,
In vivo,,CHEMBL618264,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax value at a dose of 100 mg/kg in male SD rats,Intermediate,10116.0,N,8023,1,,1,A,,,6757,
In vivo,,CHEMBL618265,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax value at a dose of 50 mg/kg in male SD rats,Intermediate,10116.0,N,8024,1,,1,A,,,6757,
In vivo,,CHEMBL618266,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,10116.0,N,8025,1,,1,A,,,4186,
In vivo,,CHEMBL618267,,50597,,BAO_0000218,Rattus norvegicus,,,time required to reach maximum concentration (Cmax) after oral administration in rat,Intermediate,10116.0,N,8026,1,,1,A,,,15662,
,,CHEMBL618450,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),Intermediate,10116.0,N,8027,1,,1,A,,,429,
,,CHEMBL618451,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),Intermediate,10116.0,N,8028,1,,1,A,,,429,
,,CHEMBL618452,,50597,,BAO_0000218,Rattus norvegicus,,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,10116.0,N,8029,1,,1,A,,,5546,
,,CHEMBL618453,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,Intermediate,10116.0,N,8030,1,,1,A,,,3173,
,,CHEMBL618454,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,Intermediate,10116.0,N,8031,1,,1,A,,,3173,
,,CHEMBL618455,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,Intermediate,10116.0,N,8032,1,,1,A,,,3173,
In vivo,,CHEMBL618456,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,Intermediate,10116.0,N,8033,1,,1,A,,,4257,
In vivo,,CHEMBL618457,,50597,,BAO_0000218,Rattus norvegicus,,,Compound distribution in rat tissues was determined,Intermediate,10116.0,N,8034,1,,1,A,,,6011,
In vivo,,CHEMBL618458,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was evaluated in rat,Intermediate,10116.0,N,8035,1,,1,A,,,5472,
,,CHEMBL618459,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,Intermediate,10116.0,N,8036,1,,1,A,,,14346,
,,CHEMBL876733,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,Intermediate,10116.0,N,8037,1,,1,A,,,14346,
,,CHEMBL618460,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,Intermediate,9615.0,N,8038,1,,1,A,,,14346,
,,CHEMBL618461,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,Intermediate,10116.0,N,8039,1,,1,A,,,14346,
,,CHEMBL618462,,22224,,BAO_0000019,,,,Area under the curve was determined after oral administration (300 uM/Kg),Autocuration,,U,8040,1,,0,A,,,15469,
,,CHEMBL618463,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,Intermediate,10116.0,N,8041,1,,1,A,,,14346,
,,CHEMBL618464,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,Intermediate,10116.0,N,8042,1,,1,A,,,14346,
,,CHEMBL618465,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,Intermediate,10116.0,N,8043,1,,1,A,,,14346,
,,CHEMBL618466,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,Intermediate,10116.0,N,8044,1,,1,A,,,14346,
,,CHEMBL618467,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,Intermediate,10116.0,N,8045,1,,1,A,,,14346,
,,CHEMBL618468,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,Intermediate,10116.0,N,8046,1,,1,A,,,15372,
,,CHEMBL618469,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,Intermediate,9615.0,N,8047,1,,1,A,,,12935,
,,CHEMBL618470,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,Intermediate,9615.0,N,8048,1,,1,A,,,12935,
,,CHEMBL618471,,22224,,BAO_0000218,,,,Plasma drug AUC in rat (PO dose),Autocuration,,U,8049,1,,0,A,,,14813,
,,CHEMBL618472,,50594,,BAO_0000218,Mus musculus,,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,Intermediate,10090.0,N,8050,1,,1,A,,,15792,
,,CHEMBL618473,,22224,,BAO_0000218,,,,Area under was determined at a dose of 30 mg/kg,Autocuration,,U,8051,1,,0,A,,,3579,
,,CHEMBL621699,,50506,,BAO_0000218,Mustela putorius furo,,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,Intermediate,9669.0,N,8052,1,,1,A,,,12487,
,,CHEMBL621700,,50597,,BAO_0000218,Rattus norvegicus,,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,Intermediate,10116.0,N,8053,1,,1,A,,,12487,
,,CHEMBL621701,,50597,,BAO_0000218,Rattus norvegicus,,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,Intermediate,10116.0,N,8054,1,,1,A,,,12487,
,,CHEMBL621702,,50506,,BAO_0000218,Mustela putorius furo,,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,Intermediate,9669.0,N,8055,1,,1,A,,,12487,
,,CHEMBL621703,,50588,,BAO_0000218,Canis lupus familiaris,,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,Intermediate,9615.0,N,8056,1,,1,A,,,12487,
,,CHEMBL621704,,50588,,BAO_0000218,Canis lupus familiaris,,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,Intermediate,9615.0,N,8057,1,,1,A,,,12487,
,,CHEMBL624259,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",Intermediate,10116.0,N,8058,1,,1,A,,,12902,
,,CHEMBL624260,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",Intermediate,10116.0,N,8059,1,,1,A,,,12902,
,,CHEMBL624430,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",Intermediate,10116.0,N,8060,1,,1,A,,,12902,
,,CHEMBL624431,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",Intermediate,10116.0,N,8061,1,,1,A,,,12902,
,,CHEMBL624432,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",Intermediate,10116.0,N,8062,1,,1,A,,,12902,
,,CHEMBL624433,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",Intermediate,10116.0,N,8063,1,,1,A,,,12902,
,,CHEMBL624434,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",Intermediate,10116.0,N,8064,1,,1,A,,,12902,
,,CHEMBL624435,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",Intermediate,10116.0,N,8065,1,,1,A,,,12902,
,,CHEMBL618570,,50594,,BAO_0000218,Mus musculus,,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,Intermediate,10090.0,N,8066,1,,1,A,,,12745,
,,CHEMBL618571,,50594,,BAO_0000218,Mus musculus,,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,10090.0,N,8067,1,,1,A,,,12745,
,,CHEMBL618572,,50594,,BAO_0000218,Mus musculus,,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,Intermediate,10090.0,N,8068,1,,1,A,,,12745,
,,CHEMBL618573,,50594,,BAO_0000218,Mus musculus,,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,10090.0,N,8069,1,,1,A,,,12745,
,,CHEMBL619267,,50594,,BAO_0000218,Mus musculus,,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,Intermediate,10090.0,N,8070,1,,1,A,,,12745,
,,CHEMBL619431,,50594,,BAO_0000218,Mus musculus,,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,10090.0,N,8071,1,,1,A,,,12745,
,,CHEMBL619432,,50594,,BAO_0000218,Mus musculus,,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,Intermediate,10090.0,N,8072,1,,1,A,,,12745,
,,CHEMBL619433,,50594,,BAO_0000218,Mus musculus,,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,10090.0,N,8073,1,,1,A,,,12745,
,,CHEMBL619434,,22224,Plasma,BAO_0000218,,1969.0,,AUC in mice after oral dose (50 mg/kg),Autocuration,,U,8074,1,,0,A,,,13298,
,,CHEMBL619435,,50594,Serum,BAO_0000218,Mus musculus,1977.0,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,Intermediate,10090.0,N,8075,1,,1,A,,,12226,
,,CHEMBL619436,,22224,Plasma,BAO_0000019,,1969.0,,AUC (0-4 hr) ug/ml/h,Autocuration,,U,8076,1,,0,A,,,12634,
,,CHEMBL619437,,50597,,BAO_0000218,Rattus norvegicus,,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,Intermediate,10116.0,N,8077,1,,1,A,,,14810,
,,CHEMBL619438,,22224,,BAO_0000218,,,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,Autocuration,,U,8078,1,,0,A,,,13889,
,,CHEMBL619439,,50594,,BAO_0000218,Mus musculus,,,Compound was evaluated for Area under curve in mice,Intermediate,10090.0,N,8079,1,,1,A,,,10018,
,,CHEMBL619440,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Intermediate,10116.0,N,8080,1,,1,A,,,8758,
,,CHEMBL619441,,22224,,BAO_0000218,,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Autocuration,,U,8081,1,,0,F,,,8758,
,,CHEMBL619442,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Intermediate,10116.0,N,8082,1,,1,A,,,8758,
,,CHEMBL875156,,22224,,BAO_0000019,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,Autocuration,,U,8083,1,,0,A,,,2249,
,,CHEMBL619443,,22224,,BAO_0000019,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,Autocuration,,U,8084,1,,0,A,,,2249,
,,CHEMBL619444,,22224,,BAO_0000019,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,Autocuration,,U,8085,1,,0,A,,,2249,
,,CHEMBL623464,,22224,,BAO_0000019,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,Autocuration,,U,8086,1,,0,A,,,2249,
,,CHEMBL623465,,50594,,BAO_0000218,Mus musculus,,,Compound was evaluated for area under curve when administered through oral route in mouse,Intermediate,10090.0,N,8087,1,,1,A,,,15115,
In vivo,,CHEMBL623466,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,Intermediate,10116.0,N,8088,1,,1,A,,,6518,
In vivo,,CHEMBL623467,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,Intermediate,10116.0,N,8089,1,,1,A,,,6518,
In vivo,,CHEMBL623468,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat,Intermediate,10116.0,N,8090,1,,1,A,,,6249,
In vivo,,CHEMBL622660,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Intermediate,10116.0,N,8091,1,,1,A,,,2463,
In vivo,,CHEMBL622661,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance rate in Sprague-Dawley rats,Intermediate,10116.0,N,8092,1,,1,A,,,4969,
In vivo,,CHEMBL622662,,50597,,BAO_0000218,Rattus norvegicus,,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,10116.0,N,8093,1,,1,F,,,17720,
In vivo,,CHEMBL622663,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (total body clearance) in rat,Intermediate,10116.0,N,8094,1,,1,A,,,3457,
In vivo,,CHEMBL622664,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,Intermediate,10116.0,N,8095,1,,1,A,,,5983,
,,CHEMBL622665,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Intermediate,10116.0,N,8096,1,,1,A,,,6295,
,,CHEMBL622666,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Intermediate,10116.0,N,8097,1,,1,A,,,6296,
In vivo,,CHEMBL621615,,50597,,BAO_0000218,Rattus norvegicus,,,Cl in rat i.v. at 2 mg/kg concentration,Intermediate,10116.0,N,8098,1,,1,A,,,17686,
In vivo,,CHEMBL621616,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance of compound after intravenous administration in rats at 24 uM/kg,Intermediate,10116.0,N,8099,1,,1,A,,,17764,
In vivo,,CHEMBL621617,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance was determined,Intermediate,10116.0,N,8100,1,,1,A,,,5503,
In vivo,,CHEMBL621618,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance by intravenous administration of 3.4 mg/kg in rat,Intermediate,10116.0,N,8101,1,,1,A,,,4368,
In vivo,,CHEMBL621619,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,10116.0,N,8102,1,,1,A,,,6005,
In vivo,,CHEMBL621620,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance rate after i.v. administration in rats,Intermediate,10116.0,N,8103,1,,1,A,,,5031,
In vivo,,CHEMBL621786,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,10116.0,N,8104,1,,1,A,,,4890,
In vivo,,CHEMBL621787,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,10116.0,N,8105,1,,1,A,,,5182,
In vivo,,CHEMBL621788,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,Intermediate,10116.0,N,8106,1,,1,A,,,5979,
In vivo,,CHEMBL621789,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance (Cl) after oral administration in rat,Intermediate,10116.0,N,8107,1,,1,A,,,5656,
In vivo,,CHEMBL621790,,50597,,BAO_0000218,Rattus norvegicus,,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,Intermediate,10116.0,N,8108,1,,1,A,,,17804,
In vivo,,CHEMBL621791,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was tested for plasma clearance in rat,Intermediate,10116.0,N,8109,1,,1,A,,,4839,
In vitro,Microsomes,CHEMBL621792,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro microsome metabolism clearance in rat was determined,Intermediate,10116.0,N,8110,1,,1,A,,,5041,
In vitro,Microsomes,CHEMBL621793,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Intermediate,10116.0,N,8111,1,,1,A,,,5041,
In vivo,,CHEMBL621794,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,8112,1,,1,A,,,5974,
In vivo,,CHEMBL621795,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,In vivo plasma clearance was determined,Intermediate,10116.0,N,8113,1,,1,A,,,5496,
In vivo,,CHEMBL621796,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,Intermediate,10116.0,N,8114,1,,1,A,,,5739,
In vivo,,CHEMBL621797,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Intermediate,10116.0,N,8115,1,,1,A,Hepatocyte,401.0,5676,
In vivo,,CHEMBL621798,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Plasma clearance) was measured in rat,Intermediate,10116.0,N,8116,1,,1,A,,,4239,
In vivo,,CHEMBL621799,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (clearance) in rat i.v.,Intermediate,10116.0,N,8117,1,,1,A,,,5676,
In vivo,,CHEMBL621800,,50597,,BAO_0000218,Rattus norvegicus,,,"Plasma Clearance was evaluated in rats, iv",Intermediate,10116.0,N,8118,1,,1,A,,,1918,
In vivo,,CHEMBL621801,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance (in vivo) in rats was determined,Intermediate,10116.0,N,8119,1,,1,A,,,17800,
In vivo,,CHEMBL621802,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,Intermediate,10116.0,N,8120,1,,1,A,,,6056,
In vivo,,CHEMBL618596,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was determined,Intermediate,10116.0,N,8121,1,,1,A,,,5496,
In vivo,,CHEMBL618597,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,Intermediate,10116.0,N,8122,1,,1,A,,,5939,
In vivo,,CHEMBL618598,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,Intermediate,10116.0,N,8123,1,,1,A,,,5939,
In vivo,,CHEMBL618599,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rats,Intermediate,10116.0,N,8124,1,,1,A,,,17752,
In vivo,,CHEMBL618600,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance rate determined in rat,Intermediate,10116.0,N,8125,1,,1,A,,,4576,
In vivo,,CHEMBL618601,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was determined in rat,Intermediate,10116.0,N,8126,1,,1,A,,,6011,
In vivo,,CHEMBL618602,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was determined,Intermediate,10116.0,N,8127,1,,1,A,,,5510,
In vivo,,CHEMBL618603,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance value in rat,Intermediate,10116.0,N,8128,1,,1,A,,,5948,
Ex vivo,,CHEMBL618604,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Intermediate,10116.0,N,8129,1,,1,A,,,6125,
In vivo,,CHEMBL618605,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance in rat,Intermediate,10116.0,N,8130,1,,1,A,,,4839,
In vivo,,CHEMBL618606,,50597,,BAO_0000218,Rattus norvegicus,,,Total body clearance in rat i.v. at 2 mg/kg concentration,Intermediate,10116.0,N,8131,1,,1,A,,,17686,
In vivo,,CHEMBL618607,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance of compound in rats after intravenous administration,Intermediate,10116.0,N,8132,1,,1,A,,,6571,
In vivo,,CHEMBL618608,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance after iv administration to rats,Intermediate,10116.0,N,8133,1,,1,A,,,3364,
In vivo,,CHEMBL618609,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Intermediate,10116.0,N,8134,1,,1,A,,,13569,
In vivo,,CHEMBL618610,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Intermediate,10116.0,N,8135,1,,1,A,,,13569,
In vivo,,CHEMBL618611,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Intermediate,10116.0,N,8136,1,,1,A,,,13569,
In vivo,,CHEMBL618612,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Intermediate,10116.0,N,8137,1,,1,A,,,13569,
In vivo,,CHEMBL618613,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Intermediate,10116.0,N,8138,1,,1,A,,,13569,
In vivo,,CHEMBL621076,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Intermediate,10116.0,N,8139,1,,1,A,,,13569,
In vivo,,CHEMBL621077,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Intermediate,10116.0,N,8140,1,,1,A,,,13569,
In vivo,,CHEMBL621078,,50597,,BAO_0000218,Rattus norvegicus,,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,10116.0,N,8141,1,,1,A,,,17670,
In vivo,,CHEMBL621251,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance in rat,Intermediate,10116.0,N,8142,1,,1,A,,,5970,
In vivo,,CHEMBL621252,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance in rat after oral administration at 10 mg/kg,Intermediate,10116.0,N,8143,1,,1,A,,,6495,
In vivo,,CHEMBL621253,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance in rat.,Intermediate,10116.0,N,8144,1,,1,A,,,4590,
In vivo,,CHEMBL621254,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance rate following an oral dose of 20 mg/kg in rats,Intermediate,10116.0,N,8145,1,,1,A,,,6193,
In vivo,,CHEMBL621255,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,Intermediate,10116.0,N,8146,1,,1,A,,,2832,
In vivo,,CHEMBL621256,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,Intermediate,10116.0,N,8147,1,,1,A,,,1052,
In vivo,,CHEMBL621257,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,Intermediate,10116.0,N,8148,1,,1,A,,,9866,
In vivo,,CHEMBL621258,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,Intermediate,10116.0,N,8149,1,,1,A,,,9866,
In vivo,,CHEMBL621259,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,Intermediate,10116.0,N,8150,1,,1,A,,,9866,
In vivo,,CHEMBL621260,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,Intermediate,10116.0,N,8151,1,,1,A,,,9866,
In vivo,,CHEMBL876494,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,Intermediate,10116.0,N,8152,1,,1,A,,,9866,
In vivo,,CHEMBL621261,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,Intermediate,10116.0,N,8153,1,,1,A,,,9866,
In vivo,,CHEMBL621262,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,Intermediate,10116.0,N,8154,1,,1,A,,,9866,
In vivo,,CHEMBL621263,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,10116.0,N,8155,1,,1,A,,,9866,
In vivo,,CHEMBL621264,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,Intermediate,10116.0,N,8156,1,,1,A,,,9866,
In vivo,,CHEMBL621265,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,Intermediate,10116.0,N,8157,1,,1,A,,,9866,
In vivo,,CHEMBL621266,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,Intermediate,10116.0,N,8158,1,,1,A,,,9866,
In vivo,,CHEMBL621267,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,Intermediate,10116.0,N,8159,1,,1,A,,,9866,
In vivo,,CHEMBL621268,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,Intermediate,10116.0,N,8160,1,,1,A,,,9866,
In vivo,,CHEMBL621269,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,Intermediate,10116.0,N,8161,1,,1,A,,,9866,
In vivo,,CHEMBL621270,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,Intermediate,10116.0,N,8162,1,,1,A,,,9866,
In vivo,,CHEMBL621271,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,Intermediate,10116.0,N,8163,1,,1,A,,,9866,
In vivo,,CHEMBL621272,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,Intermediate,10116.0,N,8164,1,,1,A,,,9866,
In vivo,,CHEMBL621273,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,Intermediate,10116.0,N,8165,1,,1,A,,,9866,
In vivo,,CHEMBL621274,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,Intermediate,10116.0,N,8166,1,,1,A,,,9866,
In vivo,,CHEMBL876495,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,Intermediate,10116.0,N,8167,1,,1,A,,,9866,
In vivo,,CHEMBL621275,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,Intermediate,10116.0,N,8168,1,,1,A,,,9866,
In vivo,,CHEMBL621276,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,Intermediate,10116.0,N,8169,1,,1,A,,,9866,
In vivo,,CHEMBL621277,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,Intermediate,10116.0,N,8170,1,,1,A,,,9866,
In vivo,,CHEMBL621278,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,Intermediate,10116.0,N,8171,1,,1,A,,,9866,
In vivo,,CHEMBL621279,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,Intermediate,10116.0,N,8172,1,,1,A,,,9866,
In vivo,,CHEMBL621280,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),Intermediate,10116.0,N,8173,1,,1,A,,,9866,
In vivo,,CHEMBL621281,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,Intermediate,10116.0,N,8174,1,,1,A,,,9866,
In vivo,,CHEMBL621282,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,Intermediate,10116.0,N,8175,1,,1,A,,,9866,
In vivo,,CHEMBL621283,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,Intermediate,10116.0,N,8176,1,,1,A,,,9866,
In vivo,,CHEMBL621284,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,Intermediate,10116.0,N,8177,1,,1,A,,,9866,
In vivo,,CHEMBL621285,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,Intermediate,10116.0,N,8178,1,,1,A,,,9866,
In vivo,,CHEMBL621286,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,Intermediate,10116.0,N,8179,1,,1,A,,,9866,
In vivo,,CHEMBL623220,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,Intermediate,10116.0,N,8180,1,,1,A,,,9866,
In vivo,,CHEMBL623221,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,Intermediate,10116.0,N,8181,1,,1,A,,,9866,
In vivo,,CHEMBL876029,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,Intermediate,10116.0,N,8182,1,,1,A,,,9866,
In vivo,,CHEMBL623222,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,Intermediate,10116.0,N,8183,1,,1,A,,,9866,
In vivo,,CHEMBL623223,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,Intermediate,10116.0,N,8184,1,,1,A,,,9866,
In vivo,,CHEMBL621445,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,Intermediate,10116.0,N,8185,1,,1,A,,,9866,
In vivo,,CHEMBL621446,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8186,1,,1,A,,,13950,
In vivo,,CHEMBL621447,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8187,1,,1,A,,,13950,
In vivo,,CHEMBL619681,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8188,1,,1,A,,,13950,
In vivo,,CHEMBL619682,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8189,1,,1,A,,,13950,
In vivo,,CHEMBL619683,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8190,1,,1,A,,,13950,
In vivo,,CHEMBL619684,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8191,1,,1,A,,,13950,
In vivo,,CHEMBL619685,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8192,1,,1,A,,,13950,
In vivo,,CHEMBL619686,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8193,1,,1,A,,,13950,
In vivo,,CHEMBL619687,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8194,1,,1,A,,,13950,
In vivo,,CHEMBL619688,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8195,1,,1,A,,,13950,
In vivo,,CHEMBL619689,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8196,1,,1,A,,,13950,
In vivo,,CHEMBL619690,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8197,1,,1,A,,,13950,
In vivo,,CHEMBL619691,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8198,1,,1,A,,,13950,
In vivo,,CHEMBL619692,,50597,,BAO_0000218,Rattus norvegicus,,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,Intermediate,10116.0,N,8199,1,,1,A,,,6062,
,,CHEMBL619693,,50597,,BAO_0000218,Rattus norvegicus,,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,10116.0,N,8200,1,,1,A,,,3598,
In vivo,,CHEMBL619694,,50597,,BAO_0000218,Rattus norvegicus,,,Vc value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,10116.0,N,8201,1,,1,A,,,1908,
In vivo,,CHEMBL619695,,50597,,BAO_0000218,Rattus norvegicus,,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,Intermediate,10116.0,N,8202,1,,1,A,,,17596,
In vivo,,CHEMBL619696,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for pharmacokinetic parameter volume of distribution,Intermediate,10116.0,N,8203,1,,1,A,,,4891,
In vivo,,CHEMBL619697,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for volume of distribution in rat,Intermediate,10116.0,N,8204,1,,1,A,,,740,
In vivo,,CHEMBL619698,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume distribution was determined; steady state(ss),Intermediate,10116.0,N,8205,1,,1,A,,,16366,
In vivo,,CHEMBL619699,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume of distribution after iv administration to rats,Intermediate,10116.0,N,8206,1,,1,A,,,3364,
In vivo,,CHEMBL619700,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume of distribution dosing at 3 mg/kg iv,Intermediate,10116.0,N,8207,1,,1,A,,,2552,
In vivo,,CHEMBL619701,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was evaluated for volume of distribution in rat,Intermediate,10116.0,N,8208,1,,1,A,,,406,
In vivo,,CHEMBL619702,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for volume of distribution in rat,Intermediate,10116.0,N,8209,1,,1,A,,,12500,
In vivo,,CHEMBL620335,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,Intermediate,10116.0,N,8210,1,,1,A,,,12500,
In vivo,,CHEMBL620336,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution (VD) after oral administration in rat,Intermediate,10116.0,N,8211,1,,1,A,,,5656,
In vivo,,CHEMBL620337,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,10116.0,N,8212,1,,1,A,,,17671,
In vivo,,CHEMBL620520,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution in rat,Intermediate,10116.0,N,8213,1,,1,A,,,1094,
In vivo,,CHEMBL620521,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution in rat,Intermediate,10116.0,N,8214,1,,1,A,,,5833,
In vivo,,CHEMBL875825,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution in rat after peroral administration at 10 mg/kg,Intermediate,10116.0,N,8215,1,,1,A,,,5939,
In vivo,,CHEMBL620522,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution in rat after peroral administration at 5 mg/kg,Intermediate,10116.0,N,8216,1,,1,A,,,5939,
In vivo,,CHEMBL620523,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,10116.0,N,8217,1,,1,A,,,6005,
In vivo,,CHEMBL620524,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in rat.,Intermediate,10116.0,N,8218,1,,1,A,,,1696,
In vivo,,CHEMBL620525,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in rat,Intermediate,10116.0,N,8219,1,,1,A,,,6672,
In vivo,,CHEMBL620526,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in rat,Intermediate,10116.0,N,8220,1,,1,A,,,6673,
In vivo,,CHEMBL620527,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in rat by iv administration,Intermediate,10116.0,N,8221,1,,1,A,,,5871,
In vivo,,CHEMBL620528,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in rats,Intermediate,10116.0,N,8222,1,,1,A,,,6803,
In vivo,,CHEMBL620529,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,10116.0,N,8223,1,,1,A,,,5199,
,,CHEMBL620530,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution at the dose of 2 mg/kg in rat,Intermediate,10116.0,N,8224,1,,1,A,,,4727,
In vivo,,CHEMBL620531,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume of distribution was determined,Intermediate,10116.0,N,8225,1,,1,A,,,16367,
In vivo,,CHEMBL620532,,22224,,BAO_0000218,Macaca mulatta,,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Intermediate,9544.0,U,8226,1,,0,A,,,5005,
In vivo,,CHEMBL620533,,22224,,BAO_0000218,Rattus norvegicus,,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,Intermediate,10116.0,U,8227,1,,0,A,,,5005,
In vivo,,CHEMBL620534,,22224,,BAO_0000218,Rattus norvegicus,,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,Intermediate,10116.0,U,8228,1,,0,A,,,5005,
In vivo,,CHEMBL620535,,50597,,BAO_0000218,Rattus norvegicus,,,Mean (%CV) PK parameters for Vdss(mL/kg).,Intermediate,10116.0,N,8229,1,,1,A,,,15765,
In vivo,,CHEMBL875826,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,Intermediate,10116.0,N,8230,1,,1,A,,,2792,
In vivo,,CHEMBL620536,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,Intermediate,10116.0,N,8231,1,,1,A,,,2792,
In vivo,,CHEMBL620537,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,10116.0,N,8232,1,,1,A,,,5334,
In vivo,,CHEMBL618526,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,Intermediate,10116.0,N,8233,1,,1,A,,,5334,
In vivo,,CHEMBL618527,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,Intermediate,10116.0,N,8234,1,,1,A,,,5739,
In vivo,,CHEMBL618528,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Vdss) in rat,Intermediate,10116.0,N,8235,1,,1,A,,,5789,
In vivo,,CHEMBL618529,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (vdss) was measured in rat,Intermediate,10116.0,N,8236,1,,1,A,,,4239,
In vivo,,CHEMBL618530,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,Intermediate,10116.0,N,8237,1,,1,A,,,4709,
In vivo,,CHEMBL618531,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in rat,Intermediate,10116.0,N,8238,1,,1,A,,,6642,
In vivo,,CHEMBL618532,,50597,,BAO_0000218,Rattus norvegicus,,,The pharmacokinetic parameter volume of distribution in vivo in rats,Intermediate,10116.0,N,8239,1,,1,A,,,5247,
In vivo,,CHEMBL618533,,50597,,BAO_0000218,Rattus norvegicus,,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,10116.0,N,8240,1,,1,F,,,17720,
In vivo,,CHEMBL618534,,50597,,BAO_0000218,Rattus norvegicus,,,Vdss in rat i.v. at 2 mg/kg concentration,Intermediate,10116.0,N,8241,1,,1,A,,,17686,
In vivo,,CHEMBL618535,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution after intravenous administration (1 mg/kg) in rat,Intermediate,10116.0,N,8242,1,,1,A,,,4689,
In vivo,,CHEMBL618536,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,10116.0,N,8243,1,,1,A,,,5654,
In vivo,,CHEMBL618537,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,10116.0,N,8244,1,,1,A,,,5654,
In vivo,,CHEMBL618538,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution at a dose of 10 uM/kg in rat was determined,Intermediate,10116.0,N,8245,1,,1,A,,,4527,
In vivo,,CHEMBL618539,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,10116.0,N,8246,1,,1,A,,,4521,
In vivo,,CHEMBL618540,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution was calculated in rat,Intermediate,10116.0,N,8247,1,,1,A,,,6057,
In vivo,,CHEMBL618541,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution was determined,Intermediate,10116.0,N,8248,1,,1,A,,,5510,
In vivo,,CHEMBL618542,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution after intravenous administration was evaluated in rat,Intermediate,10116.0,N,8249,1,,1,A,,,2938,
In vivo,,CHEMBL622544,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,10116.0,N,8250,1,,1,A,,,6679,
In vivo,,CHEMBL622545,,50597,,BAO_0000218,Rattus norvegicus,,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",Intermediate,10116.0,N,8251,1,,1,A,,,6685,
In vivo,,CHEMBL622546,,50597,,BAO_0000218,Rattus norvegicus,,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,10116.0,N,8252,1,,1,A,,,6685,
In vivo,,CHEMBL622547,,50597,,BAO_0000218,Rattus norvegicus,,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",Intermediate,10116.0,N,8253,1,,1,A,,,6685,
In vivo,,CHEMBL622548,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in steady state was determined in rat,Intermediate,10116.0,N,8254,1,,1,A,,,5145,
In vivo,,CHEMBL622549,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,10116.0,N,8255,1,,1,A,,,6467,
In vivo,,CHEMBL622550,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,10116.0,N,8256,1,,1,A,,,6467,
,,CHEMBL622551,,50594,,BAO_0000218,Mus musculus,,,Compound was evaluated for area under curve when administered through oral route to mouse,Intermediate,10090.0,N,8257,1,,1,A,,,15115,
,,CHEMBL622552,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Intermediate,10116.0,N,8258,1,,1,A,,,8758,
,,CHEMBL622553,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Intermediate,10116.0,N,8259,1,,1,A,,,8758,
In vivo,,CHEMBL622554,,22224,,BAO_0000218,,,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,Autocuration,,U,8260,1,,0,F,,,8267,
,,CHEMBL622555,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,Intermediate,9615.0,N,8261,1,,1,A,,,8267,
,,CHEMBL622556,,50594,,BAO_0000218,Mus musculus,,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,Intermediate,10090.0,N,8262,1,,1,A,,,14239,
,,CHEMBL622557,,50594,,BAO_0000218,Mus musculus,,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,Intermediate,10090.0,N,8263,1,,1,A,,,14239,
,,CHEMBL622558,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,Intermediate,10090.0,N,8264,1,,1,A,,,10754,
,,CHEMBL622559,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,Intermediate,10090.0,N,8265,1,,1,A,,,10754,
,,CHEMBL622560,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,Intermediate,9615.0,N,8266,1,,1,A,,,10754,
,,CHEMBL622561,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,10116.0,N,8267,1,,1,A,,,14681,
,,CHEMBL622562,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,Intermediate,10116.0,N,8268,1,,1,A,,,14681,
,,CHEMBL622563,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,10116.0,N,8269,1,,1,A,,,14681,
,,CHEMBL622564,,22224,,BAO_0000019,,,,Concentration of compound in Central nervous system,Autocuration,,U,8270,1,,0,A,,,13118,
,,CHEMBL622565,,22224,,BAO_0000019,,,,Concentration of compound in Central nervous system; Not detectable,Autocuration,,U,8271,1,,0,A,,,13118,
,,CHEMBL622566,,50594,,BAO_0000218,Mus musculus,,,"Concentration of diester in the blood, following oral administration in mice",Intermediate,10090.0,N,8272,1,,1,A,,,13318,
,,CHEMBL624515,,50594,,BAO_0000218,Mus musculus,,,"Concentration of monoester in the blood, following oral administration in mice",Intermediate,10090.0,N,8273,1,,1,A,,,13318,
,,CHEMBL624516,,50594,,BAO_0000218,Mus musculus,,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,Intermediate,10090.0,N,8274,1,,1,A,,,13318,
,,CHEMBL624517,,22224,,BAO_0000019,,,,Evaluated for Pharmacokinetic property: Area under the curve,Autocuration,,U,8275,1,,0,A,,,15692,
,,CHEMBL624518,,50594,,BAO_0000218,Mus musculus,,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,Intermediate,10090.0,N,8276,1,,1,A,,,14839,
,,CHEMBL624519,,100710,,BAO_0000218,Macaca fascicularis,,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,Intermediate,9541.0,N,8277,1,,1,A,,,14839,
,,CHEMBL624520,,100710,,BAO_0000218,Macaca fascicularis,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,Intermediate,9541.0,N,8278,1,,1,A,,,14839,
,,CHEMBL624521,,100710,,BAO_0000218,Macaca fascicularis,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,Intermediate,9541.0,N,8279,1,,1,A,,,14839,
,,CHEMBL624522,,100710,,BAO_0000218,Macaca fascicularis,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,Intermediate,9541.0,N,8280,1,,1,A,,,14839,
,,CHEMBL624523,,100710,,BAO_0000218,Macaca fascicularis,,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,9541.0,N,8281,1,,1,A,,,14839,
,,CHEMBL624409,,100710,,BAO_0000218,Macaca fascicularis,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,9541.0,N,8282,1,,1,A,,,14839,
,,CHEMBL624410,,100710,,BAO_0000218,Macaca fascicularis,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",Intermediate,9541.0,N,8283,1,,1,A,,,14839,
,,CHEMBL624411,,100710,,BAO_0000218,Macaca fascicularis,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,9541.0,N,8284,1,,1,A,,,14839,
,,CHEMBL623531,,100710,,BAO_0000218,Macaca fascicularis,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",Intermediate,9541.0,N,8285,1,,1,A,,,14839,
,,CHEMBL623532,,100710,,BAO_0000218,Macaca fascicularis,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,9541.0,N,8286,1,,1,A,,,14839,
,,CHEMBL623533,,100710,,BAO_0000218,Macaca fascicularis,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",Intermediate,9541.0,N,8287,1,,1,A,,,14839,
,,CHEMBL623534,,100710,,BAO_0000218,Macaca fascicularis,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,9541.0,N,8288,1,,1,A,,,14839,
,,CHEMBL623535,,50594,,BAO_0000218,Mus musculus,,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,Intermediate,10090.0,N,8289,1,,1,A,,,14839,
,,CHEMBL623536,,50594,,BAO_0000218,Mus musculus,,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,Intermediate,10090.0,N,8290,1,,1,A,,,14839,
,,CHEMBL623537,,50594,,BAO_0000218,Mus musculus,,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,Intermediate,10090.0,N,8291,1,,1,A,,,14839,
,,CHEMBL623538,,50594,,BAO_0000218,Mus musculus,,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,10090.0,N,8292,1,,1,A,,,14839,
,,CHEMBL623539,,50594,,BAO_0000218,Mus musculus,,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,Intermediate,10090.0,N,8293,1,,1,A,,,14839,
,,CHEMBL623540,,50594,,BAO_0000218,Mus musculus,,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,10090.0,N,8294,1,,1,A,,,14839,
,,CHEMBL623541,,50594,,BAO_0000218,Mus musculus,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",Intermediate,10090.0,N,8295,1,,1,A,,,14839,
,,CHEMBL623542,,50594,,BAO_0000218,Mus musculus,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",Intermediate,10090.0,N,8296,1,,1,A,,,14839,
,,CHEMBL623543,,50594,,BAO_0000218,Mus musculus,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",Intermediate,10090.0,N,8297,1,,1,A,,,14839,
,,CHEMBL623544,,50594,,BAO_0000218,Mus musculus,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",Intermediate,10090.0,N,8298,1,,1,A,,,14839,
,,CHEMBL623545,,50594,,BAO_0000218,Mus musculus,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",Intermediate,10090.0,N,8299,1,,1,A,,,14839,
,,CHEMBL623546,,50594,,BAO_0000218,Mus musculus,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",Intermediate,10090.0,N,8300,1,,1,A,,,14839,
In vivo,,CHEMBL623547,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,Intermediate,10116.0,N,8301,1,,1,A,,,5408,
In vivo,,CHEMBL623548,,50597,,BAO_0000218,Rattus norvegicus,,,High i.v. clearance in Dawley rats,Intermediate,10116.0,N,8302,1,,1,A,,,6827,
In vitro,Microsomes,CHEMBL623549,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,In vitro clearance in rat liver microsomes,Intermediate,10116.0,N,8303,1,,1,A,,,17538,
In vitro,Microsomes,CHEMBL623550,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Intrinsic clearance in rat liver microsomes was determined,Intermediate,10116.0,N,8304,1,,1,A,,,6331,
In vitro,,CHEMBL875276,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Intrinsic clearance in rat hepatocytes was determined,Intermediate,10116.0,N,8305,1,,1,A,Hepatocyte,401.0,5948,
In vivo,,CHEMBL621872,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma Clearance was determined,Intermediate,10116.0,N,8306,1,,1,A,,,4026,
In vivo,,CHEMBL621873,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,Intermediate,10116.0,N,8307,1,,1,A,,,6647,
In vivo,,CHEMBL621874,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat.,Intermediate,10116.0,N,8308,1,,1,A,,,1696,
In vivo,,CHEMBL621875,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rats,Intermediate,10116.0,N,8309,1,,1,A,,,6597,
In vivo,,CHEMBL621876,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,Intermediate,10116.0,N,8310,1,,1,A,,,347,
In vivo,,CHEMBL621877,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,Intermediate,10116.0,N,8311,1,,1,A,,,16423,
In vivo,,CHEMBL621878,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was measured in rat,Intermediate,10116.0,N,8312,1,,1,A,,,2879,
In vivo,,CHEMBL621879,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,10116.0,N,8313,1,,1,A,,,4883,
In vivo,,CHEMBL621880,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",Intermediate,10116.0,N,8314,1,,1,A,,,5328,
In vivo,,CHEMBL621881,,50597,,BAO_0000218,Rattus norvegicus,,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,Intermediate,10116.0,N,8315,1,,1,A,,,5160,
In vivo,,CHEMBL621882,,50597,,BAO_0000218,Rattus norvegicus,,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,10116.0,N,8316,1,,1,A,,,17582,
In vivo,,CHEMBL875283,,50597,,BAO_0000218,Rattus norvegicus,,,Total clearance at 1 mg/kg was determined in rat,Intermediate,10116.0,N,8317,1,,1,A,,,17651,
In vivo,,CHEMBL621883,,50597,,BAO_0000218,Rattus norvegicus,,,Total clearance at 10 mg/kg was determined in rat,Intermediate,10116.0,N,8318,1,,1,A,,,17651,
In vivo,,CHEMBL621884,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance in rat,Intermediate,10116.0,N,8319,1,,1,A,,,6596,
In vivo,,CHEMBL621885,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance rate determined in rats,Intermediate,10116.0,N,8320,1,,1,A,,,4796,
In vivo,,CHEMBL621886,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance of compound in rat was evaluated,Intermediate,10116.0,N,8321,1,,1,A,,,6850,
In vivo,,CHEMBL621887,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Intermediate,10116.0,N,8322,1,,1,A,,,5932,
In vivo,,CHEMBL621888,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (blood clearance) in rat,Intermediate,10116.0,N,8323,1,,1,A,,,3371,
In vivo,,CHEMBL621889,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat,Intermediate,10116.0,N,8324,1,,1,A,,,2083,
In vivo,,CHEMBL621890,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rats,Intermediate,10116.0,N,8325,1,,1,A,,,4942,
In vitro,Microsomes,CHEMBL621891,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Intermediate,10116.0,N,8326,1,,1,A,,,6838,
In vivo,,CHEMBL621892,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance in Dawley rat,Intermediate,10116.0,N,8327,1,,1,A,,,5353,
In vivo,,CHEMBL621893,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance rat,Intermediate,10116.0,N,8328,1,,1,A,,,6641,
In vivo,,CHEMBL621894,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),Intermediate,10116.0,N,8329,1,,1,A,,,6641,
In vivo,,CHEMBL621895,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance rat; Not determined,Intermediate,10116.0,N,8330,1,,1,A,,,6641,
In vivo,,CHEMBL875284,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,Intermediate,10116.0,N,8331,1,,1,A,,,6444,
In vivo,,CHEMBL618699,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,10116.0,N,8332,1,,1,A,,,6444,
In vivo,,CHEMBL618700,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,10116.0,N,8333,1,,1,A,,,6444,
In vivo,,CHEMBL618701,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,10116.0,N,8334,1,,1,A,,,6211,
In vivo,,CHEMBL876600,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Intermediate,10116.0,N,8335,1,,1,A,,,12873,
In vivo,,CHEMBL618702,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance of compound in rat after 1 mg/kg i.v. administration,Intermediate,10116.0,N,8336,1,,1,A,,,6570,
In vivo,,CHEMBL618703,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for Hepatic clearance in rat,Intermediate,10116.0,N,8337,1,,1,A,,,3341,
In vivo,,CHEMBL618704,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo clearance after 5 mg/kg dose,Intermediate,10116.0,N,8338,1,,1,A,,,4891,
In vivo,,CHEMBL618705,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was tested for plasma clearance in rats,Intermediate,10116.0,N,8339,1,,1,A,,,1094,
In vivo,,CHEMBL618706,,50597,,BAO_0000218,Rattus norvegicus,,,Hepatic clearance after intravenous administration was evaluated in rat,Intermediate,10116.0,N,8340,1,,1,A,,,2938,
In vivo,,CHEMBL618707,,50597,,BAO_0000218,Rattus norvegicus,,,Lower clearance in rat (i.v.) at 0.5 mpk,Intermediate,10116.0,N,8341,1,,1,A,,,17853,
In vivo,,CHEMBL618708,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Pharmacokinetic parameter expressed as plasma clearance in rat,Intermediate,10116.0,N,8342,1,,1,A,,,6049,
In vivo,,CHEMBL618709,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Clp) in rat,Intermediate,10116.0,N,8343,1,,1,A,,,5789,
In vivo,,CHEMBL618710,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in Sprague-Dawley rats,Intermediate,10116.0,N,8344,1,,1,A,,,4514,
In vivo,,CHEMBL618711,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance (Clp) in rat,Intermediate,10116.0,N,8345,1,,1,A,,,6448,
In vivo,,CHEMBL618712,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,Intermediate,10116.0,N,8346,1,,1,A,,,6062,
In vivo,,CHEMBL618713,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,Intermediate,10116.0,N,8347,1,,1,A,,,5710,
In vivo,,CHEMBL618714,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance after intravenous administration of 1 mg/kg in rat,Intermediate,10116.0,N,8348,1,,1,A,,,4709,
In vivo,,CHEMBL618715,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,10116.0,N,8349,1,,1,A,,,4521,
In vivo,,CHEMBL618716,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat was determined,Intermediate,10116.0,N,8350,1,,1,A,,,1742,
In vivo,,CHEMBL876601,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance measured in rat,Intermediate,10116.0,N,8351,1,,1,A,,,6057,
In vivo,,CHEMBL618717,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was calculated in rat,Intermediate,10116.0,N,8352,1,,1,A,,,6057,
In vivo,,CHEMBL618718,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat,Intermediate,10116.0,N,8353,1,,1,A,,,5145,
In vivo,,CHEMBL618719,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat,Intermediate,10116.0,N,8354,1,,1,A,,,5833,
In vivo,,CHEMBL618720,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat,Intermediate,10116.0,N,8355,1,,1,A,,,6453,
In vivo,,CHEMBL618721,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat,Intermediate,10116.0,N,8356,1,,1,A,,,6640,
In vivo,,CHEMBL621477,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rats,Intermediate,10116.0,N,8357,1,,1,A,,,6305,
In vivo,,CHEMBL621478,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat,Intermediate,10116.0,N,8358,1,,1,A,,,6642,
In vivo,,CHEMBL621479,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was evaluated in rat,Intermediate,10116.0,N,8359,1,,1,A,,,5472,
In vivo,,CHEMBL621480,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was evaluated in rat; Not tested,Intermediate,10116.0,N,8360,1,,1,A,,,5472,
In vivo,,CHEMBL621481,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance rate was determined for the compound in rat,Intermediate,10116.0,N,8361,1,,1,A,,,5144,
In vivo,,CHEMBL621482,,50597,,BAO_0000218,Rattus norvegicus,,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",Intermediate,10116.0,N,8362,1,,1,A,,,6685,
In vivo,,CHEMBL621483,,50597,,BAO_0000218,Rattus norvegicus,,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,10116.0,N,8363,1,,1,A,,,6685,
In vivo,,CHEMBL621484,,50597,,BAO_0000218,Rattus norvegicus,,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",Intermediate,10116.0,N,8364,1,,1,A,,,6685,
In vivo,,CHEMBL621485,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8365,1,,1,A,,,13950,
In vivo,,CHEMBL621486,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8366,1,,1,A,,,13950,
In vivo,,CHEMBL621487,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8367,1,,1,A,,,13950,
In vivo,,CHEMBL621488,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8368,1,,1,A,,,13950,
In vivo,,CHEMBL621489,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8369,1,,1,A,,,13950,
In vivo,,CHEMBL621490,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8370,1,,1,A,,,13950,
In vivo,,CHEMBL621491,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8371,1,,1,A,,,13950,
In vivo,,CHEMBL621492,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8372,1,,1,A,,,13950,
In vivo,,CHEMBL621493,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8373,1,,1,A,,,13950,
In vivo,,CHEMBL621494,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8374,1,,1,A,,,13950,
In vivo,,CHEMBL621495,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8375,1,,1,A,,,13950,
In vivo,,CHEMBL621496,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8376,1,,1,A,,,13950,
In vivo,,CHEMBL621497,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8377,1,,1,A,,,13950,
In vivo,,CHEMBL621498,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8378,1,,1,A,,,13950,
In vivo,,CHEMBL621499,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8379,1,,1,A,,,13950,
In vivo,,CHEMBL618634,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8380,1,,1,A,,,13950,
In vivo,,CHEMBL618635,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8381,1,,1,A,,,13950,
In vivo,,CHEMBL618636,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8382,1,,1,A,,,13950,
In vivo,,CHEMBL619737,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8383,1,,1,A,,,13950,
In vivo,,CHEMBL619738,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8384,1,,1,A,,,13950,
In vivo,,CHEMBL624329,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8385,1,,1,A,,,13950,
In vivo,,CHEMBL624330,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8386,1,,1,A,,,13950,
In vivo,,CHEMBL624331,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8387,1,,1,A,,,13950,
In vivo,,CHEMBL624332,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8388,1,,1,A,,,13950,
In vivo,,CHEMBL624333,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8389,1,,1,A,,,13950,
In vivo,,CHEMBL624334,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8390,1,,1,A,,,13950,
In vivo,,CHEMBL624335,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8391,1,,1,A,,,13950,
In vivo,,CHEMBL620016,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8392,1,,1,A,,,13950,
In vivo,,CHEMBL620169,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8393,1,,1,A,,,13950,
In vivo,,CHEMBL620170,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8394,1,,1,A,,,13950,
In vivo,,CHEMBL620171,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8395,1,,1,A,,,13950,
In vivo,,CHEMBL620172,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8396,1,,1,A,,,13950,
In vivo,,CHEMBL620173,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8397,1,,1,A,,,13950,
In vivo,,CHEMBL620174,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8398,1,,1,A,,,13950,
In vivo,,CHEMBL620175,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8399,1,,1,A,,,13950,
In vivo,,CHEMBL620176,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8400,1,,1,A,,,13950,
In vivo,,CHEMBL620177,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8401,1,,1,A,,,13950,
,,CHEMBL620178,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8402,1,,1,A,,,13950,
,,CHEMBL620179,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8403,1,,1,A,,,13950,
,,CHEMBL620180,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8404,1,,1,A,,,13950,
In vivo,,CHEMBL620181,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,Intermediate,10116.0,N,8405,1,,1,A,,,6570,
In vivo,,CHEMBL620182,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution of compound in rats after intravenous administration,Intermediate,10116.0,N,8406,1,,1,A,,,6571,
In vivo,,CHEMBL620183,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in rat,Intermediate,10116.0,N,8407,1,,1,A,,,6453,
In vivo,,CHEMBL620184,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,Intermediate,10116.0,N,8408,1,,1,A,,,6444,
In vivo,,CHEMBL620185,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,10116.0,N,8409,1,,1,A,,,6444,
In vivo,,CHEMBL620186,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,10116.0,N,8410,1,,1,A,,,6444,
In vivo,,CHEMBL620187,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was determined in Dawley rat,Intermediate,10116.0,N,8411,1,,1,A,,,5353,
In vivo,,CHEMBL620188,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,10116.0,N,8412,1,,1,A,,,5334,
In vivo,,CHEMBL620189,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was reported in Sprague-Dawley rat,Intermediate,10116.0,N,8413,1,,1,A,,,5334,
In vivo,,CHEMBL620190,,50597,,BAO_0000218,Rattus norvegicus,,,Volumes of distribution in rat after peroral administration,Intermediate,10116.0,N,8414,1,,1,A,,,6641,
In vivo,,CHEMBL620191,,50597,,BAO_0000218,Rattus norvegicus,,,Volumes of distribution in rat after po administration,Intermediate,10116.0,N,8415,1,,1,A,,,6641,
In vivo,,CHEMBL620192,,50597,,BAO_0000218,Rattus norvegicus,,,Volumes of distribution in rat after po administration; Not determined,Intermediate,10116.0,N,8416,1,,1,A,,,6641,
In vivo,,CHEMBL620193,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Volume) in rat i.v.,Intermediate,10116.0,N,8417,1,,1,A,,,5676,
In vivo,,CHEMBL620194,,50597,,BAO_0000218,Rattus norvegicus,,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,Intermediate,10116.0,N,8418,1,,1,A,,,6410,
In vivo,,CHEMBL876730,,50597,,BAO_0000218,Rattus norvegicus,,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,10116.0,N,8419,1,,1,A,,,17670,
In vivo,,CHEMBL620195,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution in rat after oral administration at 10 mg/kg,Intermediate,10116.0,N,8420,1,,1,A,,,6495,
In vivo,,CHEMBL620196,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,Intermediate,10116.0,N,8421,1,,1,A,,,5408,
In vivo,,CHEMBL620197,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,10116.0,N,8422,1,,1,A,,,4883,
In vivo,,CHEMBL620198,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,Intermediate,10116.0,N,8423,1,,1,A,,,6647,
In vivo,,CHEMBL620199,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in rats,Intermediate,10116.0,N,8424,1,,1,A,,,6495,
In vivo,,CHEMBL620200,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,10116.0,N,8425,1,,1,A,,,2661,
In vivo,,CHEMBL620201,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,10116.0,N,8426,1,,1,A,,,2661,
In vivo,,CHEMBL620202,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,8427,1,,1,A,,,5974,
In vivo,,CHEMBL620203,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,8428,1,,1,A,,,5974,
In vivo,,CHEMBL620204,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,Intermediate,10116.0,N,8429,1,,1,A,,,5974,
In vivo,,CHEMBL620205,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,8430,1,,1,A,,,5974,
In vivo,,CHEMBL624664,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter (Vss) in rat,Intermediate,10116.0,N,8431,1,,1,A,,,5960,
In vivo,,CHEMBL624665,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Volume) in rat i.v.,Intermediate,10116.0,N,8432,1,,1,A,,,5676,
,,CHEMBL624666,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Vss) in rat,Intermediate,10116.0,N,8433,1,,1,A,,,5948,
In vivo,,CHEMBL624667,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Intermediate,10116.0,N,8434,1,,1,A,,,5979,
In vivo,,CHEMBL624668,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,8435,1,,1,A,,,5978,
In vivo,,CHEMBL624669,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,8436,1,,1,A,,,5978,
In vivo,,CHEMBL624670,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,8437,1,,1,A,,,5978,
In vivo,,CHEMBL624671,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,8438,1,,1,A,,,5978,
In vivo,,CHEMBL624672,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume distribution in rat,Intermediate,10116.0,N,8439,1,,1,A,,,6448,
In vivo,,CHEMBL624673,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",Intermediate,10116.0,N,8440,1,,1,A,,,12873,
In vivo,,CHEMBL624674,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state volume of distribution determined in rat,Intermediate,10116.0,N,8441,1,,1,A,,,4576,
In vivo,,CHEMBL624675,,50597,,BAO_0000218,Rattus norvegicus,,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,10116.0,N,8442,1,,1,A,,,17582,
In vivo,,CHEMBL621728,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,10116.0,N,8443,1,,1,A,,,1466,
,,CHEMBL621729,,50597,,BAO_0000218,Rattus norvegicus,,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,Intermediate,10116.0,N,8444,1,,1,A,,,5182,
,,CHEMBL621730,,50597,,BAO_0000218,Rattus norvegicus,,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,Intermediate,10116.0,N,8445,1,,1,A,,,5182,
In vivo,,CHEMBL621731,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution in rat after administration of 2 mg/kg iv,Intermediate,10116.0,N,8446,1,,1,A,,,6535,
In vivo,,CHEMBL621732,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution in rat after administration of 2 mg/kg iv,Intermediate,10116.0,N,8447,1,,1,A,,,6535,
In vivo,,CHEMBL621908,,50597,,BAO_0000218,Rattus norvegicus,,,Volume in steady state distribution value was determined,Intermediate,10116.0,N,8448,1,,1,A,,,5041,
In vivo,,CHEMBL875347,,50597,,BAO_0000218,Rattus norvegicus,,,Volume in steady state distribution value was determined; ND denotes no data,Intermediate,10116.0,N,8449,1,,1,A,,,5041,
In vivo,,CHEMBL621909,,50597,,BAO_0000218,Rattus norvegicus,,,Volume in steady state distribution value was determined; ND denotes not determined,Intermediate,10116.0,N,8450,1,,1,A,,,5041,
In vivo,,CHEMBL621910,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,10116.0,N,8451,1,,1,A,,,17065,
In vivo,,CHEMBL621911,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution at steady state was evaluated in rats,Intermediate,10116.0,N,8452,1,,1,A,,,6597,
In vivo,,CHEMBL621912,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution at steady state was observed after intravenous administration in rat,Intermediate,10116.0,N,8453,1,,1,A,,,15662,
In vivo,,CHEMBL621913,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in steady state was determined in rat,Intermediate,10116.0,N,8454,1,,1,A,,,6485,
In vivo,,CHEMBL621914,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in steady state was determined in rat,Intermediate,10116.0,N,8455,1,,1,A,,,17655,
In vivo,,CHEMBL621915,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution after i.v. administration,Intermediate,10116.0,N,8456,1,,1,A,,,6616,
In vivo,,CHEMBL621916,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,10116.0,N,8457,1,,1,A,,,1916,
In vivo,,CHEMBL621917,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Intermediate,10090.0,N,8458,1,,1,A,,,16438,
In vivo,,CHEMBL621918,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Intermediate,10090.0,N,8459,1,,1,A,,,16438,
In vivo,,CHEMBL621919,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Biodistribution of compound (oxidized form) in spleen tissue,Intermediate,10090.0,N,8460,1,,1,A,,,16438,
In vivo,,CHEMBL621920,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",Intermediate,10090.0,N,8461,1,,1,A,,,16438,
In vivo,,CHEMBL621921,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",Intermediate,10090.0,N,8462,1,,1,A,,,16438,
In vivo,,CHEMBL622401,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,10090.0,N,8463,1,,1,A,,,16438,
In vivo,,CHEMBL875348,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Intermediate,10090.0,N,8464,1,,1,A,,,16438,
In vivo,,CHEMBL622402,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Intermediate,10090.0,N,8465,1,,1,A,,,16438,
In vivo,,CHEMBL622403,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,Intermediate,10090.0,N,8466,1,,1,A,,,16438,
In vivo,,CHEMBL622404,,50594,Blood,BAO_0000218,Mus musculus,178.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,10090.0,N,8467,1,,1,A,,,16438,
In vivo,,CHEMBL622405,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,Intermediate,10090.0,N,8468,1,,1,A,,,16438,
In vivo,,CHEMBL622406,,50594,Brain,BAO_0000218,Mus musculus,955.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Intermediate,10090.0,N,8469,1,,1,A,,,16438,
In vivo,,CHEMBL622407,,50594,Brain,BAO_0000218,Mus musculus,955.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,10090.0,N,8470,1,,1,A,,,16438,
In vivo,,CHEMBL622408,,50594,Heart,BAO_0000218,Mus musculus,948.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,Intermediate,10090.0,N,8471,1,,1,A,,,16438,
In vivo,,CHEMBL622409,,50594,Heart,BAO_0000218,Mus musculus,948.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Intermediate,10090.0,N,8472,1,,1,A,,,16438,
In vivo,,CHEMBL622410,,50594,Heart,BAO_0000218,Mus musculus,948.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,10090.0,N,8473,1,,1,A,,,16438,
In vivo,,CHEMBL622411,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,Intermediate,10090.0,N,8474,1,,1,A,,,16438,
In vivo,,CHEMBL627864,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",Intermediate,10090.0,N,8475,1,,1,A,,,16438,
In vivo,,CHEMBL627865,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,10090.0,N,8476,1,,1,A,,,16438,
In vivo,,CHEMBL627866,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,Intermediate,10090.0,N,8477,1,,1,A,,,16438,
In vivo,,CHEMBL627751,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,10090.0,N,8478,1,,1,A,,,16438,
In vivo,,CHEMBL627752,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,Intermediate,10090.0,N,8479,1,,1,A,,,16438,
In vivo,,CHEMBL627753,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",Intermediate,10090.0,N,8480,1,,1,A,,,16438,
In vivo,,CHEMBL627754,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,10090.0,N,8481,1,,1,A,,,16438,
,,CHEMBL627755,,50594,,BAO_0000218,Mus musculus,,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,Intermediate,10090.0,N,8482,1,,1,A,,,12467,
In vivo,,CHEMBL627756,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8483,1,,1,A,,,17208,
In vivo,,CHEMBL627757,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8484,1,,1,A,,,17208,
In vivo,,CHEMBL627758,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8485,1,,1,A,,,17208,
In vivo,,CHEMBL627759,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8486,1,,1,A,,,17208,
In vivo,,CHEMBL627760,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8487,1,,1,A,,,17208,
In vivo,,CHEMBL627761,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8488,1,,1,A,,,17208,
In vivo,,CHEMBL876811,,50594,Heart,BAO_0000218,Mus musculus,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8489,1,,1,A,,,17208,
In vivo,,CHEMBL627762,,50594,Heart,BAO_0000218,Mus musculus,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8490,1,,1,A,,,17208,
In vivo,,CHEMBL627763,,50594,Heart,BAO_0000218,Mus musculus,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8491,1,,1,A,,,17208,
In vivo,,CHEMBL627764,,50594,Heart,BAO_0000218,Mus musculus,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8492,1,,1,A,,,17208,
In vivo,,CHEMBL627765,,50594,Heart,BAO_0000218,Mus musculus,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8493,1,,1,A,,,17208,
In vivo,,CHEMBL627766,,50594,Heart,BAO_0000218,Mus musculus,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8494,1,,1,A,,,17208,
In vivo,,CHEMBL627767,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8495,1,,1,A,,,17208,
In vivo,,CHEMBL627768,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8496,1,,1,A,,,17208,
In vivo,,CHEMBL628422,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8497,1,,1,A,,,17208,
In vivo,,CHEMBL628423,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8498,1,,1,A,,,17208,
In vivo,,CHEMBL628424,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,Intermediate,10116.0,N,8499,1,,1,A,,,5089,
In vivo,,CHEMBL628425,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,Intermediate,10116.0,N,8500,1,,1,A,,,5089,
In vivo,,CHEMBL628426,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,Intermediate,10116.0,N,8501,1,,1,A,,,4257,
In vivo,,CHEMBL628427,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,10116.0,N,8502,1,,1,A,,,6679,
In vivo,,CHEMBL626938,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,10116.0,N,8503,1,,1,A,,,5546,
In vivo,,CHEMBL626939,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Intermediate,10116.0,N,8504,1,,1,A,,,6141,
In vivo,,CHEMBL626940,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,10116.0,N,8505,1,,1,A,,,5334,
In vivo,,CHEMBL626941,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,10116.0,N,8506,1,,1,A,,,5334,
In vivo,,CHEMBL626942,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was reported in Sprague-Dawley rat,Intermediate,10116.0,N,8507,1,,1,A,,,5334,
In vivo,,CHEMBL876812,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance after intravenous administration (1 mg/kg) in rat,Intermediate,10116.0,N,8508,1,,1,A,,,4689,
In vivo,,CHEMBL626943,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance of compound in rats was evaluated,Intermediate,10116.0,N,8509,1,,1,A,,,6848,
In vivo,,CHEMBL626944,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,Intermediate,10116.0,N,8510,1,,1,A,,,6848,
In vivo,,CHEMBL626945,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,10116.0,N,8511,1,,1,A,,,6467,
In vivo,,CHEMBL626946,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,10116.0,N,8512,1,,1,A,,,6467,
In vivo,,CHEMBL626856,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance rate in Sprague-Dawley rats,Intermediate,10116.0,N,8513,1,,1,A,,,4956,
In vivo,,CHEMBL626857,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),Intermediate,10116.0,N,8514,1,,1,A,,,5529,
In vivo,,CHEMBL626858,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The compound was evaluated for plasma clearance in rat,Intermediate,10116.0,N,8515,1,,1,A,,,406,
In vivo,,CHEMBL627018,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Total plasma clearance in rat,Intermediate,10116.0,N,8516,1,,1,A,,,17655,
In vivo,,CHEMBL625331,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,Intermediate,10116.0,N,8517,1,,1,A,,,3293,
In vivo,,CHEMBL625332,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,Intermediate,10116.0,N,8518,1,,1,A,,,4075,
In vivo,,CHEMBL877590,,50597,,BAO_0000218,Rattus norvegicus,,,C max was determined at 10 mg/kg po dose in rats,Intermediate,10116.0,N,8519,1,,1,A,,,2792,
In vivo,,CHEMBL625333,,50597,,BAO_0000218,Rattus norvegicus,,,C max was determined at 3 mg/kg po dose in rats,Intermediate,10116.0,N,8520,1,,1,A,,,2792,
In vivo,,CHEMBL625334,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,10116.0,N,8521,1,,1,A,,,17594,
In vivo,,CHEMBL625335,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after single intravenous bolus of 1 mg/kg in rats,Intermediate,10116.0,N,8522,1,,1,A,,,17594,
In vivo,,CHEMBL625336,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax of compound at 5 mg/kg after po administration was determined in rat,Intermediate,10116.0,N,8523,1,,1,A,,,4762,
In vivo,,CHEMBL625337,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax 24 hr after 10 mg/kg oral administration in rats,Intermediate,10116.0,N,8524,1,,1,A,,,17509,
In vivo,,CHEMBL625338,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax 24 hr after 2 mg/kg oral administration in rats,Intermediate,10116.0,N,8525,1,,1,A,,,17509,
In vivo,,CHEMBL625339,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,10116.0,N,8526,1,,1,A,,,1466,
In vivo,,CHEMBL625340,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat after administration of 2 mg/kg iv,Intermediate,10116.0,N,8527,1,,1,A,,,6535,
In vivo,,CHEMBL625341,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat after administration of 2 mg/kg iv,Intermediate,10116.0,N,8528,1,,1,A,,,6535,
In vivo,,CHEMBL622687,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,Intermediate,10116.0,N,8529,1,,1,A,,,3169,
In vivo,,CHEMBL622688,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,Intermediate,10116.0,N,8530,1,,1,A,,,6515,
In vivo,,CHEMBL622689,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,Intermediate,10116.0,N,8531,1,,1,A,,,11149,
In vivo,,CHEMBL620295,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,Intermediate,10116.0,N,8532,1,,1,A,,,11149,
In vivo,,CHEMBL620296,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after 10 mg/kg oral administration in rat,Intermediate,10116.0,N,8533,1,,1,A,,,17858,
In vivo,,CHEMBL620297,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,Intermediate,10116.0,N,8534,1,,1,A,,,6518,
In vivo,,CHEMBL620298,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after IV dosing at 1 mg/kg in rat; no data,Intermediate,10116.0,N,8535,1,,1,A,,,6518,
In vivo,,CHEMBL620299,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after oral administration at 20 mpk in rats,Intermediate,10116.0,N,8536,1,,1,A,,,4426,
In vivo,,CHEMBL620300,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after oral administration at 20 mpk in rats; Not performed.,Intermediate,10116.0,N,8537,1,,1,A,,,4426,
In vivo,,CHEMBL620301,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after oral administration at 20 mpk in rats d; Not performed.,Intermediate,10116.0,N,8538,1,,1,A,,,4426,
In vivo,,CHEMBL620302,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after oral administration in rat,Intermediate,10116.0,N,8539,1,,1,A,,,5656,
In vivo,,CHEMBL620303,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after oral administration at a dose of 2 mg/kg in rat,Intermediate,10116.0,N,8540,1,,1,A,,,6518,
In vivo,,CHEMBL620304,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after oral administration at a dose of 4 mg/kg in rat,Intermediate,10116.0,N,8541,1,,1,A,,,6518,
In vivo,,CHEMBL620305,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rats after 20 mg/kg oral dose,Intermediate,10116.0,N,8542,1,,1,A,,,6113,
In vivo,,CHEMBL620306,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after peroral administration in rats at 2.4 uM/kg,Intermediate,10116.0,N,8543,1,,1,A,,,17764,
In vivo,,CHEMBL620307,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax at the dose of 2 mg/Kg administered perorally in rats,Intermediate,10116.0,N,8544,1,,1,A,,,4756,
In vivo,,CHEMBL620308,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax at the dose of 5 mg/Kg administered perorally in rats,Intermediate,10116.0,N,8545,1,,1,A,,,4756,
In vivo,,CHEMBL620309,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax by administering at 20 mg/kg p.o. in rats,Intermediate,10116.0,N,8546,1,,1,A,,,6402,
In vivo,,CHEMBL620310,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in male rat,Intermediate,10116.0,N,8547,1,,1,A,,,5610,
In vivo,,CHEMBL620311,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat,Intermediate,10116.0,N,8548,1,,1,A,,,5207,
In vivo,,CHEMBL620312,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat,Intermediate,10116.0,N,8549,1,,1,A,,,6011,
In vivo,,CHEMBL620313,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat,Intermediate,10116.0,N,8550,1,,1,A,,,6504,
In vivo,,CHEMBL620314,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat at 10 mg/kg,Intermediate,10116.0,N,8551,1,,1,A,,,6046,
In vivo,,CHEMBL620315,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat at the dose of 1 mg/kg i.v.,Intermediate,10116.0,N,8552,1,,1,A,,,6504,
In vivo,,CHEMBL620316,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat by po administration at a dose of 40 mg/kg,Intermediate,10116.0,N,8553,1,,1,A,,,5874,
In vivo,,CHEMBL620317,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat p.o. at 20 mg/kg concentration,Intermediate,10116.0,N,8554,1,,1,A,,,17686,
In vivo,,CHEMBL620318,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rats,Intermediate,10116.0,N,8555,1,,1,A,,,5836,
In vivo,,CHEMBL620319,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rats,Intermediate,10116.0,N,8556,1,,1,A,,,17596,
In vivo,,CHEMBL620320,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax was evaluated after 20 uM/kg of peroral administration,Intermediate,10116.0,N,8557,1,,1,A,,,16423,
In vivo,,CHEMBL620321,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax was measured in rats after peroral administration at 3 mg/kg,Intermediate,10116.0,N,8558,1,,1,A,,,17804,
In vivo,,CHEMBL620322,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,10116.0,N,8559,1,,1,A,,,1908,
,,CHEMBL620323,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8560,1,,1,A,,,13950,
,,CHEMBL620324,,50597,Frontal cortex,BAO_0000218,Rattus norvegicus,1870.0,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8561,1,,1,A,,,13950,
,,CHEMBL620325,,50597,Frontal cortex,BAO_0000218,Rattus norvegicus,1870.0,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8562,1,,1,A,,,13950,
,,CHEMBL620326,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8563,1,,1,A,,,13950,
,,CHEMBL620327,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8564,1,,1,A,,,13950,
,,CHEMBL620328,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8565,1,,1,A,,,13950,
,,CHEMBL620329,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8566,1,,1,A,,,13950,
,,CHEMBL620330,,50597,Midbrain,BAO_0000218,Rattus norvegicus,1891.0,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8567,1,,1,A,,,13950,
,,CHEMBL875286,,50597,Midbrain,BAO_0000218,Rattus norvegicus,1891.0,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8568,1,,1,A,,,13950,
,,CHEMBL620331,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8569,1,,1,A,,,13950,
,,CHEMBL620332,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8570,1,,1,A,,,13950,
,,CHEMBL620333,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8571,1,,1,A,,,13950,
,,CHEMBL620334,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,10116.0,N,8572,1,,1,A,,,13950,
,,CHEMBL621015,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,8573,1,,1,A,,,16434,
,,CHEMBL621016,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,10116.0,N,8574,1,,1,A,,,16434,
,,CHEMBL621191,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,8575,1,,1,A,,,16434,
,,CHEMBL621192,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,8576,1,,1,A,,,16434,
,,CHEMBL621193,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,10116.0,N,8577,1,,1,A,,,16434,
,,CHEMBL621194,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,10116.0,N,8578,1,,1,A,,,16434,
,,CHEMBL624204,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,10116.0,N,8579,1,,1,A,,,16434,
,,CHEMBL624205,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,10116.0,N,8580,1,,1,A,,,16434,
,,CHEMBL624206,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,10116.0,N,8581,1,,1,A,,,16435,
,,CHEMBL624207,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,10116.0,N,8582,1,,1,A,,,16435,
,,CHEMBL624208,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,10116.0,N,8583,1,,1,A,,,16435,
,,CHEMBL624209,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,10116.0,N,8584,1,,1,A,,,16435,
,,CHEMBL624210,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,10116.0,N,8585,1,,1,A,,,16435,
,,CHEMBL624211,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,10116.0,N,8586,1,,1,A,,,16435,
,,CHEMBL624212,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,10116.0,N,8587,1,,1,A,,,16435,
,,CHEMBL624213,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,10116.0,N,8588,1,,1,A,,,16435,
,,CHEMBL876611,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,8589,1,,1,A,,,16434,
,,CHEMBL624214,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,8590,1,,1,A,,,16434,
,,CHEMBL624215,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,8591,1,,1,A,,,16434,
,,CHEMBL624216,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,8592,1,,1,A,,,16435,
,,CHEMBL624217,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,8593,1,,1,A,,,16435,
,,CHEMBL624218,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,8594,1,,1,A,,,16435,
,,CHEMBL624219,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,8595,1,,1,A,,,16435,
,,CHEMBL624220,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,8596,1,,1,A,,,16435,
,,CHEMBL624221,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,8597,1,,1,A,,,16435,
,,CHEMBL624222,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,8598,1,,1,A,,,16434,
,,CHEMBL624223,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,10116.0,N,8599,1,,1,A,,,16434,
,,CHEMBL624224,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,8600,1,,1,A,,,16434,
,,CHEMBL624225,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,8601,1,,1,A,,,16434,
In vivo,,CHEMBL622420,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,Intermediate,10116.0,N,8602,1,,1,A,,,17764,
In vivo,,CHEMBL622421,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of steady state distribution after i.v. administration in rats,Intermediate,10116.0,N,8603,1,,1,A,,,5031,
In vivo,,CHEMBL622422,,50597,,BAO_0000218,Rattus norvegicus,,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,10116.0,N,8604,1,,1,A,,,6215,
In vivo,,CHEMBL622423,,50597,,BAO_0000218,Rattus norvegicus,,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,10116.0,N,8605,1,,1,A,,,17671,
In vivo,,CHEMBL622424,,50597,,BAO_0000218,Rattus norvegicus,,,Vss was determined,Intermediate,10116.0,N,8606,1,,1,A,,,17752,
In vivo,,CHEMBL622425,,50597,,BAO_0000218,Rattus norvegicus,,,Vss in rat,Intermediate,10116.0,N,8607,1,,1,A,,,6596,
In vivo,,CHEMBL876612,,50597,,BAO_0000218,Rattus norvegicus,,,Vss was evaluated after 10 uM/kg of intra arterial administration,Intermediate,10116.0,N,8608,1,,1,A,,,16423,
In vivo,,CHEMBL622426,,50597,,BAO_0000218,Rattus norvegicus,,,volume of distribution at steady state was observed after intravenous administration in rat,Intermediate,10116.0,N,8609,1,,1,A,,,15662,
In vivo,,CHEMBL622427,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,Intermediate,10116.0,N,8610,1,,1,A,,,6062,
In vivo,,CHEMBL622428,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic (PK) parameter Vz in rat,Intermediate,10116.0,N,8611,1,,1,A,,,5874,
In vivo,,CHEMBL622429,,50597,,BAO_0000218,Rattus norvegicus,,,Volume distribution in rats,Intermediate,10116.0,N,8612,1,,1,A,,,4942,
In vivo,,CHEMBL622430,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in rat; No data,Intermediate,10116.0,N,8613,1,,1,A,,,17796,
In vivo,,CHEMBL622431,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,10116.0,N,8614,1,,1,A,,,4890,
,,CHEMBL622432,,50597,Ileum,BAO_0000218,Rattus norvegicus,2116.0,,% absorption predicted from in vitro rat ileum transport studies,Intermediate,10116.0,N,8615,1,,1,A,,,15765,
In vivo,,CHEMBL622433,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Intermediate,10116.0,N,8616,1,,1,A,,,13569,
In vivo,,CHEMBL622434,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Intermediate,10116.0,N,8617,1,,1,A,,,13569,
In vivo,,CHEMBL622435,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,Intermediate,10116.0,N,8618,1,,1,A,,,13569,
In vivo,,CHEMBL618748,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),Intermediate,10116.0,N,8619,1,,1,A,,,13569,
In vivo,,CHEMBL618749,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Intermediate,10116.0,N,8620,1,,1,A,,,13569,
In vivo,,CHEMBL618750,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Intermediate,10116.0,N,8621,1,,1,A,,,13569,
In vivo,,CHEMBL618751,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Intermediate,10116.0,N,8622,1,,1,A,,,13569,
In vivo,,CHEMBL618752,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Intermediate,10116.0,N,8623,1,,1,A,,,13569,
In vivo,,CHEMBL618753,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,8624,1,,1,A,,,4576,
In vivo,,CHEMBL618754,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,Intermediate,10116.0,N,8625,1,,1,A,,,750,
In vivo,,CHEMBL618755,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,8626,1,,1,A,,,750,
In vivo,,CHEMBL618756,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,8627,1,,1,A,,,4590,
In vivo,,CHEMBL618757,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,8628,1,,1,A,,,1716,
In vivo,,CHEMBL618758,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,8629,1,,1,A,,,1974,
In vivo,,CHEMBL621088,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 30 mg/kg),Intermediate,10116.0,N,8630,1,,1,A,,,4502,
,,CHEMBL621089,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (cLogP) in rat,Intermediate,10116.0,N,8631,1,,1,A,,,3371,
,,CHEMBL621090,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,Intermediate,10116.0,N,8632,1,,1,F,,,9099,
,,CHEMBL621091,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,Intermediate,10116.0,N,8633,1,,1,F,,,9099,
In vivo,,CHEMBL876731,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance in rat.,Intermediate,10116.0,N,8634,1,,1,A,,,4590,
In vivo,,CHEMBL621092,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for its clearance when administered intravenously in rat,Intermediate,10116.0,N,8635,1,,1,A,,,3184,
In vivo,,CHEMBL621093,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,10116.0,N,8636,1,,1,A,,,16456,
,,CHEMBL621094,,50597,,BAO_0000218,Rattus norvegicus,,,Blood: Brain distribution ratio is determined in rat,Intermediate,10116.0,N,8637,1,,1,A,,,4199,
,,CHEMBL621095,,50597,,BAO_0000218,Rattus norvegicus,,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,Intermediate,10116.0,N,8638,1,,1,A,,,4199,
,,CHEMBL621096,,50597,,BAO_0000218,Rattus norvegicus,,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,Intermediate,10116.0,N,8639,1,,1,A,,,4199,
In vivo,,CHEMBL621097,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,8640,1,,1,A,,,8677,
,,CHEMBL621098,,50597,,BAO_0000218,Rattus norvegicus,,,Percent dose excreted in 0-48 hours administered ip to male rat,Intermediate,10116.0,N,8641,1,,1,F,,,7449,
,,CHEMBL621099,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8642,1,,1,A,,,11977,
,,CHEMBL621100,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8643,1,,1,A,,,11977,
,,CHEMBL621101,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,8644,1,,1,A,,,11977,
,,CHEMBL621102,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8645,1,,1,A,,,11977,
,,CHEMBL876732,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8646,1,,1,A,,,11977,
,,CHEMBL621103,,50597,,BAO_0000218,Rattus norvegicus,,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8647,1,,1,A,,,11977,
,,CHEMBL621104,,50597,,BAO_0000218,Rattus norvegicus,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8648,1,,1,A,,,11977,
,,CHEMBL621105,,50597,,BAO_0000218,Rattus norvegicus,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,8649,1,,1,A,,,11977,
,,CHEMBL621106,,50597,,BAO_0000218,Rattus norvegicus,,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8650,1,,1,A,,,11977,
,,CHEMBL621107,,50597,,BAO_0000218,Rattus norvegicus,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8651,1,,1,A,,,11977,
,,CHEMBL621108,,50597,,BAO_0000218,Rattus norvegicus,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8652,1,,1,A,,,11977,
,,CHEMBL621109,,50597,,BAO_0000218,Rattus norvegicus,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8653,1,,1,A,,,11977,
In vivo,,CHEMBL621110,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8654,1,,1,A,,,17208,
In vivo,,CHEMBL621111,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8655,1,,1,A,,,17208,
In vivo,,CHEMBL622541,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8656,1,,1,A,,,17208,
In vivo,,CHEMBL622542,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8657,1,,1,A,,,17208,
In vivo,,CHEMBL622543,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8658,1,,1,A,,,17208,
In vivo,,CHEMBL624412,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8659,1,,1,A,,,17208,
In vivo,,CHEMBL624413,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8660,1,,1,A,,,17208,
In vivo,,CHEMBL624414,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8661,1,,1,A,,,17208,
In vivo,,CHEMBL624415,,50594,Lung,BAO_0000218,Mus musculus,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8662,1,,1,A,,,17208,
In vivo,,CHEMBL624416,,50594,Lung,BAO_0000218,Mus musculus,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8663,1,,1,A,,,17208,
In vivo,,CHEMBL624417,,50594,Lung,BAO_0000218,Mus musculus,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8664,1,,1,A,,,17208,
In vivo,,CHEMBL624418,,50594,Lung,BAO_0000218,Mus musculus,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8665,1,,1,A,,,17208,
In vivo,,CHEMBL624419,,50594,Lung,BAO_0000218,Mus musculus,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8666,1,,1,A,,,17208,
In vivo,,CHEMBL624420,,50594,Lung,BAO_0000218,Mus musculus,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8667,1,,1,A,,,17208,
In vivo,,CHEMBL624421,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8668,1,,1,A,,,17208,
In vivo,,CHEMBL624422,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8669,1,,1,A,,,17208,
In vivo,,CHEMBL624423,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8670,1,,1,A,,,17208,
In vivo,,CHEMBL625123,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8671,1,,1,A,,,17208,
In vivo,,CHEMBL625124,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8672,1,,1,A,,,17208,
In vivo,,CHEMBL625125,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8673,1,,1,A,,,17208,
In vivo,,CHEMBL625126,,50594,Zone of skin,BAO_0000218,Mus musculus,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8674,1,,1,A,,,17208,
In vivo,,CHEMBL626947,,50594,Zone of skin,BAO_0000218,Mus musculus,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8675,1,,1,A,,,17208,
In vivo,,CHEMBL626948,,50594,Zone of skin,BAO_0000218,Mus musculus,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8676,1,,1,A,,,17208,
In vivo,,CHEMBL626949,,50594,Zone of skin,BAO_0000218,Mus musculus,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8677,1,,1,A,,,17208,
In vivo,,CHEMBL626950,,50594,Zone of skin,BAO_0000218,Mus musculus,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8678,1,,1,A,,,17208,
In vivo,,CHEMBL626951,,50594,Zone of skin,BAO_0000218,Mus musculus,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8679,1,,1,A,,,17208,
In vivo,,CHEMBL626952,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8680,1,,1,A,,,17208,
In vivo,,CHEMBL626953,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8681,1,,1,A,,,17208,
In vivo,,CHEMBL626954,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8682,1,,1,A,,,17208,
In vivo,,CHEMBL626955,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8683,1,,1,A,,,17208,
In vivo,,CHEMBL626956,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8684,1,,1,A,,,17208,
In vivo,,CHEMBL626957,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8685,1,,1,A,,,17208,
In vivo,,CHEMBL626958,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8686,1,,1,A,,,17208,
In vivo,,CHEMBL626959,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8687,1,,1,A,,,17208,
In vivo,,CHEMBL626960,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8688,1,,1,A,,,17208,
In vivo,,CHEMBL626961,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8689,1,,1,A,,,17208,
In vivo,,CHEMBL627589,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8690,1,,1,A,,,17208,
In vivo,,CHEMBL627590,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,10090.0,N,8691,1,,1,A,,,17208,
,,CHEMBL627591,,50594,,BAO_0000218,Mus musculus,,,Time taken for EC90 was determined when tested in mouse,Intermediate,10090.0,N,8692,1,,1,A,,,3132,
,,CHEMBL627592,,50594,,BAO_0000218,Mus musculus,,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,Intermediate,10090.0,N,8693,1,,1,A,,,3132,
In vivo,,CHEMBL627593,,50594,,BAO_0000218,Mus musculus,,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),Intermediate,10090.0,N,8694,1,,1,A,,,16597,
,,CHEMBL627594,,50594,,BAO_0000218,Mus musculus,,,Half life in mice,Intermediate,10090.0,N,8695,1,,1,A,,,5727,
In vivo,,CHEMBL876813,,50594,,BAO_0000218,Mus musculus,,,Half life period in mouse after 10 mg/Kg dose,Intermediate,10090.0,N,8696,1,,1,A,,,5302,
In vivo,,CHEMBL627595,,50594,,BAO_0000218,Mus musculus,,,Half life period in mouse after 10 mg/kg dose,Intermediate,10090.0,N,8697,1,,1,A,,,5302,
In vivo,,CHEMBL627596,,50594,,BAO_0000218,Mus musculus,,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,Intermediate,10090.0,N,8698,1,,1,A,,,6348,
In vivo,,CHEMBL627597,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value at 5 mg/kg po was determined in rat,Intermediate,10116.0,N,8699,1,,1,A,,,5964,
In vivo,,CHEMBL627598,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value evaluated in rat,Intermediate,10116.0,N,8700,1,,1,A,,,6078,
In vivo,,CHEMBL627599,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,Intermediate,10116.0,N,8701,1,,1,A,,,5206,
In vivo,,CHEMBL627600,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value after administration of 20 mg/Kg oral dose in rat,Intermediate,10116.0,N,8702,1,,1,A,,,2959,
In vivo,,CHEMBL627601,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value at 1 mg/kg po in rat,Intermediate,10116.0,N,8703,1,,1,A,,,5964,
In vivo,,CHEMBL627776,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value at 5 mg/kg po in rat,Intermediate,10116.0,N,8704,1,,1,A,,,5964,
In vivo,,CHEMBL627777,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value at a dose of 10 mg/kg in male SD rats,Intermediate,10116.0,N,8705,1,,1,A,,,6757,
In vivo,,CHEMBL627778,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value at a dose of 100 mg/kg in male SD rats,Intermediate,10116.0,N,8706,1,,1,A,,,6757,
In vivo,,CHEMBL627779,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value at a dose of 50 mg/kg in male SD rats,Intermediate,10116.0,N,8707,1,,1,A,,,6757,
In vivo,,CHEMBL876814,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value in rats at 10 mg/kg,Intermediate,10116.0,N,8708,1,,1,A,,,17617,
In vivo,,CHEMBL627780,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value was evaluated in rats at a dose of 20 mg/kg,Intermediate,10116.0,N,8709,1,,1,A,,,1445,
In vivo,,CHEMBL627781,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value was determined after peroral administration of 20 mg/kg in rat,Intermediate,10116.0,N,8710,1,,1,A,,,6082,
In vivo,,CHEMBL627782,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Intermediate,10116.0,N,8711,1,,1,A,,,1446,
In vivo,,CHEMBL627783,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,Intermediate,10116.0,N,8712,1,,1,A,,,5407,
In vivo,,CHEMBL627784,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,Intermediate,10116.0,N,8713,1,,1,A,,,2690,
In vivo,,CHEMBL627785,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,10116.0,N,8714,1,,1,A,,,2661,
In vivo,,CHEMBL627786,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,10116.0,N,8715,1,,1,A,,,2661,
In vivo,,CHEMBL627787,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,Intermediate,10116.0,N,8716,1,,1,A,,,4891,
In vivo,,CHEMBL627788,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,Intermediate,10116.0,N,8717,1,,1,A,,,2807,
In vivo,,CHEMBL626579,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,Intermediate,10116.0,N,8718,1,,1,A,,,2807,
In vivo,,CHEMBL626580,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,Intermediate,10116.0,N,8719,1,,1,A,,,2807,
In vivo,,CHEMBL876815,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,Intermediate,10116.0,N,8720,1,,1,A,,,3634,
In vivo,,CHEMBL626581,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,Intermediate,10116.0,N,8721,1,,1,A,,,1881,
In vivo,,CHEMBL626582,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,Intermediate,10116.0,N,8722,1,,1,A,,,1881,
In vivo,,CHEMBL626583,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,Intermediate,10116.0,N,8723,1,,1,A,,,429,
In vivo,,CHEMBL626205,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,8724,1,,1,A,,,5974,
In vivo,,CHEMBL626206,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,8725,1,,1,A,,,5974,
In vivo,,CHEMBL626207,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,8726,1,,1,A,,,5974,
In vivo,,CHEMBL623882,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,8727,1,,1,A,,,5974,
In vivo,,CHEMBL623883,,50597,,BAO_0000218,Rattus norvegicus,,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,Intermediate,10116.0,N,8728,1,,1,A,,,17582,
In vivo,,CHEMBL623884,,50597,,BAO_0000218,Rattus norvegicus,,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,Intermediate,10116.0,N,8729,1,,1,A,,,17582,
In vivo,,CHEMBL623885,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Intermediate,10116.0,N,8730,1,,1,A,,,3032,
In vivo,,CHEMBL623886,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,Intermediate,10116.0,N,8731,1,,1,A,,,6295,
In vivo,,CHEMBL623887,,50597,,BAO_0000218,Rattus norvegicus,,,Maximal concentration in rat was determined,Intermediate,10116.0,N,8732,1,,1,A,,,6619,
In vivo,,CHEMBL623888,,50597,,BAO_0000218,Rattus norvegicus,,,Maximal concentration after i.v. administration,Intermediate,10116.0,N,8733,1,,1,A,,,6616,
In vivo,,CHEMBL623889,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,Intermediate,10116.0,N,8734,1,,1,A,,,3249,
In vivo,,CHEMBL623890,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,Intermediate,10116.0,N,8735,1,,1,A,,,17791,
In vivo,,CHEMBL623891,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Cmax in rat plasma after oral dose (50 mg/Kg),Intermediate,10116.0,N,8736,1,,1,A,,,17791,
In vivo,,CHEMBL623892,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximal plasma concentration was determined.,Intermediate,10116.0,N,8737,1,,1,A,,,1360,
In vivo,,CHEMBL623893,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximal plasma drug concentration was determined,Intermediate,10116.0,N,8738,1,,1,A,,,2552,
In vivo,,CHEMBL877616,,50597,,BAO_0000218,Rattus norvegicus,,,Maximal concentration in rats after peroral administration,Intermediate,10116.0,N,8739,1,,1,A,,,6571,
In vivo,,CHEMBL623894,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration in rat after 2 mg/kg peroral administration,Intermediate,10116.0,N,8740,1,,1,A,,,6570,
In vivo,,CHEMBL623895,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,Intermediate,10116.0,N,8741,1,,1,A,,,6567,
In vivo,,CHEMBL623896,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration of compound in rat was evaluated.,Intermediate,10116.0,N,8742,1,,1,A,,,3031,
In vivo,,CHEMBL623897,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,10116.0,N,8743,1,,1,A,,,3436,
In vivo,,CHEMBL623898,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,10116.0,N,8744,1,,1,A,,,3436,
In vivo,,CHEMBL623899,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,Intermediate,10116.0,N,8745,1,,1,A,,,2083,
In vivo,,CHEMBL623900,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,10116.0,N,8746,1,,1,A,,,3436,
In vivo,,CHEMBL623901,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,10116.0,N,8747,1,,1,A,,,4527,
In vivo,,CHEMBL623902,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration was evaluated in rats,Intermediate,10116.0,N,8748,1,,1,A,,,1974,
In vivo,,CHEMBL623903,,50597,Cerebrospinal fluid,BAO_0000218,Rattus norvegicus,1359.0,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,10116.0,N,8749,1,,1,A,,,3307,
In vivo,,CHEMBL623904,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,10116.0,N,8750,1,,1,A,,,3307,
In vivo,,CHEMBL877617,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,10116.0,N,8751,1,,1,A,,,1916,
In vivo,,CHEMBL623905,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,Intermediate,10116.0,N,8752,1,,1,A,,,1500,
In vivo,,CHEMBL623906,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,Intermediate,10116.0,N,8753,1,,1,A,,,1500,
In vivo,,CHEMBL623907,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,10116.0,N,8754,1,,1,A,,,4186,
,,CHEMBL623908,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,10116.0,N,8755,1,,1,A,,,16434,
,,CHEMBL623909,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,Intermediate,10116.0,N,8756,1,,1,A,,,16434,
,,CHEMBL623910,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,10116.0,N,8757,1,,1,A,,,16434,
,,CHEMBL623911,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,10116.0,N,8758,1,,1,A,,,16434,
,,CHEMBL623912,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,10116.0,N,8759,1,,1,A,,,16435,
,,CHEMBL624616,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,10116.0,N,8760,1,,1,A,,,16435,
,,CHEMBL624617,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,10116.0,N,8761,1,,1,A,,,16435,
,,CHEMBL624618,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,10116.0,N,8762,1,,1,A,,,16435,
,,CHEMBL624619,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,10116.0,N,8763,1,,1,A,,,16435,
,,CHEMBL624794,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,10116.0,N,8764,1,,1,A,,,16435,
,,CHEMBL624795,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,10116.0,N,8765,1,,1,A,,,16435,
,,CHEMBL623921,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,10116.0,N,8766,1,,1,A,,,16435,
,,CHEMBL623922,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,8767,1,,1,A,,,16434,
,,CHEMBL623923,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,8768,1,,1,A,,,16434,
,,CHEMBL623924,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,8769,1,,1,A,,,16434,
,,CHEMBL623925,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,8770,1,,1,A,,,16435,
,,CHEMBL623926,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,8771,1,,1,A,,,16435,
,,CHEMBL623927,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,8772,1,,1,A,,,16435,
,,CHEMBL623928,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,8773,1,,1,A,,,16435,
,,CHEMBL623929,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,8774,1,,1,A,,,16435,
,,CHEMBL623930,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,8775,1,,1,A,,,16435,
,,CHEMBL623931,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,8776,1,,1,A,,,16434,
,,CHEMBL622165,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,10116.0,N,8777,1,,1,A,,,16434,
,,CHEMBL621249,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,8778,1,,1,A,,,16434,
,,CHEMBL621250,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,8779,1,,1,A,,,16434,
,,CHEMBL621448,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,10116.0,N,8780,1,,1,A,,,16434,
,,CHEMBL621449,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,10116.0,N,8781,1,,1,A,,,16434,
,,CHEMBL621450,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,10116.0,N,8782,1,,1,A,,,16434,
,,CHEMBL621451,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,10116.0,N,8783,1,,1,A,,,16434,
,,CHEMBL621452,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,10116.0,N,8784,1,,1,A,,,16435,
,,CHEMBL621453,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,10116.0,N,8785,1,,1,A,,,16435,
,,CHEMBL621454,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,10116.0,N,8786,1,,1,A,,,16435,
,,CHEMBL621455,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,10116.0,N,8787,1,,1,A,,,16435,
,,CHEMBL621456,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,10116.0,N,8788,1,,1,A,,,16435,
,,CHEMBL625145,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,10116.0,N,8789,1,,1,A,,,16435,
,,CHEMBL875847,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,10116.0,N,8790,1,,1,A,,,16435,
,,CHEMBL625146,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,10116.0,N,8791,1,,1,A,,,16435,
,,CHEMBL625147,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,8792,1,,1,A,,,16434,
,,CHEMBL625148,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,8793,1,,1,A,,,16434,
,,CHEMBL625149,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,8794,1,,1,A,,,16434,
,,CHEMBL625150,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,8795,1,,1,A,,,16435,
,,CHEMBL625151,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,8796,1,,1,A,,,16435,
,,CHEMBL625152,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,8797,1,,1,A,,,16435,
,,CHEMBL625153,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,8798,1,,1,A,,,16435,
,,CHEMBL625154,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,8799,1,,1,A,,,16435,
,,CHEMBL625155,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,8800,1,,1,A,,,16435,
,,CHEMBL625156,,50597,,BAO_0000218,Rattus norvegicus,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,8801,1,,1,A,,,11977,
,,CHEMBL624354,,50597,,BAO_0000218,Rattus norvegicus,,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8802,1,,1,A,,,11977,
,,CHEMBL624355,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8803,1,,1,A,,,11977,
,,CHEMBL624356,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8804,1,,1,A,,,11977,
,,CHEMBL624357,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8805,1,,1,A,,,11977,
,,CHEMBL624358,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8806,1,,1,A,,,11977,
,,CHEMBL624359,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8807,1,,1,A,,,11977,
,,CHEMBL624360,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8808,1,,1,A,,,11977,
,,CHEMBL624361,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,8809,1,,1,A,,,11977,
,,CHEMBL624362,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8810,1,,1,A,,,11977,
,,CHEMBL624363,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8811,1,,1,A,,,11977,
In vivo,,CHEMBL624364,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8812,1,,1,A,,,11977,
In vivo,,CHEMBL624365,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8813,1,,1,A,,,11977,
In vivo,,CHEMBL624366,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8814,1,,1,A,,,11977,
In vivo,,CHEMBL624367,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8815,1,,1,A,,,11977,
In vivo,,CHEMBL624368,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8816,1,,1,A,,,11977,
In vivo,,CHEMBL624369,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8817,1,,1,A,,,11977,
In vivo,,CHEMBL624370,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,8818,1,,1,A,,,11977,
In vivo,,CHEMBL625069,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8819,1,,1,A,,,11977,
In vivo,,CHEMBL625070,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8820,1,,1,A,,,11977,
In vivo,,CHEMBL626051,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8821,1,,1,A,,,11977,
In vivo,,CHEMBL626052,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8822,1,,1,A,,,11977,
In vivo,,CHEMBL626053,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,8823,1,,1,A,,,11977,
In vivo,,CHEMBL626054,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8824,1,,1,A,,,11977,
In vivo,,CHEMBL626055,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8825,1,,1,A,,,11977,
In vivo,,CHEMBL626056,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8826,1,,1,A,,,11977,
In vivo,,CHEMBL626057,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8827,1,,1,A,,,11977,
In vivo,,CHEMBL625193,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8828,1,,1,A,,,11977,
In vivo,,CHEMBL625194,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8829,1,,1,A,,,11977,
In vivo,,CHEMBL625195,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8830,1,,1,A,,,11977,
In vivo,,CHEMBL625196,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8831,1,,1,A,,,11977,
In vivo,,CHEMBL625197,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,8832,1,,1,A,,,11977,
In vivo,,CHEMBL625198,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8833,1,,1,A,,,11977,
In vivo,,CHEMBL627929,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8834,1,,1,A,,,11977,
In vivo,,CHEMBL627074,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8835,1,,1,A,,,11977,
In vivo,,CHEMBL627075,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8836,1,,1,A,,,11977,
In vivo,,CHEMBL627076,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,8837,1,,1,A,,,11977,
In vivo,,CHEMBL627077,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8838,1,,1,A,,,11977,
In vivo,,CHEMBL627078,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8839,1,,1,A,,,11977,
In vivo,,CHEMBL627079,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,8840,1,,1,A,,,11977,
In vivo,,CHEMBL873824,,50594,,BAO_0000218,Mus musculus,,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,Intermediate,10090.0,N,8841,1,,1,A,,,4573,
In vivo,,CHEMBL627080,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Half life in mouse plasma was determined at dose 25 mg/kg,Intermediate,10090.0,N,8842,1,,1,A,,,3132,
,,CHEMBL627081,,50594,,BAO_0000218,Mus musculus,,,Half life was determined,Intermediate,10090.0,N,8843,1,,1,A,,,17718,
In vivo,,CHEMBL627082,,50594,,BAO_0000218,Mus musculus,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Intermediate,10090.0,N,8844,1,,1,A,,,17728,
In vivo,,CHEMBL627083,,50594,,BAO_0000218,Mus musculus,,,Half-life in male mice after 1 mg/kg intravenous dose,Intermediate,10090.0,N,8845,1,,1,A,,,5961,
,,CHEMBL627085,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Half life in mice plasma,Intermediate,10090.0,N,8847,1,,1,A,,,17731,
,,CHEMBL627086,,50594,,BAO_0000218,Mus musculus,,,Half life in mouse,Intermediate,10090.0,N,8848,1,,1,A,,,17592,
In vivo,,CHEMBL627087,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Half life in mouse plasma at dose 25 mg/kg,Intermediate,10090.0,N,8849,1,,1,A,,,3132,
In vivo,,CHEMBL627088,,50594,,BAO_0000218,Mus musculus,,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,Intermediate,10090.0,N,8850,1,,1,A,,,17729,
In vivo,,CHEMBL627089,,50594,,BAO_0000218,Mus musculus,,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,Intermediate,10090.0,N,8851,1,,1,A,,,17729,
In vivo,,CHEMBL627090,,50594,,BAO_0000218,Mus musculus,,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,Intermediate,10090.0,N,8852,1,,1,A,,,17729,
In vivo,,CHEMBL627091,,50594,,BAO_0000218,Mus musculus,,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),Intermediate,10090.0,N,8853,1,,1,A,,,3277,
In vivo,,CHEMBL627092,,50594,,BAO_0000218,Mus musculus,,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",Intermediate,10090.0,N,8854,1,,1,A,,,3760,
In vivo,,CHEMBL876785,,50594,,BAO_0000218,Mus musculus,,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",Intermediate,10090.0,N,8855,1,,1,A,,,3760,
In vivo,,CHEMBL627093,,50594,,BAO_0000218,Mus musculus,,,Half-life by iv administration in mouse,Intermediate,10090.0,N,8856,1,,1,A,,,2862,
In vivo,,CHEMBL627094,,50594,,BAO_0000218,Mus musculus,,,Half-life by oral administration in mouse,Intermediate,10090.0,N,8857,1,,1,A,,,2862,
,,CHEMBL627095,,50594,,BAO_0000218,Mus musculus,,,Half-life in mice,Intermediate,10090.0,N,8858,1,,1,A,,,5980,
,,CHEMBL627096,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Half-life using mouse brain homogenate,Intermediate,10090.0,N,8859,1,,1,A,,,6159,
,,CHEMBL627097,,50594,,BAO_0000218,Mus musculus,,,Half-life was measured in mice,Intermediate,10090.0,N,8860,1,,1,A,,,6254,
In vivo,,CHEMBL627098,,50594,,BAO_0000218,Mus musculus,,,Half-life was measured in mouse after an iv dose of 1 mg/kg,Intermediate,10090.0,N,8861,1,,1,A,,,6062,
,,CHEMBL627099,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Half-life period was determined in mouse blood,Intermediate,10090.0,N,8862,1,,1,A,,,1574,
,,CHEMBL627100,,50594,Brain,BAO_0000218,Mus musculus,955.0,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",Intermediate,10090.0,N,8863,1,,1,A,,,56,
,,CHEMBL627101,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Plasma half life in mouse,Intermediate,10090.0,N,8864,1,,1,A,,,993,
,,CHEMBL627102,,50594,,BAO_0000218,Mus musculus,,,Stability of the peptide in the presence of mouse serum,Intermediate,10090.0,N,8865,1,,1,A,,,6652,
,,CHEMBL627103,,50594,,BAO_0000218,Mus musculus,,,Terminal half life of compound was determined in mouse,Intermediate,10090.0,N,8866,1,,1,A,,,17852,
In vivo,,CHEMBL627104,,50594,,BAO_0000218,Mus musculus,,,Terminal half life was evaluated in mice after intravenous administration,Intermediate,10090.0,N,8867,1,,1,A,,,2675,
In vivo,,CHEMBL627105,,50594,,BAO_0000218,Mus musculus,,,Terminal half life was evaluated in mice after oral administration,Intermediate,10090.0,N,8868,1,,1,A,,,2675,
,,CHEMBL876786,,50594,,BAO_0000218,Mus musculus,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,Intermediate,10090.0,N,8869,1,,1,A,,,499,
,,CHEMBL873825,,50594,,BAO_0000218,Mus musculus,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,Intermediate,10090.0,N,8870,1,,1,A,,,499,
,,CHEMBL627106,,50594,,BAO_0000218,Mus musculus,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,Intermediate,10090.0,N,8871,1,,1,A,,,499,
In vivo,,CHEMBL626336,,50594,,BAO_0000218,Mus musculus,,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,Intermediate,10090.0,N,8872,1,,1,A,,,14239,
In vivo,,CHEMBL877462,,50594,,BAO_0000218,Mus musculus,,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",Intermediate,10090.0,N,8873,1,,1,A,,,5506,
In vivo,,CHEMBL626337,,50594,,BAO_0000218,Mus musculus,,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",Intermediate,10090.0,N,8874,1,,1,A,,,5506,
,,CHEMBL626338,,50594,,BAO_0000218,Mus musculus,,,Half life after intraperitoneal administration of 100 mg/kg in mice,Intermediate,10090.0,N,8875,1,,1,A,,,17734,
In vivo,,CHEMBL626339,,50594,,BAO_0000218,Mus musculus,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,Intermediate,10090.0,N,8876,1,,1,A,,,17728,
In vivo,,CHEMBL626340,,50594,,BAO_0000218,Mus musculus,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Intermediate,10090.0,N,8877,1,,1,A,,,17728,
In vivo,,CHEMBL625377,,50594,,BAO_0000218,Mus musculus,,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,Intermediate,10090.0,N,8878,1,,1,A,,,17728,
In vivo,,CHEMBL625378,,50594,,BAO_0000218,Mus musculus,,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,Intermediate,10090.0,N,8879,1,,1,A,,,17728,
In vivo,,CHEMBL625379,,50594,,BAO_0000218,Mus musculus,,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,Intermediate,10090.0,N,8880,1,,1,A,,,17728,
,Microsomes,CHEMBL625380,,22224,,BAO_0000251,Sus scrofa,,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Autocuration,9823.0,U,8881,1,,0,A,,,14294,
,Microsomes,CHEMBL625381,,22224,,BAO_0000251,Sus scrofa,,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Autocuration,9823.0,U,8882,1,,0,A,,,14294,
,,CHEMBL625382,,22224,,BAO_0000019,Sus scrofa,,,Stability to porcine renal DHP-I,Autocuration,9823.0,U,8883,1,,0,A,,,6056,
In vivo,,CHEMBL873828,,22224,,BAO_0000218,Sus scrofa,,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,Autocuration,9823.0,U,8884,1,,0,A,,,1317,
In vivo,,CHEMBL625383,,22224,,BAO_0000218,Sus scrofa,,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,Autocuration,9823.0,U,8885,1,,0,A,,,1317,
,,CHEMBL625384,,22224,,BAO_0000019,Sus scrofa,,,Half-life of the parent prodrug in porcine esterase solution,Autocuration,9823.0,U,8886,1,,0,A,,,5229,
,,CHEMBL625385,,22224,,BAO_0000019,Sus scrofa,,,"First order rate constant, k was determined in in pig liver Esterase",Autocuration,9823.0,U,8887,1,,0,A,,,4231,
,,CHEMBL625386,,22224,Liver,BAO_0000221,Sus scrofa,2107.0,,Half life of the in pig liver Esterase,Autocuration,9823.0,U,8888,1,,0,A,,,4231,
,,CHEMBL623571,,22224,Liver,BAO_0000221,Sus scrofa,2107.0,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,Autocuration,9823.0,U,8889,1,,0,A,,,5318,
,,CHEMBL623572,,22224,Liver,BAO_0000221,Sus scrofa,2107.0,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,Autocuration,9823.0,U,8890,1,,0,A,,,5318,
,,CHEMBL623573,,22224,Liver,BAO_0000221,Sus scrofa,2107.0,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,Autocuration,9823.0,U,8891,1,,0,A,,,5318,
,,CHEMBL623574,,22224,Liver,BAO_0000221,Sus scrofa,2107.0,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,Autocuration,9823.0,U,8892,1,,0,A,,,3305,
,,CHEMBL623575,,22224,Liver,BAO_0000221,Sus scrofa,2107.0,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,Autocuration,9823.0,U,8893,1,,0,A,,,3305,
,,CHEMBL623749,,22224,Liver,BAO_0000221,Sus scrofa,2107.0,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,Autocuration,9823.0,U,8894,1,,0,A,,,2842,
,,CHEMBL623750,,22224,Liver,BAO_0000221,Sus scrofa,2107.0,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,Autocuration,9823.0,U,8895,1,,0,A,,,2842,
In vitro,,CHEMBL623751,,22224,Liver,BAO_0000221,Sus scrofa,2107.0,,Half-life in vitro in pig liver,Autocuration,9823.0,U,8896,1,,0,A,,,889,
,,CHEMBL623752,,22224,Liver,BAO_0000221,Sus scrofa,2107.0,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,Autocuration,9823.0,U,8897,1,,0,A,,,1904,
In vivo,,CHEMBL623753,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,Intermediate,10116.0,N,8898,1,,1,A,,,4186,
In vivo,,CHEMBL623754,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Intermediate,10116.0,N,8899,1,,1,A,,,2774,
In vivo,,CHEMBL623755,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration in rat plasma was determined,Intermediate,10116.0,N,8900,1,,1,A,,,1742,
In vivo,,CHEMBL623756,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration in rats,Intermediate,10116.0,N,8901,1,,1,A,,,3169,
In vivo,,CHEMBL623757,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration in rats at 1-2 hours,Intermediate,10116.0,N,8902,1,,1,A,,,3169,
In vivo,,CHEMBL623758,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,Intermediate,10116.0,N,8903,1,,1,A,,,2081,
In vivo,,CHEMBL623759,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,10116.0,N,8904,1,,1,A,,,3307,
In vivo,,CHEMBL623760,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration at the dose of 2 mg/kg in rat,Intermediate,10116.0,N,8905,1,,1,A,,,4727,
In vivo,,CHEMBL623761,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration was evaluated in rats,Intermediate,10116.0,N,8906,1,,1,A,,,6597,
In vivo,,CHEMBL623762,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,Intermediate,10116.0,N,8907,1,,1,A,,,16365,
In vivo,,CHEMBL877594,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,Intermediate,10116.0,N,8908,1,,1,A,,,16365,
In vivo,,CHEMBL623763,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,Intermediate,10116.0,N,8909,1,,1,A,,,16365,
In vivo,,CHEMBL623764,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,Intermediate,10116.0,N,8910,1,,1,A,,,16365,
In vivo,,CHEMBL623765,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,Intermediate,10116.0,N,8911,1,,1,A,,,16365,
In vivo,,CHEMBL623766,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,Intermediate,10116.0,N,8912,1,,1,A,,,2591,
In vivo,,CHEMBL623767,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,Intermediate,10116.0,N,8913,1,,1,A,,,2591,
In vivo,,CHEMBL623768,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,Intermediate,10116.0,N,8914,1,,1,A,,,2591,
In vivo,,CHEMBL623769,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,10116.0,N,8915,1,,1,A,,,5978,
In vivo,,CHEMBL623770,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,10116.0,N,8916,1,,1,A,,,5978,
In vivo,,CHEMBL623771,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,10116.0,N,8917,1,,1,A,,,5978,
In vivo,,CHEMBL623772,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,10116.0,N,8918,1,,1,A,,,5978,
In vivo,,CHEMBL623773,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,10116.0,N,8919,1,,1,A,,,5978,
In vivo,,CHEMBL623774,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,10116.0,N,8920,1,,1,A,,,5978,
In vivo,,CHEMBL623775,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,10116.0,N,8921,1,,1,A,,,5978,
In vivo,,CHEMBL623776,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat (PO dose),Intermediate,10116.0,N,8922,1,,1,A,,,14465,
In vivo,,CHEMBL622191,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,8923,1,,1,A,,,4723,
In vivo,,CHEMBL622192,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,8924,1,,1,A,,,4723,
In vivo,,CHEMBL622193,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration determined in rat,Intermediate,10116.0,N,8925,1,,1,A,,,4576,
In vivo,,CHEMBL622194,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,10116.0,N,8926,1,,1,A,,,12873,
In vivo,,CHEMBL622195,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,10116.0,N,8927,1,,1,A,,,12873,
In vivo,,CHEMBL622196,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration in rat,Intermediate,10116.0,N,8928,1,,1,A,,,6824,
In vivo,,CHEMBL622197,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,10116.0,N,8929,1,,1,A,,,17065,
In vivo,,CHEMBL622198,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,Intermediate,10116.0,N,8930,1,,1,A,,,2932,
In vivo,,CHEMBL622199,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,Intermediate,10116.0,N,8931,1,,1,A,,,2932,
In vivo,,CHEMBL622200,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration of compound was measured in rat,Intermediate,10116.0,N,8932,1,,1,A,,,2879,
In vivo,,CHEMBL622201,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration after 20 mg/kg oral administration in rat,Intermediate,10116.0,N,8933,1,,1,A,,,2864,
In vivo,,CHEMBL623990,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration after oral administration to rats,Intermediate,10116.0,N,8934,1,,1,A,,,16367,
In vivo,,CHEMBL623991,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,10116.0,N,8935,1,,1,A,,,17717,
In vivo,,CHEMBL623992,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",Intermediate,10116.0,N,8936,1,,1,A,,,17717,
In vivo,,CHEMBL623993,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,10116.0,N,8937,1,,1,A,,,17717,
In vivo,,CHEMBL623994,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,10116.0,N,8938,1,,1,A,,,17717,
In vivo,,CHEMBL623995,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,Intermediate,10116.0,N,8939,1,,1,F,,,17720,
In vivo,,CHEMBL623996,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,10116.0,N,8940,1,,1,F,,,17720,
In vivo,,CHEMBL623997,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,Intermediate,10116.0,N,8941,1,,1,F,,,17720,
In vivo,,CHEMBL623998,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration dosed orally in rats,Intermediate,10116.0,N,8942,1,,1,A,,,4516,
In vivo,,CHEMBL623999,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration dosed orally in rats after 6 hours,Intermediate,10116.0,N,8943,1,,1,A,,,4516,
In vivo,,CHEMBL624000,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,Intermediate,10116.0,N,8944,1,,1,A,,,4516,
In vivo,,CHEMBL624001,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Intermediate,10116.0,N,8945,1,,1,A,,,5199,
In vivo,,CHEMBL624002,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration in rat after po administration,Intermediate,10116.0,N,8946,1,,1,A,,,17538,
In vivo,,CHEMBL624003,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",Intermediate,10116.0,N,8947,1,,1,A,,,6685,
In vivo,,CHEMBL624004,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",Intermediate,10116.0,N,8948,1,,1,A,,,6685,
,,CHEMBL624005,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,8949,1,,1,A,,,16434,
,,CHEMBL624006,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,10116.0,N,8950,1,,1,A,,,16434,
,,CHEMBL624007,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,8951,1,,1,A,,,16434,
,,CHEMBL624008,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,8952,1,,1,A,,,16434,
,,CHEMBL624009,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,10116.0,N,8953,1,,1,A,,,16434,
,,CHEMBL874387,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,10116.0,N,8954,1,,1,A,,,16434,
,,CHEMBL624010,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,10116.0,N,8955,1,,1,A,,,16434,
,,CHEMBL624011,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,10116.0,N,8956,1,,1,A,,,16434,
,,CHEMBL624012,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,10116.0,N,8957,1,,1,A,,,16435,
,,CHEMBL624013,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,10116.0,N,8958,1,,1,A,,,16435,
,,CHEMBL624736,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,10116.0,N,8959,1,,1,A,,,16435,
,,CHEMBL624737,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,10116.0,N,8960,1,,1,A,,,16435,
,,CHEMBL624738,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,8961,1,,1,A,,,16434,
,,CHEMBL624739,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,8962,1,,1,A,,,16434,
,,CHEMBL624740,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,8963,1,,1,A,,,16434,
,,CHEMBL624896,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,8964,1,,1,A,,,16435,
,,CHEMBL624897,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,8965,1,,1,A,,,16435,
,,CHEMBL624108,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,8966,1,,1,A,,,16435,
,,CHEMBL624109,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,8967,1,,1,A,,,16435,
,,CHEMBL624110,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,8968,1,,1,A,,,16435,
,,CHEMBL624111,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,8969,1,,1,A,,,16435,
,,CHEMBL624112,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,10116.0,N,8970,1,,1,A,,,16435,
,,CHEMBL624113,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,10116.0,N,8971,1,,1,A,,,16435,
,,CHEMBL619709,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,10116.0,N,8972,1,,1,A,,,16435,
,,CHEMBL619710,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,10116.0,N,8973,1,,1,A,,,16435,
,,CHEMBL619711,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,8974,1,,1,A,,,16434,
,,CHEMBL619712,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,10116.0,N,8975,1,,1,A,,,16434,
,,CHEMBL619713,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,8976,1,,1,A,,,16434,
,,CHEMBL619714,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,8977,1,,1,A,,,16434,
,,CHEMBL619715,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,10116.0,N,8978,1,,1,A,,,16434,
,,CHEMBL619716,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,10116.0,N,8979,1,,1,A,,,16434,
,,CHEMBL619717,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,10116.0,N,8980,1,,1,A,,,16434,
,,CHEMBL619718,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,10116.0,N,8981,1,,1,A,,,16434,
,,CHEMBL619719,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,10116.0,N,8982,1,,1,A,,,16435,
,,CHEMBL875329,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,10116.0,N,8983,1,,1,A,,,16435,
,,CHEMBL619720,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,10116.0,N,8984,1,,1,A,,,16435,
,,CHEMBL619721,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,10116.0,N,8985,1,,1,A,,,16435,
,,CHEMBL619722,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,10116.0,N,8986,1,,1,A,,,16435,
,,CHEMBL619723,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,10116.0,N,8987,1,,1,A,,,16435,
,,CHEMBL619724,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,10116.0,N,8988,1,,1,A,,,16435,
,,CHEMBL619725,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,10116.0,N,8989,1,,1,A,,,16435,
,,CHEMBL619726,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,8990,1,,1,A,,,16434,
,,CHEMBL619727,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,8991,1,,1,A,,,16434,
,,CHEMBL619728,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,8992,1,,1,A,,,16434,
,,CHEMBL619729,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,8993,1,,1,A,,,16435,
In vivo,,CHEMBL619730,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8994,1,,1,A,,,11977,
In vivo,,CHEMBL619731,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8995,1,,1,A,,,11977,
In vivo,,CHEMBL619732,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,8996,1,,1,A,,,11977,
In vivo,,CHEMBL619733,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8997,1,,1,A,,,11977,
In vivo,,CHEMBL619734,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8998,1,,1,A,,,11977,
In vivo,,CHEMBL619735,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,8999,1,,1,A,,,11977,
In vivo,,CHEMBL875330,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9000,1,,1,A,,,11977,
In vivo,,CHEMBL628465,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,9001,1,,1,A,,,11977,
In vivo,,CHEMBL628466,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9002,1,,1,A,,,11977,
In vivo,,CHEMBL628467,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9003,1,,1,A,,,11977,
In vivo,,CHEMBL628468,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9004,1,,1,A,,,11977,
In vivo,,CHEMBL628469,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9005,1,,1,A,,,11977,
In vivo,,CHEMBL628470,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,9006,1,,1,A,,,11977,
In vivo,,CHEMBL628471,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9007,1,,1,A,,,11977,
In vivo,,CHEMBL628472,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9008,1,,1,A,,,11977,
In vivo,,CHEMBL625191,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9009,1,,1,A,,,11977,
In vivo,,CHEMBL625192,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9010,1,,1,A,,,11977,
In vivo,,CHEMBL875337,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,10116.0,N,9011,1,,1,A,,,11977,
In vivo,,CHEMBL626341,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9012,1,,1,A,,,11977,
In vivo,,CHEMBL626342,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9013,1,,1,A,,,11977,
In vivo,,CHEMBL621943,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,10116.0,N,9014,1,,1,A,,,11977,
,,CHEMBL621944,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rats,Intermediate,10116.0,N,9015,1,,1,A,,,3748,
,,CHEMBL621945,,50597,,BAO_0000218,Rattus norvegicus,,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,Intermediate,10116.0,N,9016,1,,1,A,,,15765,
,,CHEMBL621946,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),Intermediate,10116.0,N,9017,1,,1,A,,,4871,
,,CHEMBL621947,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,Intermediate,10116.0,N,9018,1,,1,A,,,4871,
,,CHEMBL621948,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),Intermediate,10116.0,N,9019,1,,1,A,,,4872,
,,CHEMBL621949,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,Intermediate,10116.0,N,9020,1,,1,A,,,4872,
,,CHEMBL621950,,50597,,BAO_0000218,Rattus norvegicus,,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),Intermediate,10116.0,N,9021,1,,1,A,,,5413,
,,CHEMBL621951,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,Intermediate,10116.0,N,9022,1,,1,A,,,5413,
In vivo,,CHEMBL621952,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,Intermediate,10116.0,N,9023,1,,1,A,,,15272,
,,CHEMBL621953,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Stability (%) in rat liver microsomes,Intermediate,10116.0,N,9024,1,,1,A,,,4689,
,,CHEMBL621954,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was calculated after intravenous administration,Intermediate,10116.0,N,9025,1,,1,A,,,6057,
,,CHEMBL621955,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was calculated after iv administration in rat,Intermediate,10116.0,N,9026,1,,1,A,,,6057,
,,CHEMBL621956,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was calculated in rat after peroral administration,Intermediate,10116.0,N,9027,1,,1,A,,,6057,
,,CHEMBL621957,,50597,,BAO_0000218,Rattus norvegicus,,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,10116.0,N,9028,1,,1,A,,,6211,
,,CHEMBL621958,,50597,,BAO_0000218,Rattus norvegicus,,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,Intermediate,10116.0,N,9029,1,,1,A,,,5710,
,,CHEMBL621959,,50597,,BAO_0000218,Rattus norvegicus,,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,Intermediate,10116.0,N,9030,1,,1,A,,,5710,
,,CHEMBL621960,,50597,,BAO_0000218,Rattus norvegicus,,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,Intermediate,10116.0,N,9031,1,,1,A,,,17853,
,,CHEMBL621961,,50597,,BAO_0000218,Rattus norvegicus,,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,Intermediate,10116.0,N,9032,1,,1,A,,,17853,
,,CHEMBL621962,,50597,,BAO_0000218,Rattus norvegicus,,,p value of the compound,Intermediate,10116.0,N,9033,1,,1,A,,,15765,
,,CHEMBL876787,,50597,,BAO_0000218,Rattus norvegicus,,,p value of the compound,Intermediate,10116.0,N,9034,1,,1,F,,,15765,
,,CHEMBL621963,,50597,,BAO_0000218,Rattus norvegicus,,,p value of the compound,Intermediate,10116.0,N,9035,1,,1,A,,,15765,
,,CHEMBL622637,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,10116.0,N,9036,1,,1,A,,,6175,
,,CHEMBL622638,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,10116.0,N,9037,1,,1,A,,,6175,
,,CHEMBL626561,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,10116.0,N,9038,1,,1,A,,,6175,
,,CHEMBL626562,,22224,,BAO_0000019,Oryctolagus cuniculus,,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),Autocuration,9986.0,U,9039,1,,0,F,,,7991,
,,CHEMBL626563,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),Autocuration,9986.0,U,9040,1,,0,A,,,429,
,,CHEMBL626564,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),Autocuration,9986.0,U,9041,1,,0,A,,,429,
In vivo,,CHEMBL626565,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Autocuration,9986.0,U,9042,1,,0,A,,,6253,
In vivo,,CHEMBL626566,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Autocuration,9986.0,U,9043,1,,0,A,,,6253,
In vivo,,CHEMBL626567,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Clearance rate in rabbits,Autocuration,9986.0,U,9044,1,,0,A,,,3615,
In vivo,,CHEMBL626568,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,9986.0,U,9045,1,,0,A,,,4059,
In vivo,,CHEMBL626569,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,9986.0,U,9046,1,,0,A,,,5124,
In vivo,,CHEMBL626570,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,9986.0,U,9047,1,,0,A,,,5124,
In vivo,,CHEMBL626571,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,9986.0,U,9048,1,,0,A,,,5124,
In vivo,,CHEMBL626572,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,Autocuration,9986.0,U,9049,1,,0,A,,,429,
In vivo,,CHEMBL626573,,22224,Plasma,BAO_0000218,Oryctolagus cuniculus,1969.0,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,9986.0,U,9050,1,,0,A,,,4059,
,Microsomes,CHEMBL626574,,22224,Liver,BAO_0000251,Oryctolagus cuniculus,2107.0,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Autocuration,9986.0,U,9051,1,,0,A,,,9659,
,Microsomes,CHEMBL626575,,22224,Liver,BAO_0000251,Oryctolagus cuniculus,2107.0,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Autocuration,9986.0,U,9052,1,,0,A,,,9659,
,,CHEMBL626576,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,Autocuration,9986.0,U,9053,1,,0,A,,,3639,
,,CHEMBL626577,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Dose at which bioavailability of perorally administered compound was tested in rabbit,Autocuration,9986.0,U,9054,1,,0,A,,,3639,
In vivo,,CHEMBL626578,,22224,,BAO_0000218,Oryctolagus cuniculus,,,The compound was tested for its bioavailability in rabbit (by oral dosage).,Autocuration,9986.0,U,9055,1,,0,A,,,3639,
In vivo,,CHEMBL625263,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,9986.0,U,9056,1,,0,A,,,5124,
In vivo,,CHEMBL625264,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,9986.0,U,9057,1,,0,A,,,5124,
In vivo,,CHEMBL625265,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,9986.0,U,9058,1,,0,A,,,5124,
,Microsomes,CHEMBL625266,,22224,,BAO_0000251,Oryctolagus cuniculus,,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Autocuration,9986.0,U,9059,1,,0,A,,,14294,
,Microsomes,CHEMBL876796,,22224,,BAO_0000251,Oryctolagus cuniculus,,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Autocuration,9986.0,U,9060,1,,0,A,,,14294,
In vivo,,CHEMBL625267,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,Autocuration,9986.0,U,9061,1,,0,A,,,429,
In vivo,,CHEMBL625268,,22224,Plasma,BAO_0000218,Oryctolagus cuniculus,1969.0,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,9986.0,U,9062,1,,0,A,,,5124,
In vivo,,CHEMBL625269,,22224,Plasma,BAO_0000218,Oryctolagus cuniculus,1969.0,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,9986.0,U,9063,1,,0,A,,,5124,
In vivo,,CHEMBL624689,,22224,Plasma,BAO_0000218,Oryctolagus cuniculus,1969.0,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,9986.0,U,9064,1,,0,A,,,5124,
In vivo,,CHEMBL624690,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,Autocuration,9986.0,U,9065,1,,0,A,,,429,
,,CHEMBL624691,,22224,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),Autocuration,9986.0,U,9066,1,,0,A,,,429,
,,CHEMBL624692,,22224,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),Autocuration,9986.0,U,9067,1,,0,A,,,429,
In vivo,,CHEMBL624693,,22224,,BAO_0000218,Oryctolagus cuniculus,,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,9986.0,U,9068,1,,0,A,,,4059,
In vivo,,CHEMBL624694,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,Autocuration,9986.0,U,9069,1,,0,A,,,4137,
In vitro,,CHEMBL877596,,22224,,BAO_0000221,Oryctolagus cuniculus,,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,Autocuration,9986.0,U,9070,1,,0,A,,,11672,
,,CHEMBL624695,,22224,,BAO_0000019,Oryctolagus cuniculus,,,Time within which only 10% of the drug was degraded,Autocuration,9986.0,U,9071,1,,0,A,,,12886,
,,CHEMBL624696,,22224,Liver,BAO_0000221,Oryctolagus cuniculus,2107.0,,Half life period in rabbit liver homogenate,Autocuration,9986.0,U,9072,1,,0,A,,,3853,
,,CHEMBL624697,,22224,,BAO_0000019,Oryctolagus cuniculus,,,Half life value in rabbits,Autocuration,9986.0,U,9073,1,,0,A,,,3615,
In vivo,,CHEMBL624698,,22224,Blood,BAO_0000218,Oryctolagus cuniculus,178.0,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Autocuration,9986.0,U,9074,1,,0,A,,,6253,
In vivo,,CHEMBL624699,,22224,Blood,BAO_0000218,Oryctolagus cuniculus,178.0,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Autocuration,9986.0,U,9075,1,,0,A,,,6253,
In vivo,,CHEMBL624700,,22224,,BAO_0000218,Oryctolagus cuniculus,,,Half-life period in rabbits following intravenous administration at 2 mg/kg,Autocuration,9986.0,U,9076,1,,0,A,,,6077,
,,CHEMBL622903,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC 0-8 hr value in rats at 10 mg/kg,Intermediate,10116.0,N,9077,1,,1,A,,,17617,
,,CHEMBL622904,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC after administration at 2000 mg/kg/day in rats,Intermediate,10116.0,N,9078,1,,1,A,,,17594,
,,CHEMBL622905,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,Intermediate,10116.0,N,9079,1,,1,A,,,6149,
,,CHEMBL622906,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,10116.0,N,9080,1,,1,A,,,17260,
,,CHEMBL622907,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,10116.0,N,9081,1,,1,A,,,17260,
,,CHEMBL622908,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC in rat after oral administration at 10.5 mg/kg dose,Intermediate,10116.0,N,9082,1,,1,A,,,6644,
,,CHEMBL622909,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC in rat after oral administration at 11.2 mg/kg dose,Intermediate,10116.0,N,9083,1,,1,A,,,6644,
,,CHEMBL622910,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC in rat after oral administration at 9.7 mg/kg dose,Intermediate,10116.0,N,9084,1,,1,A,,,6644,
,,CHEMBL622911,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,AUC in rat brain after oral administration at 10 mg/kg,Intermediate,10116.0,N,9085,1,,1,A,,,6495,
,,CHEMBL622912,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC in rat p.o.,Intermediate,10116.0,N,9086,1,,1,A,,,6504,
,,CHEMBL622913,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC in rat p.o. at 20 mg/kg concentration,Intermediate,10116.0,N,9087,1,,1,A,,,17686,
,,CHEMBL622914,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC in rat plasma after oral administration at 10 mg/kg,Intermediate,10116.0,N,9088,1,,1,A,,,6495,
,,CHEMBL622915,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC in rats,Intermediate,10116.0,N,9089,1,,1,A,,,216,
,,CHEMBL622916,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,10116.0,N,9090,1,,1,A,,,1908,
,,CHEMBL622917,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,10116.0,N,9091,1,,1,A,,,1908,
In vivo,,CHEMBL622918,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,10116.0,N,9092,1,,1,A,,,6685,
In vivo,,CHEMBL622919,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,Intermediate,10116.0,N,9093,1,,1,A,,,216,
In vivo,,CHEMBL622920,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration was evaluated in rat,Intermediate,10116.0,N,9094,1,,1,A,,,6049,
In vivo,,CHEMBL622921,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Intermediate,10116.0,N,9095,1,,1,A,,,2463,
In vivo,,CHEMBL622922,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,Intermediate,10116.0,N,9096,1,,1,A,,,6679,
In vivo,,CHEMBL622923,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Intermediate,10116.0,N,9097,1,,1,A,,,6681,
In vivo,,CHEMBL877604,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,10116.0,N,9098,1,,1,A,,,4890,
In vivo,,CHEMBL622924,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,Intermediate,10116.0,N,9099,1,,1,A,,,6410,
In vivo,,CHEMBL622925,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,10116.0,N,9100,1,,1,A,,,6410,
In vivo,,CHEMBL622926,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,Intermediate,10116.0,N,9101,1,,1,A,,,16366,
In vivo,,CHEMBL623625,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,Intermediate,10116.0,N,9102,1,,1,A,,,6227,
In vivo,,CHEMBL623626,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,10116.0,N,9103,1,,1,A,,,3598,
In vivo,,CHEMBL623627,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma drug concentration was determined,Intermediate,10116.0,N,9104,1,,1,A,,,1465,
In vivo,,CHEMBL623628,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,Intermediate,10116.0,N,9105,1,,1,A,,,4368,
In vivo,,CHEMBL623629,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Mean peak plasma concentration was observed after intravenous administration in rat,Intermediate,10116.0,N,9106,1,,1,A,,,15662,
In vivo,,CHEMBL623630,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Mean peak plasma concentration was observed after oral administration in rat,Intermediate,10116.0,N,9107,1,,1,A,,,15662,
In vivo,,CHEMBL623804,,50597,,BAO_0000218,Rattus norvegicus,,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,Intermediate,10116.0,N,9108,1,,1,A,,,5355,
In vivo,,CHEMBL623805,,50597,,BAO_0000218,Rattus norvegicus,,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,Intermediate,10116.0,N,9109,1,,1,A,,,5355,
In vivo,,CHEMBL623806,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Peak oral plasma concentration was determined in rats by oral administration,Intermediate,10116.0,N,9110,1,,1,A,,,1567,
In vivo,,CHEMBL623807,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Peak plasma concentration (Cmax) was determined,Intermediate,10116.0,N,9111,1,,1,A,,,4026,
In vivo,,CHEMBL623808,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,Intermediate,10116.0,N,9112,1,,1,A,,,6193,
In vivo,,CHEMBL623809,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Peak plasma concentration (Cmax) in rats,Intermediate,10116.0,N,9113,1,,1,A,,,4026,
In vivo,,CHEMBL623810,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Peak plasma concentration at 1 mg/kg peroral administration,Intermediate,10116.0,N,9114,1,,1,A,,,6485,
In vivo,,CHEMBL623811,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Peak plasma concentration in rat,Intermediate,10116.0,N,9115,1,,1,A,,,17655,
In vivo,,CHEMBL623812,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,10116.0,N,9116,1,,1,A,,,14941,
In vivo,,CHEMBL877605,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,Intermediate,10116.0,N,9117,1,,1,A,,,5394,
In vivo,,CHEMBL623813,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Cmax) in rat,Intermediate,10116.0,N,9118,1,,1,A,,,4408,
In vivo,,CHEMBL623814,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,10116.0,N,9119,1,,1,A,,,5983,
In vivo,,CHEMBL623815,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat after 3mg/kg oral dose,Intermediate,10116.0,N,9120,1,,1,A,,,4878,
In vivo,,CHEMBL623816,,50597,,BAO_0000218,Rattus norvegicus,,Sprague-Dawley,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,Intermediate,10116.0,N,9121,1,,1,A,,,5862,
In vivo,,CHEMBL623145,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rats after 20 mg/kg oral dose,Intermediate,10116.0,N,9122,1,,1,A,,,4517,
In vivo,,CHEMBL623146,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Cmax in rat plasma after 30mg/kg oral dose,Intermediate,10116.0,N,9123,1,,1,A,,,5932,
In vivo,,CHEMBL623147,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma concentration after oral administration of 100 mg/kg to rats,Intermediate,10116.0,N,9124,1,,1,A,,,5436,
In vivo,,CHEMBL623042,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,10116.0,N,9125,1,,1,A,,,4910,
In vivo,,CHEMBL623043,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for the Cmax in rat at 10 mg/kg per orally,Intermediate,10116.0,N,9126,1,,1,A,,,4950,
In vivo,,CHEMBL623044,,50597,,BAO_0000218,Rattus norvegicus,,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,9127,1,,1,A,,,15078,
In vivo,,CHEMBL623045,,50597,,BAO_0000218,Rattus norvegicus,,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,9128,1,,1,A,,,15078,
In vivo,,CHEMBL623046,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability as oral Cmax in rats at 30 mins,Intermediate,10116.0,N,9129,1,,1,A,,,3360,
In vivo,,CHEMBL623226,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability as oral Cmax in rats at 6hr,Intermediate,10116.0,N,9130,1,,1,A,,,3360,
In vivo,,CHEMBL623227,,50597,,BAO_0000218,Rattus norvegicus,,,The maximum concentration of compound was measured at the dose of 100 umol/kg,Intermediate,10116.0,N,9131,1,,1,A,,,15022,
In vivo,,CHEMBL623228,,50597,,BAO_0000218,Rattus norvegicus,,,The maximum concentration of compound was measured at the dose of 300 umol/kg,Intermediate,10116.0,N,9132,1,,1,A,,,15022,
In vivo,,CHEMBL623229,,50597,,BAO_0000218,Rattus norvegicus,,,The maximum concentration of compound was measured at the dose of 30 umol/kg,Intermediate,10116.0,N,9133,1,,1,A,,,15022,
In vivo,,CHEMBL623230,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The maximum plasma levels for the compounds were determined by LC-MS.,Intermediate,10116.0,N,9134,1,,1,A,,,5160,
In vivo,,CHEMBL623231,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,mean peak plasma concentration was observed after intravenous administration in rat,Intermediate,10116.0,N,9135,1,,1,A,,,15662,
In vivo,,CHEMBL623232,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,mean peak plasma concentration was observed after oral administration in rat,Intermediate,10116.0,N,9136,1,,1,A,,,15662,
,,CHEMBL623233,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,Intermediate,10116.0,N,9137,1,,1,A,,,4709,
,,CHEMBL623234,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,Intermediate,10116.0,N,9138,1,,1,A,,,3535,
,,CHEMBL623235,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration in plasma (portal) following oral dose in rats at 1 hr,Intermediate,10116.0,N,9139,1,,1,A,,,3535,
,,CHEMBL623236,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration in plasma (portal) following oral dose in rats at 2 hr,Intermediate,10116.0,N,9140,1,,1,A,,,3535,
,,CHEMBL623237,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,Intermediate,10116.0,N,9141,1,,1,A,,,3535,
,,CHEMBL623238,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,Intermediate,10116.0,N,9142,1,,1,A,,,3535,
,,CHEMBL623239,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,Intermediate,10116.0,N,9143,1,,1,A,,,3535,
In vivo,,CHEMBL623240,,22224,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,Intermediate,10116.0,U,9144,1,,0,A,,,5005,
,,CHEMBL623241,,50597,Hypothalamus,BAO_0000218,Rattus norvegicus,1898.0,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",Intermediate,10116.0,N,9145,1,,1,A,,,6326,
,,CHEMBL623242,,50597,Hypothalamus,BAO_0000218,Rattus norvegicus,1898.0,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",Intermediate,10116.0,N,9146,1,,1,A,,,6326,
,,CHEMBL874394,,50597,,BAO_0000218,Rattus norvegicus,,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",Intermediate,10116.0,N,9147,1,,1,A,,,6326,
,,CHEMBL623243,,50597,,BAO_0000218,Rattus norvegicus,,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",Intermediate,10116.0,N,9148,1,,1,A,,,6326,
,,CHEMBL623244,,50597,,BAO_0000218,Rattus norvegicus,,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9149,1,,1,A,,,17411,
,,CHEMBL623245,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,9150,1,,1,A,,,16435,
,,CHEMBL623246,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,9151,1,,1,A,,,16435,
,,CHEMBL623247,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,9152,1,,1,A,,,16435,
,,CHEMBL623248,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,9153,1,,1,A,,,16435,
,,CHEMBL623249,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,9154,1,,1,A,,,16435,
,,CHEMBL625072,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,9155,1,,1,A,,,16434,
,,CHEMBL625073,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,10116.0,N,9156,1,,1,A,,,16434,
,,CHEMBL625074,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,9157,1,,1,A,,,16434,
,,CHEMBL625075,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,9158,1,,1,A,,,16434,
,,CHEMBL625076,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,Intermediate,10116.0,N,9159,1,,1,A,,,16434,
,,CHEMBL625077,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,10116.0,N,9160,1,,1,A,,,16434,
,,CHEMBL625078,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,10116.0,N,9161,1,,1,A,,,16434,
,,CHEMBL874395,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,10116.0,N,9162,1,,1,A,,,16434,
,,CHEMBL625079,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,10116.0,N,9163,1,,1,A,,,16435,
,,CHEMBL625080,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,10116.0,N,9164,1,,1,A,,,16435,
,,CHEMBL625081,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,10116.0,N,9165,1,,1,A,,,16435,
,,CHEMBL625082,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,10116.0,N,9166,1,,1,A,,,16435,
,,CHEMBL625083,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,10116.0,N,9167,1,,1,A,,,16435,
,,CHEMBL625084,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,10116.0,N,9168,1,,1,A,,,16435,
,,CHEMBL625085,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,10116.0,N,9169,1,,1,A,,,16435,
,,CHEMBL625086,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,10116.0,N,9170,1,,1,A,,,16435,
,,CHEMBL625087,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,9171,1,,1,A,,,16434,
,,CHEMBL625088,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,9172,1,,1,A,,,16434,
,,CHEMBL622205,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,9173,1,,1,A,,,16434,
,,CHEMBL622206,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,9174,1,,1,A,,,16435,
,,CHEMBL622207,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,9175,1,,1,A,,,16435,
,,CHEMBL622366,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,9176,1,,1,A,,,16435,
,,CHEMBL622367,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,9177,1,,1,A,,,16435,
,,CHEMBL875331,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,9178,1,,1,A,,,16435,
,,CHEMBL622368,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,9179,1,,1,A,,,16435,
,,CHEMBL622369,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,9180,1,,1,A,,,16434,
,,CHEMBL622370,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,10116.0,N,9181,1,,1,A,,,16434,
,,CHEMBL622371,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,9182,1,,1,A,,,16434,
,,CHEMBL622372,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,9183,1,,1,A,,,16434,
,,CHEMBL622373,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,10116.0,N,9184,1,,1,A,,,16434,
,,CHEMBL622374,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,10116.0,N,9185,1,,1,A,,,16434,
,,CHEMBL622375,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,10116.0,N,9186,1,,1,A,,,16434,
,,CHEMBL622376,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,10116.0,N,9187,1,,1,A,,,16434,
,,CHEMBL622377,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,10116.0,N,9188,1,,1,A,,,16435,
,,CHEMBL622378,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,10116.0,N,9189,1,,1,A,,,16435,
,,CHEMBL622379,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,10116.0,N,9190,1,,1,A,,,16435,
,,CHEMBL622380,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,10116.0,N,9191,1,,1,A,,,16435,
,,CHEMBL622381,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,10116.0,N,9192,1,,1,A,,,16435,
,,CHEMBL622382,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,10116.0,N,9193,1,,1,A,,,16435,
,,CHEMBL622383,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,9194,1,,1,A,,,16434,
,,CHEMBL875332,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,10116.0,N,9195,1,,1,A,,,6175,
,,CHEMBL622384,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,10116.0,N,9196,1,,1,A,,,6175,
,,CHEMBL622385,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,10116.0,N,9197,1,,1,A,,,6175,
,,CHEMBL622386,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,10116.0,N,9198,1,,1,A,,,6175,
,,CHEMBL622387,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for the plasma binding in rat,Intermediate,10116.0,N,9199,1,,1,A,,,10839,
,,CHEMBL622388,,50597,,BAO_0000218,Rattus norvegicus,,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",Intermediate,10116.0,N,9200,1,,1,A,,,16459,
,,CHEMBL622389,,50597,,BAO_0000218,Rattus norvegicus,,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",Intermediate,10116.0,N,9201,1,,1,A,,,16459,
,,CHEMBL622390,,50597,,BAO_0000218,Rattus norvegicus,,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",Intermediate,10116.0,N,9202,1,,1,A,,,16459,
,,CHEMBL622391,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),Intermediate,10116.0,N,9203,1,,1,A,,,16459,
,,CHEMBL622392,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),Intermediate,10116.0,N,9204,1,,1,A,,,16459,
,,CHEMBL622393,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),Intermediate,10116.0,N,9205,1,,1,A,,,16459,
,,CHEMBL622394,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma level at 2 hr after administration of the compound,Intermediate,10116.0,N,9206,1,,1,A,,,3278,
,,CHEMBL622395,,50597,,BAO_0000218,Rattus norvegicus,,,plasma level at 2 hr after administration of the compound,Intermediate,10116.0,N,9207,1,,1,A,,,3278,
,,CHEMBL622396,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Stability in rat serum measured as % recovery at 1 min,Intermediate,10116.0,N,9208,1,,1,A,,,4684,
,,CHEMBL624894,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Stability in rat serum measured as % recovery at 10 min,Intermediate,10116.0,N,9209,1,,1,A,,,4684,
,,CHEMBL624895,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Stability in rat serum measured as % recovery at 10 mins,Intermediate,10116.0,N,9210,1,,1,A,,,4684,
,,CHEMBL624058,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Stability in rat serum measured as % recovery at 2 hr,Intermediate,10116.0,N,9211,1,,1,A,,,4684,
,,CHEMBL624059,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Stability in rat serum measured as % recovery at 3 min,Intermediate,10116.0,N,9212,1,,1,A,,,4684,
,,CHEMBL624060,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Stability in rat serum measured as % recovery at 3 mins,Intermediate,10116.0,N,9213,1,,1,A,,,4684,
,,CHEMBL624061,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Stability in rat serum measured as % recovery at 5 min,Intermediate,10116.0,N,9214,1,,1,A,,,4684,
,,CHEMBL624062,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Stability in rat serum measured as % recovery at 5 mins,Intermediate,10116.0,N,9215,1,,1,A,,,4684,
In vivo,,CHEMBL624063,,50597,,BAO_0000218,Rattus norvegicus,,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,10116.0,N,9216,1,,1,A,,,16456,
In vivo,,CHEMBL624064,,50597,,BAO_0000218,Rattus norvegicus,,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,10116.0,N,9217,1,,1,A,,,16456,
,,CHEMBL624065,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,Intermediate,10116.0,N,9218,1,,1,A,,,723,
,,CHEMBL624066,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,Intermediate,10116.0,N,9219,1,,1,A,,,723,
In vivo,,CHEMBL877490,,50597,,BAO_0000218,Rattus norvegicus,,,Half life tested in mature male rat at a dose of 30 mg/kg,Intermediate,10116.0,N,9220,1,,1,A,,,5160,
In vivo,,CHEMBL874442,,50597,,BAO_0000218,Rattus norvegicus,,,Half life after intravenous administration of 1 mg/kg in rat,Intermediate,10116.0,N,9221,1,,1,A,,,4709,
In vivo,,CHEMBL626890,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period after administration (30 mg/kg) in rat,Intermediate,10116.0,N,9222,1,,1,A,,,5633,
In vivo,,CHEMBL626891,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat after 5 mg/Kg dose,Intermediate,10116.0,N,9223,1,,1,A,,,5302,
In vivo,,CHEMBL626892,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat after 5 mg/kg dose,Intermediate,10116.0,N,9224,1,,1,A,,,5302,
,,CHEMBL626893,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was determined,Intermediate,10116.0,N,9225,1,,1,A,,,17791,
,,CHEMBL626894,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was evaluated in rat,Intermediate,10116.0,N,9226,1,,1,A,,,17791,
,,CHEMBL626895,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was evaluated in rat; 0.5-1.0,Intermediate,10116.0,N,9227,1,,1,A,,,17791,
,,CHEMBL626896,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was evaluated in rat; 5.9-7.5,Intermediate,10116.0,N,9228,1,,1,A,,,17791,
,,CHEMBL626897,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in rat plasma,Intermediate,10116.0,N,9229,1,,1,A,,,14512,
,,CHEMBL626898,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life time in rat was determined,Intermediate,10116.0,N,9230,1,,1,A,,,6230,
In vivo,,CHEMBL626899,,50597,,BAO_0000218,Rattus norvegicus,,,Terminal half-life after iv administration to rats,Intermediate,10116.0,N,9231,1,,1,A,,,3364,
In vivo,,CHEMBL626900,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,Intermediate,10116.0,N,9232,1,,1,A,,,6874,
,,CHEMBL626901,,50597,,BAO_0000218,Rattus norvegicus,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,Intermediate,10116.0,N,9233,1,,1,A,,,857,
In vivo,,CHEMBL626902,,50597,,BAO_0000218,Rattus norvegicus,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),Intermediate,10116.0,N,9234,1,,1,A,,,858,
In vivo,,CHEMBL626903,,50597,,BAO_0000218,Rattus norvegicus,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),Intermediate,10116.0,N,9235,1,,1,A,,,858,
In vivo,,CHEMBL874443,,50597,,BAO_0000218,Rattus norvegicus,,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,Intermediate,10116.0,N,9236,1,,1,A,,,5355,
In vivo,,CHEMBL626904,,50597,,BAO_0000218,Rattus norvegicus,,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,Intermediate,10116.0,N,9237,1,,1,A,,,5355,
,,CHEMBL626905,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rats,Intermediate,10116.0,N,9238,1,,1,A,,,6305,
In vivo,,CHEMBL873830,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,Intermediate,10116.0,N,9239,1,,1,A,,,13501,
In vivo,,CHEMBL626906,,50597,,BAO_0000218,Rattus norvegicus,,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,Intermediate,10116.0,N,9240,1,,1,A,,,17594,
In vivo,,CHEMBL631076,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,10116.0,N,9241,1,,1,A,,,4186,
,,CHEMBL631077,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biological half-life was measured in plasma of rats,Intermediate,10116.0,N,9242,1,,1,A,,,2932,
In vivo,,CHEMBL631078,,50597,,BAO_0000218,Rattus norvegicus,,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,10116.0,N,9243,1,,1,A,,,17065,
In vivo,,CHEMBL631079,,50597,,BAO_0000218,Rattus norvegicus,,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,Intermediate,10116.0,N,9244,1,,1,A,,,15765,
In vivo,,CHEMBL631080,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,Intermediate,10116.0,N,9245,1,,1,A,,,2713,
In vivo,,CHEMBL631081,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,10116.0,N,9246,1,,1,A,,,2661,
In vivo,,CHEMBL631239,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,10116.0,N,9247,1,,1,A,,,2661,
,,CHEMBL631240,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was evaluated for plasma half life in rat,Intermediate,10116.0,N,9248,1,,1,A,,,740,
,,CHEMBL631241,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC value at a dose of 5 mg/kg (p.o.) in rats,Intermediate,10116.0,N,9249,1,,1,A,,,6597,
,,CHEMBL631242,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC value after administration of 20 mg/Kg oral dose in rat,Intermediate,10116.0,N,9250,1,,1,A,,,2959,
,,CHEMBL631243,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,10116.0,N,9251,1,,1,A,,,17594,
,,CHEMBL874444,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC0-96 after administration at 50 mg/kg,Intermediate,10116.0,N,9252,1,,1,A,,,17596,
,,CHEMBL631244,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,Intermediate,10116.0,N,9253,1,,1,A,,,17594,
,,CHEMBL631245,,50597,,BAO_0000218,Rattus norvegicus,,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",Intermediate,10116.0,N,9254,1,,1,A,,,3293,
,,CHEMBL627162,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,Intermediate,10116.0,N,9255,1,,1,A,,,6757,
,,CHEMBL627163,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,Intermediate,10116.0,N,9256,1,,1,A,,,6757,
,,CHEMBL627164,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,Intermediate,10116.0,N,9257,1,,1,A,,,6757,
,,CHEMBL627165,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,Intermediate,10116.0,N,9258,1,,1,A,,,5979,
,,CHEMBL627166,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,Intermediate,10116.0,N,9259,1,,1,A,,,5979,
,,CHEMBL627167,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,Intermediate,10116.0,N,9260,1,,1,A,,,5979,
,,CHEMBL627822,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (AUC) at a dose of 30 mg/kg in rats,Intermediate,10116.0,N,9261,1,,1,A,,,4026,
,,CHEMBL627823,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Intermediate,10116.0,N,9262,1,,1,A,,,5355,
,,CHEMBL627824,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,Intermediate,10116.0,N,9263,1,,1,A,,,5355,
,,CHEMBL627825,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Intermediate,10116.0,N,9264,1,,1,A,,,5355,
,,CHEMBL627826,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,Intermediate,10116.0,N,9265,1,,1,A,,,5633,
,,CHEMBL627827,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (Pharmacokinetic property) was determined,Intermediate,10116.0,N,9266,1,,1,A,,,1716,
,,CHEMBL627828,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (Pharmacokinetic property) of the compound; Not determined,Intermediate,10116.0,N,9267,1,,1,A,,,1716,
,,CHEMBL627829,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve after intravenous administration (1 mg/kg) in rat,Intermediate,10116.0,N,9268,1,,1,A,,,4689,
,,CHEMBL627830,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,Intermediate,10116.0,N,9269,1,,1,A,,,4527,
,,CHEMBL627831,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,10116.0,N,9270,1,,1,A,,,4527,
,,CHEMBL627832,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in male SD rats was observed after oral administration in rat,Intermediate,10116.0,N,9271,1,,1,A,,,15662,
,,CHEMBL627833,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,Intermediate,10116.0,N,9272,1,,1,A,,,4413,
,,CHEMBL627834,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,10116.0,N,9273,1,,1,A,,,3598,
,,CHEMBL628004,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,Expert,10116.0,N,9274,1,,1,A,,,3598,
,,CHEMBL628005,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve at 5 mg/kg po was determined in rat,Intermediate,10116.0,N,9275,1,,1,A,,,5964,
,,CHEMBL628006,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in Rat at a oral dose of 5 mg/kg,Intermediate,10116.0,N,9276,1,,1,A,,,4689,
,,CHEMBL628007,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,10116.0,N,9277,1,,1,A,,,4186,
,,CHEMBL625676,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined,Intermediate,10116.0,N,9278,1,,1,A,,,5510,
,,CHEMBL631309,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,Intermediate,10116.0,N,9279,1,,1,A,,,17858,
,,CHEMBL631310,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve after intravenous administration at 3 mg/kg,Intermediate,10116.0,N,9280,1,,1,A,,,17804,
,,CHEMBL631311,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,Intermediate,10116.0,N,9281,1,,1,A,,,6106,
,,CHEMBL631312,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve at 4 hr in rat,Intermediate,10116.0,N,9282,1,,1,A,,,5964,
,,CHEMBL631313,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve at a dose of 30 mg/kg,Intermediate,10116.0,N,9283,1,,1,A,,,4026,
,,CHEMBL631314,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,Intermediate,10116.0,N,9284,1,,1,A,,,4756,
,,CHEMBL631315,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,Intermediate,10116.0,N,9285,1,,1,A,,,4756,
,,CHEMBL631316,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve for a 2-mpk po dose in SD rats,Intermediate,10116.0,N,9286,1,,1,A,,,5862,
,,CHEMBL631317,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in SD rats,Intermediate,10116.0,N,9287,1,,1,A,,,5862,
,,CHEMBL874471,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in rat after oral administration at 13 mg/kg dose,Intermediate,10116.0,N,9288,1,,1,A,,,6644,
,,CHEMBL631318,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in rat by po administration at 0-24 hr,Intermediate,10116.0,N,9289,1,,1,A,,,5871,
,,CHEMBL631319,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under curve in rat plasma,Intermediate,10116.0,N,9290,1,,1,A,,,5919,
,,CHEMBL631320,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,Intermediate,10116.0,N,9291,1,,1,A,,,5939,
,,CHEMBL631321,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,Intermediate,10116.0,N,9292,1,,1,A,,,5939,
,,CHEMBL631322,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,Intermediate,10116.0,N,9293,1,,1,A,,,10,
,,CHEMBL631323,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,Intermediate,10116.0,N,9294,1,,1,A,,,11149,
,,CHEMBL631324,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve value in rat at a dose of 5 mg/kg,Intermediate,10116.0,N,9295,1,,1,A,,,5302,
,,CHEMBL631325,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined after oral administration in rats,Intermediate,10116.0,N,9296,1,,1,A,,,17796,
,,CHEMBL631326,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,10116.0,N,9297,1,,1,A,,,4890,
,,CHEMBL631327,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined after peroral administration in rat,Intermediate,10116.0,N,9298,1,,1,A,,,6011,
,,CHEMBL631328,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined at a dose 30 mpk administered orally.,Intermediate,10116.0,N,9299,1,,1,A,,,5375,
,,CHEMBL631329,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,Intermediate,10116.0,N,9300,1,,1,A,,,17764,
,,CHEMBL627217,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,Intermediate,10116.0,N,9301,1,,1,A,,,4368,
,,CHEMBL626352,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined in male rat,Intermediate,10116.0,N,9302,1,,1,A,,,5610,
,,CHEMBL626353,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined in rat after PO administration,Intermediate,10116.0,N,9303,1,,1,A,,,5833,
,,CHEMBL626354,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined in rat after a 3 mg/kg of oral dose,Intermediate,10116.0,N,9304,1,,1,A,,,4257,
,,CHEMBL626355,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,Intermediate,10116.0,N,9305,1,,1,A,,,5937,
,,CHEMBL626356,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,Intermediate,10116.0,N,9306,1,,1,A,,,5932,
,,CHEMBL626357,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,Intermediate,10116.0,N,9307,1,,1,A,,,5932,
,,CHEMBL626358,,50597,,BAO_0000218,Rattus norvegicus,,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9308,1,,1,A,,,17411,
,,CHEMBL626359,,50597,,BAO_0000218,Rattus norvegicus,,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9309,1,,1,A,,,17411,
,,CHEMBL626360,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Peak plasma concentration in rat at a dose of 3 mg/kg,Intermediate,10116.0,N,9310,1,,1,A,,,17771,
,,CHEMBL626361,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration at 2 hr in rats was evaluated.,Intermediate,10116.0,N,9311,1,,1,A,,,1628,
,,CHEMBL626362,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration at 2 hr in rats was evaluated; Not available,Intermediate,10116.0,N,9312,1,,1,A,,,1628,
,,CHEMBL626363,,50597,,BAO_0000218,Rattus norvegicus,,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9313,1,,1,A,,,17411,
,,CHEMBL626970,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,10116.0,N,9314,1,,1,A,,,4910,
,,CHEMBL626971,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,10116.0,N,9315,1,,1,A,,,4910,
,,CHEMBL626972,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,10116.0,N,9316,1,,1,A,,,4910,
,,CHEMBL626973,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,10116.0,N,9317,1,,1,A,,,4910,
,,CHEMBL626974,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,10116.0,N,9318,1,,1,A,,,4910,
,,CHEMBL874592,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,10116.0,N,9319,1,,1,A,,,4910,
,,CHEMBL626975,,50597,,BAO_0000218,Rattus norvegicus,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,Intermediate,10116.0,N,9320,1,,1,A,,,5510,
,,CHEMBL626976,,50597,,BAO_0000218,Rattus norvegicus,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,Intermediate,10116.0,N,9321,1,,1,A,,,5510,
,,CHEMBL626977,,50597,,BAO_0000218,Rattus norvegicus,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,Intermediate,10116.0,N,9322,1,,1,A,,,5510,
,,CHEMBL626978,,50597,,BAO_0000218,Rattus norvegicus,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,Intermediate,10116.0,N,9323,1,,1,A,,,5510,
,,CHEMBL626979,,50597,,BAO_0000218,Rattus norvegicus,,,PK study was carried to determine the relative absorption ranking in rat.,Intermediate,10116.0,N,9324,1,,1,A,,,16427,
In vivo,,CHEMBL626980,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,Intermediate,10116.0,N,9325,1,,1,A,,,4689,
,,CHEMBL626981,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",Intermediate,10116.0,N,9326,1,,1,A,,,11450,
,,CHEMBL626982,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",Intermediate,10116.0,N,9327,1,,1,A,,,11450,
,,CHEMBL626983,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",Intermediate,10116.0,N,9328,1,,1,A,,,11450,
,,CHEMBL622522,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",Intermediate,10116.0,N,9329,1,,1,A,,,11450,
,,CHEMBL622523,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",Intermediate,10116.0,N,9330,1,,1,A,,,11450,
,,CHEMBL622524,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",Intermediate,10116.0,N,9331,1,,1,A,,,11450,
,,CHEMBL622525,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",Intermediate,10116.0,N,9332,1,,1,A,,,11450,
,,CHEMBL622526,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",Intermediate,10116.0,N,9333,1,,1,A,,,11450,
,,CHEMBL619849,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",Intermediate,10116.0,N,9334,1,,1,A,,,11450,
,,CHEMBL619850,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",Intermediate,10116.0,N,9335,1,,1,A,,,11450,
,,CHEMBL623864,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",Intermediate,10116.0,N,9336,1,,1,A,,,11450,
,,CHEMBL623865,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",Intermediate,10116.0,N,9337,1,,1,A,,,11450,
,,CHEMBL623866,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",Intermediate,10116.0,N,9338,1,,1,A,,,11450,
,,CHEMBL623867,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",Intermediate,10116.0,N,9339,1,,1,A,,,11450,
,,CHEMBL877615,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",Intermediate,10116.0,N,9340,1,,1,A,,,11450,
,,CHEMBL623868,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",Intermediate,10116.0,N,9341,1,,1,A,,,11450,
,,CHEMBL623869,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",Intermediate,10116.0,N,9342,1,,1,A,,,11450,
,,CHEMBL623870,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",Intermediate,10116.0,N,9343,1,,1,A,,,11450,
,,CHEMBL623871,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,9344,1,,1,A,,,16434,
,,CHEMBL623872,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,9345,1,,1,A,,,16434,
,,CHEMBL622129,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,9346,1,,1,A,,,16435,
,,CHEMBL622130,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,9347,1,,1,A,,,16435,
,,CHEMBL622131,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,9348,1,,1,A,,,16435,
,,CHEMBL622132,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,9349,1,,1,A,,,16435,
,,CHEMBL622133,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,9350,1,,1,A,,,16435,
,,CHEMBL622134,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,9351,1,,1,A,,,16435,
,,CHEMBL622135,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,10116.0,N,9352,1,,1,A,,,16435,
,,CHEMBL622136,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,10116.0,N,9353,1,,1,A,,,16435,
,,CHEMBL622137,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,9354,1,,1,A,,,16434,
,,CHEMBL622138,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,10116.0,N,9355,1,,1,A,,,16434,
,,CHEMBL623017,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,9356,1,,1,A,,,16434,
,,CHEMBL623018,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,9357,1,,1,A,,,16434,
,,CHEMBL623019,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,10116.0,N,9358,1,,1,A,,,16434,
,,CHEMBL623020,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,10116.0,N,9359,1,,1,A,,,16434,
,,CHEMBL623021,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,Intermediate,10116.0,N,9360,1,,1,A,,,16434,
,,CHEMBL623022,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,10116.0,N,9361,1,,1,A,,,16434,
,,CHEMBL623023,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,10116.0,N,9362,1,,1,A,,,16435,
,,CHEMBL623024,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,10116.0,N,9363,1,,1,A,,,16435,
,,CHEMBL623025,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,10116.0,N,9364,1,,1,A,,,16435,
,,CHEMBL620545,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,10116.0,N,9365,1,,1,A,,,16435,
,,CHEMBL620546,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,10116.0,N,9366,1,,1,A,,,16435,
,,CHEMBL620547,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,10116.0,N,9367,1,,1,A,,,16435,
,,CHEMBL620548,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,10116.0,N,9368,1,,1,A,,,16435,
,,CHEMBL620549,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,10116.0,N,9369,1,,1,A,,,16435,
,,CHEMBL620550,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,9370,1,,1,A,,,16434,
,,CHEMBL620551,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,9371,1,,1,A,,,16434,
,,CHEMBL620552,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,9372,1,,1,A,,,16434,
,,CHEMBL620553,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,9373,1,,1,A,,,16435,
,,CHEMBL620554,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,9374,1,,1,A,,,16435,
,,CHEMBL875845,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,9375,1,,1,A,,,16435,
,,CHEMBL620555,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,9376,1,,1,A,,,16435,
,,CHEMBL620556,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,9377,1,,1,A,,,16435,
,,CHEMBL620557,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,9378,1,,1,A,,,16435,
,,CHEMBL620558,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,9379,1,,1,A,,,16434,
,,CHEMBL620559,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,10116.0,N,9380,1,,1,A,,,16434,
,,CHEMBL622939,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,9381,1,,1,A,,,16434,
,,CHEMBL622940,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,9382,1,,1,A,,,16434,
,,CHEMBL622941,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,10116.0,N,9383,1,,1,A,,,16434,
,,CHEMBL622942,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,10116.0,N,9384,1,,1,A,,,16434,
,,CHEMBL622943,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,10116.0,N,9385,1,,1,A,,,16434,
,,CHEMBL622944,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,10116.0,N,9386,1,,1,A,,,16434,
,,CHEMBL622945,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,10116.0,N,9387,1,,1,A,,,16435,
,,CHEMBL622946,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,10116.0,N,9388,1,,1,A,,,16435,
,,CHEMBL622947,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for terminal half life in rat,Intermediate,10116.0,N,9389,1,,1,A,,,3341,
In vivo,,CHEMBL622948,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,Intermediate,10116.0,N,9390,1,,1,A,,,3634,
In vivo,,CHEMBL622949,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,Intermediate,10116.0,N,9391,1,,1,A,,,3634,
,,CHEMBL622950,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for its half life in rat,Intermediate,10116.0,N,9392,1,,1,A,,,4839,
In vivo,,CHEMBL622951,,22224,Plasma,BAO_0000218,Macaca mulatta,1969.0,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,Intermediate,9544.0,U,9393,1,,0,A,,,5005,
,,CHEMBL622952,,22224,Plasma,BAO_0000366,Rattus norvegicus,1969.0,,Compound was tested for its plasma half life in Sprague Dawley rats,Intermediate,10116.0,U,9394,1,,0,A,,,5005,
,,CHEMBL622953,,22224,Plasma,BAO_0000366,Rattus norvegicus,1969.0,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,Intermediate,10116.0,U,9395,1,,0,A,,,5005,
,,CHEMBL873818,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was tested for plasma half-life period in rat,Intermediate,10116.0,N,9396,1,,1,A,,,1094,
In vivo,,CHEMBL622954,,50597,,BAO_0000218,Rattus norvegicus,,,Elimination half life after i.v. administration of compound in rats,Intermediate,10116.0,N,9397,1,,1,A,,,5031,
In vivo,,CHEMBL622955,,50597,,BAO_0000218,Rattus norvegicus,,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,Intermediate,10116.0,N,9398,1,,1,A,,,6518,
In vivo,,CHEMBL875229,,50597,,BAO_0000218,Rattus norvegicus,,,Elimination half-life after IV dosing at 1 mg/kg in rat,Intermediate,10116.0,N,9399,1,,1,A,,,6518,
In vivo,,CHEMBL622956,,50597,,BAO_0000218,Rattus norvegicus,,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,Intermediate,10116.0,N,9400,1,,1,A,,,6518,
In vivo,,CHEMBL622957,,50597,,BAO_0000218,Rattus norvegicus,,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,Intermediate,10116.0,N,9401,1,,1,A,,,6518,
In vivo,,CHEMBL622958,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Intermediate,10116.0,N,9402,1,,1,A,,,5408,
In vivo,,CHEMBL622959,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,10116.0,N,9403,1,,1,A,,,5408,
In vivo,,CHEMBL622960,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Intermediate,10116.0,N,9404,1,,1,A,,,5408,
In vivo,,CHEMBL622961,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,10116.0,N,9405,1,,1,A,,,5408,
In vivo,,CHEMBL622962,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for the half life in rat (in vivo),Intermediate,10116.0,N,9406,1,,1,A,,,4687,
,,CHEMBL622963,,50597,,BAO_0000218,Rattus norvegicus,,,Hafl life in rat,Intermediate,10116.0,N,9407,1,,1,A,,,6640,
,,CHEMBL622964,,50597,,BAO_0000218,Rattus norvegicus,,,Hafl life rat,Intermediate,10116.0,N,9408,1,,1,A,,,6640,
,,CHEMBL622965,,50597,,BAO_0000218,Rattus norvegicus,,,Hafl life rat,Intermediate,10116.0,N,9409,1,,1,A,,,6641,
,,CHEMBL622966,,50597,,BAO_0000218,Rattus norvegicus,,,Hafl life rat; Not determined,Intermediate,10116.0,N,9410,1,,1,A,,,6640,
,,CHEMBL622967,,50597,,BAO_0000218,Rattus norvegicus,,,Hafl life rat; Not determined,Intermediate,10116.0,N,9411,1,,1,A,,,6641,
In vivo,,CHEMBL622968,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9412,1,,1,A,,,17411,
In vivo,,CHEMBL622969,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9413,1,,1,A,,,17411,
In vivo,,CHEMBL875327,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9414,1,,1,A,,,17411,
In vivo,,CHEMBL628638,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat after 1 mg/kg i.v. administration,Intermediate,10116.0,N,9415,1,,1,A,,,6570,
In vivo,,CHEMBL628639,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat after 2 mg/kg peroral administration,Intermediate,10116.0,N,9416,1,,1,A,,,6570,
In vivo,,CHEMBL625840,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9417,1,,1,A,,,17411,
In vivo,,CHEMBL625841,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of 10 mg/kg oral dose determined in rats,Intermediate,10116.0,N,9418,1,,1,A,,,4722,
In vivo,,CHEMBL625842,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,9419,1,,1,A,,,5978,
In vivo,,CHEMBL625843,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,9420,1,,1,A,,,5978,
In vivo,,CHEMBL625844,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,9421,1,,1,A,,,5978,
In vivo,,CHEMBL873822,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,9422,1,,1,A,,,5978,
In vivo,,CHEMBL625845,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,9423,1,,1,A,,,5978,
In vivo,,CHEMBL627059,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,9424,1,,1,A,,,5978,
In vivo,,CHEMBL627060,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,9425,1,,1,A,,,5978,
In vivo,,CHEMBL627061,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,9426,1,,1,A,,,5978,
In vivo,,CHEMBL627709,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound at 5 mg/kg after po administration was determined in rat,Intermediate,10116.0,N,9427,1,,1,A,,,4762,
In vivo,,CHEMBL627710,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound determined after intravenous administration to rat,Intermediate,10116.0,N,9428,1,,1,A,,,5327,
,,CHEMBL627711,,50597,,BAO_0000218,Rattus norvegicus,,,Half life of compound was determined in rat,Intermediate,10116.0,N,9429,1,,1,A,,,4847,
In vivo,,CHEMBL627712,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,10116.0,N,9430,1,,1,A,,,17720,
In vivo,,CHEMBL627713,,50597,,BAO_0000218,Rattus norvegicus,,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,9431,1,,1,A,,,4723,
In vivo,,CHEMBL627714,,50597,,BAO_0000218,Rattus norvegicus,,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,9432,1,,1,A,,,4723,
In vivo,,CHEMBL627889,,22224,,BAO_0000218,Macaca fascicularis,,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,Intermediate,9541.0,U,9433,1,,0,A,,,4256,
In vivo,,CHEMBL627890,,22224,,BAO_0000218,Rattus norvegicus,,,Half life determined in rat by intravenous administration,Intermediate,10116.0,U,9434,1,,0,A,,,4256,
In vivo,,CHEMBL627891,,50597,,BAO_0000218,Rattus norvegicus,,,Half life determined in rats after iv administration,Intermediate,10116.0,N,9435,1,,1,A,,,4722,
In vivo,,CHEMBL627892,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life in rat plasma after administration of 2 mg/kg iv,Intermediate,10116.0,N,9436,1,,1,A,,,6535,
In vivo,,CHEMBL627893,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life in rat plasma after administration of 2 mg/kg iv,Intermediate,10116.0,N,9437,1,,1,A,,,6535,
,,CHEMBL627894,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life in rat plasma was determined,Intermediate,10116.0,N,9438,1,,1,A,,,1435,
,,CHEMBL627895,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life in rat plasma was determined; NA means not applicable,Intermediate,10116.0,N,9439,1,,1,A,,,1435,
,,CHEMBL627896,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat was tested,Intermediate,10116.0,N,9440,1,,1,A,,,5206,
,,CHEMBL627897,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life measured in rat plasma,Intermediate,10116.0,N,9441,1,,1,A,,,6080,
,,CHEMBL627898,,50597,,BAO_0000218,Rattus norvegicus,,,Half life recorded in rats,Intermediate,10116.0,N,9442,1,,1,A,,,4449,
,,CHEMBL627899,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was calculated,Intermediate,10116.0,N,9443,1,,1,A,,,6057,
,,CHEMBL873823,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was calculated in rat,Intermediate,10116.0,N,9444,1,,1,A,,,6057,
,,CHEMBL627900,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was determined,Intermediate,10116.0,N,9445,1,,1,A,,,3747,
In vivo,,CHEMBL627901,,50597,,BAO_0000218,Rattus norvegicus,,,Half life after 10 mg/kg oral administration in rat,Intermediate,10116.0,N,9446,1,,1,A,,,17858,
In vivo,,CHEMBL627902,,50597,,BAO_0000218,Rattus norvegicus,,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,Intermediate,10116.0,N,9447,1,,1,A,,,16365,
In vivo,,CHEMBL627903,,50597,,BAO_0000218,Rattus norvegicus,,,Half life after administering orally a dose of 30 mg/kg,Intermediate,10116.0,N,9448,1,,1,A,,,16365,
,,CHEMBL627904,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,Intermediate,10116.0,N,9449,1,,1,A,,,5031,
,,CHEMBL627905,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,Intermediate,10116.0,N,9450,1,,1,A,,,4722,
,,CHEMBL627906,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,Intermediate,10116.0,N,9451,1,,1,A,,,6078,
,,CHEMBL627907,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,Intermediate,10116.0,N,9452,1,,1,A,,,6078,
,,CHEMBL876783,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,Intermediate,10116.0,N,9453,1,,1,A,,,6078,
,,CHEMBL627908,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,Intermediate,10116.0,N,9454,1,,1,A,,,6078,
,,CHEMBL627909,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,10116.0,N,9455,1,,1,A,,,17065,
,,CHEMBL627910,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,Intermediate,10116.0,N,9456,1,,1,A,,,1353,
,,CHEMBL627911,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),Intermediate,10116.0,N,9457,1,,1,A,,,1353,
,,CHEMBL627912,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),Intermediate,10116.0,N,9458,1,,1,A,,,1353,
,,CHEMBL627913,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),Intermediate,10116.0,N,9459,1,,1,A,,,1353,
,,CHEMBL627914,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),Intermediate,10116.0,N,9460,1,,1,A,,,1353,
,,CHEMBL627915,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,Intermediate,10116.0,N,9461,1,,1,A,,,16423,
,,CHEMBL627916,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was evaluated after 20 uM/kg of peroral administration,Intermediate,10116.0,N,9462,1,,1,A,,,16423,
,,CHEMBL627917,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,Intermediate,10116.0,N,9463,1,,1,A,,,6062,
,,CHEMBL627918,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,Intermediate,10116.0,N,9464,1,,1,A,,,6056,
,,CHEMBL627919,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,Intermediate,10116.0,N,9465,1,,1,A,,,5182,
,,CHEMBL627920,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,Intermediate,10116.0,N,9466,1,,1,A,,,6410,
,,CHEMBL627921,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve was evaluated at an oral dose of 30 mg/kg,Intermediate,10116.0,N,9467,1,,1,A,,,6410,
,,CHEMBL627922,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,9468,1,,1,A,,,4723,
,,CHEMBL876784,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,9469,1,,1,A,,,4723,
,,CHEMBL627923,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,9470,1,,1,A,,,4723,
,,CHEMBL626208,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,9471,1,,1,A,,,4723,
,,CHEMBL626209,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,9472,1,,1,A,,,4723,
,,CHEMBL626210,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,9473,1,,1,A,,,4723,
,,CHEMBL627994,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Intermediate,10116.0,N,9474,1,,1,A,,,2463,
,,CHEMBL627995,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,Intermediate,10116.0,N,9475,1,,1,A,,,4709,
,,CHEMBL627996,,50597,,BAO_0000218,Rattus norvegicus,,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,Intermediate,10116.0,N,9476,1,,1,A,,,4075,
,,CHEMBL627997,,50597,,BAO_0000218,Rattus norvegicus,,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,Intermediate,10116.0,N,9477,1,,1,A,,,5394,
,,CHEMBL627998,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,10116.0,N,9478,1,,1,A,,,2661,
,,CHEMBL628640,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,10116.0,N,9479,1,,1,A,,,2661,
,,CHEMBL628641,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,10116.0,N,9480,1,,1,A,,,2661,
,,CHEMBL628642,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,10116.0,N,9481,1,,1,A,,,2661,
,,CHEMBL628643,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for area under the curve expressed as (h*ug/ml),Intermediate,10116.0,N,9482,1,,1,A,,,17791,
,,CHEMBL628644,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for area under curve in rat,Intermediate,10116.0,N,9483,1,,1,A,,,2591,
,,CHEMBL628645,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,Intermediate,10116.0,N,9484,1,,1,A,,,6567,
,,CHEMBL628646,,50597,,BAO_0000218,Rattus norvegicus,,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,10116.0,N,9485,1,,1,A,,,6211,
,,CHEMBL628647,,50597,,BAO_0000218,Rattus norvegicus,,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),Intermediate,10116.0,N,9486,1,,1,A,,,5529,
,,CHEMBL628648,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Intermediate,10116.0,N,9487,1,,1,A,,,5408,
,,CHEMBL625358,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,10116.0,N,9488,1,,1,A,,,5408,
,,CHEMBL625359,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Intermediate,10116.0,N,9489,1,,1,A,,,5408,
,,CHEMBL625360,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,10116.0,N,9490,1,,1,A,,,5408,
,,CHEMBL625361,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),Intermediate,10116.0,N,9491,1,,1,A,,,429,
,,CHEMBL625362,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),Intermediate,10116.0,N,9492,1,,1,A,,,429,
,,CHEMBL625363,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),Intermediate,10116.0,N,9493,1,,1,A,,,429,
,,CHEMBL625364,,50597,,BAO_0000218,Rattus norvegicus,,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Intermediate,10116.0,N,9494,1,,1,A,,,4796,
,,CHEMBL625365,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,9495,1,,1,A,,,5974,
,,CHEMBL625366,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,9496,1,,1,A,,,5974,
,,CHEMBL625367,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,9497,1,,1,A,,,5974,
,,CHEMBL625368,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",Intermediate,10116.0,N,9498,1,,1,A,,,11450,
,,CHEMBL625369,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",Intermediate,10116.0,N,9499,1,,1,A,,,11450,
,,CHEMBL625370,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",Intermediate,10116.0,N,9500,1,,1,A,,,11450,
,,CHEMBL625371,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",Intermediate,10116.0,N,9501,1,,1,A,,,11450,
,,CHEMBL625372,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",Intermediate,10116.0,N,9502,1,,1,A,,,11450,
,,CHEMBL625373,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",Intermediate,10116.0,N,9503,1,,1,A,,,11450,
,,CHEMBL625374,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",Intermediate,10116.0,N,9504,1,,1,A,,,11450,
,,CHEMBL877593,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",Intermediate,10116.0,N,9505,1,,1,A,,,11450,
,,CHEMBL625375,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",Intermediate,10116.0,N,9506,1,,1,A,,,11450,
,,CHEMBL625376,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",Intermediate,10116.0,N,9507,1,,1,A,,,11450,
,,CHEMBL621973,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",Intermediate,10116.0,N,9508,1,,1,A,,,11450,
,,CHEMBL621974,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",Intermediate,10116.0,N,9509,1,,1,A,,,11450,
,,CHEMBL621975,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",Intermediate,10116.0,N,9510,1,,1,A,,,11450,
,,CHEMBL622166,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",Intermediate,10116.0,N,9511,1,,1,A,,,11450,
,,CHEMBL622167,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",Intermediate,10116.0,N,9512,1,,1,A,,,11450,
,,CHEMBL622168,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",Intermediate,10116.0,N,9513,1,,1,A,,,11450,
,,CHEMBL622169,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",Intermediate,10116.0,N,9514,1,,1,A,,,11450,
,,CHEMBL622170,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",Intermediate,10116.0,N,9515,1,,1,A,,,11450,
,,CHEMBL622171,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",Intermediate,10116.0,N,9516,1,,1,A,,,11450,
,,CHEMBL622172,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",Intermediate,10116.0,N,9517,1,,1,A,,,11450,
,,CHEMBL622173,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",Intermediate,10116.0,N,9518,1,,1,A,,,11450,
,,CHEMBL622174,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",Intermediate,10116.0,N,9519,1,,1,A,,,11450,
,,CHEMBL622175,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",Intermediate,10116.0,N,9520,1,,1,A,,,11450,
,,CHEMBL622176,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",Intermediate,10116.0,N,9521,1,,1,A,,,11450,
,,CHEMBL622177,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",Intermediate,10116.0,N,9522,1,,1,A,,,11450,
,,CHEMBL622178,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",Intermediate,10116.0,N,9523,1,,1,A,,,11450,
,,CHEMBL622179,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",Intermediate,10116.0,N,9524,1,,1,A,,,11450,
,,CHEMBL622180,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",Intermediate,10116.0,N,9525,1,,1,A,,,11450,
,,CHEMBL622181,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,10116.0,N,9526,1,,1,A,,,16435,
,,CHEMBL622182,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,10116.0,N,9527,1,,1,A,,,16435,
,,CHEMBL622183,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,10116.0,N,9528,1,,1,A,,,16435,
,,CHEMBL622184,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,10116.0,N,9529,1,,1,A,,,16435,
,,CHEMBL622185,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,10116.0,N,9530,1,,1,A,,,16435,
,,CHEMBL622186,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,10116.0,N,9531,1,,1,A,,,16435,
,,CHEMBL622187,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,9532,1,,1,A,,,16434,
,,CHEMBL625002,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,9533,1,,1,A,,,16434,
,,CHEMBL622090,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,9534,1,,1,A,,,16434,
,,CHEMBL622091,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,9535,1,,1,A,,,16435,
,,CHEMBL622092,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,9536,1,,1,A,,,16435,
,,CHEMBL622093,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,9537,1,,1,A,,,16435,
,,CHEMBL622094,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,9538,1,,1,A,,,16435,
,,CHEMBL622095,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,9539,1,,1,A,,,16435,
,,CHEMBL622264,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,9540,1,,1,A,,,16435,
,,CHEMBL622265,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,9541,1,,1,A,,,16434,
,,CHEMBL622266,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,10116.0,N,9542,1,,1,A,,,16434,
,,CHEMBL622267,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,9543,1,,1,A,,,16434,
,,CHEMBL622268,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,9544,1,,1,A,,,16434,
,,CHEMBL622269,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,10116.0,N,9545,1,,1,A,,,16434,
,,CHEMBL625071,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,10116.0,N,9546,1,,1,A,,,16434,
,,CHEMBL621621,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,10116.0,N,9547,1,,1,A,,,16434,
,,CHEMBL621622,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,10116.0,N,9548,1,,1,A,,,16434,
,,CHEMBL621623,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,10116.0,N,9549,1,,1,A,,,16435,
,,CHEMBL621624,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,10116.0,N,9550,1,,1,A,,,16435,
,,CHEMBL621625,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,10116.0,N,9551,1,,1,A,,,16435,
,,CHEMBL621626,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,10116.0,N,9552,1,,1,A,,,16435,
,,CHEMBL621627,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,10116.0,N,9553,1,,1,A,,,16435,
,,CHEMBL621628,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,10116.0,N,9554,1,,1,A,,,16435,
,,CHEMBL875328,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,10116.0,N,9555,1,,1,A,,,16435,
,,CHEMBL621629,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,10116.0,N,9556,1,,1,A,,,16435,
,,CHEMBL621630,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,9557,1,,1,A,,,16434,
,,CHEMBL621631,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,9558,1,,1,A,,,16434,
,,CHEMBL621632,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,9559,1,,1,A,,,16434,
,,CHEMBL621633,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,9560,1,,1,A,,,16435,
,,CHEMBL621634,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,9561,1,,1,A,,,16435,
,,CHEMBL621635,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,9562,1,,1,A,,,16435,
,,CHEMBL621636,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,9563,1,,1,A,,,16435,
,,CHEMBL621637,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,9564,1,,1,A,,,16435,
,,CHEMBL621638,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,9565,1,,1,A,,,16435,
,,CHEMBL618883,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,9566,1,,1,A,,,16434,
,,CHEMBL618884,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,10116.0,N,9567,1,,1,A,,,16434,
,,CHEMBL628627,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,9568,1,,1,A,,,16434,
,,CHEMBL628628,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,9569,1,,1,A,,,16434,
,,CHEMBL628629,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,10116.0,N,9570,1,,1,A,,,16434,
In vivo,,CHEMBL628630,,50597,,BAO_0000218,Rattus norvegicus,,,Half life after administering orally a dose of 3 mg/kg,Intermediate,10116.0,N,9571,1,,1,A,,,16365,
In vivo,,CHEMBL628631,,50597,,BAO_0000218,Rattus norvegicus,,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,Intermediate,10116.0,N,9572,1,,1,A,,,16365,
In vivo,,CHEMBL628632,,50597,,BAO_0000218,Rattus norvegicus,,,Half life after administering intravenously a dose of 1 mg/kg,Intermediate,10116.0,N,9573,1,,1,A,,,16365,
In vivo,,CHEMBL628633,,50597,,BAO_0000218,Rattus norvegicus,,,Half life after oral dosing in rats,Intermediate,10116.0,N,9574,1,,1,A,,,526,
In vivo,,CHEMBL628634,,50597,,BAO_0000218,Rattus norvegicus,,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,Intermediate,10116.0,N,9575,1,,1,A,,,16365,
In vivo,,CHEMBL627789,,50597,,BAO_0000218,Rattus norvegicus,,,Half life by intravenous administration of 3.4 mg/kg in rat,Intermediate,10116.0,N,9576,1,,1,A,,,4368,
,,CHEMBL627790,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat,Intermediate,10116.0,N,9577,1,,1,A,,,3371,
,,CHEMBL627791,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat,Intermediate,10116.0,N,9578,1,,1,A,,,6448,
,,CHEMBL627792,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat,Intermediate,10116.0,N,9579,1,,1,A,,,6453,
In vivo,,CHEMBL627793,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat after intravenous administration of the compound,Intermediate,10116.0,N,9580,1,,1,A,,,4353,
In vivo,,CHEMBL627794,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,Intermediate,10116.0,N,9581,1,,1,A,,,4353,
In vivo,,CHEMBL627795,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat after po administration of the compound,Intermediate,10116.0,N,9582,1,,1,A,,,4353,
In vivo,,CHEMBL627796,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat after po administration of the compound; ND means Not determined,Intermediate,10116.0,N,9583,1,,1,A,,,4353,
In vivo,,CHEMBL875335,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,Intermediate,10116.0,N,9584,1,,1,A,,,4353,
In vivo,,CHEMBL627797,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,Intermediate,10116.0,N,9585,1,,1,A,,,4353,
In vivo,,CHEMBL627798,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat i.v.,Intermediate,10116.0,N,9586,1,,1,A,,,5789,
In vivo,,CHEMBL627799,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat i.v. at 2 mg/kg concentration,Intermediate,10116.0,N,9587,1,,1,A,,,17686,
,,CHEMBL627800,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rats,Intermediate,10116.0,N,9588,1,,1,A,,,6495,
In vivo,,CHEMBL627801,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rats after intravenous administration,Intermediate,10116.0,N,9589,1,,1,A,,,484,
In vivo,,CHEMBL627802,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,10116.0,N,9590,1,,1,A,,,6467,
,,CHEMBL627803,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat,Expert,10116.0,N,9591,1,,1,A,,,6642,
In vivo,,CHEMBL873820,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was evaluated after intravenous administration to rats,Intermediate,10116.0,N,9592,1,,1,A,,,16367,
,,CHEMBL627804,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),Intermediate,10116.0,N,9593,1,,1,A,,,1369,
,,CHEMBL627805,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was evaluated in rat,Intermediate,10116.0,N,9594,1,,1,A,,,5472,
,,CHEMBL627806,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was evaluated in rat,Intermediate,10116.0,N,9595,1,,1,A,,,6049,
,,CHEMBL627107,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was evaluated in rat; Not tested,Intermediate,10116.0,N,9596,1,,1,A,,,5472,
In vivo,,CHEMBL627108,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,Intermediate,10116.0,N,9597,1,,1,A,,,16366,
In vivo,,CHEMBL627109,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,Intermediate,10116.0,N,9598,1,,1,A,,,11149,
In vivo,,CHEMBL627110,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,Intermediate,10116.0,N,9599,1,,1,A,,,11149,
In vivo,,CHEMBL627111,,22224,,BAO_0000218,Primates,,,Half life was measured in monkey at dose of 10 mg/kg by po administration,Intermediate,9443.0,U,9600,1,,0,A,,,2891,
In vivo,,CHEMBL627112,,22224,,BAO_0000218,Primates,,,Half life was measured in monkey at dose of 10 mg/kg by po administration,Intermediate,9443.0,U,9601,1,,0,A,,,2891,
In vivo,,CHEMBL627113,,22224,,BAO_0000218,Rattus norvegicus,,,Half life was measured in rat at dose of 30 mg/kg by iv administration,Intermediate,10116.0,U,9602,1,,0,A,,,2891,
In vivo,,CHEMBL627114,,22224,,BAO_0000218,Rattus norvegicus,,,Half life was measured in rat at dose of 30 mg/kg by po administration,Intermediate,10116.0,U,9603,1,,0,A,,,2891,
,,CHEMBL627115,,50597,,BAO_0000218,Rattus norvegicus,,,Half life (t1/2) was determined,Intermediate,10116.0,N,9604,1,,1,A,,,4026,
,,CHEMBL627116,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period at a dose of 10 uM/kg in rat was determined,Intermediate,10116.0,N,9605,1,,1,A,,,4527,
In vivo,,CHEMBL627117,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,Intermediate,10116.0,N,9606,1,,1,A,,,4527,
,,CHEMBL627118,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was determined,Intermediate,10116.0,N,9607,1,,1,A,,,5503,
In vivo,,CHEMBL627119,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period after intravenous administration at 20 mpk in rats,Intermediate,10116.0,N,9608,1,,1,A,,,4426,
In vivo,,CHEMBL627120,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,Intermediate,10116.0,N,9609,1,,1,A,,,4426,
In vivo,,CHEMBL626922,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period after intravenous administration in rat,Intermediate,10116.0,N,9610,1,,1,A,,,6109,
In vivo,,CHEMBL626923,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,10116.0,N,9611,1,,1,A,,,5654,
In vivo,,CHEMBL626924,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,10116.0,N,9612,1,,1,A,,,5654,
,,CHEMBL626925,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life period in 80% rat plasma at 37 degree Centigrade,Intermediate,10116.0,N,9613,1,,1,A,,,4755,
,,CHEMBL626926,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in SD rats,Intermediate,10116.0,N,9614,1,,1,A,,,5862,
,,CHEMBL626927,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),Intermediate,10116.0,N,9615,1,,1,A,,,1515,
,,CHEMBL626928,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),Intermediate,10116.0,N,9616,1,,1,A,,,1515,
,,CHEMBL626929,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,10116.0,N,9617,1,,1,A,,,1515,
,,CHEMBL626930,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,10116.0,N,9618,1,,1,A,,,1515,
,,CHEMBL626931,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat,Intermediate,10116.0,N,9619,1,,1,A,,,5960,
,,CHEMBL626932,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat,Intermediate,10116.0,N,9620,1,,1,A,,,6103,
,,CHEMBL626933,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat,Intermediate,10116.0,N,9621,1,,1,A,,,6317,
In vivo,,CHEMBL873826,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat after oral administration at 10.5 mg/kg dose,Intermediate,10116.0,N,9622,1,,1,A,,,6644,
In vivo,,CHEMBL626934,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat after oral administration at 11.2 mg/kg dose,Intermediate,10116.0,N,9623,1,,1,A,,,6644,
In vivo,,CHEMBL626935,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat after oral administration at 13 mg/kg dose,Intermediate,10116.0,N,9624,1,,1,A,,,6644,
In vivo,,CHEMBL626936,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat after oral administration at 9.7 mg/kg dose,Intermediate,10116.0,N,9625,1,,1,A,,,6644,
,,CHEMBL626937,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,9626,1,,1,A,,,5974,
,,CHEMBL625906,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Intermediate,10116.0,N,9627,1,,1,A,,,6295,
,,CHEMBL625907,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Intermediate,10116.0,N,9628,1,,1,A,,,6296,
,,CHEMBL625908,,50597,,BAO_0000218,Rattus norvegicus,,,PK study was carried to determine AUC (area under curve) value in rat,Intermediate,10116.0,N,9629,1,,1,A,,,16427,
,,CHEMBL625909,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC after intravenous administration to rats,Intermediate,10116.0,N,9630,1,,1,A,,,16367,
,,CHEMBL625910,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC after oral administration to rats,Intermediate,10116.0,N,9631,1,,1,A,,,16367,
,,CHEMBL625911,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,Intermediate,10116.0,N,9632,1,,1,A,,,16365,
,,CHEMBL625912,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,Intermediate,10116.0,N,9633,1,,1,A,,,16365,
,,CHEMBL626538,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,Intermediate,10116.0,N,9634,1,,1,A,,,16365,
,,CHEMBL876794,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,Intermediate,10116.0,N,9635,1,,1,A,,,16365,
,,CHEMBL626539,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,Intermediate,10116.0,N,9636,1,,1,A,,,16365,
,,CHEMBL626540,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,Intermediate,10116.0,N,9637,1,,1,A,,,16365,
,,CHEMBL626541,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,Intermediate,10116.0,N,9638,1,,1,A,,,5394,
,,CHEMBL626542,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,Intermediate,10116.0,N,9639,1,,1,A,,,5394,
,,CHEMBL626543,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,Intermediate,10116.0,N,9640,1,,1,A,,,2792,
,,CHEMBL626544,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,Intermediate,10116.0,N,9641,1,,1,A,,,2792,
,,CHEMBL626545,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,Intermediate,10116.0,N,9642,1,,1,A,,,2792,
,,CHEMBL626546,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,Intermediate,10116.0,N,9643,1,,1,A,,,2792,
,,CHEMBL626547,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter area under curve was reported,Intermediate,10116.0,N,9644,1,,1,A,,,5334,
,,CHEMBL626548,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (AUC) in rat,Intermediate,10116.0,N,9645,1,,1,A,,,4408,
,,CHEMBL626549,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,10116.0,N,9646,1,,1,A,,,5983,
,,CHEMBL626550,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,Intermediate,10116.0,N,9647,1,,1,A,,,4397,
,,CHEMBL626551,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,Intermediate,10116.0,N,9648,1,,1,A,,,4397,
,,CHEMBL623777,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property was determined,Intermediate,10116.0,N,9649,1,,1,A,,,5491,
,,CHEMBL623778,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,Intermediate,10116.0,N,9650,1,,1,A,,,5491,
,,CHEMBL623779,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,Intermediate,10116.0,N,9651,1,,1,A,,,5491,
,,CHEMBL623780,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,10116.0,N,9652,1,,1,A,,,4199,
,,CHEMBL622015,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,10116.0,N,9653,1,,1,A,,,4199,
,,CHEMBL622016,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,10116.0,N,9654,1,,1,A,,,4199,
,,CHEMBL622017,,50597,,BAO_0000218,Rattus norvegicus,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",Intermediate,10116.0,N,9655,1,,1,A,,,5173,
,,CHEMBL622018,,50597,,BAO_0000218,Rattus norvegicus,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",Intermediate,10116.0,N,9656,1,,1,A,,,5173,
,,CHEMBL622019,,50597,,BAO_0000218,Rattus norvegicus,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",Intermediate,10116.0,N,9657,1,,1,A,,,5173,
,,CHEMBL622020,,50597,,BAO_0000218,Rattus norvegicus,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",Intermediate,10116.0,N,9658,1,,1,A,,,5173,
,,CHEMBL622021,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,Intermediate,10116.0,N,9659,1,,1,A,,,16366,
,,CHEMBL622022,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,Intermediate,10116.0,N,9660,1,,1,A,,,16366,
,,CHEMBL622023,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,Intermediate,10116.0,N,9661,1,,1,A,,,5327,
,,CHEMBL622024,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,Intermediate,10116.0,N,9662,1,,1,A,,,6681,
,,CHEMBL622693,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),Intermediate,10116.0,N,9663,1,,1,A,,,12873,
,,CHEMBL622694,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),Intermediate,10116.0,N,9664,1,,1,A,,,12873,
,,CHEMBL622695,,50597,,BAO_0000218,Rattus norvegicus,,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Intermediate,10116.0,N,9665,1,,1,A,,,6685,
,,CHEMBL622696,,50597,,BAO_0000218,Rattus norvegicus,,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Intermediate,10116.0,N,9666,1,,1,A,,,6685,
,,CHEMBL622697,,50597,,BAO_0000218,Rattus norvegicus,,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",Intermediate,10116.0,N,9667,1,,1,A,,,6685,
,,CHEMBL622874,,50597,,BAO_0000218,Rattus norvegicus,,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",Intermediate,10116.0,N,9668,1,,1,A,,,6619,
,,CHEMBL622875,,50597,,BAO_0000218,Rattus norvegicus,,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",Intermediate,10116.0,N,9669,1,,1,A,,,6619,
,,CHEMBL622876,,50597,,BAO_0000218,Rattus norvegicus,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Intermediate,10116.0,N,9670,1,,1,A,,,10363,
,,CHEMBL622877,,50597,,BAO_0000218,Rattus norvegicus,,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Intermediate,10116.0,N,9671,1,,1,A,,,4796,
,,CHEMBL622878,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,10116.0,N,9672,1,,1,A,,,4910,
,,CHEMBL622879,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,Intermediate,10116.0,N,9673,1,,1,A,,,4910,
,,CHEMBL877602,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,Intermediate,10116.0,N,9674,1,,1,A,,,4839,
,,CHEMBL622880,,50597,,BAO_0000218,Rattus norvegicus,,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,9675,1,,1,A,,,15078,
,,CHEMBL622881,,50597,,BAO_0000218,Rattus norvegicus,,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,9676,1,,1,A,,,15078,
,,CHEMBL622882,,50597,,BAO_0000218,Rattus norvegicus,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,9677,1,,1,A,,,15078,
,,CHEMBL622883,,50597,,BAO_0000218,Rattus norvegicus,,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,9678,1,,1,A,,,15078,
,,CHEMBL622884,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",Intermediate,10116.0,N,9679,1,,1,A,,,11450,
,,CHEMBL622885,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",Intermediate,10116.0,N,9680,1,,1,A,,,11450,
,,CHEMBL622886,,50597,,BAO_0000218,Rattus norvegicus,,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,10116.0,N,9681,1,,1,A,,,8151,
,,CHEMBL622887,,50597,,BAO_0000218,Rattus norvegicus,,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Intermediate,10116.0,N,9682,1,,1,A,,,8151,
,,CHEMBL622888,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Intermediate,10116.0,N,9683,1,,1,A,,,8151,
In vivo,,CHEMBL622889,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9684,1,,1,A,,,8677,
In vivo,,CHEMBL622890,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9685,1,,1,A,,,8677,
In vivo,,CHEMBL622891,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9686,1,,1,A,,,8677,
In vivo,,CHEMBL877603,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9687,1,,1,A,,,8677,
In vivo,,CHEMBL622892,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9688,1,,1,A,,,8677,
In vivo,,CHEMBL622893,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9689,1,,1,A,,,8677,
In vivo,,CHEMBL622894,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9690,1,,1,A,,,8677,
In vivo,,CHEMBL622895,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9691,1,,1,A,,,8677,
In vivo,,CHEMBL622896,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,Intermediate,10116.0,N,9692,1,,1,A,,,8677,
In vivo,,CHEMBL622897,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9693,1,,1,A,,,8677,
In vivo,,CHEMBL622898,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9694,1,,1,A,,,8677,
In vivo,,CHEMBL622899,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9695,1,,1,A,,,8677,
In vivo,,CHEMBL622900,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9696,1,,1,A,,,8677,
In vivo,,CHEMBL624114,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9697,1,,1,A,,,8677,
In vivo,,CHEMBL624115,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9698,1,,1,A,,,8677,
In vivo,,CHEMBL624116,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9699,1,,1,A,,,8677,
In vivo,,CHEMBL624117,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9700,1,,1,A,,,8677,
In vivo,,CHEMBL624118,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9701,1,,1,A,,,8677,
In vivo,,CHEMBL624119,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9702,1,,1,A,,,8677,
In vivo,,CHEMBL624120,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9703,1,,1,A,,,8677,
In vivo,,CHEMBL624121,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9704,1,,1,A,,,8677,
In vivo,,CHEMBL624122,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9705,1,,1,A,,,8677,
In vivo,,CHEMBL624123,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9706,1,,1,A,,,8677,
In vivo,,CHEMBL624124,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9707,1,,1,A,,,8677,
In vivo,,CHEMBL624125,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9708,1,,1,A,,,8677,
In vivo,,CHEMBL624126,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9709,1,,1,A,,,8677,
In vivo,,CHEMBL624127,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9710,1,,1,A,,,8677,
In vivo,,CHEMBL624128,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9711,1,,1,A,,,8677,
In vivo,,CHEMBL624129,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9712,1,,1,A,,,8677,
In vivo,,CHEMBL624130,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9713,1,,1,A,,,8677,
In vivo,,CHEMBL622340,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9714,1,,1,A,,,8677,
In vivo,,CHEMBL622341,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9715,1,,1,A,,,8677,
In vivo,,CHEMBL622342,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9716,1,,1,A,,,8677,
In vivo,,CHEMBL622343,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9717,1,,1,A,,,8677,
In vivo,,CHEMBL622344,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9718,1,,1,A,,,8677,
In vivo,,CHEMBL622345,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9719,1,,1,A,,,8677,
In vivo,,CHEMBL622346,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9720,1,,1,A,,,8677,
In vivo,,CHEMBL622347,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9721,1,,1,A,,,8677,
In vivo,,CHEMBL622348,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9722,1,,1,A,,,8677,
In vivo,,CHEMBL622349,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9723,1,,1,A,,,8677,
,,CHEMBL622350,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,10116.0,N,9724,1,,1,A,,,16434,
,,CHEMBL622351,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,10116.0,N,9725,1,,1,A,,,16434,
,,CHEMBL622352,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,10116.0,N,9726,1,,1,A,,,16434,
,,CHEMBL622353,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,10116.0,N,9727,1,,1,A,,,16435,
,,CHEMBL622354,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,10116.0,N,9728,1,,1,A,,,16435,
,,CHEMBL622355,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,10116.0,N,9729,1,,1,A,,,16435,
,,CHEMBL622356,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,10116.0,N,9730,1,,1,A,,,16435,
,,CHEMBL622357,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,10116.0,N,9731,1,,1,A,,,16435,
,,CHEMBL622358,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,10116.0,N,9732,1,,1,A,,,16435,
,,CHEMBL622359,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,10116.0,N,9733,1,,1,A,,,16435,
,,CHEMBL874393,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,10116.0,N,9734,1,,1,A,,,16435,
,,CHEMBL622872,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,9735,1,,1,A,,,16434,
,,CHEMBL622873,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,9736,1,,1,A,,,16434,
,,CHEMBL623047,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,9737,1,,1,A,,,16434,
,,CHEMBL623048,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,9738,1,,1,A,,,16435,
,,CHEMBL623049,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,9739,1,,1,A,,,16435,
,,CHEMBL623050,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,9740,1,,1,A,,,16435,
,,CHEMBL623051,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,9741,1,,1,A,,,16435,
,,CHEMBL623052,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,9742,1,,1,A,,,16435,
,,CHEMBL626343,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,9743,1,,1,A,,,16435,
,,CHEMBL626344,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,10116.0,N,9744,1,,1,A,,,16434,
,,CHEMBL626345,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,10116.0,N,9745,1,,1,A,,,16434,
,,CHEMBL626346,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,10116.0,N,9746,1,,1,A,,,16434,
,,CHEMBL626347,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,10116.0,N,9747,1,,1,A,,,16434,
,,CHEMBL626348,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,10116.0,N,9748,1,,1,A,,,16434,
,,CHEMBL626349,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,10116.0,N,9749,1,,1,A,,,16434,
,,CHEMBL626350,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,10116.0,N,9750,1,,1,F,,,16435,
,,CHEMBL626351,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,10116.0,N,9751,1,,1,A,,,16435,
,,CHEMBL627650,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,10116.0,N,9752,1,,1,A,,,16435,
,,CHEMBL627651,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,10116.0,N,9753,1,,1,F,,,16435,
,,CHEMBL627652,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,10116.0,N,9754,1,,1,A,,,16435,
,,CHEMBL627653,,50597,,BAO_0000218,Rattus norvegicus,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,10116.0,N,9755,1,,1,A,,,16435,
,,CHEMBL627654,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,Intermediate,10116.0,N,9756,1,,1,A,,,13091,
,,CHEMBL627835,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,Intermediate,10116.0,N,9757,1,,1,A,,,13091,
,,CHEMBL627836,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,Intermediate,10116.0,N,9758,1,,1,A,,,13091,
,,CHEMBL627837,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,Intermediate,10116.0,N,9759,1,,1,A,,,13091,
,,CHEMBL627838,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,Intermediate,10116.0,N,9760,1,,1,A,,,13091,
,,CHEMBL875338,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,Intermediate,10116.0,N,9761,1,,1,A,,,13091,
,,CHEMBL627839,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,Intermediate,10116.0,N,9762,1,,1,A,,,13091,
,,CHEMBL627840,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,Intermediate,10116.0,N,9763,1,,1,A,,,13091,
,,CHEMBL627841,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,Intermediate,10116.0,N,9764,1,,1,A,,,13091,
,,CHEMBL627842,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,Intermediate,10116.0,N,9765,1,,1,A,,,13091,
,,CHEMBL627843,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,Intermediate,10116.0,N,9766,1,,1,A,,,13091,
,,CHEMBL627844,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,Intermediate,10116.0,N,9767,1,,1,A,,,13091,
,,CHEMBL627845,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,Intermediate,10116.0,N,9768,1,,1,A,,,13091,
In vivo,,CHEMBL627846,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period in rat by iv administration at a dose of 3 mg/kg,Intermediate,10116.0,N,9769,1,,1,A,,,5874,
,,CHEMBL627847,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),Intermediate,10116.0,N,9770,1,,1,A,,,1515,
,,CHEMBL873821,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),Intermediate,10116.0,N,9771,1,,1,A,,,1515,
,,CHEMBL626079,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,10116.0,N,9772,1,,1,A,,,1515,
,,CHEMBL626080,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,10116.0,N,9773,1,,1,A,,,1515,
,,CHEMBL626081,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life period was evaluated in rat plasma,Intermediate,10116.0,N,9774,1,,1,A,,,5491,
,,CHEMBL875344,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life period was evaluated in rat plasma; Not tested,Intermediate,10116.0,N,9775,1,,1,A,,,5491,
,,CHEMBL626082,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was evaluated in rats,Intermediate,10116.0,N,9776,1,,1,A,,,1918,
In vivo,,CHEMBL626250,,50597,,BAO_0000218,Rattus norvegicus,,,"Half life period was evaluated in rats, iv",Intermediate,10116.0,N,9777,1,,1,A,,,1918,
In vivo,,CHEMBL626251,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period after intravenous administration at 5 mg/kg in rat,Intermediate,10116.0,N,9778,1,,1,A,,,6113,
In vivo,,CHEMBL626252,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,10116.0,N,9779,1,,1,A,,,5546,
In vivo,,CHEMBL626253,,50597,,BAO_0000218,Rattus norvegicus,,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,Intermediate,10116.0,N,9780,1,,1,A,,,5553,
,,CHEMBL626254,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life stability of compound was evaluated in rat plasma,Intermediate,10116.0,N,9781,1,,1,A,,,4188,
In vivo,,CHEMBL626255,,50597,,BAO_0000218,Rattus norvegicus,,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,10116.0,N,9782,1,,1,A,,,6215,
In vivo,,CHEMBL626256,,50597,,BAO_0000218,Rattus norvegicus,,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Intermediate,10116.0,N,9783,1,,1,A,,,6141,
In vivo,,CHEMBL626257,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,10116.0,N,9784,1,,1,A,,,5182,
In vivo,,CHEMBL626258,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,Intermediate,10116.0,N,9785,1,,1,A,,,5182,
In vivo,,CHEMBL626259,,50597,,BAO_0000218,Rattus norvegicus,,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,Intermediate,10116.0,N,9786,1,,1,A,,,5710,
In vivo,,CHEMBL626260,,50597,,BAO_0000218,Rattus norvegicus,,,Half in rat i.v.,Intermediate,10116.0,N,9787,1,,1,A,,,5789,
In vivo,,CHEMBL875345,,50597,,BAO_0000218,Rattus norvegicus,,,Half period in rat after intravenous administration,Intermediate,10116.0,N,9788,1,,1,A,,,6011,
In vivo,,CHEMBL626261,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,10116.0,N,9789,1,,1,A,,,17594,
In vitro,,CHEMBL626262,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Half-life measured in in vitro Cathepsin B assay in rat liver,Intermediate,10116.0,N,9790,1,,1,A,,,12357,
,,CHEMBL626263,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life of compound was determined in rats,Intermediate,10116.0,N,9791,1,,1,A,,,5210,
In vivo,,CHEMBL625270,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life at 10 mg/kg in rat upon intravenous administration,Intermediate,10116.0,N,9792,1,,1,A,,,17596,
,,CHEMBL625271,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life determined in rat,Intermediate,10116.0,N,9793,1,,1,A,,,6672,
,,CHEMBL625272,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life determined in rat,Intermediate,10116.0,N,9794,1,,1,A,,,6673,
In vivo,,CHEMBL625273,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,10116.0,N,9795,1,,1,A,,,4910,
,,CHEMBL625274,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",Intermediate,10116.0,N,9796,1,,1,A,,,3741,
In vivo,,CHEMBL625275,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,10116.0,N,9797,1,,1,A,,,17671,
In vivo,,CHEMBL625276,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,Intermediate,10116.0,N,9798,1,,1,A,,,4910,
,,CHEMBL625277,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in rat plasma,Intermediate,10116.0,N,9799,1,,1,A,,,17537,
,,CHEMBL625278,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in rat plasma was determined,Intermediate,10116.0,N,9800,1,,1,A,,,4965,
,,CHEMBL625279,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in rat plasma; Not tested,Intermediate,10116.0,N,9801,1,,1,A,,,17537,
,,CHEMBL625280,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Half-life in rat serum,Intermediate,10116.0,N,9802,1,,1,A,,,6124,
,,CHEMBL876797,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Half-life in rat serum; na is not available,Intermediate,10116.0,N,9803,1,,1,A,,,6124,
,,CHEMBL625281,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was calculated in rat,Intermediate,10116.0,N,9804,1,,1,A,,,6078,
,,CHEMBL873827,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life was calculated in rat plasma,Intermediate,10116.0,N,9805,1,,1,A,,,17668,
,,CHEMBL625282,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was determined,Intermediate,10116.0,N,9806,1,,1,A,,,3185,
,,CHEMBL625283,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was determined,Intermediate,10116.0,N,9807,1,,1,A,,,4883,
In vivo,,CHEMBL625284,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life after administration of 20 mg/Kg oral dose in rat,Intermediate,10116.0,N,9808,1,,1,A,,,2959,
In vivo,,CHEMBL625285,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life after administration of 3.2 mg/kg intravenously in male rat,Intermediate,10116.0,N,9809,1,,1,A,,,4029,
In vivo,,CHEMBL625286,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life after intravenous administration in female rat,Intermediate,10116.0,N,9810,1,,1,A,,,4029,
In vivo,,CHEMBL625287,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life after intravenous administration in male rat,Intermediate,10116.0,N,9811,1,,1,A,,,4029,
In vivo,,CHEMBL625288,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life after intravenous dose in rat,Intermediate,10116.0,N,9812,1,,1,A,,,6180,
,,CHEMBL625289,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Half-life in a rat liver homogenate preparation,Intermediate,10116.0,N,9813,1,,1,A,,,1557,
,,CHEMBL625290,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in plasma of rat,Intermediate,10116.0,N,9814,1,,1,A,,,12500,
,,CHEMBL876798,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in plasma of rat at dose of 3-10 mgkg,Intermediate,10116.0,N,9815,1,,1,A,,,12500,
,,CHEMBL625291,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat,Intermediate,10116.0,N,9816,1,,1,A,,,5064,
,,CHEMBL625292,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat,Intermediate,10116.0,N,9817,1,,1,A,,,5145,
,,CHEMBL625293,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat,Intermediate,10116.0,N,9818,1,,1,A,,,5147,
,,CHEMBL622832,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat,Intermediate,10116.0,N,9819,1,,1,A,,,5833,
,,CHEMBL622833,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat,Intermediate,10116.0,N,9820,1,,1,A,,,6596,
,,CHEMBL622834,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat,Intermediate,10116.0,N,9821,1,,1,A,,,17655,
In vivo,,CHEMBL622835,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat after oral administration at 10 mg/kg,Intermediate,10116.0,N,9822,1,,1,A,,,6495,
In vivo,,CHEMBL622836,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat after po administration at a dose of 10 mg/kg,Intermediate,10116.0,N,9823,1,,1,A,,,17538,
In vivo,,CHEMBL622837,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,Intermediate,10116.0,N,9824,1,,1,A,,,17538,
In vivo,,CHEMBL622838,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat at 3 mg/kg dose administered intravenously,Intermediate,10116.0,N,9825,1,,1,A,,,10,
,,CHEMBL622839,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Half-life in rat brain homogenate,Intermediate,10116.0,N,9826,1,,1,A,,,17669,
,,CHEMBL622840,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in rat plasma,Intermediate,10116.0,N,9827,1,,1,A,,,17065,
,,CHEMBL622841,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rats,Intermediate,10116.0,N,9828,1,,1,A,,,4333,
,,CHEMBL622842,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in Dawley rats,Intermediate,10116.0,N,9829,1,,1,A,,,6827,
In vitro,,CHEMBL622843,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in vitro in rat plasma,Intermediate,10116.0,N,9830,1,,1,A,,,889,
In vitro,,CHEMBL622844,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,Intermediate,10116.0,N,9831,1,,1,A,,,889,
,,CHEMBL622845,,50597,,BAO_0000218,Rattus norvegicus,,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",Intermediate,10116.0,N,9832,1,,1,A,,,3747,
,,CHEMBL622846,,50597,,BAO_0000218,Rattus norvegicus,,,The area under the curve of compound was measured at the dose of 100 umol/kg,Intermediate,10116.0,N,9833,1,,1,A,,,15022,
,,CHEMBL622847,,50597,,BAO_0000218,Rattus norvegicus,,,The area under the curve of compound was measured at the dose of 300 umol/kg,Intermediate,10116.0,N,9834,1,,1,A,,,15022,
,,CHEMBL622848,,50597,,BAO_0000218,Rattus norvegicus,,,The area under the curve of compound was measured at the dose of 30 umol/kg,Intermediate,10116.0,N,9835,1,,1,A,,,15022,
In vivo,,CHEMBL622849,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability as oral AUC in rats,Intermediate,10116.0,N,9836,1,,1,A,,,3360,
,,CHEMBL622850,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The plasma concentration versus time curve (AUC) was determined,Intermediate,10116.0,N,9837,1,,1,A,,,5334,
,,CHEMBL876807,,50597,,BAO_0000218,Rattus norvegicus,,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9838,1,,1,A,,,17411,
,,CHEMBL622851,,50597,,BAO_0000218,Rattus norvegicus,,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9839,1,,1,A,,,17411,
,,CHEMBL622852,,50597,,BAO_0000218,Rattus norvegicus,,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9840,1,,1,A,,,17411,
,,CHEMBL622853,,50597,,BAO_0000218,Rattus norvegicus,,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,Intermediate,10116.0,N,9841,1,,1,A,,,6570,
,,CHEMBL622854,,50597,,BAO_0000218,Rattus norvegicus,,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,Intermediate,10116.0,N,9842,1,,1,A,,,6570,
,,CHEMBL622855,,50597,,BAO_0000218,Rattus norvegicus,,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,10116.0,N,9843,1,,1,A,,,17411,
,,CHEMBL622856,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,10116.0,N,9844,1,,1,A,,,14941,
,,CHEMBL622857,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,10116.0,N,9845,1,,1,A,,,14941,
,,CHEMBL622858,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC in rat after po administration at a dose of 10 mg/kg,Intermediate,10116.0,N,9846,1,,1,A,,,17538,
,,CHEMBL622859,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,Intermediate,10116.0,N,9847,1,,1,A,,,17752,
,,CHEMBL622860,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,Intermediate,10116.0,N,9848,1,,1,A,,,17509,
,,CHEMBL622861,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,Intermediate,10116.0,N,9849,1,,1,A,,,17509,
,,CHEMBL622862,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,Intermediate,10116.0,N,9850,1,,1,A,,,17509,
,,CHEMBL622863,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,Intermediate,10116.0,N,9851,1,,1,A,,,17509,
,,CHEMBL623817,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve value 6 hr after po administration in rat,Intermediate,10116.0,N,9852,1,,1,A,,,17509,
,,CHEMBL623818,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,10116.0,N,9853,1,,1,A,,,17717,
,,CHEMBL623819,,50597,,BAO_0000218,Rattus norvegicus,,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",Intermediate,10116.0,N,9854,1,,1,A,,,17717,
,,CHEMBL623820,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,10116.0,N,9855,1,,1,A,,,17717,
,,CHEMBL623821,,50597,,BAO_0000218,Rattus norvegicus,,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,10116.0,N,9856,1,,1,A,,,17717,
,,CHEMBL623822,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC normalized for dose (AUCN) in rat,Intermediate,10116.0,N,9857,1,,1,A,,,6642,
,,CHEMBL623823,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in rat after p.o. administration,Intermediate,10116.0,N,9858,1,,1,A,,,6640,
,,CHEMBL623824,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in rat after p.o. administration,Intermediate,10116.0,N,9859,1,,1,A,,,6641,
,,CHEMBL623825,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in rat after p.o. administration; Not determined,Intermediate,10116.0,N,9860,1,,1,A,,,6641,
,,CHEMBL622070,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in rat after peroral administration,Intermediate,10116.0,N,9861,1,,1,A,,,6641,
,,CHEMBL622071,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (carotid artery) value of the compound,Intermediate,10116.0,N,9862,1,,1,A,,,3603,
,,CHEMBL622072,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability expressed as the area under curve of rat carotid artery,Intermediate,10116.0,N,9863,1,,1,A,,,3550,
,,CHEMBL622073,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve in male SD rats was observed after intravenous administration in rat,Intermediate,10116.0,N,9864,1,,1,A,,,15662,
,,CHEMBL622074,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve of the compound was determined,Intermediate,10116.0,N,9865,1,,1,A,,,17720,
,,CHEMBL622075,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,Intermediate,10116.0,N,9866,1,,1,A,,,5407,
,,CHEMBL622076,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,Intermediate,10116.0,N,9867,1,,1,A,,,17752,
,,CHEMBL622077,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,Intermediate,10116.0,N,9868,1,,1,A,,,17752,
,,CHEMBL622078,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve (portal vein) value of the compound,Intermediate,10116.0,N,9869,1,,1,A,,,3603,
,,CHEMBL622079,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability expressed as the area under curve of rat portal vein,Intermediate,10116.0,N,9870,1,,1,A,,,3550,
,,CHEMBL622080,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Area Under plasma concentration time curve in rat upon peroral administration,Intermediate,10116.0,N,9871,1,,1,A,,,17655,
,,CHEMBL877612,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,Intermediate,10116.0,N,9872,1,,1,A,,,17582,
,,CHEMBL622081,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,Intermediate,10116.0,N,9873,1,,1,A,,,17582,
,,CHEMBL622082,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for oral bioavailability in rats,Intermediate,10116.0,N,9874,1,,1,A,,,17791,
,,CHEMBL622083,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for oral bioavailability in rats after iv administration,Intermediate,10116.0,N,9875,1,,1,A,,,17791,
,,CHEMBL622084,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for oral bioavailability in rats; 30-80,Intermediate,10116.0,N,9876,1,,1,A,,,17791,
,,CHEMBL622085,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for oral bioavailability in rats; 50-60,Intermediate,10116.0,N,9877,1,,1,A,,,17791,
,,CHEMBL622086,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for oral bioavailability in rats; no data,Intermediate,10116.0,N,9878,1,,1,A,,,17791,
,,CHEMBL622087,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for oral bioavailability in rats; peptide,Intermediate,10116.0,N,9879,1,,1,A,,,17791,
,,CHEMBL622088,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",Intermediate,10116.0,N,9880,1,,1,A,,,7768,
,,CHEMBL622089,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",Intermediate,10116.0,N,9881,1,,1,A,,,7768,
,,CHEMBL623685,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",Intermediate,10116.0,N,9882,1,,1,A,,,7768,
,,CHEMBL623686,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",Intermediate,10116.0,N,9883,1,,1,A,,,7768,
In vivo,,CHEMBL623687,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9884,1,,1,A,,,8677,
In vivo,,CHEMBL623688,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9885,1,,1,A,,,8677,
In vivo,,CHEMBL623689,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9886,1,,1,A,,,8677,
In vivo,,CHEMBL622485,,50597,Stomach,BAO_0000218,Rattus norvegicus,945.0,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9887,1,,1,A,,,8677,
In vivo,,CHEMBL622486,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9888,1,,1,A,,,8677,
In vivo,,CHEMBL877613,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9889,1,,1,A,,,8677,
In vivo,,CHEMBL622487,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9890,1,,1,A,,,8677,
In vivo,,CHEMBL622488,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9891,1,,1,A,,,8677,
In vivo,,CHEMBL622489,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,10116.0,N,9892,1,,1,A,,,8677,
,,CHEMBL622490,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,10116.0,N,9893,1,,1,A,,,6899,
,,CHEMBL622491,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Intermediate,10116.0,N,9894,1,,1,A,,,6899,
,,CHEMBL622492,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,Intermediate,10116.0,N,9895,1,,1,A,,,6899,
,,CHEMBL622493,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,10116.0,N,9896,1,,1,A,,,6899,
,,CHEMBL622494,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Intermediate,10116.0,N,9897,1,,1,A,,,6899,
,,CHEMBL622495,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,10116.0,N,9898,1,,1,A,,,8677,
,,CHEMBL622496,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,Intermediate,10116.0,N,9899,1,,1,A,,,6899,
,,CHEMBL622497,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,10116.0,N,9900,1,,1,A,,,6899,
,,CHEMBL622498,,50597,,BAO_0000218,Rattus norvegicus,,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,Intermediate,10116.0,N,9901,1,,1,A,,,2189,
,,CHEMBL624918,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,Intermediate,10116.0,N,9902,1,,1,A,,,2189,
,,CHEMBL624919,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,Intermediate,10116.0,N,9903,1,,1,A,,,2189,
In vivo,,CHEMBL624920,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of compound in rat blood after 5 min of administration,Intermediate,10116.0,N,9904,1,,1,A,,,10839,
In vivo,,CHEMBL624921,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of compound in rat blood after 5 min of administration.,Intermediate,10116.0,N,9905,1,,1,A,,,10839,
In vivo,,CHEMBL624922,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of compound in rat brain after 5 min of administration,Intermediate,10116.0,N,9906,1,,1,A,,,10839,
In vivo,,CHEMBL624923,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of compound in rat heart after 5 min of administration,Intermediate,10116.0,N,9907,1,,1,A,,,10839,
In vivo,,CHEMBL624924,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of compound in rat heart after 5 min of administration.,Intermediate,10116.0,N,9908,1,,1,A,,,10839,
In vivo,,CHEMBL624925,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of compound in rat kidney after 5 min of administration,Intermediate,10116.0,N,9909,1,,1,A,,,10839,
In vivo,,CHEMBL624926,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of compound in rat kidney after 5 min of administration.,Intermediate,10116.0,N,9910,1,,1,A,,,10839,
In vivo,,CHEMBL624927,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of compound in rat liver after 5 min of administration,Intermediate,10116.0,N,9911,1,,1,A,,,10839,
In vivo,,CHEMBL874402,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of compound in rat liver after 5 min of administration.,Intermediate,10116.0,N,9912,1,,1,A,,,10839,
In vivo,,CHEMBL624928,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of compound in rat lung after 5 min of administration,Intermediate,10116.0,N,9913,1,,1,A,,,10839,
In vivo,,CHEMBL624929,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of compound in rat lung after 5 min of administration.,Intermediate,10116.0,N,9914,1,,1,A,,,10839,
In vivo,,CHEMBL624930,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of compound in rat muscle after 5 min of administration,Intermediate,10116.0,N,9915,1,,1,A,,,10839,
In vivo,,CHEMBL624931,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of compound in rat muscle after 5 min of administration.,Intermediate,10116.0,N,9916,1,,1,A,,,10839,
,,CHEMBL624932,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,10116.0,N,9917,1,,1,A,,,4043,
,,CHEMBL624933,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,10116.0,N,9918,1,,1,A,,,4043,
,,CHEMBL624934,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,10116.0,N,9919,1,,1,A,,,4043,
,,CHEMBL624935,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,10116.0,N,9920,1,,1,A,,,4043,
,,CHEMBL624936,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,10116.0,N,9921,1,,1,A,,,4043,
,,CHEMBL624937,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,10116.0,N,9922,1,,1,A,,,4043,
,,CHEMBL624938,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,10116.0,N,9923,1,,1,A,,,4043,
,,CHEMBL624939,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,10116.0,N,9924,1,,1,A,,,4043,
,,CHEMBL624940,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,10116.0,N,9925,1,,1,A,,,4043,
,,CHEMBL874403,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,10116.0,N,9926,1,,1,A,,,4043,
,,CHEMBL624941,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,Intermediate,10116.0,N,9927,1,,1,A,,,1446,
,,CHEMBL624942,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,Intermediate,10116.0,N,9928,1,,1,A,,,9971,
,,CHEMBL624943,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,Intermediate,10116.0,N,9929,1,,1,A,,,9971,
In vivo,,CHEMBL624944,,50597,,BAO_0000218,Rattus norvegicus,,,% Bioavailability after 1 day of the drug administration in rats,Intermediate,10116.0,N,9930,1,,1,A,,,5765,
In vivo,,CHEMBL624945,,50597,,BAO_0000218,Rattus norvegicus,,,% Bioavailability after 4 day of the drug administration in rats,Intermediate,10116.0,N,9931,1,,1,A,,,5765,
In vivo,,CHEMBL624946,,50597,,BAO_0000218,Rattus norvegicus,,,Absolute bioavailability was evaluated in rat,Intermediate,10116.0,N,9932,1,,1,A,,,4257,
,,CHEMBL624947,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,Intermediate,10116.0,N,9933,1,,1,A,,,13091,
,,CHEMBL624948,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,Intermediate,10116.0,N,9934,1,,1,A,,,13091,
,,CHEMBL624949,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,Intermediate,10116.0,N,9935,1,,1,A,,,13091,
,,CHEMBL622025,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,Intermediate,10116.0,N,9936,1,,1,A,,,13091,
,,CHEMBL622026,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,Intermediate,10116.0,N,9937,1,,1,A,,,13091,
,,CHEMBL622027,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,Intermediate,10116.0,N,9938,1,,1,A,,,13091,
,,CHEMBL622028,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,Intermediate,10116.0,N,9939,1,,1,A,,,13091,
,,CHEMBL622029,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,Intermediate,10116.0,N,9940,1,,1,A,,,13091,
,,CHEMBL622208,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,Intermediate,10116.0,N,9941,1,,1,A,,,13091,
,,CHEMBL622209,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,Intermediate,10116.0,N,9942,1,,1,A,,,13091,
,,CHEMBL622210,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,Intermediate,10116.0,N,9943,1,,1,A,,,13091,
,,CHEMBL622211,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,Intermediate,10116.0,N,9944,1,,1,A,,,13091,
,,CHEMBL622212,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,Intermediate,10116.0,N,9945,1,,1,A,,,13091,
,,CHEMBL622213,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,Intermediate,10116.0,N,9946,1,,1,A,,,13091,
,,CHEMBL874404,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,Intermediate,10116.0,N,9947,1,,1,A,,,13091,
,,CHEMBL620452,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,Intermediate,10116.0,N,9948,1,,1,A,,,13091,
,,CHEMBL620453,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,Intermediate,10116.0,N,9949,1,,1,A,,,13091,
,,CHEMBL620454,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,Intermediate,10116.0,N,9950,1,,1,A,,,13091,
,,CHEMBL624067,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,Intermediate,10116.0,N,9951,1,,1,A,,,13091,
,,CHEMBL624068,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,Intermediate,10116.0,N,9952,1,,1,A,,,13091,
,,CHEMBL624069,,50597,Female gonad,BAO_0000218,Rattus norvegicus,992.0,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,Intermediate,10116.0,N,9953,1,,1,A,,,13091,
,,CHEMBL624070,,50597,Female gonad,BAO_0000218,Rattus norvegicus,992.0,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,Intermediate,10116.0,N,9954,1,,1,A,,,13091,
,,CHEMBL624071,,50597,Female gonad,BAO_0000218,Rattus norvegicus,992.0,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,Intermediate,10116.0,N,9955,1,,1,A,,,13091,
,,CHEMBL624072,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,Intermediate,10116.0,N,9956,1,,1,A,,,13091,
,,CHEMBL624073,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,Intermediate,10116.0,N,9957,1,,1,A,,,13091,
,,CHEMBL624788,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,Intermediate,10116.0,N,9958,1,,1,A,,,13091,
,,CHEMBL624789,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,Intermediate,10116.0,N,9959,1,,1,A,,,13091,
,,CHEMBL624790,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,Intermediate,10116.0,N,9960,1,,1,A,,,13091,
,,CHEMBL624791,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,Intermediate,10116.0,N,9961,1,,1,A,,,13091,
,,CHEMBL624792,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,Intermediate,10116.0,N,9962,1,,1,A,,,13091,
,,CHEMBL624793,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,Intermediate,10116.0,N,9963,1,,1,A,,,13091,
,,CHEMBL877491,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,Intermediate,10116.0,N,9964,1,,1,A,,,13091,
,,CHEMBL624957,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,Intermediate,10116.0,N,9965,1,,1,A,,,13091,
,,CHEMBL624958,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,Intermediate,10116.0,N,9966,1,,1,A,,,13091,
,,CHEMBL624959,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,Intermediate,10116.0,N,9967,1,,1,A,,,13091,
,,CHEMBL624960,,50597,,BAO_0000218,Rattus norvegicus,,,Dissociation constant was determined,Intermediate,10116.0,N,9968,1,,1,A,,,11977,
,,CHEMBL624961,,50597,,BAO_0000218,Rattus norvegicus,,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,10116.0,N,9969,1,,1,A,,,14941,
,,CHEMBL624962,,50597,,BAO_0000218,Rattus norvegicus,,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,9970,1,,1,A,,,15078,
,,CHEMBL624963,,50597,,BAO_0000218,Rattus norvegicus,,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,9971,1,,1,A,,,15078,
,,CHEMBL624964,,50597,,BAO_0000218,Rattus norvegicus,,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,Intermediate,10116.0,N,9972,1,,1,A,,,4755,
,,CHEMBL624965,,50597,,BAO_0000218,Rattus norvegicus,,,LogP value was evaluated in the in situ rat gut perfusion assay,Intermediate,10116.0,N,9973,1,,1,A,,,589,
In vivo,,CHEMBL624966,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,10116.0,N,9974,1,,1,A,,,17582,
In vivo,,CHEMBL624967,,50597,,BAO_0000218,Rattus norvegicus,,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,Intermediate,10116.0,N,9975,1,,1,A,,,5031,
In vivo,,CHEMBL624968,,50597,,BAO_0000218,Rattus norvegicus,,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,Intermediate,10116.0,N,9976,1,,1,A,,,17764,
,,CHEMBL624969,,50597,,BAO_0000218,Rattus norvegicus,,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,10116.0,N,9977,1,,1,A,,,17720,
,,CHEMBL624970,,50597,,BAO_0000218,Rattus norvegicus,,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,Expert,10116.0,N,9978,1,,1,F,,,2862,
,,CHEMBL624971,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was evaluated after 10 uM/kg of intra arterial administration,Intermediate,10116.0,N,9979,1,,1,A,,,16423,
In vivo,,CHEMBL624972,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was evaluated after 20 uM/kg of peroral administration,Intermediate,10116.0,N,9980,1,,1,A,,,16423,
In vivo,,CHEMBL624973,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,10116.0,N,9981,1,,1,A,,,6005,
,,CHEMBL624974,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life was evaluated in plasma of rat,Intermediate,10116.0,N,9982,1,,1,A,,,2938,
In vivo,,CHEMBL624975,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,Intermediate,10116.0,N,9983,1,,1,A,,,6410,
In vivo,,CHEMBL877492,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,10116.0,N,9984,1,,1,A,,,6410,
In vivo,,CHEMBL624976,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was measured in rat after an iv dose of 1 mg/kg,Intermediate,10116.0,N,9985,1,,1,A,,,6062,
In vivo,,CHEMBL624977,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life period of compound in rats after peroral administration,Intermediate,10116.0,N,9986,1,,1,A,,,6571,
,,CHEMBL626848,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life period of compound was measured in rat plasma.,Intermediate,10116.0,N,9987,1,,1,A,,,3136,
,,CHEMBL626849,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life period of compound was measured in rat plasma; ND is not determined,Intermediate,10116.0,N,9988,1,,1,A,,,3136,
,,CHEMBL626850,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half-life period of compound was measured in rat plasma; not determined,Intermediate,10116.0,N,9989,1,,1,A,,,3136,
In vivo,,CHEMBL626851,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,10116.0,N,9990,1,,1,A,,,4521,
In vivo,,CHEMBL626852,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life period in rat by iv administration,Intermediate,10116.0,N,9991,1,,1,A,,,5871,
In vivo,,CHEMBL626853,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life period in rats following intravenous administration at 2 mg/kg,Intermediate,10116.0,N,9992,1,,1,A,,,6077,
In vivo,,CHEMBL626854,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,10116.0,N,9993,1,,1,A,,,6679,
,,CHEMBL627486,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life period was determined for the compound in rat,Intermediate,10116.0,N,9994,1,,1,A,,,5144,
In vivo,,CHEMBL627487,,50597,,BAO_0000218,Rattus norvegicus,,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",Intermediate,10116.0,N,9995,1,,1,A,,,4498,
In vivo,,CHEMBL627488,,50597,,BAO_0000218,Rattus norvegicus,,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",Intermediate,10116.0,N,9996,1,,1,A,,,4498,
In vivo,,CHEMBL627489,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,10116.0,N,9997,1,,1,A,,,1908,
In vivo,,CHEMBL627490,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,10116.0,N,9998,1,,1,A,,,6211,
In vivo,,CHEMBL873829,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),Intermediate,10116.0,N,9999,1,,1,A,,,5529,
In vivo,,CHEMBL627655,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was determined in rat at a dose of 1 mpk i.v.,Intermediate,10116.0,N,10000,1,,1,A,,,6444,
In vivo,,CHEMBL625994,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,10116.0,N,10001,1,,1,A,,,6444,
In vivo,,CHEMBL625995,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,10116.0,N,10002,1,,1,A,,,6444,
,,CHEMBL625996,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life in rat,Intermediate,10116.0,N,10003,1,,1,A,,,5207,
In vitro,,CHEMBL625850,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,In vitro half life in rat plasma,Intermediate,10116.0,N,10004,1,,1,A,,,530,
In vitro,,CHEMBL625851,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",Intermediate,10116.0,N,10005,1,,1,A,,,1116,
In vitro,,CHEMBL625852,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro half life in rat,Intermediate,10116.0,N,10006,1,,1,A,,,3219,
In vivo,,CHEMBL625853,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo half life period after intravenous administration in rat,Intermediate,10116.0,N,10007,1,,1,A,,,6109,
In vivo,,CHEMBL625854,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,10116.0,N,10008,1,,1,A,,,17582,
In vivo,,CHEMBL874450,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,10116.0,N,10009,1,,1,A,,,17582,
In vivo,,CHEMBL625855,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,10010,1,,1,A,,,5974,
In vivo,,CHEMBL625856,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,10011,1,,1,A,,,5974,
In vivo,,CHEMBL625857,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,10012,1,,1,A,,,5974,
In vivo,,CHEMBL873831,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,10013,1,,1,A,,,5974,
In vivo,,CHEMBL625858,,50597,,BAO_0000218,Rattus norvegicus,,,Longer half-life in rat (i.v.) at 0.5 mpk,Intermediate,10116.0,N,10014,1,,1,A,,,17853,
In vivo,,CHEMBL625859,,50597,,BAO_0000218,Rattus norvegicus,,,Longer half-life in rat (p.o.) at 2.0 mpk,Intermediate,10116.0,N,10015,1,,1,A,,,17853,
,,CHEMBL625860,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (half life) in rat,Intermediate,10116.0,N,10016,1,,1,A,,,3457,
In vivo,,CHEMBL625861,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,Intermediate,10116.0,N,10017,1,,1,A,,,2792,
In vivo,,CHEMBL625862,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,Intermediate,10116.0,N,10018,1,,1,A,,,2792,
In vivo,,CHEMBL625863,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,Intermediate,10116.0,N,10019,1,,1,A,,,2792,
In vivo,,CHEMBL625864,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,Intermediate,10116.0,N,10020,1,,1,A,,,2792,
In vivo,,CHEMBL625865,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,Intermediate,10116.0,N,10021,1,,1,A,,,5739,
In vivo,,CHEMBL625866,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic half time was determined intravenously in rats.,Intermediate,10116.0,N,10022,1,,1,A,,,15765,
In vivo,,CHEMBL625867,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,Intermediate,10116.0,N,10023,1,,1,A,,,6567,
,,CHEMBL625868,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half life of hydrolysis of the compound,Intermediate,10116.0,N,10024,1,,1,A,,,2448,
In vivo,,CHEMBL625869,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,Intermediate,10116.0,N,10025,1,,1,A,,,5423,
,,CHEMBL874451,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half life period was calculated in rat,Intermediate,10116.0,N,10026,1,,1,A,,,4853,
,,CHEMBL625870,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life in Sprague-Dawley rats,Intermediate,10116.0,N,10027,1,,1,A,,,4514,
,,CHEMBL625871,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life in Sprague-Dawley rats; Not determined,Intermediate,10116.0,N,10028,1,,1,A,,,4514,
,,CHEMBL625872,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life in rats,Intermediate,10116.0,N,10029,1,,1,A,,,1500,
,,CHEMBL625873,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life in rats; <MQL,Intermediate,10116.0,N,10030,1,,1,A,,,1500,
,,CHEMBL625874,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life period (0-8 h) was determined,Intermediate,10116.0,N,10031,1,,1,A,,,5334,
,,CHEMBL625875,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,Intermediate,10116.0,N,10032,1,,1,A,,,5334,
In vivo,,CHEMBL625876,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,10116.0,N,10033,1,,1,A,,,5334,
In vivo,,CHEMBL631258,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,10116.0,N,10034,1,,1,A,,,5334,
,,CHEMBL631259,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,Intermediate,10116.0,N,10035,1,,1,A,,,4956,
,,CHEMBL631260,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,Intermediate,10116.0,N,10036,1,,1,A,,,4956,
,,CHEMBL631261,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",Intermediate,10116.0,N,10037,1,,1,A,,,7768,
,,CHEMBL631262,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",Intermediate,10116.0,N,10038,1,,1,A,,,7768,
,,CHEMBL631263,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",Intermediate,10116.0,N,10039,1,,1,A,,,7768,
,,CHEMBL631264,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",Intermediate,10116.0,N,10040,1,,1,A,,,7768,
,,CHEMBL631265,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",Intermediate,10116.0,N,10041,1,,1,A,,,7768,
,,CHEMBL631266,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",Intermediate,10116.0,N,10042,1,,1,A,,,7768,
,,CHEMBL631267,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",Intermediate,10116.0,N,10043,1,,1,A,,,7768,
,,CHEMBL631268,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",Intermediate,10116.0,N,10044,1,,1,A,,,7768,
,,CHEMBL631269,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",Intermediate,10116.0,N,10045,1,,1,A,,,7768,
,,CHEMBL631270,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",Intermediate,10116.0,N,10046,1,,1,A,,,7768,
,,CHEMBL631271,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Intermediate,10116.0,N,10047,1,,1,A,,,7768,
,,CHEMBL631272,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",Intermediate,10116.0,N,10048,1,,1,A,,,7768,
,,CHEMBL631273,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",Intermediate,10116.0,N,10049,1,,1,A,,,7768,
,,CHEMBL631274,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",Intermediate,10116.0,N,10050,1,,1,A,,,7768,
,,CHEMBL631275,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",Intermediate,10116.0,N,10051,1,,1,A,,,7768,
,,CHEMBL626984,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",Intermediate,10116.0,N,10052,1,,1,A,,,7768,
,,CHEMBL626985,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",Intermediate,10116.0,N,10053,1,,1,A,,,7768,
,,CHEMBL626986,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Intermediate,10116.0,N,10054,1,,1,A,,,7768,
,,CHEMBL626987,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",Intermediate,10116.0,N,10055,1,,1,A,,,7768,
,,CHEMBL626988,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",Intermediate,10116.0,N,10056,1,,1,A,,,7768,
,,CHEMBL626989,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",Intermediate,10116.0,N,10057,1,,1,A,,,7768,
,,CHEMBL626990,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",Intermediate,10116.0,N,10058,1,,1,A,,,7768,
,,CHEMBL626991,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",Intermediate,10116.0,N,10059,1,,1,A,,,7768,
,,CHEMBL626992,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",Intermediate,10116.0,N,10060,1,,1,A,,,7768,
,,CHEMBL626993,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",Intermediate,10116.0,N,10061,1,,1,A,,,7768,
,,CHEMBL874593,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",Intermediate,10116.0,N,10062,1,,1,A,,,7768,
,,CHEMBL626994,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",Intermediate,10116.0,N,10063,1,,1,A,,,7768,
,,CHEMBL626995,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",Intermediate,10116.0,N,10064,1,,1,A,,,7768,
,,CHEMBL626190,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",Intermediate,10116.0,N,10065,1,,1,A,,,7768,
,,CHEMBL626191,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",Intermediate,10116.0,N,10066,1,,1,A,,,7768,
,,CHEMBL626364,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",Intermediate,10116.0,N,10067,1,,1,A,,,7768,
,,CHEMBL626365,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",Intermediate,10116.0,N,10068,1,,1,A,,,7768,
,,CHEMBL626366,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",Intermediate,10116.0,N,10069,1,,1,A,,,7768,
,,CHEMBL626367,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",Intermediate,10116.0,N,10070,1,,1,A,,,7768,
,,CHEMBL626368,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",Intermediate,10116.0,N,10071,1,,1,A,,,7768,
,,CHEMBL626369,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",Intermediate,10116.0,N,10072,1,,1,A,,,7768,
,,CHEMBL626370,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",Intermediate,10116.0,N,10073,1,,1,A,,,7768,
In vivo,,CHEMBL626371,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",Intermediate,10116.0,N,10074,1,,1,A,,,4498,
In vivo,,CHEMBL626372,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",Intermediate,10116.0,N,10075,1,,1,A,,,4498,
In vivo,,CHEMBL626373,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability after a dose of 10 mg/kg p.o.,Intermediate,10116.0,N,10076,1,,1,A,,,3603,
In vivo,,CHEMBL626374,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,Intermediate,10116.0,N,10077,1,,1,A,,,6215,
In vivo,,CHEMBL626375,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,Intermediate,10116.0,N,10078,1,,1,A,,,5710,
In vivo,,CHEMBL626376,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),Intermediate,10116.0,N,10079,1,,1,A,,,5710,
In vivo,,CHEMBL626377,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat po was determined,Intermediate,10116.0,N,10080,1,,1,A,,,5676,
In vivo,,CHEMBL626378,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability of compound at 10 mg/kg in rat after oral administration,Intermediate,10116.0,N,10081,1,,1,A,,,17667,
In vivo,,CHEMBL626379,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,Intermediate,10116.0,N,10082,1,,1,A,,,17667,
In vivo,,CHEMBL626380,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,10116.0,N,10083,1,,1,A,,,6848,
In vivo,,CHEMBL626381,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,10116.0,N,10084,1,,1,A,,,6848,
In vivo,,CHEMBL626382,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10085,1,,1,A,,,17267,
In vivo,,CHEMBL626383,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (Sprague-Dawley) (female),Intermediate,10116.0,N,10086,1,,1,A,,,6362,
In vivo,,CHEMBL874652,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,10116.0,N,10087,1,,1,A,,,17671,
In vivo,,CHEMBL626384,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),Intermediate,10116.0,N,10088,1,,1,A,,,17671,
In vivo,,CHEMBL626385,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,Intermediate,10116.0,N,10089,1,,1,A,,,4333,
In vivo,,CHEMBL626386,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat at an oral dose of 2 mg/kg,Intermediate,10116.0,N,10090,1,,1,A,,,6077,
In vivo,,CHEMBL626387,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10091,1,,1,A,,,3278,
In vivo,,CHEMBL626388,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10092,1,,1,A,,,5964,
In vivo,,CHEMBL626389,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10093,1,,1,A,,,4884,
In vivo,,CHEMBL626390,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10094,1,,1,A,,,4905,
In vivo,,CHEMBL626391,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,Intermediate,10116.0,N,10095,1,,1,A,,,4884,
In vivo,,CHEMBL626392,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10096,1,,1,A,,,6850,
In vivo,,CHEMBL626393,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10097,1,,1,A,,,2864,
In vivo,,CHEMBL623026,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was determined in rat,Intermediate,10116.0,N,10098,1,,1,A,,,5780,
In vivo,,CHEMBL623027,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability,Intermediate,10116.0,N,10099,1,,1,A,,,1465,
In vivo,,CHEMBL623028,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability,Intermediate,10116.0,N,10100,1,,1,A,,,5199,
In vivo,,CHEMBL623029,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat after 1 day dosing,Intermediate,10116.0,N,10101,1,,1,A,,,5765,
In vivo,,CHEMBL623030,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat after 4 day dosing,Intermediate,10116.0,N,10102,1,,1,A,,,5765,
In vivo,,CHEMBL623031,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,Intermediate,10116.0,N,10103,1,,1,A,,,6518,
In vivo,,CHEMBL623032,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,Intermediate,10116.0,N,10104,1,,1,A,,,6518,
In vivo,,CHEMBL623033,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,Intermediate,10116.0,N,10105,1,,1,A,,,6518,
In vivo,,CHEMBL623034,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,Intermediate,10116.0,N,10106,1,,1,A,,,6518,
In vivo,,CHEMBL623035,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,Intermediate,10116.0,N,10107,1,,1,A,,,2083,
In vivo,,CHEMBL623036,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,10116.0,N,10108,1,,1,A,,,17260,
In vivo,,CHEMBL623037,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,10116.0,N,10109,1,,1,A,,,4956,
In vivo,,CHEMBL623038,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,Intermediate,10116.0,N,10110,1,,1,A,,,4368,
In vivo,,CHEMBL874385,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,Intermediate,10116.0,N,10111,1,,1,A,,,17752,
In vivo,,CHEMBL623039,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (Fisher) (fasted),Intermediate,10116.0,N,10112,1,,1,A,,,1446,
In vivo,,CHEMBL623040,,22224,,BAO_0000218,Primates,,,Bioavailability in monkey after po administration of 10 mg/kg dose,Intermediate,9443.0,U,10113,1,,0,A,,,2891,
In vivo,,CHEMBL623041,,22224,,BAO_0000218,Primates,,,Oral bioavailability in monkey (dose 10 mg/kg),Intermediate,9443.0,U,10114,1,,0,A,,,2891,
In vivo,,CHEMBL623741,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10115,1,,1,A,,,6672,
In vivo,,CHEMBL623742,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10116,1,,1,A,,,6673,
In vivo,,CHEMBL623743,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10117,1,,1,A,,,17655,
In vivo,,CHEMBL623744,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10118,1,,1,A,,,17796,
In vivo,,CHEMBL623745,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 2.0 mg/kg p.o.),Intermediate,10116.0,N,10119,1,,1,A,,,17853,
In vivo,,CHEMBL623746,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),Intermediate,10116.0,N,10120,1,,1,A,,,4521,
In vivo,,CHEMBL623747,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 5 mg/kg p.o.),Intermediate,10116.0,N,10121,1,,1,A,,,4940,
In vivo,,CHEMBL623748,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat after po administration of 30 mg/kg dose,Intermediate,10116.0,U,10122,1,,0,A,,,2891,
In vivo,,CHEMBL623916,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat after po administration of 30 mg/kg dose,Intermediate,10116.0,U,10123,1,,0,A,,,2891,
In vivo,,CHEMBL623917,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,10116.0,N,10124,1,,1,A,,,4521,
In vivo,,CHEMBL623918,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 2 mg/kg i.v.),Intermediate,10116.0,N,10125,1,,1,A,,,17686,
In vivo,,CHEMBL874386,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10126,1,,1,A,,,17796,
In vivo,,CHEMBL623919,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Bioavailability in rat; Only traces detected in rat plasma,Intermediate,10116.0,N,10127,1,,1,A,,,17796,
In vivo,,CHEMBL623920,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10128,1,,1,A,,,5064,
In vivo,,CHEMBL623148,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability upon oral administration of compound,Intermediate,10116.0,N,10129,1,,1,A,,,5147,
In vivo,,CHEMBL623149,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),Intermediate,10116.0,N,10130,1,,1,A,,,1916,
In vivo,,CHEMBL623150,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10131,1,,1,A,,,6049,
In vivo,,CHEMBL623151,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",Intermediate,10116.0,N,10132,1,,1,A,,,1445,
In vivo,,CHEMBL623152,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",Intermediate,10116.0,N,10133,1,,1,A,,,1445,
,,CHEMBL623153,,50597,,BAO_0000218,Rattus norvegicus,,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,Expert,10116.0,N,10134,1,,1,F,,,2862,
,,CHEMBL623154,,50597,,BAO_0000218,Rattus norvegicus,,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,Expert,10116.0,N,10135,1,,1,F,,,2862,
,,CHEMBL623155,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro and metabolic stability was determined,Intermediate,10116.0,N,10136,1,,1,A,,,4194,
,,CHEMBL623156,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro metabolic stability in rat hepatocytes,Intermediate,10116.0,N,10137,1,,1,A,,,4194,
,,CHEMBL623157,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,Intermediate,10116.0,N,10138,1,,1,A,,,5486,
In vitro,,CHEMBL623158,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Metabolic rate for compound was observed in rat hepatocytes,Intermediate,10116.0,N,10139,1,,1,A,Hepatocyte,401.0,17582,
,,CHEMBL623159,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,Intermediate,10116.0,N,10140,1,,1,A,,,5600,
,,CHEMBL874390,,50597,,BAO_0000218,Rattus norvegicus,,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),Intermediate,10116.0,N,10141,1,,1,A,,,14294,
,,CHEMBL623160,,50597,,BAO_0000218,Rattus norvegicus,,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),Intermediate,10116.0,N,10142,1,,1,A,,,14294,
,,CHEMBL623161,,50597,,BAO_0000218,Rattus norvegicus,,,Metabolism of compound in rat S9 microsomes; Trace,Intermediate,10116.0,N,10143,1,,1,A,,,14294,
,,CHEMBL623162,,50597,,BAO_0000218,Rattus norvegicus,,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,Intermediate,10116.0,N,10144,1,,1,A,,,17847,
,,CHEMBL623163,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,Intermediate,10116.0,N,10145,1,,1,A,,,11020,
,,CHEMBL623164,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,Intermediate,10116.0,N,10146,1,,1,A,,,11020,
,,CHEMBL623165,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,Intermediate,10116.0,N,10147,1,,1,A,,,11020,
,,CHEMBL623166,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,Intermediate,10116.0,N,10148,1,,1,A,,,11020,
,,CHEMBL624983,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,Intermediate,10116.0,N,10149,1,,1,A,,,11020,
,,CHEMBL624984,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,Intermediate,10116.0,N,10150,1,,1,A,,,11020,
,,CHEMBL624985,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,Intermediate,10116.0,N,10151,1,,1,A,,,11020,
,,CHEMBL622970,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,Intermediate,10116.0,N,10152,1,,1,A,,,11020,
,,CHEMBL622971,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,Intermediate,10116.0,N,10153,1,,1,A,,,11020,
,,CHEMBL622972,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,Intermediate,10116.0,N,10154,1,,1,A,,,11020,
,,CHEMBL622973,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,10116.0,N,10155,1,,1,A,,,11020,
,,CHEMBL622974,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,Intermediate,10116.0,N,10156,1,,1,A,,,11020,
,,CHEMBL622975,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,Intermediate,10116.0,N,10157,1,,1,A,,,11020,
,,CHEMBL622976,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,Intermediate,10116.0,N,10158,1,,1,A,,,11020,
,,CHEMBL622977,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,Intermediate,10116.0,N,10159,1,,1,A,,,11020,
,,CHEMBL624351,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Intermediate,10116.0,N,10160,1,,1,A,,,11020,
,,CHEMBL624352,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,Intermediate,10116.0,N,10161,1,,1,A,,,11020,
,,CHEMBL624353,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,10116.0,N,10162,1,,1,A,,,11020,
,,CHEMBL622397,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,Intermediate,10116.0,N,10163,1,,1,A,,,11020,
,,CHEMBL622398,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,Intermediate,10116.0,N,10164,1,,1,A,,,11020,
,,CHEMBL622399,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,Intermediate,10116.0,N,10165,1,,1,A,,,11020,
,,CHEMBL622400,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,10116.0,N,10166,1,,1,A,,,11020,
,,CHEMBL628428,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,Intermediate,10116.0,N,10167,1,,1,A,,,11020,
,,CHEMBL628590,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,Intermediate,10116.0,N,10168,1,,1,A,,,11020,
,,CHEMBL628591,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Intermediate,10116.0,N,10169,1,,1,A,,,11020,
,,CHEMBL628592,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,Intermediate,10116.0,N,10170,1,,1,A,,,11020,
,,CHEMBL628593,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,10116.0,N,10171,1,,1,A,,,11020,
,,CHEMBL875333,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,Intermediate,10116.0,N,10172,1,,1,A,,,11020,
,,CHEMBL628594,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Intermediate,10116.0,N,10173,1,,1,A,,,11020,
,,CHEMBL628595,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,Intermediate,10116.0,N,10174,1,,1,A,,,4969,
,,CHEMBL628596,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Stability in rat plasma was determined,Intermediate,10116.0,N,10175,1,,1,A,,,6737,
,,CHEMBL628597,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Stability in rat plasma was determined; ND= no data,Intermediate,10116.0,N,10176,1,,1,A,,,6737,
,,CHEMBL628598,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Tested for plasma half life period in rat (0-8 hr),Intermediate,10116.0,N,10177,1,,1,A,,,5089,
,,CHEMBL628599,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Tested for plasma half life period in rat (0-8 hr); Not determined,Intermediate,10116.0,N,10178,1,,1,A,,,5089,
In vivo,,CHEMBL628600,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,10116.0,N,10179,1,,1,A,,,1466,
In vivo,,CHEMBL628601,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,10116.0,N,10180,1,,1,A,,,1466,
,,CHEMBL628602,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for the half life in rat,Intermediate,10116.0,N,10181,1,,1,A,,,4950,
In vitro,,CHEMBL628603,,50597,,BAO_0000218,Rattus norvegicus,,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,Intermediate,10116.0,N,10182,1,,1,A,,,2412,
In vitro,,CHEMBL628604,,50597,,BAO_0000218,Rattus norvegicus,,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,Intermediate,10116.0,N,10183,1,,1,A,,,2412,
In vitro,,CHEMBL628605,,50597,,BAO_0000218,Rattus norvegicus,,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,Intermediate,10116.0,N,10184,1,,1,A,,,2412,
In vitro,,CHEMBL628606,,50597,,BAO_0000218,Rattus norvegicus,,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,Intermediate,10116.0,N,10185,1,,1,A,,,2412,
In vitro,,CHEMBL628607,,50597,,BAO_0000218,Rattus norvegicus,,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,Intermediate,10116.0,N,10186,1,,1,A,,,2412,
,,CHEMBL628608,,50597,,BAO_0000218,Rattus norvegicus,,,The biological half life the compound was measured at the dose of 100 umol/kg,Intermediate,10116.0,N,10187,1,,1,A,,,15022,
,,CHEMBL628609,,50597,,BAO_0000218,Rattus norvegicus,,,The biological half life the compound was measured at the dose of 30 umol/kg,Intermediate,10116.0,N,10188,1,,1,A,,,15022,
,,CHEMBL628610,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The compound was evaluated for plasma half life period in rat,Intermediate,10116.0,N,10189,1,,1,A,,,406,
In vivo,,CHEMBL873819,,50597,,BAO_0000218,Rattus norvegicus,,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,10190,1,,1,A,,,15078,
In vivo,,CHEMBL628611,,50597,,BAO_0000218,Rattus norvegicus,,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,10191,1,,1,A,,,15078,
In vivo,,CHEMBL628612,,50597,,BAO_0000218,Rattus norvegicus,,,The pharmacokinetic parameter half-life period in vivo in rats,Intermediate,10116.0,N,10192,1,,1,A,,,5247,
In vivo,,CHEMBL628613,,50597,,BAO_0000218,Rattus norvegicus,,,"The pharmacokinetic property, Half-life was determined",Intermediate,10116.0,N,10193,1,,1,A,,,5041,
In vivo,,CHEMBL628614,,50597,,BAO_0000218,Rattus norvegicus,,,"The pharmacokinetic property, Half-life in rat in vivo",Intermediate,10116.0,N,10194,1,,1,A,,,5041,
In vivo,,CHEMBL628615,,50597,,BAO_0000218,Rattus norvegicus,,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",Intermediate,10116.0,N,10195,1,,1,A,,,5041,
In vivo,,CHEMBL628616,,50597,,BAO_0000218,Rattus norvegicus,,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",Intermediate,10116.0,N,10196,1,,1,A,,,5041,
,,CHEMBL627924,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The plasma half life period in rats,Intermediate,10116.0,N,10197,1,,1,A,,,3918,
,,CHEMBL627925,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,Intermediate,10116.0,N,10198,1,,1,A,,,2906,
In vivo,,CHEMBL627926,,50597,,BAO_0000218,Rattus norvegicus,,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,10116.0,N,10199,1,,1,A,,,6467,
,,CHEMBL627927,,50597,,BAO_0000218,Rattus norvegicus,,,t1/2 (apparent elimination)of the compound was determined,Intermediate,10116.0,N,10200,1,,1,A,,,5510,
,,CHEMBL627928,,50597,,BAO_0000218,Rattus norvegicus,,,t1/2 value in rat,Intermediate,10116.0,N,10201,1,,1,A,,,3788,
,,CHEMBL627539,,50597,,BAO_0000218,Rattus norvegicus,,,Half life in rat,Intermediate,10116.0,N,10202,1,,1,A,,,17796,
In vivo,,CHEMBL876790,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Intermediate,10116.0,N,10203,1,,1,A,,,12873,
In vivo,,CHEMBL858186,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,Intermediate,10116.0,N,10204,1,,1,A,,,5983,
,,CHEMBL627540,,50597,,BAO_0000218,Rattus norvegicus,,,Half-life period in fasted rats,Intermediate,10116.0,N,10205,1,,1,A,,,15765,
In vivo,,CHEMBL627541,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,10116.0,N,10206,1,,1,A,,,2661,
In vivo,,CHEMBL627715,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,10116.0,N,10207,1,,1,A,,,2661,
In vivo,,CHEMBL627716,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Intermediate,10116.0,N,10208,1,,1,A,,,429,
,,CHEMBL627717,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum time required to achieve Cmax was determined in rat,Intermediate,10116.0,N,10209,1,,1,A,,,17655,
In vivo,,CHEMBL627718,,50597,,BAO_0000218,Rattus norvegicus,,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,10116.0,N,10210,1,,1,A,,,17717,
In vivo,,CHEMBL627719,,50597,,BAO_0000218,Rattus norvegicus,,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,10116.0,N,10211,1,,1,A,,,17717,
In vivo,,CHEMBL627720,,50597,,BAO_0000218,Rattus norvegicus,,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,10116.0,N,10212,1,,1,A,,,17717,
In vivo,,CHEMBL627721,,50597,,BAO_0000218,Rattus norvegicus,,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,Intermediate,10116.0,N,10213,1,,1,A,,,6570,
In vivo,,CHEMBL627722,,50597,,BAO_0000218,Rattus norvegicus,,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,Intermediate,10116.0,N,10214,1,,1,A,,,6570,
In vivo,,CHEMBL627723,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,10215,1,,1,A,,,5978,
In vivo,,CHEMBL626058,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,10216,1,,1,A,,,5978,
In vivo,,CHEMBL626059,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,10217,1,,1,A,,,5978,
In vivo,,CHEMBL626060,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,10218,1,,1,A,,,5978,
In vivo,,CHEMBL626061,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,10116.0,N,10219,1,,1,A,,,17720,
In vivo,,CHEMBL876791,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,10220,1,,1,A,,,4723,
In vivo,,CHEMBL626062,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,10116.0,N,10221,1,,1,A,,,4723,
In vivo,,CHEMBL626063,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax at the dose of 2 mg/Kg administered perorally in rats,Intermediate,10116.0,N,10222,1,,1,A,,,4756,
In vivo,,CHEMBL626064,,50597,,BAO_0000218,Rattus norvegicus,,,Tmax at the dose of 5 mg/Kg administered perorally in rats,Intermediate,10116.0,N,10223,1,,1,A,,,4756,
In vivo,,CHEMBL626065,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,Intermediate,10116.0,N,10224,1,,1,A,,,17720,
In vivo,,CHEMBL626066,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,Intermediate,10116.0,N,10225,1,,1,A,,,17720,
In vivo,,CHEMBL626067,,50597,,BAO_0000218,Rattus norvegicus,,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,10116.0,N,10226,1,,1,A,,,1466,
,,CHEMBL626068,,50597,,BAO_0000218,Rattus norvegicus,,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,Intermediate,10116.0,N,10227,1,,1,F,,,7449,
,,CHEMBL626069,,50597,,BAO_0000218,Rattus norvegicus,,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,Intermediate,10116.0,N,10228,1,,1,F,,,7449,
,,CHEMBL626070,,50597,,BAO_0000218,Rattus norvegicus,,,Percent total excretion of 3-methoxyacetaminophen glucuronide,Intermediate,10116.0,N,10229,1,,1,F,,,7449,
,,CHEMBL626071,,50597,,BAO_0000218,Rattus norvegicus,,,Percent total excretion of N-methoxyacetaminophen glucuronide,Intermediate,10116.0,N,10230,1,,1,F,,,7449,
,,CHEMBL626072,,50597,,BAO_0000218,Rattus norvegicus,,,Percent total excretion of N-methoxyacetaminophen sulfate,Intermediate,10116.0,N,10231,1,,1,F,,,7449,
,,CHEMBL626073,,50597,,BAO_0000218,Rattus norvegicus,,,Percent total excretion of acetaminophen,Intermediate,10116.0,N,10232,1,,1,F,,,7449,
,,CHEMBL626741,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",Intermediate,10116.0,N,10233,1,,1,A,,,7768,
,,CHEMBL626742,,50597,,BAO_0000218,Rattus norvegicus,,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",Intermediate,10116.0,N,10234,1,,1,A,,,17655,
,,CHEMBL626743,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,Intermediate,10116.0,N,10235,1,,1,A,,,17735,
,,CHEMBL876792,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,Intermediate,10116.0,N,10236,1,,1,A,,,5960,
,,CHEMBL626744,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,10116.0,N,10237,1,,1,A,,,17735,
,,CHEMBL626745,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for antidiuretic activity in rats,Intermediate,10116.0,N,10238,1,,1,A,,,7116,
In vivo,,CHEMBL626746,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC in rat after 3mg/kg oral dose,Intermediate,10116.0,N,10239,1,,1,A,,,4878,
,,CHEMBL626747,,50597,,BAO_0000218,Rattus norvegicus,,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,Intermediate,10116.0,N,10240,1,,1,A,,,5939,
,,CHEMBL626748,,50597,,BAO_0000218,Rattus norvegicus,,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,Intermediate,10116.0,N,10241,1,,1,A,,,5939,
,,CHEMBL626749,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability administered orally at a dose of 10 mg/kg to rats,Intermediate,10116.0,N,10242,1,,1,A,,,16367,
,,CHEMBL626750,,50597,,BAO_0000218,Rattus norvegicus,,,Oral Bioavailability was determined,Intermediate,10116.0,N,10243,1,,1,A,,,16366,
,,CHEMBL626751,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10244,1,,1,A,,,4426,
,,CHEMBL626913,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat; Not performed.,Intermediate,10116.0,N,10245,1,,1,A,,,4426,
,,CHEMBL626914,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability,Intermediate,10116.0,N,10246,1,,1,A,,,5041,
,,CHEMBL626915,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was determined; ND denotes no data,Intermediate,10116.0,N,10247,1,,1,A,,,5041,
,,CHEMBL626916,,50597,,BAO_0000218,Rattus norvegicus,,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,Intermediate,10116.0,N,10248,1,,1,A,,,1500,
,,CHEMBL626917,,50597,,BAO_0000218,Rattus norvegicus,,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,Intermediate,10116.0,N,10249,1,,1,A,,,1500,
,,CHEMBL626918,,50597,,BAO_0000218,Rattus norvegicus,,,Binding towards rat plasma protein at 10 uM,Intermediate,10116.0,N,10250,1,,1,A,,,17409,
,,CHEMBL626919,,50597,,BAO_0000218,Rattus norvegicus,,,Binding towards rat plasma protein at 100 uM,Intermediate,10116.0,N,10251,1,,1,A,,,17409,
In vivo,,CHEMBL626920,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,10116.0,N,10252,1,,1,A,,,2959,
In vivo,,CHEMBL621976,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,Intermediate,10116.0,N,10253,1,,1,A,,,13501,
In vivo,,CHEMBL877599,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat after 5 mg/kg oral gavage,Intermediate,10116.0,N,10254,1,,1,A,,,6567,
In vivo,,CHEMBL621977,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10255,1,,1,A,,,6571,
In vivo,,CHEMBL621978,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 1 mg/kg i.v.),Intermediate,10116.0,N,10256,1,,1,A,,,6715,
In vivo,,CHEMBL621979,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 3 mg/kg p.o.),Intermediate,10116.0,N,10257,1,,1,A,,,6715,
In vivo,,CHEMBL621980,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10258,1,,1,A,,,2932,
In vivo,,CHEMBL621981,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability of the compound in rats after administration of 30 mg/kg,Intermediate,10116.0,N,10259,1,,1,A,,,4171,
In vivo,,CHEMBL621982,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability after administration of 10 mg/kg in rats,Intermediate,10116.0,N,10260,1,,1,A,,,17509,
In vivo,,CHEMBL882953,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability after administration of 2 mg/kg in rats,Intermediate,10116.0,N,10261,1,,1,A,,,17509,
In vivo,,CHEMBL621983,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,10116.0,N,10262,1,,1,A,,,4527,
In vivo,,CHEMBL621984,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in dogs was determined; high,Intermediate,10116.0,N,10263,1,,1,A,,,4026,
In vivo,,CHEMBL621985,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in monkey after intravenous administration at 1 mpk,Intermediate,10116.0,N,10264,1,,1,A,,,6659,
In vivo,,CHEMBL621986,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in monkey after peroral administration at 10 mpk,Intermediate,10116.0,N,10265,1,,1,A,,,6659,
In vivo,,CHEMBL621987,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat after intravenous administration at 1 mpk,Intermediate,10116.0,N,10266,1,,1,A,,,6659,
In vivo,,CHEMBL877600,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat after intravenous administration at 2 mpk,Intermediate,10116.0,N,10267,1,,1,F,,,6659,
In vivo,,CHEMBL621988,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat after peroral administration at 30 mpk,Intermediate,10116.0,N,10268,1,,1,A,,,6659,
In vivo,,CHEMBL621989,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat after peroral administration at at 100 mpk,Intermediate,10116.0,N,10269,1,,1,F,,,6659,
In vivo,,CHEMBL621990,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rats was evaluated,Intermediate,10116.0,N,10270,1,,1,A,,,6597,
In vivo,,CHEMBL621991,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,Intermediate,10116.0,N,10271,1,,1,A,,,1202,
In vivo,,CHEMBL621992,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,Intermediate,10116.0,N,10272,1,,1,A,,,1202,
In vivo,,CHEMBL621993,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,Intermediate,10116.0,N,10273,1,,1,A,,,1202,
In vivo,,CHEMBL621994,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,Intermediate,10116.0,N,10274,1,,1,A,,,1202,
In vivo,,CHEMBL621995,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10275,1,,1,A,,,5207,
In vivo,,CHEMBL621996,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10276,1,,1,A,,,5970,
In vivo,,CHEMBL621997,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,10116.0,N,10277,1,,1,A,,,17538,
In vivo,,CHEMBL621998,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,Intermediate,10116.0,N,10278,1,,1,A,,,17538,
In vivo,,CHEMBL621999,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,10116.0,N,10279,1,,1,A,,,1466,
In vivo,,CHEMBL622000,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10280,1,,1,A,,,2879,
In vivo,,CHEMBL622001,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was measured in rat after oral administration; 2-4,Intermediate,10116.0,N,10281,1,,1,A,,,2879,
In vivo,,CHEMBL622002,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was measured in rat after oral administration; 3-7,Intermediate,10116.0,N,10282,1,,1,A,,,2879,
In vivo,,CHEMBL622003,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (intraduodenal administration),Intermediate,10116.0,N,10283,1,,1,A,,,3777,
In vivo,,CHEMBL877601,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (intraduodenal administration),Intermediate,10116.0,N,10284,1,,1,A,,,3777,
In vivo,,CHEMBL624871,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10285,1,,1,A,,,3777,
In vivo,,CHEMBL622004,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10286,1,,1,A,,,3777,
In vivo,,CHEMBL882954,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),Intermediate,10116.0,N,10287,1,,1,A,,,5423,
In vivo,,CHEMBL622005,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,Intermediate,10116.0,N,10288,1,,1,A,,,16365,
In vivo,,CHEMBL622006,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,Intermediate,10116.0,N,10289,1,,1,A,,,16365,
In vivo,,CHEMBL622007,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was measured in rat,Intermediate,10116.0,N,10290,1,,1,A,,,4239,
In vivo,,CHEMBL622008,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was reported,Intermediate,10116.0,N,10291,1,,1,A,,,5438,
In vivo,,CHEMBL622009,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,10116.0,N,10292,1,,1,A,,,5334,
In vivo,,CHEMBL622010,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,10116.0,N,10293,1,,1,A,,,5334,
In vivo,,CHEMBL622011,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,10116.0,N,10294,1,,1,A,,,4199,
In vivo,,CHEMBL622012,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),Intermediate,10116.0,N,10295,1,,1,A,,,4199,
In vivo,,CHEMBL622013,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),Intermediate,10116.0,N,10296,1,,1,A,,,4199,
In vivo,,CHEMBL622014,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,10116.0,N,10297,1,,1,A,,,4890,
In vivo,,CHEMBL624749,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was determined at 3 mg/kg po dose in rats,Intermediate,10116.0,N,10298,1,,1,A,,,2792,
In vivo,,CHEMBL624750,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 2 mg/kg),Intermediate,10116.0,N,10299,1,,1,A,,,5529,
In vivo,,CHEMBL624751,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",Intermediate,10116.0,N,10300,1,,1,A,,,6685,
In vivo,,CHEMBL624752,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,10116.0,N,10301,1,,1,A,,,6685,
In vivo,,CHEMBL624753,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,10116.0,N,10302,1,,1,A,,,6685,
In vivo,,CHEMBL624754,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,Intermediate,10116.0,N,10303,1,,1,A,,,6005,
In vivo,,CHEMBL624755,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,10116.0,N,10304,1,,1,A,,,6410,
In vivo,,CHEMBL624756,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,10116.0,N,10305,1,,1,A,,,6410,
In vivo,,CHEMBL624757,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10306,1,,1,A,,,6103,
In vivo,,CHEMBL624758,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,10116.0,N,10307,1,,1,A,,,6410,
In vivo,,CHEMBL622270,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,10116.0,N,10308,1,,1,A,,,6410,
In vivo,,CHEMBL622271,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (Sprague-Dawley),Intermediate,10116.0,N,10309,1,,1,A,,,5353,
In vivo,,CHEMBL622272,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat at the dose of 2 mg/kg,Intermediate,10116.0,N,10310,1,,1,A,,,4727,
In vivo,,CHEMBL622273,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10311,1,,1,A,,,17804,
In vivo,,CHEMBL622274,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (cannulated) (dose 2 mg/kg),Intermediate,10116.0,N,10312,1,,1,A,,,5809,
In vivo,,CHEMBL622275,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability value of compound in rats was determined after peroral administration,Intermediate,10116.0,N,10313,1,,1,A,,,17804,
In vivo,,CHEMBL622276,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 20 mg/kg),Intermediate,10116.0,N,10314,1,,1,A,,,3634,
In vivo,,CHEMBL622277,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10315,1,,1,A,,,3341,
In vivo,,CHEMBL622278,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 5 mg/kg),Intermediate,10116.0,N,10316,1,,1,A,,,2690,
In vivo,,CHEMBL622279,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10317,1,,1,A,,,3184,
In vivo,,CHEMBL622280,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10318,1,,1,A,,,740,
In vivo,,CHEMBL624083,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for oral bioavailability in rats; 15-27 %,Intermediate,10116.0,N,10319,1,,1,A,,,1806,
In vivo,,CHEMBL624084,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,Intermediate,10116.0,N,10320,1,,1,A,,,4891,
In vivo,,CHEMBL624085,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),Intermediate,10116.0,N,10321,1,,1,A,,,3634,
In vivo,,CHEMBL624086,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for bioavailability in rats,Intermediate,10116.0,N,10322,1,,1,A,,,64,
In vivo,,CHEMBL624087,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10323,1,,1,A,,,4839,
In vivo,,CHEMBL624088,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10324,1,,1,A,,,1094,
In vivo,,CHEMBL624089,,22224,,BAO_0000218,Macaca mulatta,,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,Intermediate,9544.0,U,10325,1,,0,A,,,5005,
In vivo,,CHEMBL624090,,22224,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,10116.0,U,10326,1,,0,A,,,5005,
In vivo,,CHEMBL624091,,50597,,BAO_0000218,Rattus norvegicus,,,Evaluated for the bioavailability in rat (in vivo),Intermediate,10116.0,N,10327,1,,1,A,,,4687,
In vivo,,CHEMBL624092,,50597,,BAO_0000218,Rattus norvegicus,,,F value of compound in rats was determined after peroral administration,Intermediate,10116.0,N,10328,1,,1,A,,,17804,
In vivo,,CHEMBL624093,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,10329,1,,1,A,,,5974,
In vivo,,CHEMBL624094,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,10330,1,,1,A,,,5974,
In vivo,,CHEMBL624095,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,10331,1,,1,A,,,5974,
In vivo,,CHEMBL624096,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,10116.0,N,10332,1,,1,A,,,5974,
In vivo,,CHEMBL624097,,50597,,BAO_0000218,Rattus norvegicus,,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",Intermediate,10116.0,N,10333,1,,1,A,,,1088,
In vivo,,CHEMBL624098,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum fall in carotid flow in rat,Intermediate,10116.0,N,10334,1,,1,A,,,1742,
In vivo,,CHEMBL874392,,50597,,BAO_0000218,Rattus norvegicus,,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,Intermediate,10116.0,N,10335,1,,1,A,,,4689,
In vivo,,CHEMBL624099,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 5 mg/kg),Intermediate,10116.0,N,10336,1,,1,A,,,2463,
In vivo,,CHEMBL624100,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,10116.0,N,10337,1,,1,A,,,5654,
In vivo,,CHEMBL624101,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,10116.0,N,10338,1,,1,A,,,5654,
In vivo,,CHEMBL624102,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (male Wistar),Intermediate,10116.0,N,10339,1,,1,A,,,6874,
In vivo,,CHEMBL624103,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability after administration (30 mg/kg) in rat; good,Intermediate,10116.0,N,10340,1,,1,A,,,5633,
In vivo,,CHEMBL624104,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability at the dose of 2 mg/kg in rat,Intermediate,10116.0,N,10341,1,,1,A,,,5496,
In vivo,,CHEMBL624105,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability determined in rats,Intermediate,10116.0,N,10342,1,,1,A,,,2358,
In vivo,,CHEMBL624106,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),Intermediate,10116.0,N,10343,1,,1,A,,,16456,
In vivo,,CHEMBL624107,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose single 10 mg/kg),Intermediate,10116.0,N,10344,1,,1,A,,,5302,
In vivo,,CHEMBL623943,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose single 10 mg/kg),Intermediate,10116.0,N,10345,1,,1,A,,,5302,
In vivo,,CHEMBL623944,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 5 mg/kg,Intermediate,10116.0,N,10346,1,,1,A,,,5302,
,,CHEMBL623945,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,Intermediate,10116.0,N,10347,1,,1,A,,,11020,
,,CHEMBL623946,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,Intermediate,10116.0,N,10348,1,,1,A,,,11020,
,,CHEMBL623947,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,Intermediate,10116.0,N,10349,1,,1,A,,,11020,
,,CHEMBL623948,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,Intermediate,10116.0,N,10350,1,,1,A,,,11020,
,,CHEMBL623949,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,Intermediate,10116.0,N,10351,1,,1,A,,,11020,
,,CHEMBL623950,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,Intermediate,10116.0,N,10352,1,,1,A,,,11020,
,,CHEMBL874398,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,Intermediate,10116.0,N,10353,1,,1,A,,,11020,
,,CHEMBL623951,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,Intermediate,10116.0,N,10354,1,,1,A,,,11020,
,,CHEMBL623952,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,Intermediate,10116.0,N,10355,1,,1,A,,,11020,
,,CHEMBL623953,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,Intermediate,10116.0,N,10356,1,,1,A,,,11020,
,,CHEMBL623954,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,Intermediate,10116.0,N,10357,1,,1,A,,,11020,
,,CHEMBL623955,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,Intermediate,10116.0,N,10358,1,,1,A,,,11020,
,,CHEMBL623956,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,Intermediate,10116.0,N,10359,1,,1,A,,,11020,
,,CHEMBL627807,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,Intermediate,10116.0,N,10360,1,,1,A,,,11020,
,,CHEMBL627808,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,Intermediate,10116.0,N,10361,1,,1,A,,,11020,
,,CHEMBL627809,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,Intermediate,10116.0,N,10362,1,,1,A,,,11020,
,,CHEMBL627810,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,Intermediate,10116.0,N,10363,1,,1,A,,,11020,
,,CHEMBL627811,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",Intermediate,10116.0,N,10364,1,,1,A,,,11020,
,,CHEMBL627812,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",Intermediate,10116.0,N,10365,1,,1,A,,,11020,
,,CHEMBL627813,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",Intermediate,10116.0,N,10366,1,,1,A,,,11020,
,,CHEMBL627814,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",Intermediate,10116.0,N,10367,1,,1,A,,,11020,
,,CHEMBL875336,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",Intermediate,10116.0,N,10368,1,,1,A,,,11020,
,,CHEMBL627815,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",Intermediate,10116.0,N,10369,1,,1,A,,,11020,
,,CHEMBL627816,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",Intermediate,10116.0,N,10370,1,,1,A,,,11020,
,,CHEMBL627817,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",Intermediate,10116.0,N,10371,1,,1,A,,,11020,
,,CHEMBL627818,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",Intermediate,10116.0,N,10372,1,,1,A,,,11020,
,,CHEMBL627819,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",Intermediate,10116.0,N,10373,1,,1,A,,,11020,
,,CHEMBL627820,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",Intermediate,10116.0,N,10374,1,,1,A,,,11020,
,,CHEMBL627821,,50597,,BAO_0000218,Rattus norvegicus,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",Intermediate,10116.0,N,10375,1,,1,A,,,11020,
,,CHEMBL628464,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Intermediate,10116.0,N,10376,1,,1,A,,,11020,
,,CHEMBL626239,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,Intermediate,10116.0,N,10377,1,,1,A,,,11020,
,,CHEMBL626240,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,10116.0,N,10378,1,,1,A,,,11020,
,,CHEMBL626241,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,Intermediate,10116.0,N,10379,1,,1,A,,,11020,
,,CHEMBL626242,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,Intermediate,10116.0,N,10380,1,,1,A,,,11020,
,,CHEMBL626243,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,Intermediate,10116.0,N,10381,1,,1,A,,,11020,
,,CHEMBL626244,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,Intermediate,10116.0,N,10382,1,,1,A,,,11020,
,,CHEMBL626907,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,Intermediate,10116.0,N,10383,1,,1,A,,,11020,
,,CHEMBL626908,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Intermediate,10116.0,N,10384,1,,1,A,,,11020,
,,CHEMBL626909,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,10116.0,N,10385,1,,1,A,,,11020,
,,CHEMBL626910,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Intermediate,10116.0,N,10386,1,,1,A,,,11020,
,,CHEMBL875342,,50597,,BAO_0000218,Rattus norvegicus,,,Percent total excretion of acetaminophen cysteine conjugate,Intermediate,10116.0,N,10387,1,,1,F,,,7449,
,,CHEMBL626911,,50597,,BAO_0000218,Rattus norvegicus,,,Percent total excretion of acetaminophen glucuronide,Intermediate,10116.0,N,10388,1,,1,F,,,7449,
,,CHEMBL626912,,50597,,BAO_0000218,Rattus norvegicus,,,Percent total excretion of acetaminophen sulfate,Intermediate,10116.0,N,10389,1,,1,F,,,7449,
,,CHEMBL627065,,50597,,BAO_0000218,Rattus norvegicus,,,Percent total excretion of acetaminophen-mercapturic acid,Intermediate,10116.0,N,10390,1,,1,F,,,7449,
,,CHEMBL627066,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,Intermediate,10116.0,N,10391,1,,1,A,,,3172,
In vivo,,CHEMBL627067,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,10116.0,N,10392,1,,1,A,,,16456,
In vivo,,CHEMBL627068,,22224,Muscle tissue,BAO_0000218,ratrat,2385.0,,Biodistribution of compound in rat muscle after 5 min of administration,Autocuration,8656.0,U,10393,1,,0,A,,,10839,
In vivo,,CHEMBL627069,,22224,Muscle tissue,BAO_0000218,ratrat,2385.0,,Biodistribution of compound in rat muscle after 5 min of administration.,Autocuration,8656.0,U,10394,1,,0,A,,,10839,
In vivo,,CHEMBL627070,,22224,,BAO_0000218,Ovis aries,,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,9940.0,U,10395,1,,0,A,,,5334,
In vivo,,CHEMBL627071,,22224,,BAO_0000218,Ovis aries,,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,9940.0,U,10396,1,,0,A,,,5334,
In vivo,,CHEMBL627072,,22224,,BAO_0000218,Ovis aries,,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,9940.0,U,10397,1,,0,A,,,5334,
In vivo,,CHEMBL627073,,22224,,BAO_0000218,Ovis aries,,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,9940.0,U,10398,1,,0,A,,,5334,
In vivo,,CHEMBL625387,,22224,,BAO_0000218,Ovis aries,,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,9940.0,U,10399,1,,0,A,,,5334,
In vivo,,CHEMBL625388,,22224,,BAO_0000218,Ovis aries,,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,9940.0,U,10400,1,,0,A,,,5334,
In vivo,,CHEMBL625389,,22224,Plasma,BAO_0000218,Ovis aries,1969.0,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,9940.0,U,10401,1,,0,A,,,5334,
In vivo,,CHEMBL875343,,22224,Plasma,BAO_0000218,Ovis aries,1969.0,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,9940.0,U,10402,1,,0,A,,,5334,
,,CHEMBL876795,,50497,,BAO_0000218,Serpentes,,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),Intermediate,8570.0,N,10403,1,,1,A,,,1735,
,,CHEMBL626552,,50497,,BAO_0000218,Serpentes,,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,Intermediate,8570.0,N,10404,1,,1,A,,,1469,
,,CHEMBL626553,,50497,,BAO_0000218,Serpentes,,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,Intermediate,8570.0,N,10405,1,,1,A,,,1336,
,,CHEMBL626554,,22224,Plasma,BAO_0000366,Homo sapiens,1969.0,,The human biological plasma half life of the compound,Autocuration,9606.0,U,10406,1,,0,A,,,12403,
,,CHEMBL626555,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Intermediate,10116.0,N,10407,1,,1,A,,,8151,
,,CHEMBL626556,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,Intermediate,10116.0,N,10408,1,,1,A,,,8004,
,,CHEMBL626557,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,Intermediate,10116.0,N,10409,1,,1,A,,,8004,
,,CHEMBL626558,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,Intermediate,10116.0,N,10410,1,,1,A,,,8004,
,,CHEMBL626559,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,Intermediate,10116.0,N,10411,1,,1,A,,,8004,
,,CHEMBL626560,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,10116.0,N,10412,1,,1,A,,,8004,
,,CHEMBL876803,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,Intermediate,10116.0,N,10413,1,,1,A,,,8004,
,,CHEMBL627964,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,Intermediate,10116.0,N,10414,1,,1,A,,,8004,
,,CHEMBL627965,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,Intermediate,10116.0,N,10415,1,,1,A,,,8004,
,,CHEMBL627966,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,Intermediate,10116.0,N,10416,1,,1,A,,,8004,
,,CHEMBL627967,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,Intermediate,10116.0,N,10417,1,,1,A,,,8004,
,,CHEMBL627968,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,10116.0,N,10418,1,,1,A,,,8004,
,,CHEMBL627969,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,Intermediate,10116.0,N,10419,1,,1,A,,,8004,
,,CHEMBL627970,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,10116.0,N,10420,1,,1,A,,,8004,
,,CHEMBL627971,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,Intermediate,10116.0,N,10421,1,,1,A,,,8004,
,,CHEMBL627972,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,Intermediate,10116.0,N,10422,1,,1,A,,,8004,
,,CHEMBL856029,,180,,BAO_0000357,Homo sapiens,,,Dissociation constant against binding to human cyclophilin A,Expert,9606.0,D,10423,1,,9,B,,,15917,
,,CHEMBL627973,,11591,,BAO_0000019,Bos taurus,,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,Expert,9913.0,H,10424,1,,8,B,,,12396,
,,CHEMBL627974,,22224,,BAO_0000019,,,,-Log C was determined by performing the electroshock minimum test,Autocuration,,U,10425,1,,0,A,,,7065,
,,CHEMBL627975,,22224,,BAO_0000019,,,,-Log C was determined by performing the foot shock test,Autocuration,,U,10426,1,,0,A,,,7065,
,,CHEMBL627976,,22224,,BAO_0000019,,,,-Log C was determined by performing the incl screen test,Autocuration,,U,10427,1,,0,A,,,7065,
,,CHEMBL627977,,22224,,BAO_0000019,,,,-Log C was determined by performing the maximum electroshock test,Autocuration,,U,10428,1,,0,A,,,7065,
,,CHEMBL627978,,22224,,BAO_0000019,,,,-Log C was determined by performing the pentylenetetrazole test,Autocuration,,U,10429,1,,0,A,,,7065,
,,CHEMBL627979,,22224,,BAO_0000019,,,,Tested for experimental arotinoid inhibitory dose,Autocuration,,U,10430,1,,0,A,,,12415,
,,CHEMBL876804,,22224,,BAO_0000019,,,,Negative log transformed activity,Autocuration,,U,10431,1,,0,A,,,10256,
,,CHEMBL627980,,22224,,BAO_0000019,,,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",Autocuration,,U,10432,1,,0,A,,,7991,
,,CHEMBL627981,,50512,,BAO_0000218,Cavia porcellus,,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,Intermediate,10141.0,N,10433,1,,1,A,,,14342,
,,CHEMBL627982,,50512,,BAO_0000218,Cavia porcellus,,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,Intermediate,10141.0,N,10434,1,,1,A,,,14342,
,,CHEMBL627983,,50512,,BAO_0000218,Cavia porcellus,,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,Intermediate,10141.0,N,10435,1,,1,A,,,14342,
,,CHEMBL627984,,50512,Ileum,BAO_0000218,Cavia porcellus,2116.0,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,Intermediate,10141.0,N,10436,1,,1,A,,,14342,
,,CHEMBL627985,,22229,,BAO_0000100,,,,Solubility in water was determined; values expressed as -log,Autocuration,,U,10437,1,,0,P,,,6047,
,,CHEMBL627986,,22224,,BAO_0000019,,,,Ratio of Kcat to that of Km was determined,Autocuration,,U,10438,1,,0,A,,,17269,
,,CHEMBL627987,,22224,,BAO_0000019,,,,Observed first order rate constant,Autocuration,,U,10439,1,,0,A,,,10026,
,,CHEMBL627988,,22224,,BAO_0000019,,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,Autocuration,,U,10440,1,,0,A,,,14583,
In vivo,,CHEMBL627989,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,10116.0,N,10441,1,,1,A,,,2661,
In vivo,,CHEMBL627990,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,10116.0,N,10442,1,,1,A,,,2661,
In vivo,,CHEMBL876805,,50597,,BAO_0000218,Rattus norvegicus,,,Oral Bioavailability after administration of 10 mg/kg in male rat,Intermediate,10116.0,N,10443,1,,1,A,,,4029,
In vivo,,CHEMBL627991,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),Intermediate,10116.0,N,10444,1,,1,A,,,17735,
In vivo,,CHEMBL627992,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10445,1,,1,A,,,4576,
In vivo,,CHEMBL627993,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,10116.0,N,10446,1,,1,A,,,17582,
In vivo,,CHEMBL622817,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability at 1 mg/kg was determined in rat,Intermediate,10116.0,N,10447,1,,1,A,,,17651,
In vivo,,CHEMBL622818,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability at 10 mg/kg was determined in rat,Intermediate,10116.0,N,10448,1,,1,A,,,17651,
In vivo,,CHEMBL622819,,50597,,BAO_0000218,Rattus norvegicus,,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",Intermediate,10116.0,N,10449,1,,1,A,,,17670,
In vivo,,CHEMBL872267,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10450,1,,1,A,,,5045,
In vivo,,CHEMBL622820,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10451,1,,1,A,,,1696,
In vivo,,CHEMBL622821,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,Intermediate,10116.0,N,10452,1,,1,A,,,17764,
In vivo,,CHEMBL622822,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10453,1,,1,A,,,6448,
In vivo,,CHEMBL622823,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10454,1,,1,A,,,6596,
In vivo,,CHEMBL622824,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10455,1,,1,A,,,17547,
In vivo,,CHEMBL622825,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat at a dose of 3 mg/kg,Intermediate,10116.0,N,10456,1,,1,A,,,17771,
In vivo,,CHEMBL622901,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat after oral administration at 10 mg/kg,Intermediate,10116.0,N,10457,1,,1,A,,,6495,
In vivo,,CHEMBL622902,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10458,1,,1,A,,,4558,
In vivo,,CHEMBL621844,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10459,1,,1,A,,,17596,
In vivo,,CHEMBL621845,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in Dawley rats,Intermediate,10116.0,N,10460,1,,1,A,,,6827,
In vivo,,CHEMBL621846,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability,Intermediate,10116.0,N,10461,1,,1,A,,,4026,
In vivo,,CHEMBL621847,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 30 mg/kg),Intermediate,10116.0,N,10462,1,,1,A,,,10,
In vivo,,CHEMBL877609,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,10116.0,N,10463,1,,1,A,,,17717,
In vivo,,CHEMBL621848,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 3 mg/kg i.v.),Intermediate,10116.0,N,10464,1,,1,A,,,17717,
In vivo,,CHEMBL621849,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,10116.0,N,10465,1,,1,A,,,17717,
In vivo,,CHEMBL622030,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 60 mg/kg p.o.),Intermediate,10116.0,N,10466,1,,1,A,,,17717,
In vivo,,CHEMBL622031,,50597,,BAO_0000218,Rattus norvegicus,,,Percent oral bioavailability determined in rats,Intermediate,10116.0,N,10467,1,,1,A,,,4796,
In vivo,,CHEMBL622032,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,10116.0,N,10468,1,,1,A,,,4883,
In vivo,,CHEMBL622033,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was evaluated for bioavailability in rats; 32-51,Intermediate,10116.0,N,10469,1,,1,A,,,2137,
In vivo,,CHEMBL622034,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,10116.0,N,10470,1,,1,A,,,2959,
In vivo,,CHEMBL622035,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10471,1,,1,A,,,1361,
In vivo,,CHEMBL882966,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability percent in rat at the dose of 2 mg/kg,Intermediate,10116.0,N,10472,1,,1,A,,,4727,
In vivo,,CHEMBL622036,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was evaluated after 20 uM/kg of peroral administration,Intermediate,10116.0,N,10473,1,,1,A,,,16423,
In vivo,,CHEMBL622037,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10474,1,,1,A,,,5206,
In vivo,,CHEMBL622038,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10475,1,,1,A,,,6448,
In vivo,,CHEMBL622039,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rats,Intermediate,10116.0,N,10476,1,,1,A,,,17723,
In vivo,,CHEMBL622040,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,10116.0,N,10477,1,,1,A,,,17738,
In vivo,,CHEMBL622041,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10478,1,,1,A,,,17738,
In vivo,,CHEMBL622042,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10479,1,,1,A,,,17738,
In vivo,,CHEMBL622043,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10480,1,,1,A,,,17738,
In vivo,,CHEMBL622044,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10481,1,,1,A,,,17738,
In vivo,,CHEMBL622045,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10482,1,,1,A,,,17738,
In vivo,,CHEMBL622046,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10483,1,,1,A,,,17738,
In vivo,,CHEMBL622047,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10484,1,,1,A,,,17738,
In vivo,,CHEMBL877610,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10485,1,,1,A,,,17738,
In vivo,,CHEMBL622048,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10486,1,,1,A,,,17738,
In vivo,,CHEMBL622049,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10487,1,,1,A,,,17738,
In vivo,,CHEMBL622050,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10488,1,,1,A,,,17738,
In vivo,,CHEMBL622051,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10489,1,,1,A,,,17738,
In vivo,,CHEMBL622052,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10490,1,,1,A,,,17738,
In vivo,,CHEMBL622053,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10491,1,,1,A,,,17738,
In vivo,,CHEMBL622054,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10492,1,,1,A,,,17738,
In vivo,,CHEMBL622055,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10493,1,,1,A,,,17738,
In vivo,,CHEMBL622056,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rats was determined; High,Intermediate,10116.0,N,10494,1,,1,A,,,5237,
In vivo,,CHEMBL622057,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in the rat was determined,Intermediate,10116.0,N,10495,1,,1,A,,,5503,
In vivo,,CHEMBL628008,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,Intermediate,10116.0,N,10496,1,,1,A,,,15765,
In vivo,,CHEMBL622058,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),Intermediate,10116.0,N,10497,1,,1,A,,,15660,
In vivo,,CHEMBL622059,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,10498,1,,1,A,,,5978,
In vivo,,CHEMBL622060,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,10499,1,,1,A,,,5978,
In vivo,,CHEMBL622061,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,10500,1,,1,A,,,5978,
In vivo,,CHEMBL622062,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,10116.0,N,10501,1,,1,A,,,5978,
In vivo,,CHEMBL622063,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,Intermediate,10116.0,N,10502,1,,1,A,,,5656,
In vivo,,CHEMBL877611,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,10116.0,N,10503,1,,1,A,,,3598,
In vivo,,CHEMBL622064,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound in Sprague Dawley rats,Intermediate,10116.0,N,10504,1,,1,A,,,4216,
In vivo,,CHEMBL622065,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound in rat,Intermediate,10116.0,N,10505,1,,1,A,,,17839,
In vivo,,CHEMBL622066,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 2 mg/kg),Intermediate,10116.0,N,10506,1,,1,A,,,6570,
In vivo,,CHEMBL622067,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound in rat was determined,Intermediate,10116.0,N,10507,1,,1,A,,,5334,
In vivo,,CHEMBL622068,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound in rats,Intermediate,10116.0,N,10508,1,,1,A,,,6886,
In vivo,,CHEMBL622069,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound was determined in rats,Intermediate,10116.0,N,10509,1,,1,A,,,5210,
In vivo,,CHEMBL624796,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability at a dose of 30 mg/kg in rats,Intermediate,10116.0,N,10510,1,,1,A,,,4170,
In vivo,,CHEMBL624797,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,10116.0,N,10511,1,,1,A,,,6028,
In vivo,,CHEMBL623053,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,10116.0,N,10512,1,,1,A,,,6028,
In vivo,,CHEMBL623054,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability evaluated in rat,Intermediate,10116.0,N,10513,1,,1,A,,,6078,
In vivo,,CHEMBL623055,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in fasted rat,Intermediate,10116.0,N,10514,1,,1,A,,,6168,
In vivo,,CHEMBL623056,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in fed rat,Intermediate,10116.0,N,10515,1,,1,A,,,6168,
In vivo,,CHEMBL623057,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),Intermediate,10116.0,N,10516,1,,1,A,,,5160,
In vivo,,CHEMBL623058,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10517,1,,1,A,,,6057,
In vivo,,CHEMBL623059,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 10 mg/kg p.o.),Intermediate,10116.0,N,10518,1,,1,A,,,6535,
In vivo,,CHEMBL623060,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat after administration of 10 mg/kg po,Intermediate,10116.0,N,10519,1,,1,A,,,6535,
In vivo,,CHEMBL623061,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10520,1,,1,A,,,4194,
In vivo,,CHEMBL623062,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10521,1,,1,A,,,6230,
In vivo,,CHEMBL623063,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10522,1,,1,A,,,6619,
In vivo,,CHEMBL623064,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10523,1,,1,A,,,17607,
In vivo,,CHEMBL623065,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in ratrs,Intermediate,10116.0,N,10524,1,,1,A,,,4942,
In vivo,,CHEMBL623066,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10525,1,,1,A,,,4942,
In vivo,,CHEMBL623067,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10526,1,,1,A,,,6646,
In vivo,,CHEMBL623068,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rats was determined; High,Intermediate,10116.0,N,10527,1,,1,A,,,5237,
In vivo,,CHEMBL623069,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10528,1,,1,A,,,6646,
In vivo,,CHEMBL623070,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10529,1,,1,A,,,4449,
In vivo,,CHEMBL623071,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability was calculated in rat,Intermediate,10116.0,N,10530,1,,1,A,,,6057,
In vivo,,CHEMBL623072,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability,Intermediate,10116.0,N,10531,1,,1,A,,,2552,
In vivo,,CHEMBL623073,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability,Intermediate,10116.0,N,10532,1,,1,A,,,5496,
In vivo,,CHEMBL623074,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability,Intermediate,10116.0,N,10533,1,,1,A,,,6484,
In vivo,,CHEMBL623075,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability,Intermediate,10116.0,N,10534,1,,1,A,,,6485,
In vivo,,CHEMBL623076,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability after i.v. administration,Intermediate,10116.0,N,10535,1,,1,A,,,6616,
In vivo,,CHEMBL623077,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,10116.0,N,10536,1,,1,A,,,4969,
In vivo,,CHEMBL623078,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley),Intermediate,10116.0,N,10537,1,,1,A,,,5862,
In vivo,,CHEMBL623079,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in Sprague-Dawley rats,Intermediate,10116.0,N,10538,1,,1,A,,,4514,
In vivo,,CHEMBL623080,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,10116.0,N,10539,1,,1,A,,,4514,
In vivo,,CHEMBL623081,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,10116.0,N,10540,1,,1,A,,,4514,
In vivo,,CHEMBL623082,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,Intermediate,10116.0,N,10541,1,,1,A,,,5546,
In vivo,,CHEMBL874400,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in fasted rat,Intermediate,10116.0,N,10542,1,,1,A,,,6168,
In vivo,,CHEMBL623083,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in fed rat,Intermediate,10116.0,N,10543,1,,1,A,,,6168,
In vivo,,CHEMBL623084,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10544,1,,1,A,,,3624,
In vivo,,CHEMBL623085,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10545,1,,1,A,,,5213,
In vivo,,CHEMBL623086,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10546,1,,1,A,,,5496,
In vivo,,CHEMBL623087,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10547,1,,1,A,,,5553,
In vivo,,CHEMBL623088,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10548,1,,1,A,,,5833,
In vivo,,CHEMBL623089,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10549,1,,1,A,,,5836,
In vivo,,CHEMBL623090,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10550,1,,1,A,,,5865,
In vivo,,CHEMBL623091,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10551,1,,1,A,,,5960,
In vivo,,CHEMBL623092,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10552,1,,1,A,,,6249,
In vivo,,CHEMBL623093,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10553,1,,1,A,,,6448,
In vivo,,CHEMBL874401,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10554,1,,1,A,,,6453,
In vivo,,CHEMBL623094,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10555,1,,1,A,,,6640,
In vivo,,CHEMBL623095,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10556,1,,1,A,,,17607,
In vivo,,CHEMBL623096,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat after peroral administration at 10 mg/kg,Intermediate,10116.0,N,10557,1,,1,A,,,5939,
In vivo,,CHEMBL624913,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat after peroral administration at 5 mg/kg,Intermediate,10116.0,N,10558,1,,1,A,,,5939,
In vivo,,CHEMBL624914,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),Intermediate,10116.0,N,10559,1,,1,A,,,6281,
In vivo,,CHEMBL624915,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,Intermediate,10116.0,N,10560,1,,1,A,,,5874,
In vivo,,CHEMBL624916,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat; Not measured,Intermediate,10116.0,N,10561,1,,1,A,,,5213,
In vivo,,CHEMBL624917,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10562,1,,1,A,,,4964,
,,CHEMBL625157,,50597,,BAO_0000218,Rattus norvegicus,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,Intermediate,10116.0,N,10563,1,,1,A,,,11020,
,,CHEMBL625158,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,In vitro metabolic potential in rat liver microsomes,Intermediate,10116.0,N,10564,1,,1,A,,,6251,
In vivo,,CHEMBL625159,,50597,,BAO_0000218,Rattus norvegicus,,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",Intermediate,10116.0,N,10565,1,,1,A,,,1568,
In vivo,,CHEMBL625160,,50597,,BAO_0000218,Rattus norvegicus,,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",Intermediate,10116.0,N,10566,1,,1,A,,,3032,
In vivo,,CHEMBL625161,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,Intermediate,10116.0,N,10567,1,,1,A,,,3748,
In vivo,,CHEMBL625162,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10568,1,,1,A,,,401,
In vivo,,CHEMBL625163,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10569,1,,1,A,,,6512,
In vivo,,CHEMBL625164,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rats at 10 mg/kg,Intermediate,10116.0,N,10570,1,,1,A,,,17617,
In vivo,,CHEMBL625165,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,10116.0,N,10571,1,,1,A,,,6679,
In vivo,,CHEMBL625166,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10572,1,,1,A,,,6742,
,,CHEMBL625167,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,Intermediate,10116.0,N,10573,1,,1,A,,,589,
,,CHEMBL625168,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,Intermediate,10116.0,N,10574,1,,1,A,,,589,
In vivo,,CHEMBL625169,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance of the compound,Intermediate,10116.0,N,10575,1,,1,A,,,3185,
In vivo,,CHEMBL626264,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,Intermediate,10116.0,N,10576,1,,1,A,,,17596,
In vivo,,CHEMBL626265,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,Intermediate,10116.0,N,10577,1,,1,A,,,2713,
In vivo,,CHEMBL626266,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The compound was tested for plasma clearance in rat,Intermediate,10116.0,N,10578,1,,1,A,,,12500,
In vivo,,CHEMBL626267,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,Intermediate,10116.0,N,10579,1,,1,A,,,12500,
,,CHEMBL626268,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration upon oral administration of 1 mg/Kg in rats,Intermediate,10116.0,N,10580,1,,1,A,,,2713,
,,CHEMBL626269,,50597,,BAO_0000218,Rattus norvegicus,,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,Intermediate,10116.0,N,10581,1,,1,A,,,1446,
,,CHEMBL626270,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,Intermediate,10116.0,N,10582,1,,1,A,,,6227,
,,CHEMBL626271,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,Intermediate,10116.0,N,10583,1,,1,A,,,4709,
,,CHEMBL626272,,50597,,BAO_0000218,Rattus norvegicus,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",Intermediate,10116.0,N,10584,1,,1,A,,,5510,
,,CHEMBL626273,,50597,,BAO_0000218,Rattus norvegicus,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Intermediate,10116.0,N,10585,1,,1,A,,,5510,
,,CHEMBL875346,,50597,,BAO_0000218,Rattus norvegicus,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Intermediate,10116.0,N,10586,1,,1,A,,,5510,
,,CHEMBL626274,,50597,,BAO_0000218,Rattus norvegicus,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",Intermediate,10116.0,N,10587,1,,1,A,,,5510,
,,CHEMBL626275,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for protein binding in rat plasma,Intermediate,10116.0,N,10588,1,,1,A,,,4514,
,,CHEMBL624646,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,Intermediate,10116.0,N,10589,1,,1,A,,,2713,
,,CHEMBL624647,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,Intermediate,10116.0,N,10590,1,,1,A,,,2713,
,,CHEMBL624648,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,Intermediate,10116.0,N,10591,1,,1,A,,,5340,
,,CHEMBL624649,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve ratio was determined (po/iv) in rat,Intermediate,10116.0,N,10592,1,,1,A,,,12058,
,,CHEMBL624650,,50597,,BAO_0000218,Rattus norvegicus,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,Intermediate,10116.0,N,10593,1,,1,A,,,11195,
,,CHEMBL624651,,50597,,BAO_0000218,Rattus norvegicus,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,Intermediate,10116.0,N,10594,1,,1,A,,,11195,
,,CHEMBL624652,,50597,,BAO_0000218,Rattus norvegicus,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,Intermediate,10116.0,N,10595,1,,1,A,,,11195,
,,CHEMBL624653,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,Intermediate,10116.0,N,10596,1,,1,A,,,6495,
,,CHEMBL624654,,50597,,BAO_0000218,Rattus norvegicus,,,Ratio of AUCbrain to AUCplasma,Intermediate,10116.0,N,10597,1,,1,A,,,6078,
,,CHEMBL624655,,50597,,BAO_0000218,Rattus norvegicus,,,Ratio of brain to plasma,Intermediate,10116.0,N,10598,1,,1,A,,,5656,
,,CHEMBL624656,,50597,,BAO_0000218,Rattus norvegicus,,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,Intermediate,10116.0,N,10599,1,,1,A,,,4910,
,,CHEMBL624657,,50597,,BAO_0000218,Rattus norvegicus,,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Intermediate,10116.0,N,10600,1,,1,A,,,4910,
,,CHEMBL624658,,50597,,BAO_0000218,Rattus norvegicus,,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Intermediate,10116.0,N,10601,1,,1,A,,,4910,
,,CHEMBL624659,,50597,,BAO_0000218,Rattus norvegicus,,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,Intermediate,10116.0,N,10602,1,,1,A,,,10130,
,,CHEMBL624660,,50597,,BAO_0000218,Rattus norvegicus,,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,Intermediate,10116.0,N,10603,1,,1,A,,,10130,
,,CHEMBL624661,,50597,,BAO_0000218,Rattus norvegicus,,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,Intermediate,10116.0,N,10604,1,,1,A,,,10130,
,,CHEMBL624662,,50597,,BAO_0000218,Rattus norvegicus,,,Steady state brain :blood ratio was determined,Intermediate,10116.0,N,10605,1,,1,A,,,5213,
,,CHEMBL625199,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,10116.0,N,10606,1,,1,A,,,4910,
,,CHEMBL625200,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Intermediate,10116.0,N,10607,1,,1,A,,,4910,
,,CHEMBL625201,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,10116.0,N,10608,1,,1,A,,,4910,
,,CHEMBL625202,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Intermediate,10116.0,N,10609,1,,1,A,,,4910,
,,CHEMBL625203,,50597,,BAO_0000218,Rattus norvegicus,,,Percentage recovery after 3h incubation with rat hapatocytes was determined,Intermediate,10116.0,N,10610,1,,1,A,,,2083,
,,CHEMBL625204,,50597,,BAO_0000218,Rattus norvegicus,,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,Intermediate,10116.0,N,10611,1,,1,A,,,2082,
,,CHEMBL625205,,50597,,BAO_0000218,Rattus norvegicus,,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,Intermediate,10116.0,N,10612,1,,1,A,,,2082,
,,CHEMBL625206,,50597,,BAO_0000218,Rattus norvegicus,,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,Intermediate,10116.0,N,10613,1,,1,A,,,6351,
,,CHEMBL625207,,22224,,BAO_0000019,,,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",Autocuration,,U,10614,1,,0,A,,,14583,
,,CHEMBL625208,,22224,,BAO_0000019,,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,Autocuration,,U,10615,1,,0,A,,,14583,
,,CHEMBL625209,,50587,,BAO_0000218,Homo sapiens,,,In vivo absorption in Caco-2 cell line monolayers was determined,Intermediate,9606.0,N,10616,1,,1,A,Caco-2,495.0,4608,
,,CHEMBL625210,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,10617,1,,0,P,,,13668,
,,CHEMBL625211,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determine after peroral administration at 10 mpk in Rat,Intermediate,10116.0,N,10618,1,,1,A,,,5669,
,,CHEMBL625212,,50797,,BAO_0000218,Macaca mulatta,,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,Intermediate,9544.0,N,10619,1,,1,A,,,5669,
,,CHEMBL625213,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determine after peroral administration at 160 mpk in Rat,Intermediate,10116.0,N,10620,1,,1,A,,,5669,
,,CHEMBL625214,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determine after peroral administration at 20 mpk in Rat,Intermediate,10116.0,N,10621,1,,1,A,,,5669,
,,CHEMBL874542,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve was determine after peroral administration at 50 mpk in Rat,Intermediate,10116.0,N,10622,1,,1,A,,,5669,
,,CHEMBL625215,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP) (AlogP),Autocuration,,U,10623,1,,0,P,,,6472,
,,CHEMBL625216,,22224,,BAO_0000019,,,,Activated partial thromboplastin time measured,Autocuration,,U,10624,1,,0,A,,,15106,
,,CHEMBL625217,,22224,,BAO_0000100,,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),Autocuration,,U,10625,1,,0,P,,,15207,
,,CHEMBL625218,,22224,,BAO_0000100,,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),Autocuration,,U,10626,1,,0,P,,,15207,
,,CHEMBL622864,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,Intermediate,9615.0,N,10627,1,,1,A,,,13941,
,,CHEMBL622865,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,Intermediate,10116.0,N,10628,1,,1,A,,,13941,
,,CHEMBL622866,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,Intermediate,10116.0,N,10629,1,,1,A,,,13941,
,,CHEMBL622867,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,Intermediate,9615.0,N,10630,1,,1,A,,,13941,
,,CHEMBL876808,,50512,Plasma,BAO_0000218,Cavia porcellus,1969.0,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,Intermediate,10141.0,N,10631,1,,1,A,,,15240,
,,CHEMBL627725,,22224,Brain,BAO_0000019,,955.0,,AUC in brain,Autocuration,,U,10632,1,,0,A,,,10655,
,,CHEMBL627726,,22224,Serum,BAO_0000019,,1977.0,,AUC in serum,Autocuration,,U,10633,1,,0,A,,,10655,
,,CHEMBL627727,,22224,Plasma,BAO_0000019,,1969.0,,AUC was determined,Autocuration,,U,10634,1,,0,A,,,6504,
,,CHEMBL627728,,22224,Plasma,BAO_0000019,,1969.0,,AUC of the compound.,Autocuration,,U,10635,1,,0,A,,,10615,
,,CHEMBL627729,,22224,Plasma,BAO_0000019,,1969.0,,AUC value (0-4 hr),Autocuration,,U,10636,1,,0,A,,,10353,
,,CHEMBL627730,,22224,Plasma,BAO_0000019,,1969.0,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",Autocuration,,U,10637,1,,0,A,,,14907,
,,CHEMBL627731,,22224,Plasma,BAO_0000019,,1969.0,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,Autocuration,,U,10638,1,,0,A,,,14907,
,,CHEMBL627732,,22224,Plasma,BAO_0000019,,1969.0,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",Autocuration,,U,10639,1,,0,A,,,14907,
,,CHEMBL627733,,22224,Plasma,BAO_0000019,,1969.0,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",Autocuration,,U,10640,1,,0,A,,,14907,
,,CHEMBL627734,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC(area under curve) was determined after intravenous administration in rats,Intermediate,10116.0,N,10641,1,,1,A,,,16359,
,,CHEMBL627735,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC(area under curve) was determined after oral administration in rats,Intermediate,10116.0,N,10642,1,,1,A,,,16359,
,,CHEMBL627736,,50512,Plasma,BAO_0000218,Cavia porcellus,1969.0,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,Intermediate,10141.0,N,10643,1,,1,A,,,15240,
,,CHEMBL876809,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,Intermediate,10116.0,N,10644,1,,1,A,,,15240,
,,CHEMBL627737,,22224,,BAO_0000019,,,,Area Under Curve after oral dosing of 100 uM/Kg,Autocuration,,U,10645,1,,0,A,,,15469,
,,CHEMBL627738,,22224,,BAO_0000019,,,,Area Under Curve after oral dosing of 30 uM/Kg,Autocuration,,U,10646,1,,0,A,,,15469,
,,CHEMBL627739,,22224,,BAO_0000019,,,,Area Under Curve was measured by ploting the graph between concentration verses time,Autocuration,,U,10647,1,,0,A,,,13520,
,,CHEMBL626143,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,Intermediate,9615.0,N,10648,1,,1,A,,,17025,
,,CHEMBL626144,,22224,,BAO_0000218,Simiiformes,,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,Autocuration,314293.0,U,10649,1,,0,A,,,17025,
,,CHEMBL626145,,50592,,BAO_0000218,Oryctolagus cuniculus,,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,Intermediate,9986.0,N,10650,1,,1,A,,,17025,
,,CHEMBL626146,,50597,,BAO_0000218,Rattus norvegicus,,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,Intermediate,10116.0,N,10651,1,,1,A,,,17025,
,,CHEMBL626147,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,Intermediate,10116.0,N,10652,1,,1,A,,,12032,
,,CHEMBL626148,,22224,,BAO_0000019,,,,Area under curve (AUC) was determined,Autocuration,,U,10653,1,,0,A,,,10291,
,,CHEMBL626149,,22224,,BAO_0000218,,,,Area under curve (AUC) following ip administration at 1 mg/kg,Autocuration,,U,10654,1,,0,A,,,5767,
,,CHEMBL626150,,22224,,BAO_0000019,,,,Area under curve (AUC) was determined; ND is Not determined,Autocuration,,U,10655,1,,0,A,,,1434,
,,CHEMBL626151,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,Intermediate,9615.0,N,10656,1,,1,A,,,14925,
,,CHEMBL626152,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,Intermediate,9615.0,N,10657,1,,1,A,,,14925,
,,CHEMBL626153,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,Intermediate,9615.0,N,10658,1,,1,A,,,14925,
,,CHEMBL626154,,22224,,BAO_0000019,,,,Area under curve (AUR) was determined,Autocuration,,U,10659,1,,0,A,,,1434,
,,CHEMBL626155,,22224,,BAO_0000019,,,,Area under curve at 1 uM/dg administered intravenously,Autocuration,,U,10660,1,,0,A,,,11883,
,,CHEMBL626156,,22224,,BAO_0000019,,,,Area under curve at 10 uM/dg administered perorally,Autocuration,,U,10661,1,,0,A,,,11883,
,,CHEMBL626157,,22224,,BAO_0000019,,,,Area under curve at 2 uM/dg administered intravenously,Autocuration,,U,10662,1,,0,A,,,11883,
,,CHEMBL626158,,22224,,BAO_0000019,,,,Area under curve at 20 uM/dg administered perorally,Autocuration,,U,10663,1,,0,A,,,11883,
,,CHEMBL626159,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve at a peroral dose of 3 mg/kg in dog,Intermediate,9615.0,N,10664,1,,1,A,,,15233,
,,CHEMBL626160,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve at a peroral dose of 3 mg/kg in rat,Intermediate,10116.0,N,10665,1,,1,A,,,15233,
,,CHEMBL626161,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve at an iv dose of 1 mg/kg in dog,Intermediate,9615.0,N,10666,1,,1,A,,,15233,
,,CHEMBL626162,,50597,,BAO_0000218,Rattus norvegicus,,,Area under curve at an iv dose of 1 mg/kg in rat,Intermediate,10116.0,N,10667,1,,1,A,,,15233,
,,CHEMBL626163,,22224,,BAO_0000019,,,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,Autocuration,,U,10668,1,,0,A,,,12978,
,,CHEMBL626164,,22224,,BAO_0000019,,,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,Autocuration,,U,10669,1,,0,A,,,12978,
,,CHEMBL626165,,50594,,BAO_0000218,Mus musculus,,,Area under curve measured as conc vs time after intravenous administration to mice.,Intermediate,10090.0,N,10670,1,,1,A,,,11355,
,,CHEMBL626166,,50594,,BAO_0000218,Mus musculus,,,Area under curve measured as conc vs time after peroral administration to mice.,Intermediate,10090.0,N,10671,1,,1,A,,,11355,
,,CHEMBL626167,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Intermediate,9615.0,N,10672,1,,1,A,,,12923,
,,CHEMBL626168,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,Intermediate,9615.0,N,10673,1,,1,A,,,12923,
,,CHEMBL877463,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,Intermediate,9615.0,N,10674,1,,1,A,,,12923,
,,CHEMBL626169,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,Intermediate,9615.0,N,10675,1,,1,A,,,12923,
In vivo,,CHEMBL626170,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10676,1,,1,A,,,17738,
In vivo,,CHEMBL626171,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10677,1,,1,A,,,17738,
In vivo,,CHEMBL626172,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10678,1,,1,A,,,17738,
In vivo,,CHEMBL626173,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10679,1,,1,A,,,17738,
In vivo,,CHEMBL626174,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,10116.0,N,10680,1,,1,A,,,17738,
In vivo,,CHEMBL626175,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10681,1,,1,A,,,17738,
In vivo,,CHEMBL626176,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10682,1,,1,A,,,17738,
In vivo,,CHEMBL626177,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10683,1,,1,A,,,17738,
In vivo,,CHEMBL622499,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10684,1,,1,A,,,17738,
In vivo,,CHEMBL622500,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,10116.0,N,10685,1,,1,A,,,17738,
In vivo,,CHEMBL622501,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10686,1,,1,A,,,17738,
In vivo,,CHEMBL622502,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10687,1,,1,A,,,17738,
In vivo,,CHEMBL622503,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10688,1,,1,A,,,17738,
In vivo,,CHEMBL877614,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10689,1,,1,A,,,17738,
In vivo,,CHEMBL624839,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10690,1,,1,A,,,17738,
In vivo,,CHEMBL624840,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10691,1,,1,A,,,17738,
In vivo,,CHEMBL624841,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10692,1,,1,A,,,17738,
In vivo,,CHEMBL624842,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10693,1,,1,A,,,17738,
In vivo,,CHEMBL624843,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10694,1,,1,A,,,17738,
In vivo,,CHEMBL624844,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,Intermediate,10116.0,N,10695,1,,1,A,,,17738,
In vivo,,CHEMBL624845,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10696,1,,1,A,,,17738,
In vivo,,CHEMBL621904,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,Intermediate,10116.0,N,10697,1,,1,A,,,17738,
In vivo,,CHEMBL621905,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,Intermediate,10116.0,N,10698,1,,1,A,,,11195,
In vivo,,CHEMBL874382,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,Intermediate,10116.0,N,10699,1,,1,A,,,11195,
In vivo,,CHEMBL621906,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,Intermediate,10116.0,N,10700,1,,1,A,,,11195,
In vivo,,CHEMBL621907,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,Intermediate,10116.0,N,10701,1,,1,A,,,11195,
In vivo,,CHEMBL622096,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,Intermediate,10116.0,N,10702,1,,1,A,,,11195,
In vivo,,CHEMBL622097,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,Intermediate,10116.0,N,10703,1,,1,A,,,11195,
In vivo,,CHEMBL622098,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,Intermediate,10116.0,N,10704,1,,1,A,,,11195,
In vivo,,CHEMBL622099,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,Intermediate,10116.0,N,10705,1,,1,A,,,11195,
In vivo,,CHEMBL622100,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,Intermediate,10116.0,N,10706,1,,1,A,,,11195,
In vivo,,CHEMBL622101,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,Intermediate,10116.0,N,10707,1,,1,A,,,11195,
In vivo,,CHEMBL622102,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,Intermediate,10116.0,N,10708,1,,1,A,,,11195,
In vivo,,CHEMBL622103,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,Intermediate,10116.0,N,10709,1,,1,A,,,11195,
In vivo,,CHEMBL622104,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,Intermediate,10116.0,N,10710,1,,1,A,,,11195,
In vivo,,CHEMBL622105,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,Intermediate,10116.0,N,10711,1,,1,A,,,11195,
In vivo,,CHEMBL622106,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,Intermediate,10116.0,N,10712,1,,1,A,,,11195,
In vivo,,CHEMBL622107,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,Intermediate,10116.0,N,10713,1,,1,A,,,11195,
In vivo,,CHEMBL622108,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,Intermediate,10116.0,N,10714,1,,1,A,,,11195,
In vivo,,CHEMBL622109,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,Intermediate,10116.0,N,10715,1,,1,A,,,11195,
In vivo,,CHEMBL622110,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,Intermediate,10116.0,N,10716,1,,1,A,,,11195,
In vivo,,CHEMBL622111,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,Intermediate,10116.0,N,10717,1,,1,A,,,11195,
In vivo,,CHEMBL874383,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,Intermediate,10116.0,N,10718,1,,1,A,,,11195,
In vivo,,CHEMBL622112,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,Intermediate,10116.0,N,10719,1,,1,A,,,11195,
In vivo,,CHEMBL622113,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,Intermediate,10116.0,N,10720,1,,1,A,,,11195,
In vivo,,CHEMBL622114,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,Intermediate,10116.0,N,10721,1,,1,A,,,11195,
In vivo,,CHEMBL622115,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,Intermediate,10116.0,N,10722,1,,1,A,,,11195,
In vivo,,CHEMBL622116,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,Intermediate,10116.0,N,10723,1,,1,A,,,11195,
In vivo,,CHEMBL622117,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10724,1,,1,A,,,6193,
In vivo,,CHEMBL622118,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10725,1,,1,A,,,6803,
In vivo,,CHEMBL622119,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rats at 6 mg/kg,Intermediate,10116.0,N,10726,1,,1,A,,,6647,
In vivo,,CHEMBL622120,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 6 mg/kg),Intermediate,10116.0,N,10727,1,,1,A,,,6647,
In vivo,,CHEMBL622121,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,Intermediate,10116.0,N,10728,1,,1,A,,,6647,
In vivo,,CHEMBL622122,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10729,1,,1,A,,,6640,
In vivo,,CHEMBL622123,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10730,1,,1,A,,,6641,
In vivo,,CHEMBL622124,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10731,1,,1,A,,,6641,
In vivo,,CHEMBL622125,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10732,1,,1,A,,,6642,
In vivo,,CHEMBL622126,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability,Intermediate,10116.0,N,10733,1,,1,A,,,5472,
In vivo,,CHEMBL620455,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,10116.0,N,10734,1,,1,A,,,6141,
In vivo,,CHEMBL620456,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10735,1,,1,A,,,4390,
In vivo,,CHEMBL620457,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10736,1,,1,A,,,5472,
In vivo,,CHEMBL620458,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability was evaluated; Not tested,Intermediate,10116.0,N,10737,1,,1,A,,,5472,
In vivo,,CHEMBL620459,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability,Intermediate,10116.0,N,10738,1,,1,A,,,5438,
In vivo,,CHEMBL620460,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat by oral dosing,Intermediate,10116.0,N,10739,1,,1,A,,,4883,
In vivo,,CHEMBL620461,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 10 mg/kg p.o.),Intermediate,10116.0,N,10740,1,,1,A,,,1908,
In vivo,,CHEMBL620462,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley),Intermediate,10116.0,N,10741,1,,1,A,,,4853,
In vivo,,CHEMBL620463,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,10116.0,N,10742,1,,1,A,,,4853,
In vivo,,CHEMBL620464,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,10116.0,N,10743,1,,1,A,,,4853,
In vivo,,CHEMBL620465,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,10116.0,N,10744,1,,1,A,,,4853,
In vivo,,CHEMBL620466,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),Intermediate,10116.0,N,10745,1,,1,A,,,4853,
In vivo,,CHEMBL620467,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,Intermediate,10116.0,N,10746,1,,1,A,,,4853,
In vivo,,CHEMBL620468,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,Intermediate,10116.0,N,10747,1,,1,A,,,4853,
In vivo,,CHEMBL620469,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,Intermediate,10116.0,N,10748,1,,1,A,,,12873,
In vivo,,CHEMBL620470,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,Intermediate,10116.0,N,10749,1,,1,A,,,12873,
In vivo,,CHEMBL620471,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10750,1,,1,A,,,3169,
In vivo,,CHEMBL620472,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10751,1,,1,A,,,6305,
In vivo,,CHEMBL620473,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,Intermediate,10116.0,N,10752,1,,1,A,,,4762,
In vivo,,CHEMBL620474,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10753,1,,1,A,,,17847,
In vivo,,CHEMBL620475,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),Intermediate,10116.0,N,10754,1,,1,A,,,6211,
In vivo,,CHEMBL620476,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10755,1,,1,A,,,6011,
In vivo,,CHEMBL620477,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10756,1,,1,A,,,6317,
In vivo,,CHEMBL620478,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,Intermediate,10116.0,N,10757,1,,1,A,,,6644,
In vivo,,CHEMBL618768,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,Intermediate,10116.0,N,10758,1,,1,A,,,6644,
In vivo,,CHEMBL618769,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,Intermediate,10116.0,N,10759,1,,1,A,,,6644,
In vivo,,CHEMBL618770,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,Intermediate,10116.0,N,10760,1,,1,A,,,6644,
In vivo,,CHEMBL618771,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability (dose 20 mg/kg p.o.),Intermediate,10116.0,N,10761,1,,1,A,,,6113,
In vivo,,CHEMBL618772,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,Intermediate,10116.0,N,10762,1,,1,A,,,5937,
In vivo,,CHEMBL618773,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat at 10 mg/kg of the compound,Intermediate,10116.0,N,10763,1,,1,A,,,5711,
In vivo,,CHEMBL875842,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,10116.0,N,10764,1,,1,A,,,17717,
In vivo,,CHEMBL618774,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 3 mg/kg i.v.),Intermediate,10116.0,N,10765,1,,1,A,,,17717,
In vivo,,CHEMBL618775,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,10116.0,N,10766,1,,1,A,,,17717,
In vivo,,CHEMBL618776,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 60 mg/kg p.o.),Intermediate,10116.0,N,10767,1,,1,A,,,17717,
In vivo,,CHEMBL618777,,50597,,BAO_0000218,Rattus norvegicus,,,Percent bioavailability (F) in rats after iv administration,Intermediate,10116.0,N,10768,1,,1,A,,,4722,
In vivo,,CHEMBL618778,,50597,,BAO_0000218,Rattus norvegicus,,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,Intermediate,10116.0,N,10769,1,,1,A,,,4722,
In vivo,,CHEMBL618779,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 5 uM/kg p.o.),Intermediate,10116.0,N,10770,1,,1,A,,,4353,
In vivo,,CHEMBL618780,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability,Intermediate,10116.0,N,10771,1,,1,A,,,15662,
In vivo,,CHEMBL618781,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 2 mg/kg p.o.),Intermediate,10116.0,N,10772,1,,1,A,,,4756,
In vivo,,CHEMBL618782,,50597,,BAO_0000218,Rattus norvegicus,,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,Intermediate,10116.0,N,10773,1,,1,A,,,4756,
In vivo,,CHEMBL618783,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 20 mg/kg),Intermediate,10116.0,N,10774,1,,1,A,,,3436,
In vivo,,CHEMBL618784,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10775,1,,1,A,,,17800,
In vivo,,CHEMBL618785,,50597,,BAO_0000218,Rattus norvegicus,,,Percent oral bioavailability evaluated in rat,Intermediate,10116.0,N,10776,1,,1,A,,,15762,
In vivo,,CHEMBL618786,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10777,1,,1,A,,,5089,
In vivo,,CHEMBL618787,,50597,,BAO_0000218,Rattus norvegicus,,,Percent oral bioavailability in rat; Not determined,Intermediate,10116.0,N,10778,1,,1,A,,,5089,
In vivo,,CHEMBL618788,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Intermediate,10116.0,N,10779,1,,1,A,,,3185,
In vivo,,CHEMBL618789,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Intermediate,10116.0,N,10780,1,,1,A,,,5145,
In vivo,,CHEMBL618790,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),Intermediate,10116.0,N,10781,1,,1,A,,,3457,
In vivo,,CHEMBL618791,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),Intermediate,10116.0,N,10782,1,,1,A,,,3457,
In vivo,,CHEMBL875843,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,Intermediate,10116.0,N,10783,1,,1,A,,,5983,
In vivo,,CHEMBL618792,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,10116.0,N,10784,1,,1,A,,,5739,
In vivo,,CHEMBL623395,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax at a dose of 30 mg/kg in rat,Intermediate,10116.0,N,10785,1,,1,A,,,3579,
In vivo,,CHEMBL623396,,22224,,BAO_0000218,Simiiformes,,,Cmax in monkeys at a dose of 1 mg/kg,Autocuration,314293.0,U,10786,1,,0,A,,,17788,
In vivo,,CHEMBL623397,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat,Intermediate,10116.0,N,10787,1,,1,A,,,14956,
In vivo,,CHEMBL623398,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rats at a dose of 1 mg/kg,Intermediate,10116.0,N,10788,1,,1,A,,,17788,
In vivo,,CHEMBL623399,,50594,,BAO_0000218,Mus musculus,,,Cmax was measured in mice after an oral dose of 50 mg/kg.,Intermediate,10090.0,N,10789,1,,1,A,,,9750,
In vivo,,CHEMBL623400,,22224,,BAO_0000218,,,,"Cmax value at a dose of 12.7 uM/kg, po",Autocuration,,U,10790,1,,0,A,,,12767,
In vivo,,CHEMBL623401,,22224,,BAO_0000218,,,,"Cmax value at a dose of 6.3 uM/kg, iv",Autocuration,,U,10791,1,,0,A,,,12767,
In vivo,,CHEMBL623402,,22224,,BAO_0000218,,,,"Cmax value at a dose of 7.1 uM/kg, iv",Autocuration,,U,10792,1,,0,A,,,12767,
In vivo,,CHEMBL623403,,22224,,BAO_0000218,,,,Cmax value of compound was determined after 1 hr,Autocuration,,U,10793,1,,0,A,,,12703,
In vivo,,CHEMBL623404,,22224,,BAO_0000218,,,,Cmax value of the compound,Autocuration,,U,10794,1,,0,A,,,15778,
In vivo,,CHEMBL625997,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value administered intraintestinal in rats.,Intermediate,10116.0,N,10795,1,,1,A,,,12818,
In vivo,,CHEMBL625998,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value administered perorally was determined in rat; Not determined,Intermediate,10116.0,N,10796,1,,1,A,,,14964,
In vivo,,CHEMBL625999,,22224,,BAO_0000218,,,,Cmax value at the dose of 2.3 mg/kg,Autocuration,,U,10797,1,,0,A,,,15808,
In vivo,,CHEMBL626000,,22224,,BAO_0000218,,,,Cmax value at the dose of 5 mg/kg,Autocuration,,U,10798,1,,0,A,,,15808,
In vivo,,CHEMBL626001,,22224,,BAO_0000218,,,,Cmax value in the period of 8 hr after dosing. ,Autocuration,,U,10799,1,,0,A,,,15778,
In vivo,,CHEMBL626002,,22224,,BAO_0000218,,,,Cmax value at a oral dose of 20 mg/kg; Not tested,Autocuration,,U,10800,1,,0,A,,,3715,
In vivo,,CHEMBL626003,,22224,,BAO_0000218,,,,Cmax value at a oral dose of 20 mg/kg,Autocuration,,U,10801,1,,0,A,,,3715,
In vivo,,CHEMBL626004,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Intermediate,10116.0,N,10802,1,,1,A,,,1446,
In vivo,,CHEMBL626005,,50512,,BAO_0000218,Cavia porcellus,,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,Intermediate,10141.0,N,10803,1,,1,A,,,15240,
In vivo,,CHEMBL626006,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,Intermediate,10116.0,N,10804,1,,1,A,,,15240,
In vivo,,CHEMBL626007,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,Intermediate,10116.0,N,10805,1,,1,A,,,14810,
In vivo,,CHEMBL626008,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,Intermediate,10090.0,N,10806,1,,1,A,,,14239,
In vivo,,CHEMBL626009,,50588,Liver,BAO_0000218,Canis lupus familiaris,2107.0,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,Intermediate,9615.0,N,10807,1,,1,A,,,12555,
In vivo,,CHEMBL626010,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,Intermediate,9615.0,N,10808,1,,1,A,,,10754,
In vivo,,CHEMBL626011,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,Intermediate,10090.0,N,10809,1,,1,A,,,10754,
In vivo,,CHEMBL626012,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,Intermediate,10090.0,N,10810,1,,1,A,,,10754,
In vivo,,CHEMBL626013,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,Intermediate,10090.0,N,10811,1,,1,A,,,10754,
In vivo,,CHEMBL626014,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,Intermediate,10090.0,N,10812,1,,1,A,,,10754,
In vivo,,CHEMBL877496,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,Intermediate,10090.0,N,10813,1,,1,A,,,10754,
In vivo,,CHEMBL626015,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,Intermediate,9615.0,N,10814,1,,1,F,,,14600,
In vivo,,CHEMBL626016,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,Intermediate,9615.0,N,10815,1,,1,F,,,14600,
In vivo,,CHEMBL626017,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,Intermediate,9615.0,N,10816,1,,1,F,,,14600,
In vivo,,CHEMBL626018,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Bioavailability as maximal plasma concentration in dogs,Intermediate,9615.0,N,10817,1,,1,A,,,13543,
In vivo,,CHEMBL626692,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Bioavailability as maximal plasma concentration in dogs,Intermediate,9615.0,N,10818,1,,1,A,,,13543,
In vivo,,CHEMBL626693,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Bioavailability as maximal plasma concentration in rats,Intermediate,10116.0,N,10819,1,,1,A,,,13543,
In vivo,,CHEMBL626694,,22224,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Bioavailability as maximal plasma concentration in rats,Autocuration,10116.0,U,10820,1,,0,A,,,13543,
In vivo,,CHEMBL626695,,50588,Blood,BAO_0000218,Canis lupus familiaris,178.0,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,9615.0,N,10821,1,,1,A,,,14600,
In vivo,,CHEMBL626696,,50588,Blood,BAO_0000218,Canis lupus familiaris,178.0,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,9615.0,N,10822,1,,1,A,,,14600,
In vivo,,CHEMBL626697,,50588,Blood,BAO_0000218,Canis lupus familiaris,178.0,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,9615.0,N,10823,1,,1,A,,,14600,
In vivo,,CHEMBL626859,,50588,Blood,BAO_0000218,Canis lupus familiaris,178.0,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,Intermediate,9615.0,N,10824,1,,1,A,,,14600,
In vivo,,CHEMBL626860,,50588,Blood,BAO_0000218,Canis lupus familiaris,178.0,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,9615.0,N,10825,1,,1,A,,,14600,
In vivo,,CHEMBL626861,,50588,Blood,BAO_0000218,Canis lupus familiaris,178.0,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,9615.0,N,10826,1,,1,A,,,14600,
In vivo,,CHEMBL626296,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,10116.0,N,10827,1,,1,A,,,14681,
In vivo,,CHEMBL626297,,22224,,BAO_0000218,,,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,Autocuration,,U,10828,1,,0,A,,,15905,
In vivo,,CHEMBL626298,,22224,Plasma,BAO_0000218,,1969.0,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,Autocuration,,U,10829,1,,0,A,,,15905,
In vivo,,CHEMBL626299,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",Intermediate,10116.0,N,10830,1,,1,A,,,13304,
In vivo,,CHEMBL626300,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,Intermediate,10116.0,N,10831,1,,1,A,,,15137,
In vivo,,CHEMBL626301,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,Intermediate,10116.0,N,10832,1,,1,A,,,15137,
In vivo,,CHEMBL626962,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,Intermediate,10116.0,N,10833,1,,1,A,,,15137,
In vivo,,CHEMBL626963,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,Intermediate,10116.0,N,10834,1,,1,A,,,15137,
In vivo,,CHEMBL626964,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,Intermediate,10116.0,N,10835,1,,1,A,,,15137,
In vivo,,CHEMBL626965,,100710,Plasma,BAO_0000218,Macaca fascicularis,1969.0,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,Intermediate,9541.0,N,10836,1,,1,A,,,14839,
In vivo,,CHEMBL626966,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,10090.0,N,10837,1,,1,A,,,14839,
In vivo,,CHEMBL626967,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,10090.0,N,10838,1,,1,A,,,14839,
In vivo,,CHEMBL626968,,100710,Plasma,BAO_0000218,Macaca fascicularis,1969.0,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,Intermediate,9541.0,N,10839,1,,1,A,,,14839,
,,CHEMBL626969,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,Intermediate,10116.0,N,10840,1,,1,A,,,8418,
,,CHEMBL627126,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,Intermediate,10116.0,N,10841,1,,1,A,,,8418,
,,CHEMBL631276,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,Intermediate,10116.0,N,10842,1,,1,A,,,8418,
,,CHEMBL631277,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,Intermediate,10116.0,N,10843,1,,1,A,,,8418,
,,CHEMBL631278,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,Intermediate,10116.0,N,10844,1,,1,A,,,8418,
,,CHEMBL874457,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,Intermediate,10116.0,N,10845,1,,1,A,,,8418,
,,CHEMBL631279,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,Intermediate,10116.0,N,10846,1,,1,A,,,8418,
,,CHEMBL631280,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,Intermediate,10116.0,N,10847,1,,1,A,,,8418,
,,CHEMBL631281,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,Intermediate,10116.0,N,10848,1,,1,A,,,8418,
,,CHEMBL631968,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,Intermediate,10116.0,N,10849,1,,1,A,,,8418,
,,CHEMBL631969,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,Intermediate,10116.0,N,10850,1,,1,A,,,8418,
,,CHEMBL631970,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,Intermediate,10116.0,N,10851,1,,1,A,,,8418,
,,CHEMBL631971,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,Intermediate,10116.0,N,10852,1,,1,A,,,8418,
,,CHEMBL631972,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,Intermediate,10116.0,N,10853,1,,1,A,,,8418,
,,CHEMBL630435,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,Intermediate,10116.0,N,10854,1,,1,A,,,8418,
,,CHEMBL630436,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,Intermediate,10116.0,N,10855,1,,1,A,,,8418,
,,CHEMBL630437,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,Intermediate,10116.0,N,10856,1,,1,A,,,8418,
,,CHEMBL630438,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,Intermediate,10116.0,N,10857,1,,1,A,,,8418,
,,CHEMBL630439,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,Intermediate,10116.0,N,10858,1,,1,A,,,8418,
,,CHEMBL630440,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,Intermediate,10116.0,N,10859,1,,1,A,,,8418,
,,CHEMBL630441,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,Intermediate,10116.0,N,10860,1,,1,A,,,8418,
,,CHEMBL630442,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,Intermediate,10116.0,N,10861,1,,1,A,,,8418,
,,CHEMBL625234,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,Intermediate,10116.0,N,10862,1,,1,A,,,8418,
,,CHEMBL625235,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,Intermediate,10116.0,N,10863,1,,1,A,,,8418,
,,CHEMBL625236,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,Intermediate,10116.0,N,10864,1,,1,A,,,8418,
,,CHEMBL625237,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,Intermediate,10116.0,N,10865,1,,1,A,,,8418,
,,CHEMBL626125,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,Intermediate,10116.0,N,10866,1,,1,A,,,8418,
,,CHEMBL626126,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,Intermediate,10116.0,N,10867,1,,1,A,,,8418,
,,CHEMBL626127,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,Intermediate,10116.0,N,10868,1,,1,A,,,8418,
,,CHEMBL626128,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,Intermediate,10116.0,N,10869,1,,1,A,,,8418,
,,CHEMBL626129,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,Intermediate,10116.0,N,10870,1,,1,A,,,8418,
,,CHEMBL626130,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,Intermediate,10116.0,N,10871,1,,1,A,,,8418,
,,CHEMBL626131,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,Intermediate,10116.0,N,10872,1,,1,A,,,8418,
,,CHEMBL626132,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,Intermediate,10116.0,N,10873,1,,1,A,,,8418,
,,CHEMBL626752,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,Intermediate,10116.0,N,10874,1,,1,A,,,8418,
,,CHEMBL626753,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,Intermediate,10116.0,N,10875,1,,1,A,,,8418,
,,CHEMBL626754,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,Intermediate,10116.0,N,10876,1,,1,A,,,8418,
,,CHEMBL626755,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,Intermediate,10116.0,N,10877,1,,1,A,,,8418,
,,CHEMBL626756,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,Intermediate,10116.0,N,10878,1,,1,A,,,8418,
,,CHEMBL626757,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,Intermediate,10116.0,N,10879,1,,1,A,,,8418,
,,CHEMBL626758,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,Intermediate,10116.0,N,10880,1,,1,A,,,8418,
,,CHEMBL626759,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,Intermediate,10116.0,N,10881,1,,1,A,,,8418,
,,CHEMBL626760,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,Intermediate,10116.0,N,10882,1,,1,A,,,8418,
,,CHEMBL626394,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,10883,1,,1,A,,,6996,
,,CHEMBL626395,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,Intermediate,9615.0,N,10884,1,,1,A,,,6996,
,,CHEMBL626396,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,10885,1,,1,A,,,6996,
,,CHEMBL626397,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,9615.0,N,10886,1,,1,A,,,6996,
,,CHEMBL626398,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,9615.0,N,10887,1,,1,A,,,6996,
,,CHEMBL626399,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,10888,1,,1,A,,,6996,
,,CHEMBL874653,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,Intermediate,10116.0,N,10889,1,,1,A,,,6996,
,,CHEMBL626400,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,10890,1,,1,A,,,6996,
,,CHEMBL626401,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,10891,1,,1,A,,,6996,
,,CHEMBL626402,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,10116.0,N,10892,1,,1,A,,,6996,
,,CHEMBL626403,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,10893,1,,1,A,,,6996,
,,CHEMBL626404,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,10894,1,,1,A,,,6996,
,,CHEMBL626405,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,Intermediate,10116.0,N,10895,1,,1,A,,,6996,
,,CHEMBL625529,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,10896,1,,1,A,,,6996,
,,CHEMBL625530,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,10897,1,,1,A,,,6996,
,,CHEMBL625531,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,10116.0,N,10898,1,,1,A,,,6996,
,,CHEMBL625532,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,10899,1,,1,A,,,6996,
,,CHEMBL625533,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,10900,1,,1,A,,,6996,
,,CHEMBL875474,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,Intermediate,10116.0,N,10901,1,,1,A,,,6996,
,,CHEMBL625534,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,10902,1,,1,A,,,6996,
,,CHEMBL625535,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,10903,1,,1,A,,,6996,
,,CHEMBL625536,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Intermediate,10116.0,N,10904,1,,1,A,,,6996,
,,CHEMBL625537,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,10905,1,,1,A,,,6996,
,,CHEMBL625538,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,10906,1,,1,A,,,6996,
,,CHEMBL625539,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,Intermediate,10116.0,N,10907,1,,1,A,,,6996,
,,CHEMBL625540,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,10908,1,,1,A,,,6996,
,,CHEMBL625541,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,10909,1,,1,A,,,6996,
,,CHEMBL625542,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,10116.0,N,10910,1,,1,A,,,6996,
,,CHEMBL625543,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,10911,1,,1,A,,,6996,
,,CHEMBL625544,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,10912,1,,1,A,,,6996,
,,CHEMBL625545,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,Intermediate,9615.0,N,10913,1,,1,A,,,6996,
,,CHEMBL625546,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,10914,1,,1,A,,,6996,
,,CHEMBL625547,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,Intermediate,9615.0,N,10915,1,,1,A,,,6996,
,,CHEMBL625548,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,10916,1,,1,A,,,6996,
,,CHEMBL625549,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,10917,1,,1,A,,,6996,
,,CHEMBL625550,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,10918,1,,1,A,,,6996,
,,CHEMBL625551,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,10919,1,,1,A,,,6996,
,,CHEMBL875475,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,10920,1,,1,A,,,6996,
,,CHEMBL625552,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,10921,1,,1,A,,,6996,
,,CHEMBL625553,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,10922,1,,1,A,,,6996,
,,CHEMBL625554,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,9615.0,N,10923,1,,1,A,,,6996,
,,CHEMBL625555,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,9615.0,N,10924,1,,1,A,,,6996,
,,CHEMBL625556,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,10925,1,,1,A,,,6996,
,,CHEMBL624986,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,Intermediate,9615.0,N,10926,1,,1,A,,,6996,
,,CHEMBL624987,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,10927,1,,1,A,,,6996,
,,CHEMBL624988,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,9615.0,N,10928,1,,1,A,,,6996,
In vivo,,CHEMBL624989,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,Intermediate,9615.0,N,10929,1,,1,A,,,9025,
In vivo,,CHEMBL624990,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,Intermediate,9615.0,N,10930,1,,1,A,,,9025,
In vivo,,CHEMBL874391,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,Intermediate,9615.0,N,10931,1,,1,A,,,9025,
In vivo,,CHEMBL624991,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,Intermediate,9615.0,N,10932,1,,1,A,,,9025,
In vivo,,CHEMBL624992,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,Intermediate,9615.0,N,10933,1,,1,A,,,9025,
In vivo,,CHEMBL624993,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,Intermediate,9615.0,N,10934,1,,1,A,,,9025,
In vivo,,CHEMBL624994,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,Intermediate,9615.0,N,10935,1,,1,A,,,9025,
In vivo,,CHEMBL624995,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,Intermediate,9615.0,N,10936,1,,1,A,,,9025,
In vivo,,CHEMBL624996,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,Intermediate,9615.0,N,10937,1,,1,A,,,9025,
In vivo,,CHEMBL624997,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,Intermediate,9615.0,N,10938,1,,1,A,,,9025,
In vivo,,CHEMBL624998,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,Intermediate,9615.0,N,10939,1,,1,A,,,9025,
In vivo,,CHEMBL624999,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,Intermediate,9615.0,N,10940,1,,1,A,,,9025,
In vivo,,CHEMBL882955,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,Intermediate,9615.0,N,10941,1,,1,A,,,9025,
In vivo,,CHEMBL625000,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,Intermediate,9615.0,N,10942,1,,1,A,,,9025,
In vivo,,CHEMBL625001,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,Intermediate,9615.0,N,10943,1,,1,A,,,9025,
In vivo,,CHEMBL625089,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,Intermediate,9615.0,N,10944,1,,1,A,,,9025,
In vivo,,CHEMBL625090,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,Intermediate,9615.0,N,10945,1,,1,A,,,9025,
In vivo,,CHEMBL625091,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,Intermediate,9615.0,N,10946,1,,1,A,,,9025,
In vivo,,CHEMBL625092,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,Intermediate,9615.0,N,10947,1,,1,A,,,9025,
In vivo,,CHEMBL625093,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,Intermediate,9615.0,N,10948,1,,1,A,,,9025,
In vivo,,CHEMBL625094,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,Intermediate,9615.0,N,10949,1,,1,A,,,9025,
In vivo,,CHEMBL625095,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,Intermediate,9615.0,N,10950,1,,1,A,,,9025,
In vivo,,CHEMBL625096,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for its bioavailability in the dogs,Intermediate,9615.0,N,10951,1,,1,A,,,2249,
In vivo,,CHEMBL625097,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for its bioavailability in the rats,Intermediate,10116.0,N,10952,1,,1,A,,,2249,
In vivo,,CHEMBL882956,,22224,,BAO_0000218,,,,Compound was evaluated for oral bioavailability,Autocuration,,U,10953,1,,0,A,,,17515,
In vivo,,CHEMBL625098,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for percentage of Oral bioavailability in rats,Intermediate,10116.0,N,10954,1,,1,A,,,14541,
In vivo,,CHEMBL625099,,22224,,BAO_0000218,Cavia porcellus,,,Bioavailability in guinea pig,Autocuration,10141.0,U,10955,1,,0,A,,,12797,
In vivo,,CHEMBL625100,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for the oral bioavailability in rat,Intermediate,10116.0,N,10956,1,,1,A,,,12797,
In vivo,,CHEMBL625101,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for the oral bioavailability in dog,Intermediate,9615.0,N,10957,1,,1,A,,,12797,
In vivo,,CHEMBL874396,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for the oral bioavailability in rat,Intermediate,10116.0,N,10958,1,,1,A,,,12797,
In vivo,,CHEMBL625102,,22224,,BAO_0000218,Canis lupus familiaris,,,Bioavailability in dog (dosed i.v.),Autocuration,9615.0,U,10959,1,,0,F,,,11727,
In vivo,,CHEMBL625103,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was tested for in vivo bioavailability in dog,Intermediate,9615.0,N,10960,1,,1,A,,,13249,
In vivo,,CHEMBL625104,,100712,,BAO_0000218,Cricetinae,,,Compound was tested for in vivo bioavailability in hamsters,Intermediate,10026.0,N,10961,1,,1,A,,,13249,
In vivo,,CHEMBL625105,,22224,,BAO_0000218,Simiiformes,,,Compound was tested for in vivo bioavailability in monkey,Autocuration,314293.0,U,10962,1,,0,A,,,13249,
In vivo,,CHEMBL625106,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for in vivo bioavailability in rat,Intermediate,10116.0,N,10963,1,,1,A,,,13249,
In vivo,,CHEMBL625107,,22224,,BAO_0000218,Mus musculus,,,Oral bioavailability in mouse,Autocuration,10090.0,U,10964,1,,0,A,,,9552,
In vivo,,CHEMBL625108,,50594,,BAO_0000218,Mus musculus,,,Compound was tested for percent of oral bioavailability in mice; 56-74,Intermediate,10090.0,N,10965,1,,1,A,,,9552,
In vivo,,CHEMBL625109,,22224,,BAO_0000218,Mus musculus,,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),Autocuration,10090.0,U,10966,1,,0,A,,,14839,
In vivo,,CHEMBL625110,,22224,,BAO_0000218,Macaca fascicularis,,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),Autocuration,9541.0,U,10967,1,,0,A,,,14839,
In vivo,,CHEMBL625111,,22224,,BAO_0000218,Macaca fascicularis,,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),Autocuration,9541.0,U,10968,1,,0,A,,,14839,
In vivo,,CHEMBL625112,,50594,,BAO_0000218,Mus musculus,,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),Intermediate,10090.0,N,10969,1,,1,A,,,14839,
In vivo,,CHEMBL875334,,50594,,BAO_0000218,Mus musculus,,,Oral bioavailability in nude mice,Intermediate,10090.0,N,10970,1,,1,A,,,14839,
In vivo,,CHEMBL628617,,22224,,BAO_0000218,Primates,,,Bioavailability in monkey (i.d. dosing),Autocuration,9443.0,U,10971,1,,0,A,,,11219,
In vivo,,CHEMBL628618,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Autocuration,10116.0,U,10972,1,,0,A,,,9552,
In vivo,,CHEMBL628619,,22224,,BAO_0000218,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,Autocuration,,U,10973,1,,0,A,,,11732,
In vivo,,CHEMBL628620,,22224,,BAO_0000218,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,Autocuration,,U,10974,1,,0,A,,,11732,
In vivo,,CHEMBL628621,,100710,,BAO_0000218,Macaca fascicularis,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,9541.0,N,10975,1,,1,A,,,14839,
In vivo,,CHEMBL628622,,100710,,BAO_0000218,Macaca fascicularis,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,9541.0,N,10976,1,,1,A,,,14839,
In vivo,,CHEMBL628623,,100710,,BAO_0000218,Macaca fascicularis,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,9541.0,N,10977,1,,1,A,,,14839,
In vivo,,CHEMBL628624,,100710,Plasma,BAO_0000218,Macaca fascicularis,1969.0,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,Intermediate,9541.0,N,10978,1,,1,A,,,14839,
In vivo,,CHEMBL628625,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,10090.0,N,10979,1,,1,A,,,14839,
In vivo,,CHEMBL628626,,100710,Plasma,BAO_0000218,Macaca fascicularis,1969.0,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,Intermediate,9541.0,N,10980,1,,1,A,,,14839,
In vivo,,CHEMBL627041,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,10090.0,N,10981,1,,1,A,,,14839,
In vivo,,CHEMBL627042,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,10090.0,N,10982,1,,1,A,,,14839,
In vivo,,CHEMBL627043,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,10090.0,N,10983,1,,1,A,,,14839,
In vivo,,CHEMBL627044,,22224,Plasma,BAO_0000218,,1969.0,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,Autocuration,,U,10984,1,,0,A,,,13932,
In vivo,,CHEMBL627045,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Cmax in mouse plasma,Intermediate,10090.0,N,10985,1,,1,A,,,11637,
In vivo,,CHEMBL627046,,22224,Plasma,BAO_0000218,,1969.0,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,Autocuration,,U,10986,1,,0,A,,,11637,
In vivo,,CHEMBL627047,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximal plasma concentration in rat,Intermediate,10116.0,N,10987,1,,1,A,,,13960,
In vivo,,CHEMBL627048,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,Intermediate,10116.0,N,10988,1,,1,A,,,15905,
In vivo,,CHEMBL627049,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,Intermediate,10116.0,N,10989,1,,1,A,,,14062,
In vivo,,CHEMBL627050,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,Intermediate,10116.0,N,10990,1,,1,A,,,14062,
In vivo,,CHEMBL627051,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,Intermediate,10116.0,N,10991,1,,1,A,,,14062,
In vivo,,CHEMBL627052,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,Intermediate,10116.0,N,10992,1,,1,A,,,14062,
In vivo,,CHEMBL627053,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,Intermediate,10116.0,N,10993,1,,1,A,,,14062,
In vivo,,CHEMBL627054,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,Intermediate,10116.0,N,10994,1,,1,A,,,14062,
In vivo,,CHEMBL627055,,50594,,BAO_0000218,Mus musculus,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,10090.0,N,10995,1,,1,A,,,15011,
In vivo,,CHEMBL627056,,50594,,BAO_0000218,Mus musculus,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,10090.0,N,10996,1,,1,A,,,15011,
In vivo,,CHEMBL627057,,50594,,BAO_0000218,Mus musculus,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,10090.0,N,10997,1,,1,A,,,15011,
In vivo,,CHEMBL627058,,50594,,BAO_0000218,Mus musculus,,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,10090.0,N,10998,1,,1,A,,,15011,
In vivo,,CHEMBL626211,,50594,,BAO_0000218,Mus musculus,,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,10090.0,N,10999,1,,1,A,,,15011,
In vivo,,CHEMBL626212,,22224,,BAO_0000218,,,,Maximum Concentration of the compound.,Autocuration,,U,11000,1,,0,A,,,10291,
In vivo,,CHEMBL626213,,50588,,BAO_0000218,Canis lupus familiaris,,,Maximum Concentration was measured after iv administration into Beagle dog,Intermediate,9615.0,N,11001,1,,1,A,,,14599,
In vivo,,CHEMBL626214,,50588,,BAO_0000218,Canis lupus familiaris,,,Maximum Concentration was measured after iv administration into Beagle dog.,Intermediate,9615.0,N,11002,1,,1,A,,,14599,
In vivo,,CHEMBL626215,,50588,,BAO_0000218,Canis lupus familiaris,,,Maximum Concentration was measured after po administration into Beagle dog,Intermediate,9615.0,N,11003,1,,1,A,,,14599,
In vivo,,CHEMBL626216,,50588,,BAO_0000218,Canis lupus familiaris,,,Maximum Concentration was measured after po administration into Beagle dog.,Intermediate,9615.0,N,11004,1,,1,A,,,14599,
In vivo,,CHEMBL626217,,22224,Blood,BAO_0000218,,178.0,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,Autocuration,,U,11005,1,,0,A,,,12767,
In vivo,,CHEMBL626218,,22224,Blood,BAO_0000218,,178.0,,Maximum blood level reached after an iv dose of 12.2 uM/kg,Autocuration,,U,11006,1,,0,A,,,12767,
In vivo,,CHEMBL626219,,22224,Blood,BAO_0000218,,178.0,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,Autocuration,,U,11007,1,,0,A,,,12767,
In vivo,,CHEMBL626220,,22224,Blood,BAO_0000218,,178.0,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,Autocuration,,U,11008,1,,0,A,,,12767,
In vivo,,CHEMBL626221,,22224,Blood,BAO_0000218,,178.0,,Maximum blood level reached after an oral dose of 5.0 mg/kg,Autocuration,,U,11009,1,,0,A,,,12767,
In vivo,,CHEMBL626222,,22224,Blood,BAO_0000218,,178.0,,Maximum blood level reached at dose of 10.6 uM/kg orally,Autocuration,,U,11010,1,,0,A,,,12767,
In vivo,,CHEMBL626223,,50512,,BAO_0000218,Cavia porcellus,,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,Intermediate,10141.0,N,11011,1,,1,A,,,14706,
In vivo,,CHEMBL626224,,50512,,BAO_0000218,Cavia porcellus,,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,Intermediate,10141.0,N,11012,1,,1,A,,,14706,
In vivo,,CHEMBL626225,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,10116.0,N,11013,1,,1,A,,,14793,
In vivo,,CHEMBL626226,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,Intermediate,10116.0,N,11014,1,,1,A,,,14793,
In vivo,,CHEMBL626227,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,Intermediate,10116.0,N,11015,1,,1,A,,,14793,
In vivo,,CHEMBL626228,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,Intermediate,10116.0,N,11016,1,,1,A,,,14793,
In vivo,,CHEMBL626229,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,10116.0,N,11017,1,,1,A,,,14793,
In vivo,,CHEMBL626921,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,Intermediate,10116.0,N,11018,1,,1,A,,,14793,
In vivo,,CHEMBL876793,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,Intermediate,10116.0,N,11019,1,,1,A,,,14793,
In vivo,,CHEMBL625309,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,Intermediate,10116.0,N,11020,1,,1,A,,,14793,
In vivo,,CHEMBL625310,,50278,,BAO_0000218,Bacillus subtilis,,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Intermediate,1423.0,N,11021,1,,1,A,,,10524,
In vivo,,CHEMBL625311,,22224,,BAO_0000218,Simiiformes,,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,Autocuration,314293.0,U,11022,1,,0,A,,,11871,
In vivo,,CHEMBL625312,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,Intermediate,10116.0,N,11023,1,,1,A,,,11871,
In vivo,,CHEMBL625313,,22224,,BAO_0000218,,,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,Autocuration,,U,11024,1,,0,A,,,3437,
In vivo,,CHEMBL625314,,50594,,BAO_0000218,Mus musculus,,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,Intermediate,10090.0,N,11025,1,,1,A,,,12038,
In vivo,,CHEMBL625315,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration in male rats after iv administration of 20 mg/kg,Intermediate,10116.0,N,11026,1,,1,A,,,12038,
,,CHEMBL625316,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,Intermediate,10116.0,N,11027,1,,1,A,,,8418,
,,CHEMBL625317,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,Intermediate,10116.0,N,11028,1,,1,A,,,8418,
,,CHEMBL625318,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,Intermediate,10116.0,N,11029,1,,1,A,,,8418,
,,CHEMBL625319,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,Intermediate,10116.0,N,11030,1,,1,A,,,8418,
,,CHEMBL625320,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,Intermediate,10116.0,N,11031,1,,1,A,,,8418,
,,CHEMBL625321,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,Intermediate,10116.0,N,11032,1,,1,A,,,8418,
,,CHEMBL625322,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,Intermediate,10116.0,N,11033,1,,1,A,,,8418,
,,CHEMBL876801,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,Intermediate,10116.0,N,11034,1,,1,A,,,8418,
,,CHEMBL625323,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,Intermediate,10116.0,N,11035,1,,1,A,,,8418,
,,CHEMBL625324,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,Intermediate,10116.0,N,11036,1,,1,A,,,8418,
,,CHEMBL625325,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,Intermediate,10116.0,N,11037,1,,1,A,,,8418,
,,CHEMBL625326,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,Intermediate,10116.0,N,11038,1,,1,A,,,8418,
,,CHEMBL625327,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,Intermediate,10116.0,N,11039,1,,1,A,,,8418,
,,CHEMBL625328,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,Intermediate,10116.0,N,11040,1,,1,A,,,8418,
,,CHEMBL625329,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,Intermediate,10116.0,N,11041,1,,1,A,,,8418,
,,CHEMBL625330,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,Intermediate,10116.0,N,11042,1,,1,A,,,8418,
,,CHEMBL627774,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,Intermediate,10116.0,N,11043,1,,1,A,,,8418,
,,CHEMBL627775,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,Intermediate,10116.0,N,11044,1,,1,A,,,8418,
,,CHEMBL627949,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,Intermediate,10116.0,N,11045,1,,1,A,,,8418,
,,CHEMBL627950,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,Intermediate,10116.0,N,11046,1,,1,A,,,8418,
,,CHEMBL627951,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,Intermediate,10116.0,N,11047,1,,1,A,,,8418,
,,CHEMBL627952,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,Intermediate,10116.0,N,11048,1,,1,A,,,8418,
,,CHEMBL627953,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,Intermediate,10116.0,N,11049,1,,1,A,,,8418,
,,CHEMBL627954,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,Intermediate,10116.0,N,11050,1,,1,A,,,8418,
,,CHEMBL627955,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,Intermediate,10116.0,N,11051,1,,1,A,,,8418,
,,CHEMBL627956,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,Intermediate,10116.0,N,11052,1,,1,A,,,8418,
,,CHEMBL876802,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,Intermediate,10116.0,N,11053,1,,1,A,,,8418,
,,CHEMBL627957,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,Intermediate,10116.0,N,11054,1,,1,A,,,8418,
,,CHEMBL627958,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,Intermediate,10116.0,N,11055,1,,1,A,,,8418,
,,CHEMBL627959,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,Intermediate,10116.0,N,11056,1,,1,A,,,8418,
,,CHEMBL627960,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,Intermediate,10116.0,N,11057,1,,1,A,,,8418,
,,CHEMBL627961,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,Intermediate,10116.0,N,11058,1,,1,A,,,8418,
,,CHEMBL627962,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,Intermediate,10116.0,N,11059,1,,1,A,,,8418,
,,CHEMBL627963,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,10116.0,N,11060,1,,1,A,,,9796,
,,CHEMBL624759,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11061,1,,1,A,,,9796,
,,CHEMBL624760,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11062,1,,1,A,,,9796,
,,CHEMBL624761,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11063,1,,1,A,,,9796,
,,CHEMBL877607,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11064,1,,1,A,,,9796,
,,CHEMBL624762,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,10116.0,N,11065,1,,1,A,,,9796,
,,CHEMBL624763,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11066,1,,1,A,,,9796,
,,CHEMBL624764,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11067,1,,1,A,,,9796,
,,CHEMBL624765,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11068,1,,1,A,,,9796,
,,CHEMBL624766,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11069,1,,1,A,,,9796,
,,CHEMBL624767,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,11070,1,,1,A,,,6996,
,,CHEMBL624768,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,Intermediate,9615.0,N,11071,1,,1,A,,,6996,
,,CHEMBL624769,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,11072,1,,1,A,,,6996,
,,CHEMBL624770,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,9615.0,N,11073,1,,1,A,,,6996,
,,CHEMBL624771,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,9615.0,N,11074,1,,1,A,,,6996,
,,CHEMBL624772,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,11075,1,,1,A,,,6996,
,,CHEMBL624773,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,Intermediate,10116.0,N,11076,1,,1,A,,,6996,
,,CHEMBL624774,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,11077,1,,1,A,,,6996,
,,CHEMBL624775,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,11078,1,,1,A,,,6996,
,,CHEMBL624776,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,10116.0,N,11079,1,,1,A,,,6996,
,,CHEMBL624777,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,11080,1,,1,A,,,6996,
,,CHEMBL624778,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,11081,1,,1,A,,,6996,
,,CHEMBL624779,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,Intermediate,10116.0,N,11082,1,,1,A,,,6996,
,,CHEMBL624780,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,10116.0,N,11083,1,,1,A,,,6996,
,,CHEMBL624781,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,11084,1,,1,A,,,6996,
,,CHEMBL877608,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,11085,1,,1,A,,,6996,
,,CHEMBL624782,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,11086,1,,1,A,,,6996,
,,CHEMBL624783,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,11087,1,,1,A,,,6996,
,,CHEMBL624784,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,Intermediate,10116.0,N,11088,1,,1,A,,,6996,
,,CHEMBL624785,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,11089,1,,1,A,,,6996,
,,CHEMBL624786,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,11090,1,,1,A,,,6996,
,,CHEMBL624787,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,11091,1,,1,A,,,6996,
,,CHEMBL628676,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,11092,1,,1,A,,,6996,
,,CHEMBL621842,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,Intermediate,10116.0,N,11093,1,,1,A,,,6996,
,,CHEMBL621843,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,11094,1,,1,A,,,6996,
,,CHEMBL623873,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,11095,1,,1,A,,,6996,
,,CHEMBL623874,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,10116.0,N,11096,1,,1,A,,,6996,
,,CHEMBL623875,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,11097,1,,1,A,,,6996,
,,CHEMBL623876,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,11098,1,,1,A,,,6996,
,,CHEMBL623877,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,Intermediate,9615.0,N,11099,1,,1,A,,,6996,
,,CHEMBL623878,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,11100,1,,1,A,,,6996,
,,CHEMBL623879,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,Intermediate,9615.0,N,11101,1,,1,A,,,6996,
,,CHEMBL623880,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,11102,1,,1,A,,,6996,
,,CHEMBL623881,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,11103,1,,1,A,,,6996,
,,CHEMBL623957,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,11104,1,,1,A,,,6996,
,,CHEMBL623958,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,11105,1,,1,A,,,6996,
,,CHEMBL623959,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,11106,1,,1,A,,,6996,
,,CHEMBL623960,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,11107,1,,1,A,,,6996,
,,CHEMBL623961,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,11108,1,,1,A,,,6996,
,,CHEMBL623962,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,9615.0,N,11109,1,,1,A,,,6996,
,,CHEMBL624676,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,9615.0,N,11110,1,,1,A,,,6996,
,,CHEMBL624677,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,11111,1,,1,A,,,6996,
,,CHEMBL624678,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,Intermediate,9615.0,N,11112,1,,1,A,,,6996,
,,CHEMBL624679,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,11113,1,,1,A,,,6996,
,,CHEMBL624680,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,9615.0,N,11114,1,,1,A,,,6996,
In vivo,,CHEMBL624849,,22224,,BAO_0000218,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,Autocuration,,U,11115,1,,0,A,,,11732,
In vivo,,CHEMBL624850,,22224,,BAO_0000218,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,Autocuration,,U,11116,1,,0,A,,,11732,
In vivo,,CHEMBL874399,,22224,,BAO_0000218,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,Autocuration,,U,11117,1,,0,A,,,11732,
In vivo,,CHEMBL624851,,22224,,BAO_0000218,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,Autocuration,,U,11118,1,,0,A,,,11732,
In vivo,,CHEMBL624852,,22224,,BAO_0000218,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,Autocuration,,U,11119,1,,0,A,,,11732,
In vivo,,CHEMBL624853,,22224,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (dose 10 mg/kg),Autocuration,10116.0,U,11120,1,,0,A,,,13359,
In vivo,,CHEMBL624854,,22224,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley),Autocuration,10116.0,U,11121,1,,0,A,,,16618,
In vivo,,CHEMBL624855,,22224,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Autocuration,10116.0,U,11122,1,,0,A,,,13960,
In vivo,,CHEMBL624856,,22224,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rats was determined in vivo,Autocuration,10116.0,U,11123,1,,0,A,,,13917,
In vivo,,CHEMBL882957,,22224,,BAO_0000218,Canis lupus familiaris,,,Oral bioavailability in dog,Autocuration,9615.0,U,11124,1,,0,A,,,14266,
In vivo,,CHEMBL624857,,22224,,BAO_0000218,Simiiformes,,,Oral bioavailability of compound in monkey,Autocuration,314293.0,U,11125,1,,0,A,,,12359,
In vivo,,CHEMBL622202,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound in rat,Intermediate,10116.0,N,11126,1,,1,A,,,12359,
In vivo,,CHEMBL622203,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat of PMEA prodrug,Autocuration,10116.0,U,11127,1,,0,A,,,12359,
In vivo,,CHEMBL625522,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,Intermediate,10116.0,N,11128,1,,1,A,,,12359,
In vivo,,CHEMBL622868,,22224,,BAO_0000218,Macaca mulatta,,,Serum conc at 3 hours following 25 mg/kg dose,Autocuration,9544.0,U,11129,1,,0,A,,,10791,
In vivo,,CHEMBL622869,,22224,Urine,BAO_0000218,Macaca mulatta,1088.0,,Urine conc 0-5 hours following 25 mg/kg dose,Autocuration,9544.0,U,11130,1,,0,A,,,10791,
In vivo,,CHEMBL622870,,22224,Urine,BAO_0000218,Macaca mulatta,1088.0,,Urine conc 0-24 hours following 25 mg/kg dose,Autocuration,9544.0,U,11131,1,,0,A,,,10791,
In vivo,,CHEMBL622871,,22224,,BAO_0000218,Chlorocebus aethiops,,,Oral bioavailability in African green monkeys; 20-25,Autocuration,9534.0,U,11132,1,,0,A,,,138,
In vivo,,CHEMBL620560,,100710,,BAO_0000218,Macaca fascicularis,,,Oral bioavailability in cynomolgus monkey.,Intermediate,9541.0,N,11133,1,,1,A,,,14521,
In vivo,,CHEMBL620561,,22224,,BAO_0000218,Canis lupus familiaris,,,Oral bioavailability in dog,Autocuration,9615.0,U,11134,1,,0,A,,,13953,
In vivo,,CHEMBL620562,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral bioavailability in dog at 10 mg/kg oral dose,Intermediate,9615.0,N,11135,1,,1,A,,,12836,
In vivo,,CHEMBL620563,,100712,,BAO_0000218,Cricetinae,,,Oral bioavailability in hamster at 10 mg/kg oral dose,Intermediate,10026.0,N,11136,1,,1,A,,,12836,
In vivo,,CHEMBL620564,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat at 10 mg/kg oral dose,Intermediate,10116.0,N,11137,1,,1,A,,,12836,
In vivo,,CHEMBL872265,,22224,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Autocuration,10116.0,U,11138,1,,0,A,,,14521,
In vivo,,CHEMBL620565,,22224,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Autocuration,10116.0,U,11139,1,,0,A,,,13953,
In vivo,,CHEMBL620566,,22224,,BAO_0000218,Eutheria,,,Oral bioavailability,Autocuration,9347.0,U,11140,1,,0,A,,,6799,
In vivo,,CHEMBL620567,,22224,,BAO_0000218,,,,Oral bioavailability was determined; range 49-102%,Autocuration,,U,11141,1,,0,A,,,11311,
In vivo,,CHEMBL620568,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral bioavailability was determined in dogs,Intermediate,9615.0,N,11142,1,,1,A,,,4013,
In vivo,,CHEMBL620569,,22224,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat,Autocuration,10116.0,U,11143,1,,0,A,,,4013,
In vivo,,CHEMBL620570,,22224,,BAO_0000218,Eutheria,,,Oral bioavailability,Autocuration,9347.0,U,11144,1,,0,A,,,17591,
In vivo,,CHEMBL620571,,22224,,BAO_0000218,,,,Oral bioavailability was determined; Not orally available,Autocuration,,U,11145,1,,0,A,,,17591,
In vivo,,CHEMBL620572,,50594,,BAO_0000218,Mus musculus,,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,10090.0,N,11146,1,,1,A,,,15011,
In vivo,,CHEMBL620573,,22224,,BAO_0000218,Mus musculus,,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),Autocuration,10090.0,U,11147,1,,0,A,,,15011,
In vivo,,CHEMBL620574,,22224,,BAO_0000218,Mus musculus,,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,Autocuration,10090.0,U,11148,1,,0,A,,,15011,
In vivo,,CHEMBL620575,,22224,,BAO_0000218,Macaca mulatta,,,Oral bioavailability in Rhesus monkey,Autocuration,9544.0,U,11149,1,,0,A,,,9552,
In vivo,,CHEMBL620576,,22224,,BAO_0000218,Canis lupus familiaris,,,Oral bioavailability in dog (female mongrel),Autocuration,9615.0,U,11150,1,,0,A,,,9552,
In vivo,,CHEMBL875846,,22224,,BAO_0000218,,,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,Autocuration,,U,11151,1,,0,A,,,3639,
In vivo,,CHEMBL620577,,22224,,BAO_0000218,Canis lupus familiaris,,,Oral bioavailability in dog,Autocuration,9615.0,U,11152,1,,0,A,,,13397,
In vivo,,CHEMBL620578,,22224,,BAO_0000218,,,,Percentage Bioavailability was evaluated.,Autocuration,,U,11153,1,,0,A,,,3031,
In vivo,,CHEMBL620579,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat administered i.d.,Autocuration,10116.0,U,11154,1,,0,A,,,12818,
In vivo,,CHEMBL621248,,22224,,BAO_0000218,Eutheria,,,Bioavailability,Autocuration,9347.0,U,11155,1,,0,A,,,4847,
In vivo,,CHEMBL625390,,22224,,BAO_0000218,Canis lupus familiaris,,,Bioavailability in dog (male Beagle) i.v. administration,Autocuration,9615.0,U,11156,1,,0,A,,,12421,
In vivo,,CHEMBL625391,,22224,,BAO_0000218,Rattus norvegicus,,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",Autocuration,10116.0,U,11157,1,,0,A,,,11966,
In vivo,,CHEMBL872266,,22224,,BAO_0000218,Primates,,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),Autocuration,9443.0,U,11158,1,,0,A,,,11218,
In vivo,,CHEMBL625392,,22224,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability in rat (Sprague-Dawley) (male),Autocuration,10116.0,U,11159,1,,0,A,,,13129,
In vivo,,CHEMBL625393,,50597,,BAO_0000218,Rattus norvegicus,,,The oral bioavailability was measured on rats after oral administration,Intermediate,10116.0,N,11160,1,,1,A,,,12350,
In vivo,,CHEMBL625394,,50597,,BAO_0000218,Rattus norvegicus,,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Intermediate,10116.0,N,11161,1,,1,A,,,2231,
In vivo,,CHEMBL625395,,50797,,BAO_0000218,Macaca mulatta,,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Intermediate,9544.0,N,11162,1,,1,A,,,2231,
In vivo,,CHEMBL625396,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 10 mg/kg i.d.),Autocuration,10116.0,U,11163,1,,0,A,,,12187,
In vivo,,CHEMBL625397,,22224,,BAO_0000218,Canis lupus familiaris,,,Bioavailability in dog (male Beagle) i.v. administration,Autocuration,9615.0,U,11164,1,,0,A,,,12421,
In vivo,,CHEMBL625398,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11165,1,,1,A,,,13256,
In vivo,,CHEMBL625399,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11166,1,,1,A,,,13256,
In vivo,,CHEMBL626074,,50594,Cerebellum,BAO_0000218,Mus musculus,2037.0,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11167,1,,1,A,,,13256,
In vivo,,CHEMBL626075,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11168,1,,1,A,,,13256,
In vivo,,CHEMBL626076,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Intermediate,10116.0,N,11169,1,,1,A,,,2231,
In vivo,,CHEMBL626077,,50797,Plasma,BAO_0000218,Macaca mulatta,1969.0,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Intermediate,9544.0,N,11170,1,,1,A,,,2231,
In vivo,,CHEMBL626078,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),Intermediate,10116.0,N,11171,1,,1,A,,,12178,
In vivo,,CHEMBL625846,,22224,Blood,BAO_0000218,,178.0,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),Autocuration,,U,11172,1,,0,A,,,12178,
In vivo,,CHEMBL625847,,22224,Blood,BAO_0000218,,178.0,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),Autocuration,,U,11173,1,,0,A,,,12178,
In vivo,,CHEMBL625848,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,Expert,10116.0,N,11174,1,,1,A,,,15633,
In vivo,,CHEMBL625849,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration of compound in plasma administered orally to rats,Intermediate,10116.0,N,11175,1,,1,A,,,14258,
In vivo,,CHEMBL626023,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",Intermediate,9615.0,N,11176,1,,1,A,,,14224,
In vivo,,CHEMBL626024,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",Intermediate,9615.0,N,11177,1,,1,A,,,14224,
In vivo,,CHEMBL626025,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",Intermediate,9615.0,N,11178,1,,1,A,,,14224,
In vivo,,CHEMBL626026,,22224,,BAO_0000218,,,,Maximum concentration after 10 mg/kg by oral administration,Autocuration,,U,11179,1,,0,A,,,5566,
In vivo,,CHEMBL626027,,22224,,BAO_0000218,,,,Maximum concentration at a dose of 1.5 mg/kg,Autocuration,,U,11180,1,,0,A,,,16935,
In vivo,,CHEMBL626028,,22224,,BAO_0000218,,,,Maximum concentration at a dose of 2.0 mg/kg,Autocuration,,U,11181,1,,0,A,,,16935,
In vivo,,CHEMBL626029,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximum concentration in dog plasma,Intermediate,9615.0,N,11182,1,,1,A,,,14224,
In vivo,,CHEMBL626030,,22224,Plasma,BAO_0000218,,1969.0,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,Autocuration,,U,11183,1,,0,A,,,12536,
In vivo,,CHEMBL626031,,22224,Plasma,BAO_0000218,,1969.0,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,Autocuration,,U,11184,1,,0,A,,,12536,
In vivo,,CHEMBL626032,,22224,Plasma,BAO_0000218,,1969.0,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,Autocuration,,U,11185,1,,0,A,,,12536,
In vivo,,CHEMBL626033,,22224,Plasma,BAO_0000218,,1969.0,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,Autocuration,,U,11186,1,,0,A,,,12536,
In vivo,,CHEMBL626034,,22224,Plasma,BAO_0000218,,1969.0,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,Autocuration,,U,11187,1,,0,A,,,12536,
In vivo,,CHEMBL626035,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),Intermediate,9615.0,N,11188,1,,1,A,,,9994,
In vivo,,CHEMBL626036,,22224,Plasma,BAO_0000218,,1969.0,,Maximum concentration in plasma at Tmax,Autocuration,,U,11189,1,,0,A,,,1434,
In vivo,,CHEMBL626037,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,Expert,9615.0,N,11190,1,,1,A,,,12836,
In vivo,,CHEMBL626038,,100712,Plasma,BAO_0000218,Cricetinae,1969.0,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,Intermediate,10026.0,N,11191,1,,1,A,,,12836,
In vivo,,CHEMBL626039,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,Intermediate,10116.0,N,11192,1,,1,A,,,12836,
In vivo,,CHEMBL626040,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,Intermediate,10116.0,N,11193,1,,1,A,,,12545,
In vivo,,CHEMBL626041,,50592,Plasma,BAO_0000218,Oryctolagus cuniculus,1969.0,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,Intermediate,9986.0,N,11194,1,,1,A,,,13856,
In vivo,,CHEMBL626042,,22224,,BAO_0000218,,,,Maximum concentration was calculated,Autocuration,,U,11195,1,,0,A,,,3550,
In vivo,,CHEMBL626043,,22224,,BAO_0000218,,,,Maximum concentration was calculated.,Autocuration,,U,11196,1,,0,A,,,2632,
In vivo,,CHEMBL626044,,22224,,BAO_0000218,,,,Maximum concentration at a peroral dose of 10 mg/kg,Autocuration,,U,11197,1,,0,A,,,5566,
In vivo,,CHEMBL626045,,22224,,BAO_0000218,,,,Maximum concentration of the drug at 10 uM/dg administered perorally,Autocuration,,U,11198,1,,0,A,,,11883,
In vivo,,CHEMBL626046,,22224,,BAO_0000218,,,,Maximum concentration of the drug at 2 uM/dg administered intravenously,Autocuration,,U,11199,1,,0,A,,,11883,
In vivo,,CHEMBL626047,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",Intermediate,9615.0,N,11200,1,,1,A,,,14122,
In vivo,,CHEMBL626048,,100712,Plasma,BAO_0000218,Cricetinae,1969.0,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",Intermediate,10026.0,N,11201,1,,1,A,,,14122,
In vivo,,CHEMBL626049,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",Intermediate,10116.0,N,11202,1,,1,A,,,14122,
In vivo,,CHEMBL626050,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,Intermediate,10116.0,N,11203,1,,1,A,,,12542,
In vivo,,CHEMBL874541,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,Intermediate,9615.0,N,11204,1,,1,A,,,12542,
In vivo,,CHEMBL622826,,100712,Plasma,BAO_0000218,Cricetinae,1969.0,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,Intermediate,10026.0,N,11205,1,,1,A,,,12542,
In vivo,,CHEMBL622827,,100712,Plasma,BAO_0000218,Cricetinae,1969.0,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,Intermediate,10026.0,N,11206,1,,1,A,,,12542,
In vivo,,CHEMBL622828,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,Intermediate,10116.0,N,11207,1,,1,A,,,12542,
In vivo,,CHEMBL622829,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,Intermediate,10116.0,N,11208,1,,1,A,,,14080,
In vivo,,CHEMBL876806,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration reached following intravenous administration in male rat,Intermediate,10116.0,N,11209,1,,1,A,,,11911,
In vivo,,CHEMBL622830,,50588,,BAO_0000218,Canis lupus familiaris,,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,Intermediate,9615.0,N,11210,1,,1,A,,,13204,
In vivo,,CHEMBL622831,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,Intermediate,10116.0,N,11211,1,,1,A,,,13204,
In vivo,,CHEMBL626794,,50588,,BAO_0000218,Canis lupus familiaris,,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,Intermediate,9615.0,N,11212,1,,1,A,,,14346,
In vivo,,CHEMBL626795,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,Intermediate,10116.0,N,11213,1,,1,A,,,14346,
In vivo,,CHEMBL626796,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,Intermediate,10116.0,N,11214,1,,1,A,,,14346,
In vivo,,CHEMBL626797,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,Intermediate,10116.0,N,11215,1,,1,A,,,14346,
In vivo,,CHEMBL626798,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum drug concentration is determined after oral dosing in rats.,Intermediate,10116.0,N,11216,1,,1,A,,,14127,
In vivo,,CHEMBL626799,,50588,,BAO_0000218,Canis lupus familiaris,,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,Intermediate,9615.0,N,11217,1,,1,A,,,14339,
In vivo,,CHEMBL626800,,50588,,BAO_0000218,Canis lupus familiaris,,,Maximum observed concentration in oral (5 mg/kg) fed dogs,Intermediate,9615.0,N,11218,1,,1,A,,,14339,
In vivo,,CHEMBL626801,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration,Autocuration,,U,11219,1,,0,A,,,13494,
In vivo,,CHEMBL876816,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,Intermediate,10116.0,N,11220,1,,1,A,,,14925,
In vivo,,CHEMBL626802,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,Intermediate,10116.0,N,11221,1,,1,A,,,14474,
In vivo,,CHEMBL626803,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,Intermediate,9615.0,N,11222,1,,1,A,,,14474,
In vivo,,CHEMBL626804,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration following oral administration of 30 umol/kg,Autocuration,,U,11223,1,,0,A,,,13917,
,,CHEMBL626805,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,Intermediate,10116.0,N,11224,1,,1,A,,,9796,
,,CHEMBL626309,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,10116.0,N,11225,1,,1,A,,,9796,
,,CHEMBL626310,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11226,1,,1,A,,,9796,
,,CHEMBL626311,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11227,1,,1,A,,,9796,
,,CHEMBL626312,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11228,1,,1,A,,,9796,
,,CHEMBL626313,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11229,1,,1,A,,,9796,
,,CHEMBL626314,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,10116.0,N,11230,1,,1,A,,,9796,
,,CHEMBL626315,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11231,1,,1,A,,,9796,
,,CHEMBL626316,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11232,1,,1,A,,,9796,
,,CHEMBL626317,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,10116.0,N,11233,1,,1,A,,,9796,
,,CHEMBL626318,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,10116.0,N,11234,1,,1,A,,,8363,
,,CHEMBL626319,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,10116.0,N,11235,1,,1,A,,,8363,
,,CHEMBL626320,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,10116.0,N,11236,1,,1,A,,,8363,
,,CHEMBL875053,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,10116.0,N,11237,1,,1,A,,,8363,
,,CHEMBL626321,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,10116.0,N,11238,1,,1,A,,,8363,
,,CHEMBL626322,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,10116.0,N,11239,1,,1,A,,,8363,
,,CHEMBL626323,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,10116.0,N,11240,1,,1,A,,,8363,
,,CHEMBL626324,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,10116.0,N,11241,1,,1,A,,,8363,
,,CHEMBL626325,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,10116.0,N,11242,1,,1,A,,,8363,
,,CHEMBL626326,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,10116.0,N,11243,1,,1,A,,,8363,
,,CHEMBL626327,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,10116.0,N,11244,1,,1,A,,,8363,
,,CHEMBL626328,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,10116.0,N,11245,1,,1,A,,,8363,
,,CHEMBL626329,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11246,1,,1,A,,,8684,
,,CHEMBL626330,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11247,1,,1,A,,,8684,
,,CHEMBL626331,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11248,1,,1,A,,,8684,
,,CHEMBL626332,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11249,1,,1,A,,,8684,
,,CHEMBL626333,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11250,1,,1,A,,,8684,
,,CHEMBL626334,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11251,1,,1,A,,,8684,
,,CHEMBL626335,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11252,1,,1,A,,,8684,
,,CHEMBL624798,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11253,1,,1,A,,,8684,
,,CHEMBL624799,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",Intermediate,10116.0,N,11254,1,,1,A,,,8684,
,,CHEMBL624800,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",Intermediate,10116.0,N,11255,1,,1,A,,,8684,
,,CHEMBL624801,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",Intermediate,10116.0,N,11256,1,,1,A,,,8684,
,,CHEMBL624802,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",Intermediate,10116.0,N,11257,1,,1,A,,,8684,
,,CHEMBL624803,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",Intermediate,10116.0,N,11258,1,,1,A,,,8684,
,,CHEMBL624804,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",Intermediate,10116.0,N,11259,1,,1,A,,,8684,
,,CHEMBL624805,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",Intermediate,10116.0,N,11260,1,,1,A,,,8684,
,,CHEMBL624806,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",Intermediate,10116.0,N,11261,1,,1,A,,,8684,
,,CHEMBL624807,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11262,1,,1,A,,,8684,
,,CHEMBL624808,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11263,1,,1,A,,,8684,
,,CHEMBL624809,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11264,1,,1,A,,,8684,
,,CHEMBL624810,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11265,1,,1,A,,,8684,
,,CHEMBL877618,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11266,1,,1,A,,,8684,
,,CHEMBL624811,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11267,1,,1,A,,,8684,
,,CHEMBL624812,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11268,1,,1,A,,,8684,
,,CHEMBL624813,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11269,1,,1,A,,,8684,
,,CHEMBL624814,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11270,1,,1,A,,,8684,
,,CHEMBL624815,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11271,1,,1,A,,,8684,
,,CHEMBL624816,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11272,1,,1,A,,,8684,
,,CHEMBL624817,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11273,1,,1,A,,,8684,
,,CHEMBL624818,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,11274,1,,1,A,,,6996,
,,CHEMBL624819,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,Intermediate,9615.0,N,11275,1,,1,A,,,6996,
,,CHEMBL624820,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,11276,1,,1,A,,,6996,
,,CHEMBL624821,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,9615.0,N,11277,1,,1,A,,,6996,
,,CHEMBL624822,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,9615.0,N,11278,1,,1,A,,,6996,
,,CHEMBL624823,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,11279,1,,1,A,,,6996,
,,CHEMBL624824,,50212,,BAO_0000218,Escherichia coli,,,Observed diffusion coefficient in organic solvent for Escherichia coli,Intermediate,562.0,N,11280,1,,1,A,,,15599,
,,CHEMBL624825,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,10116.0,N,11281,1,,1,A,,,9614,
,,CHEMBL624826,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,10116.0,N,11282,1,,1,A,,,9614,
,,CHEMBL876817,,50597,Cardiac atrium,BAO_0000218,Rattus norvegicus,2081.0,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,10116.0,N,11283,1,,1,A,,,9614,
,,CHEMBL624827,,50597,Cardiac atrium,BAO_0000218,Rattus norvegicus,2081.0,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,10116.0,N,11284,1,,1,A,,,9614,
,,CHEMBL624828,,50597,,BAO_0000218,Rattus norvegicus,,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,10116.0,N,11285,1,,1,A,,,9614,
,,CHEMBL624829,,50597,,BAO_0000218,Rattus norvegicus,,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,10116.0,N,11286,1,,1,A,,,9614,
,,CHEMBL624830,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,10116.0,N,11287,1,,1,A,,,9614,
,,CHEMBL624831,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,10116.0,N,11288,1,,1,A,,,9614,
,,CHEMBL624832,,50597,Cardiac atrium,BAO_0000218,Rattus norvegicus,2081.0,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,10116.0,N,11289,1,,1,A,,,9614,
,,CHEMBL624833,,50597,Cardiac atrium,BAO_0000218,Rattus norvegicus,2081.0,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,10116.0,N,11290,1,,1,A,,,9614,
,,CHEMBL624834,,50597,,BAO_0000218,Rattus norvegicus,,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,10116.0,N,11291,1,,1,A,,,9614,
,,CHEMBL624835,,50597,,BAO_0000218,Rattus norvegicus,,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,10116.0,N,11292,1,,1,A,,,9614,
,,CHEMBL624836,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,10116.0,N,11293,1,,1,A,,,9614,
,,CHEMBL624837,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,10116.0,N,11294,1,,1,A,,,9614,
,,CHEMBL624838,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,Intermediate,10116.0,N,11295,1,,1,A,,,9071,
,,CHEMBL622188,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,Intermediate,10116.0,N,11296,1,,1,A,,,9071,
,,CHEMBL622189,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,Intermediate,10116.0,N,11297,1,,1,A,,,9071,
,,CHEMBL622190,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,Intermediate,10116.0,N,11298,1,,1,A,,,9071,
,,CHEMBL625170,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,Intermediate,10116.0,N,11299,1,,1,A,,,9071,
,,CHEMBL625171,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Intermediate,10116.0,N,11300,1,,1,A,,,9071,
,,CHEMBL625172,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Intermediate,10116.0,N,11301,1,,1,A,,,9071,
,,CHEMBL625173,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,Intermediate,10116.0,N,11302,1,,1,A,,,9071,
,,CHEMBL625174,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,Intermediate,10116.0,N,11303,1,,1,A,,,9071,
,,CHEMBL625175,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,Intermediate,10116.0,N,11304,1,,1,A,,,9071,
,,CHEMBL625176,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,Intermediate,10116.0,N,11305,1,,1,A,,,9071,
,,CHEMBL625177,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Intermediate,10116.0,N,11306,1,,1,A,,,9071,
,,CHEMBL625178,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,Intermediate,10116.0,N,11307,1,,1,A,,,9071,
,,CHEMBL625179,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,Intermediate,10116.0,N,11308,1,,1,A,,,9071,
,,CHEMBL625180,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Intermediate,10116.0,N,11309,1,,1,A,,,9071,
,,CHEMBL625181,,22224,,BAO_0000218,,,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",Autocuration,,U,11310,1,,0,A,,,10677,
,,CHEMBL625182,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,Intermediate,10090.0,N,11311,1,,1,A,,,9750,
,,CHEMBL625183,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11312,1,,1,A,,,8319,
,,CHEMBL875848,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,10116.0,N,11313,1,,1,A,,,8319,
,,CHEMBL622260,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11314,1,,1,A,,,8319,
,,CHEMBL622261,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,10116.0,N,11315,1,,1,A,,,8319,
,,CHEMBL622262,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11316,1,,1,A,,,8319,
,,CHEMBL622263,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,10116.0,N,11317,1,,1,A,,,8319,
,,CHEMBL622418,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11318,1,,1,A,,,8319,
,,CHEMBL622419,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,10116.0,N,11319,1,,1,A,,,8319,
In vivo,,CHEMBL623388,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11320,1,,1,A,,,13256,
In vivo,,CHEMBL623389,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11321,1,,1,A,,,13256,
In vivo,,CHEMBL623390,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11322,1,,1,A,,,13256,
In vivo,,CHEMBL623391,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11323,1,,1,A,,,13256,
In vivo,,CHEMBL623392,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11324,1,,1,A,,,13256,
In vivo,,CHEMBL623393,,50594,Cerebellum,BAO_0000218,Mus musculus,2037.0,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11325,1,,1,A,,,13256,
In vivo,,CHEMBL623394,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11326,1,,1,A,,,13256,
In vivo,,CHEMBL618885,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11327,1,,1,A,,,13256,
In vivo,,CHEMBL618886,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11328,1,,1,A,,,13256,
In vivo,,CHEMBL618887,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11329,1,,1,A,,,13256,
In vivo,,CHEMBL619535,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11330,1,,1,A,,,13256,
In vivo,,CHEMBL619536,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11331,1,,1,A,,,13256,
In vivo,,CHEMBL619537,,50594,Cerebellum,BAO_0000218,Mus musculus,2037.0,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11332,1,,1,A,,,13256,
In vivo,,CHEMBL619705,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11333,1,,1,A,,,13256,
In vivo,,CHEMBL619706,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11334,1,,1,A,,,13256,
In vivo,,CHEMBL619707,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11335,1,,1,A,,,13256,
In vivo,,CHEMBL619708,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11336,1,,1,A,,,13256,
In vivo,,CHEMBL625219,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11337,1,,1,A,,,13256,
In vivo,,CHEMBL625220,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11338,1,,1,A,,,13256,
In vivo,,CHEMBL625221,,50594,Cerebellum,BAO_0000218,Mus musculus,2037.0,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11339,1,,1,A,,,13256,
In vivo,,CHEMBL625222,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11340,1,,1,A,,,13256,
In vivo,,CHEMBL625223,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11341,1,,1,A,,,13256,
In vivo,,CHEMBL625224,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11342,1,,1,A,,,13256,
In vivo,,CHEMBL625225,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,10090.0,N,11343,1,,1,A,,,13256,
In vivo,,CHEMBL625226,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in Rat blood after 24 hours of iv administration,Intermediate,10116.0,N,11344,1,,1,A,,,8829,
In vivo,,CHEMBL625227,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,Intermediate,10116.0,N,11345,1,,1,A,,,8829,
In vivo,,CHEMBL625228,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in Rat blood after 30 minutes of iv administration,Intermediate,10116.0,N,11346,1,,1,A,,,8829,
In vivo,,CHEMBL875354,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,Intermediate,10116.0,N,11347,1,,1,A,,,8829,
In vivo,,CHEMBL625229,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in Rat blood after 5 minutes of iv administration,Intermediate,10116.0,N,11348,1,,1,A,,,8829,
In vivo,,CHEMBL625230,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,Intermediate,10116.0,N,11349,1,,1,A,,,8829,
In vivo,,CHEMBL625231,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in Rat heart after 24 hours of iv administration,Intermediate,10116.0,N,11350,1,,1,A,,,8829,
In vivo,,CHEMBL625900,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,Intermediate,10116.0,N,11351,1,,1,A,,,8829,
In vivo,,CHEMBL625901,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in Rat heart after 30 minutes of iv administration,Intermediate,10116.0,N,11352,1,,1,A,,,8829,
In vivo,,CHEMBL625902,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,Intermediate,10116.0,N,11353,1,,1,A,,,8829,
In vivo,,CHEMBL625903,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in Rat heart after 5 minutes of iv administration,Intermediate,10116.0,N,11354,1,,1,A,,,8829,
In vivo,,CHEMBL625904,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,Intermediate,10116.0,N,11355,1,,1,A,,,8829,
In vivo,,CHEMBL625905,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in Rat liver after 24 hours of iv administration,Intermediate,10116.0,N,11356,1,,1,A,,,8829,
In vivo,,CHEMBL627861,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,Intermediate,10116.0,N,11357,1,,1,A,,,8829,
In vivo,,CHEMBL627862,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in Rat liver after 30 minutes of iv administration,Intermediate,10116.0,N,11358,1,,1,A,,,8829,
In vivo,,CHEMBL627863,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Intermediate,10116.0,N,11359,1,,1,A,,,8829,
In vivo,,CHEMBL627769,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in Rat liver after 30 minutes of iv administration,Intermediate,10116.0,N,11360,1,,1,A,,,8829,
In vivo,,CHEMBL627770,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Intermediate,9615.0,N,11361,1,,1,A,,,13249,
In vivo,,CHEMBL627771,,100710,,BAO_0000218,Macaca fascicularis,,,Cmax in cynomolgus monkey (PO dose),Intermediate,9541.0,N,11362,1,,1,A,,,13622,
In vivo,,CHEMBL627772,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat (PO dose),Intermediate,10116.0,N,11363,1,,1,A,,,13622,
In vivo,,CHEMBL627773,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax in rat (PO dose),Intermediate,10116.0,N,11364,1,,1,A,,,13622,
In vivo,,CHEMBL621922,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,Intermediate,10116.0,N,11365,1,,1,A,,,13494,
In vivo,,CHEMBL621923,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Cmax in rat plasma after oral dose (10 mg/kg),Intermediate,10116.0,N,11366,1,,1,A,,,12170,
In vivo,,CHEMBL621924,,22224,Plasma,BAO_0000218,,1969.0,,Cmax in plasma after oral dose (10 mg/kg),Autocuration,,U,11367,1,,0,A,,,12170,
In vivo,,CHEMBL621925,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,Intermediate,9615.0,N,11368,1,,1,A,,,17025,
In vivo,,CHEMBL621926,,22224,Plasma,BAO_0000218,Simiiformes,1969.0,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,Autocuration,314293.0,U,11369,1,,0,A,,,17025,
In vivo,,CHEMBL621927,,50592,Plasma,BAO_0000218,Oryctolagus cuniculus,1969.0,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,Intermediate,9986.0,N,11370,1,,1,A,,,17025,
In vivo,,CHEMBL621928,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,Intermediate,10116.0,N,11371,1,,1,A,,,17025,
In vivo,,CHEMBL621929,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,Intermediate,10116.0,N,11372,1,,1,A,,,14187,
In vivo,,CHEMBL621930,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,Intermediate,10090.0,N,11373,1,,1,A,,,14816,
In vivo,,CHEMBL621931,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration after oral dosing in rat,Intermediate,10116.0,N,11374,1,,1,A,,,17820,
In vivo,,CHEMBL621932,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Autocuration,,U,11375,1,,0,A,,,14380,
In vivo,,CHEMBL621933,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,,U,11376,1,,0,A,,,14380,
In vivo,,CHEMBL621934,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,Intermediate,9615.0,N,11377,1,,1,A,,,14691,
In vivo,,CHEMBL621935,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,Intermediate,9615.0,N,11378,1,,1,A,,,14691,
In vivo,,CHEMBL621936,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,Intermediate,10116.0,N,11379,1,,1,A,,,13375,
In vivo,,CHEMBL621937,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration was determined,Autocuration,,U,11380,1,,0,A,,,6236,
In vivo,,CHEMBL621938,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,,U,11381,1,,0,A,,,14380,
In vivo,,CHEMBL621939,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,,U,11382,1,,0,A,,,14380,
In vivo,,CHEMBL621940,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,Autocuration,,U,11383,1,,0,A,,,14380,
In vivo,,CHEMBL621941,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,Autocuration,,U,11384,1,,0,A,,,14380,
In vivo,,CHEMBL621942,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Autocuration,,U,11385,1,,0,A,,,14380,
In vivo,,CHEMBL626178,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,,U,11386,1,,0,A,,,14380,
In vivo,,CHEMBL626179,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,,U,11387,1,,0,A,,,14380,
In vivo,,CHEMBL626180,,22224,Plasma,BAO_0000218,,1969.0,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,Autocuration,,U,11388,1,,0,A,,,14380,
In vivo,,CHEMBL626181,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma Cmax in rat (PO dose),Intermediate,10116.0,N,11389,1,,1,A,,,13622,
In vivo,,CHEMBL626182,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,Intermediate,10116.0,N,11390,1,,1,A,,,15372,
In vivo,,CHEMBL626183,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,Intermediate,10116.0,N,11391,1,,1,A,,,15372,
In vivo,,CHEMBL626184,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,Intermediate,10116.0,N,11392,1,,1,A,,,15372,
In vivo,,CHEMBL626185,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,Intermediate,10116.0,N,11393,1,,1,A,,,15372,
In vivo,,CHEMBL626186,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,Intermediate,9615.0,N,11394,1,,1,A,,,14925,
In vivo,,CHEMBL877589,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,Intermediate,9615.0,N,11395,1,,1,A,,,14925,
In vivo,,CHEMBL626187,,22224,,BAO_0000218,,,,Maximum concentration of the drug at 1 uM/dg administered intravenously,Autocuration,,U,11396,1,,0,A,,,11883,
In vivo,,CHEMBL626188,,22224,,BAO_0000218,,,,Maximum concentration of the drug at 20 uM/dg administered perorally,Autocuration,,U,11397,1,,0,A,,,11883,
In vivo,,CHEMBL626189,,22224,,BAO_0000218,,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,Autocuration,,U,11398,1,,0,A,,,13391,
In vivo,,CHEMBL626855,,22224,Blood,BAO_0000218,,178.0,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,U,11399,1,,0,A,,,13391,
In vivo,,CHEMBL623781,,22224,Blood,BAO_0000218,,178.0,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,U,11400,1,,0,A,,,13391,
In vivo,,CHEMBL623782,,22224,Blood,BAO_0000218,,178.0,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,U,11401,1,,0,A,,,13391,
In vivo,,CHEMBL623783,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,Intermediate,10116.0,N,11402,1,,1,A,,,16360,
In vivo,,CHEMBL623784,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Cmax in dog plasma after 1mg/kg oral dose,Intermediate,9615.0,N,11403,1,,1,A,,,3673,
In vivo,,CHEMBL623785,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,Intermediate,9615.0,N,11404,1,,1,A,,,14431,
In vivo,,CHEMBL623786,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,Intermediate,10116.0,N,11405,1,,1,A,,,14431,
In vivo,,CHEMBL623787,,50597,,BAO_0000218,Rattus norvegicus,,,Oral maximum concentration in rat,Intermediate,10116.0,N,11406,1,,1,A,,,14964,
In vivo,,CHEMBL623788,,50597,,BAO_0000218,Rattus norvegicus,,,Oral maximum concentration in rat,Intermediate,10116.0,N,11407,1,,1,A,,,14964,
In vivo,,CHEMBL623789,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,Intermediate,10090.0,N,11408,1,,1,A,,,14209,
In vivo,,CHEMBL623790,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Peak concentration in blood after intravenous administration to mice,Intermediate,10090.0,N,11409,1,,1,A,,,11355,
In vivo,,CHEMBL623791,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Peak concentration in blood after peroral administration to mice,Intermediate,10090.0,N,11410,1,,1,A,,,11355,
In vivo,,CHEMBL623792,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Peak concentration in rat plasma was determined,Intermediate,10116.0,N,11411,1,,1,A,,,11966,
In vivo,,CHEMBL623793,,22224,Plasma,BAO_0000218,Simiiformes,1969.0,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,Autocuration,314293.0,U,11412,1,,0,A,,,8918,
In vivo,,CHEMBL623794,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,Intermediate,10090.0,N,11413,1,,1,A,,,8918,
In vivo,,CHEMBL623795,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,Intermediate,10116.0,N,11414,1,,1,A,,,8918,
,,CHEMBL623796,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11415,1,,1,A,,,8684,
,,CHEMBL623797,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11416,1,,1,A,,,8684,
,,CHEMBL623798,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11417,1,,1,A,,,8684,
,,CHEMBL623799,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11418,1,,1,A,,,8684,
,,CHEMBL624490,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11419,1,,1,A,,,8684,
,,CHEMBL624491,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11420,1,,1,A,,,8684,
,,CHEMBL624492,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11421,1,,1,A,,,8684,
,,CHEMBL624493,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11422,1,,1,A,,,8684,
,,CHEMBL877595,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11423,1,,1,A,,,8684,
,,CHEMBL624494,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11424,1,,1,A,,,8684,
,,CHEMBL624495,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11425,1,,1,A,,,8684,
,,CHEMBL624681,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11426,1,,1,A,,,8684,
,,CHEMBL624682,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11427,1,,1,A,,,8684,
,,CHEMBL624683,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11428,1,,1,A,,,8684,
,,CHEMBL624684,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11429,1,,1,A,,,8684,
,,CHEMBL624685,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11430,1,,1,A,,,8684,
,,CHEMBL624686,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11431,1,,1,A,,,8684,
,,CHEMBL624687,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11432,1,,1,A,,,8684,
,,CHEMBL624688,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11433,1,,1,A,,,8684,
,,CHEMBL627161,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11434,1,,1,A,,,8684,
,,CHEMBL622127,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11435,1,,1,A,,,8684,
,,CHEMBL622128,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11436,1,,1,A,,,8684,
,,CHEMBL874384,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11437,1,,1,A,,,8684,
,,CHEMBL624898,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11438,1,,1,A,,,8684,
,,CHEMBL624899,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11439,1,,1,A,,,8684,
,,CHEMBL624900,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11440,1,,1,A,,,8684,
,,CHEMBL624901,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11441,1,,1,A,,,8684,
,,CHEMBL624902,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11442,1,,1,A,,,8684,
,,CHEMBL624903,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11443,1,,1,A,,,8684,
,,CHEMBL624904,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11444,1,,1,A,,,8684,
,,CHEMBL624905,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11445,1,,1,A,,,8684,
,,CHEMBL624906,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11446,1,,1,A,,,8684,
,,CHEMBL624907,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11447,1,,1,A,,,8684,
,,CHEMBL624908,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11448,1,,1,A,,,8684,
,,CHEMBL624909,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11449,1,,1,A,,,8684,
,,CHEMBL624910,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11450,1,,1,A,,,8684,
,,CHEMBL624911,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11451,1,,1,A,,,8684,
,,CHEMBL874388,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11452,1,,1,A,,,8684,
,,CHEMBL624912,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11453,1,,1,A,,,8684,
,,CHEMBL622930,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11454,1,,1,A,,,8684,
,,CHEMBL623121,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11455,1,,1,A,,,8684,
,,CHEMBL623122,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11456,1,,1,A,,,8684,
,,CHEMBL623123,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11457,1,,1,A,,,8684,
,,CHEMBL623124,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11458,1,,1,A,,,8684,
,,CHEMBL623125,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11459,1,,1,A,,,8684,
,,CHEMBL623126,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11460,1,,1,A,,,8684,
,,CHEMBL623127,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11461,1,,1,A,,,8684,
,,CHEMBL623128,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11462,1,,1,A,,,8684,
,,CHEMBL623129,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11463,1,,1,A,,,8684,
,,CHEMBL623130,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11464,1,,1,A,,,8684,
,,CHEMBL623131,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11465,1,,1,A,,,8684,
,,CHEMBL623132,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11466,1,,1,A,,,8684,
,,CHEMBL623133,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11467,1,,1,A,,,8319,
,,CHEMBL623134,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11468,1,,1,A,,,8319,
,,CHEMBL874389,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11469,1,,1,A,,,8319,
,,CHEMBL623135,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,10116.0,N,11470,1,,1,A,,,8319,
,,CHEMBL623136,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11471,1,,1,A,,,8319,
,,CHEMBL623137,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,10116.0,N,11472,1,,1,A,,,8319,
,,CHEMBL623138,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11473,1,,1,A,,,8319,
,,CHEMBL623139,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,10116.0,N,11474,1,,1,A,,,8319,
,,CHEMBL623140,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11475,1,,1,A,,,8319,
,,CHEMBL623141,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,10116.0,N,11476,1,,1,A,,,8319,
,,CHEMBL623142,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11477,1,,1,A,,,8319,
,,CHEMBL623143,,50597,,BAO_0000218,Rattus norvegicus,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11478,1,,1,A,,,8319,
,,CHEMBL623144,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,Intermediate,10090.0,N,11479,1,,1,A,,,14571,
,,CHEMBL623405,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,Intermediate,10116.0,N,11480,1,,1,A,,,14571,
,,CHEMBL624074,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11481,1,,1,A,,,8319,
,,CHEMBL624075,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,10116.0,N,11482,1,,1,A,,,8319,
,,CHEMBL624076,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11483,1,,1,A,,,8319,
,,CHEMBL624077,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,10116.0,N,11484,1,,1,A,,,8319,
,,CHEMBL624078,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11485,1,,1,A,,,8319,
,,CHEMBL624079,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,10116.0,N,11486,1,,1,A,,,8319,
,,CHEMBL624261,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11487,1,,1,A,,,8319,
,,CHEMBL624262,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,10116.0,N,11488,1,,1,A,,,8319,
,,CHEMBL624263,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11489,1,,1,A,,,8319,
,,CHEMBL624264,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11490,1,,1,A,,,8319,
,,CHEMBL624265,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11491,1,,1,A,,,8319,
,,CHEMBL624266,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,10116.0,N,11492,1,,1,A,,,8319,
,,CHEMBL624267,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11493,1,,1,A,,,8319,
,,CHEMBL624268,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,10116.0,N,11494,1,,1,A,,,8319,
,,CHEMBL875227,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11495,1,,1,A,,,8319,
,,CHEMBL624269,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,10116.0,N,11496,1,,1,A,,,8319,
,,CHEMBL624270,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11497,1,,1,A,,,8319,
,,CHEMBL624271,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,10116.0,N,11498,1,,1,A,,,8319,
,,CHEMBL624272,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11499,1,,1,A,,,8319,
,,CHEMBL624273,,50597,,BAO_0000218,Rattus norvegicus,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,10116.0,N,11500,1,,1,A,,,8319,
,,CHEMBL624274,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,Intermediate,10116.0,N,11501,1,,1,A,,,12064,
,,CHEMBL624275,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,Intermediate,10116.0,N,11502,1,,1,A,,,12064,
,,CHEMBL624276,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,Intermediate,10116.0,N,11503,1,,1,A,,,12064,
,,CHEMBL624277,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,Intermediate,10116.0,N,11504,1,,1,A,,,12038,
,,CHEMBL624278,,22224,,BAO_0000019,,,,% dose converted to 2-amino-5-chlorophenyl sulfate,Autocuration,,U,11505,1,,0,A,,,14314,
,,CHEMBL624279,,22224,,BAO_0000019,,,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),Autocuration,,U,11506,1,,0,A,,,14314,
,,CHEMBL624280,,50597,Feces,BAO_0000218,Rattus norvegicus,1988.0,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,10116.0,N,11507,1,,1,A,,,11488,
,,CHEMBL624281,,50597,Feces,BAO_0000218,Rattus norvegicus,1988.0,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,10116.0,N,11508,1,,1,A,,,11488,
,,CHEMBL622933,,50597,Feces,BAO_0000218,Rattus norvegicus,1988.0,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,10116.0,N,11509,1,,1,A,,,11488,
,,CHEMBL622934,,50597,Feces,BAO_0000218,Rattus norvegicus,1988.0,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,10116.0,N,11510,1,,1,A,,,11488,
In vivo,,CHEMBL622935,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Intermediate,10116.0,N,11511,1,,1,A,,,8829,
In vivo,,CHEMBL622936,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in Rat liver after 5 minutes of iv administration,Intermediate,10116.0,N,11512,1,,1,A,,,8829,
In vivo,,CHEMBL875228,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,Intermediate,10116.0,N,11513,1,,1,A,,,8829,
In vivo,,CHEMBL622937,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in Rat lung after 24 hours of iv administration,Intermediate,10116.0,N,11514,1,,1,A,,,8829,
In vivo,,CHEMBL622938,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,Intermediate,10116.0,N,11515,1,,1,A,,,8829,
In vivo,,CHEMBL619736,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in Rat lung after 30 minutes of iv administration,Intermediate,10116.0,N,11516,1,,1,A,,,8829,
In vivo,,CHEMBL625117,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,Intermediate,10116.0,N,11517,1,,1,A,,,8829,
In vivo,,CHEMBL625118,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in Rat lung after 5 minutes of iv administration,Intermediate,10116.0,N,11518,1,,1,A,,,8829,
In vivo,,CHEMBL625119,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,Intermediate,10116.0,N,11519,1,,1,A,,,8829,
In vivo,,CHEMBL625120,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",Intermediate,10116.0,N,11520,1,,1,A,,,14972,
In vivo,,CHEMBL625121,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",Intermediate,10116.0,N,11521,1,,1,A,,,14972,
In vivo,,CHEMBL625122,,50597,Thalamus,BAO_0000218,Rattus norvegicus,10000006.0,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",Intermediate,10116.0,N,11522,1,,1,A,,,14972,
In vivo,,CHEMBL622204,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11523,1,,1,A,,,14608,
In vivo,,CHEMBL877503,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11524,1,,1,A,,,14608,
In vivo,,CHEMBL627127,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11525,1,,1,A,,,14608,
In vivo,,CHEMBL627128,,22224,Hippocampus,BAO_0000218,,10000000.0,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,Autocuration,,U,11526,1,,0,A,,,14608,
In vivo,,CHEMBL627129,,22224,Hippocampus,BAO_0000218,,10000000.0,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,Autocuration,,U,11527,1,,0,A,,,14608,
In vivo,,CHEMBL627130,,22224,Hippocampus,BAO_0000218,,10000000.0,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,Autocuration,,U,11528,1,,0,A,,,14608,
In vivo,,CHEMBL627131,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11529,1,,1,A,,,14608,
In vivo,,CHEMBL627132,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11530,1,,1,A,,,14608,
In vivo,,CHEMBL627133,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11531,1,,1,A,,,14608,
In vivo,,CHEMBL627134,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11532,1,,1,A,,,14608,
In vivo,,CHEMBL627135,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11533,1,,1,A,,,14608,
In vivo,,CHEMBL627136,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11534,1,,1,A,,,14608,
In vivo,,CHEMBL628435,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11535,1,,1,A,,,14608,
In vivo,,CHEMBL628436,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11536,1,,1,A,,,14608,
In vivo,,CHEMBL628437,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11537,1,,1,A,,,14608,
In vivo,,CHEMBL628438,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11538,1,,1,A,,,14608,
In vivo,,CHEMBL628439,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11539,1,,1,A,,,14608,
In vivo,,CHEMBL628440,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11540,1,,1,A,,,14608,
In vivo,,CHEMBL628441,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11541,1,,1,A,,,14608,
In vivo,,CHEMBL628442,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11542,1,,1,A,,,14608,
In vivo,,CHEMBL628443,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11543,1,,1,A,,,14608,
In vivo,,CHEMBL628444,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11544,1,,1,A,,,14608,
In vivo,,CHEMBL628445,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11545,1,,1,A,,,14608,
In vivo,,CHEMBL877504,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11546,1,,1,A,,,14608,
In vivo,,CHEMBL628446,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11547,1,,1,A,,,14608,
In vivo,,CHEMBL626874,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11548,1,,1,A,,,14608,
In vivo,,CHEMBL626875,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11549,1,,1,A,,,14608,
In vivo,,CHEMBL626876,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11550,1,,1,A,,,14608,
In vivo,,CHEMBL626877,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11551,1,,1,A,,,14608,
In vivo,,CHEMBL626878,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11552,1,,1,A,,,14608,
In vivo,,CHEMBL626879,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11553,1,,1,A,,,14608,
In vivo,,CHEMBL626880,,22224,Plasma,BAO_0000218,Simiiformes,1969.0,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,Autocuration,314293.0,U,11554,1,,0,A,,,8918,
In vivo,,CHEMBL626881,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,Intermediate,10090.0,N,11555,1,,1,A,,,8918,
In vivo,,CHEMBL626882,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,Intermediate,10116.0,N,11556,1,,1,A,,,8918,
In vivo,,CHEMBL626883,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Peak plasma concentration was measured in dogs,Intermediate,9615.0,N,11557,1,,1,A,,,14470,
In vivo,,CHEMBL626884,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,10116.0,N,11558,1,,1,A,,,14393,
In vivo,,CHEMBL626885,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Intermediate,10116.0,N,11559,1,,1,A,,,14886,
In vivo,,CHEMBL626886,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Intermediate,10116.0,N,11560,1,,1,A,,,14886,
In vivo,,CHEMBL626887,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Intermediate,10116.0,N,11561,1,,1,A,,,14886,
In vivo,,CHEMBL626888,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,10116.0,N,11562,1,,1,A,,,14393,
In vivo,,CHEMBL626889,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,Intermediate,9615.0,N,11563,1,,1,A,,,13465,
In vivo,,CHEMBL626761,,22224,,BAO_0000218,Simiiformes,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,Autocuration,314293.0,U,11564,1,,0,A,,,13465,
In vivo,,CHEMBL626762,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,Intermediate,9615.0,N,11565,1,,1,A,,,13465,
In vivo,,CHEMBL626763,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,Intermediate,9615.0,N,11566,1,,1,A,,,13465,
In vivo,,CHEMBL626764,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,Intermediate,10116.0,N,11567,1,,1,A,,,13465,
In vivo,,CHEMBL626765,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,Intermediate,10116.0,N,11568,1,,1,A,,,13465,
In vivo,,CHEMBL626766,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,Intermediate,9615.0,N,11569,1,,1,A,,,13465,
In vivo,,CHEMBL626767,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,Intermediate,10116.0,N,11570,1,,1,A,,,13465,
In vivo,,CHEMBL626768,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,Intermediate,10116.0,N,11571,1,,1,A,,,13465,
In vivo,,CHEMBL626769,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,Intermediate,9615.0,N,11572,1,,1,A,,,13465,
In vivo,,CHEMBL874463,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,Intermediate,9615.0,N,11573,1,,1,A,,,13465,
In vivo,,CHEMBL626770,,22224,,BAO_0000218,Simiiformes,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,Autocuration,314293.0,U,11574,1,,0,A,,,13465,
In vivo,,CHEMBL626771,,22224,,BAO_0000218,Simiiformes,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,Autocuration,314293.0,U,11575,1,,0,A,,,13465,
In vivo,,CHEMBL626772,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,Intermediate,10116.0,N,11576,1,,1,A,,,13465,
In vivo,,CHEMBL626773,,100710,,BAO_0000218,Macaca fascicularis,,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Intermediate,9541.0,N,11577,1,,1,A,,,14731,
In vivo,,CHEMBL626774,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,Intermediate,10090.0,N,11578,1,,1,A,,,14731,
In vivo,,CHEMBL626775,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,Intermediate,9615.0,N,11579,1,,1,A,,,13376,
In vivo,,CHEMBL626776,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,Intermediate,9615.0,N,11580,1,,1,A,,,13376,
In vivo,,CHEMBL626777,,50597,,BAO_0000218,Rattus norvegicus,,,Maximum concentration (Cmax) in rat when administered orally,Intermediate,10116.0,N,11581,1,,1,A,,,14443,
In vivo,,CHEMBL626778,,22224,Plasma,BAO_0000218,Simiiformes,1969.0,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,Autocuration,314293.0,U,11582,1,,0,A,,,13465,
In vivo,,CHEMBL626779,,22224,,BAO_0000218,Rattus norvegicus,,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",Autocuration,10116.0,U,11583,1,,0,A,,,16359,
In vivo,,CHEMBL626780,,22224,,BAO_0000218,Rattus norvegicus,,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",Autocuration,10116.0,U,11584,1,,0,A,,,16359,
In vivo,,CHEMBL626781,,22224,Plasma,BAO_0000218,,1969.0,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,Autocuration,,U,11585,1,,0,A,,,15618,
In vivo,,CHEMBL632164,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic profile Cmax was evaluated in rats,Intermediate,10116.0,N,11586,1,,1,A,,,14554,
In vivo,,CHEMBL632165,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),Intermediate,9615.0,N,11587,1,,1,A,,,11537,
In vivo,,CHEMBL632166,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),Intermediate,10090.0,N,11588,1,,1,A,,,11537,
In vivo,,CHEMBL632167,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),Intermediate,9615.0,N,11589,1,,1,A,,,11537,
In vivo,,CHEMBL632168,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),Intermediate,10090.0,N,11590,1,,1,A,,,11537,
In vivo,,CHEMBL632169,,22224,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Cmax in rat plasma,Autocuration,10116.0,U,11591,1,,0,A,,,2021,
In vivo,,CHEMBL632170,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Cmax in dog plasma after 30mg/kg oral dose,Intermediate,9615.0,N,11592,1,,1,A,,,5932,
In vivo,,CHEMBL632171,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Cmax in rat plasma after 30mg/kg oral dose,Intermediate,10116.0,N,11593,1,,1,A,,,5932,
In vivo,,CHEMBL632172,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma level in rats at 30 mg/kg,Intermediate,10116.0,N,11594,1,,1,A,,,17320,
In vivo,,CHEMBL632173,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Tested for maximum plasma concentration in mice,Intermediate,10090.0,N,11595,1,,1,A,,,15831,
In vivo,,CHEMBL632174,,50597,,BAO_0000218,Rattus norvegicus,,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,11596,1,,1,A,,,15078,
In vivo,,CHEMBL632175,,50597,,BAO_0000218,Rattus norvegicus,,,The Cmax values in female wistar rats.,Intermediate,10116.0,N,11597,1,,1,A,,,14941,
In vivo,,CHEMBL632176,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,Intermediate,9615.0,N,11598,1,,1,A,,,15343,
In vivo,,CHEMBL632177,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,Intermediate,10116.0,N,11599,1,,1,A,,,15343,
In vivo,,CHEMBL632178,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,Intermediate,10116.0,N,11600,1,,1,A,,,14856,
In vivo,,CHEMBL632179,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,Intermediate,10116.0,N,11601,1,,1,A,,,13129,
In vivo,,CHEMBL632180,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,Intermediate,10116.0,N,11602,1,,1,A,,,13098,
In vivo,,CHEMBL632181,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,Intermediate,10116.0,N,11603,1,,1,A,,,13098,
In vivo,,CHEMBL632182,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,Intermediate,10116.0,N,11604,1,,1,A,,,13098,
In vivo,,CHEMBL632183,,22224,Blood,BAO_0000218,Mus musculus,178.0,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,Autocuration,10090.0,U,11605,1,,0,A,,,15478,
In vivo,,CHEMBL632184,,50588,,BAO_0000218,Canis lupus familiaris,,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,Intermediate,9615.0,N,11606,1,,1,A,,,15341,
In vivo,,CHEMBL874470,,50597,,BAO_0000218,Rattus norvegicus,,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,Intermediate,10116.0,N,11607,1,,1,A,,,15341,
,,CHEMBL631302,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11608,1,,1,A,,,8684,
,,CHEMBL631303,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11609,1,,1,A,,,8684,
,,CHEMBL631304,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11610,1,,1,A,,,8684,
,,CHEMBL631305,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11611,1,,1,A,,,8684,
,,CHEMBL631306,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11612,1,,1,A,,,8684,
,,CHEMBL631307,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11613,1,,1,A,,,8684,
,,CHEMBL631308,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11614,1,,1,A,,,8684,
,,CHEMBL625557,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11615,1,,1,A,,,8684,
,,CHEMBL625558,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11616,1,,1,A,,,8684,
,,CHEMBL625559,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11617,1,,1,A,,,8684,
,,CHEMBL625560,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11618,1,,1,A,,,8684,
,,CHEMBL625561,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11619,1,,1,A,,,8684,
,,CHEMBL625562,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11620,1,,1,A,,,8684,
,,CHEMBL875320,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11621,1,,1,A,,,8684,
,,CHEMBL625563,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11622,1,,1,A,,,8684,
,,CHEMBL625564,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11623,1,,1,A,,,8684,
,,CHEMBL625565,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11624,1,,1,A,,,8684,
,,CHEMBL625566,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11625,1,,1,A,,,8684,
,,CHEMBL625567,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11626,1,,1,A,,,8684,
,,CHEMBL625568,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11627,1,,1,A,,,8684,
,,CHEMBL628217,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11628,1,,1,A,,,8684,
,,CHEMBL628218,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11629,1,,1,A,,,8684,
,,CHEMBL628219,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11630,1,,1,A,,,8684,
,,CHEMBL628220,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",Intermediate,10116.0,N,11631,1,,1,A,,,8684,
,,CHEMBL628221,,22224,,BAO_0000019,,,,Distribution in the blood after 120 min of intravenous administration,Autocuration,,U,11632,1,,0,A,,,8926,
,,CHEMBL628222,,22224,,BAO_0000019,,,,Distribution in the blood after 15 min of intravenous administration,Autocuration,,U,11633,1,,0,A,,,8926,
,,CHEMBL628223,,22224,,BAO_0000019,,,,Distribution in the blood after 30 min of intravenous administration,Autocuration,,U,11634,1,,0,A,,,8926,
,,CHEMBL628224,,22224,,BAO_0000019,,,,Distribution in the blood after 5 min of intravenous administration,Autocuration,,U,11635,1,,0,A,,,8926,
,,CHEMBL628225,,22224,,BAO_0000019,,,,Distribution in the blood after 60 min of intravenous administration,Autocuration,,U,11636,1,,0,A,,,8926,
,,CHEMBL628226,,22224,,BAO_0000019,,,,Distribution in the blood after 90 min of intravenous administration,Autocuration,,U,11637,1,,0,A,,,8926,
,,CHEMBL628227,,22224,,BAO_0000019,,,,Distribution in the bone after 120 min of intravenous administration,Autocuration,,U,11638,1,,0,A,,,8926,
,,CHEMBL875481,,22224,,BAO_0000019,,,,Distribution in the bone after 15 min of intravenous administration,Autocuration,,U,11639,1,,0,A,,,8926,
,,CHEMBL628228,,22224,,BAO_0000019,,,,Distribution in the bone after 30 min of intravenous administration,Autocuration,,U,11640,1,,0,A,,,8926,
,,CHEMBL628229,,22224,,BAO_0000019,,,,Distribution in the bone after 5 min of intravenous administration,Autocuration,,U,11641,1,,0,A,,,8926,
,,CHEMBL628230,,22224,,BAO_0000019,,,,Distribution in the bone after 60 min of intravenous administration,Autocuration,,U,11642,1,,0,A,,,8926,
,,CHEMBL628231,,22224,,BAO_0000019,,,,Distribution in the bone after 90 min of intravenous administration,Autocuration,,U,11643,1,,0,A,,,8926,
,,CHEMBL628232,,22224,,BAO_0000019,,,,Distribution in the heart after 120 min of intravenous administration,Autocuration,,U,11644,1,,0,A,,,8926,
,,CHEMBL628233,,22224,,BAO_0000019,,,,Distribution in the heart after 15 min of intravenous administration,Autocuration,,U,11645,1,,0,A,,,8926,
,,CHEMBL628234,,22224,,BAO_0000019,,,,Distribution in the heart after 30 min of intravenous administration,Autocuration,,U,11646,1,,0,A,,,8926,
,,CHEMBL628235,,22224,,BAO_0000019,,,,Distribution in the heart after 5 min of intravenous administration,Autocuration,,U,11647,1,,0,A,,,8926,
,,CHEMBL628236,,22224,,BAO_0000019,,,,Distribution in the heart after 60 min of intravenous administration,Autocuration,,U,11648,1,,0,A,,,8926,
,,CHEMBL628237,,22224,,BAO_0000019,,,,Distribution in the heart after 90 min of intravenous administration,Autocuration,,U,11649,1,,0,A,,,8926,
,,CHEMBL628238,,22224,,BAO_0000019,,,,Distribution in the kidneys after 120 min of intravenous administration,Autocuration,,U,11650,1,,0,A,,,8926,
,,CHEMBL628239,,22224,,BAO_0000019,,,,Distribution in the kidneys after 15 min of intravenous administration,Autocuration,,U,11651,1,,0,A,,,8926,
,,CHEMBL628240,,22224,,BAO_0000019,,,,Distribution in the kidneys after 30 min of intravenous administration,Autocuration,,U,11652,1,,0,A,,,8926,
,,CHEMBL628241,,22224,,BAO_0000019,,,,Distribution in the kidneys after 5 min of intravenous administration,Autocuration,,U,11653,1,,0,A,,,8926,
,,CHEMBL628242,,22224,,BAO_0000019,,,,Distribution in the kidneys after 60 min of intravenous administration,Autocuration,,U,11654,1,,0,A,,,8926,
,,CHEMBL875482,,22224,,BAO_0000019,,,,Distribution in the kidneys after 90 min of intravenous administration,Autocuration,,U,11655,1,,0,A,,,8926,
,,CHEMBL628243,,22224,,BAO_0000019,,,,Distribution in the liver after 120 min of intravenous administration,Autocuration,,U,11656,1,,0,A,,,8926,
,,CHEMBL628244,,22224,,BAO_0000019,,,,Distribution in the liver after 15 min of intravenous administration,Autocuration,,U,11657,1,,0,A,,,8926,
,,CHEMBL628245,,22224,,BAO_0000019,,,,Distribution in the liver after 30 min of intravenous administration,Autocuration,,U,11658,1,,0,A,,,8926,
,,CHEMBL628246,,22224,,BAO_0000019,,,,Distribution in the liver after 5 min of intravenous administration,Autocuration,,U,11659,1,,0,A,,,8926,
,,CHEMBL628247,,22224,,BAO_0000019,,,,Distribution in the liver after 60 min of intravenous administration,Autocuration,,U,11660,1,,0,A,,,8926,
,,CHEMBL628248,,22224,,BAO_0000019,,,,Distribution in the liver after 90 min of intravenous administration,Autocuration,,U,11661,1,,0,A,,,8926,
,,CHEMBL628249,,22224,,BAO_0000019,,,,Distribution in the lung after 120 min of intravenous administration,Autocuration,,U,11662,1,,0,A,,,8926,
,,CHEMBL625452,,50594,,BAO_0000218,Mus musculus,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",Intermediate,10090.0,N,11663,1,,1,A,,,14839,
,,CHEMBL625453,,50594,,BAO_0000218,Mus musculus,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",Intermediate,10090.0,N,11664,1,,1,A,,,14839,
,,CHEMBL625454,,50594,,BAO_0000218,Mus musculus,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",Intermediate,10090.0,N,11665,1,,1,A,,,14839,
,,CHEMBL623844,,50594,,BAO_0000218,Mus musculus,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",Intermediate,10090.0,N,11666,1,,1,A,,,14839,
,,CHEMBL623845,,50597,,BAO_0000218,Rattus norvegicus,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,Intermediate,10116.0,N,11667,1,,1,A,,,12178,
,,CHEMBL623846,,50597,,BAO_0000218,Rattus norvegicus,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,Intermediate,10116.0,N,11668,1,,1,A,,,12178,
,,CHEMBL623847,,22224,,BAO_0000218,,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,Autocuration,,U,11669,1,,0,A,,,12178,
,,CHEMBL623848,,100710,,BAO_0000218,Macaca fascicularis,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,9541.0,N,11670,1,,1,A,,,12186,
,,CHEMBL623849,,100710,,BAO_0000218,Macaca fascicularis,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Intermediate,9541.0,N,11671,1,,1,A,,,12186,
,,CHEMBL623850,,100710,,BAO_0000218,Macaca fascicularis,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,9541.0,N,11672,1,,1,A,,,12186,
,,CHEMBL623851,,100710,,BAO_0000218,Macaca fascicularis,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Intermediate,9541.0,N,11673,1,,1,A,,,12186,
,,CHEMBL623852,,22224,,BAO_0000218,Simiiformes,,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,314293.0,U,11674,1,,0,A,,,12187,
,,CHEMBL624551,,50506,,BAO_0000218,Mustela putorius furo,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Intermediate,9669.0,N,11675,1,,1,A,,,12187,
,,CHEMBL624552,,50506,,BAO_0000218,Mustela putorius furo,,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Intermediate,9669.0,N,11676,1,,1,A,,,12187,
,,CHEMBL624553,,22224,,BAO_0000218,Simiiformes,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,314293.0,U,11677,1,,0,A,,,12187,
,,CHEMBL624554,,22224,,BAO_0000218,Simiiformes,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,Autocuration,314293.0,U,11678,1,,0,A,,,12187,
,,CHEMBL624555,,50597,,BAO_0000218,Rattus norvegicus,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Intermediate,10116.0,N,11679,1,,1,A,,,12187,
,,CHEMBL624741,,50597,,BAO_0000218,Rattus norvegicus,,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,10116.0,N,11680,1,,1,A,,,12187,
,,CHEMBL624742,,50588,,BAO_0000218,Canis lupus familiaris,,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",Intermediate,9615.0,N,11681,1,,1,A,,,14122,
,,CHEMBL624743,,100712,,BAO_0000218,Cricetinae,,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,10026.0,N,11682,1,,1,A,,,14122,
,,CHEMBL877606,,50597,,BAO_0000218,Rattus norvegicus,,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",Intermediate,10116.0,N,11683,1,,1,A,,,14122,
,,CHEMBL624744,,22224,,BAO_0000218,,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,Autocuration,,U,11684,1,,0,A,,,13391,
,,CHEMBL624745,,22224,Blood,BAO_0000218,,178.0,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,U,11685,1,,0,A,,,13391,
,,CHEMBL624746,,22224,Blood,BAO_0000218,,178.0,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,U,11686,1,,0,A,,,13391,
,,CHEMBL624747,,22224,Blood,BAO_0000218,,178.0,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,U,11687,1,,0,A,,,13391,
,,CHEMBL624748,,22224,,BAO_0000019,,,,Oral absorption expressed as Area under curve was determined,Autocuration,,U,11688,1,,0,A,,,16360,
,,CHEMBL622504,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,Intermediate,9615.0,N,11689,1,,1,A,,,3673,
,,CHEMBL622505,,50588,,BAO_0000218,Canis lupus familiaris,,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",Intermediate,9615.0,N,11690,1,,1,A,,,14122,
,,CHEMBL622506,,100712,,BAO_0000218,Cricetinae,,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,10026.0,N,11691,1,,1,A,,,14122,
,,CHEMBL622507,,100712,,BAO_0000218,Cricetinae,,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,10026.0,N,11692,1,,1,A,,,14122,
,,CHEMBL622508,,50597,,BAO_0000218,Rattus norvegicus,,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",Intermediate,10116.0,N,11693,1,,1,A,,,14122,
,,CHEMBL622509,,22224,,BAO_0000019,,,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,Autocuration,,U,11694,1,,0,A,,,13889,
,,CHEMBL622510,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,10116.0,N,11695,1,,1,A,,,14393,
,,CHEMBL622511,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),Intermediate,10116.0,N,11696,1,,1,A,,,17279,
,,CHEMBL622512,,100710,,BAO_0000218,Macaca fascicularis,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Intermediate,9541.0,N,11697,1,,1,A,,,14548,
,,CHEMBL622513,,100710,,BAO_0000218,Macaca fascicularis,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Intermediate,9541.0,N,11698,1,,1,A,,,14548,
,,CHEMBL622514,,100710,,BAO_0000218,Macaca fascicularis,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,Intermediate,9541.0,N,11699,1,,1,A,,,14548,
,,CHEMBL622515,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Intermediate,9615.0,N,11700,1,,1,A,,,14548,
,,CHEMBL622516,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,Intermediate,9615.0,N,11701,1,,1,A,,,14548,
,,CHEMBL622517,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Intermediate,10116.0,N,11702,1,,1,A,,,14548,
,,CHEMBL622518,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,Intermediate,10116.0,N,11703,1,,1,A,,,14548,
,,CHEMBL622519,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,Intermediate,10116.0,N,11704,1,,1,A,,,14548,
In vivo,,CHEMBL622520,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11705,1,,1,A,,,14608,
In vivo,,CHEMBL622521,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11706,1,,1,A,,,14608,
In vivo,,CHEMBL625113,,50594,Zone of skin,BAO_0000218,Mus musculus,14.0,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10090.0,N,11707,1,,1,A,,,14608,
In vivo,,CHEMBL625114,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11708,1,,1,A,,,14608,
In vivo,,CHEMBL874397,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11709,1,,1,A,,,14608,
In vivo,,CHEMBL625115,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11710,1,,1,A,,,14608,
In vivo,,CHEMBL625116,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11711,1,,1,A,,,14608,
In vivo,,CHEMBL623932,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11712,1,,1,A,,,14608,
In vivo,,CHEMBL623933,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11713,1,,1,A,,,14608,
In vivo,,CHEMBL623934,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11714,1,,1,A,,,14608,
In vivo,,CHEMBL623935,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11715,1,,1,A,,,14608,
In vivo,,CHEMBL623936,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,10116.0,N,11716,1,,1,A,,,14608,
In vivo,,CHEMBL623937,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,10116.0,N,11717,1,,1,A,,,14608,
In vivo,,CHEMBL623938,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,10116.0,N,11718,1,,1,A,,,14608,
,,CHEMBL623939,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,10090.0,N,11719,1,,1,A,,,15383,
,,CHEMBL623940,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,10090.0,N,11720,1,,1,A,,,15383,
,,CHEMBL623941,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,10090.0,N,11721,1,,1,A,,,15383,
,,CHEMBL627216,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,10090.0,N,11722,1,,1,A,,,15383,
,,CHEMBL623942,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,10090.0,N,11723,1,,1,A,,,15383,
,,CHEMBL618793,,50594,Brain,BAO_0000218,Mus musculus,955.0,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,10090.0,N,11724,1,,1,A,,,15383,
,,CHEMBL618794,,50594,Brain,BAO_0000218,Mus musculus,955.0,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,10090.0,N,11725,1,,1,A,,,15383,
,,CHEMBL618795,,50594,Brain,BAO_0000218,Mus musculus,955.0,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,10090.0,N,11726,1,,1,A,,,15383,
,,CHEMBL618796,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,10090.0,N,11727,1,,1,A,,,15383,
,,CHEMBL618797,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,10090.0,N,11728,1,,1,A,,,15383,
,,CHEMBL618798,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Intermediate,10090.0,N,11729,1,,1,A,,,15383,
,,CHEMBL618799,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,10090.0,N,11730,1,,1,A,,,15383,
,,CHEMBL618800,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,10090.0,N,11731,1,,1,A,,,15383,
,,CHEMBL618801,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,10090.0,N,11732,1,,1,A,,,15383,
,,CHEMBL618802,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,10090.0,N,11733,1,,1,A,,,15383,
,,CHEMBL618803,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,10090.0,N,11734,1,,1,A,,,15383,
,,CHEMBL618804,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Intermediate,10090.0,N,11735,1,,1,A,,,15383,
,,CHEMBL618805,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,10090.0,N,11736,1,,1,A,,,15383,
,,CHEMBL618806,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,10090.0,N,11737,1,,1,A,,,15383,
,,CHEMBL618807,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,10090.0,N,11738,1,,1,A,,,15383,
,,CHEMBL618808,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,10090.0,N,11739,1,,1,A,,,15383,
,,CHEMBL618809,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,10090.0,N,11740,1,,1,A,,,15383,
,,CHEMBL618810,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,10090.0,N,11741,1,,1,A,,,15383,
,,CHEMBL618811,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,10090.0,N,11742,1,,1,A,,,15383,
,,CHEMBL875844,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,10090.0,N,11743,1,,1,A,,,15383,
,,CHEMBL618812,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,10090.0,N,11744,1,,1,A,,,15383,
,,CHEMBL618813,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,10090.0,N,11745,1,,1,A,,,15383,
,,CHEMBL618814,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,10090.0,N,11746,1,,1,A,,,15383,
,,CHEMBL618815,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,10090.0,N,11747,1,,1,A,,,15383,
,,CHEMBL618816,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,10090.0,N,11748,1,,1,A,,,15383,
,,CHEMBL618817,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,10090.0,N,11749,1,,1,A,,,15383,
,,CHEMBL620544,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,10090.0,N,11750,1,,1,A,,,15383,
In vivo,,CHEMBL626230,,50597,,BAO_0000218,Rattus norvegicus,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,Intermediate,10116.0,N,11751,1,,1,A,,,15341,
In vivo,,CHEMBL626231,,50597,,BAO_0000218,Rattus norvegicus,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,Intermediate,10116.0,N,11752,1,,1,A,,,15341,
In vivo,,CHEMBL626232,,50597,,BAO_0000218,Rattus norvegicus,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,Intermediate,10116.0,N,11753,1,,1,A,,,15341,
In vivo,,CHEMBL626233,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,Intermediate,9615.0,N,11754,1,,1,A,,,14906,
In vivo,,CHEMBL626234,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,Intermediate,10116.0,N,11755,1,,1,A,,,14906,
In vivo,,CHEMBL875341,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,Intermediate,10116.0,N,11756,1,,1,A,,,14906,
In vivo,,CHEMBL626235,,50587,Plasma,BAO_0000218,Homo sapiens,1969.0,,The maximum plasma concentration (100 mg/kg) administered orally in human,Intermediate,9606.0,N,11757,1,,1,A,,,14215,
In vivo,,CHEMBL626236,,22224,Plasma,BAO_0000218,Callithrix,1969.0,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,Autocuration,9481.0,U,11758,1,,0,A,,,14215,
In vivo,,CHEMBL626237,,22224,Plasma,BAO_0000218,Simiiformes,1969.0,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,Autocuration,314293.0,U,11759,1,,0,A,,,14215,
In vivo,,CHEMBL626238,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,Intermediate,9615.0,N,11760,1,,1,A,,,14215,
In vivo,,CHEMBL622412,,50587,Plasma,BAO_0000218,Homo sapiens,1969.0,,The maximum plasma concentration (200 mg/kg) administered orally in human,Intermediate,9606.0,N,11761,1,,1,A,,,14215,
In vivo,,CHEMBL623114,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,Intermediate,10116.0,N,11762,1,,1,A,,,14215,
In vivo,,CHEMBL623115,,22224,Plasma,BAO_0000218,Callithrix,1969.0,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,Autocuration,9481.0,U,11763,1,,0,A,,,14215,
In vivo,,CHEMBL623116,,22224,Plasma,BAO_0000218,Simiiformes,1969.0,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,Autocuration,314293.0,U,11764,1,,0,A,,,14215,
In vivo,,CHEMBL623117,,22224,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,The maximum plasma concentration (30 mg/kg) administered orally in dog,Autocuration,9615.0,U,11765,1,,0,A,,,14215,
In vivo,,CHEMBL623118,,50587,Plasma,BAO_0000218,Homo sapiens,1969.0,,The maximum plasma concentration (400 mg/kg) administered orally in human,Intermediate,9606.0,N,11766,1,,1,A,,,14215,
In vivo,,CHEMBL623119,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,Intermediate,10116.0,N,11767,1,,1,A,,,14215,
In vivo,,CHEMBL623120,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The maximum plasma concentration (50 mg/kg) administered orally in rat,Intermediate,10116.0,N,11768,1,,1,A,,,14215,
In vivo,,CHEMBL623286,,50587,Plasma,BAO_0000218,Homo sapiens,1969.0,,The maximum plasma concentration (800 mg/kg) administered orally in human,Intermediate,9606.0,N,11769,1,,1,A,,,14215,
In vivo,,CHEMBL623287,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The maximum plasma concentration was measured on rats,Intermediate,10116.0,N,11770,1,,1,A,,,14067,
In vivo,,CHEMBL623288,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The maximum plasma concentration was measured on rats after oral administration,Intermediate,10116.0,N,11771,1,,1,A,,,12350,
In vivo,,CHEMBL623289,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma drug Cmax in rat (PO dose),Intermediate,10116.0,N,11772,1,,1,A,,,14813,
In vivo,,CHEMBL623290,,22224,,BAO_0000218,,,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,Autocuration,,U,11773,1,,0,A,,,12536,
In vivo,,CHEMBL623291,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,maximum Plasma concentration in Dog was determined after Peroral administration,Intermediate,9615.0,N,11774,1,,1,A,,,14169,
In vivo,,CHEMBL623292,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,maximum Plasma concentration in Rats was determined after Peroral administration,Intermediate,10116.0,N,11775,1,,1,A,,,14169,
In vivo,,CHEMBL623293,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Intermediate,9615.0,N,11776,1,,1,A,,,15604,
In vivo,,CHEMBL623294,,22224,Plasma,BAO_0000218,Simiiformes,1969.0,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Autocuration,314293.0,U,11777,1,,0,A,,,15604,
In vivo,,CHEMBL623295,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Intermediate,10116.0,N,11778,1,,1,A,,,15604,
In vivo,,CHEMBL623296,,50594,,BAO_0000218,Mus musculus,,,maximum concentration was measured when administered through oral route in mice,Intermediate,10090.0,N,11779,1,,1,A,,,14387,
,,CHEMBL875349,,50594,,BAO_0000218,Mus musculus,,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,Intermediate,10090.0,N,11780,1,,1,A,,,15115,
,,CHEMBL623297,,22224,,BAO_0000019,Simiiformes,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,Autocuration,314293.0,U,11781,1,,0,A,,,15115,
,,CHEMBL623298,,22224,,BAO_0000019,Simiiformes,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,Autocuration,314293.0,U,11782,1,,0,A,,,15115,
,,CHEMBL623299,,22224,,BAO_0000019,Simiiformes,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,Autocuration,314293.0,U,11783,1,,0,A,,,15115,
,,CHEMBL623300,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter was evaluated in rats,Intermediate,10116.0,N,11784,1,,1,A,,,16359,
,,CHEMBL623301,,50594,,BAO_0000218,Mus musculus,,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Intermediate,10090.0,N,11785,1,,1,A,,,12829,
,,CHEMBL623302,,50594,,BAO_0000218,Mus musculus,,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,Intermediate,10090.0,N,11786,1,,1,A,,,12829,
,,CHEMBL623303,,50594,,BAO_0000218,Mus musculus,,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Intermediate,10090.0,N,11787,1,,1,A,,,12829,
,,CHEMBL623304,,50594,,BAO_0000218,Mus musculus,,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,Intermediate,10090.0,N,11788,1,,1,A,,,12829,
,,CHEMBL623305,,50594,,BAO_0000218,Mus musculus,,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,Intermediate,10090.0,N,11789,1,,1,A,,,12829,
,,CHEMBL623306,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,Intermediate,10116.0,N,11790,1,,1,A,,,15137,
,,CHEMBL623307,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,Intermediate,10116.0,N,11791,1,,1,A,,,15137,
,,CHEMBL623308,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,Intermediate,10116.0,N,11792,1,,1,A,,,15137,
,,CHEMBL623309,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,Intermediate,10090.0,N,11793,1,,1,A,,,15137,
,,CHEMBL623310,,50594,,BAO_0000218,Mus musculus,,,Plasma Concentration after 120 min of oral administration to mice,Intermediate,10090.0,N,11794,1,,1,A,,,13509,
,,CHEMBL623311,,50594,,BAO_0000218,Mus musculus,,,Plasma Concentration after 30 min of oral administration to mice,Intermediate,10090.0,N,11795,1,,1,A,,,13509,
,,CHEMBL623312,,100710,,BAO_0000218,Macaca fascicularis,,,Plasma Concentration after 60 min of oral administration to mice,Intermediate,9541.0,N,11796,1,,1,A,,,13509,
,,CHEMBL875350,,50594,,BAO_0000218,Mus musculus,,,Plasma Concentration after 60 min of oral administration to mice; Not determined,Intermediate,10090.0,N,11797,1,,1,A,,,13509,
,,CHEMBL628635,,50594,,BAO_0000218,Mus musculus,,,Plasma Concentration after 90 min of oral administration to mice,Intermediate,10090.0,N,11798,1,,1,A,,,13509,
,,CHEMBL628636,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,Intermediate,10116.0,N,11799,1,,1,A,,,12064,
,,CHEMBL628637,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,Intermediate,10116.0,N,11800,1,,1,A,,,12064,
,,CHEMBL628058,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,Intermediate,10116.0,N,11801,1,,1,A,,,12064,
,,CHEMBL628059,,50597,,BAO_0000218,Rattus norvegicus,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,Intermediate,10116.0,N,11802,1,,1,A,,,10677,
,,CHEMBL628060,,50597,,BAO_0000218,Rattus norvegicus,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,Intermediate,10116.0,N,11803,1,,1,A,,,10677,
,,CHEMBL628061,,22224,,BAO_0000019,,,,Distribution in the lung after 15 min of intravenous administration,Autocuration,,U,11804,1,,0,A,,,8926,
,,CHEMBL628062,,22224,,BAO_0000019,,,,Distribution in the lung after 30 min of intravenous administration,Autocuration,,U,11805,1,,0,A,,,8926,
,,CHEMBL628063,,22224,,BAO_0000019,,,,Distribution in the lung after 5 min of intravenous administration,Autocuration,,U,11806,1,,0,A,,,8926,
,,CHEMBL628064,,22224,,BAO_0000019,,,,Distribution in the lung after 60 min of intravenous administration,Autocuration,,U,11807,1,,0,A,,,8926,
,,CHEMBL628065,,22224,,BAO_0000019,,,,Distribution in the lung after 90 min of intravenous administration,Autocuration,,U,11808,1,,0,A,,,8926,
,,CHEMBL628066,,22224,Muscle tissue,BAO_0000019,,2385.0,,Distribution in the muscle after 120 min of intravenous administration,Autocuration,,U,11809,1,,0,A,,,8926,
,,CHEMBL628067,,22224,Muscle tissue,BAO_0000019,,2385.0,,Distribution in the muscle after 15 min of intravenous administration,Autocuration,,U,11810,1,,0,A,,,8926,
,,CHEMBL874646,,50594,Muscle tissue,BAO_0000218,Mus musculus,2385.0,,Distribution in the muscle after 30 min of intravenous administration,Intermediate,10090.0,N,11811,1,,1,A,,,8926,
,,CHEMBL628068,,22224,Muscle tissue,BAO_0000019,,2385.0,,Distribution in the muscle after 5 min of intravenous administration,Autocuration,,U,11812,1,,0,A,,,8926,
,,CHEMBL628069,,22224,Muscle tissue,BAO_0000019,,2385.0,,Distribution in the muscle after 60 min of intravenous administration,Autocuration,,U,11813,1,,0,A,,,8926,
,,CHEMBL628070,,22224,Muscle tissue,BAO_0000019,,2385.0,,Distribution in the muscle after 90 min of intravenous administration,Autocuration,,U,11814,1,,0,A,,,8926,
,,CHEMBL628071,,22224,Spleen,BAO_0000019,,2106.0,,Distribution in the spleen after 120 min of intravenous administration,Autocuration,,U,11815,1,,0,A,,,8926,
,,CHEMBL628072,,22224,Spleen,BAO_0000019,,2106.0,,Distribution in the spleen after 15 min of intravenous administration,Autocuration,,U,11816,1,,0,A,,,8926,
,,CHEMBL628073,,22224,Spleen,BAO_0000019,,2106.0,,Distribution in the spleen after 30 min of intravenous administration,Autocuration,,U,11817,1,,0,A,,,8926,
,,CHEMBL628074,,22224,Spleen,BAO_0000019,,2106.0,,Distribution in the spleen after 5 min of intravenous administration,Autocuration,,U,11818,1,,0,A,,,8926,
,,CHEMBL628075,,22224,Spleen,BAO_0000019,,2106.0,,Distribution in the spleen after 60 min of intravenous administration,Autocuration,,U,11819,1,,0,A,,,8926,
,,CHEMBL628076,,22224,Spleen,BAO_0000019,,2106.0,,Distribution in the spleen after 90 min of intravenous administration,Autocuration,,U,11820,1,,0,A,,,8926,
,,CHEMBL628077,,50597,Adrenal cortex,BAO_0000218,Rattus norvegicus,1235.0,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,Intermediate,10116.0,N,11821,1,,1,A,,,7570,
,,CHEMBL628078,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,Intermediate,10116.0,N,11822,1,,1,A,,,7570,
,,CHEMBL628079,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,Intermediate,10116.0,N,11823,1,,1,A,,,7570,
,,CHEMBL628080,,50597,Female gonad,BAO_0000218,Rattus norvegicus,992.0,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,Intermediate,10116.0,N,11824,1,,1,A,,,7570,
,,CHEMBL628081,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,Intermediate,10116.0,N,11825,1,,1,A,,,7570,
,,CHEMBL628082,,50597,Adrenal cortex,BAO_0000218,Rattus norvegicus,1235.0,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,Intermediate,10116.0,N,11826,1,,1,A,,,7570,
,,CHEMBL874647,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,Intermediate,10116.0,N,11827,1,,1,A,,,7570,
,,CHEMBL626406,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,Intermediate,10116.0,N,11828,1,,1,A,,,7570,
,,CHEMBL626407,,50597,Female gonad,BAO_0000218,Rattus norvegicus,992.0,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,Intermediate,10116.0,N,11829,1,,1,A,,,7570,
,,CHEMBL626408,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,Intermediate,10116.0,N,11830,1,,1,A,,,7570,
,,CHEMBL626409,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",Intermediate,10116.0,N,11831,1,,1,A,,,8608,
,,CHEMBL626410,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",Intermediate,10116.0,N,11832,1,,1,A,,,8608,
,,CHEMBL626411,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",Intermediate,10116.0,N,11833,1,,1,A,,,8608,
,,CHEMBL626412,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",Intermediate,10116.0,N,11834,1,,1,A,,,8608,
,,CHEMBL626413,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",Intermediate,10116.0,N,11835,1,,1,A,,,8608,
,,CHEMBL626414,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",Intermediate,10116.0,N,11836,1,,1,A,,,8608,
,,CHEMBL626415,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",Intermediate,10116.0,N,11837,1,,1,A,,,8608,
,,CHEMBL626416,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",Intermediate,10116.0,N,11838,1,,1,A,,,8608,
,,CHEMBL627062,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",Intermediate,10116.0,N,11839,1,,1,A,,,8608,
,,CHEMBL627063,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",Intermediate,10116.0,N,11840,1,,1,A,,,8608,
,,CHEMBL627064,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",Intermediate,10116.0,N,11841,1,,1,A,,,8608,
,,CHEMBL627227,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",Intermediate,10116.0,N,11842,1,,1,A,,,8608,
,,CHEMBL627228,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",Intermediate,10116.0,N,11843,1,,1,A,,,8608,
,,CHEMBL627229,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",Intermediate,10116.0,N,11844,1,,1,A,,,8608,
,,CHEMBL625792,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",Intermediate,10116.0,N,11845,1,,1,A,,,8608,
,,CHEMBL625793,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",Intermediate,10116.0,N,11846,1,,1,A,,,8608,
,,CHEMBL625794,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",Intermediate,10116.0,N,11847,1,,1,A,,,8608,
,,CHEMBL625795,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",Intermediate,10116.0,N,11848,1,,1,A,,,8608,
,,CHEMBL625796,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,Intermediate,10090.0,N,11849,1,,1,A,,,13792,
,,CHEMBL625797,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,Intermediate,9615.0,N,11850,1,,1,A,,,13376,
,,CHEMBL625798,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,Intermediate,9615.0,N,11851,1,,1,A,,,13376,
,,CHEMBL875613,,22224,,BAO_0000218,,,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,,U,11852,1,,0,A,,,14380,
,,CHEMBL625799,,22224,,BAO_0000218,,,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,,U,11853,1,,0,A,,,14380,
,,CHEMBL625800,,22224,,BAO_0000218,,,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,Autocuration,,U,11854,1,,0,A,,,14380,
,,CHEMBL625801,,22224,,BAO_0000218,,,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Autocuration,,U,11855,1,,0,A,,,14380,
,,CHEMBL625802,,22224,,BAO_0000218,,,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Autocuration,,U,11856,1,,0,A,,,14380,
,,CHEMBL625803,,22224,,BAO_0000218,,,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,,U,11857,1,,0,A,,,14380,
,,CHEMBL625804,,22224,,BAO_0000019,,,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,Autocuration,,U,11858,1,,0,A,,,14380,
,,CHEMBL622530,,22224,,BAO_0000218,,,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,Autocuration,,U,11859,1,,0,A,,,14380,
,,CHEMBL622531,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,Intermediate,10090.0,N,11860,1,,1,A,,,13701,
,,CHEMBL622532,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,10090.0,N,11861,1,,1,A,,,13701,
,,CHEMBL623176,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,10090.0,N,11862,1,,1,A,,,13701,
,,CHEMBL623177,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Intermediate,10090.0,N,11863,1,,1,A,,,13701,
,,CHEMBL623178,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,10090.0,N,11864,1,,1,A,,,13701,
,,CHEMBL623179,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,Intermediate,10090.0,N,11865,1,,1,A,,,13701,
,,CHEMBL623180,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Intermediate,10090.0,N,11866,1,,1,A,,,13701,
,,CHEMBL623181,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,10090.0,N,11867,1,,1,A,,,13701,
,,CHEMBL624131,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,10090.0,N,11868,1,,1,A,,,13701,
,,CHEMBL624132,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),Intermediate,10090.0,N,11869,1,,1,A,,,13701,
,,CHEMBL624133,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Intermediate,10090.0,N,11870,1,,1,A,,,13701,
,,CHEMBL624846,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,Intermediate,10090.0,N,11871,1,,1,A,,,13701,
,,CHEMBL624847,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Intermediate,10090.0,N,11872,1,,1,A,,,13701,
,,CHEMBL624848,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,10090.0,N,11873,1,,1,A,,,13701,
,,CHEMBL625012,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,10090.0,N,11874,1,,1,A,,,13701,
,,CHEMBL625013,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,10090.0,N,11875,1,,1,A,,,13701,
,,CHEMBL625014,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,Intermediate,10090.0,N,11876,1,,1,A,,,13701,
,,CHEMBL625015,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),Intermediate,10090.0,N,11877,1,,1,A,,,13701,
,,CHEMBL625016,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Intermediate,10090.0,N,11878,1,,1,A,,,13701,
,,CHEMBL625017,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,Intermediate,10090.0,N,11879,1,,1,A,,,13701,
,,CHEMBL625018,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,10090.0,N,11880,1,,1,A,,,13701,
,,CHEMBL625019,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),Intermediate,10090.0,N,11881,1,,1,A,,,13701,
,,CHEMBL625020,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),Intermediate,10090.0,N,11882,1,,1,A,,,13701,
,,CHEMBL625021,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,Intermediate,10090.0,N,11883,1,,1,A,,,13701,
,,CHEMBL625022,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,10116.0,N,11884,1,,1,A,,,14393,
,,CHEMBL625023,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,Intermediate,10090.0,N,11885,1,,1,A,,,14731,
,,CHEMBL625024,,100710,,BAO_0000218,Macaca fascicularis,,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,Intermediate,9541.0,N,11886,1,,1,A,,,14731,
,,CHEMBL627626,,100710,,BAO_0000218,Macaca fascicularis,,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Intermediate,9541.0,N,11887,1,,1,A,,,14731,
,,CHEMBL627627,,22224,Brain,BAO_0000218,,955.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Autocuration,,U,11888,1,,0,A,,,13758,
,,CHEMBL627628,,22224,Serum,BAO_0000218,,1977.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,Autocuration,,U,11889,1,,0,A,,,13758,
,,CHEMBL627629,,22224,Brain,BAO_0000218,,955.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Autocuration,,U,11890,1,,0,A,,,13758,
,,CHEMBL627630,,22224,Serum,BAO_0000218,,1977.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,Autocuration,,U,11891,1,,0,A,,,13758,
,,CHEMBL627631,,22224,,BAO_0000019,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),Autocuration,,U,11892,1,,0,A,,,16359,
,,CHEMBL629515,,22224,,BAO_0000218,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),Autocuration,,U,11893,1,,0,A,,,16359,
,,CHEMBL629516,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,10090.0,N,11894,1,,1,A,,,15383,
,,CHEMBL629517,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,10090.0,N,11895,1,,1,A,,,15383,
,,CHEMBL629518,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,10090.0,N,11896,1,,1,A,,,15383,
,,CHEMBL877499,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,10090.0,N,11897,1,,1,A,,,15383,
,,CHEMBL629519,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,10090.0,N,11898,1,,1,A,,,15383,
,,CHEMBL629520,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,10090.0,N,11899,1,,1,A,,,15383,
,,CHEMBL629521,,50594,,BAO_0000218,Mus musculus,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,10090.0,N,11900,1,,1,A,,,15383,
,,CHEMBL629522,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),Intermediate,10090.0,N,11901,1,,1,A,,,14439,
,,CHEMBL629523,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),Intermediate,10090.0,N,11902,1,,1,A,,,14439,
,,CHEMBL629524,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),Intermediate,10090.0,N,11903,1,,1,A,,,14439,
,,CHEMBL629525,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),Intermediate,10090.0,N,11904,1,,1,A,,,14439,
,,CHEMBL629526,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),Intermediate,10090.0,N,11905,1,,1,A,,,14439,
,,CHEMBL629527,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),Intermediate,10090.0,N,11906,1,,1,A,,,14439,
,,CHEMBL629528,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),Intermediate,10090.0,N,11907,1,,1,A,,,14439,
,,CHEMBL629529,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),Intermediate,10090.0,N,11908,1,,1,A,,,14439,
,,CHEMBL629530,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),Intermediate,10090.0,N,11909,1,,1,A,,,14439,
,,CHEMBL629531,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),Intermediate,10090.0,N,11910,1,,1,A,,,14439,
,,CHEMBL628656,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),Intermediate,10090.0,N,11911,1,,1,A,,,14439,
,,CHEMBL628657,,50594,,BAO_0000218,Mus musculus,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),Intermediate,10090.0,N,11912,1,,1,A,,,14439,
In vivo,,CHEMBL628658,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,11913,1,,1,A,,,13751,
In vivo,,CHEMBL628659,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,10116.0,N,11914,1,,1,A,,,13751,
In vivo,,CHEMBL877500,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,10116.0,N,11915,1,,1,A,,,13751,
In vivo,,CHEMBL628660,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,10116.0,N,11916,1,,1,A,,,13751,
In vivo,,CHEMBL628661,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,10116.0,N,11917,1,,1,A,,,13751,
In vivo,,CHEMBL628662,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,11918,1,,1,A,,,13751,
In vivo,,CHEMBL628663,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,10116.0,N,11919,1,,1,A,,,13751,
In vivo,,CHEMBL628664,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,10116.0,N,11920,1,,1,A,,,13751,
In vivo,,CHEMBL628665,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,10116.0,N,11921,1,,1,A,,,13751,
In vivo,,CHEMBL628666,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,10116.0,N,11922,1,,1,A,,,13751,
In vivo,,CHEMBL628667,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,10116.0,N,11923,1,,1,A,,,13751,
In vivo,,CHEMBL628668,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,10116.0,N,11924,1,,1,A,,,13751,
In vivo,,CHEMBL628669,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,11925,1,,1,A,,,13751,
In vivo,,CHEMBL628670,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,10116.0,N,11926,1,,1,A,,,13751,
In vivo,,CHEMBL628671,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,10116.0,N,11927,1,,1,A,,,13751,
In vivo,,CHEMBL628672,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,10116.0,N,11928,1,,1,A,,,13751,
In vivo,,CHEMBL630300,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,10116.0,N,11929,1,,1,A,,,13751,
In vivo,,CHEMBL629787,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,10116.0,N,11930,1,,1,A,,,13751,
In vivo,,CHEMBL629788,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,11931,1,,1,A,,,13751,
In vivo,,CHEMBL629789,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,10116.0,N,11932,1,,1,A,,,13751,
In vivo,,CHEMBL629790,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,10116.0,N,11933,1,,1,A,,,13751,
In vivo,,CHEMBL629791,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,10116.0,N,11934,1,,1,A,,,13751,
In vivo,,CHEMBL629792,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,10116.0,N,11935,1,,1,A,,,13751,
In vivo,,CHEMBL629793,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,11936,1,,1,A,,,13751,
In vivo,,CHEMBL629794,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,10116.0,N,11937,1,,1,A,,,13751,
,,CHEMBL874459,,50597,,BAO_0000218,Rattus norvegicus,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,Intermediate,10116.0,N,11938,1,,1,A,,,10677,
,,CHEMBL629795,,50597,,BAO_0000218,Rattus norvegicus,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,Intermediate,10116.0,N,11939,1,,1,A,,,10677,
,,CHEMBL629796,,50597,,BAO_0000218,Rattus norvegicus,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,Intermediate,10116.0,N,11940,1,,1,A,,,10677,
,,CHEMBL629797,,50597,,BAO_0000218,Rattus norvegicus,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,Intermediate,10116.0,N,11941,1,,1,A,,,10677,
,,CHEMBL629798,,50597,,BAO_0000218,Rattus norvegicus,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,Intermediate,10116.0,N,11942,1,,1,A,,,10677,
In vivo,,CHEMBL629799,,50597,Adrenal gland,BAO_0000218,Rattus norvegicus,2369.0,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11943,1,,1,A,,,10911,
In vivo,,CHEMBL629800,,50597,Adrenal gland,BAO_0000218,Rattus norvegicus,2369.0,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11944,1,,1,A,,,10911,
In vivo,,CHEMBL629801,,50597,Adrenal gland,BAO_0000218,Rattus norvegicus,2369.0,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11945,1,,1,A,,,10911,
In vivo,,CHEMBL629802,,50597,Adrenal gland,BAO_0000218,Rattus norvegicus,2369.0,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,Intermediate,10116.0,N,11946,1,,1,A,,,10911,
In vivo,,CHEMBL629803,,50597,Adrenal gland,BAO_0000218,Rattus norvegicus,2369.0,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11947,1,,1,A,,,10911,
In vivo,,CHEMBL629804,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11948,1,,1,A,,,10911,
In vivo,,CHEMBL629805,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11949,1,,1,A,,,10911,
In vivo,,CHEMBL629806,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11950,1,,1,A,,,10911,
In vivo,,CHEMBL629807,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11951,1,,1,A,,,10911,
In vivo,,CHEMBL629808,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11952,1,,1,A,,,10911,
In vivo,,CHEMBL629809,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11953,1,,1,A,,,10911,
In vivo,,CHEMBL629810,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11954,1,,1,A,,,10911,
In vivo,,CHEMBL629811,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11955,1,,1,A,,,10911,
In vivo,,CHEMBL629812,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11956,1,,1,A,,,10911,
In vivo,,CHEMBL629813,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11957,1,,1,A,,,10911,
In vivo,,CHEMBL874460,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11958,1,,1,A,,,10911,
In vivo,,CHEMBL629814,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11959,1,,1,A,,,10911,
In vivo,,CHEMBL629815,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11960,1,,1,A,,,10911,
In vivo,,CHEMBL629816,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11961,1,,1,A,,,10911,
In vivo,,CHEMBL629817,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11962,1,,1,A,,,10911,
In vivo,,CHEMBL626643,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11963,1,,1,A,,,10911,
In vivo,,CHEMBL626644,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11964,1,,1,A,,,10911,
In vivo,,CHEMBL626806,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11965,1,,1,A,,,10911,
In vivo,,CHEMBL626807,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11966,1,,1,A,,,10911,
In vivo,,CHEMBL627261,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11967,1,,1,A,,,10911,
In vivo,,CHEMBL627262,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11968,1,,1,A,,,10911,
In vivo,,CHEMBL627263,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11969,1,,1,A,,,10911,
In vivo,,CHEMBL627264,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11970,1,,1,A,,,10911,
In vivo,,CHEMBL627265,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11971,1,,1,A,,,10911,
In vivo,,CHEMBL627266,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11972,1,,1,A,,,10911,
In vivo,,CHEMBL627267,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11973,1,,1,A,,,10911,
In vivo,,CHEMBL627268,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11974,1,,1,A,,,10911,
In vivo,,CHEMBL627269,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11975,1,,1,A,,,10911,
In vivo,,CHEMBL627270,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,11976,1,,1,A,,,10911,
,,CHEMBL627271,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",Intermediate,10116.0,N,11977,1,,1,A,,,8608,
,,CHEMBL627946,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",Intermediate,10116.0,N,11978,1,,1,A,,,8608,
,,CHEMBL875472,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",Intermediate,10116.0,N,11979,1,,1,A,,,8608,
,,CHEMBL627947,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",Intermediate,10116.0,N,11980,1,,1,A,,,8608,
,,CHEMBL627948,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",Intermediate,10116.0,N,11981,1,,1,A,,,8608,
,,CHEMBL628113,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",Intermediate,10116.0,N,11982,1,,1,A,,,8608,
,,CHEMBL628114,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",Intermediate,10116.0,N,11983,1,,1,A,,,8608,
,,CHEMBL628115,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",Intermediate,10116.0,N,11984,1,,1,A,,,8608,
,,CHEMBL628116,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",Intermediate,10116.0,N,11985,1,,1,A,,,8608,
,,CHEMBL628117,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",Intermediate,10116.0,N,11986,1,,1,A,,,8608,
,,CHEMBL628118,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",Intermediate,10116.0,N,11987,1,,1,A,,,8608,
,,CHEMBL628119,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",Intermediate,10116.0,N,11988,1,,1,A,,,8608,
,,CHEMBL628120,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",Intermediate,10116.0,N,11989,1,,1,A,,,8608,
,,CHEMBL628121,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",Intermediate,10116.0,N,11990,1,,1,A,,,8608,
,,CHEMBL628122,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",Intermediate,10116.0,N,11991,1,,1,A,,,8608,
,,CHEMBL627297,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",Intermediate,10116.0,N,11992,1,,1,A,,,8608,
,,CHEMBL627298,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",Intermediate,10116.0,N,11993,1,,1,A,,,8608,
,,CHEMBL627299,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",Intermediate,10116.0,N,11994,1,,1,A,,,8608,
,,CHEMBL627300,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",Intermediate,10116.0,N,11995,1,,1,A,,,8608,
,,CHEMBL627301,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",Intermediate,10116.0,N,11996,1,,1,A,,,8608,
,,CHEMBL627302,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",Intermediate,10116.0,N,11997,1,,1,A,,,8608,
,,CHEMBL627303,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",Intermediate,10116.0,N,11998,1,,1,A,,,8608,
,,CHEMBL627304,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",Intermediate,10116.0,N,11999,1,,1,A,,,8608,
,,CHEMBL627305,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",Intermediate,10116.0,N,12000,1,,1,A,,,8608,
,,CHEMBL627306,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Intermediate,10116.0,N,12001,1,,1,A,,,8608,
,,CHEMBL623982,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",Intermediate,10116.0,N,12002,1,,1,A,,,8608,
,,CHEMBL623983,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",Intermediate,10116.0,N,12003,1,,1,A,,,8608,
,,CHEMBL623984,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",Intermediate,10116.0,N,12004,1,,1,A,,,8608,
,,CHEMBL623985,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",Intermediate,10116.0,N,12005,1,,1,A,,,8608,
,,CHEMBL623986,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",Intermediate,10116.0,N,12006,1,,1,A,,,8608,
,,CHEMBL623987,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",Intermediate,10116.0,N,12007,1,,1,A,,,8608,
,,CHEMBL623988,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",Intermediate,10116.0,N,12008,1,,1,A,,,8608,
,,CHEMBL623989,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",Intermediate,10116.0,N,12009,1,,1,A,,,8608,
,,CHEMBL622215,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",Intermediate,10116.0,N,12010,1,,1,A,,,8608,
,,CHEMBL622216,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",Intermediate,10116.0,N,12011,1,,1,A,,,8608,
,,CHEMBL877481,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",Intermediate,10116.0,N,12012,1,,1,A,,,8608,
,,CHEMBL622217,,22224,,BAO_0000218,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),Autocuration,,U,12013,1,,0,A,,,16359,
,,CHEMBL622218,,50594,,BAO_0000218,Mus musculus,,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Intermediate,10090.0,N,12014,1,,1,A,,,13701,
,,CHEMBL622219,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic profile AUC was evaluated in rats,Intermediate,10116.0,N,12015,1,,1,A,,,14554,
,,CHEMBL622220,,22224,,BAO_0000019,,,,Pharmacokinetic property (Area under curve),Autocuration,,U,12016,1,,0,A,,,6241,
,,CHEMBL622221,,50588,,BAO_0000218,Canis lupus familiaris,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",Intermediate,9615.0,N,12017,1,,1,A,,,11537,
,,CHEMBL622222,,50594,,BAO_0000218,Mus musculus,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",Intermediate,10090.0,N,12018,1,,1,A,,,11537,
,,CHEMBL622223,,50588,,BAO_0000218,Canis lupus familiaris,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",Intermediate,9615.0,N,12019,1,,1,A,,,11537,
,,CHEMBL622224,,50594,,BAO_0000218,Mus musculus,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",Intermediate,10090.0,N,12020,1,,1,A,,,11537,
,,CHEMBL622225,,22224,,BAO_0000019,,,,Plasma concentration (AUC) was determined,Autocuration,,U,12021,1,,0,A,,,13118,
,,CHEMBL622226,,22224,,BAO_0000019,,,,Plasma concentration (AUC) was determined; Not detectable,Autocuration,,U,12022,1,,0,A,,,13118,
,,CHEMBL624154,,50512,,BAO_0000218,Cavia porcellus,,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),Intermediate,10141.0,N,12023,1,,1,A,,,9562,
,,CHEMBL624155,,50597,,BAO_0000218,Rattus norvegicus,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,Intermediate,10116.0,N,12024,1,,1,A,,,10363,
,,CHEMBL624156,,50597,,BAO_0000218,Rattus norvegicus,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Intermediate,10116.0,N,12025,1,,1,A,,,10363,
,,CHEMBL624157,,50597,,BAO_0000218,Rattus norvegicus,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,Intermediate,10116.0,N,12026,1,,1,A,,,10363,
,,CHEMBL624158,,50597,,BAO_0000218,Rattus norvegicus,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,Intermediate,10116.0,N,12027,1,,1,A,,,10363,
,,CHEMBL624159,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,Intermediate,10116.0,N,12028,1,,1,A,,,12504,
,,CHEMBL624160,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,Intermediate,10116.0,N,12029,1,,1,A,,,12504,
,,CHEMBL624161,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,Intermediate,10116.0,N,12030,1,,1,A,,,12504,
,,CHEMBL624162,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,Intermediate,10116.0,N,12031,1,,1,A,,,12504,
,,CHEMBL624163,,50588,,BAO_0000218,Canis lupus familiaris,,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,Intermediate,9615.0,N,12032,1,,1,A,,,13317,
,,CHEMBL624164,,50597,,BAO_0000218,Rattus norvegicus,,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,12033,1,,1,A,,,15078,
,,CHEMBL624165,,50597,,BAO_0000218,Rattus norvegicus,,,The AUC(0-infinity) values in female wistar rats.,Intermediate,10116.0,N,12034,1,,1,A,,,14941,
,,CHEMBL624166,,50597,,BAO_0000218,Rattus norvegicus,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,12035,1,,1,A,,,15078,
,,CHEMBL624167,,50597,,BAO_0000218,Rattus norvegicus,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",Intermediate,10116.0,N,12036,1,,1,A,,,15078,
,,CHEMBL624168,,50597,,BAO_0000218,Rattus norvegicus,,,The AUC(0-t)values in female wistar rats.,Intermediate,10116.0,N,12037,1,,1,A,,,14941,
,,CHEMBL624169,,50597,,BAO_0000218,Rattus norvegicus,,,The Area under the concentration time curve of compound was measured on rats,Intermediate,10116.0,N,12038,1,,1,A,,,14067,
,,CHEMBL624170,,50587,,BAO_0000218,Homo sapiens,,,The area under curve (100 mg/kg) administered orally in humans,Intermediate,9606.0,N,12039,1,,1,A,,,14215,
,,CHEMBL624171,,22224,,BAO_0000218,Callithrix,,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,Autocuration,9481.0,U,12040,1,,0,A,,,14215,
,,CHEMBL624172,,22224,,BAO_0000218,Simiiformes,,,The area under curve (12.5 mg/kg) administered intravenously in monkey,Autocuration,314293.0,U,12041,1,,0,A,,,14215,
,,CHEMBL624173,,50588,,BAO_0000218,Canis lupus familiaris,,,The area under curve (15 mg/kg) administered intravenously in dog,Intermediate,9615.0,N,12042,1,,1,A,,,14215,
,,CHEMBL877488,,50587,,BAO_0000218,Homo sapiens,,,The area under curve (200 mg/kg) administered orally in humans,Intermediate,9606.0,N,12043,1,,1,A,,,14215,
,,CHEMBL624174,,50597,,BAO_0000218,Rattus norvegicus,,,The area under curve (25 mg/kg) administered intravenously in rat,Intermediate,10116.0,N,12044,1,,1,A,,,14215,
,,CHEMBL624175,,22224,,BAO_0000218,Callithrix,,,The area under curve (25 mg/kg) administered orally in marmoset,Autocuration,9481.0,U,12045,1,,0,A,,,14215,
,,CHEMBL624176,,22224,,BAO_0000218,Simiiformes,,,The area under curve (25 mg/kg) administered orally in monkey,Autocuration,314293.0,U,12046,1,,0,A,,,14215,
,,CHEMBL624177,,50588,,BAO_0000218,Canis lupus familiaris,,,The area under curve (30 mg/kg) administered orally in dog,Intermediate,9615.0,N,12047,1,,1,A,,,14215,
,,CHEMBL624178,,50587,,BAO_0000218,Homo sapiens,,,The area under curve (400 mg/kg) administered orally in humans,Intermediate,9606.0,N,12048,1,,1,A,,,14215,
,,CHEMBL624179,,50597,,BAO_0000218,Rattus norvegicus,,,The area under curve (50 mg/kg) administered orally in fasted rat,Intermediate,10116.0,N,12049,1,,1,A,,,14215,
,,CHEMBL627689,,50597,,BAO_0000218,Rattus norvegicus,,,The area under curve (50 mg/kg) administered orally in rat,Intermediate,10116.0,N,12050,1,,1,A,,,14215,
,,CHEMBL627690,,50587,,BAO_0000218,Homo sapiens,,,The area under curve (800 mg/kg) administered orally in humans,Intermediate,9606.0,N,12051,1,,1,A,,,14215,
,,CHEMBL627691,,22224,,BAO_0000019,,,,The compound was evaluated for area under the curve,Autocuration,,U,12052,1,,0,A,,,11324,
,,CHEMBL627692,,22224,,BAO_0000019,Callithrix,,,The compound was evaluated for area under the curve in marmosets,Autocuration,9481.0,U,12053,1,,0,A,,,11324,
,,CHEMBL627693,,22224,,BAO_0000019,Callithrix,,,The compound was evaluated for area under the curve in marmosets,Autocuration,9481.0,U,12054,1,,0,A,,,11324,
,,CHEMBL627694,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,10116.0,N,12055,1,,1,A,,,13875,
,,CHEMBL627695,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,10116.0,N,12056,1,,1,A,,,13875,
,,CHEMBL627696,,22224,,BAO_0000218,,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),Autocuration,,U,12057,1,,0,A,,,13875,
,,CHEMBL627697,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,10116.0,N,12058,1,,1,A,,,13875,
,,CHEMBL627698,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,10116.0,N,12059,1,,1,A,,,13875,
,,CHEMBL627699,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,10116.0,N,12060,1,,1,A,,,13875,
,,CHEMBL627700,,50597,,BAO_0000218,Rattus norvegicus,,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,Intermediate,10116.0,N,12061,1,,1,A,,,13807,
,,CHEMBL627701,,50597,,BAO_0000218,Rattus norvegicus,,,Total drug exposure is determined after oral dosing in rats.,Intermediate,10116.0,N,12062,1,,1,A,,,14127,
,,CHEMBL627702,,22224,,BAO_0000218,,,,Total drug exposure (5 mg/kg) when administered intravenously,Autocuration,,U,12063,1,,0,A,,,15116,
,,CHEMBL627703,,22224,,BAO_0000218,,,,Total drug exposure (5 mg/kg) when administered orally,Autocuration,,U,12064,1,,0,A,,,15116,
,,CHEMBL626873,,22224,,BAO_0000218,Simiiformes,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Autocuration,314293.0,U,12065,1,,0,A,,,15604,
,,CHEMBL629583,,50597,,BAO_0000218,Rattus norvegicus,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Intermediate,10116.0,N,12066,1,,1,A,,,15604,
,,CHEMBL629584,,50588,,BAO_0000218,Canis lupus familiaris,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Intermediate,9615.0,N,12067,1,,1,A,,,15604,
,,CHEMBL629585,,50588,,BAO_0000218,Canis lupus familiaris,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Intermediate,9615.0,N,12068,1,,1,A,,,15604,
In vivo,,CHEMBL629586,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,10116.0,N,12069,1,,1,A,,,13751,
In vivo,,CHEMBL629587,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,12070,1,,1,A,,,13751,
In vivo,,CHEMBL629588,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,10116.0,N,12071,1,,1,A,,,13751,
In vivo,,CHEMBL629589,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,10116.0,N,12072,1,,1,A,,,13751,
In vivo,,CHEMBL629590,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,10116.0,N,12073,1,,1,A,,,13751,
In vivo,,CHEMBL629591,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,10116.0,N,12074,1,,1,A,,,13751,
In vivo,,CHEMBL629592,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,12075,1,,1,A,,,13751,
In vivo,,CHEMBL629593,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,10116.0,N,12076,1,,1,A,,,13751,
In vivo,,CHEMBL629594,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,10116.0,N,12077,1,,1,A,,,13751,
In vivo,,CHEMBL629595,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,10116.0,N,12078,1,,1,A,,,13751,
In vivo,,CHEMBL630290,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,10116.0,N,12079,1,,1,A,,,13751,
In vivo,,CHEMBL627137,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,10116.0,N,12080,1,,1,A,,,13751,
In vivo,,CHEMBL627138,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,10116.0,N,12081,1,,1,A,,,13751,
In vivo,,CHEMBL627139,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,12082,1,,1,A,,,13751,
In vivo,,CHEMBL627140,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,10116.0,N,12083,1,,1,A,,,13751,
In vivo,,CHEMBL627141,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,10116.0,N,12084,1,,1,A,,,13751,
In vivo,,CHEMBL627142,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,10116.0,N,12085,1,,1,A,,,13751,
In vivo,,CHEMBL627143,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,10116.0,N,12086,1,,1,A,,,13751,
In vivo,,CHEMBL874449,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,10116.0,N,12087,1,,1,A,,,13751,
In vivo,,CHEMBL627144,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,10116.0,N,12088,1,,1,A,,,13751,
In vivo,,CHEMBL627145,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,12089,1,,1,A,,,13751,
In vivo,,CHEMBL627146,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,10116.0,N,12090,1,,1,A,,,13751,
In vivo,,CHEMBL627147,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,10116.0,N,12091,1,,1,A,,,13751,
In vivo,,CHEMBL627148,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,10116.0,N,12092,1,,1,A,,,13751,
In vivo,,CHEMBL627149,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,10116.0,N,12093,1,,1,A,,,13751,
In vivo,,CHEMBL632160,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,10116.0,N,12094,1,,1,A,,,13751,
In vivo,,CHEMBL632161,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,10116.0,N,12095,1,,1,A,,,13751,
In vivo,,CHEMBL632162,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,10116.0,N,12096,1,,1,A,,,13751,
In vivo,,CHEMBL632163,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,12097,1,,1,A,,,13751,
In vivo,,CHEMBL874469,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,10116.0,N,12098,1,,1,A,,,13751,
In vivo,,CHEMBL627182,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,10116.0,N,12099,1,,1,A,,,13751,
In vivo,,CHEMBL627183,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,10116.0,N,12100,1,,1,A,,,13751,
In vivo,,CHEMBL627184,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,10116.0,N,12101,1,,1,A,,,13751,
In vivo,,CHEMBL627185,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,10116.0,N,12102,1,,1,A,,,13751,
In vivo,,CHEMBL627186,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,10116.0,N,12103,1,,1,A,,,13751,
In vivo,,CHEMBL627187,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,12104,1,,1,A,,,13751,
In vivo,,CHEMBL627188,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,10116.0,N,12105,1,,1,A,,,13751,
In vivo,,CHEMBL627189,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,10116.0,N,12106,1,,1,A,,,13751,
In vivo,,CHEMBL627190,,50597,,BAO_0000218,Rattus norvegicus,,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,12107,1,,1,A,,,13751,
In vivo,,CHEMBL627191,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,10116.0,N,12108,1,,1,A,,,13751,
In vivo,,CHEMBL627192,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,10116.0,N,12109,1,,1,A,,,13751,
In vivo,,CHEMBL627193,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,10116.0,N,12110,1,,1,A,,,13751,
In vivo,,CHEMBL874590,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12111,1,,1,A,,,10911,
In vivo,,CHEMBL627194,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12112,1,,1,A,,,10911,
In vivo,,CHEMBL627195,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12113,1,,1,A,,,10911,
In vivo,,CHEMBL627196,,50597,Female gonad,BAO_0000218,Rattus norvegicus,992.0,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12114,1,,1,A,,,10911,
In vivo,,CHEMBL627197,,50597,Female gonad,BAO_0000218,Rattus norvegicus,992.0,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12115,1,,1,A,,,10911,
In vivo,,CHEMBL627198,,50597,Female gonad,BAO_0000218,Rattus norvegicus,992.0,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12116,1,,1,A,,,10911,
In vivo,,CHEMBL627199,,50597,Female gonad,BAO_0000218,Rattus norvegicus,992.0,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,Intermediate,10116.0,N,12117,1,,1,A,,,10911,
In vivo,,CHEMBL627200,,50597,Female gonad,BAO_0000218,Rattus norvegicus,992.0,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12118,1,,1,A,,,10911,
In vivo,,CHEMBL627201,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12119,1,,1,A,,,10911,
In vivo,,CHEMBL627202,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12120,1,,1,A,,,10911,
In vivo,,CHEMBL627203,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12121,1,,1,A,,,10911,
In vivo,,CHEMBL627204,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12122,1,,1,A,,,10911,
In vivo,,CHEMBL627205,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12123,1,,1,A,,,10911,
In vivo,,CHEMBL627206,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12124,1,,1,A,,,10911,
In vivo,,CHEMBL627207,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12125,1,,1,A,,,10911,
In vivo,,CHEMBL627208,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12126,1,,1,A,,,10911,
In vivo,,CHEMBL627209,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12127,1,,1,A,,,10911,
In vivo,,CHEMBL627210,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12128,1,,1,A,,,10911,
In vivo,,CHEMBL627211,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12129,1,,1,A,,,10911,
In vivo,,CHEMBL627212,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12130,1,,1,A,,,10911,
In vivo,,CHEMBL627213,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12131,1,,1,A,,,10911,
In vivo,,CHEMBL626599,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12132,1,,1,A,,,10911,
In vivo,,CHEMBL626600,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12133,1,,1,A,,,10911,
In vivo,,CHEMBL626601,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,10116.0,N,12134,1,,1,A,,,10911,
,,CHEMBL627484,,22224,,BAO_0000019,,,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,Autocuration,,U,12135,1,,0,A,,,8081,
,,CHEMBL627485,,100710,Plasma,BAO_0000218,Macaca fascicularis,1969.0,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),Intermediate,9541.0,N,12136,1,,1,A,,,17248,
,,CHEMBL628147,,100710,Plasma,BAO_0000218,Macaca fascicularis,1969.0,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,Intermediate,9541.0,N,12137,1,,1,A,,,17248,
,,CHEMBL628148,,100710,Plasma,BAO_0000218,Macaca fascicularis,1969.0,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,Intermediate,9541.0,N,12138,1,,1,A,,,17248,
,,CHEMBL628149,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),Intermediate,9615.0,N,12139,1,,1,A,,,17248,
,,CHEMBL628150,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,Intermediate,9615.0,N,12140,1,,1,A,,,17248,
,,CHEMBL628318,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,Intermediate,9615.0,N,12141,1,,1,A,,,17248,
,,CHEMBL628319,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,Intermediate,9615.0,N,12142,1,,1,A,,,17248,
,,CHEMBL875609,,50588,,BAO_0000218,Canis lupus familiaris,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Intermediate,9615.0,N,12143,1,,1,A,,,15592,
,,CHEMBL628320,,22224,,BAO_0000019,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,Autocuration,,U,12144,1,,0,A,,,7040,
,,CHEMBL628321,,22224,,BAO_0000019,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,Autocuration,,U,12145,1,,0,A,,,7040,
,,CHEMBL628322,,22224,,BAO_0000019,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,Autocuration,,U,12146,1,,0,A,,,7040,
,,CHEMBL628323,,22224,,BAO_0000019,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,Autocuration,,U,12147,1,,0,A,,,7040,
,,CHEMBL628324,,22224,,BAO_0000019,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,Autocuration,,U,12148,1,,0,A,,,7040,
,,CHEMBL628325,,22224,,BAO_0000019,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,Autocuration,,U,12149,1,,0,A,,,7040,
,,CHEMBL628326,,22224,,BAO_0000019,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,Autocuration,,U,12150,1,,0,A,,,7040,
,,CHEMBL628327,,50588,Adrenal medulla,BAO_0000218,Canis lupus familiaris,1236.0,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",Intermediate,9615.0,N,12151,1,,1,A,,,9614,
,,CHEMBL628328,,50588,Adrenal medulla,BAO_0000218,Canis lupus familiaris,1236.0,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",Intermediate,9615.0,N,12152,1,,1,A,,,9614,
,,CHEMBL628329,,50588,Blood,BAO_0000218,Canis lupus familiaris,178.0,,"Concentration of compound in blood of dog 1, after administering intravenously",Intermediate,9615.0,N,12153,1,,1,A,,,9614,
,,CHEMBL628330,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",Intermediate,10116.0,N,12154,1,,1,A,,,8608,
,,CHEMBL628331,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",Intermediate,10116.0,N,12155,1,,1,A,,,8608,
,,CHEMBL628332,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",Intermediate,10116.0,N,12156,1,,1,A,,,8608,
,,CHEMBL628333,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",Intermediate,10116.0,N,12157,1,,1,A,,,8608,
,,CHEMBL628334,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",Intermediate,10116.0,N,12158,1,,1,A,,,8608,
,,CHEMBL628335,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",Intermediate,10116.0,N,12159,1,,1,A,,,8608,
,,CHEMBL628336,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",Intermediate,10116.0,N,12160,1,,1,A,,,8608,
,,CHEMBL628337,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Intermediate,10116.0,N,12161,1,,1,A,,,8608,
,,CHEMBL628338,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",Intermediate,10116.0,N,12162,1,,1,A,,,8608,
,,CHEMBL875610,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",Intermediate,10116.0,N,12163,1,,1,A,,,8608,
,,CHEMBL628339,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",Intermediate,10116.0,N,12164,1,,1,A,,,8608,
,,CHEMBL628340,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",Intermediate,10116.0,N,12165,1,,1,A,,,8608,
,,CHEMBL628341,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",Intermediate,10116.0,N,12166,1,,1,A,,,8608,
,,CHEMBL622214,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",Intermediate,10116.0,N,12167,1,,1,A,,,8608,
,,CHEMBL623167,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",Intermediate,10116.0,N,12168,1,,1,A,,,8608,
,,CHEMBL623168,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",Intermediate,10116.0,N,12169,1,,1,A,,,8608,
,,CHEMBL623169,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",Intermediate,10116.0,N,12170,1,,1,A,,,8608,
,,CHEMBL623170,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",Intermediate,10116.0,N,12171,1,,1,A,,,8608,
,,CHEMBL627224,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",Intermediate,10116.0,N,12172,1,,1,A,,,8608,
,,CHEMBL875634,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",Intermediate,10116.0,N,12173,1,,1,A,,,8608,
,,CHEMBL627225,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",Intermediate,10116.0,N,12174,1,,1,A,,,8608,
,,CHEMBL627226,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",Intermediate,10116.0,N,12175,1,,1,A,,,8608,
,,CHEMBL626083,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",Intermediate,10116.0,N,12176,1,,1,A,,,8608,
,,CHEMBL626084,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",Intermediate,10116.0,N,12177,1,,1,A,,,8608,
,,CHEMBL626085,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",Intermediate,10116.0,N,12178,1,,1,A,,,8608,
,,CHEMBL626086,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",Intermediate,10116.0,N,12179,1,,1,A,,,8608,
,,CHEMBL626087,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",Intermediate,10116.0,N,12180,1,,1,A,,,8608,
,,CHEMBL626088,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",Intermediate,10116.0,N,12181,1,,1,A,,,8608,
,,CHEMBL626089,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",Intermediate,10116.0,N,12182,1,,1,A,,,8608,
,,CHEMBL626090,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",Intermediate,10116.0,N,12183,1,,1,A,,,8608,
,,CHEMBL626091,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",Intermediate,10116.0,N,12184,1,,1,A,,,8608,
,,CHEMBL626092,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",Intermediate,10116.0,N,12185,1,,1,A,,,8608,
,,CHEMBL626093,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",Intermediate,10116.0,N,12186,1,,1,A,,,8608,
,,CHEMBL626094,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",Intermediate,10116.0,N,12187,1,,1,A,,,8608,
,,CHEMBL626095,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",Intermediate,10116.0,N,12188,1,,1,A,,,8608,
,,CHEMBL626096,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",Intermediate,10116.0,N,12189,1,,1,A,,,8608,
,,CHEMBL626097,,22224,,BAO_0000218,Simiiformes,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Autocuration,314293.0,U,12190,1,,0,A,,,15604,
,,CHEMBL626098,,50597,,BAO_0000218,Rattus norvegicus,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Intermediate,10116.0,N,12191,1,,1,A,,,15604,
,,CHEMBL626099,,22224,Plasma,BAO_0000218,,1969.0,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,Autocuration,,U,12192,1,,0,A,,,1806,
,,CHEMBL626100,,22224,Plasma,BAO_0000218,,1969.0,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,Autocuration,,U,12193,1,,0,A,,,1806,
,,CHEMBL626101,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,AUC 0-inf in dog,Intermediate,9615.0,N,12194,1,,1,A,,,17237,
,,CHEMBL626102,,50512,Plasma,BAO_0000218,Cavia porcellus,1969.0,,AUC 0-inf in guinea pig,Intermediate,10141.0,N,12195,1,,1,A,,,17237,
,,CHEMBL626103,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,AUC 0-t in dog,Intermediate,9615.0,N,12196,1,,1,A,,,17237,
,,CHEMBL628391,,50512,Plasma,BAO_0000218,Cavia porcellus,1969.0,,AUC 0-t in guinea pig,Intermediate,10141.0,N,12197,1,,1,A,,,17237,
,,CHEMBL628392,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for brain to plasma partition in rat,Intermediate,10116.0,N,12198,1,,1,A,,,15194,
,,CHEMBL628393,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for brain to plasma partition in rat.,Intermediate,10116.0,N,12199,1,,1,A,,,15194,
,,CHEMBL628394,,22224,Blood,BAO_0000019,,178.0,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,Autocuration,,U,12200,1,,0,A,,,8787,
,,CHEMBL628395,,50588,,BAO_0000218,Canis lupus familiaris,,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,Intermediate,9615.0,N,12201,1,,1,A,,,17025,
,,CHEMBL628396,,22224,,BAO_0000218,Simiiformes,,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,314293.0,U,12202,1,,0,A,,,17025,
,,CHEMBL628397,,50592,,BAO_0000218,Oryctolagus cuniculus,,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,9986.0,N,12203,1,,1,A,,,17025,
,,CHEMBL628398,,50597,,BAO_0000218,Rattus norvegicus,,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,Intermediate,10116.0,N,12204,1,,1,A,,,17025,
,,CHEMBL628399,,50797,,BAO_0000218,Macaca mulatta,,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,Intermediate,9544.0,N,12205,1,,1,A,,,4236,
,,CHEMBL628400,,50588,,BAO_0000218,Canis lupus familiaris,,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,Intermediate,9615.0,N,12206,1,,1,A,,,15343,
,,CHEMBL874907,,50597,,BAO_0000218,Rattus norvegicus,,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,Intermediate,10116.0,N,12207,1,,1,A,,,15343,
,,CHEMBL628401,,22224,,BAO_0000019,,,,Area under curve of the compound was determined,Autocuration,,U,12208,1,,0,A,,,17720,
,,CHEMBL628402,,22224,Plasma,BAO_0000218,Simiiformes,1969.0,,AUC in monkeys at a dose of 1 mg/kg,Autocuration,314293.0,U,12209,1,,0,A,,,17788,
,,CHEMBL628403,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,AUC in rats at a dose of 1 mg/kg,Intermediate,10116.0,N,12210,1,,1,A,,,17788,
,,CHEMBL628404,,22224,,BAO_0000019,,,,Compound was evaluated for the overall absorbance loss at pH of 2,Autocuration,,U,12211,1,,0,A,,,8778,
,,CHEMBL628405,,22224,,BAO_0000019,,,,Compound was evaluated for the overall absorbance loss at pH of 4,Autocuration,,U,12212,1,,0,A,,,8778,
,,CHEMBL628406,,22224,,BAO_0000019,,,,Compound was evaluated for the overall absorbance loss at pH of 7,Autocuration,,U,12213,1,,0,A,,,8778,
,,CHEMBL628407,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for its absorption in the rats,Intermediate,10116.0,N,12214,1,,1,A,,,2249,
,,CHEMBL628408,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Intermediate,10116.0,N,12215,1,,1,A,,,8881,
,,CHEMBL629171,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,Intermediate,10116.0,N,12216,1,,1,A,,,8881,
,,CHEMBL629172,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Intermediate,10116.0,N,12217,1,,1,A,,,8881,
,,CHEMBL629173,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,Intermediate,10116.0,N,12218,1,,1,A,,,8881,
,,CHEMBL629174,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum,Intermediate,10116.0,N,12219,1,,1,A,,,15286,
,,CHEMBL629175,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 10-17,Intermediate,10116.0,N,12220,1,,1,A,,,15286,
,,CHEMBL629176,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 10-18,Intermediate,10116.0,N,12221,1,,1,A,,,15286,
,,CHEMBL629177,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 10-19,Intermediate,10116.0,N,12222,1,,1,A,,,15286,
,,CHEMBL629178,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 12-15,Intermediate,10116.0,N,12223,1,,1,A,,,15286,
,,CHEMBL631869,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 13-19,Intermediate,10116.0,N,12224,1,,1,A,,,15286,
,,CHEMBL631870,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 14-17,Intermediate,10116.0,N,12225,1,,1,A,,,15286,
,,CHEMBL631871,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 15-18,Intermediate,10116.0,N,12226,1,,1,A,,,15286,
,,CHEMBL631872,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 2-5,Intermediate,10116.0,N,12227,1,,1,A,,,15286,
,,CHEMBL875775,,22224,Ileum,BAO_0000221,,2116.0,,In vitro percent permeability into rat ileum; Range is 23-42,Autocuration,,U,12228,1,,0,A,,,15286,
,,CHEMBL631873,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 28-36,Intermediate,10116.0,N,12229,1,,1,A,,,15286,
,,CHEMBL631874,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 29-35,Intermediate,10116.0,N,12230,1,,1,A,,,15286,
,,CHEMBL631875,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 46-66,Intermediate,10116.0,N,12231,1,,1,A,,,15286,
,,CHEMBL631876,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 50-68,Intermediate,10116.0,N,12232,1,,1,A,,,15286,
,,CHEMBL631877,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; Range is 78-81,Intermediate,10116.0,N,12233,1,,1,A,,,15286,
,,CHEMBL631878,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,Intermediate,10116.0,N,12234,1,,1,A,,,15286,
,,CHEMBL631879,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; nd indicates not detected,Intermediate,10116.0,N,12235,1,,1,A,,,15286,
,,CHEMBL631880,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; nt indicates not detected,Intermediate,10116.0,N,12236,1,,1,A,,,15286,
,,CHEMBL631881,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro percent permeability into rat ileum; nt indicates not tested,Intermediate,10116.0,N,12237,1,,1,A,,,15286,
,,CHEMBL631882,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for oral absorption in bile-duct cannulated rats,Intermediate,10116.0,N,12238,1,,1,A,,,13770,
,,CHEMBL630749,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for oral absorption in bile-duct cannulated rats.,Intermediate,10116.0,N,12239,1,,1,A,,,13770,
,,CHEMBL630750,,50587,,BAO_0000218,Homo sapiens,,,Oral absorption using Caco-2 cell monolayers.,Intermediate,9606.0,N,12240,1,,1,A,,,5202,
,,CHEMBL630253,,50587,,BAO_0000218,Homo sapiens,,,Percent of the drug absorbed after administration to humans was determined,Intermediate,9606.0,N,12241,1,,1,A,,,14920,
,,CHEMBL630254,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Intermediate,10116.0,N,12242,1,,1,A,,,14103,
,,CHEMBL630255,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Intermediate,10116.0,N,12243,1,,1,A,,,14103,
,,CHEMBL630256,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Intermediate,10116.0,N,12244,1,,1,A,,,14103,
In vivo,,CHEMBL875781,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,10116.0,N,12245,1,,1,A,,,13751,
In vivo,,CHEMBL630257,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,10116.0,N,12246,1,,1,A,,,13751,
In vivo,,CHEMBL630258,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,10116.0,N,12247,1,,1,A,,,13751,
,,CHEMBL630259,,50597,,BAO_0000218,Rattus norvegicus,,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",Intermediate,10116.0,N,12248,1,,1,A,,,15807,
,,CHEMBL630260,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",Intermediate,10116.0,N,12249,1,,1,A,,,15807,
,,CHEMBL630261,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",Intermediate,10116.0,N,12250,1,,1,A,,,15807,
,,CHEMBL630262,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,Intermediate,10116.0,N,12251,1,,1,A,,,14950,
,,CHEMBL630263,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,Intermediate,10116.0,N,12252,1,,1,A,,,14950,
,,CHEMBL630264,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,Intermediate,10116.0,N,12253,1,,1,A,,,14950,
,,CHEMBL630265,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,Intermediate,10116.0,N,12254,1,,1,A,,,14950,
,,CHEMBL630266,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,Intermediate,10116.0,N,12255,1,,1,A,,,14950,
,,CHEMBL630267,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,Intermediate,10116.0,N,12256,1,,1,A,,,14950,
,,CHEMBL630268,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,Intermediate,10116.0,N,12257,1,,1,A,,,14950,
,,CHEMBL630269,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,Intermediate,10116.0,N,12258,1,,1,A,,,14950,
,,CHEMBL630270,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,Intermediate,10116.0,N,12259,1,,1,A,,,14950,
,,CHEMBL630141,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,Intermediate,10116.0,N,12260,1,,1,A,,,14950,
,,CHEMBL630142,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,Intermediate,10116.0,N,12261,1,,1,A,,,14950,
,,CHEMBL630143,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,Intermediate,10116.0,N,12262,1,,1,A,,,14950,
,,CHEMBL630144,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,Intermediate,10116.0,N,12263,1,,1,A,,,14950,
,,CHEMBL630145,,50597,Prostate gland,BAO_0000218,Rattus norvegicus,2367.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,Intermediate,10116.0,N,12264,1,,1,A,,,14950,
,,CHEMBL630146,,50597,Prostate gland,BAO_0000218,Rattus norvegicus,2367.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,Intermediate,10116.0,N,12265,1,,1,A,,,14950,
,,CHEMBL630147,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,Intermediate,10116.0,N,12266,1,,1,A,,,14950,
,,CHEMBL630148,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,Intermediate,10116.0,N,12267,1,,1,A,,,14950,
,,CHEMBL630149,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,Intermediate,10116.0,N,12268,1,,1,A,,,14950,
,,CHEMBL630150,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,Intermediate,10116.0,N,12269,1,,1,A,,,14950,
,,CHEMBL630151,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,Intermediate,10116.0,N,12270,1,,1,A,,,14950,
,,CHEMBL632031,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,Intermediate,10116.0,N,12271,1,,1,A,,,14950,
,,CHEMBL632032,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,Intermediate,10116.0,N,12272,1,,1,A,,,14950,
,,CHEMBL632033,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,Intermediate,10116.0,N,12273,1,,1,A,,,14950,
,,CHEMBL632034,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,Intermediate,10116.0,N,12274,1,,1,A,,,14950,
,,CHEMBL632035,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,Intermediate,10116.0,N,12275,1,,1,A,,,14950,
,,CHEMBL632036,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,Intermediate,10116.0,N,12276,1,,1,A,,,14950,
,,CHEMBL632037,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,Intermediate,10116.0,N,12277,1,,1,A,,,14950,
,,CHEMBL632038,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Intermediate,10116.0,N,12278,1,,1,A,,,8631,
,,CHEMBL632039,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Intermediate,10116.0,N,12279,1,,1,A,,,8631,
,,CHEMBL632040,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Intermediate,10116.0,N,12280,1,,1,A,,,8631,
,,CHEMBL632041,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Intermediate,10116.0,N,12281,1,,1,A,,,8631,
,,CHEMBL632042,,50588,Blood,BAO_0000218,Canis lupus familiaris,178.0,,"Concentration of compound in blood of dog 2, after administering intravenously",Intermediate,9615.0,N,12282,1,,1,A,,,9614,
,,CHEMBL632043,,50588,,BAO_0000218,Canis lupus familiaris,,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",Intermediate,9615.0,N,12283,1,,1,A,,,9614,
,,CHEMBL632044,,50588,,BAO_0000218,Canis lupus familiaris,,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",Intermediate,9615.0,N,12284,1,,1,A,,,9614,
,,CHEMBL632045,,50588,Liver,BAO_0000218,Canis lupus familiaris,2107.0,,"Concentration of compound in liver of dog 1, after administering intravenously",Intermediate,9615.0,N,12285,1,,1,A,,,9614,
,,CHEMBL632046,,50588,Liver,BAO_0000218,Canis lupus familiaris,2107.0,,"Concentration of compound in liver of dog 2, after administering intravenously",Intermediate,9615.0,N,12286,1,,1,A,,,9614,
,,CHEMBL632047,,50588,Lung,BAO_0000218,Canis lupus familiaris,2048.0,,"Concentration of compound in lung of dog 1, after administering intravenously",Intermediate,9615.0,N,12287,1,,1,A,,,9614,
,,CHEMBL632048,,50588,Lung,BAO_0000218,Canis lupus familiaris,2048.0,,"Concentration of compound in lung of dog 2, after administering intravenously",Intermediate,9615.0,N,12288,1,,1,A,,,9614,
,,CHEMBL632049,,50588,Muscle tissue,BAO_0000218,Canis lupus familiaris,2385.0,,"Concentration of compound in muscle of dog 1, after administering intravenously",Intermediate,9615.0,N,12289,1,,1,A,,,9614,
,,CHEMBL876418,,50588,Muscle tissue,BAO_0000218,Canis lupus familiaris,2385.0,,"Concentration of compound in muscle of dog 2, after administering intravenously",Intermediate,9615.0,N,12290,1,,1,A,,,9614,
,,CHEMBL632050,,50588,Spleen,BAO_0000218,Canis lupus familiaris,2106.0,,"Concentration of compound in spleen of dog 1,after administering intravenously",Intermediate,9615.0,N,12291,1,,1,A,,,9614,
,,CHEMBL632051,,50588,Spleen,BAO_0000218,Canis lupus familiaris,2106.0,,"Concentration of compound in spleen of dog 2, after administering intravenously",Intermediate,9615.0,N,12292,1,,1,A,,,9614,
,,CHEMBL632052,,22224,,BAO_0000218,,,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,Autocuration,,U,12293,1,,0,F,,,10353,
,,CHEMBL632053,,22224,,BAO_0000218,,,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,Autocuration,,U,12294,1,,0,F,,,10353,
,,CHEMBL632054,,22224,,BAO_0000218,,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,Autocuration,,U,12295,1,,0,A,,,10353,
,,CHEMBL632055,,22224,,BAO_0000218,,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,Autocuration,,U,12296,1,,0,F,,,10353,
,,CHEMBL631181,,22224,,BAO_0000218,,,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,Autocuration,,U,12297,1,,0,F,,,10353,
,,CHEMBL631182,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,Autocuration,,U,12298,1,,0,A,,,9196,
,,CHEMBL631183,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,,U,12299,1,,0,A,,,9196,
,,CHEMBL631184,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,U,12300,1,,0,A,,,9196,
,,CHEMBL629774,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,U,12301,1,,0,A,,,9196,
,,CHEMBL629775,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,U,12302,1,,0,A,,,9196,
,,CHEMBL876549,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,U,12303,1,,0,A,,,9196,
,,CHEMBL628172,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,U,12304,1,,0,A,,,9196,
,,CHEMBL628173,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,,U,12305,1,,0,A,,,9196,
,,CHEMBL628174,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,Autocuration,,U,12306,1,,0,A,,,9196,
,,CHEMBL628175,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,Autocuration,,U,12307,1,,0,A,,,9196,
,,CHEMBL628176,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,,U,12308,1,,0,A,,,9196,
,,CHEMBL628177,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,,U,12309,1,,0,A,,,9196,
,,CHEMBL628178,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,U,12310,1,,0,A,,,9196,
,,CHEMBL628179,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,,U,12311,1,,0,A,,,9196,
,,CHEMBL628180,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,Autocuration,,U,12312,1,,0,A,,,9196,
,,CHEMBL628181,,22224,,BAO_0000218,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,Autocuration,,U,12313,1,,0,A,,,9196,
,,CHEMBL628182,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,U,12314,1,,0,A,,,9196,
,,CHEMBL628183,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,U,12315,1,,0,A,,,9196,
,,CHEMBL628184,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,Autocuration,,U,12316,1,,0,A,,,9196,
,,CHEMBL628185,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,U,12317,1,,0,A,,,9196,
,,CHEMBL875617,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,U,12318,1,,0,A,,,9196,
,,CHEMBL628186,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,Autocuration,,U,12319,1,,0,A,,,9196,
,,CHEMBL628187,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,U,12320,1,,0,A,,,9196,
,,CHEMBL628188,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,,U,12321,1,,0,A,,,9196,
,,CHEMBL628189,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,Autocuration,,U,12322,1,,0,A,,,9196,
,,CHEMBL628190,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,Autocuration,,U,12323,1,,0,A,,,9196,
,,CHEMBL628191,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,,U,12324,1,,0,A,,,9196,
,,CHEMBL626513,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,Autocuration,,U,12325,1,,0,A,,,9196,
,,CHEMBL626514,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",Intermediate,10116.0,N,12326,1,,1,A,,,8608,
,,CHEMBL626515,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",Intermediate,10116.0,N,12327,1,,1,A,,,8608,
,,CHEMBL626516,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",Intermediate,10116.0,N,12328,1,,1,A,,,8608,
,,CHEMBL626517,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",Intermediate,10116.0,N,12329,1,,1,A,,,8608,
,,CHEMBL626518,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",Intermediate,10116.0,N,12330,1,,1,A,,,8608,
,,CHEMBL626519,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",Intermediate,10116.0,N,12331,1,,1,A,,,8608,
,,CHEMBL626520,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",Intermediate,10116.0,N,12332,1,,1,A,,,8608,
,,CHEMBL626521,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",Intermediate,10116.0,N,12333,1,,1,A,,,8608,
,,CHEMBL626522,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",Intermediate,10116.0,N,12334,1,,1,A,,,8608,
,,CHEMBL626523,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",Intermediate,10116.0,N,12335,1,,1,A,,,8608,
,,CHEMBL626524,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",Intermediate,10116.0,N,12336,1,,1,A,,,8608,
,,CHEMBL626688,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",Intermediate,10116.0,N,12337,1,,1,A,,,8608,
,,CHEMBL626689,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",Intermediate,10116.0,N,12338,1,,1,A,,,8608,
,,CHEMBL626690,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",Intermediate,10116.0,N,12339,1,,1,A,,,8608,
,,CHEMBL626691,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",Intermediate,10116.0,N,12340,1,,1,A,,,8608,
,,CHEMBL627319,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",Intermediate,10116.0,N,12341,1,,1,A,,,8608,
,,CHEMBL624052,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",Intermediate,10116.0,N,12342,1,,1,A,,,8608,
,,CHEMBL624053,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",Intermediate,10116.0,N,12343,1,,1,A,,,8608,
,,CHEMBL624054,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,10116.0,N,12344,1,,1,A,,,8085,
,,CHEMBL624055,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,10116.0,N,12345,1,,1,A,,,8085,
,,CHEMBL624056,,50597,,BAO_0000218,Rattus norvegicus,,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,10116.0,N,12346,1,,1,A,,,8085,
,,CHEMBL624057,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,10116.0,N,12347,1,,1,A,,,8085,
,,CHEMBL622281,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,10116.0,N,12348,1,,1,A,,,8085,
,,CHEMBL622282,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,10116.0,N,12349,1,,1,A,,,8085,
,,CHEMBL622283,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,10116.0,N,12350,1,,1,A,,,8085,
,,CHEMBL622284,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,10116.0,N,12351,1,,1,A,,,8085,
,,CHEMBL622285,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,10116.0,N,12352,1,,1,A,,,8085,
,,CHEMBL622286,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,10116.0,N,12353,1,,1,A,,,8085,
,,CHEMBL622287,,22224,,BAO_0000100,,,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,Autocuration,,U,12354,1,,0,P,,,7657,
,,CHEMBL622288,,50594,,BAO_0000218,Mus musculus,,,Partition coefficient (logD7.4),Intermediate,10090.0,N,12355,1,,1,A,,,8935,
,,CHEMBL622289,,50594,,BAO_0000218,Mus musculus,,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Intermediate,10090.0,N,12356,1,,1,A,,,13792,
,,CHEMBL622290,,50594,Brain,BAO_0000218,Mus musculus,955.0,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Intermediate,10090.0,N,12357,1,,1,A,,,13792,
,,CHEMBL622291,,50594,,BAO_0000218,Mus musculus,,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Intermediate,10090.0,N,12358,1,,1,A,,,13792,
,,CHEMBL622292,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Intermediate,10090.0,N,12359,1,,1,A,,,13792,
,,CHEMBL622293,,50594,,BAO_0000218,Mus musculus,,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Intermediate,10090.0,N,12360,1,,1,A,,,13792,
,,CHEMBL622294,,50594,Brain,BAO_0000218,Mus musculus,955.0,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Intermediate,10090.0,N,12361,1,,1,A,,,13792,
,,CHEMBL622295,,50594,,BAO_0000218,Mus musculus,,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Intermediate,10090.0,N,12362,1,,1,A,,,13792,
,,CHEMBL622296,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Intermediate,10116.0,N,12363,1,,1,A,,,13792,
,,CHEMBL874409,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,Intermediate,10116.0,N,12364,1,,1,A,,,14103,
,,CHEMBL622297,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Intermediate,10116.0,N,12365,1,,1,A,,,14103,
,,CHEMBL622298,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Intermediate,10116.0,N,12366,1,,1,A,,,14103,
,,CHEMBL622299,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Intermediate,10116.0,N,12367,1,,1,A,,,14103,
,,CHEMBL622300,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Intermediate,10116.0,N,12368,1,,1,A,,,14103,
,,CHEMBL622301,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Intermediate,10116.0,N,12369,1,,1,A,,,14103,
,,CHEMBL622302,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Intermediate,10116.0,N,12370,1,,1,A,,,14103,
,,CHEMBL622303,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Intermediate,10116.0,N,12371,1,,1,A,,,14103,
,,CHEMBL622304,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Intermediate,10116.0,N,12372,1,,1,A,,,14103,
,,CHEMBL622305,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,Intermediate,10116.0,N,12373,1,,1,A,,,14103,
,,CHEMBL622306,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Intermediate,10116.0,N,12374,1,,1,A,,,14103,
,,CHEMBL626864,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,Intermediate,10116.0,N,12375,1,,1,A,,,14103,
,,CHEMBL626865,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Intermediate,10116.0,N,12376,1,,1,A,,,14103,
,,CHEMBL626866,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,Intermediate,10116.0,N,12377,1,,1,A,,,14103,
,,CHEMBL626867,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Intermediate,10116.0,N,12378,1,,1,A,,,14103,
,,CHEMBL626868,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Intermediate,10116.0,N,12379,1,,1,A,,,14103,
,,CHEMBL626869,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,Intermediate,10116.0,N,12380,1,,1,A,,,14103,
,,CHEMBL626870,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Intermediate,10116.0,N,12381,1,,1,A,,,14103,
,,CHEMBL626871,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,Intermediate,10116.0,N,12382,1,,1,A,,,14103,
,,CHEMBL626872,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Intermediate,10116.0,N,12383,1,,1,A,,,14103,
,,CHEMBL632185,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Intermediate,10116.0,N,12384,1,,1,A,,,14103,
,,CHEMBL632186,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,Intermediate,10116.0,N,12385,1,,1,A,,,14103,
,,CHEMBL629310,,22224,,BAO_0000019,,,,Amount of acetic acid produced by the compound,Autocuration,,U,12386,1,,0,A,,,12904,
,,CHEMBL629311,,22224,,BAO_0000019,,,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,Autocuration,,U,12387,1,,0,A,,,12904,
,,CHEMBL629312,,50597,,BAO_0000218,Rattus norvegicus,,,Log of (Cbrain/Cblood) in rats,Intermediate,10116.0,N,12388,1,,1,A,,,9663,
,,CHEMBL629313,,22224,,BAO_0000221,,,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),Autocuration,,U,12389,1,,0,A,,,7652,
,,CHEMBL629314,,22224,,BAO_0000221,,,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,,U,12390,1,,0,A,,,7652,
,,CHEMBL629315,,22224,,BAO_0000221,,,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),Autocuration,,U,12391,1,,0,A,,,7652,
,,CHEMBL629316,,22224,,BAO_0000219,,,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),Autocuration,,U,12392,1,,0,B,,,7652,
,,CHEMBL629317,,22224,,BAO_0000221,,,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,,U,12393,1,,0,A,,,7652,
,,CHEMBL629318,,22224,,BAO_0000019,,,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),Autocuration,,U,12394,1,,0,A,,,7652,
,,CHEMBL877497,,22224,,BAO_0000019,,,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),Autocuration,,U,12395,1,,0,A,,,7652,
,,CHEMBL629319,,22224,,BAO_0000019,,,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),Autocuration,,U,12396,1,,0,A,,,7652,
,,CHEMBL629320,,22224,,BAO_0000019,,,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,,U,12397,1,,0,A,,,7652,
,,CHEMBL629496,,22224,,BAO_0000019,,,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),Autocuration,,U,12398,1,,0,A,,,7652,
,,CHEMBL629497,,22224,,BAO_0000019,,,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),Autocuration,,U,12399,1,,0,A,,,7652,
,,CHEMBL629498,,22224,,BAO_0000019,,,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),Autocuration,,U,12400,1,,0,A,,,7652,
,,CHEMBL629499,,22224,,BAO_0000019,,,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),Autocuration,,U,12401,1,,0,A,,,7652,
,,CHEMBL629500,,22224,,BAO_0000019,,,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),Autocuration,,U,12402,1,,0,A,,,7652,
,,CHEMBL629501,,22224,,BAO_0000019,,,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),Autocuration,,U,12403,1,,0,A,,,7652,
,,CHEMBL629502,,22224,,BAO_0000019,,,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),Autocuration,,U,12404,1,,0,A,,,7652,
In vivo,,CHEMBL629503,,22224,,BAO_0000218,,,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,Autocuration,,U,12405,1,,0,F,,,8267,
,,CHEMBL629504,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,Intermediate,9615.0,N,12406,1,,1,A,,,8267,
,,CHEMBL629505,,22224,,BAO_0000019,,,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,Autocuration,,U,12407,1,,0,A,,,14479,
,,CHEMBL629506,,22224,,BAO_0000019,,,,Compound was evaluated for total body clearance,Autocuration,,U,12408,1,,0,A,,,17515,
,,CHEMBL629507,,22224,,BAO_0000019,,,,Compound was evaluated for volume of distribution at steady state,Autocuration,,U,12409,1,,0,A,,,17515,
,,CHEMBL877498,,22224,,BAO_0000019,,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,Autocuration,,U,12410,1,,0,A,,,8142,
,,CHEMBL629508,,22224,,BAO_0000019,,,,Percentage of the diamine which is monoprotonated at pH 7.4,Autocuration,,U,12411,1,,0,A,,,14849,
,,CHEMBL629509,,22224,,BAO_0000019,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,Autocuration,,U,12412,1,,0,A,,,7653,
,,CHEMBL629510,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Intermediate,10116.0,N,12413,1,,1,A,,,8631,
,,CHEMBL629511,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,10116.0,N,12414,1,,1,A,,,8631,
,,CHEMBL629512,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,10116.0,N,12415,1,,1,A,,,8631,
,,CHEMBL629513,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,10116.0,N,12416,1,,1,A,,,8631,
,,CHEMBL629514,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Intermediate,10116.0,N,12417,1,,1,A,,,8631,
,,CHEMBL628447,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,10116.0,N,12418,1,,1,A,,,8631,
,,CHEMBL628448,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Intermediate,10116.0,N,12419,1,,1,A,,,8631,
,,CHEMBL628449,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Intermediate,10116.0,N,12420,1,,1,A,,,8631,
,,CHEMBL631119,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Intermediate,10116.0,N,12421,1,,1,A,,,8631,
,,CHEMBL631120,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Intermediate,10116.0,N,12422,1,,1,A,,,8631,
,,CHEMBL631121,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Intermediate,10116.0,N,12423,1,,1,A,,,8631,
,,CHEMBL874458,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,Intermediate,10116.0,N,12424,1,,1,A,,,8631,
,,CHEMBL631122,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,10116.0,N,12425,1,,1,A,,,8631,
,,CHEMBL631123,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,10116.0,N,12426,1,,1,A,,,8631,
,,CHEMBL631124,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,10116.0,N,12427,1,,1,A,,,8631,
,,CHEMBL631125,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,10116.0,N,12428,1,,1,A,,,8631,
,,CHEMBL631290,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,10116.0,N,12429,1,,1,A,,,8631,
,,CHEMBL631291,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,10116.0,N,12430,1,,1,A,,,8631,
,,CHEMBL631292,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,10116.0,N,12431,1,,1,A,,,8631,
,,CHEMBL631293,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,10116.0,N,12432,1,,1,A,,,8631,
,,CHEMBL631294,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,10116.0,N,12433,1,,1,A,,,8631,
,,CHEMBL631295,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,10116.0,N,12434,1,,1,A,,,8631,
,,CHEMBL631296,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Intermediate,10116.0,N,12435,1,,1,A,,,8631,
,,CHEMBL631297,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,10116.0,N,12436,1,,1,A,,,8631,
,,CHEMBL631298,,22224,,BAO_0000218,,,,Maximum biodistribution (Bmax) was determined.,Autocuration,,U,12437,1,,0,A,,,10263,
,,CHEMBL631299,,50594,,BAO_0000218,Mus musculus,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,Intermediate,10090.0,N,12438,1,,1,A,,,12364,
,,CHEMBL631300,,50594,,BAO_0000218,Mus musculus,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,Intermediate,10090.0,N,12439,1,,1,A,,,12364,
,,CHEMBL631301,,50594,,BAO_0000218,Mus musculus,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,Intermediate,10090.0,N,12440,1,,1,A,,,12364,
,,CHEMBL630291,,50594,,BAO_0000218,Mus musculus,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,Intermediate,10090.0,N,12441,1,,1,A,,,12364,
,,CHEMBL630292,,22224,,BAO_0000218,,,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,U,12442,1,,0,A,,,14793,
,,CHEMBL630293,,22224,,BAO_0000218,,,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,Autocuration,,U,12443,1,,0,A,,,14793,
,,CHEMBL630294,,22224,,BAO_0000218,,,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,Autocuration,,U,12444,1,,0,A,,,14793,
,,CHEMBL630295,,22224,,BAO_0000218,,,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,U,12445,1,,0,A,,,14793,
,,CHEMBL630296,,22224,,BAO_0000218,,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,U,12446,1,,0,A,,,14793,
,,CHEMBL626782,,22224,,BAO_0000218,,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,U,12447,1,,0,A,,,14793,
,,CHEMBL626783,,22224,,BAO_0000218,,,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,U,12448,1,,0,A,,,14793,
,,CHEMBL626784,,22224,,BAO_0000218,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,U,12449,1,,0,A,,,14793,
,,CHEMBL626785,,22224,,BAO_0000218,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,U,12450,1,,0,A,,,14793,
,,CHEMBL626786,,22224,,BAO_0000218,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,U,12451,1,,0,A,,,14793,
,,CHEMBL626787,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,U,12452,1,,0,A,,,9196,
,,CHEMBL626788,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,Autocuration,,U,12453,1,,0,A,,,9196,
,,CHEMBL625927,,22224,,BAO_0000218,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,,U,12454,1,,0,A,,,9196,
,,CHEMBL625928,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12455,1,,1,A,,,8374,
,,CHEMBL625929,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,10116.0,N,12456,1,,1,A,,,8374,
,,CHEMBL625930,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Intermediate,10116.0,N,12457,1,,1,A,,,8374,
,,CHEMBL625931,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",Intermediate,10116.0,N,12458,1,,1,A,,,8374,
,,CHEMBL627230,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,Intermediate,10116.0,N,12459,1,,1,A,,,8374,
,,CHEMBL627231,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12460,1,,1,A,,,8374,
,,CHEMBL627232,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,10116.0,N,12461,1,,1,A,,,8374,
,,CHEMBL627233,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Intermediate,10116.0,N,12462,1,,1,A,,,8374,
,,CHEMBL875470,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12463,1,,1,A,,,8374,
,,CHEMBL627234,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12464,1,,1,A,,,8374,
,,CHEMBL627235,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12465,1,,1,A,,,8374,
,,CHEMBL627236,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12466,1,,1,A,,,8374,
,,CHEMBL627237,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12467,1,,1,A,,,8374,
,,CHEMBL627238,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12468,1,,1,A,,,8374,
,,CHEMBL627239,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12469,1,,1,A,,,8374,
,,CHEMBL627240,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12470,1,,1,A,,,8374,
,,CHEMBL627241,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12471,1,,1,A,,,8374,
,,CHEMBL627242,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12472,1,,1,A,,,8374,
,,CHEMBL627243,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,Intermediate,10116.0,N,12473,1,,1,A,,,8374,
,,CHEMBL627244,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,10116.0,N,12474,1,,1,A,,,8374,
,,CHEMBL627245,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12475,1,,1,A,,,8374,
,,CHEMBL627246,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12476,1,,1,A,,,8374,
,,CHEMBL627247,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12477,1,,1,A,,,8374,
,,CHEMBL627248,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12478,1,,1,A,,,8374,
,,CHEMBL627249,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12479,1,,1,A,,,8374,
,,CHEMBL625569,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12480,1,,1,A,,,8374,
,,CHEMBL625570,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12481,1,,1,A,,,8374,
,,CHEMBL625571,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12482,1,,1,A,,,8374,
,,CHEMBL625572,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,10116.0,N,12483,1,,1,A,,,8374,
,,CHEMBL625573,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,10116.0,N,12484,1,,1,A,,,8374,
,,CHEMBL625574,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,Intermediate,10116.0,N,12485,1,,1,A,,,8374,
,,CHEMBL626245,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,10116.0,N,12486,1,,1,A,,,8374,
,,CHEMBL626246,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12487,1,,1,A,,,8374,
,,CHEMBL626247,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,U,12488,1,,0,A,,,9196,
,,CHEMBL626248,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,U,12489,1,,0,A,,,9196,
,,CHEMBL626249,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,Autocuration,,U,12490,1,,0,A,,,9196,
,,CHEMBL626420,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,U,12491,1,,0,A,,,9196,
,,CHEMBL626421,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,,U,12492,1,,0,A,,,9196,
,,CHEMBL626422,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,,U,12493,1,,0,A,,,9196,
,,CHEMBL626423,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,U,12494,1,,0,A,,,9196,
,,CHEMBL626424,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,U,12495,1,,0,A,,,9196,
,,CHEMBL626425,,50588,,BAO_0000218,Canis lupus familiaris,,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,Intermediate,9615.0,N,12496,1,,1,A,,,12023,
,,CHEMBL875476,,50597,,BAO_0000218,Rattus norvegicus,,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,Intermediate,10116.0,N,12497,1,,1,A,,,12023,
,,CHEMBL626426,,100710,,BAO_0000218,Macaca fascicularis,,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,Intermediate,9541.0,N,12498,1,,1,A,,,12023,
,,CHEMBL626427,,22224,,BAO_0000100,,,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,Autocuration,,U,12499,1,,0,P,,,10580,
,,CHEMBL626428,,22224,,BAO_0000100,,,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,Autocuration,,U,12500,1,,0,P,,,10580,
,,CHEMBL626429,,22224,,BAO_0000019,,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,Autocuration,,U,12501,1,,0,A,,,16032,
,,CHEMBL625025,,22224,Urine,BAO_0000019,,1088.0,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,Autocuration,,U,12502,1,,0,A,,,16032,
,,CHEMBL625026,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12503,1,,1,A,,,8594,
,,CHEMBL625027,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12504,1,,1,A,,,8594,
,,CHEMBL874410,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12505,1,,1,A,,,8594,
,,CHEMBL625028,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,10116.0,N,12506,1,,1,A,,,8594,
,,CHEMBL625029,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,10116.0,N,12507,1,,1,A,,,8594,
,,CHEMBL625030,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12508,1,,1,A,,,8594,
,,CHEMBL625031,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12509,1,,1,A,,,8594,
,,CHEMBL625032,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12510,1,,1,A,,,8594,
,,CHEMBL625033,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12511,1,,1,A,,,8594,
,,CHEMBL625034,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12512,1,,1,A,,,8594,
,,CHEMBL624872,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12513,1,,1,A,,,8594,
,,CHEMBL624873,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12514,1,,1,A,,,8594,
,,CHEMBL624874,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12515,1,,1,A,,,8594,
,,CHEMBL624875,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,10116.0,N,12516,1,,1,A,,,8594,
,,CHEMBL624876,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,10116.0,N,12517,1,,1,A,,,8594,
,,CHEMBL624877,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12518,1,,1,A,,,8594,
,,CHEMBL624878,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12519,1,,1,A,,,8594,
,,CHEMBL624879,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12520,1,,1,A,,,8594,
,,CHEMBL624880,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12521,1,,1,A,,,8594,
,,CHEMBL624881,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,Intermediate,10116.0,N,12522,1,,1,A,,,8594,
,,CHEMBL624882,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",Intermediate,10116.0,N,12523,1,,1,A,,,8594,
,,CHEMBL624883,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12524,1,,1,A,,,8594,
,,CHEMBL624884,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12525,1,,1,A,,,8594,
,,CHEMBL624885,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12526,1,,1,A,,,8594,
,,CHEMBL624886,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,10116.0,N,12527,1,,1,A,,,8594,
,,CHEMBL624887,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,10116.0,N,12528,1,,1,A,,,8594,
,,CHEMBL624888,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12529,1,,1,A,,,8594,
,,CHEMBL624889,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12530,1,,1,A,,,8594,
,,CHEMBL624890,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12531,1,,1,A,,,8594,
,,CHEMBL621964,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12532,1,,1,A,,,8594,
,,CHEMBL621965,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12533,1,,1,A,,,8594,
,,CHEMBL621966,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12534,1,,1,A,,,8594,
,,CHEMBL621967,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12535,1,,1,A,,,8594,
,,CHEMBL622164,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12536,1,,1,A,,,8594,
,,CHEMBL623097,,22224,,BAO_0000019,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),Autocuration,,U,12537,1,,0,A,,,7653,
,,CHEMBL623098,,22224,,BAO_0000019,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),Autocuration,,U,12538,1,,0,A,,,7653,
,,CHEMBL623099,,22224,,BAO_0000019,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,Autocuration,,U,12539,1,,0,A,,,7653,
,,CHEMBL623100,,22224,,BAO_0000019,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,Autocuration,,U,12540,1,,0,A,,,7653,
,,CHEMBL628673,,50597,,BAO_0000218,Rattus norvegicus,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",Intermediate,10116.0,N,12541,1,,1,A,,,9104,
,,CHEMBL628674,,50597,,BAO_0000218,Rattus norvegicus,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",Intermediate,10116.0,N,12542,1,,1,A,,,9104,
,,CHEMBL628675,,50597,,BAO_0000218,Rattus norvegicus,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",Intermediate,10116.0,N,12543,1,,1,A,,,9104,
,,CHEMBL627644,,50597,,BAO_0000218,Rattus norvegicus,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",Intermediate,10116.0,N,12544,1,,1,A,,,9104,
,,CHEMBL627645,,50597,,BAO_0000218,Rattus norvegicus,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",Intermediate,10116.0,N,12545,1,,1,A,,,9104,
,,CHEMBL627646,,50597,,BAO_0000218,Rattus norvegicus,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",Intermediate,10116.0,N,12546,1,,1,A,,,9104,
,,CHEMBL627647,,50597,,BAO_0000218,Rattus norvegicus,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",Intermediate,10116.0,N,12547,1,,1,A,,,9104,
,,CHEMBL627648,,50597,,BAO_0000218,Rattus norvegicus,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",Intermediate,10116.0,N,12548,1,,1,A,,,9104,
,,CHEMBL627649,,50597,,BAO_0000218,Rattus norvegicus,,,Free level in rat plasma,Intermediate,10116.0,N,12549,1,,1,A,,,12902,
,,CHEMBL628313,,22224,,BAO_0000019,,,,Level reaching in blood plasma of rat or human was determined,Autocuration,,U,12550,1,,0,A,,,6614,
,,CHEMBL628314,,50597,,BAO_0000218,Rattus norvegicus,,,Log (Cbrain/Cblood) in rats,Intermediate,10116.0,N,12551,1,,1,A,,,9663,
,,CHEMBL628315,,22224,,BAO_0000019,,,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,Autocuration,,U,12552,1,,0,A,,,17658,
,,CHEMBL628316,,22224,,BAO_0000019,,,,Mean percentage of compound transport through membrane; expressed as membrane transport,Autocuration,,U,12553,1,,0,A,,,17658,
,,CHEMBL628317,,22224,,BAO_0000218,,,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,Autocuration,,U,12554,1,,0,A,,,14314,
,,CHEMBL628473,,22224,,BAO_0000019,,,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,Autocuration,,U,12555,1,,0,A,,,7385,
,,CHEMBL628474,,22224,,BAO_0000019,,,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",Autocuration,,U,12556,1,,0,A,,,7385,
,,CHEMBL628475,,22224,,BAO_0000019,,,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,Autocuration,,U,12557,1,,0,A,,,7385,
,,CHEMBL628476,,22224,,BAO_0000019,,,,Net water uptake by a carrier mediated transport (%cm) mechanism,Autocuration,,U,12558,1,,0,A,,,1329,
,,CHEMBL628477,,22224,,BAO_0000218,Simiiformes,,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,314293.0,U,12559,1,,0,A,,,12187,
,,CHEMBL628478,,50506,,BAO_0000218,Mustela putorius furo,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Intermediate,9669.0,N,12560,1,,1,A,,,12187,
,,CHEMBL628479,,50506,,BAO_0000218,Mustela putorius furo,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Intermediate,9669.0,N,12561,1,,1,A,,,12187,
,,CHEMBL628480,,22224,,BAO_0000218,Simiiformes,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,314293.0,U,12562,1,,0,A,,,12187,
,,CHEMBL628481,,22224,,BAO_0000218,Simiiformes,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",Autocuration,314293.0,U,12563,1,,0,A,,,12187,
,,CHEMBL628482,,50597,,BAO_0000218,Rattus norvegicus,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Intermediate,10116.0,N,12564,1,,1,A,,,12187,
,,CHEMBL628483,,50597,,BAO_0000218,Rattus norvegicus,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,10116.0,N,12565,1,,1,A,,,12187,
,,CHEMBL628484,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Intermediate,10116.0,N,12566,1,,1,A,,,9278,
,,CHEMBL628485,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,10116.0,N,12567,1,,1,A,,,9278,
,,CHEMBL628486,,100710,Plasma,BAO_0000218,Macaca fascicularis,1969.0,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",Intermediate,9541.0,N,12568,1,,1,A,,,9278,
,,CHEMBL628487,,50587,Plasma,BAO_0000218,Homo sapiens,1969.0,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",Intermediate,9606.0,N,12569,1,,1,A,,,9278,
,,CHEMBL628488,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Intermediate,10116.0,N,12570,1,,1,A,,,9278,
,,CHEMBL628489,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,10116.0,N,12571,1,,1,A,,,9278,
,,CHEMBL628490,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,10116.0,N,12572,1,,1,A,,,9278,
,,CHEMBL628491,,100710,,BAO_0000218,Macaca fascicularis,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,9541.0,N,12573,1,,1,A,,,12186,
,,CHEMBL877507,,100710,,BAO_0000218,Macaca fascicularis,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,9541.0,N,12574,1,,1,A,,,12186,
,,CHEMBL628492,,22224,,BAO_0000218,,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Autocuration,,U,12575,1,,0,A,,,12186,
,,CHEMBL628493,,22224,,BAO_0000019,Simiiformes,,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),Autocuration,314293.0,U,12576,1,,0,A,,,12041,
,,CHEMBL628494,,22224,,BAO_0000019,Simiiformes,,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),Autocuration,314293.0,U,12577,1,,0,A,,,12041,
,,CHEMBL628495,,22224,,BAO_0000019,Simiiformes,,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),Autocuration,314293.0,U,12578,1,,0,A,,,12041,
,,CHEMBL628496,,50587,,BAO_0000218,Homo sapiens,,,Permeability in Caco-2 assay at 10E-6,Intermediate,9606.0,N,12579,1,,1,A,,,6737,
,,CHEMBL628497,,22224,Brain,BAO_0000218,,955.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Autocuration,,U,12580,1,,0,A,,,13758,
,,CHEMBL628498,,22224,Brain,BAO_0000218,,955.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Autocuration,,U,12581,1,,0,A,,,13758,
,,CHEMBL628499,,22224,,BAO_0000019,,,,Plasma protein binding was determined,Autocuration,,U,12582,1,,0,A,,,5676,
,,CHEMBL627656,,22224,,BAO_0000218,,,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,U,12583,1,,0,A,,,14793,
,,CHEMBL627657,,22224,,BAO_0000218,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,U,12584,1,,0,A,,,14793,
,,CHEMBL626808,,22224,,BAO_0000218,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,U,12585,1,,0,A,,,14793,
,,CHEMBL626809,,22224,,BAO_0000218,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,U,12586,1,,0,A,,,14793,
,,CHEMBL626810,,22224,,BAO_0000218,,,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,U,12587,1,,0,A,,,14793,
,,CHEMBL626811,,22224,,BAO_0000218,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,U,12588,1,,0,A,,,14793,
,,CHEMBL874465,,22224,,BAO_0000218,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,U,12589,1,,0,A,,,14793,
,,CHEMBL626812,,22224,,BAO_0000218,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,U,12590,1,,0,A,,,14793,
,,CHEMBL626813,,22224,,BAO_0000218,,,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,U,12591,1,,0,A,,,14793,
,,CHEMBL626814,,22224,,BAO_0000218,,,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,U,12592,1,,0,A,,,14793,
,,CHEMBL626815,,22224,,BAO_0000019,,,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,Autocuration,,U,12593,1,,0,A,,,14000,
,,CHEMBL628566,,22224,,BAO_0000019,,,,Partition coefficient (logP),Autocuration,,U,12594,1,,0,A,,,5948,
,,CHEMBL628567,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,,U,12595,1,,0,P,,,13824,
,,CHEMBL628568,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12596,1,,0,P,,,10778,
In vivo,,CHEMBL628569,,50588,,BAO_0000218,Canis lupus familiaris,,,C max in dog,Intermediate,9615.0,N,12597,1,,1,A,,,17237,
In vivo,,CHEMBL628570,,50512,,BAO_0000218,Cavia porcellus,,,C max in guinea pig,Intermediate,10141.0,N,12598,1,,1,A,,,17237,
In vivo,,CHEMBL628571,,22224,,BAO_0000218,,,,C max value was evaluated,Autocuration,,U,12599,1,,0,A,,,2809,
In vivo,,CHEMBL628572,,22224,,BAO_0000218,,,,Cmax value after oral dose of 0.1 mg//kg,Autocuration,,U,12600,1,,0,A,,,11954,
In vivo,,CHEMBL628573,,22224,,BAO_0000218,,,,Cmax value after oral dose of 0.3 mg/kg,Autocuration,,U,12601,1,,0,A,,,11954,
In vivo,,CHEMBL628574,,22224,,BAO_0000218,,,,Cmax value after oral dose of 1 mg/kg,Autocuration,,U,12602,1,,0,A,,,11954,
In vivo,,CHEMBL628575,,22224,,BAO_0000218,,,,Cmax value after oral dose of 10 mg/kg,Autocuration,,U,12603,1,,0,A,,,11954,
In vivo,,CHEMBL628576,,22224,,BAO_0000218,,,,Cmax value after oral dose of 23.4 mg/kg,Autocuration,,U,12604,1,,0,A,,,11954,
In vivo,,CHEMBL628577,,22224,,BAO_0000218,,,,Cmax value after oral dose of 3 mg/kg,Autocuration,,U,12605,1,,0,A,,,11954,
In vivo,,CHEMBL628578,,22224,,BAO_0000218,,,,Cmax value after oral dose of 3.87 mg/kg,Autocuration,,U,12606,1,,0,A,,,11954,
In vivo,,CHEMBL874466,,50588,,BAO_0000218,Canis lupus familiaris,,,Cmax value in female Beagle dogs,Intermediate,9615.0,N,12607,1,,1,A,,,12768,
In vivo,,CHEMBL628579,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax value in male rats,Intermediate,10116.0,N,12608,1,,1,A,,,12768,
In vivo,,CHEMBL628580,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Cmax value in rat plasma when administered 20 mg/kg perorally,Intermediate,10116.0,N,12609,1,,1,A,,,12780,
In vivo,,CHEMBL628581,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,9615.0,N,12610,1,,1,A,,,15592,
In vivo,,CHEMBL628582,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,9615.0,N,12611,1,,1,A,,,15592,
,,CHEMBL628583,,50588,,BAO_0000218,Canis lupus familiaris,,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,Intermediate,9615.0,N,12612,1,,1,A,,,17025,
,,CHEMBL625782,,22224,,BAO_0000218,Simiiformes,,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,314293.0,U,12613,1,,0,A,,,17025,
,,CHEMBL625783,,50592,,BAO_0000218,Oryctolagus cuniculus,,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,9986.0,N,12614,1,,1,A,,,17025,
,,CHEMBL625784,,50597,,BAO_0000218,Rattus norvegicus,,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,Intermediate,10116.0,N,12615,1,,1,A,,,17025,
,,CHEMBL625785,,50797,Plasma,BAO_0000218,Macaca mulatta,1969.0,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,Intermediate,9544.0,N,12616,1,,1,A,,,4236,
,,CHEMBL625786,,50597,,BAO_0000218,Rattus norvegicus,,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,Intermediate,10116.0,N,12617,1,,1,A,,,15791,
,,CHEMBL874467,,22224,,BAO_0000019,,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,Autocuration,,U,12618,1,,0,A,,,11149,
,,CHEMBL625787,,50588,,BAO_0000218,Canis lupus familiaris,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Intermediate,9615.0,N,12619,1,,1,A,,,15592,
,,CHEMBL625964,,50677,,BAO_0000218,Human immunodeficiency virus,,,cytotoxicity against HIV protease enzyme.,Intermediate,12721.0,N,12620,1,,1,A,,,15778,
,,CHEMBL625965,,50594,,BAO_0000218,Mus musculus,,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,Intermediate,10090.0,N,12621,1,,1,A,,,12745,
,,CHEMBL625966,,50594,,BAO_0000218,Mus musculus,,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,Intermediate,10090.0,N,12622,1,,1,A,,,12745,
In vivo,,CHEMBL625967,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,The plasma clearance in dog.,Intermediate,9615.0,N,12623,1,,1,A,,,13941,
In vivo,,CHEMBL625968,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The plasma clearance in rat.,Intermediate,10116.0,N,12624,1,,1,A,,,13941,
In vivo,,CHEMBL625969,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Clearance from plasma in male Sprague-Dawley rats,Intermediate,10116.0,N,12625,1,,1,A,,,16449,
In vivo,,CHEMBL625970,,100710,Plasma,BAO_0000218,Macaca fascicularis,1969.0,,Clearance from plasma in male cynomolgus monkeys,Intermediate,9541.0,N,12626,1,,1,A,,,16449,
In vivo,,CHEMBL625971,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",Intermediate,9615.0,N,12627,1,,1,A,,,14224,
In vivo,,CHEMBL625972,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Clearance of compound in dog plasma,Intermediate,9615.0,N,12628,1,,1,A,,,14224,
In vivo,,CHEMBL625973,,50587,Plasma,BAO_0000218,Homo sapiens,1969.0,,Clearance of compound in human plasma,Intermediate,9606.0,N,12629,1,,1,A,,,14224,
In vivo,,CHEMBL625974,,50588,,BAO_0000218,Canis lupus familiaris,,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,Intermediate,9615.0,N,12630,1,,1,A,,,14317,
In vivo,,CHEMBL625975,,50588,,BAO_0000218,Canis lupus familiaris,,,Clearance of compound when administered intravenously as an individual dose to a single dog.,Intermediate,9615.0,N,12631,1,,1,A,,,14317,
In vivo,,CHEMBL625976,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,"Clearance (10 mg/kg, intravenously) in dog plasma",Intermediate,9615.0,N,12632,1,,1,A,,,14224,
In vivo,,CHEMBL625977,,50588,,BAO_0000218,Canis lupus familiaris,,,Clearance value in dog,Intermediate,9615.0,N,12633,1,,1,A,,,17237,
In vivo,,CHEMBL625978,,50512,,BAO_0000218,Cavia porcellus,,,Clearance value in guinea pig,Intermediate,10141.0,N,12634,1,,1,A,,,17237,
In vivo,,CHEMBL874468,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance values in rats after iv administration.,Intermediate,10116.0,N,12635,1,,1,A,,,14187,
In vivo,,CHEMBL625421,,22224,Plasma,BAO_0000218,,1969.0,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,Autocuration,,U,12636,1,,0,A,,,4806,
In vivo,,CHEMBL625422,,50592,,BAO_0000218,Oryctolagus cuniculus,,,In vivo clearance (5 mg/kg) was determined in rabbits,Intermediate,9986.0,N,12637,1,,1,A,,,15025,
In vivo,,CHEMBL625423,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma Clearance rate was determined for the compound in rats,Intermediate,10116.0,N,12638,1,,1,A,,,13197,
In vivo,,CHEMBL625424,,22224,,BAO_0000218,Saimiri,,,Plasma Clearance rate was determined for the compound in squirrel monkeys,Autocuration,9520.0,U,12639,1,,0,A,,,13197,
In vivo,,CHEMBL625425,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance in rat,Intermediate,10116.0,N,12640,1,,1,A,,,13960,
In vivo,,CHEMBL625426,,22224,,BAO_0000218,,,,Plasma clearance of the compound,Autocuration,,U,12641,1,,0,A,,,17820,
In vivo,,CHEMBL625427,,50512,,BAO_0000218,Cavia porcellus,,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,Intermediate,10141.0,N,12642,1,,1,A,,,14706,
In vivo,,CHEMBL625428,,50512,,BAO_0000218,Cavia porcellus,,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,Intermediate,10141.0,N,12643,1,,1,A,,,14706,
In vivo,,CHEMBL625429,,22224,,BAO_0000218,,,,Plasma clearance was determined,Autocuration,,U,12644,1,,0,A,,,6504,
In vivo,,CHEMBL625430,,50588,,BAO_0000218,Canis lupus familiaris,,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,Intermediate,9615.0,N,12645,1,,1,A,,,14925,
In vivo,,CHEMBL625431,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance rate was determined for the compound in rats,Intermediate,10116.0,N,12646,1,,1,A,,,13197,
In vivo,,CHEMBL627307,,22224,,BAO_0000218,Saimiri,,,Plasma clearance rate was determined for the compound in squirrel monkeys,Autocuration,9520.0,U,12647,1,,0,A,,,13197,
In vivo,,CHEMBL627308,,22224,,BAO_0000218,,,,Slow clearance (CL) was determined,Autocuration,,U,12648,1,,0,A,,,3437,
,,CHEMBL627309,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,,U,12649,1,,0,A,,,9196,
,,CHEMBL627310,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,Autocuration,,U,12650,1,,0,A,,,9196,
,,CHEMBL627311,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,Autocuration,,U,12651,1,,0,A,,,9196,
,,CHEMBL627312,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,,U,12652,1,,0,A,,,9196,
,,CHEMBL627313,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,Autocuration,,U,12653,1,,0,A,,,9196,
,,CHEMBL627314,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,,U,12654,1,,0,A,,,9196,
,,CHEMBL627315,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,,U,12655,1,,0,A,,,9196,
,,CHEMBL627316,,22224,,BAO_0000218,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,U,12656,1,,0,A,,,9196,
,,CHEMBL627317,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,U,12657,1,,0,A,,,9196,
,,CHEMBL627318,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,U,12658,1,,0,A,,,9196,
,,CHEMBL627999,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,Autocuration,,U,12659,1,,0,A,,,9196,
,,CHEMBL628000,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,U,12660,1,,0,A,,,9196,
,,CHEMBL628001,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,,U,12661,1,,0,A,,,9196,
,,CHEMBL628002,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,U,12662,1,,0,A,,,9196,
,,CHEMBL625610,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,,U,12663,1,,0,A,,,9196,
,,CHEMBL625611,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,U,12664,1,,0,A,,,9196,
,,CHEMBL625612,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,Autocuration,,U,12665,1,,0,A,,,9196,
,,CHEMBL625613,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,Autocuration,,U,12666,1,,0,A,,,9196,
,,CHEMBL875479,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,U,12667,1,,0,A,,,9196,
,,CHEMBL625614,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,,U,12668,1,,0,A,,,9196,
,,CHEMBL625615,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,,U,12669,1,,0,A,,,9196,
,,CHEMBL626302,,22224,,BAO_0000218,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,Autocuration,,U,12670,1,,0,A,,,9196,
,,CHEMBL626303,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12671,1,,1,A,,,8374,
,,CHEMBL627420,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,10116.0,N,12672,1,,1,A,,,8374,
,,CHEMBL627421,,50597,,BAO_0000218,Rattus norvegicus,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,Intermediate,10116.0,N,12673,1,,1,A,,,13477,
,,CHEMBL625695,,50597,,BAO_0000218,Rattus norvegicus,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,Intermediate,10116.0,N,12674,1,,1,A,,,13477,
,,CHEMBL625696,,50597,,BAO_0000218,Rattus norvegicus,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,Intermediate,10116.0,N,12675,1,,1,A,,,13477,
,,CHEMBL875606,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Distribution of compound in mice brain was measured after 1 hr,Intermediate,10090.0,N,12676,1,,1,A,,,10009,
,,CHEMBL625697,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Distribution of compound in mice brain was measured after 24 hr r,Intermediate,10090.0,N,12677,1,,1,A,,,10009,
,,CHEMBL625698,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Distribution of compound in mice brain was measured after 2 hr,Intermediate,10090.0,N,12678,1,,1,A,,,10009,
,,CHEMBL625699,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Distribution of compound in mice brain was measured after 3 hr,Intermediate,10090.0,N,12679,1,,1,A,,,10009,
,,CHEMBL625700,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Distribution of compound in mice brain was measured after 6 hr,Intermediate,10090.0,N,12680,1,,1,A,,,10009,
,,CHEMBL625701,,50594,,BAO_0000218,Mus musculus,,,Distribution of compound in mice liver was measured after 1 hr,Intermediate,10090.0,N,12681,1,,1,A,,,10009,
,,CHEMBL625702,,50594,,BAO_0000218,Mus musculus,,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,Intermediate,10090.0,N,12682,1,,1,A,,,10009,
,,CHEMBL625703,,50594,,BAO_0000218,Mus musculus,,,Distribution of compound in mice liver was measured after 2 hr,Intermediate,10090.0,N,12683,1,,1,A,,,10009,
,,CHEMBL625704,,50594,,BAO_0000218,Mus musculus,,,Distribution of compound in mice liver was measured after 3 hr,Intermediate,10090.0,N,12684,1,,1,A,,,10009,
,,CHEMBL625705,,50594,,BAO_0000218,Mus musculus,,,Distribution of compound in mice liver was measured after 6 hr,Intermediate,10090.0,N,12685,1,,1,A,,,10009,
,,CHEMBL625706,,50588,Adrenal medulla,BAO_0000218,Canis lupus familiaris,1236.0,,Distribution in dog adrenal medulla 30 min after administration.,Intermediate,9615.0,N,12686,1,,1,A,,,8170,
,,CHEMBL625707,,50588,Adrenal medulla,BAO_0000218,Canis lupus familiaris,1236.0,,Distribution in dog adrenal medulla 72 hours after administration.,Intermediate,9615.0,N,12687,1,,1,A,,,8170,
,,CHEMBL625708,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog Ovary 24 hours after administration.,Intermediate,9615.0,N,12688,1,,1,A,,,8170,
,,CHEMBL625709,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog Ovary 72 hours after administration.,Intermediate,9615.0,N,12689,1,,1,A,,,8170,
,,CHEMBL624180,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog adipose 24 hours after administration.,Intermediate,9615.0,N,12690,1,,1,A,,,8170,
,,CHEMBL624181,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog adipose 72 hours after administration.,Intermediate,9615.0,N,12691,1,,1,A,,,8170,
,,CHEMBL624182,,50588,Adrenal cortex,BAO_0000218,Canis lupus familiaris,1235.0,,Distribution in female dog adrenal cortex 72 hours after administration.,Intermediate,9615.0,N,12692,1,,1,A,,,8170,
,,CHEMBL624183,,50588,Adrenal cortex,BAO_0000218,Canis lupus familiaris,1235.0,,Distribution in female dog adrenal cortex 72 hours after administration.,Intermediate,9615.0,N,12693,1,,1,A,,,8170,
,,CHEMBL624184,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,10116.0,N,12694,1,,1,A,,,8594,
,,CHEMBL877489,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,10116.0,N,12695,1,,1,A,,,8594,
,,CHEMBL624185,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12696,1,,1,A,,,8594,
,,CHEMBL624186,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12697,1,,1,A,,,8594,
,,CHEMBL624187,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12698,1,,1,A,,,8594,
,,CHEMBL624188,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12699,1,,1,A,,,8594,
,,CHEMBL624189,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12700,1,,1,A,,,8594,
,,CHEMBL624190,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12701,1,,1,A,,,8594,
,,CHEMBL624191,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12702,1,,1,A,,,8594,
,,CHEMBL624192,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12703,1,,1,A,,,8594,
,,CHEMBL624193,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,10116.0,N,12704,1,,1,A,,,8594,
,,CHEMBL624194,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,10116.0,N,12705,1,,1,A,,,8594,
,,CHEMBL624891,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12706,1,,1,A,,,8594,
,,CHEMBL624892,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12707,1,,1,A,,,8594,
,,CHEMBL624893,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12708,1,,1,A,,,8594,
,,CHEMBL627632,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12709,1,,1,A,,,8594,
,,CHEMBL627633,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12710,1,,1,A,,,8594,
,,CHEMBL627634,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12711,1,,1,A,,,8594,
,,CHEMBL627635,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12712,1,,1,A,,,8594,
,,CHEMBL627636,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12713,1,,1,A,,,8594,
,,CHEMBL626816,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,10116.0,N,12714,1,,1,A,,,8594,
,,CHEMBL626817,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,10116.0,N,12715,1,,1,A,,,8594,
,,CHEMBL626818,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12716,1,,1,A,,,8594,
,,CHEMBL626819,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12717,1,,1,A,,,8594,
,,CHEMBL626820,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12718,1,,1,A,,,8594,
,,CHEMBL626821,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12719,1,,1,A,,,8594,
,,CHEMBL626822,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12720,1,,1,A,,,8594,
,,CHEMBL626823,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12721,1,,1,A,,,8594,
,,CHEMBL626824,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12722,1,,1,A,,,8594,
,,CHEMBL626825,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12723,1,,1,A,,,8594,
,,CHEMBL626826,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,10116.0,N,12724,1,,1,A,,,8594,
,,CHEMBL626827,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,10116.0,N,12725,1,,1,A,,,8594,
,,CHEMBL626828,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12726,1,,1,A,,,8594,
,,CHEMBL626829,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12727,1,,1,A,,,8594,
,,CHEMBL626830,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12728,1,,1,A,,,8594,
,,CHEMBL627150,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12729,1,,1,A,,,8594,
,,CHEMBL627151,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12730,1,,1,A,,,8594,
,,CHEMBL627152,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,10116.0,N,12731,1,,1,A,,,8594,
,,CHEMBL627153,,50597,,BAO_0000218,Rattus norvegicus,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,10116.0,N,12732,1,,1,A,,,8594,
,,CHEMBL627154,,22224,,BAO_0000019,,,,Rate of acetate production by the compound was determined,Autocuration,,U,12733,1,,0,A,,,12904,
,,CHEMBL627155,,22224,,BAO_0000019,,,,Rate of acetate production by the compound was determined; Not determined,Autocuration,,U,12734,1,,0,A,,,12904,
,,CHEMBL627156,,22224,,BAO_0000019,,,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,Autocuration,,U,12735,1,,0,A,,,3730,
,,CHEMBL627157,,22224,,BAO_0000019,,,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,Autocuration,,U,12736,1,,0,A,,,3627,
,,CHEMBL627158,,50592,,BAO_0000218,Oryctolagus cuniculus,,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Intermediate,9986.0,N,12737,1,,1,A,,,13799,
,,CHEMBL627159,,50592,Plasma,BAO_0000218,Oryctolagus cuniculus,1969.0,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Intermediate,9986.0,N,12738,1,,1,A,,,13799,
,,CHEMBL627160,,50594,,BAO_0000218,Mus musculus,,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,10090.0,N,12739,1,,1,A,,,13799,
,,CHEMBL628540,,50597,,BAO_0000218,Rattus norvegicus,,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,10116.0,N,12740,1,,1,A,,,13799,
,,CHEMBL628541,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,10116.0,N,12741,1,,1,A,,,13799,
,,CHEMBL628542,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,10116.0,N,12742,1,,1,A,,,13799,
,,CHEMBL628543,,22229,,BAO_0000100,,,,Solubility after at a pH 1.2,Autocuration,,U,12743,1,,0,P,,,6629,
,,CHEMBL628544,,22229,,BAO_0000100,,,,Solubility after at pH 1.2,Autocuration,,U,12744,1,,0,P,,,6629,
,,CHEMBL628545,,22229,,BAO_0000100,,,,Solubility after injection of water,Autocuration,,U,12745,1,,0,P,,,6629,
,,CHEMBL628546,,22224,,BAO_0000019,,,,Statistical significance of IC 50 values; Expressed as R value,Autocuration,,U,12746,1,,0,A,,,14000,
,,CHEMBL874455,,22224,,BAO_0000019,,,,Systemic availability with respect to methyldopa was determined,Autocuration,,U,12747,1,,0,A,,,8267,
,,CHEMBL628547,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,Intermediate,10116.0,N,12748,1,,1,A,,,13799,
,,CHEMBL628548,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,Intermediate,10116.0,N,12749,1,,1,A,,,13799,
,,CHEMBL628549,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",Intermediate,9986.0,N,12750,1,,1,A,,,7132,
,,CHEMBL628550,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",Intermediate,9986.0,N,12751,1,,1,A,,,7132,
,,CHEMBL628551,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",Intermediate,9986.0,N,12752,1,,1,A,,,7132,
,,CHEMBL628552,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",Intermediate,9986.0,N,12753,1,,1,A,,,7132,
,,CHEMBL628553,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",Intermediate,9986.0,N,12754,1,,1,A,,,7132,
,,CHEMBL628554,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",Intermediate,9986.0,N,12755,1,,1,A,,,7132,
,,CHEMBL628555,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",Intermediate,9986.0,N,12756,1,,1,A,,,7132,
,,CHEMBL628556,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",Intermediate,9986.0,N,12757,1,,1,A,,,7132,
,,CHEMBL628557,,50592,Kidney,BAO_0000218,Oryctolagus cuniculus,2113.0,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",Intermediate,9986.0,N,12758,1,,1,A,,,7132,
,,CHEMBL628558,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",Intermediate,9986.0,N,12759,1,,1,A,,,7132,
,,CHEMBL628559,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",Intermediate,9986.0,N,12760,1,,1,A,,,7132,
,,CHEMBL628560,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",Intermediate,9986.0,N,12761,1,,1,A,,,7132,
,,CHEMBL874456,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",Intermediate,9986.0,N,12762,1,,1,A,,,7132,
,,CHEMBL628561,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",Intermediate,9986.0,N,12763,1,,1,A,,,7132,
,,CHEMBL628562,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",Intermediate,9986.0,N,12764,1,,1,A,,,7132,
,,CHEMBL628563,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",Intermediate,9986.0,N,12765,1,,1,A,,,7132,
,,CHEMBL628564,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",Intermediate,9986.0,N,12766,1,,1,A,,,7132,
,,CHEMBL628565,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",Intermediate,9986.0,N,12767,1,,1,A,,,7132,
,,CHEMBL631248,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",Intermediate,9986.0,N,12768,1,,1,A,,,7132,
,,CHEMBL631249,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",Intermediate,9986.0,N,12769,1,,1,A,,,7132,
,,CHEMBL627214,,50592,Kidney,BAO_0000218,Oryctolagus cuniculus,2113.0,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",Intermediate,9986.0,N,12770,1,,1,A,,,7132,
,,CHEMBL874591,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",Intermediate,9986.0,N,12771,1,,1,A,,,7132,
,,CHEMBL627215,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",Intermediate,9986.0,N,12772,1,,1,A,,,7132,
,,CHEMBL625471,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,Intermediate,9986.0,N,12773,1,,1,A,,,7132,
,,CHEMBL625472,,50592,,BAO_0000218,Oryctolagus cuniculus,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,Intermediate,9986.0,N,12774,1,,1,A,,,7132,
,,CHEMBL625473,,50592,,BAO_0000218,Oryctolagus cuniculus,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,Intermediate,9986.0,N,12775,1,,1,A,,,7132,
In vivo,,CHEMBL625474,,50588,,BAO_0000218,Canis lupus familiaris,,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,Intermediate,9615.0,N,12776,1,,1,A,,,13317,
In vivo,,CHEMBL625475,,50588,,BAO_0000218,Canis lupus familiaris,,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,Intermediate,9615.0,N,12777,1,,1,A,,,15341,
In vivo,,CHEMBL625476,,50597,,BAO_0000218,Rattus norvegicus,,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,Intermediate,10116.0,N,12778,1,,1,A,,,15341,
In vivo,,CHEMBL625477,,50597,,BAO_0000218,Rattus norvegicus,,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,Intermediate,10116.0,N,12779,1,,1,A,,,15341,
In vivo,,CHEMBL625478,,50597,,BAO_0000218,Rattus norvegicus,,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,Intermediate,10116.0,N,12780,1,,1,A,,,15341,
In vitro,,CHEMBL625479,,50597,esophageal tunica muscularis mucosae,BAO_0000218,Rattus norvegicus,,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,Intermediate,10116.0,N,12781,1,,1,A,,,12801,
In vitro,,CHEMBL625480,,50597,esophageal tunica muscularis mucosae,BAO_0000218,Rattus norvegicus,,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,Intermediate,10116.0,N,12782,1,,1,A,,,12801,
In vivo,,CHEMBL625481,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,Intermediate,10116.0,N,12783,1,,1,A,,,14856,
In vivo,,CHEMBL625482,,50597,,BAO_0000218,Rattus norvegicus,,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,Intermediate,10116.0,N,12784,1,,1,A,,,14062,
In vivo,,CHEMBL625483,,50597,,BAO_0000218,Rattus norvegicus,,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,Intermediate,10116.0,N,12785,1,,1,A,,,14062,
In vivo,,CHEMBL625484,,50597,,BAO_0000218,Rattus norvegicus,,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,Intermediate,10116.0,N,12786,1,,1,A,,,14062,
In vivo,,CHEMBL625485,,50597,,BAO_0000218,Rattus norvegicus,,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,Intermediate,10116.0,N,12787,1,,1,A,,,14062,
In vivo,,CHEMBL625486,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,Intermediate,9615.0,N,12788,1,,1,A,,,14346,
In vivo,,CHEMBL625487,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,Intermediate,10116.0,N,12789,1,,1,A,,,14346,
In vivo,,CHEMBL625488,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,Intermediate,10116.0,N,12790,1,,1,A,,,14346,
In vivo,,CHEMBL625489,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,Intermediate,10116.0,N,12791,1,,1,A,,,14346,
In vivo,,CHEMBL625490,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,Intermediate,10116.0,N,12792,1,,1,A,,,14346,
In vivo,,CHEMBL625491,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,Intermediate,9615.0,N,12793,1,,1,A,,,14346,
In vivo,,CHEMBL625492,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,Intermediate,10116.0,N,12794,1,,1,A,,,14346,
In vivo,,CHEMBL625493,,50587,Plasma,BAO_0000218,Homo sapiens,1969.0,,plasma clearance in human,Intermediate,9606.0,N,12795,1,,1,A,,,15711,
In vivo,,CHEMBL625494,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Intermediate,10116.0,N,12796,1,,1,A,,,14886,
In vivo,,CHEMBL625495,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Intermediate,10116.0,N,12797,1,,1,A,,,14886,
In vivo,,CHEMBL625496,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Intermediate,10116.0,N,12798,1,,1,A,,,14886,
,,CHEMBL625497,,22229,,BAO_0000100,,,,1-Octanol/water partition coefficient measured at 7.4,Autocuration,,U,12799,1,,0,P,,,4115,
,,CHEMBL625498,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12800,1,,0,P,,,13733,
,,CHEMBL625499,,22224,,BAO_0000019,,,,Partition coefficient (logP),Autocuration,,U,12801,1,,0,A,,,12102,
,,CHEMBL625500,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12802,1,,0,P,,,12676,
,,CHEMBL625501,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12803,1,,0,P,,,13733,
,,CHEMBL625502,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12804,1,,0,P,,,13740,
,,CHEMBL625503,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP) (relative to BAY K 8644),Autocuration,,U,12805,1,,0,P,,,12766,
,,CHEMBL625504,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12806,1,,0,P,,,2764,
,,CHEMBL625505,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12807,1,,0,P,,,12355,
,,CHEMBL625506,,22229,,BAO_0000100,,,,Calculated partition coefficient of the compound,Autocuration,,U,12808,1,,0,P,,,11314,
,,CHEMBL625507,,22224,,BAO_0000019,,,,Partition coefficient (logP),Autocuration,,U,12809,1,,0,A,,,12706,
,,CHEMBL625508,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12810,1,,0,P,,,12645,
,,CHEMBL625509,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12811,1,,0,P,,,13668,
,,CHEMBL625510,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12812,1,,0,P,,,12819,
,,CHEMBL883125,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12813,1,,0,P,,,13668,
,,CHEMBL625511,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12814,1,,0,P,,,13017,
,,CHEMBL874650,,22224,,BAO_0000019,,,,Partition coefficient of the compound,Autocuration,,U,12815,1,,0,A,,,2448,
,,CHEMBL625512,,22224,,BAO_0000019,,,,Partition coefficient of the compound,Autocuration,,U,12816,1,,0,A,,,11526,
,,CHEMBL625513,,22224,,BAO_0000019,,,,Partition coefficient of compound was determined,Autocuration,,U,12817,1,,0,A,,,12426,
,,CHEMBL625514,,22224,,BAO_0000019,,,,Partition coefficient was determined,Autocuration,,U,12818,1,,0,A,,,2448,
,,CHEMBL625515,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12819,1,,0,P,,,12001,
,,CHEMBL625516,,22229,,BAO_0000100,,,,partition coefficient of compound was determined,Autocuration,,U,12820,1,,0,P,,,12426,
In vivo,,CHEMBL625517,,50588,,BAO_0000218,Canis lupus familiaris,,,The total body administered intravenously in dog,Intermediate,9615.0,N,12821,1,,1,A,,,13204,
In vivo,,CHEMBL625518,,50597,,BAO_0000218,Rattus norvegicus,,,The total body administered intravenously in rats,Intermediate,10116.0,N,12822,1,,1,A,,,13204,
,,CHEMBL625519,,50594,,BAO_0000218,Mus musculus,,,Time taken for the administration to female NIH mice weighing 25-30 g.,Intermediate,10090.0,N,12823,1,,1,A,,,13889,
,,CHEMBL625520,,22224,,BAO_0000019,,,,Time taken for the administration,Autocuration,,U,12824,1,,0,A,,,13889,
In vivo,,CHEMBL874651,,50588,,BAO_0000218,Canis lupus familiaris,,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,Intermediate,9615.0,N,12825,1,,1,A,,,17025,
In vivo,,CHEMBL625521,,22224,,BAO_0000218,Simiiformes,,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,314293.0,U,12826,1,,0,A,,,17025,
In vivo,,CHEMBL623171,,50592,,BAO_0000218,Oryctolagus cuniculus,,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,9986.0,N,12827,1,,1,A,,,17025,
In vivo,,CHEMBL623853,,50597,,BAO_0000218,Rattus norvegicus,,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,Intermediate,10116.0,N,12828,1,,1,A,,,17025,
,,CHEMBL623854,,22224,,BAO_0000019,,,,Plasma clearance for the compound was determined.,Autocuration,,U,12829,1,,0,A,,,15067,
,,CHEMBL874405,,22224,,BAO_0000100,,,,CLog P value of the compound,Autocuration,,U,12830,1,,0,P,,,3091,
,,CHEMBL623855,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12831,1,,0,P,,,15592,
,,CHEMBL623856,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12832,1,,0,P,,,14738,
,,CHEMBL623857,,22224,,BAO_0000100,,,,ClogP value of the compound; nd ='no data',Autocuration,,U,12833,1,,0,P,,,14738,
,,CHEMBL623858,,22224,,BAO_0000100,,,,ClogP value of the compound; nd ='not determined',Autocuration,,U,12834,1,,0,P,,,14738,
,,CHEMBL623859,,22224,,BAO_0000100,,,,CLog P was determined,Autocuration,,U,12835,1,,0,P,,,6076,
,,CHEMBL839829,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12836,1,,0,P,,,17840,
,,CHEMBL623860,,22224,,BAO_0000019,,,,CLogP was calculated,Autocuration,,U,12837,1,,0,A,,,13589,
,,CHEMBL623861,,22224,,BAO_0000019,,,,CLogP value was determined,Autocuration,,U,12838,1,,0,A,,,17655,
,,CHEMBL623862,,22224,,BAO_0000019,,,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,Autocuration,,U,12839,1,,0,A,,,5867,
,,CHEMBL874406,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12840,1,,0,P,,,5867,
,,CHEMBL623863,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12841,1,,0,P,,,10783,
,,CHEMBL624021,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12842,1,,0,P,,,14849,
,,CHEMBL624022,,50588,Adrenal medulla,BAO_0000218,Canis lupus familiaris,1236.0,,Distribution in female dog adrenal medulla 24 hours after administration.,Intermediate,9615.0,N,12843,1,,1,A,,,8170,
,,CHEMBL624023,,50588,Adrenal medulla,BAO_0000218,Canis lupus familiaris,1236.0,,Distribution in female dog adrenal medulla 72 hours after administration.,Intermediate,9615.0,N,12844,1,,1,A,,,8170,
,,CHEMBL624024,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog bile 24 hours after administration.,Intermediate,9615.0,N,12845,1,,1,A,,,8170,
,,CHEMBL624025,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog bile 72 hr after administration.,Intermediate,9615.0,N,12846,1,,1,A,,,8170,
,,CHEMBL624026,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog blood 24 hours after administration.,Intermediate,9615.0,N,12847,1,,1,A,,,8170,
,,CHEMBL624027,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog blood 72 hours after administration.,Intermediate,9615.0,N,12848,1,,1,A,,,8170,
,,CHEMBL624028,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog heart 24 hours after administration.,Intermediate,9615.0,N,12849,1,,1,A,,,8170,
,,CHEMBL624029,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog heart 72 hours after administration.,Intermediate,9615.0,N,12850,1,,1,A,,,8170,
,,CHEMBL624030,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog kidney 24 hours after administration.,Intermediate,9615.0,N,12851,1,,1,A,,,8170,
,,CHEMBL624031,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog kidney 72 hours after administration.,Intermediate,9615.0,N,12852,1,,1,A,,,8170,
,,CHEMBL624032,,50588,Intestine,BAO_0000218,Canis lupus familiaris,160.0,,Distribution in female dog large intestine 24 hours after administration.,Intermediate,9615.0,N,12853,1,,1,A,,,8170,
,,CHEMBL874407,,50588,Intestine,BAO_0000218,Canis lupus familiaris,160.0,,Distribution in female dog large intestine 72 hours after administration.,Intermediate,9615.0,N,12854,1,,1,A,,,8170,
,,CHEMBL624033,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog liver 24 hours after administration.,Intermediate,9615.0,N,12855,1,,1,A,,,8170,
,,CHEMBL624034,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog liver 72 hours after administration.,Intermediate,9615.0,N,12856,1,,1,A,,,8170,
,,CHEMBL624035,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog lung 24 hours after administration.,Intermediate,9615.0,N,12857,1,,1,A,,,8170,
,,CHEMBL624036,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog lung 72 hours after administration.,Intermediate,9615.0,N,12858,1,,1,A,,,8170,
,,CHEMBL624037,,50588,Muscle tissue,BAO_0000218,Canis lupus familiaris,2385.0,,Distribution in female dog muscle 24 hours after administration.,Intermediate,9615.0,N,12859,1,,1,A,,,8170,
,,CHEMBL624038,,50588,Muscle tissue,BAO_0000218,Canis lupus familiaris,2385.0,,Distribution in female dog muscle 72 hours after administration.,Intermediate,9615.0,N,12860,1,,1,A,,,8170,
,,CHEMBL624039,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog pancreas 24 hours after administration.,Intermediate,9615.0,N,12861,1,,1,A,,,8170,
,,CHEMBL624040,,50588,,BAO_0000218,Canis lupus familiaris,,,Distribution in female dog pancreas 72 hours after administration.,Intermediate,9615.0,N,12862,1,,1,A,,,8170,
,,CHEMBL624041,,50588,Intestine,BAO_0000218,Canis lupus familiaris,160.0,,Distribution in female dog small intestine 24 hours after administration.,Intermediate,9615.0,N,12863,1,,1,A,,,8170,
,,CHEMBL624042,,50588,Intestine,BAO_0000218,Canis lupus familiaris,160.0,,Distribution in female dog small intestine 72 hours after administration.,Intermediate,9615.0,N,12864,1,,1,A,,,8170,
,,CHEMBL624043,,50588,Spleen,BAO_0000218,Canis lupus familiaris,2106.0,,Distribution in female dog spleen 24 hours after administration.,Intermediate,9615.0,N,12865,1,,1,A,,,8170,
,,CHEMBL624044,,50588,Spleen,BAO_0000218,Canis lupus familiaris,2106.0,,Distribution in female dog spleen 72 hours after administration.,Intermediate,9615.0,N,12866,1,,1,A,,,8170,
,,CHEMBL624045,,50588,Stomach,BAO_0000218,Canis lupus familiaris,945.0,,Distribution in female dog stomach 24 hours after administration.,Intermediate,9615.0,N,12867,1,,1,A,,,8170,
,,CHEMBL624046,,50588,Stomach,BAO_0000218,Canis lupus familiaris,945.0,,Distribution in female dog stomach 72 hours after administration.,Intermediate,9615.0,N,12868,1,,1,A,,,8170,
,,CHEMBL624047,,50588,Thyroid gland,BAO_0000218,Canis lupus familiaris,2046.0,,Distribution in female dog thyroid 24 hours after administration.,Intermediate,9615.0,N,12869,1,,1,A,,,8170,
,,CHEMBL624048,,50588,Thyroid gland,BAO_0000218,Canis lupus familiaris,2046.0,,Distribution in female dog thyroid 72 hours after administration.,Intermediate,9615.0,N,12870,1,,1,A,,,8170,
,,CHEMBL874408,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Distribution in female dog urine 24 hours after administration.,Intermediate,9615.0,N,12871,1,,1,A,,,8170,
,,CHEMBL624049,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Distribution in female dog urine 72 hr after administration.,Intermediate,9615.0,N,12872,1,,1,A,,,8170,
,,CHEMBL624050,,22224,Plasma,BAO_0000218,,1969.0,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,Autocuration,,U,12873,1,,0,A,,,14283,
,,CHEMBL624051,,22224,,BAO_0000019,,,,Plasma concentration at 7 hr after intravenous dosing,Autocuration,,U,12874,1,,0,A,,,5623,
,,CHEMBL623278,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,Intermediate,10116.0,N,12875,1,,1,A,,,13477,
,,CHEMBL623279,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,Intermediate,10116.0,N,12876,1,,1,A,,,13477,
,,CHEMBL623280,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,Intermediate,10116.0,N,12877,1,,1,A,,,13477,
,,CHEMBL623963,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,Intermediate,10116.0,N,12878,1,,1,A,,,13477,
,,CHEMBL623964,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,Intermediate,10116.0,N,12879,1,,1,A,,,13477,
,,CHEMBL623965,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,Intermediate,10116.0,N,12880,1,,1,A,,,13477,
,,CHEMBL623966,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,Intermediate,10116.0,N,12881,1,,1,A,,,13477,
,,CHEMBL874415,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,Intermediate,10116.0,N,12882,1,,1,A,,,13477,
,,CHEMBL623967,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,Intermediate,10116.0,N,12883,1,,1,A,,,13477,
,,CHEMBL623968,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,Intermediate,10116.0,N,12884,1,,1,A,,,13477,
,,CHEMBL623969,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,Intermediate,10116.0,N,12885,1,,1,A,,,13477,
,,CHEMBL628409,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,Intermediate,10116.0,N,12886,1,,1,A,,,13477,
,,CHEMBL628410,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,Intermediate,10116.0,N,12887,1,,1,A,,,13477,
,,CHEMBL628411,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,Intermediate,10116.0,N,12888,1,,1,A,,,13477,
,,CHEMBL628412,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,Intermediate,10116.0,N,12889,1,,1,A,,,13477,
,,CHEMBL628413,,22224,,BAO_0000019,,,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,Autocuration,,U,12890,1,,0,A,,,12553,
,,CHEMBL628414,,22224,Plasma,BAO_0000019,,1969.0,,The concentration in plasmat; Not determined,Autocuration,,U,12891,1,,0,A,,,14548,
,,CHEMBL628415,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue level at 10 mg/kg/po in wistar rats in blood,Intermediate,10116.0,N,12892,1,,1,A,,,14393,
,,CHEMBL628416,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,Intermediate,10116.0,N,12893,1,,1,A,,,14393,
,,CHEMBL628417,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue level at 10 mg/kg/po in wistar rats in heart,Intermediate,10116.0,N,12894,1,,1,A,,,14393,
,,CHEMBL874908,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Tissue level at 10 mg/kg/po in wistar rats in liver,Intermediate,10116.0,N,12895,1,,1,A,,,14393,
,,CHEMBL628418,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue level at 10 mg/kg/po in wistar rats in plasma,Intermediate,10116.0,N,12896,1,,1,A,,,14393,
,,CHEMBL628419,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,Intermediate,10116.0,N,12897,1,,1,A,,,14393,
,,CHEMBL628420,,50597,,BAO_0000218,Rattus norvegicus,,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,Intermediate,10116.0,N,12898,1,,1,A,,,14393,
,,CHEMBL628421,,22224,,BAO_0000019,,,,Water solubility at 37 degree C.,Autocuration,,U,12899,1,,0,A,,,1629,
,,CHEMBL626726,,22229,,BAO_0000100,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,Autocuration,,U,12900,1,,0,P,,,8194,
,,CHEMBL626727,,22229,,BAO_0000100,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,,U,12901,1,,0,P,,,8194,
,,CHEMBL626728,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12902,1,,1,A,,,8594,
,,CHEMBL626729,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12903,1,,1,A,,,8594,
,,CHEMBL626730,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12904,1,,1,A,,,8594,
,,CHEMBL626731,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12905,1,,1,A,,,8594,
,,CHEMBL626732,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12906,1,,1,A,,,8594,
,,CHEMBL626733,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12907,1,,1,A,,,8594,
,,CHEMBL626734,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12908,1,,1,A,,,8594,
,,CHEMBL626735,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12909,1,,1,A,,,8594,
,,CHEMBL874909,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12910,1,,1,A,,,8594,
,,CHEMBL626736,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12911,1,,1,A,,,8594,
,,CHEMBL626737,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12912,1,,1,A,,,8594,
,,CHEMBL630999,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12913,1,,1,A,,,8594,
,,CHEMBL631000,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12914,1,,1,A,,,8594,
,,CHEMBL631001,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12915,1,,1,A,,,8594,
,,CHEMBL631002,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12916,1,,1,A,,,8594,
,,CHEMBL631003,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12917,1,,1,A,,,8594,
,,CHEMBL631004,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12918,1,,1,A,,,8594,
,,CHEMBL631005,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12919,1,,1,A,,,8594,
,,CHEMBL631006,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12920,1,,1,A,,,8594,
,,CHEMBL631007,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12921,1,,1,A,,,8594,
,,CHEMBL631008,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12922,1,,1,A,,,8594,
,,CHEMBL631009,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12923,1,,1,A,,,8594,
,,CHEMBL631010,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12924,1,,1,A,,,8594,
,,CHEMBL631011,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12925,1,,1,A,,,8594,
,,CHEMBL631012,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12926,1,,1,A,,,8594,
,,CHEMBL630271,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12927,1,,1,A,,,8594,
,,CHEMBL630272,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12928,1,,1,A,,,8594,
,,CHEMBL630273,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12929,1,,1,A,,,8594,
,,CHEMBL630274,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12930,1,,1,A,,,8594,
,,CHEMBL630275,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12931,1,,1,A,,,8594,
,,CHEMBL875782,,50597,,BAO_0000218,Rattus norvegicus,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12932,1,,1,A,,,8594,
,,CHEMBL630276,,50597,,BAO_0000218,Rattus norvegicus,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12933,1,,1,A,,,8594,
,,CHEMBL630277,,50597,,BAO_0000218,Rattus norvegicus,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12934,1,,1,A,,,8594,
,,CHEMBL630278,,50597,,BAO_0000218,Rattus norvegicus,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12935,1,,1,A,,,8594,
,,CHEMBL630279,,50597,,BAO_0000218,Rattus norvegicus,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,Intermediate,10116.0,N,12936,1,,1,A,,,8594,
,,CHEMBL630280,,22224,,BAO_0000019,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,Autocuration,,U,12937,1,,0,A,,,8151,
,,CHEMBL630281,,22224,,BAO_0000019,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Autocuration,,U,12938,1,,0,A,,,8151,
,,CHEMBL630282,,50592,,BAO_0000218,Oryctolagus cuniculus,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,Intermediate,9986.0,N,12939,1,,1,A,,,7132,
,,CHEMBL630283,,50592,,BAO_0000218,Oryctolagus cuniculus,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,Intermediate,9986.0,N,12940,1,,1,A,,,7132,
,,CHEMBL630284,,22224,,BAO_0000019,,,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),Autocuration,,U,12941,1,,0,A,,,5797,
,,CHEMBL630285,,22224,,BAO_0000019,,,,Alkylating activity was determined,Autocuration,,U,12942,1,,0,A,,,7849,
,Microsomes,CHEMBL630286,,22224,,BAO_0000251,,,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),Autocuration,,U,12943,1,,0,A,,,14220,
,,CHEMBL630069,,50592,,BAO_0000218,Oryctolagus cuniculus,,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",Intermediate,9986.0,N,12944,1,,1,A,,,8650,
,,CHEMBL630070,,50592,,BAO_0000218,Oryctolagus cuniculus,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",Intermediate,9986.0,N,12945,1,,1,A,,,8650,
,,CHEMBL630071,,50592,,BAO_0000218,Oryctolagus cuniculus,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",Intermediate,9986.0,N,12946,1,,1,A,,,8650,
,,CHEMBL630072,,50592,,BAO_0000218,Oryctolagus cuniculus,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",Intermediate,9986.0,N,12947,1,,1,A,,,8650,
,,CHEMBL875110,,50592,,BAO_0000218,Oryctolagus cuniculus,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",Intermediate,9986.0,N,12948,1,,1,A,,,8650,
,,CHEMBL630073,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for antidiuretic activity in rats,Intermediate,10116.0,N,12949,1,,1,A,,,7116,
,,CHEMBL630074,,22224,,BAO_0000019,,,,Compound was tested for inactivation kinetic values,Autocuration,,U,12950,1,,0,A,,,14131,
In vivo,,CHEMBL630075,,22224,,BAO_0000218,,,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,Autocuration,,U,12951,1,,0,A,,,7415,
,,CHEMBL630076,,22224,,BAO_0000019,,,,Dissociation rate calculated from the first-order equation using the t1/2 value,Autocuration,,U,12952,1,,0,A,,,13178,
,,CHEMBL630077,,22229,,BAO_0000100,,,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,Autocuration,,U,12953,1,,0,P,,,8815,
,,CHEMBL630078,,22229,,BAO_0000100,,,,Aqueous solubility was measured,Autocuration,,U,12954,1,,0,P,,,1450,
,,CHEMBL630079,,22229,,BAO_0000100,,,,Aqueous solubility was measured at a pH 4,Autocuration,,U,12955,1,,0,P,,,1450,
,,CHEMBL630080,,22229,,BAO_0000100,,,,Aqueous solubility (pH 7),Autocuration,,U,12956,1,,0,P,,,1450,
,,CHEMBL630081,,22229,,BAO_0000100,,,,Aqueous solubility was measured at a pH 9,Autocuration,,U,12957,1,,0,P,,,1450,
,,CHEMBL630082,,22224,,BAO_0000019,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",Autocuration,,U,12958,1,,0,A,,,12711,
,,CHEMBL630083,,22224,,BAO_0000019,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",Autocuration,,U,12959,1,,0,A,,,12711,
,,CHEMBL630084,,22224,,BAO_0000019,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",Autocuration,,U,12960,1,,0,A,,,12711,
,,CHEMBL629198,,22229,,BAO_0000100,,,,Aqueous solubility of the compound,Autocuration,,U,12961,1,,0,P,,,15032,
,,CHEMBL629199,,22229,,BAO_0000100,,,,Aqueous solubility at 37 degree Celsius at pH 7.38,Autocuration,,U,12962,1,,0,P,,,9964,
,,CHEMBL629200,,22229,,BAO_0000100,,,,Aqueous solubility in pH 7.4 phosphate buffer,Autocuration,,U,12963,1,,0,P,,,14962,
,,CHEMBL629201,,50588,,BAO_0000218,Canis lupus familiaris,,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,Intermediate,9615.0,N,12964,1,,1,A,,,12487,
,,CHEMBL629202,,50588,,BAO_0000218,Canis lupus familiaris,,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,Intermediate,9615.0,N,12965,1,,1,A,,,12487,
,,CHEMBL875111,,50587,,BAO_0000218,Homo sapiens,,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,9606.0,N,12966,1,,1,A,,,10026,
,,CHEMBL629203,,50587,,BAO_0000218,Homo sapiens,,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,Intermediate,9606.0,N,12967,1,,1,A,,,10026,
,,CHEMBL629204,,50587,,BAO_0000218,Homo sapiens,,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,9606.0,N,12968,1,,1,A,,,10026,
,,CHEMBL629205,,50587,,BAO_0000218,Homo sapiens,,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,9606.0,N,12969,1,,1,A,,,10026,
,,CHEMBL629206,,50587,,BAO_0000218,Homo sapiens,,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,9606.0,N,12970,1,,1,A,,,10026,
,,CHEMBL631185,,22224,,BAO_0000019,,,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,Autocuration,,U,12971,1,,0,A,,,10026,
,,CHEMBL631186,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for the average bile flow rat in rats,Intermediate,10116.0,N,12972,1,,1,A,,,7415,
,,CHEMBL631187,,50592,,BAO_0000218,Oryctolagus cuniculus,,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Intermediate,9986.0,N,12973,1,,1,A,,,17025,
,,CHEMBL631188,,50592,,BAO_0000218,Oryctolagus cuniculus,,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Intermediate,9986.0,N,12974,1,,1,A,,,17025,
,,CHEMBL876419,,22224,,BAO_0000019,,,,Average half life period was determined,Autocuration,,U,12975,1,,0,A,,,10184,
,,CHEMBL631189,,22224,,BAO_0000019,,,,Average half life period was determined,Autocuration,,U,12976,1,,0,A,,,10184,
,,CHEMBL631190,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Intermediate,10298.0,N,12977,1,,1,A,,,8613,
,,CHEMBL631191,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Intermediate,10298.0,N,12978,1,,1,A,,,8613,
,,CHEMBL631192,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,Intermediate,10298.0,N,12979,1,,1,A,,,8613,
,,CHEMBL632400,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,Intermediate,10298.0,N,12980,1,,1,A,,,8613,
,,CHEMBL630564,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Intermediate,10298.0,N,12981,1,,1,A,,,8613,
,,CHEMBL630565,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Intermediate,10298.0,N,12982,1,,1,A,,,8613,
,,CHEMBL630566,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,Intermediate,10298.0,N,12983,1,,1,A,,,8613,
,,CHEMBL631229,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,Intermediate,10298.0,N,12984,1,,1,A,,,8613,
,,CHEMBL631230,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,Intermediate,10298.0,N,12985,1,,1,A,,,8613,
,,CHEMBL876428,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12986,1,,0,P,,,6030,
,,CHEMBL631231,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12987,1,,0,P,,,6147,
,,CHEMBL631232,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP) (MacLogP),Autocuration,,U,12988,1,,0,P,,,14556,
,,CHEMBL631233,,22224,,BAO_0000019,,,,Hydrophilicity was determined,Autocuration,,U,12989,1,,0,A,,,768,
,,CHEMBL631234,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12990,1,,0,P,,,14452,
,,CHEMBL883126,,22224,,BAO_0000019,,,,Increased absorption was determined,Autocuration,,U,12991,1,,0,A,,,5237,
,,CHEMBL631235,,22224,,BAO_0000100,,,,Lipophilicity value was evaluated,Autocuration,,U,12992,1,,0,P,,,14378,
,,CHEMBL631236,,22224,,BAO_0000100,,,,Log P value of the compound.,Autocuration,,U,12993,1,,0,P,,,14418,
,,CHEMBL631237,,22224,,BAO_0000019,,,,Partition coefficient of compound was determined,Autocuration,,U,12994,1,,0,A,,,5249,
,,CHEMBL631238,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12995,1,,0,P,,,14621,
,,CHEMBL876429,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12996,1,,0,P,,,12542,
,,CHEMBL631414,,22224,,BAO_0000019,,,,Partition coefficient was measured by medchem software; Not calculated,Autocuration,,U,12997,1,,0,A,,,12542,
,,CHEMBL631415,,22224,,BAO_0000100,,,,Partition coefficient was measured by octanol-water using standard shake-flask method,Autocuration,,U,12998,1,,0,P,,,12542,
,,CHEMBL631416,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,12999,1,,0,P,,,15462,
,,CHEMBL631417,,22224,,BAO_0000019,,,,Partition coefficient (logP),Autocuration,,U,13000,1,,0,A,,,14884,
,,CHEMBL631418,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13001,1,,0,P,,,16526,
,,CHEMBL631419,,22229,,BAO_0000100,,,,The Octanol/Water partition coefficient CLogP,Autocuration,,U,13002,1,,0,P,,,13693,
,,CHEMBL631420,,22224,,BAO_0000019,,,,The pharmacokinetic parameter C Log p was reported,Autocuration,,U,13003,1,,0,A,,,13693,
,,CHEMBL631421,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13004,1,,0,P,,,13779,
,,CHEMBL631422,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13005,1,,0,P,,,14772,
,,CHEMBL631423,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13006,1,,0,P,,,14393,
In vivo,,CHEMBL876430,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,10116.0,N,13007,1,,1,A,,,14793,
In vivo,,CHEMBL631424,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,Intermediate,10116.0,N,13008,1,,1,A,,,14793,
In vivo,,CHEMBL631425,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Compound was administered intravenously in dog to evaluate plasma clearance values,Intermediate,9615.0,N,13009,1,,1,A,,,13744,
In vivo,,CHEMBL631426,,22224,Plasma,BAO_0000218,Simiiformes,1969.0,,Compound was administered intravenously in monkey to evaluate plasma clearance values,Autocuration,314293.0,U,13010,1,,0,A,,,13744,
In vivo,,CHEMBL631427,,50594,Plasma,BAO_0000218,Mus musculus,1969.0,,Compound was administered intravenously in mouse to evaluate plasma clearance values,Intermediate,10090.0,N,13011,1,,1,A,,,13744,
In vivo,,CHEMBL631428,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,Intermediate,9615.0,N,13012,1,,1,A,,,13207,
In vitro,Microsomes,CHEMBL631429,,50797,Liver,BAO_0000218,Macaca mulatta,2107.0,,Intrinsic clearance in Rhesus liver microsome,Intermediate,9544.0,N,13013,1,,1,A,,,5669,
In vitro,Microsomes,CHEMBL631430,,50588,Liver,BAO_0000218,Canis lupus familiaris,2107.0,,Intrinsic clearance in dog liver microsome,Intermediate,9615.0,N,13014,1,,1,A,,,5669,
In vitro,Microsomes,CHEMBL631431,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Intrinsic clearance in rat liver microsome,Intermediate,10116.0,N,13015,1,,1,A,,,5669,
In vivo,,CHEMBL631432,,50797,Plasma,BAO_0000218,Macaca mulatta,1969.0,,Low plasma clearance was calculated in rhesus monkey,Intermediate,9544.0,N,13016,1,,1,A,,,4853,
In vivo,,CHEMBL631433,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,Intermediate,9615.0,N,13017,1,,1,A,,,16452,
In vivo,,CHEMBL631434,,22224,,BAO_0000218,,,,Plasma clearance after intravenous dose of 0.3 mg/kg,Autocuration,,U,13018,1,,0,A,,,11954,
In vivo,,CHEMBL631435,,22224,,BAO_0000218,,,,Plasma clearance after intravenous dose of 1 mg/kg,Autocuration,,U,13019,1,,0,A,,,11954,
In vivo,,CHEMBL631436,,22224,,BAO_0000218,,,,Plasma clearance after intravenous dose of 3 mg/kg,Autocuration,,U,13020,1,,0,A,,,11954,
In vivo,,CHEMBL631437,,22224,,BAO_0000218,,,,Plasma clearance after intravenous dose of 3.87 mg/kg,Autocuration,,U,13021,1,,0,A,,,11954,
In vivo,,CHEMBL631438,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance after peroral administration at 10 mpk in Rat,Intermediate,10116.0,N,13022,1,,1,A,,,5669,
In vivo,,CHEMBL876431,,50797,,BAO_0000218,Macaca mulatta,,,Plasma clearance after peroral administration at 10 mpk in Rhesus,Intermediate,9544.0,N,13023,1,,1,A,,,5669,
In vivo,,CHEMBL631439,,50588,,BAO_0000218,Canis lupus familiaris,,,Plasma clearance after peroral administration at 10 mpk in dog,Intermediate,9615.0,N,13024,1,,1,A,,,5669,
In vivo,,CHEMBL631440,,50597,,BAO_0000218,Rattus norvegicus,,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,Intermediate,10116.0,N,13025,1,,1,A,,,13662,
,,CHEMBL631441,,22224,,BAO_0000019,,,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),Autocuration,,U,13026,1,,0,A,,,8272,
,,CHEMBL631442,,22224,,BAO_0000019,,,,Critical Micellar concentration was determined,Autocuration,,U,13027,1,,0,A,,,13410,
,,CHEMBL626525,,22224,,BAO_0000019,,,,Critical Micellar concentration of the compound. was determined,Autocuration,,U,13028,1,,0,A,,,13410,
,,CHEMBL627168,,22224,,BAO_0000019,,,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,Autocuration,,U,13029,1,,0,A,,,12628,
,,CHEMBL875618,,22224,,BAO_0000019,,,,Critical micellar concentration was measured in water by the dye solubilization method,Autocuration,,U,13030,1,,0,A,,,9675,
,,CHEMBL626612,,22224,,BAO_0000019,,,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,Autocuration,,U,13031,1,,0,B,,,12628,
,,CHEMBL626613,,22224,,BAO_0000019,,,,CMR value (relative to BAY K 8644),Autocuration,,U,13032,1,,0,A,,,12766,
,,CHEMBL626614,,22224,,BAO_0000019,,,,Carbamoylating activity was determined,Autocuration,,U,13033,1,,0,A,,,7849,
,,CHEMBL626615,,22224,,BAO_0000218,Simiiformes,,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,Autocuration,314293.0,U,13034,1,,0,A,,,12187,
,,CHEMBL626616,,22224,,BAO_0000019,,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,Autocuration,,U,13035,1,,0,A,,,2040,
,,CHEMBL626617,,22224,,BAO_0000019,,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,Autocuration,,U,13036,1,,0,A,,,2040,
In vivo,,CHEMBL626618,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,Intermediate,9615.0,N,13037,1,,1,A,,,14180,
In vivo,,CHEMBL626619,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,Intermediate,10116.0,N,13038,1,,1,A,,,14180,
In vivo,,CHEMBL626620,,50588,,BAO_0000218,Canis lupus familiaris,,,"Clearance rate at 0.46 mg/kg, iv, in dogs",Intermediate,9615.0,N,13039,1,,1,A,,,14474,
In vivo,,CHEMBL626621,,50597,,BAO_0000218,Rattus norvegicus,,,"Clearance rate at 5.5 mg/kg, iv, in rat",Intermediate,10116.0,N,13040,1,,1,A,,,14474,
In vivo,,CHEMBL626622,,100710,,BAO_0000218,Macaca fascicularis,,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Intermediate,9541.0,N,13041,1,,1,A,,,14548,
In vivo,,CHEMBL626623,,100710,,BAO_0000218,Macaca fascicularis,,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Intermediate,9541.0,N,13042,1,,1,A,,,14548,
In vivo,,CHEMBL626624,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Intermediate,9615.0,N,13043,1,,1,A,,,14548,
In vivo,,CHEMBL626625,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Intermediate,10116.0,N,13044,1,,1,A,,,14548,
Ex vivo,,CHEMBL626626,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Intermediate,10116.0,N,13045,1,,1,A,,,6125,
In vivo,,CHEMBL626627,,22224,,BAO_0000218,,,,Tested for the total clearance of the compound,Autocuration,,U,13046,1,,0,A,,,6874,
In vivo,,CHEMBL626628,,50588,,BAO_0000218,Canis lupus familiaris,,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,Intermediate,9615.0,N,13047,1,,1,A,,,15343,
In vivo,,CHEMBL626629,,22224,,BAO_0000218,,,,Total body clearance was determined,Autocuration,,U,13048,1,,0,A,,,6236,
,,CHEMBL626630,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,10116.0,N,13049,1,,1,A,,,11510,
,,CHEMBL626631,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,10116.0,N,13050,1,,1,A,,,11510,
,,CHEMBL626632,,22229,,BAO_0000100,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,Autocuration,,U,13051,1,,0,P,,,8194,
,,CHEMBL626633,,22229,,BAO_0000100,,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,,U,13052,1,,0,P,,,8194,
,,CHEMBL626634,,22229,,BAO_0000100,,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,Autocuration,,U,13053,1,,0,P,,,8194,
,,CHEMBL626635,,22229,,BAO_0000100,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,Autocuration,,U,13054,1,,0,P,,,8194,
,,CHEMBL626636,,22229,,BAO_0000100,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,,U,13055,1,,0,P,,,8194,
,,CHEMBL626637,,22229,,BAO_0000100,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,Autocuration,,U,13056,1,,0,P,,,8194,
,,CHEMBL626638,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),Intermediate,4754.0,N,13057,1,,1,A,,,13273,
,,CHEMBL626639,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,Intermediate,4754.0,N,13058,1,,1,A,,,13273,
,,CHEMBL626640,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,Intermediate,4754.0,N,13059,1,,1,A,,,13273,
,,CHEMBL626641,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,Intermediate,4754.0,N,13060,1,,1,A,,,13273,
,,CHEMBL627272,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,Intermediate,4754.0,N,13061,1,,1,A,,,13273,
,,CHEMBL627273,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,Intermediate,4754.0,N,13062,1,,1,A,,,13273,
,,CHEMBL627441,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),Intermediate,4754.0,N,13063,1,,1,A,,,13273,
,,CHEMBL628355,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),Intermediate,4754.0,N,13064,1,,1,A,,,13273,
,,CHEMBL628356,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),Intermediate,4754.0,N,13065,1,,1,A,,,13273,
,,CHEMBL628357,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),Intermediate,4754.0,N,13066,1,,1,A,,,13273,
,,CHEMBL628358,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),Intermediate,4754.0,N,13067,1,,1,A,,,13273,
,,CHEMBL622307,,50339,,BAO_0000218,Pneumocystis carinii,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),Intermediate,4754.0,N,13068,1,,1,A,,,13273,
,,CHEMBL622527,,22224,,BAO_0000019,,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,Autocuration,,U,13069,1,,0,A,,,13118,
,,CHEMBL622528,,22224,,BAO_0000019,,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,Autocuration,,U,13070,1,,0,A,,,13118,
,,CHEMBL622529,,22224,,BAO_0000019,,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,Autocuration,,U,13071,1,,0,A,,,13118,
,,CHEMBL622992,,22224,,BAO_0000019,,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,Autocuration,,U,13072,1,,0,A,,,13118,
,,CHEMBL622993,,22224,,BAO_0000019,,,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,Autocuration,,U,13073,1,,0,A,,,13118,
,,CHEMBL622994,,22224,,BAO_0000019,,,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,Autocuration,,U,13074,1,,0,A,,,13118,
,,CHEMBL622995,,50597,,BAO_0000218,Rattus norvegicus,,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",Intermediate,10116.0,N,13075,1,,1,A,,,10633,
,,CHEMBL622996,,50597,,BAO_0000218,Rattus norvegicus,,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",Intermediate,10116.0,N,13076,1,,1,A,,,10633,
,,CHEMBL622997,,50597,,BAO_0000218,Rattus norvegicus,,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",Intermediate,10116.0,N,13077,1,,1,A,,,10633,
,,CHEMBL622998,,50597,,BAO_0000218,Rattus norvegicus,,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",Intermediate,10116.0,N,13078,1,,1,A,,,10633,
,,CHEMBL622999,,22224,,BAO_0000218,,,,Cp max following ip administration at 1 mg/kg,Autocuration,,U,13079,1,,0,A,,,5767,
In vivo,,CHEMBL623000,,22224,Plasma,BAO_0000218,,1969.0,,Maximum concentration in plasma was reported at 0.5 hour,Autocuration,,U,13080,1,,0,A,,,3302,
In vivo,,CHEMBL623001,,22224,Plasma,BAO_0000218,,1969.0,,Maximum concentration in plasma was reported at 2 hour,Autocuration,,U,13081,1,,0,A,,,3302,
,,CHEMBL623002,,50594,,BAO_0000218,Mus musculus,,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,Intermediate,10090.0,N,13082,1,,1,A,,,12467,
,,CHEMBL623003,,22229,,BAO_0000100,,,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),Autocuration,,U,13083,1,,0,P,,,11778,
,,CHEMBL623004,,22224,,BAO_0000019,,,,Steady state concentration was evaluated,Autocuration,,U,13084,1,,0,A,,,4321,
,,CHEMBL623005,,22224,,BAO_0000019,,,,Partition coefficient (logP),Autocuration,,U,13085,1,,0,A,,,14884,
,,CHEMBL623006,,22224,,BAO_0000019,,,,Partition coefficient (logD7.4),Autocuration,,U,13086,1,,0,A,,,15234,
In vivo,,CHEMBL623007,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,Intermediate,10116.0,N,13087,1,,1,A,,,14198,
In vivo,,CHEMBL623008,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,Intermediate,10116.0,N,13088,1,,1,A,,,14198,
In vivo,,CHEMBL876654,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,Intermediate,10116.0,N,13089,1,,1,A,,,14198,
In vivo,,CHEMBL623009,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,Intermediate,10116.0,N,13090,1,,1,A,,,14198,
In vivo,,CHEMBL623010,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,Intermediate,10116.0,N,13091,1,,1,A,,,14198,
In vivo,,CHEMBL623011,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,Intermediate,10116.0,N,13092,1,,1,A,,,14198,
In vivo,,CHEMBL623012,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,Intermediate,10116.0,N,13093,1,,1,A,,,14198,
,,CHEMBL623013,,22224,,BAO_0000019,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Autocuration,,U,13094,1,,0,A,,,8151,
,,CHEMBL623014,,22224,,BAO_0000019,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Autocuration,,U,13095,1,,0,A,,,8151,
,,CHEMBL623015,,22224,Urine,BAO_0000019,,1088.0,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,Autocuration,,U,13096,1,,0,A,,,8151,
,,CHEMBL623016,,22224,Urine,BAO_0000019,,1088.0,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Autocuration,,U,13097,1,,0,A,,,8151,
,,CHEMBL624858,,22224,Urine,BAO_0000019,,1088.0,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,Autocuration,,U,13098,1,,0,A,,,8151,
,,CHEMBL624859,,50597,,BAO_0000218,Rattus norvegicus,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,Intermediate,10116.0,N,13099,1,,1,A,,,8151,
,,CHEMBL624860,,50597,,BAO_0000218,Rattus norvegicus,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Intermediate,10116.0,N,13100,1,,1,A,,,8151,
,,CHEMBL624861,,50597,,BAO_0000218,Rattus norvegicus,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,10116.0,N,13101,1,,1,A,,,8151,
,,CHEMBL624862,,50597,,BAO_0000218,Rattus norvegicus,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Intermediate,10116.0,N,13102,1,,1,A,,,8151,
,,CHEMBL624863,,50597,,BAO_0000218,Rattus norvegicus,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,Intermediate,10116.0,N,13103,1,,1,A,,,8151,
,,CHEMBL876655,,50597,,BAO_0000218,Rattus norvegicus,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,10116.0,N,13104,1,,1,A,,,8151,
,,CHEMBL624864,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Intermediate,9615.0,N,13105,1,,1,A,,,6996,
,,CHEMBL624865,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Intermediate,9615.0,N,13106,1,,1,A,,,6996,
,,CHEMBL624866,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,9615.0,N,13107,1,,1,A,,,6996,
,,CHEMBL624867,,50588,,BAO_0000218,Canis lupus familiaris,,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,Expert,9615.0,N,13108,1,,1,F,,,6996,
,,CHEMBL624868,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Intermediate,9615.0,N,13109,1,,1,A,,,6996,
,,CHEMBL628450,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,Intermediate,9615.0,N,13110,1,,1,A,,,6996,
,,CHEMBL628451,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Intermediate,9615.0,N,13111,1,,1,A,,,6996,
,,CHEMBL628452,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Intermediate,9615.0,N,13112,1,,1,A,,,6996,
,,CHEMBL628453,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,9615.0,N,13113,1,,1,A,,,6996,
,,CHEMBL628454,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,Intermediate,9615.0,N,13114,1,,1,A,,,6996,
,,CHEMBL628455,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Intermediate,9615.0,N,13115,1,,1,A,,,6996,
,,CHEMBL628456,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Intermediate,9615.0,N,13116,1,,1,A,,,6996,
,,CHEMBL628457,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,9615.0,N,13117,1,,1,A,,,6996,
,,CHEMBL877505,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,Intermediate,9615.0,N,13118,1,,1,A,,,6996,
,,CHEMBL628458,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,Intermediate,9615.0,N,13119,1,,1,A,,,6996,
,,CHEMBL628459,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Intermediate,9615.0,N,13120,1,,1,A,,,6996,
,,CHEMBL628460,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Intermediate,9615.0,N,13121,1,,1,A,,,6996,
,,CHEMBL628461,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Intermediate,9615.0,N,13122,1,,1,A,,,6996,
,,CHEMBL628462,,22224,,BAO_0000218,,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",Autocuration,,U,13123,1,,0,B,,,6996,
,,CHEMBL628463,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Intermediate,9615.0,N,13124,1,,1,A,,,6996,
,,CHEMBL625666,,50597,,BAO_0000218,Rattus norvegicus,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",Expert,10116.0,N,13125,1,,1,F,,,6996,
,,CHEMBL625667,,22224,,BAO_0000218,,,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Autocuration,,U,13126,1,,0,B,,,6996,
,,CHEMBL625668,,50597,,BAO_0000218,Rattus norvegicus,,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Expert,10116.0,N,13127,1,,1,A,,,6996,
,,CHEMBL625669,,50597,,BAO_0000218,Rattus norvegicus,,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Intermediate,10116.0,N,13128,1,,1,A,,,6996,
,,CHEMBL625670,,22224,,BAO_0000019,,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,Autocuration,,U,13129,1,,0,A,,,7114,
,,CHEMBL625671,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,Intermediate,10116.0,N,13130,1,,1,A,,,7114,
,,CHEMBL625672,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,Intermediate,10298.0,N,13131,1,,1,A,,,8613,
,,CHEMBL625673,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,Intermediate,10298.0,N,13132,1,,1,A,,,8613,
,,CHEMBL625674,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,Intermediate,10298.0,N,13133,1,,1,A,,,8613,
,,CHEMBL625675,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,Intermediate,10298.0,N,13134,1,,1,A,,,8613,
,,CHEMBL627637,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Intermediate,10298.0,N,13135,1,,1,A,,,8613,
,,CHEMBL627638,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,Intermediate,10298.0,N,13136,1,,1,A,,,8613,
,,CHEMBL627639,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,Intermediate,10298.0,N,13137,1,,1,A,,,8613,
,,CHEMBL627640,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,Intermediate,10298.0,N,13138,1,,1,A,,,8613,
,,CHEMBL627641,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,Intermediate,10298.0,N,13139,1,,1,A,,,8613,
,,CHEMBL627642,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Intermediate,10298.0,N,13140,1,,1,A,,,8613,
,,CHEMBL877506,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Intermediate,10298.0,N,13141,1,,1,A,,,8613,
,,CHEMBL627275,,50594,,BAO_0000218,Mus musculus,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Intermediate,10090.0,N,13142,1,,1,A,,,8613,
,,CHEMBL627643,,50506,,BAO_0000218,Mustela putorius furo,,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",Intermediate,9669.0,N,13143,1,,1,A,,,11219,
,,CHEMBL631246,,50506,,BAO_0000218,Mustela putorius furo,,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Intermediate,9669.0,N,13144,1,,1,A,,,11219,
,,CHEMBL631247,,50506,,BAO_0000218,Mustela putorius furo,,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Intermediate,9669.0,N,13145,1,,1,A,,,11219,
,,CHEMBL629532,,50506,,BAO_0000218,Mustela putorius furo,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Intermediate,9669.0,N,13146,1,,1,A,,,11219,
,,CHEMBL629533,,50506,,BAO_0000218,Mustela putorius furo,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,Intermediate,9669.0,N,13147,1,,1,A,,,11219,
,,CHEMBL629534,,50506,,BAO_0000218,Mustela putorius furo,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Intermediate,9669.0,N,13148,1,,1,A,,,11219,
,,CHEMBL629535,,50506,,BAO_0000218,Mustela putorius furo,,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,Intermediate,9669.0,N,13149,1,,1,A,,,11219,
,,CHEMBL625932,,22224,,BAO_0000019,,,,Pharmacokinetic parameter :drug bound to plasma was reported,Autocuration,,U,13150,1,,0,A,,,14837,
,,CHEMBL625933,,22224,,BAO_0000019,,,,compound was evaluated for drug bound in plasma,Autocuration,,U,13151,1,,0,A,,,14837,
,,CHEMBL625934,,50597,,BAO_0000218,Rattus norvegicus,,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,Intermediate,10116.0,N,13152,1,,1,A,,,15343,
,,CHEMBL625935,,22224,,BAO_0000218,Eutheria,,,Bioavailability,Autocuration,9347.0,U,13153,1,,0,A,,,13761,
,,CHEMBL625936,,50597,,BAO_0000218,Rattus norvegicus,,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,Intermediate,10116.0,N,13154,1,,1,A,,,14810,
,,CHEMBL625937,,50597,,BAO_0000218,Rattus norvegicus,,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,Intermediate,10116.0,N,13155,1,,1,A,,,14810,
,,CHEMBL625938,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Intermediate,9615.0,N,13156,1,,1,A,,,13249,
,,CHEMBL625939,,50597,Bile,BAO_0000218,Rattus norvegicus,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,Intermediate,10116.0,N,13157,1,,1,A,,,9267,
,,CHEMBL625940,,50597,Bile,BAO_0000218,Rattus norvegicus,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,Intermediate,10116.0,N,13158,1,,1,A,,,9267,
,,CHEMBL874464,,50597,Bile,BAO_0000218,Rattus norvegicus,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,Intermediate,10116.0,N,13159,1,,1,A,,,9267,
,,CHEMBL625941,,50597,Bile,BAO_0000218,Rattus norvegicus,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,Intermediate,10116.0,N,13160,1,,1,A,,,9267,
,,CHEMBL625942,,50597,Bile,BAO_0000218,Rattus norvegicus,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,Intermediate,10116.0,N,13161,1,,1,A,,,9267,
,,CHEMBL625943,,50597,Bile,BAO_0000218,Rattus norvegicus,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,Intermediate,10116.0,N,13162,1,,1,A,,,9267,
,,CHEMBL625944,,50587,Serum,BAO_0000218,Homo sapiens,1977.0,,In vitro protein binding in human serum at 5 ug/ml,Intermediate,9606.0,N,13163,1,,1,A,,,15549,
,,CHEMBL625945,,22224,,BAO_0000019,,,,Serum protein binding ability was measured,Autocuration,,U,13164,1,,0,A,,,10929,
,,CHEMBL625946,,22224,,BAO_0000019,,,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),Autocuration,,U,13165,1,,0,A,,,15444,
In vivo,,CHEMBL625947,,22224,,BAO_0000218,Canis lupus familiaris,,,Oral bioavailability in dog,Autocuration,9615.0,U,13166,1,,0,A,,,12860,
In vivo,,CHEMBL625948,,50597,,BAO_0000218,Rattus norvegicus,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Intermediate,10116.0,N,13167,1,,1,A,,,12170,
In vivo,,CHEMBL625949,,22224,,BAO_0000218,,,,Absolute oral bioavailability at an iv dose of 14 mg/kg,Autocuration,,U,13168,1,,0,A,,,15173,
In vivo,,CHEMBL625950,,22224,,BAO_0000218,,,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,Autocuration,,U,13169,1,,0,A,,,15173,
In vivo,,CHEMBL625951,,22224,,BAO_0000218,Eutheria,,,Oral bioavailability (dose 15 mg/kg i.v.),Autocuration,9347.0,U,13170,1,,0,A,,,15173,
In vivo,,CHEMBL625952,,22224,,BAO_0000218,,,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,Autocuration,,U,13171,1,,0,A,,,15173,
In vivo,,CHEMBL625953,,22224,,BAO_0000218,,,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,Autocuration,,U,13172,1,,0,A,,,15173,
In vivo,,CHEMBL625954,,22224,,BAO_0000218,,,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,Autocuration,,U,13173,1,,0,A,,,15173,
In vivo,,CHEMBL882959,,22224,,BAO_0000218,,,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,Autocuration,,U,13174,1,,0,A,,,15173,
In vivo,,CHEMBL625955,,50588,,BAO_0000218,Canis lupus familiaris,,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,Intermediate,9615.0,N,13175,1,,1,A,,,11767,
In vivo,,CHEMBL625956,,22224,,BAO_0000218,Mustela putorius furo,,,Bioavailability in ferret,Autocuration,9669.0,U,13176,1,,0,A,,,11219,
In vivo,,CHEMBL625957,,100710,,BAO_0000218,Macaca fascicularis,,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,Intermediate,9541.0,N,13177,1,,1,A,,,12186,
,,CHEMBL625958,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,10116.0,N,13178,1,,1,A,,,11510,
,,CHEMBL625959,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,10116.0,N,13179,1,,1,A,,,11510,
,,CHEMBL626642,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,10116.0,N,13180,1,,1,A,,,11510,
,,CHEMBL631330,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,10116.0,N,13181,1,,1,A,,,11510,
,,CHEMBL631331,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,10116.0,N,13182,1,,1,A,,,11510,
,,CHEMBL631332,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,10116.0,N,13183,1,,1,A,,,11510,
,,CHEMBL631333,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,10116.0,N,13184,1,,1,A,,,11510,
,,CHEMBL632018,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,10116.0,N,13185,1,,1,A,,,11510,
,,CHEMBL632019,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,10116.0,N,13186,1,,1,A,,,11510,
,,CHEMBL632020,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,10116.0,N,13187,1,,1,A,,,11510,
,,CHEMBL632021,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,10116.0,N,13188,1,,1,A,,,11510,
,,CHEMBL632022,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,10116.0,N,13189,1,,1,A,,,11510,
,,CHEMBL632023,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,10116.0,N,13190,1,,1,A,,,11510,
,,CHEMBL632024,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,10116.0,N,13191,1,,1,A,,,11510,
,,CHEMBL874472,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,10116.0,N,13192,1,,1,A,,,11510,
,,CHEMBL632025,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,10116.0,N,13193,1,,1,A,,,11510,
,,CHEMBL632026,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,10116.0,N,13194,1,,1,A,,,11510,
,,CHEMBL632027,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,10116.0,N,13195,1,,1,A,,,11510,
,,CHEMBL632028,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,10116.0,N,13196,1,,1,A,,,11510,
,,CHEMBL626430,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,10116.0,N,13197,1,,1,A,,,11510,
,,CHEMBL626431,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,10116.0,N,13198,1,,1,A,,,11510,
,,CHEMBL626432,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,10116.0,N,13199,1,,1,A,,,11510,
,,CHEMBL626433,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,10116.0,N,13200,1,,1,A,,,11510,
,,CHEMBL626434,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,10116.0,N,13201,1,,1,A,,,11510,
,,CHEMBL627280,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,10116.0,N,13202,1,,1,A,,,11510,
,,CHEMBL627281,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,10116.0,N,13203,1,,1,A,,,11510,
,,CHEMBL627282,,50597,,BAO_0000218,Rattus norvegicus,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,10116.0,N,13204,1,,1,A,,,11510,
,,CHEMBL627283,,22224,,BAO_0000019,,,,Total body clearance was measured at given dose,Autocuration,,U,13205,1,,0,A,,,7199,
,,CHEMBL627284,,22224,,BAO_0000218,,,,Total body clearance was measured at given dose.,Autocuration,,U,13206,1,,0,A,,,7199,
,,CHEMBL627285,,50597,,BAO_0000218,Rattus norvegicus,,,Metabolic clearance from the body in rat,Intermediate,10116.0,N,13207,1,,1,A,,,7095,
In vivo,,CHEMBL627286,,22224,,BAO_0000218,,,,Renal clearance from the body,Autocuration,,U,13208,1,,0,A,,,7095,
In vivo,,CHEMBL875477,,50597,,BAO_0000218,Rattus norvegicus,,,Renal clearance from the body in rat,Intermediate,10116.0,N,13209,1,,1,A,,,7095,
In vivo,,CHEMBL627287,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,Intermediate,10116.0,N,13210,1,,1,A,,,12528,
In vivo,,CHEMBL627288,,50588,,BAO_0000218,Canis lupus familiaris,,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,Intermediate,9615.0,N,13211,1,,1,A,,,12528,
,,CHEMBL627289,,50597,,BAO_0000218,Rattus norvegicus,,,Total clearance from the body in rat,Intermediate,10116.0,N,13212,1,,1,A,,,7095,
In vivo,,CHEMBL627290,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Clearance into cortex from rat plasma or PBS,Intermediate,10116.0,N,13213,1,,1,A,,,14223,
In vivo,,CHEMBL627291,,22224,,BAO_0000218,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,Autocuration,,U,13214,1,,0,A,,,13569,
In vivo,,CHEMBL627292,,22224,,BAO_0000218,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,Autocuration,,U,13215,1,,0,A,,,13569,
In vivo,,CHEMBL627293,,22224,,BAO_0000218,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,Autocuration,,U,13216,1,,0,A,,,13569,
In vivo,,CHEMBL627294,,22224,,BAO_0000218,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Autocuration,,U,13217,1,,0,A,,,13569,
In vivo,,CHEMBL875478,,22224,,BAO_0000218,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,Autocuration,,U,13218,1,,0,A,,,13569,
In vivo,,CHEMBL627295,,22224,,BAO_0000218,,,,Clearance was determined,Autocuration,,U,13219,1,,0,A,,,13979,
In vivo,,CHEMBL627296,,50594,,BAO_0000218,Mus musculus,,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,Intermediate,10090.0,N,13220,1,,1,A,,,14315,
In vivo,,CHEMBL626119,,50592,,BAO_0000218,Oryctolagus cuniculus,,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,Intermediate,9986.0,N,13221,1,,1,A,,,14315,
In vivo,,CHEMBL626120,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,Intermediate,10116.0,N,13222,1,,1,A,,,14315,
In vivo,,CHEMBL626121,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance in rat after iv dose (100 ug/kg),Intermediate,10116.0,N,13223,1,,1,A,,,12174,
In vivo,,CHEMBL626122,,22224,,BAO_0000218,Cavia porcellus,,,Clearance in guinea pig,Autocuration,10141.0,U,13224,1,,0,A,,,12797,
In vivo,,CHEMBL626123,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for clearance in rat,Intermediate,10116.0,N,13225,1,,1,A,,,12797,
In vivo,,CHEMBL623456,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for the clearance in dog,Intermediate,9615.0,N,13226,1,,1,A,,,12797,
In vivo,,CHEMBL623457,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for the clearance in rat,Intermediate,10116.0,N,13227,1,,1,A,,,12797,
In vivo,,CHEMBL623458,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested in vivo for clearance after iv administration in the rat,Intermediate,10116.0,N,13228,1,,1,A,,,11500,
In vivo,,CHEMBL623459,,22224,,BAO_0000218,,,,IV clearance determined at an iv dose of 14 mg/kg,Autocuration,,U,13229,1,,0,A,,,15173,
In vivo,,CHEMBL875484,,22224,,BAO_0000218,,,,IV clearance determined at an iv dose of 15.2 mg/kg,Autocuration,,U,13230,1,,0,A,,,15173,
In vivo,,CHEMBL623460,,22224,,BAO_0000218,,,,IV clearance determined at an iv dose of 15 mg/kg,Autocuration,,U,13231,1,,0,A,,,15173,
In vivo,,CHEMBL623461,,22224,,BAO_0000218,,,,IV clearance determined at an peroral dose of 30 mg/kg.,Autocuration,,U,13232,1,,0,A,,,15173,
In vivo,,CHEMBL623462,,22224,,BAO_0000218,,,,IV clearance determined at an peroral dose of 30.2 mg/kg.,Autocuration,,U,13233,1,,0,A,,,15173,
In vivo,,CHEMBL627386,,22224,,BAO_0000218,,,,IV clearance determined at an peroral dose of 30.3 mg/kg.,Autocuration,,U,13234,1,,0,A,,,15173,
In vivo,,CHEMBL627387,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,Intermediate,10116.0,N,13235,1,,1,A,,,14198,
In vivo,,CHEMBL627388,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,Intermediate,10116.0,N,13236,1,,1,A,,,14198,
In vivo,,CHEMBL627389,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,Intermediate,10116.0,N,13237,1,,1,A,,,14198,
In vivo,,CHEMBL627390,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,Intermediate,10116.0,N,13238,1,,1,A,,,14198,
In vivo,,CHEMBL627391,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,Intermediate,10116.0,N,13239,1,,1,A,,,14198,
In vivo,,CHEMBL627392,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,Intermediate,10116.0,N,13240,1,,1,A,,,14198,
In vivo,,CHEMBL627393,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,Intermediate,10116.0,N,13241,1,,1,A,,,14198,
In vivo,,CHEMBL627394,,50597,Trachea,BAO_0000218,Rattus norvegicus,3126.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,Intermediate,10116.0,N,13242,1,,1,A,,,14198,
In vivo,,CHEMBL627395,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,Intermediate,10116.0,N,13243,1,,1,A,,,14198,
In vivo,,CHEMBL875485,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,Intermediate,10116.0,N,13244,1,,1,A,,,14198,
In vivo,,CHEMBL627396,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,Intermediate,10116.0,N,13245,1,,1,A,,,14198,
In vivo,,CHEMBL627397,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,Intermediate,10116.0,N,13246,1,,1,A,,,14198,
In vivo,,CHEMBL627398,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,Intermediate,10116.0,N,13247,1,,1,A,,,14198,
In vivo,,CHEMBL627399,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,Intermediate,10116.0,N,13248,1,,1,A,,,14198,
In vivo,,CHEMBL627400,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,Intermediate,10116.0,N,13249,1,,1,A,,,14198,
In vivo,,CHEMBL627401,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,Intermediate,10116.0,N,13250,1,,1,A,,,14198,
In vivo,,CHEMBL627402,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,Intermediate,10116.0,N,13251,1,,1,A,,,14198,
In vivo,,CHEMBL627403,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,Intermediate,10116.0,N,13252,1,,1,A,,,14198,
In vivo,,CHEMBL627404,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,Intermediate,10116.0,N,13253,1,,1,A,,,14198,
In vivo,,CHEMBL623101,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,Intermediate,10116.0,N,13254,1,,1,A,,,14198,
In vivo,,CHEMBL877480,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,Intermediate,10116.0,N,13255,1,,1,A,,,14198,
In vivo,,CHEMBL623102,,50597,Trachea,BAO_0000218,Rattus norvegicus,3126.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,Intermediate,10116.0,N,13256,1,,1,A,,,14198,
In vivo,,CHEMBL623103,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,Intermediate,10116.0,N,13257,1,,1,A,,,14198,
In vivo,,CHEMBL623104,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,Intermediate,10116.0,N,13258,1,,1,A,,,14198,
In vivo,,CHEMBL623105,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,Intermediate,10116.0,N,13259,1,,1,A,,,14198,
In vivo,,CHEMBL623106,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,Intermediate,10116.0,N,13260,1,,1,A,,,14198,
In vivo,,CHEMBL623107,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,Intermediate,10116.0,N,13261,1,,1,A,,,14198,
In vivo,,CHEMBL623108,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,Intermediate,10116.0,N,13262,1,,1,A,,,14198,
In vivo,,CHEMBL623109,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,Intermediate,10116.0,N,13263,1,,1,A,,,14198,
In vivo,,CHEMBL623110,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,Intermediate,10116.0,N,13264,1,,1,A,,,14198,
In vivo,,CHEMBL623111,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,Intermediate,10116.0,N,13265,1,,1,A,,,14198,
In vivo,,CHEMBL625060,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,Intermediate,10116.0,N,13266,1,,1,A,,,14198,
In vivo,,CHEMBL625061,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,Intermediate,10116.0,N,13267,1,,1,A,,,14198,
In vivo,,CHEMBL625062,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,Intermediate,10116.0,N,13268,1,,1,A,,,14198,
In vivo,,CHEMBL625063,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,Intermediate,10116.0,N,13269,1,,1,A,,,14198,
In vivo,,CHEMBL625064,,50597,Trachea,BAO_0000218,Rattus norvegicus,3126.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,Intermediate,10116.0,N,13270,1,,1,A,,,14198,
In vivo,,CHEMBL625065,,50597,Bone,BAO_0000218,Rattus norvegicus,10000001.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,Intermediate,10116.0,N,13271,1,,1,A,,,14198,
In vivo,,CHEMBL625066,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,Intermediate,10116.0,N,13272,1,,1,A,,,14198,
In vivo,,CHEMBL625067,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,Intermediate,10116.0,N,13273,1,,1,A,,,14198,
In vivo,,CHEMBL625068,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,Intermediate,10116.0,N,13274,1,,1,A,,,14198,
In vivo,,CHEMBL622159,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,Intermediate,10116.0,N,13275,1,,1,A,,,14198,
In vivo,,CHEMBL622160,,50597,Intestine,BAO_0000218,Rattus norvegicus,160.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,Intermediate,10116.0,N,13276,1,,1,A,,,14198,
In vivo,,CHEMBL622161,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,Intermediate,10116.0,N,13277,1,,1,A,,,14198,
In vivo,,CHEMBL622162,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,Intermediate,10116.0,N,13278,1,,1,A,,,14198,
In vivo,,CHEMBL622163,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,Intermediate,10116.0,N,13279,1,,1,A,,,14198,
In vivo,,CHEMBL622313,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,Intermediate,10116.0,N,13280,1,,1,A,,,14198,
In vivo,,CHEMBL622314,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,Intermediate,10116.0,N,13281,1,,1,A,,,14198,
In vivo,,CHEMBL622315,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,Intermediate,10116.0,N,13282,1,,1,A,,,14198,
In vivo,,CHEMBL622316,,50597,Trachea,BAO_0000218,Rattus norvegicus,3126.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,Intermediate,10116.0,N,13283,1,,1,A,,,14198,
,,CHEMBL877486,,50212,,BAO_0000218,Escherichia coli,,,Normal diffusion coefficient in water for Escherichia coli,Intermediate,562.0,N,13284,1,,1,A,,,15599,
,,CHEMBL622317,,22224,,BAO_0000019,,,,Average max percent decrease in RVR (renal vascular resistance) was determined,Autocuration,,U,13285,1,,0,A,,,8204,
,,CHEMBL622318,,22224,,BAO_0000019,,,,Average max percent decrease in RVR (renal vascular resistance) was determined.,Autocuration,,U,13286,1,,0,A,,,8204,
,,CHEMBL622319,,22224,,BAO_0000019,,,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,Autocuration,,U,13287,1,,0,A,,,6154,
,,CHEMBL622320,,22224,,BAO_0000019,,,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,Autocuration,,U,13288,1,,0,A,,,6154,
,,CHEMBL622321,,22224,,BAO_0000019,,,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,Autocuration,,U,13289,1,,0,A,,,6154,
,,CHEMBL622322,,22224,,BAO_0000019,,,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,Autocuration,,U,13290,1,,0,A,,,6154,
,,CHEMBL622323,,22224,,BAO_0000019,,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,Autocuration,,U,13291,1,,0,A,,,7114,
,,CHEMBL622324,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,Intermediate,10116.0,N,13292,1,,1,A,,,7114,
,,CHEMBL622325,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Intermediate,9615.0,N,13293,1,,1,A,,,8133,
,,CHEMBL622326,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,9615.0,N,13294,1,,1,A,,,8133,
,,CHEMBL877487,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",Intermediate,9615.0,N,13295,1,,1,A,,,8133,
,,CHEMBL622327,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,9615.0,N,13296,1,,1,A,,,8133,
,,CHEMBL622328,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",Intermediate,9615.0,N,13297,1,,1,A,,,8133,
,,CHEMBL622329,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Intermediate,9615.0,N,13298,1,,1,A,,,8133,
,,CHEMBL622330,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,9615.0,N,13299,1,,1,A,,,8133,
,,CHEMBL622331,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Intermediate,9615.0,N,13300,1,,1,A,,,8133,
,,CHEMBL622332,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,9615.0,N,13301,1,,1,A,,,8133,
,,CHEMBL622333,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",Intermediate,9615.0,N,13302,1,,1,A,,,8133,
,,CHEMBL627658,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,314293.0,U,13303,1,,0,A,,,8133,
,,CHEMBL630428,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",Autocuration,314293.0,U,13304,1,,0,A,,,8133,
,,CHEMBL630429,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,314293.0,U,13305,1,,0,A,,,8133,
,,CHEMBL630430,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",Autocuration,314293.0,U,13306,1,,0,A,,,8133,
,,CHEMBL630431,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",Autocuration,314293.0,U,13307,1,,0,A,,,8133,
,,CHEMBL630432,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,10116.0,N,13308,1,,1,A,,,8133,
,,CHEMBL630433,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Intermediate,10116.0,N,13309,1,,1,A,,,8133,
,,CHEMBL630434,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Intermediate,10116.0,N,13310,1,,1,A,,,8133,
,,CHEMBL629372,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Intermediate,10116.0,N,13311,1,,1,A,,,8133,
,,CHEMBL629553,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",Intermediate,10116.0,N,13312,1,,1,A,,,8133,
,,CHEMBL629554,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Intermediate,10116.0,N,13313,1,,1,A,,,8133,
,,CHEMBL874447,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Intermediate,10116.0,N,13314,1,,1,A,,,8133,
,,CHEMBL629555,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Intermediate,10116.0,N,13315,1,,1,A,,,8133,
,,CHEMBL629556,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Intermediate,10116.0,N,13316,1,,1,A,,,8133,
,,CHEMBL629557,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",Intermediate,10116.0,N,13317,1,,1,A,,,8133,
,,CHEMBL629558,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Intermediate,10116.0,N,13318,1,,1,A,,,8133,
,,CHEMBL629559,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Intermediate,10116.0,N,13319,1,,1,A,,,8133,
,,CHEMBL629560,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Intermediate,10116.0,N,13320,1,,1,A,,,8133,
,,CHEMBL629561,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Intermediate,9615.0,N,13321,1,,1,A,,,8133,
,,CHEMBL629562,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,9615.0,N,13322,1,,1,A,,,8133,
,,CHEMBL629563,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Intermediate,9615.0,N,13323,1,,1,A,,,8133,
,,CHEMBL629564,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,9615.0,N,13324,1,,1,A,,,8133,
,,CHEMBL629565,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Intermediate,9615.0,N,13325,1,,1,A,,,8133,
,,CHEMBL629566,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,9615.0,N,13326,1,,1,A,,,8133,
,,CHEMBL629567,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,9615.0,N,13327,1,,1,A,,,8133,
,,CHEMBL629568,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Intermediate,9615.0,N,13328,1,,1,A,,,8133,
,,CHEMBL629569,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",Intermediate,9615.0,N,13329,1,,1,A,,,8133,
,,CHEMBL629570,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Intermediate,9615.0,N,13330,1,,1,A,,,8133,
,,CHEMBL629571,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,314293.0,U,13331,1,,0,A,,,8133,
In vivo,,CHEMBL629572,,22224,,BAO_0000218,Rattus norvegicus,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Autocuration,10116.0,U,13332,1,,0,A,,,12170,
In vivo,,CHEMBL629573,,22224,,BAO_0000218,Rattus norvegicus,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Autocuration,10116.0,U,13333,1,,0,A,,,12170,
In vivo,,CHEMBL629574,,22224,,BAO_0000218,Eutheria,,,Bioavailability (dose 20 mg/kg),Autocuration,9347.0,U,13334,1,,0,A,,,4985,
In vivo,,CHEMBL629575,,22224,,BAO_0000218,Canis lupus familiaris,,,Bioavailability in dog,Autocuration,9615.0,U,13335,1,,0,A,,,15145,
In vivo,,CHEMBL874448,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (Sprague-Dawley) (male),Autocuration,10116.0,U,13336,1,,0,A,,,14080,
In vivo,,CHEMBL629576,,22224,,BAO_0000218,Primates,,,Bioavailability in monkey (dose 10 mg/kg i.d.),Autocuration,9443.0,U,13337,1,,0,A,,,11219,
In vivo,,CHEMBL629577,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Autocuration,10116.0,U,13338,1,,0,A,,,15145,
In vivo,,CHEMBL629578,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Autocuration,10116.0,U,13339,1,,0,A,,,15145,
In vivo,,CHEMBL629579,,22224,,BAO_0000218,Canis lupus familiaris,,,Bioavailability in dog (dose 3.0 mg/kg p.o.),Autocuration,9615.0,U,13340,1,,0,A,,,1202,
In vivo,,CHEMBL882958,,22224,,BAO_0000218,Canis lupus familiaris,,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,Autocuration,9615.0,U,13341,1,,0,A,,,1202,
In vivo,,CHEMBL629580,,50505,,BAO_0000218,Pan troglodytes,,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,Intermediate,9598.0,N,13342,1,,1,A,,,1202,
In vivo,,CHEMBL629581,,22224,,BAO_0000218,Eutheria,,,Bioavailability,Autocuration,9347.0,U,13343,1,,0,A,,,4026,
In vivo,,CHEMBL629582,,22224,,BAO_0000218,Saimiri,,,Bioavailability in squirrel monkey,Autocuration,9520.0,U,13344,1,,0,A,,,1492,
In vivo,,CHEMBL628522,,50588,,BAO_0000218,Canis lupus familiaris,,,Bioavailability was evaluated in dog,Intermediate,9615.0,N,13345,1,,1,A,,,12793,
In vivo,,CHEMBL625432,,100712,,BAO_0000218,Cricetinae,,,Bioavailability was evaluated in hamster,Intermediate,10026.0,N,13346,1,,1,A,,,12793,
In vivo,,CHEMBL625433,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat,Autocuration,10116.0,U,13347,1,,0,A,,,12793,
In vivo,,CHEMBL625434,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,10116.0,N,13348,1,,1,A,,,14793,
In vivo,,CHEMBL625435,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,Intermediate,10116.0,N,13349,1,,1,A,,,14793,
In vivo,,CHEMBL625436,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 10 mg/kg p.o.),Autocuration,10116.0,U,13350,1,,0,A,,,14793,
In vivo,,CHEMBL874588,,100710,,BAO_0000218,Macaca fascicularis,,,Bioavailability was measured in cynomolgus monkeys.,Intermediate,9541.0,N,13351,1,,1,A,,,14731,
In vivo,,CHEMBL625437,,50594,,BAO_0000218,Mus musculus,,,Bioavailability was measured in nude mice.,Intermediate,10090.0,N,13352,1,,1,A,,,14731,
In vivo,,CHEMBL625438,,22224,,BAO_0000218,Mustela putorius furo,,,Bioavailability in ferret (dose 10 mg/kg i.d.),Autocuration,9669.0,U,13353,1,,0,A,,,12187,
In vivo,,CHEMBL625439,,22224,,BAO_0000218,Simiiformes,,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),Autocuration,314293.0,U,13354,1,,0,A,,,12187,
In vivo,,CHEMBL625440,,22224,,BAO_0000218,Simiiformes,,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",Autocuration,314293.0,U,13355,1,,0,A,,,12187,
In vivo,,CHEMBL625441,,22224,,BAO_0000218,Simiiformes,,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),Autocuration,314293.0,U,13356,1,,0,A,,,12187,
In vivo,,CHEMBL625442,,22224,,BAO_0000218,Rattus norvegicus,,,Bioavailability in rat (dose 10 mg/kg i.d.),Autocuration,10116.0,U,13357,1,,0,A,,,12187,
In vivo,,CHEMBL625443,,50597,,BAO_0000218,Rattus norvegicus,,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,10116.0,N,13358,1,,1,A,,,12187,
In vivo,,CHEMBL625444,,22224,,BAO_0000218,,,,Bioavailability was determined; extremely poor,Autocuration,,U,13359,1,,0,A,,,17431,
In vivo,,CHEMBL625445,,50594,,BAO_0000218,Mus musculus,,,% bioavailability in mice after oral administration of prodrug,Intermediate,10090.0,N,13360,1,,1,A,,,13318,
In vivo,,CHEMBL625446,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,Intermediate,9615.0,N,13361,1,,1,A,,,9025,
In vivo,,CHEMBL882960,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,Intermediate,9615.0,N,13362,1,,1,A,,,9025,
In vivo,,CHEMBL625447,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,Intermediate,9615.0,N,13363,1,,1,A,,,9025,
In vivo,,CHEMBL625448,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,Intermediate,9615.0,N,13364,1,,1,A,,,9025,
In vivo,,CHEMBL625449,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,Intermediate,9615.0,N,13365,1,,1,A,,,9025,
In vivo,,CHEMBL874589,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),Intermediate,9615.0,N,13366,1,,1,A,,,9025,
In vivo,,CHEMBL625450,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,Intermediate,9615.0,N,13367,1,,1,A,,,9025,
In vivo,,CHEMBL625451,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,Intermediate,9615.0,N,13368,1,,1,A,,,9025,
In vivo,,CHEMBL626584,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,Intermediate,9615.0,N,13369,1,,1,A,,,9025,
In vivo,,CHEMBL626585,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,Intermediate,9615.0,N,13370,1,,1,A,,,9025,
In vivo,,CHEMBL626586,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,Intermediate,9615.0,N,13371,1,,1,A,,,9025,
In vivo,,CHEMBL626587,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,Intermediate,9615.0,N,13372,1,,1,A,,,9025,
In vivo,,CHEMBL626588,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,Intermediate,9615.0,N,13373,1,,1,A,,,9025,
In vivo,,CHEMBL626589,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,Intermediate,9615.0,N,13374,1,,1,A,,,9025,
In vivo,,CHEMBL626590,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,Intermediate,9615.0,N,13375,1,,1,A,,,9025,
In vivo,,CHEMBL626591,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,Intermediate,9615.0,N,13376,1,,1,A,,,9025,
In vivo,,CHEMBL627181,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,Intermediate,9615.0,N,13377,1,,1,A,,,9025,
In vivo,,CHEMBL628083,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,Intermediate,9615.0,N,13378,1,,1,A,,,9025,
In vivo,,CHEMBL628084,,22224,,BAO_0000218,,,,IV clearance determined at an peroral dose of 15 mg/kg.,Autocuration,,U,13379,1,,0,A,,,15173,
In vivo,,CHEMBL628085,,50064,,BAO_0000218,Hymenolepis nana,,,Mouse oral clearance was measured against Hymenolepiasis nana.,Expert,102285.0,N,13380,1,,1,F,,,7732,
In vivo,,CHEMBL628086,,50545,,BAO_0000218,Heligmosomoides polygyrus,,,Mouse oral clearance was measured against Nematospiroides dubius,Expert,6339.0,N,13381,1,,1,F,,,7732,
In vivo,,CHEMBL628087,,22224,,BAO_0000218,,,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,Autocuration,,U,13382,1,,0,F,,,7732,
In vivo,,CHEMBL628088,,50594,,BAO_0000218,Mus musculus,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,Intermediate,10090.0,N,13383,1,,1,A,,,7732,
In vivo,,CHEMBL628089,,22224,,BAO_0000218,,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,Autocuration,,U,13384,1,,0,B,,,7732,
In vivo,,CHEMBL628090,,22224,,BAO_0000218,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,Autocuration,,U,13385,1,,0,A,,,8328,
In vivo,,CHEMBL628091,,22224,,BAO_0000218,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,Autocuration,,U,13386,1,,0,A,,,8328,
In vivo,,CHEMBL628092,,22224,,BAO_0000218,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,Autocuration,,U,13387,1,,0,A,,,8328,
In vivo,,CHEMBL628093,,22224,,BAO_0000218,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,Autocuration,,U,13388,1,,0,A,,,8328,
In vivo,,CHEMBL875607,,22224,,BAO_0000218,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,Autocuration,,U,13389,1,,0,A,,,8328,
In vivo,,CHEMBL625710,,22224,,BAO_0000218,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,Autocuration,,U,13390,1,,0,A,,,8328,
In vivo,,CHEMBL625711,,22224,,BAO_0000218,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,Autocuration,,U,13391,1,,0,A,,,8328,
In vivo,,CHEMBL625712,,22224,,BAO_0000218,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,Autocuration,,U,13392,1,,0,A,,,8328,
In vivo,,CHEMBL625713,,22224,,BAO_0000218,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,Autocuration,,U,13393,1,,0,A,,,8328,
In vivo,,CHEMBL625714,,50588,,BAO_0000218,Canis lupus familiaris,,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,Intermediate,9615.0,N,13394,1,,1,A,,,13376,
In vivo,,CHEMBL625715,,50797,,BAO_0000218,Macaca mulatta,,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,Intermediate,9544.0,N,13395,1,,1,A,,,13477,
In vivo,,CHEMBL625716,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,Intermediate,10116.0,N,13396,1,,1,A,,,13477,
In vivo,,CHEMBL625717,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,Intermediate,10116.0,N,13397,1,,1,A,,,13477,
In vivo,,CHEMBL625718,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance was determined for the compound in rats,Intermediate,10116.0,N,13398,1,,1,A,,,13313,
In vivo,,CHEMBL625719,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,Intermediate,10116.0,N,13399,1,,1,A,,,12504,
In vivo,,CHEMBL625720,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,Intermediate,10116.0,N,13400,1,,1,A,,,12504,
In vivo,,CHEMBL625721,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,Intermediate,10116.0,N,13401,1,,1,A,,,12504,
In vivo,,CHEMBL625722,,50597,,BAO_0000218,Rattus norvegicus,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,Intermediate,10116.0,N,13402,1,,1,A,,,12504,
In vivo,,CHEMBL625723,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,Intermediate,10116.0,N,13403,1,,1,A,,,13129,
In vivo,,CHEMBL625724,,50545,,BAO_0000218,Heligmosomoides polygyrus,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,Intermediate,6339.0,N,13404,1,,1,A,,,7732,
In vivo,,CHEMBL625725,,50545,,BAO_0000218,Heligmosomoides polygyrus,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,Intermediate,6339.0,N,13405,1,,1,A,,,7732,
In vivo,,CHEMBL625726,,50545,,BAO_0000218,Heligmosomoides polygyrus,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,Intermediate,6339.0,N,13406,1,,1,A,,,7732,
In vivo,,CHEMBL875608,,50545,,BAO_0000218,Heligmosomoides polygyrus,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,Intermediate,6339.0,N,13407,1,,1,A,,,7732,
In vivo,,CHEMBL625727,,50545,,BAO_0000218,Heligmosomoides polygyrus,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,Intermediate,6339.0,N,13408,1,,1,A,,,7732,
In vivo,,CHEMBL625728,,22224,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,Autocuration,10116.0,U,13409,1,,0,A,,,9278,
In vivo,,CHEMBL625729,,22224,,BAO_0000218,Rattus norvegicus,,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Autocuration,10116.0,U,13410,1,,0,A,,,9278,
In vivo,,CHEMBL625730,,22224,,BAO_0000218,Rattus norvegicus,,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,Autocuration,10116.0,U,13411,1,,0,A,,,9278,
In vivo,,CHEMBL625731,,22224,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Autocuration,10116.0,U,13412,1,,0,A,,,9278,
In vivo,,CHEMBL626417,,22224,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Urinary clearance was determined in rat at 25 mg/kg os dosage,Autocuration,10116.0,U,13413,1,,0,A,,,9278,
In vivo,,CHEMBL626418,,50587,Urine,BAO_0000218,Homo sapiens,1088.0,,Urinary clearance was determined at 100 mg/kg oral dosage in human,Intermediate,9606.0,N,13414,1,,1,A,,,9278,
In vivo,,CHEMBL626419,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,Intermediate,9615.0,N,13415,1,,1,A,,,9278,
In vivo,,CHEMBL626592,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,Intermediate,9615.0,N,13416,1,,1,A,,,5932,
In vivo,,CHEMBL626593,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Intermediate,10116.0,N,13417,1,,1,A,,,5932,
In vivo,,CHEMBL626594,,50597,,BAO_0000218,Rattus norvegicus,,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,10116.0,N,13418,1,,1,A,,,5182,
In vivo,,CHEMBL625035,,50588,,BAO_0000218,Canis lupus familiaris,,,Clearance rate in dogs,Intermediate,9615.0,N,13419,1,,1,A,,,10499,
In vitro,,CHEMBL625036,,22224,,BAO_0000019,,,,Compound was measured for intrinsic clearance,Autocuration,,U,13420,1,,0,A,,,6051,
,,CHEMBL625037,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13421,1,,0,P,,,17508,
,,CHEMBL625038,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13422,1,,0,P,,,6228,
,,CHEMBL625039,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13423,1,,0,P,,,6231,
,,CHEMBL625040,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13424,1,,0,P,,,17740,
,,CHEMBL625041,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13425,1,,0,P,,,6495,
,,CHEMBL625042,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13426,1,,0,P,,,2171,
,,CHEMBL874411,,22224,,BAO_0000019,,,,Partition coefficient of the compound,Autocuration,,U,13427,1,,0,A,,,3255,
,,CHEMBL625043,,22224,,BAO_0000019,,,,Permeability,Autocuration,,U,13428,1,,0,A,,,6821,
,,CHEMBL625044,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13429,1,,0,P,,,2685,
,,CHEMBL625045,,22224,,BAO_0000019,,,,Partition coefficient (logD),Autocuration,,U,13430,1,,0,A,,,17584,
,,CHEMBL625046,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,,U,13431,1,,0,P,,,13824,
,,CHEMBL625047,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,,U,13432,1,,0,P,,,13824,
,,CHEMBL625048,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13433,1,,0,P,,,16479,
,,CHEMBL625049,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13434,1,,0,P,,,11997,
,,CHEMBL625050,,22229,,BAO_0000100,,,,Calculated logarithm of partition coefficient (P) was determined,Autocuration,,U,13435,1,,0,P,,,2988,
,,CHEMBL625051,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13436,1,,0,P,,,931,
,,CHEMBL874412,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13437,1,,0,P,,,4381,
,,CHEMBL625052,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13438,1,,0,P,,,4397,
,,CHEMBL625053,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13439,1,,0,P,,,5889,
,,CHEMBL623250,,22224,,BAO_0000019,,,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,Autocuration,,U,13440,1,,0,A,,,6154,
,,CHEMBL623251,,22224,,BAO_0000019,,,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,Autocuration,,U,13441,1,,0,A,,,6154,
,,CHEMBL623252,,22224,,BAO_0000019,,,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,Autocuration,,U,13442,1,,0,A,,,6154,
,,CHEMBL623253,,22224,,BAO_0000019,,,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,Autocuration,,U,13443,1,,0,A,,,6154,
,,CHEMBL623254,,22224,,BAO_0000019,,,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,Autocuration,,U,13444,1,,0,A,,,6154,
,,CHEMBL623255,,22224,,BAO_0000019,,,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,Autocuration,,U,13445,1,,0,A,,,6154,
,,CHEMBL626831,,22224,,BAO_0000019,,,,Percent degradation of compound at a pH of 1 over a 18 hr period,Autocuration,,U,13446,1,,0,A,,,6887,
,,CHEMBL877494,,22224,,BAO_0000019,,,,Percent degradation of compound at pH of 1 over an 18 hr period,Autocuration,,U,13447,1,,0,A,,,6887,
,,CHEMBL626832,,22224,,BAO_0000019,,,,Delta Logarithm of Partition Coefficient value was determined.,Autocuration,,U,13448,1,,0,A,,,14116,
,,CHEMBL626833,,22224,,BAO_0000019,,,,Delta logPoct-cyc,Autocuration,,U,13449,1,,0,A,,,11137,
,,CHEMBL626834,,22224,,BAO_0000100,,,,Lipophilicity estimated on reversed phase TLC,Autocuration,,U,13450,1,,0,P,,,7230,
,,CHEMBL626835,,22224,,BAO_0000019,,,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,Autocuration,,U,13451,1,,0,A,,,15741,
,,CHEMBL626836,,22224,,BAO_0000019,,,,Delta logPoct-cyc,Autocuration,,U,13452,1,,0,A,,,9663,
,,CHEMBL626837,,22229,,BAO_0000100,,,,Change in logarithm of partition coefficient of the compound,Autocuration,,U,13453,1,,0,P,,,9663,
,,CHEMBL626838,,22224,,BAO_0000019,,,,Delta logD (pH 6.5),Autocuration,,U,13454,1,,0,A,,,13807,
,,CHEMBL626839,,22224,,BAO_0000100,,,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",Autocuration,,U,13455,1,,0,P,,,13807,
,,CHEMBL626840,,22224,,BAO_0000019,,,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,Autocuration,,U,13456,1,,0,A,,,17425,
,,CHEMBL626841,,22224,,BAO_0000019,,,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),Autocuration,,U,13457,1,,0,A,,,12143,
,,CHEMBL626842,,22224,,BAO_0000219,,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,Autocuration,,U,13458,1,,0,A,,,12608,
,,CHEMBL626843,,22224,,BAO_0000219,,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,Autocuration,,U,13459,1,,0,A,,,12608,
,,CHEMBL626844,,50597,,BAO_0000218,Rattus norvegicus,,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,Intermediate,10116.0,N,13460,1,,1,A,,,8649,
,,CHEMBL877495,,50597,,BAO_0000218,Rattus norvegicus,,,Amount of deuterium retained was reported after normal workup in rats,Intermediate,10116.0,N,13461,1,,1,A,,,8649,
,,CHEMBL626845,,50597,,BAO_0000218,Rattus norvegicus,,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,Intermediate,10116.0,N,13462,1,,1,A,,,8649,
,,CHEMBL626846,,50597,,BAO_0000218,Rattus norvegicus,,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,Intermediate,10116.0,N,13463,1,,1,A,,,8649,
,,CHEMBL626847,,50597,,BAO_0000218,Rattus norvegicus,,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Intermediate,10116.0,N,13464,1,,1,A,,,8649,
,,CHEMBL628677,,50597,,BAO_0000218,Rattus norvegicus,,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Intermediate,10116.0,N,13465,1,,1,A,,,8649,
,,CHEMBL628678,,50597,,BAO_0000218,Rattus norvegicus,,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,Intermediate,10116.0,N,13466,1,,1,A,,,8649,
,,CHEMBL628679,,22224,,BAO_0000019,,,,Compound was subjected to electrochemical oxidation,Autocuration,,U,13467,1,,0,A,,,9659,
,,CHEMBL628680,,22224,,BAO_0000019,,,,Compound was subjected to photochemical oxidation,Autocuration,,U,13468,1,,0,A,,,9659,
,,CHEMBL628681,,22224,,BAO_0000019,,,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,Autocuration,,U,13469,1,,0,A,,,9659,
,,CHEMBL628682,,22224,,BAO_0000019,,,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,Autocuration,,U,13470,1,,0,A,,,9659,
,,CHEMBL628683,,22224,,BAO_0000019,,,,Oxidation of compound by methemoglobin in presence of hydroperoxide,Autocuration,,U,13471,1,,0,A,,,9659,
,,CHEMBL628684,,50597,,BAO_0000218,Rattus norvegicus,,,Percent diffusion through fuzzy rat skin after 48 h of incubation,Intermediate,10116.0,N,13472,1,,1,A,,,9607,
,,CHEMBL877501,,22229,,BAO_0000100,,,,Dissociation constant (pKa),Autocuration,,U,13473,1,,0,P,,,7057,
,,CHEMBL628685,,22224,,BAO_0000100,,,,Dissociation constant value of the compound; ND means not determined.,Autocuration,,U,13474,1,,0,P,,,7057,
,,CHEMBL628686,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,Intermediate,10116.0,N,13475,1,,1,A,,,7911,
,,CHEMBL628687,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,10116.0,N,13476,1,,1,A,,,7911,
,,CHEMBL628688,,50597,,BAO_0000218,Rattus norvegicus,,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,Intermediate,10116.0,N,13477,1,,1,A,,,7911,
,,CHEMBL628689,,50597,,BAO_0000218,Rattus norvegicus,,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,10116.0,N,13478,1,,1,A,,,7911,
,,CHEMBL628690,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,Intermediate,10116.0,N,13479,1,,1,A,,,7911,
,,CHEMBL629363,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Intermediate,10116.0,N,13480,1,,1,A,,,7911,
,,CHEMBL629364,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,Intermediate,10116.0,N,13481,1,,1,A,,,7911,
,,CHEMBL629365,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,10116.0,N,13482,1,,1,A,,,7911,
,,CHEMBL629366,,50597,,BAO_0000218,Rattus norvegicus,,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,Intermediate,10116.0,N,13483,1,,1,A,,,7911,
,,CHEMBL629367,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,Intermediate,10116.0,N,13484,1,,1,A,,,7911,
,,CHEMBL629368,,50597,Feces,BAO_0000218,Rattus norvegicus,1988.0,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,10116.0,N,13485,1,,1,A,,,7911,
,,CHEMBL877502,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Intermediate,10116.0,N,13486,1,,1,A,,,7911,
,,CHEMBL629369,,50594,Cerebellum,BAO_0000218,Mus musculus,2037.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,Intermediate,10090.0,N,13487,1,,1,A,,,13792,
,,CHEMBL629370,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,Intermediate,10090.0,N,13488,1,,1,A,,,13792,
,,CHEMBL629371,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",Autocuration,314293.0,U,13489,1,,0,A,,,8133,
,,CHEMBL626276,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,314293.0,U,13490,1,,0,A,,,8133,
,,CHEMBL626277,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Autocuration,314293.0,U,13491,1,,0,A,,,8133,
,,CHEMBL631250,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Autocuration,314293.0,U,13492,1,,0,A,,,8133,
,,CHEMBL631251,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,10116.0,N,13493,1,,1,A,,,8133,
,,CHEMBL631252,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Intermediate,10116.0,N,13494,1,,1,A,,,8133,
,,CHEMBL631253,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",Intermediate,10116.0,N,13495,1,,1,A,,,8133,
,,CHEMBL631254,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Intermediate,10116.0,N,13496,1,,1,A,,,8133,
,,CHEMBL631255,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Intermediate,10116.0,N,13497,1,,1,A,,,8133,
,,CHEMBL631256,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Intermediate,10116.0,N,13498,1,,1,A,,,8133,
,,CHEMBL631257,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Intermediate,10116.0,N,13499,1,,1,A,,,8133,
,,CHEMBL628009,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",Intermediate,10116.0,N,13500,1,,1,A,,,8133,
,,CHEMBL628010,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Intermediate,10116.0,N,13501,1,,1,A,,,8133,
,,CHEMBL628011,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Intermediate,10116.0,N,13502,1,,1,A,,,8133,
,,CHEMBL628012,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",Intermediate,10116.0,N,13503,1,,1,A,,,8133,
,,CHEMBL628013,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Intermediate,10116.0,N,13504,1,,1,A,,,8133,
,,CHEMBL628014,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Intermediate,10116.0,N,13505,1,,1,A,,,8133,
,,CHEMBL628015,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",Intermediate,9615.0,N,13506,1,,1,A,,,8133,
,,CHEMBL628016,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,9615.0,N,13507,1,,1,A,,,8133,
,,CHEMBL874461,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",Intermediate,9615.0,N,13508,1,,1,A,,,8133,
,,CHEMBL628017,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,9615.0,N,13509,1,,1,A,,,8133,
,,CHEMBL628018,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Intermediate,9615.0,N,13510,1,,1,A,,,8133,
,,CHEMBL628019,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,9615.0,N,13511,1,,1,A,,,8133,
,,CHEMBL628020,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,9615.0,N,13512,1,,1,A,,,8133,
,,CHEMBL628021,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Intermediate,9615.0,N,13513,1,,1,A,,,8133,
,,CHEMBL628022,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Intermediate,9615.0,N,13514,1,,1,A,,,8133,
,,CHEMBL628023,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Intermediate,9615.0,N,13515,1,,1,A,,,8133,
,,CHEMBL628024,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,314293.0,U,13516,1,,0,A,,,8133,
,,CHEMBL628025,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",Autocuration,314293.0,U,13517,1,,0,A,,,8133,
,,CHEMBL628026,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,314293.0,U,13518,1,,0,A,,,8133,
,,CHEMBL628027,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Autocuration,314293.0,U,13519,1,,0,A,,,8133,
,,CHEMBL628028,,22224,Urine,BAO_0000218,Simiiformes,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Autocuration,314293.0,U,13520,1,,0,A,,,8133,
,,CHEMBL628029,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,10116.0,N,13521,1,,1,A,,,8133,
,,CHEMBL628030,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",Intermediate,10116.0,N,13522,1,,1,A,,,8133,
,,CHEMBL628031,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Intermediate,10116.0,N,13523,1,,1,A,,,8133,
,,CHEMBL628032,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",Intermediate,10116.0,N,13524,1,,1,A,,,8133,
,,CHEMBL628033,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Intermediate,10116.0,N,13525,1,,1,A,,,8133,
,,CHEMBL628034,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",Intermediate,10116.0,N,13526,1,,1,A,,,8133,
,,CHEMBL628035,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Intermediate,10116.0,N,13527,1,,1,A,,,8133,
,,CHEMBL628036,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",Intermediate,10116.0,N,13528,1,,1,A,,,8133,
,,CHEMBL874462,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Intermediate,10116.0,N,13529,1,,1,A,,,8133,
In vivo,,CHEMBL628037,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,Intermediate,9615.0,N,13530,1,,1,A,,,9025,
In vivo,,CHEMBL628123,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,Intermediate,9615.0,N,13531,1,,1,A,,,9025,
In vivo,,CHEMBL628124,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,Intermediate,9615.0,N,13532,1,,1,A,,,9025,
In vivo,,CHEMBL628125,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,Intermediate,9615.0,N,13533,1,,1,A,,,9025,
In vivo,,CHEMBL628126,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,Intermediate,9615.0,N,13534,1,,1,A,,,9025,
In vivo,,CHEMBL628127,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),Intermediate,9615.0,N,13535,1,,1,A,,,9025,
In vivo,,CHEMBL628128,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,Intermediate,9615.0,N,13536,1,,1,A,,,9025,
In vivo,,CHEMBL628129,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,Intermediate,9615.0,N,13537,1,,1,A,,,9025,
In vivo,,CHEMBL628130,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,Intermediate,9615.0,N,13538,1,,1,A,,,9025,
In vivo,,CHEMBL628131,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,Intermediate,9615.0,N,13539,1,,1,A,,,9025,
In vivo,,CHEMBL628132,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,Intermediate,9615.0,N,13540,1,,1,A,,,9025,
In vivo,,CHEMBL628133,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,Intermediate,9615.0,N,13541,1,,1,A,,,9025,
In vivo,,CHEMBL628134,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,Intermediate,9615.0,N,13542,1,,1,A,,,9025,
In vivo,,CHEMBL628135,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,Intermediate,9615.0,N,13543,1,,1,A,,,9025,
In vivo,,CHEMBL628136,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,Intermediate,9615.0,N,13544,1,,1,A,,,9025,
In vivo,,CHEMBL628137,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,Intermediate,9615.0,N,13545,1,,1,A,,,9025,
In vivo,,CHEMBL628138,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,Intermediate,9615.0,N,13546,1,,1,A,,,9025,
In vivo,,CHEMBL628139,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,Intermediate,9615.0,N,13547,1,,1,A,,,9025,
In vivo,,CHEMBL628140,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,Intermediate,9615.0,N,13548,1,,1,A,,,9025,
In vivo,,CHEMBL628141,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,Intermediate,9615.0,N,13549,1,,1,A,,,9025,
In vivo,,CHEMBL628142,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,Intermediate,9615.0,N,13550,1,,1,A,,,9025,
In vivo,,CHEMBL628143,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,Intermediate,9615.0,N,13551,1,,1,A,,,9025,
In vivo,,CHEMBL628144,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,Intermediate,9615.0,N,13552,1,,1,A,,,9025,
In vivo,,CHEMBL628145,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,Intermediate,9615.0,N,13553,1,,1,A,,,9025,
In vivo,,CHEMBL628146,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,Intermediate,9615.0,N,13554,1,,1,A,,,9025,
In vivo,,CHEMBL625355,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,Intermediate,9615.0,N,13555,1,,1,A,,,9025,
In vivo,,CHEMBL625356,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,Intermediate,9615.0,N,13556,1,,1,A,,,9025,
In vivo,,CHEMBL625357,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,Intermediate,9615.0,N,13557,1,,1,A,,,9025,
In vivo,,CHEMBL625527,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,Intermediate,9615.0,N,13558,1,,1,A,,,9025,
In vivo,,CHEMBL875473,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),Intermediate,9615.0,N,13559,1,,1,A,,,9025,
In vivo,,CHEMBL625528,,50588,,BAO_0000218,Canis lupus familiaris,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,Intermediate,9615.0,N,13560,1,,1,A,,,9025,
In vivo,,CHEMBL626304,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,Intermediate,10116.0,N,13561,1,,1,A,,,9025,
In vivo,,CHEMBL624138,,50588,Artery,BAO_0000218,Canis lupus familiaris,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,Intermediate,9615.0,N,13562,1,,1,A,,,9025,
,,CHEMBL624139,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13563,1,,0,P,,,6448,
,,CHEMBL624140,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13564,1,,0,P,,,17221,
,,CHEMBL624141,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13565,1,,0,P,,,6545,
,,CHEMBL624142,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13566,1,,0,P,,,577,
,,CHEMBL624143,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13567,1,,0,P,,,6285,
,,CHEMBL624144,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13568,1,,0,P,,,6500,
,,CHEMBL624145,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13569,1,,0,P,,,6716,
,,CHEMBL624146,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13570,1,,0,P,,,13658,
,,CHEMBL624147,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13571,1,,0,P,,,6549,
,,CHEMBL883123,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP) (MacLogP),Autocuration,,U,13572,1,,0,P,,,14685,
,,CHEMBL624148,,22224,,BAO_0000019,,,,Partition coefficient (logP),Autocuration,,U,13573,1,,0,A,,,6893,
,,CHEMBL874416,,22224,,BAO_0000019,,,,Kinetic parameter was determined,Autocuration,,U,13574,1,,0,A,,,3687,
,,CHEMBL624149,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13575,1,,0,P,,,4207,
,,CHEMBL624150,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13576,1,,0,P,,,4626,
,,CHEMBL624151,,22224,,BAO_0000100,,,,Lipophilicity was determined,Autocuration,,U,13577,1,,0,P,,,1021,
,,CHEMBL624152,,22224,,BAO_0000100,,,,Lipophilicity was determined,Autocuration,,U,13578,1,,0,P,,,3777,
,,CHEMBL622139,,22224,,BAO_0000100,,,,Lipophilicity was determined,Autocuration,,U,13579,1,,0,P,,,17533,
,,CHEMBL622140,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13580,1,,0,P,,,6524,
,,CHEMBL622141,,22224,,BAO_0000100,,,,Lipophilicity was determined,Autocuration,,U,13581,1,,0,P,,,17533,
,,CHEMBL622142,,22224,,BAO_0000100,,,,Lipophilicity in octanol-water,Autocuration,,U,13582,1,,0,P,,,6480,
,,CHEMBL622143,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13583,1,,0,P,,,17606,
,,CHEMBL622144,,22229,,BAO_0000100,,,,Octanol-water partition coefficient was determined,Autocuration,,U,13584,1,,0,P,,,6863,
,,CHEMBL877473,,22224,,BAO_0000019,,,,Partition coefficient (logP),Autocuration,,U,13585,1,,0,A,,,1356,
,,CHEMBL622145,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13586,1,,0,P,,,3326,
,,CHEMBL622146,,22224,,BAO_0000019,,,,Partition coefficient was determined; ND means not determined,Autocuration,,U,13587,1,,0,A,,,1356,
,,CHEMBL622147,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP),Autocuration,,U,13588,1,,0,P,,,12984,
,,CHEMBL622148,,22224,,BAO_0000019,,,,Partition coefficient of the compound,Autocuration,,U,13589,1,,0,A,,,17363,
,,CHEMBL883124,,22224,,BAO_0000019,,,,Permeability was determined,Autocuration,,U,13590,1,,0,A,,,6827,
,,CHEMBL622149,,22229,,BAO_0000100,,,,The compound was evaluated for the partition coefficient,Autocuration,,U,13591,1,,0,P,,,261,
,,CHEMBL622150,,22224,,BAO_0000019,,,,Partition coefficient (logP),Autocuration,,U,13592,1,,0,A,,,2685,
,,CHEMBL622151,,22224,,BAO_0000100,,,,The lipophilicity was reported,Autocuration,,U,13593,1,,0,P,,,414,
,,CHEMBL622152,,22229,,BAO_0000100,,,,logarithm of the octanol-water partition coefficient for the compound,Autocuration,,U,13594,1,,0,P,,,15769,
,,CHEMBL622153,,22224,,BAO_0000019,,,,Clogp value was determined,Autocuration,,U,13595,1,,0,A,,,17248,
In vivo,,CHEMBL877474,,22224,,BAO_0000218,,,,Clp at a dose of 1.5 mg/kg,Autocuration,,U,13596,1,,0,A,,,16935,
In vivo,,CHEMBL622154,,22224,,BAO_0000218,,,,Clp at a dose of 2.0 mg/kg,Autocuration,,U,13597,1,,0,A,,,16935,
In vivo,,CHEMBL622155,,22224,Plasma,BAO_0000218,,1969.0,,"Clp, plasma clearance at a dose of 10 mg/kg",Autocuration,,U,13598,1,,0,A,,,14832,
In vivo,,CHEMBL622156,,22224,Plasma,BAO_0000218,,1969.0,,"Clp, plasma clearance at a dose of 50 mg/kg",Autocuration,,U,13599,1,,0,A,,,14832,
In vivo,,CHEMBL622157,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was tested for plasma clearance in rat,Intermediate,10116.0,N,13600,1,,1,A,,,2399,
In vivo,,CHEMBL622158,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Compound was tested for plasma clearance in rat; Not determined,Intermediate,10116.0,N,13601,1,,1,A,,,2399,
In vivo,,CHEMBL622807,,50597,,BAO_0000218,Rattus norvegicus,,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,Intermediate,10116.0,N,13602,1,,1,A,,,6227,
In vivo,,CHEMBL622808,,50797,,BAO_0000218,Macaca mulatta,,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,Intermediate,9544.0,N,13603,1,,1,A,,,6227,
In vivo,,CHEMBL622809,,22224,,BAO_0000218,,,,Plasma clearance by iv administration at a dose 0.003 ug/mL,Autocuration,,U,13604,1,,0,A,,,5623,
In vivo,,CHEMBL622810,,22224,,BAO_0000218,,,,Plasma clearance determined,Autocuration,,U,13605,1,,0,A,,,4854,
In vivo,,CHEMBL876653,,100712,,BAO_0000218,Cricetinae,,,Plasma clearance after iv administration at 3 mg/kg in hamster,Intermediate,10026.0,N,13606,1,,1,A,,,4493,
In vivo,,CHEMBL622811,,100712,,BAO_0000218,Cricetinae,,,Plasma clearance after iv administration at 4 mg/kg in hamster,Intermediate,10026.0,N,13607,1,,1,A,,,4493,
In vivo,,CHEMBL622986,,50597,,BAO_0000218,Rattus norvegicus,,,Rate of clearance in rat was determined,Intermediate,10116.0,N,13608,1,,1,A,,,14956,
In vivo,,CHEMBL622987,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,Intermediate,10116.0,N,13609,1,,1,A,,,15372,
In vivo,,CHEMBL622988,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,Intermediate,10116.0,N,13610,1,,1,A,,,15372,
In vivo,,CHEMBL622989,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,Intermediate,10116.0,N,13611,1,,1,A,,,15372,
In vivo,,CHEMBL622990,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,Intermediate,10116.0,N,13612,1,,1,A,,,15372,
In vivo,,CHEMBL622991,,22224,Plasma,BAO_0000218,Simiiformes,1969.0,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Autocuration,314293.0,U,13613,1,,0,A,,,15604,
In vivo,,CHEMBL622227,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Intermediate,10116.0,N,13614,1,,1,A,,,15604,
In vivo,,CHEMBL622228,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Intermediate,9615.0,N,13615,1,,1,A,,,15604,
In vivo,,CHEMBL622229,,50597,,BAO_0000218,Rattus norvegicus,,,Clpl value in rat,Intermediate,10116.0,N,13616,1,,1,A,,,14964,
In vivo,,CHEMBL622230,,50512,,BAO_0000218,Cavia porcellus,,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,Intermediate,10141.0,N,13617,1,,1,A,,,15240,
In vivo,,CHEMBL622231,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,Intermediate,10116.0,N,13618,1,,1,A,,,16449,
In vivo,,CHEMBL622232,,100710,,BAO_0000218,Macaca fascicularis,,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,Intermediate,9541.0,N,13619,1,,1,A,,,16449,
In vivo,,CHEMBL622233,,22224,,BAO_0000218,,,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,Autocuration,,U,13620,1,,0,A,,,12902,
In vivo,,CHEMBL622234,,22224,,BAO_0000218,,,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,Autocuration,,U,13621,1,,0,A,,,12902,
In vivo,,CHEMBL622235,,22224,,BAO_0000218,,,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,Autocuration,,U,13622,1,,0,A,,,12902,
In vivo,,CHEMBL622236,,22224,,BAO_0000218,,,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,Autocuration,,U,13623,1,,0,A,,,12902,
In vivo,,CHEMBL622237,,22224,,BAO_0000218,,,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,Autocuration,,U,13624,1,,0,A,,,12902,
In vivo,,CHEMBL877482,,22224,,BAO_0000218,,,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,Autocuration,,U,13625,1,,0,A,,,12902,
In vivo,,CHEMBL622238,,22224,,BAO_0000218,,,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,Autocuration,,U,13626,1,,0,A,,,12902,
In vivo,,CHEMBL622239,,22224,,BAO_0000218,,,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,Autocuration,,U,13627,1,,0,A,,,12902,
In vivo,,CHEMBL622240,,22224,Blood,BAO_0000218,,178.0,,Cmax was calculated as maximum concentration reached in the blood,Autocuration,,U,13628,1,,0,A,,,11149,
In vivo,,CHEMBL622241,,22224,Blood,BAO_0000218,,178.0,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,Autocuration,,U,13629,1,,0,A,,,11149,
In vivo,,CHEMBL631013,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax was determine after peroral administration at 10 mpk in Rat,Intermediate,10116.0,N,13630,1,,1,A,,,5669,
In vivo,,CHEMBL631014,,50797,,BAO_0000218,Macaca mulatta,,,Cmax was determine after peroral administration at 10 mpk in Rhesus,Intermediate,9544.0,N,13631,1,,1,A,,,5669,
In vivo,,CHEMBL631015,,50588,,BAO_0000218,Canis lupus familiaris,,,Cmax was determine after peroral administration at 10 mpk in dog,Intermediate,9615.0,N,13632,1,,1,A,,,5669,
In vivo,,CHEMBL631016,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax was determine after peroral administration at 160 mpk in Rat,Intermediate,10116.0,N,13633,1,,1,A,,,5669,
In vivo,,CHEMBL631017,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax was determine after peroral administration at 20 mpk in Rat,Intermediate,10116.0,N,13634,1,,1,A,,,5669,
In vivo,,CHEMBL631018,,50597,,BAO_0000218,Rattus norvegicus,,,Cmax was determine after peroral administration at 50 mpk in Rat,Intermediate,10116.0,N,13635,1,,1,A,,,5669,
In vivo,,CHEMBL631019,,22224,,BAO_0000218,,,,Cmax was determined,Autocuration,,U,13636,1,,0,A,,,4236,
,,CHEMBL875761,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,Intermediate,10090.0,N,13637,1,,1,A,,,13792,
,,CHEMBL631020,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,Intermediate,10090.0,N,13638,1,,1,A,,,13792,
,,CHEMBL631669,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,Intermediate,10090.0,N,13639,1,,1,A,,,13792,
,,CHEMBL631670,,50594,Brain,BAO_0000218,Mus musculus,955.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,Intermediate,10090.0,N,13640,1,,1,A,,,13792,
,,CHEMBL631671,,50594,Striatum,BAO_0000218,Mus musculus,2435.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,Intermediate,10090.0,N,13641,1,,1,A,,,13792,
,,CHEMBL631672,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,Intermediate,10116.0,N,13642,1,,1,A,,,8418,
,,CHEMBL631673,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,Intermediate,10116.0,N,13643,1,,1,A,,,8418,
,,CHEMBL631856,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,Intermediate,10116.0,N,13644,1,,1,A,,,8418,
,,CHEMBL631857,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,Intermediate,10116.0,N,13645,1,,1,A,,,8418,
,,CHEMBL631858,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,Intermediate,10116.0,N,13646,1,,1,A,,,8418,
,,CHEMBL631859,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,Intermediate,10116.0,N,13647,1,,1,A,,,8418,
,,CHEMBL631860,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,Intermediate,10116.0,N,13648,1,,1,A,,,8418,
,,CHEMBL631861,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,Intermediate,10116.0,N,13649,1,,1,A,,,8418,
,,CHEMBL631862,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,Intermediate,10116.0,N,13650,1,,1,A,,,8418,
,,CHEMBL631863,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,Intermediate,10116.0,N,13651,1,,1,A,,,8418,
,,CHEMBL631864,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,Intermediate,10116.0,N,13652,1,,1,A,,,8418,
,,CHEMBL631865,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,Intermediate,10116.0,N,13653,1,,1,A,,,8418,
,,CHEMBL631866,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,Intermediate,10116.0,N,13654,1,,1,A,,,8418,
,,CHEMBL629360,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,Intermediate,10116.0,N,13655,1,,1,A,,,8418,
,,CHEMBL629361,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,Intermediate,10116.0,N,13656,1,,1,A,,,8418,
,,CHEMBL629362,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,Intermediate,10116.0,N,13657,1,,1,A,,,8418,
,,CHEMBL630740,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,Intermediate,10116.0,N,13658,1,,1,A,,,8418,
,,CHEMBL630741,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,Intermediate,10116.0,N,13659,1,,1,A,,,8418,
,,CHEMBL630742,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,Intermediate,10116.0,N,13660,1,,1,A,,,8418,
,,CHEMBL630743,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,Intermediate,10116.0,N,13661,1,,1,A,,,8418,
,,CHEMBL630744,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,Intermediate,10116.0,N,13662,1,,1,A,,,8418,
,,CHEMBL630745,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,Intermediate,10116.0,N,13663,1,,1,A,,,8418,
,,CHEMBL630746,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,Intermediate,10116.0,N,13664,1,,1,A,,,8418,
,,CHEMBL630747,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,Intermediate,10116.0,N,13665,1,,1,A,,,8418,
,,CHEMBL630748,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,Intermediate,10116.0,N,13666,1,,1,A,,,8418,
,,CHEMBL632056,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,Intermediate,10116.0,N,13667,1,,1,A,,,8418,
,,CHEMBL632057,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,Intermediate,10116.0,N,13668,1,,1,A,,,8418,
,,CHEMBL632058,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,Intermediate,10116.0,N,13669,1,,1,A,,,8418,
,,CHEMBL632059,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,Intermediate,10116.0,N,13670,1,,1,A,,,8418,
,,CHEMBL632060,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,Intermediate,10116.0,N,13671,1,,1,A,,,8418,
,,CHEMBL632061,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,Intermediate,10116.0,N,13672,1,,1,A,,,8418,
,,CHEMBL629207,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,Intermediate,10116.0,N,13673,1,,1,A,,,8418,
,,CHEMBL629208,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,Intermediate,10116.0,N,13674,1,,1,A,,,8418,
,,CHEMBL629209,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,Intermediate,10116.0,N,13675,1,,1,A,,,8418,
,,CHEMBL629210,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,Intermediate,10116.0,N,13676,1,,1,A,,,8418,
,,CHEMBL629211,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,Intermediate,10116.0,N,13677,1,,1,A,,,8418,
,,CHEMBL629212,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,Intermediate,10116.0,N,13678,1,,1,A,,,8418,
,,CHEMBL629213,,50597,,BAO_0000218,Rattus norvegicus,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,Intermediate,10116.0,N,13679,1,,1,A,,,8418,
,,CHEMBL629214,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Intermediate,10116.0,N,13680,1,,1,A,,,8133,
,,CHEMBL629215,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",Intermediate,10116.0,N,13681,1,,1,A,,,8133,
,,CHEMBL635154,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",Intermediate,10116.0,N,13682,1,,1,A,,,8133,
,,CHEMBL629216,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,13683,1,,1,A,,,6996,
,,CHEMBL629217,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,Intermediate,10116.0,N,13684,1,,1,A,,,6996,
,,CHEMBL629218,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,13685,1,,1,A,,,6996,
,,CHEMBL629219,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,13686,1,,1,A,,,6996,
,,CHEMBL629220,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,10116.0,N,13687,1,,1,A,,,6996,
,,CHEMBL629221,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,13688,1,,1,A,,,6996,
,,CHEMBL631127,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,13689,1,,1,A,,,6996,
,,CHEMBL631128,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,Intermediate,10116.0,N,13690,1,,1,A,,,6996,
,,CHEMBL631129,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,13691,1,,1,A,,,6996,
,,CHEMBL631130,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,13692,1,,1,A,,,6996,
,,CHEMBL631131,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,10116.0,N,13693,1,,1,A,,,6996,
,,CHEMBL631132,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,13694,1,,1,A,,,6996,
,,CHEMBL631133,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,13695,1,,1,A,,,6996,
,,CHEMBL631134,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,Intermediate,10116.0,N,13696,1,,1,A,,,6996,
,,CHEMBL875120,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,13697,1,,1,A,,,6996,
,,CHEMBL631135,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,13698,1,,1,A,,,6996,
,,CHEMBL631136,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Intermediate,10116.0,N,13699,1,,1,A,,,6996,
,,CHEMBL631137,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,13700,1,,1,A,,,6996,
,,CHEMBL631138,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,13701,1,,1,A,,,6996,
,,CHEMBL631139,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,Intermediate,10116.0,N,13702,1,,1,A,,,6996,
,,CHEMBL631140,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,13703,1,,1,A,,,6996,
,,CHEMBL631141,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,10116.0,N,13704,1,,1,A,,,6996,
,,CHEMBL631142,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,10116.0,N,13705,1,,1,A,,,6996,
,,CHEMBL631143,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,10116.0,N,13706,1,,1,A,,,6996,
,,CHEMBL631144,,50597,,BAO_0000218,Rattus norvegicus,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,10116.0,N,13707,1,,1,A,,,6996,
,,CHEMBL631145,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,Intermediate,9615.0,N,13708,1,,1,A,,,6996,
,,CHEMBL631146,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,13709,1,,1,A,,,6996,
,,CHEMBL631147,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,Intermediate,9615.0,N,13710,1,,1,A,,,6996,
,,CHEMBL631148,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,13711,1,,1,A,,,6996,
,,CHEMBL631149,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,13712,1,,1,A,,,6996,
,,CHEMBL631150,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,13713,1,,1,A,,,6996,
,,CHEMBL631151,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,13714,1,,1,A,,,6996,
,,CHEMBL631152,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,13715,1,,1,A,,,6996,
,,CHEMBL631443,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,13716,1,,1,A,,,6996,
,,CHEMBL631444,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,13717,1,,1,A,,,6996,
,,CHEMBL631445,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,9615.0,N,13718,1,,1,A,,,6996,
,,CHEMBL631446,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,9615.0,N,13719,1,,1,A,,,6996,
,,CHEMBL631447,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),Intermediate,9615.0,N,13720,1,,1,A,,,6996,
,,CHEMBL631448,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,9615.0,N,13721,1,,1,A,,,6996,
,,CHEMBL631449,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,Intermediate,9615.0,N,13722,1,,1,A,,,6996,
,,CHEMBL631450,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,9615.0,N,13723,1,,1,A,,,6996,
,,CHEMBL629724,,50588,,BAO_0000218,Canis lupus familiaris,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,9615.0,N,13724,1,,1,A,,,6996,
In vivo,,CHEMBL629725,,50594,Zone of skin,BAO_0000218,Mus musculus,14.0,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13725,1,,1,A,,,9716,
In vivo,,CHEMBL629726,,50594,Zone of skin,BAO_0000218,Mus musculus,14.0,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13726,1,,1,A,,,9716,
In vivo,,CHEMBL629727,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13727,1,,1,A,,,9716,
In vivo,,CHEMBL630404,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13728,1,,1,A,,,9716,
In vivo,,CHEMBL630405,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13729,1,,1,A,,,9716,
In vivo,,CHEMBL630406,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13730,1,,1,A,,,9716,
In vivo,,CHEMBL630407,,50594,Stomach,BAO_0000218,Mus musculus,945.0,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13731,1,,1,A,,,9716,
In vivo,,CHEMBL630573,,50594,Stomach,BAO_0000218,Mus musculus,945.0,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13732,1,,1,A,,,9716,
In vivo,,CHEMBL630574,,50594,Stomach,BAO_0000218,Mus musculus,945.0,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13733,1,,1,A,,,9716,
In vivo,,CHEMBL630575,,50594,Stomach,BAO_0000218,Mus musculus,945.0,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13734,1,,1,A,,,9716,
In vivo,,CHEMBL630576,,50594,,BAO_0000218,Mus musculus,,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13735,1,,1,A,,,9716,
In vivo,,CHEMBL630577,,50594,,BAO_0000218,Mus musculus,,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13736,1,,1,A,,,9716,
In vivo,,CHEMBL630578,,50594,,BAO_0000218,Mus musculus,,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13737,1,,1,A,,,9716,
In vivo,,CHEMBL630579,,50594,,BAO_0000218,Mus musculus,,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,10090.0,N,13738,1,,1,A,,,9716,
,,CHEMBL630580,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),Intermediate,10090.0,N,13739,1,,1,A,,,12192,
,,CHEMBL630581,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,Intermediate,10090.0,N,13740,1,,1,A,,,12192,
,,CHEMBL630582,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),Intermediate,10090.0,N,13741,1,,1,A,,,12192,
,,CHEMBL630583,,50594,,BAO_0000218,Mus musculus,,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,Intermediate,10090.0,N,13742,1,,1,A,,,12192,
,,CHEMBL630584,,50594,,BAO_0000218,Mus musculus,,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),Intermediate,10090.0,N,13743,1,,1,A,,,12192,
,,CHEMBL630585,,50594,,BAO_0000218,Mus musculus,,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,Intermediate,10090.0,N,13744,1,,1,A,,,12192,
,,CHEMBL630586,,50594,,BAO_0000218,Mus musculus,,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),Intermediate,10090.0,N,13745,1,,1,A,,,12192,
,,CHEMBL630587,,50594,,BAO_0000218,Mus musculus,,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,Intermediate,10090.0,N,13746,1,,1,A,,,12192,
,,CHEMBL630588,,50594,,BAO_0000218,Mus musculus,,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),Intermediate,10090.0,N,13747,1,,1,A,,,12192,
,,CHEMBL630589,,50594,,BAO_0000218,Mus musculus,,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,Intermediate,10090.0,N,13748,1,,1,A,,,12192,
,,CHEMBL630590,,50594,,BAO_0000218,Mus musculus,,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),Intermediate,10090.0,N,13749,1,,1,A,,,12192,
,,CHEMBL630591,,22224,Feces,BAO_0000019,,1988.0,,Removal of 238-Plutonium(IV) in feces at 24 h,Autocuration,,U,13750,1,,0,A,,,12192,
,,CHEMBL630592,,22224,Feces,BAO_0000019,,1988.0,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),Autocuration,,U,13751,1,,0,A,,,12192,
,,CHEMBL630593,,22224,,BAO_0000019,,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,Autocuration,,U,13752,1,,0,A,,,12192,
,,CHEMBL630594,,22224,,BAO_0000019,,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),Autocuration,,U,13753,1,,0,A,,,12192,
,,CHEMBL630595,,22224,Urine,BAO_0000019,,1088.0,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),Autocuration,,U,13754,1,,0,A,,,12192,
,,CHEMBL630596,,22224,Urine,BAO_0000019,,1088.0,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),Autocuration,,U,13755,1,,0,A,,,12192,
,,CHEMBL630597,,22224,Urine,BAO_0000019,,1088.0,,Removal of 238-Plutonium(IV) in urine after 0-24 h,Autocuration,,U,13756,1,,0,A,,,12192,
,,CHEMBL630598,,22224,Urine,BAO_0000019,,1088.0,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),Autocuration,,U,13757,1,,0,A,,,12192,
,,CHEMBL630599,,22224,Urine,BAO_0000019,,1088.0,,Removal of 238-Plutonium(IV) in urine after 0-4 h,Autocuration,,U,13758,1,,0,A,,,12192,
,,CHEMBL630600,,22224,Urine,BAO_0000019,,1088.0,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),Autocuration,,U,13759,1,,0,A,,,12192,
,,CHEMBL630601,,22224,Urine,BAO_0000019,,1088.0,,Removal of 238-Plutonium(IV) in urine after 4-24 h,Autocuration,,U,13760,1,,0,A,,,12192,
,,CHEMBL630602,,22224,Urine,BAO_0000019,,1088.0,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),Autocuration,,U,13761,1,,0,A,,,12192,
,,CHEMBL630603,,22224,Urine,BAO_0000019,,1088.0,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),Autocuration,,U,13762,1,,0,A,,,12192,
,,CHEMBL630604,,22224,Urine,BAO_0000019,,1088.0,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),Autocuration,,U,13763,1,,0,A,,,12192,
In vivo,,CHEMBL624869,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13764,1,,1,A,,,12017,
In vivo,,CHEMBL624870,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13765,1,,1,A,,,12017,
In vivo,,CHEMBL623189,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,13766,1,,1,A,,,12017,
In vivo,,CHEMBL623190,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13767,1,,1,A,,,12017,
In vivo,,CHEMBL623191,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13768,1,,1,A,,,12017,
In vivo,,CHEMBL623192,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13769,1,,1,A,,,12017,
In vivo,,CHEMBL623193,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13770,1,,1,A,,,12017,
In vivo,,CHEMBL623194,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,13771,1,,1,A,,,12017,
In vivo,,CHEMBL623195,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13772,1,,1,A,,,12017,
In vivo,,CHEMBL623196,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13773,1,,1,A,,,12017,
,,CHEMBL623197,,50597,,BAO_0000218,Rattus norvegicus,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,Intermediate,10116.0,N,13774,1,,1,A,,,11836,
,,CHEMBL623198,,50597,,BAO_0000218,Rattus norvegicus,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,10116.0,N,13775,1,,1,A,,,11836,
,,CHEMBL623199,,50597,,BAO_0000218,Rattus norvegicus,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Intermediate,10116.0,N,13776,1,,1,A,,,11836,
,,CHEMBL623200,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,Intermediate,10116.0,N,13777,1,,1,A,,,11836,
,,CHEMBL623201,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,10116.0,N,13778,1,,1,A,,,11836,
,,CHEMBL623202,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,Intermediate,10116.0,N,13779,1,,1,A,,,11836,
,,CHEMBL623203,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,10116.0,N,13780,1,,1,A,,,11836,
,,CHEMBL623204,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,Intermediate,10116.0,N,13781,1,,1,A,,,11836,
,,CHEMBL623205,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,Intermediate,10116.0,N,13782,1,,1,A,,,11836,
,,CHEMBL623206,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,10116.0,N,13783,1,,1,A,,,11836,
,,CHEMBL623207,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,Intermediate,10116.0,N,13784,1,,1,A,,,11836,
,,CHEMBL623208,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,Intermediate,10116.0,N,13785,1,,1,A,,,11836,
,,CHEMBL623209,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,10116.0,N,13786,1,,1,A,,,11836,
,,CHEMBL623210,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Intermediate,10116.0,N,13787,1,,1,A,,,11836,
,,CHEMBL623211,,50597,,BAO_0000218,Rattus norvegicus,,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,10116.0,N,13788,1,,1,A,,,11836,
,,CHEMBL623212,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,10116.0,N,13789,1,,1,A,,,11836,
,,CHEMBL623213,,22224,,BAO_0000019,,,,Tested in vitro for intrinsic activity relative to quinpirole,Autocuration,,U,13790,1,,0,A,,,12640,
,,CHEMBL623214,,22224,,BAO_0000019,,,,"Relative ion enhancement, determined in pulsed ultrafiltration",Autocuration,,U,13791,1,,0,A,,,14218,
,,CHEMBL623215,,22224,,BAO_0000019,,,,% ionization at the pH 7.4 at 37 degree Centigrade,Autocuration,,U,13792,1,,0,A,,,11296,
,,CHEMBL623216,,22224,,BAO_0000019,,,,Percentage ionization was measured,Autocuration,,U,13793,1,,0,A,,,10929,
,,CHEMBL623217,,50591,,BAO_0000218,Bos taurus,,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,Intermediate,9913.0,N,13794,1,,1,A,,,13841,
,,CHEMBL623218,,22224,,BAO_0000019,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,Autocuration,,U,13795,1,,0,A,,,10431,
,,CHEMBL623913,,22224,,BAO_0000019,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,Autocuration,,U,13796,1,,0,A,,,10431,
,,CHEMBL623914,,22224,,BAO_0000019,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,Autocuration,,U,13797,1,,0,A,,,10431,
,,CHEMBL623915,,22229,,BAO_0000100,,,,Compound was evaluated for the partition coefficient in octanol/water,Autocuration,,U,13798,1,,0,P,,,8826,
,,CHEMBL624080,,22229,,BAO_0000100,,,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),Autocuration,,U,13799,1,,0,P,,,8826,
,,CHEMBL624081,,22224,,BAO_0000019,,,,Equilibrium constant measured by the pulse radiolysis at pH 7,Autocuration,,U,13800,1,,0,A,,,9884,
,,CHEMBL624082,,50587,,BAO_0000218,Homo sapiens,,,In vitro hydrolytic rate constant determined in human blood,Intermediate,9606.0,N,13801,1,,1,A,,,9827,
,,CHEMBL625054,,50587,,BAO_0000218,Homo sapiens,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,Intermediate,9606.0,N,13802,1,,1,A,,,10009,
,,CHEMBL877485,,22224,,BAO_0000019,,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,Autocuration,,U,13803,1,,0,A,,,10009,
,,CHEMBL625055,,50594,,BAO_0000218,Mus musculus,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,Intermediate,10090.0,N,13804,1,,1,A,,,10009,
,,CHEMBL625056,,50594,,BAO_0000218,Mus musculus,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,Intermediate,10090.0,N,13805,1,,1,A,,,10009,
,,CHEMBL625057,,50587,,BAO_0000218,Homo sapiens,,,In vitro oxidation of compound in presence of human plasma,Intermediate,9606.0,N,13806,1,,1,A,,,10009,
,,CHEMBL625058,,22224,,BAO_0000019,,,,In vitro oxidation of compound in presence of hydrogen peroxide,Autocuration,,U,13807,1,,0,A,,,10009,
,,CHEMBL625059,,50594,,BAO_0000218,Mus musculus,,,In vitro oxidation of compound in presence of mouse brain homogenate,Intermediate,10090.0,N,13808,1,,1,A,,,10009,
,,CHEMBL629536,,50594,,BAO_0000218,Mus musculus,,,In vitro oxidation of compound in presence of mouse liver homogenate,Intermediate,10090.0,N,13809,1,,1,A,,,10009,
,,CHEMBL629537,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,10116.0,N,13810,1,,1,A,,,11510,
,,CHEMBL629538,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,10116.0,N,13811,1,,1,A,,,11510,
,,CHEMBL629539,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,10116.0,N,13812,1,,1,A,,,11510,
,,CHEMBL874445,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,10116.0,N,13813,1,,1,A,,,11510,
,,CHEMBL629540,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,10116.0,N,13814,1,,1,A,,,11510,
,,CHEMBL629541,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,10116.0,N,13815,1,,1,A,,,11510,
,,CHEMBL629542,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,10116.0,N,13816,1,,1,A,,,11510,
,,CHEMBL630243,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,10116.0,N,13817,1,,1,A,,,11510,
,,CHEMBL630244,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,10116.0,N,13818,1,,1,A,,,11510,
,,CHEMBL630245,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,10116.0,N,13819,1,,1,A,,,11510,
,,CHEMBL630246,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,10116.0,N,13820,1,,1,A,,,11510,
,,CHEMBL630247,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,10116.0,N,13821,1,,1,A,,,11510,
,,CHEMBL630248,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,10116.0,N,13822,1,,1,A,,,11510,
In vivo,,CHEMBL630249,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood at 240 minutes after dose administration.,Intermediate,10116.0,N,13823,1,,1,A,,,13100,
In vivo,,CHEMBL630250,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood at 30 minutes after dose administration.,Intermediate,10116.0,N,13824,1,,1,A,,,13100,
In vivo,,CHEMBL630251,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood at 360 minutes after dose administration.,Intermediate,10116.0,N,13825,1,,1,A,,,13100,
In vivo,,CHEMBL630252,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood at 3 hr after dose administration.,Intermediate,10116.0,N,13826,1,,1,A,,,13100,
In vivo,,CHEMBL630408,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood at 60 minutes after dose administration.,Intermediate,10116.0,N,13827,1,,1,A,,,13100,
In vivo,,CHEMBL630409,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,Intermediate,10116.0,N,13828,1,,1,A,,,13100,
In vivo,,CHEMBL874446,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,Intermediate,10116.0,N,13829,1,,1,A,,,13100,
In vivo,,CHEMBL630410,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,Intermediate,10116.0,N,13830,1,,1,A,,,13100,
In vivo,,CHEMBL630411,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,Intermediate,10116.0,N,13831,1,,1,A,,,13100,
In vivo,,CHEMBL630412,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,Intermediate,10116.0,N,13832,1,,1,A,,,13100,
In vivo,,CHEMBL630413,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,Intermediate,10116.0,N,13833,1,,1,A,,,13100,
In vivo,,CHEMBL630414,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution in rat cerebellum at 3 hr after dose administration.,Intermediate,10116.0,N,13834,1,,1,A,,,13100,
In vivo,,CHEMBL630415,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,Intermediate,10116.0,N,13835,1,,1,A,,,13100,
In vivo,,CHEMBL630416,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat cortex at 120 minutes after dose administration.,Intermediate,10116.0,N,13836,1,,1,A,,,13100,
In vivo,,CHEMBL630417,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat cortex at 1440 minutes after dose administration.,Intermediate,10116.0,N,13837,1,,1,A,,,13100,
In vivo,,CHEMBL630418,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat cortex at 15 minutes after dose administration.,Intermediate,10116.0,N,13838,1,,1,A,,,13100,
In vivo,,CHEMBL630419,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat cortex at 240 minutes after dose administration.,Intermediate,10116.0,N,13839,1,,1,A,,,13100,
In vivo,,CHEMBL630420,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat cortex at 30 minutes after dose administration.,Intermediate,10116.0,N,13840,1,,1,A,,,13100,
In vivo,,CHEMBL630421,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat cortex at 360 minutes after dose administration.,Intermediate,10116.0,N,13841,1,,1,A,,,13100,
In vivo,,CHEMBL630422,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat cortex at 3 hr after dose administration.,Intermediate,10116.0,N,13842,1,,1,A,,,13100,
In vivo,,CHEMBL630423,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat cortex at 60 minutes after dose administration.,Intermediate,10116.0,N,13843,1,,1,A,,,13100,
In vivo,,CHEMBL630424,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart at 120 minutes after dose administration.,Intermediate,10116.0,N,13844,1,,1,A,,,13100,
In vivo,,CHEMBL630425,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart at 15 minutes after dose administration.,Intermediate,10116.0,N,13845,1,,1,A,,,13100,
In vivo,,CHEMBL629462,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart at 240 minutes after dose administration.,Intermediate,10116.0,N,13846,1,,1,A,,,13100,
In vivo,,CHEMBL630426,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart at 30 minutes after dose administration.,Intermediate,10116.0,N,13847,1,,1,A,,,13100,
In vivo,,CHEMBL630427,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart at 360 minutes after dose administration.,Intermediate,10116.0,N,13848,1,,1,A,,,13100,
In vivo,,CHEMBL625877,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart at 3 hr after dose administration.,Intermediate,10116.0,N,13849,1,,1,A,,,13100,
In vivo,,CHEMBL625878,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart at 60 minutes after dose administration.,Intermediate,10116.0,N,13850,1,,1,A,,,13100,
In vivo,,CHEMBL625879,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,Intermediate,10116.0,N,13851,1,,1,A,,,13100,
In vivo,,CHEMBL625880,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,Intermediate,10116.0,N,13852,1,,1,A,,,13100,
In vivo,,CHEMBL625881,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,Intermediate,10116.0,N,13853,1,,1,A,,,13100,
In vivo,,CHEMBL625882,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,Intermediate,10116.0,N,13854,1,,1,A,,,13100,
In vivo,,CHEMBL625883,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,Intermediate,10116.0,N,13855,1,,1,A,,,13100,
In vivo,,CHEMBL625884,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney at 120 minutes after dose administration.,Intermediate,10116.0,N,13856,1,,1,A,,,13100,
In vivo,,CHEMBL625885,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney at 1440 minutes after dose administration.,Intermediate,10116.0,N,13857,1,,1,A,,,13100,
In vivo,,CHEMBL628649,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney at 15 minutes after dose administration.,Intermediate,10116.0,N,13858,1,,1,A,,,13100,
In vivo,,CHEMBL628650,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney at 240 minutes after dose administration.,Intermediate,10116.0,N,13859,1,,1,A,,,13100,
In vivo,,CHEMBL628651,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney at 30 minutes after dose administration.,Intermediate,10116.0,N,13860,1,,1,A,,,13100,
In vivo,,CHEMBL628652,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney at 360 minutes after dose administration.,Intermediate,10116.0,N,13861,1,,1,A,,,13100,
In vivo,,CHEMBL628653,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney at 60 minutes after dose administration.,Intermediate,10116.0,N,13862,1,,1,A,,,13100,
In vivo,,CHEMBL628654,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver at 120 minutes after dose administration.,Intermediate,10116.0,N,13863,1,,1,A,,,13100,
In vivo,,CHEMBL628655,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver at 1440 minutes after dose administration.,Intermediate,10116.0,N,13864,1,,1,A,,,13100,
In vivo,,CHEMBL625238,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver at 15 minutes after dose administration.,Intermediate,10116.0,N,13865,1,,1,A,,,13100,
In vivo,,CHEMBL625239,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver at 240 minutes after dose administration.,Intermediate,10116.0,N,13866,1,,1,A,,,13100,
In vivo,,CHEMBL625240,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver at 30 minutes after dose administration.,Intermediate,10116.0,N,13867,1,,1,A,,,13100,
In vivo,,CHEMBL625241,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver at 360 minutes after dose administration.,Intermediate,10116.0,N,13868,1,,1,A,,,13100,
In vivo,,CHEMBL625242,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver at 60 minutes after dose administration.,Intermediate,10116.0,N,13869,1,,1,A,,,13100,
In vivo,,CHEMBL874587,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in rat lung at 120 minutes after dose administration.,Intermediate,10116.0,N,13870,1,,1,A,,,13100,
In vivo,,CHEMBL625405,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in rat lung at 1440 minutes after dose administration.,Intermediate,10116.0,N,13871,1,,1,A,,,13100,
In vivo,,CHEMBL625406,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in rat lung at 15 minutes after dose administration.,Intermediate,10116.0,N,13872,1,,1,A,,,13100,
In vivo,,CHEMBL625407,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in rat lung at 240 minutes after dose administration.,Intermediate,10116.0,N,13873,1,,1,A,,,13100,
In vivo,,CHEMBL625408,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in rat lung at 30 minutes after dose administration.,Intermediate,10116.0,N,13874,1,,1,A,,,13100,
In vivo,,CHEMBL625409,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in rat lung at 360 minutes after dose administration.,Intermediate,10116.0,N,13875,1,,1,A,,,13100,
,,CHEMBL625410,,50597,Thoracic aorta,BAO_0000218,Rattus norvegicus,1515.0,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,Intermediate,10116.0,N,13876,1,,1,A,,,12361,
,,CHEMBL625411,,50597,Thoracic aorta,BAO_0000218,Rattus norvegicus,1515.0,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,Intermediate,10116.0,N,13877,1,,1,A,,,12361,
,,CHEMBL625412,,50597,Thoracic aorta,BAO_0000218,Rattus norvegicus,1515.0,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,Intermediate,10116.0,N,13878,1,,1,A,,,12361,
,,CHEMBL625413,,50597,Thoracic aorta,BAO_0000218,Rattus norvegicus,1515.0,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,Intermediate,10116.0,N,13879,1,,1,A,,,12361,
,,CHEMBL625414,,50597,Thoracic aorta,BAO_0000218,Rattus norvegicus,1515.0,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,Intermediate,10116.0,N,13880,1,,1,A,,,12361,
,,CHEMBL625415,,50597,Thoracic aorta,BAO_0000218,Rattus norvegicus,1515.0,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,Intermediate,10116.0,N,13881,1,,1,A,,,12361,
,,CHEMBL625416,,50597,Thoracic aorta,BAO_0000218,Rattus norvegicus,1515.0,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,Intermediate,10116.0,N,13882,1,,1,A,,,12361,
,,CHEMBL625417,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,Intermediate,10116.0,N,13883,1,,1,A,,,12712,
,,CHEMBL625418,,50597,Feces,BAO_0000218,Rattus norvegicus,1988.0,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,Intermediate,10116.0,N,13884,1,,1,A,,,7415,
,,CHEMBL625419,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,Intermediate,10116.0,N,13885,1,,1,A,,,7415,
,,CHEMBL625420,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,Intermediate,10116.0,N,13886,1,,1,A,,,7415,
,,CHEMBL626996,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,Intermediate,10116.0,N,13887,1,,1,A,,,7415,
,,CHEMBL626997,,50597,Feces,BAO_0000218,Rattus norvegicus,1988.0,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",Intermediate,10116.0,N,13888,1,,1,A,,,7415,
,,CHEMBL626998,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",Intermediate,10116.0,N,13889,1,,1,A,,,7415,
,,CHEMBL626999,,50597,,BAO_0000218,Rattus norvegicus,,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",Intermediate,10116.0,N,13890,1,,1,A,,,7415,
,,CHEMBL627000,,50594,,BAO_0000218,Mus musculus,,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,Intermediate,10090.0,N,13891,1,,1,A,,,8050,
,,CHEMBL627001,,50594,,BAO_0000218,Mus musculus,,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,Intermediate,10090.0,N,13892,1,,1,A,,,8050,
,,CHEMBL627002,,50594,,BAO_0000218,Mus musculus,,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,Intermediate,10090.0,N,13893,1,,1,A,,,8050,
,,CHEMBL627003,,50594,,BAO_0000218,Mus musculus,,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,Intermediate,10090.0,N,13894,1,,1,A,,,8050,
,,CHEMBL627004,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,Intermediate,10090.0,N,13895,1,,1,A,,,8050,
,,CHEMBL627005,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,Intermediate,10090.0,N,13896,1,,1,A,,,8050,
,,CHEMBL874594,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,Intermediate,10090.0,N,13897,1,,1,A,,,8050,
,,CHEMBL627006,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,Intermediate,10090.0,N,13898,1,,1,A,,,8050,
,,CHEMBL627007,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,Intermediate,10090.0,N,13899,1,,1,A,,,8050,
,,CHEMBL627884,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,Intermediate,10090.0,N,13900,1,,1,A,,,8050,
,,CHEMBL627885,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,Intermediate,10090.0,N,13901,1,,1,A,,,8050,
,,CHEMBL627886,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,Intermediate,10090.0,N,13902,1,,1,A,,,8050,
,,CHEMBL627887,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,Intermediate,10090.0,N,13903,1,,1,A,,,8050,
,,CHEMBL627888,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Intermediate,10090.0,N,13904,1,,1,A,,,8050,
,,CHEMBL628057,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Intermediate,10090.0,N,13905,1,,1,A,,,8050,
,,CHEMBL627405,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Intermediate,10090.0,N,13906,1,,1,A,,,8050,
,,CHEMBL627406,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,9615.0,N,13907,1,,1,A,,,12582,
,,CHEMBL627407,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,9615.0,N,13908,1,,1,A,,,12582,
,,CHEMBL627408,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,9615.0,N,13909,1,,1,A,,,12582,
,,CHEMBL627409,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,9615.0,N,13910,1,,1,A,,,12582,
,,CHEMBL875486,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,9615.0,N,13911,1,,1,A,,,12582,
,,CHEMBL627410,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,9615.0,N,13912,1,,1,A,,,12582,
,,CHEMBL627411,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,9615.0,N,13913,1,,1,A,,,12582,
,,CHEMBL627412,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,9615.0,N,13914,1,,1,A,,,12582,
,,CHEMBL627413,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,9615.0,N,13915,1,,1,A,,,12582,
,,CHEMBL627414,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,9615.0,N,13916,1,,1,A,,,12582,
,,CHEMBL627415,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,9615.0,N,13917,1,,1,A,,,12582,
,,CHEMBL627416,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,Intermediate,9615.0,N,13918,1,,1,A,,,12582,
,,CHEMBL627417,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,9615.0,N,13919,1,,1,A,,,12582,
,,CHEMBL627418,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,9615.0,N,13920,1,,1,A,,,12582,
,,CHEMBL627419,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Intermediate,9615.0,N,13921,1,,1,A,,,12582,
,,CHEMBL627320,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Intermediate,9615.0,N,13922,1,,1,A,,,12582,
,,CHEMBL627321,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Intermediate,9615.0,N,13923,1,,1,A,,,12582,
In vivo,,CHEMBL627322,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13924,1,,1,A,,,12017,
In vivo,,CHEMBL627323,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13925,1,,1,A,,,12017,
In vivo,,CHEMBL627491,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,13926,1,,1,A,,,12017,
In vivo,,CHEMBL627492,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13927,1,,1,A,,,12017,
In vivo,,CHEMBL627493,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13928,1,,1,A,,,12017,
In vivo,,CHEMBL627494,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13929,1,,1,A,,,12017,
In vivo,,CHEMBL627495,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13930,1,,1,A,,,12017,
In vivo,,CHEMBL627496,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,13931,1,,1,A,,,12017,
In vivo,,CHEMBL627497,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13932,1,,1,A,,,12017,
In vivo,,CHEMBL627498,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13933,1,,1,A,,,12017,
In vivo,,CHEMBL627499,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13934,1,,1,A,,,12017,
In vivo,,CHEMBL627500,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13935,1,,1,A,,,12017,
In vivo,,CHEMBL627501,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,13936,1,,1,A,,,12017,
In vivo,,CHEMBL625616,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13937,1,,1,A,,,12017,
In vivo,,CHEMBL625617,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13938,1,,1,A,,,12017,
In vivo,,CHEMBL625618,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13939,1,,1,A,,,12017,
In vivo,,CHEMBL625619,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13940,1,,1,A,,,12017,
In vivo,,CHEMBL625620,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,13941,1,,1,A,,,12017,
In vivo,,CHEMBL625621,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13942,1,,1,A,,,12017,
In vivo,,CHEMBL625622,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13943,1,,1,A,,,12017,
In vivo,,CHEMBL625788,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13944,1,,1,A,,,12017,
In vivo,,CHEMBL625789,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13945,1,,1,A,,,12017,
In vivo,,CHEMBL625790,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,13946,1,,1,A,,,12017,
In vivo,,CHEMBL625791,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13947,1,,1,A,,,12017,
In vivo,,CHEMBL622334,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13948,1,,1,A,,,12017,
In vivo,,CHEMBL622335,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13949,1,,1,A,,,12017,
In vivo,,CHEMBL622336,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13950,1,,1,A,,,12017,
In vivo,,CHEMBL622337,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,13951,1,,1,A,,,12017,
In vivo,,CHEMBL622338,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13952,1,,1,A,,,12017,
In vivo,,CHEMBL622339,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13953,1,,1,A,,,12017,
In vivo,,CHEMBL624153,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13954,1,,1,A,,,12017,
In vivo,,CHEMBL628430,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13955,1,,1,A,,,12017,
In vivo,,CHEMBL628431,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,13956,1,,1,A,,,12017,
In vivo,,CHEMBL628432,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13957,1,,1,A,,,12017,
In vivo,,CHEMBL628433,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,13958,1,,1,A,,,12017,
In vivo,,CHEMBL628434,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,10116.0,N,13959,1,,1,A,,,12017,
In vivo,,CHEMBL626789,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,10116.0,N,13960,1,,1,A,,,12017,
In vivo,,CHEMBL626790,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",Intermediate,10116.0,N,13961,1,,1,A,,,12017,
In vivo,,CHEMBL626791,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,10116.0,N,13962,1,,1,A,,,12017,
In vivo,,CHEMBL626792,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,10116.0,N,13963,1,,1,A,,,12017,
In vivo,,CHEMBL626793,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,10116.0,N,13964,1,,1,A,,,12017,
,,CHEMBL627436,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,10116.0,N,13965,1,,1,A,,,11510,
,,CHEMBL627437,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,10116.0,N,13966,1,,1,A,,,11510,
,,CHEMBL627438,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,10116.0,N,13967,1,,1,A,,,11510,
,,CHEMBL627439,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,10116.0,N,13968,1,,1,A,,,11510,
,,CHEMBL627440,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,10116.0,N,13969,1,,1,A,,,11510,
,,CHEMBL627602,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,10116.0,N,13970,1,,1,A,,,11510,
,,CHEMBL627603,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,10116.0,N,13971,1,,1,A,,,11510,
,,CHEMBL627604,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,10116.0,N,13972,1,,1,A,,,11510,
,,CHEMBL627605,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,10116.0,N,13973,1,,1,A,,,11510,
,,CHEMBL627606,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,10116.0,N,13974,1,,1,A,,,11510,
,,CHEMBL627607,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,10116.0,N,13975,1,,1,A,,,11510,
,,CHEMBL627608,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,10116.0,N,13976,1,,1,A,,,11510,
,,CHEMBL627609,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,10116.0,N,13977,1,,1,A,,,11510,
,,CHEMBL627610,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,10116.0,N,13978,1,,1,A,,,11510,
,,CHEMBL627611,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,10116.0,N,13979,1,,1,A,,,11510,
,,CHEMBL627612,,50597,,BAO_0000218,Rattus norvegicus,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,10116.0,N,13980,1,,1,A,,,11510,
,,CHEMBL627613,,22229,,BAO_0000100,,,,Octanol:water partition coefficient is evaluated,Autocuration,,U,13981,1,,0,P,,,8362,
,,CHEMBL627614,,22224,,BAO_0000100,,,,Partition coefficient in 1-octanol/water system,Autocuration,,U,13982,1,,0,P,,,8257,
,,CHEMBL627615,,22224,,BAO_0000100,,,,Partition coefficient in 1-octanol/water system measured using radio active compounds,Autocuration,,U,13983,1,,0,P,,,8257,
,,CHEMBL627616,,22224,,BAO_0000100,,,,Partition coefficient in octanol/water system was determined,Autocuration,,U,13984,1,,0,P,,,9468,
,,CHEMBL627617,,22224,,BAO_0000100,,,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,Autocuration,,U,13985,1,,0,P,,,9468,
,,CHEMBL627618,,22224,,BAO_0000019,,,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,Autocuration,,U,13986,1,,0,A,,,10568,
,,CHEMBL627619,,22224,,BAO_0000019,,,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",Autocuration,,U,13987,1,,0,A,,,10568,
,,CHEMBL627620,,22224,,BAO_0000019,,,,Pseudo-first-order rate constant of the compound,Autocuration,,U,13988,1,,0,A,,,15359,
,,CHEMBL627621,,22224,,BAO_0000019,,,,Pseudo-first-order rate constant with 1-min time point,Autocuration,,U,13989,1,,0,A,,,15359,
,,CHEMBL627622,,22224,,BAO_0000019,,,,Pseudo-first-order rate constant without 1-min time point,Autocuration,,U,13990,1,,0,A,,,15359,
,,CHEMBL627623,,22224,,BAO_0000019,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,Autocuration,,U,13991,1,,0,A,,,10431,
,,CHEMBL627624,,22224,,BAO_0000019,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,Autocuration,,U,13992,1,,0,A,,,10431,
,,CHEMBL627625,,22224,,BAO_0000019,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,Autocuration,,U,13993,1,,0,A,,,10431,
,,CHEMBL628523,,22224,,BAO_0000019,,,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,Autocuration,,U,13994,1,,0,A,,,15704,
,,CHEMBL628524,,22224,,BAO_0000019,,,,The alkaline hydrolysis second order rate constant(K OH) of the compound,Autocuration,,U,13995,1,,0,A,,,15287,
,,CHEMBL628525,,22224,,BAO_0000019,,,,The efflux rate constant of the compound,Autocuration,,U,13996,1,,0,A,,,7516,
,,CHEMBL625732,,22224,,BAO_0000019,,,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,,U,13997,1,,0,A,,,12973,
,,CHEMBL625733,,22224,,BAO_0000019,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,,U,13998,1,,0,A,,,12973,
,,CHEMBL625734,,22224,,BAO_0000019,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,,U,13999,1,,0,F,,,12973,
,,CHEMBL625913,,22224,,BAO_0000019,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,Autocuration,,U,14000,1,,0,A,,,12973,
,,CHEMBL625914,,22224,,BAO_0000019,,,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,Autocuration,,U,14001,1,,0,A,,,8696,
,,CHEMBL625915,,22224,,BAO_0000019,,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,Autocuration,,U,14002,1,,0,A,,,15052,
,,CHEMBL625916,,22224,,BAO_0000019,,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,Autocuration,,U,14003,1,,0,A,,,15052,
,,CHEMBL625917,,22224,,BAO_0000019,,,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),Autocuration,,U,14004,1,,0,A,,,10503,
,,CHEMBL625918,,22224,,BAO_0000019,,,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,14005,1,,0,A,,,8354,
,,CHEMBL625919,,22224,,BAO_0000019,,,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,14006,1,,0,A,,,8354,
,,CHEMBL625920,,22224,,BAO_0000019,,,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,14007,1,,0,A,,,8354,
,,CHEMBL874453,,22224,,BAO_0000019,,,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,14008,1,,0,A,,,8354,
,,CHEMBL625921,,22224,,BAO_0000019,,,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",Autocuration,,U,14009,1,,0,A,,,8354,
,,CHEMBL625922,,22224,,BAO_0000019,,,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,Autocuration,,U,14010,1,,0,A,,,10503,
,,CHEMBL625923,,22224,,BAO_0000019,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,14011,1,,0,A,,,8354,
,,CHEMBL625924,,22224,,BAO_0000019,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,14012,1,,0,A,,,8354,
,,CHEMBL625925,,22224,,BAO_0000019,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,14013,1,,0,A,,,8354,
,,CHEMBL625926,,22224,,BAO_0000019,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,14014,1,,0,A,,,8354,
In vivo,,CHEMBL627704,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in rat lung at 60 minutes after dose administration.,Intermediate,10116.0,N,14015,1,,1,A,,,13100,
In vivo,,CHEMBL627705,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,Intermediate,10116.0,N,14016,1,,1,A,,,13100,
In vivo,,CHEMBL627706,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,Intermediate,10116.0,N,14017,1,,1,A,,,13100,
In vivo,,CHEMBL627707,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,Intermediate,10116.0,N,14018,1,,1,A,,,13100,
In vivo,,CHEMBL627708,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,Intermediate,10116.0,N,14019,1,,1,A,,,13100,
In vivo,,CHEMBL628361,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,Intermediate,10116.0,N,14020,1,,1,A,,,13100,
In vivo,,CHEMBL628362,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,Intermediate,10116.0,N,14021,1,,1,A,,,13100,
In vivo,,CHEMBL628363,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Biodistribution in rat striatum at 120 minutes after dose administration.,Intermediate,10116.0,N,14022,1,,1,A,,,13100,
In vivo,,CHEMBL628364,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Biodistribution in rat striatum at 1440 minutes after dose administration.,Intermediate,10116.0,N,14023,1,,1,A,,,13100,
In vivo,,CHEMBL628365,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Biodistribution in rat striatum at 15 minutes after dose administration.,Intermediate,10116.0,N,14024,1,,1,A,,,13100,
In vivo,,CHEMBL874454,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Biodistribution in rat striatum at 240 minutes after dose administration.,Intermediate,10116.0,N,14025,1,,1,A,,,13100,
In vivo,,CHEMBL628531,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Biodistribution in rat striatum at 30 minutes after dose administration.,Intermediate,10116.0,N,14026,1,,1,A,,,13100,
In vivo,,CHEMBL628532,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Biodistribution in rat striatum at 360 minutes after dose administration.,Intermediate,10116.0,N,14027,1,,1,A,,,13100,
In vivo,,CHEMBL628533,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Biodistribution in rat striatum at 3 hr after dose administration.,Intermediate,10116.0,N,14028,1,,1,A,,,13100,
In vivo,,CHEMBL628534,,50597,Striatum,BAO_0000218,Rattus norvegicus,2435.0,,Biodistribution in rat striatum at 60 minutes after dose administration.,Intermediate,10116.0,N,14029,1,,1,A,,,13100,
In vivo,,CHEMBL628535,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in rat thyroid at 120 minutes after dose administration.,Intermediate,10116.0,N,14030,1,,1,A,,,13100,
In vivo,,CHEMBL628536,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,Intermediate,10116.0,N,14031,1,,1,A,,,13100,
In vivo,,CHEMBL628537,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in rat thyroid at 15 minutes after dose administration.,Intermediate,10116.0,N,14032,1,,1,A,,,13100,
In vivo,,CHEMBL628538,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in rat thyroid at 240 minutes after dose administration.,Intermediate,10116.0,N,14033,1,,1,A,,,13100,
In vivo,,CHEMBL628539,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in rat thyroid at 30 minutes after dose administration.,Intermediate,10116.0,N,14034,1,,1,A,,,13100,
In vivo,,CHEMBL630297,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in rat thyroid at 360 minutes after dose administration.,Intermediate,10116.0,N,14035,1,,1,A,,,13100,
In vivo,,CHEMBL630298,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in rat thyroid at 60 minutes after dose administration.,Intermediate,10116.0,N,14036,1,,1,A,,,13100,
In vivo,,CHEMBL630299,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,Intermediate,10116.0,N,14037,1,,1,A,,,13100,
In vivo,,CHEMBL628094,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,Intermediate,10116.0,N,14038,1,,1,A,,,13100,
In vivo,,CHEMBL628095,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,Intermediate,10116.0,N,14039,1,,1,A,,,13100,
In vivo,,CHEMBL874648,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,Intermediate,10116.0,N,14040,1,,1,A,,,13100,
In vivo,,CHEMBL628096,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,Intermediate,10116.0,N,14041,1,,1,A,,,13100,
In vivo,,CHEMBL628097,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,Intermediate,10116.0,N,14042,1,,1,A,,,13100,
In vivo,,CHEMBL628098,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,Intermediate,10116.0,N,14043,1,,1,A,,,13100,
,,CHEMBL628099,,22224,,BAO_0000019,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",Autocuration,,U,14044,1,,0,A,,,13331,
,,CHEMBL628100,,22224,,BAO_0000019,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",Autocuration,,U,14045,1,,0,A,,,13331,
,,CHEMBL628101,,22224,,BAO_0000019,,,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),Autocuration,,U,14046,1,,0,A,,,13331,
,,CHEMBL628102,,22224,,BAO_0000019,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",Autocuration,,U,14047,1,,0,A,,,13331,
,,CHEMBL628103,,22224,,BAO_0000019,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",Autocuration,,U,14048,1,,0,A,,,13331,
,,CHEMBL628104,,22224,,BAO_0000019,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",Autocuration,,U,14049,1,,0,A,,,13331,
,,CHEMBL628105,,22224,,BAO_0000019,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",Autocuration,,U,14050,1,,0,A,,,13331,
,,CHEMBL628106,,22224,,BAO_0000019,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",Autocuration,,U,14051,1,,0,A,,,13331,
,,CHEMBL628107,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Intermediate,10116.0,N,14052,1,,1,A,,,10086,
,,CHEMBL628108,,22224,Urine,BAO_0000218,,1088.0,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Autocuration,,U,14053,1,,0,F,,,10086,
,,CHEMBL628109,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Intermediate,10116.0,N,14054,1,,1,A,,,10086,
,,CHEMBL625299,,22224,Urine,BAO_0000218,,1088.0,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Autocuration,,U,14055,1,,0,F,,,10086,
,,CHEMBL625300,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,Intermediate,10116.0,N,14056,1,,1,A,,,10086,
,,CHEMBL625301,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,Intermediate,10116.0,N,14057,1,,1,A,,,10086,
,,CHEMBL625302,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,Intermediate,10116.0,N,14058,1,,1,A,,,10086,
,,CHEMBL874649,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,Intermediate,10116.0,N,14059,1,,1,A,,,10086,
,,CHEMBL625303,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,Intermediate,10116.0,N,14060,1,,1,A,,,13248,
,,CHEMBL625463,,50597,,BAO_0000218,Rattus norvegicus,,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,Intermediate,10116.0,N,14061,1,,1,A,,,13248,
,,CHEMBL625464,,50587,Liver,BAO_0000218,Homo sapiens,2107.0,,In vitro metabolism in human liver microsomes,Intermediate,9606.0,N,14062,1,,1,A,,,14527,
,,CHEMBL625465,,50587,,BAO_0000218,Homo sapiens,,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,Intermediate,9606.0,N,14063,1,,1,A,,,3008,
,,CHEMBL625466,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Intermediate,9615.0,N,14064,1,,1,A,,,12582,
,,CHEMBL625467,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,9615.0,N,14065,1,,1,A,,,12582,
,,CHEMBL625468,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Intermediate,10116.0,N,14066,1,,1,A,,,12582,
,,CHEMBL625469,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,10116.0,N,14067,1,,1,A,,,12582,
,,CHEMBL625470,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,10116.0,N,14068,1,,1,A,,,12582,
,,CHEMBL632418,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,10116.0,N,14069,1,,1,A,,,12582,
,,CHEMBL627250,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,10116.0,N,14070,1,,1,A,,,12582,
,,CHEMBL627251,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,10116.0,N,14071,1,,1,A,,,12582,
,,CHEMBL627252,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,10116.0,N,14072,1,,1,A,,,12582,
,,CHEMBL627253,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,10116.0,N,14073,1,,1,A,,,12582,
,,CHEMBL627254,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,10116.0,N,14074,1,,1,A,,,12582,
,,CHEMBL875471,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,10116.0,N,14075,1,,1,A,,,12582,
,,CHEMBL627255,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,10116.0,N,14076,1,,1,A,,,12582,
,,CHEMBL627256,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,10116.0,N,14077,1,,1,A,,,12582,
,,CHEMBL627257,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,10116.0,N,14078,1,,1,A,,,12582,
,,CHEMBL627258,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,10116.0,N,14079,1,,1,A,,,12582,
,,CHEMBL627259,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,10116.0,N,14080,1,,1,A,,,12582,
,,CHEMBL627260,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,10116.0,N,14081,1,,1,A,,,12582,
,,CHEMBL623256,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,10116.0,N,14082,1,,1,A,,,12582,
,,CHEMBL874413,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,10116.0,N,14083,1,,1,A,,,12582,
,,CHEMBL623257,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,10116.0,N,14084,1,,1,A,,,12582,
,,CHEMBL623258,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,10116.0,N,14085,1,,1,A,,,12582,
,,CHEMBL623259,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,10116.0,N,14086,1,,1,A,,,12582,
,,CHEMBL623260,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,10116.0,N,14087,1,,1,A,,,12582,
,,CHEMBL623261,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,10116.0,N,14088,1,,1,A,,,12582,
,,CHEMBL623262,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,10116.0,N,14089,1,,1,A,,,12582,
,,CHEMBL623263,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,10116.0,N,14090,1,,1,A,,,12582,
,,CHEMBL623264,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,10116.0,N,14091,1,,1,A,,,12582,
,,CHEMBL623265,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,Intermediate,10116.0,N,14092,1,,1,A,,,12582,
,,CHEMBL623266,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,10116.0,N,14093,1,,1,A,,,12582,
,,CHEMBL623267,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,10116.0,N,14094,1,,1,A,,,12582,
,,CHEMBL623268,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,10116.0,N,14095,1,,1,A,,,12582,
,,CHEMBL623269,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,10116.0,N,14096,1,,1,A,,,12582,
,,CHEMBL623270,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,10116.0,N,14097,1,,1,A,,,12582,
,,CHEMBL623271,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,Intermediate,10116.0,N,14098,1,,1,A,,,12582,
,,CHEMBL623272,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,10116.0,N,14099,1,,1,A,,,12582,
,,CHEMBL623273,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,10116.0,N,14100,1,,1,A,,,12582,
,,CHEMBL623274,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,10116.0,N,14101,1,,1,A,,,12582,
,,CHEMBL874414,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,10116.0,N,14102,1,,1,A,,,12582,
,,CHEMBL623275,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,10116.0,N,14103,1,,1,A,,,12582,
,,CHEMBL629150,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,10116.0,N,14104,1,,1,A,,,12582,
,,CHEMBL623276,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,10116.0,N,14105,1,,1,A,,,12582,
,,CHEMBL623277,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,10116.0,N,14106,1,,1,A,,,12582,
,,CHEMBL623112,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,10116.0,N,14107,1,,1,A,,,12582,
,,CHEMBL623113,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,10116.0,N,14108,1,,1,A,,,12582,
,,CHEMBL623800,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,10116.0,N,14109,1,,1,A,,,12582,
,,CHEMBL623801,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,10116.0,N,14110,1,,1,A,,,12582,
In vivo,,CHEMBL623802,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,10116.0,N,14111,1,,1,A,,,12017,
In vivo,,CHEMBL623803,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14112,1,,1,A,,,12017,
In vivo,,CHEMBL623970,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14113,1,,1,A,,,12017,
In vivo,,CHEMBL623971,,50597,Uterus,BAO_0000218,Rattus norvegicus,995.0,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14114,1,,1,A,,,12017,
In vivo,,CHEMBL623972,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),Intermediate,10116.0,N,14115,1,,1,A,,,14045,
In vivo,,CHEMBL623973,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),Intermediate,10116.0,N,14116,1,,1,A,,,14045,
In vivo,,CHEMBL623974,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),Intermediate,10116.0,N,14117,1,,1,A,,,14045,
In vivo,,CHEMBL623975,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),Intermediate,10116.0,N,14118,1,,1,A,,,14045,
In vivo,,CHEMBL623976,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),Intermediate,10116.0,N,14119,1,,1,A,,,14045,
In vivo,,CHEMBL623977,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),Intermediate,10116.0,N,14120,1,,1,A,,,14045,
In vivo,,CHEMBL623978,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),Intermediate,10116.0,N,14121,1,,1,A,,,14045,
In vivo,,CHEMBL623979,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),Intermediate,10116.0,N,14122,1,,1,A,,,14045,
In vivo,,CHEMBL623980,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),Intermediate,10116.0,N,14123,1,,1,A,,,14045,
In vivo,,CHEMBL623981,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),Intermediate,10116.0,N,14124,1,,1,A,,,14045,
In vivo,,CHEMBL626278,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),Intermediate,10116.0,N,14125,1,,1,A,,,14045,
In vivo,,CHEMBL626279,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),Intermediate,10116.0,N,14126,1,,1,A,,,14045,
In vivo,,CHEMBL626280,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in mice bladder plus excreted urine was determined,Intermediate,10090.0,N,14127,1,,1,A,,,14045,
,,CHEMBL626281,,50594,,BAO_0000218,Mus musculus,,,"Percentage biodistribution in mouse blood, 10 minutes post injection",Intermediate,10090.0,N,14128,1,,1,A,,,14045,
,,CHEMBL626282,,50594,,BAO_0000218,Mus musculus,,,"Percentage biodistribution in mouse blood, 30 minutes post injection",Intermediate,10090.0,N,14129,1,,1,A,,,14045,
,,CHEMBL626283,,50594,,BAO_0000218,Mus musculus,,,"Percentage biodistribution in mouse blood, 5 minutes post injection",Intermediate,10090.0,N,14130,1,,1,A,,,14045,
,,CHEMBL626284,,50594,,BAO_0000218,Mus musculus,,,"Percentage biodistribution in mouse blood, 60 minutes post injection",Intermediate,10090.0,N,14131,1,,1,A,,,14045,
,,CHEMBL626285,,50594,Brain,BAO_0000218,Mus musculus,955.0,,"Percentage biodistribution in mouse brain, 10 minutes post injection",Intermediate,10090.0,N,14132,1,,1,A,,,14045,
,,CHEMBL626286,,50594,Brain,BAO_0000218,Mus musculus,955.0,,"Percentage biodistribution in mouse brain, 30 minutes post injection",Intermediate,10090.0,N,14133,1,,1,A,,,14045,
,,CHEMBL626287,,50594,Brain,BAO_0000218,Mus musculus,955.0,,"Percentage biodistribution in mouse brain, 5 minutes post injection",Intermediate,10090.0,N,14134,1,,1,A,,,14045,
,,CHEMBL626288,,50594,Brain,BAO_0000218,Mus musculus,955.0,,"Percentage biodistribution in mouse brain, 60 minutes post injection",Intermediate,10090.0,N,14135,1,,1,A,,,14045,
,,CHEMBL626289,,50594,,BAO_0000218,Mus musculus,,,"Percentage biodistribution in mouse heart, 10 minutes post injection",Intermediate,10090.0,N,14136,1,,1,A,,,14045,
,,CHEMBL626290,,50594,,BAO_0000218,Mus musculus,,,"Percentage biodistribution in mouse heart, 30 minutes post injection",Intermediate,10090.0,N,14137,1,,1,A,,,14045,
,,CHEMBL626291,,50594,,BAO_0000218,Mus musculus,,,"Percentage biodistribution in mouse heart, 5 minutes post injection",Intermediate,10090.0,N,14138,1,,1,A,,,14045,
,,CHEMBL839888,,50594,,BAO_0000218,Mus musculus,,,"Percentage biodistribution in mouse heart, 60 minutes post injection",Intermediate,10090.0,N,14139,1,,1,A,,,14045,
,,CHEMBL626292,,50594,Intestine,BAO_0000218,Mus musculus,160.0,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",Intermediate,10090.0,N,14140,1,,1,A,,,14045,
,,CHEMBL626293,,50594,Intestine,BAO_0000218,Mus musculus,160.0,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",Intermediate,10090.0,N,14141,1,,1,A,,,14045,
,,CHEMBL626294,,50594,Intestine,BAO_0000218,Mus musculus,160.0,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",Intermediate,10090.0,N,14142,1,,1,A,,,14045,
,,CHEMBL626295,,50594,Intestine,BAO_0000218,Mus musculus,160.0,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",Intermediate,10090.0,N,14143,1,,1,A,,,14045,
,,CHEMBL627659,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,"Percentage biodistribution in mouse liver, 10 minutes post injection",Intermediate,10090.0,N,14144,1,,1,A,,,14045,
,,CHEMBL627660,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",Intermediate,10090.0,N,14145,1,,1,A,,,14045,
,,CHEMBL627661,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,"Percentage biodistribution in mouse liver, 5 minutes post injection",Intermediate,10090.0,N,14146,1,,1,A,,,14045,
In vivo,,CHEMBL627662,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution in mice liver at 60 minutes of post injection,Intermediate,10090.0,N,14147,1,,1,A,,,14045,
In vivo,,CHEMBL627663,,50594,Lung,BAO_0000218,Mus musculus,2048.0,,Biodistribution in mice lungs at 10 min of post injection,Intermediate,10090.0,N,14148,1,,1,A,,,14045,
,,CHEMBL627664,,50594,,BAO_0000218,Mus musculus,,,"Percentage biodistribution in mouse lung, 30 minutes post injection",Intermediate,10090.0,N,14149,1,,1,A,,,14045,
,,CHEMBL627665,,50594,,BAO_0000218,Mus musculus,,,"Percentage biodistribution in mousee lung, 5 minutes post injection",Intermediate,10090.0,N,14150,1,,1,A,,,14045,
In vivo,,CHEMBL627666,,50594,Lung,BAO_0000218,Mus musculus,2048.0,,Biodistribution in mice lungs at 60 min of post injection,Intermediate,10090.0,N,14151,1,,1,A,,,14045,
,,CHEMBL627667,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Percentage biodistribution in mouse spleen,Intermediate,10090.0,N,14152,1,,1,A,,,14045,
,,CHEMBL627668,,50594,Stomach,BAO_0000218,Mus musculus,945.0,,Percentage biodistribution in mouse stomach,Intermediate,10090.0,N,14153,1,,1,A,,,14045,
,,CHEMBL627669,,50594,Urine,BAO_0000218,Mus musculus,1088.0,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,Intermediate,10090.0,N,14154,1,,1,A,,,11745,
In vivo,,CHEMBL627670,,22224,Urinary bladder,BAO_0000218,,1255.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,Autocuration,,U,14155,1,,0,A,,,13257,
In vivo,,CHEMBL627671,,22224,Blood,BAO_0000218,,178.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,Autocuration,,U,14156,1,,0,A,,,13257,
In vivo,,CHEMBL627672,,22224,Bone element,BAO_0000218,,1474.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,Autocuration,,U,14157,1,,0,A,,,13257,
In vivo,,CHEMBL627673,,22224,,BAO_0000218,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,Autocuration,,U,14158,1,,0,A,,,13257,
In vivo,,CHEMBL627674,,22224,Kidney,BAO_0000218,,2113.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,Autocuration,,U,14159,1,,0,A,,,13257,
In vivo,,CHEMBL627675,,22224,Liver,BAO_0000218,,2107.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,Autocuration,,U,14160,1,,0,A,,,13257,
In vivo,,CHEMBL627676,,22224,Lung,BAO_0000218,,2048.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,Autocuration,,U,14161,1,,0,A,,,13257,
In vivo,,CHEMBL627677,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,Autocuration,,U,14162,1,,0,A,,,13257,
,,CHEMBL627678,,22224,,BAO_0000019,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",Autocuration,,U,14163,1,,0,A,,,8354,
,,CHEMBL627679,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Affinity for protein binding expressed as association constant in fresh rat serum,Intermediate,10116.0,N,14164,1,,1,A,,,7095,
,,CHEMBL627680,,22224,,BAO_0000019,,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,Autocuration,,U,14165,1,,0,A,,,12185,
,,CHEMBL627681,,22224,,BAO_0000019,,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,Autocuration,,U,14166,1,,0,A,,,12185,
,,CHEMBL627682,,22224,,BAO_0000019,,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,Autocuration,,U,14167,1,,0,A,,,12185,
,,CHEMBL627683,,22224,,BAO_0000019,,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,Autocuration,,U,14168,1,,0,A,,,12185,
,,CHEMBL627684,,22224,,BAO_0000019,,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,Autocuration,,U,14169,1,,0,A,,,12686,
,,CHEMBL874441,,22224,,BAO_0000019,,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",Autocuration,,U,14170,1,,0,A,,,12686,
,,CHEMBL627685,,22224,,BAO_0000019,,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,Autocuration,,U,14171,1,,0,A,,,12686,
,,CHEMBL627686,,22224,,BAO_0000019,,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",Autocuration,,U,14172,1,,0,A,,,12686,
,,CHEMBL627687,,22224,,BAO_0000019,,,,Apparent rate constant Koff for inactivation of dTMP synthase.,Autocuration,,U,14173,1,,0,A,,,8057,
,,CHEMBL627688,,22224,,BAO_0000019,,,,The irreversible inhibitor activity by second order rate equation.,Autocuration,,U,14174,1,,0,A,,,15778,
,,CHEMBL628038,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,Intermediate,10116.0,N,14175,1,,1,A,,,12375,
,,CHEMBL628039,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,Intermediate,10116.0,N,14176,1,,1,A,,,12375,
,,CHEMBL628040,,50597,,BAO_0000218,Rattus norvegicus,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,Intermediate,10116.0,N,14177,1,,1,A,,,12375,
,,CHEMBL628041,,22224,,BAO_0000019,,,,Dissociation rate calculated from the first-order equation using t1/2 value,Autocuration,,U,14178,1,,0,A,,,13588,
,,CHEMBL630226,,22224,,BAO_0000019,,,,The compound was tested for Binding constant against DNA,Autocuration,,U,14179,1,,0,A,,,15039,
,,CHEMBL628042,,22224,,BAO_0000019,,,,First order rate constant for cyclization of the compound,Autocuration,,U,14180,1,,0,A,,,9500,
,,CHEMBL625232,,22224,,BAO_0000019,,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,Autocuration,,U,14181,1,,0,A,,,10014,
,,CHEMBL625233,,22224,,BAO_0000019,,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,Autocuration,,U,14182,1,,0,A,,,10014,
,,CHEMBL625979,,22224,,BAO_0000019,,,,Hydrolysis rate constant was determined,Autocuration,,U,14183,1,,0,A,,,568,
,,CHEMBL625980,,22224,,BAO_0000019,,,,Observed first order rate constant,Autocuration,,U,14184,1,,0,A,,,10026,
,,CHEMBL625981,,22224,,BAO_0000019,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,,U,14185,1,,0,A,,,10281,
,,CHEMBL625982,,22224,,BAO_0000019,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,,U,14186,1,,0,A,,,10281,
,,CHEMBL625983,,22224,,BAO_0000019,,,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,Autocuration,,U,14187,1,,0,A,,,9680,
,,CHEMBL625984,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14188,1,,0,A,,,13028,
,,CHEMBL625985,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14189,1,,0,A,,,13028,
,,CHEMBL625986,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14190,1,,0,A,,,13028,
,,CHEMBL625987,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14191,1,,0,A,,,13028,
,,CHEMBL625988,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14192,1,,0,A,,,13028,
,,CHEMBL625989,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14193,1,,0,A,,,13028,
,,CHEMBL625990,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14194,1,,0,A,,,13028,
,,CHEMBL625991,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14195,1,,0,A,,,13028,
,,CHEMBL625992,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14196,1,,0,A,,,13028,
,,CHEMBL625993,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14197,1,,0,A,,,13028,
,,CHEMBL631973,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14198,1,,0,A,,,13028,
,,CHEMBL632143,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14199,1,,0,A,,,13028,
,,CHEMBL632144,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14200,1,,0,A,,,13028,
,,CHEMBL632145,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14201,1,,0,A,,,13028,
,,CHEMBL632146,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14202,1,,0,A,,,13028,
,,CHEMBL632147,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14203,1,,0,A,,,13028,
,,CHEMBL632148,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14204,1,,0,A,,,13028,
,,CHEMBL632149,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14205,1,,0,A,,,13028,
,,CHEMBL632150,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14206,1,,0,A,,,13028,
,,CHEMBL632151,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14207,1,,0,A,,,13028,
,,CHEMBL632152,,50587,,BAO_0000218,Homo sapiens,,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,Intermediate,9606.0,N,14208,1,,1,A,,,3008,
,,CHEMBL632153,,50587,,BAO_0000218,Homo sapiens,,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Intermediate,9606.0,N,14209,1,,1,A,,,4509,
,,CHEMBL632154,,50587,,BAO_0000218,Homo sapiens,,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Intermediate,9606.0,N,14210,1,,1,A,,,4509,
,,CHEMBL632155,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,Intermediate,10298.0,N,14211,1,,1,A,,,8613,
,,CHEMBL632156,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,Intermediate,10298.0,N,14212,1,,1,A,,,8613,
,,CHEMBL632157,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,Intermediate,10298.0,N,14213,1,,1,A,,,8613,
,,CHEMBL632158,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,Intermediate,10298.0,N,14214,1,,1,A,,,8613,
,,CHEMBL632159,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,Intermediate,10298.0,N,14215,1,,1,A,,,8613,
,,CHEMBL626305,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,Intermediate,10298.0,N,14216,1,,1,A,,,8613,
,,CHEMBL626306,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,Intermediate,10298.0,N,14217,1,,1,A,,,8613,
,,CHEMBL626307,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,Intermediate,10298.0,N,14218,1,,1,A,,,8613,
,,CHEMBL626308,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,Intermediate,10298.0,N,14219,1,,1,A,,,8613,
,,CHEMBL626479,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,Intermediate,10298.0,N,14220,1,,1,A,,,8613,
,,CHEMBL626480,,50602,,BAO_0000218,Human herpesvirus 1,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,Intermediate,10298.0,N,14221,1,,1,A,,,8613,
,,CHEMBL626481,,22229,,BAO_0000100,,,,Calculated partition coefficient (clogP) (MlogP),Autocuration,,U,14222,1,,0,P,,,6021,
,,CHEMBL626482,,22224,,BAO_0000019,,,,Equipotent potent ratio relative to carbachol (nicotinic activity),Autocuration,,U,14223,1,,0,A,,,9348,
,,CHEMBL626483,,50588,,BAO_0000218,Canis lupus familiaris,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",Intermediate,9615.0,N,14224,1,,1,A,,,15592,
,,CHEMBL626484,,50588,,BAO_0000218,Canis lupus familiaris,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",Intermediate,9615.0,N,14225,1,,1,A,,,15592,
,,CHEMBL626485,,22229,,BAO_0000100,,,,Solubility at pH 7.4 in micro g/mL;NA denotes available,Autocuration,,U,14226,1,,0,P,,,15592,
,,CHEMBL626486,,22229,,BAO_0000100,,,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,Autocuration,,U,14227,1,,0,P,,,15592,
,,CHEMBL626487,,22229,,BAO_0000100,,,,Solubility at pH 7.4 in ug/mL;NA denotes not available,Autocuration,,U,14228,1,,0,P,,,15592,
In vivo,,CHEMBL626488,,50588,Plasma,BAO_0000218,Canis lupus familiaris,1969.0,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,9615.0,N,14229,1,,1,A,,,15592,
,,CHEMBL626489,,50597,Serum,BAO_0000218,Rattus norvegicus,1977.0,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,Intermediate,10116.0,N,14230,1,,1,A,,,7095,
,,CHEMBL626490,,22224,,BAO_0000019,,,,Area under the MAP curve measured over 5 min; ND means Not determined,Autocuration,,U,14231,1,,0,A,,,16618,
,,CHEMBL626491,,22224,,BAO_0000100,,,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,Autocuration,,U,14232,1,,0,P,,,16835,
,,CHEMBL626492,,22229,,BAO_0000100,,,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,Autocuration,,U,14233,1,,0,P,,,15284,
,,CHEMBL626493,,22224,,BAO_0000019,,,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,Autocuration,,U,14234,1,,0,A,,,15750,
In vivo,,CHEMBL626494,,50597,,BAO_0000218,Rattus norvegicus,,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,Intermediate,10116.0,N,14235,1,,1,A,,,16618,
In vivo,,CHEMBL626495,,22224,,BAO_0000218,,,,Half life after oral tested,Autocuration,,U,14236,1,,0,A,,,16618,
,,CHEMBL626496,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,Half life was determined in plasma of rat; NT indicates not tested,Intermediate,10116.0,N,14237,1,,1,A,,,15812,
In vivo,,CHEMBL626497,,50597,,BAO_0000218,Rattus norvegicus,,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,Intermediate,10116.0,N,14238,1,,1,A,,,16618,
In vivo,,CHEMBL626498,,22224,,BAO_0000218,,,,Oral bioavailability after oral tested,Autocuration,,U,14239,1,,0,A,,,16618,
,,CHEMBL626499,,50597,,BAO_0000218,Rattus norvegicus,,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),Intermediate,10116.0,N,14240,1,,1,A,,,13098,
,,CHEMBL626500,,50597,,BAO_0000218,Rattus norvegicus,,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),Intermediate,10116.0,N,14241,1,,1,A,,,13098,
,,CHEMBL626501,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,half life was determined in plasma of rat; NT indicates not tested,Intermediate,10116.0,N,14242,1,,1,A,,,15812,
,,CHEMBL626502,,50597,Plasma,BAO_0000218,Rattus norvegicus,1969.0,,half life was determined in plasma of rat; NT means not tested,Intermediate,10116.0,N,14243,1,,1,A,,,15812,
,,CHEMBL626503,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,Intermediate,10116.0,N,14244,1,,1,A,,,11510,
,,CHEMBL626504,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,Intermediate,10116.0,N,14245,1,,1,A,,,11510,
,,CHEMBL626505,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,Intermediate,10116.0,N,14246,1,,1,A,,,11510,
,,CHEMBL626506,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,Intermediate,10116.0,N,14247,1,,1,A,,,11510,
,,CHEMBL626507,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,Intermediate,10116.0,N,14248,1,,1,A,,,11510,
,,CHEMBL626508,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,Intermediate,10116.0,N,14249,1,,1,A,,,11510,
,,CHEMBL626509,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,Intermediate,10116.0,N,14250,1,,1,A,,,11510,
,,CHEMBL875480,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,Intermediate,10116.0,N,14251,1,,1,A,,,11510,
,,CHEMBL626510,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,Intermediate,10116.0,N,14252,1,,1,A,,,11510,
,,CHEMBL626511,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,Intermediate,10116.0,N,14253,1,,1,A,,,11510,
,,CHEMBL626512,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,Intermediate,10116.0,N,14254,1,,1,A,,,11510,
,,CHEMBL628208,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,Intermediate,10116.0,N,14255,1,,1,A,,,11510,
,,CHEMBL628209,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,Intermediate,10116.0,N,14256,1,,1,A,,,11510,
,,CHEMBL628210,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,Intermediate,10116.0,N,14257,1,,1,A,,,11510,
,,CHEMBL628211,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,Intermediate,10116.0,N,14258,1,,1,A,,,11510,
,,CHEMBL628212,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,Intermediate,10116.0,N,14259,1,,1,A,,,11510,
,,CHEMBL628213,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,Intermediate,10116.0,N,14260,1,,1,A,,,11510,
,,CHEMBL628214,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,10116.0,N,14261,1,,1,A,,,12582,
,,CHEMBL628215,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,10116.0,N,14262,1,,1,A,,,12582,
,,CHEMBL628216,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,10116.0,N,14263,1,,1,A,,,12582,
,,CHEMBL626595,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,10116.0,N,14264,1,,1,A,,,12582,
,,CHEMBL626596,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,10116.0,N,14265,1,,1,A,,,12582,
,,CHEMBL626597,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,10116.0,N,14266,1,,1,A,,,12582,
,,CHEMBL626598,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,10116.0,N,14267,1,,1,A,,,12582,
,,CHEMBL622242,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,10116.0,N,14268,1,,1,A,,,12582,
,,CHEMBL622243,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,10116.0,N,14269,1,,1,A,,,12582,
,,CHEMBL622244,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,10116.0,N,14270,1,,1,A,,,12582,
,,CHEMBL622245,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,10116.0,N,14271,1,,1,A,,,12582,
,,CHEMBL622246,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,10116.0,N,14272,1,,1,A,,,12582,
,,CHEMBL622247,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,10116.0,N,14273,1,,1,A,,,12582,
,,CHEMBL622248,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,10116.0,N,14274,1,,1,A,,,12582,
,,CHEMBL877483,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,10116.0,N,14275,1,,1,A,,,12582,
,,CHEMBL622249,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,10116.0,N,14276,1,,1,A,,,12582,
,,CHEMBL622250,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,9615.0,N,14277,1,,1,A,,,12582,
,,CHEMBL622251,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,9615.0,N,14278,1,,1,A,,,12582,
,,CHEMBL622252,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,9615.0,N,14279,1,,1,A,,,12582,
,,CHEMBL622253,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,9615.0,N,14280,1,,1,A,,,12582,
,,CHEMBL622254,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,9615.0,N,14281,1,,1,A,,,12582,
,,CHEMBL622255,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,9615.0,N,14282,1,,1,A,,,12582,
,,CHEMBL622256,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,9615.0,N,14283,1,,1,A,,,12582,
,,CHEMBL622257,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,9615.0,N,14284,1,,1,A,,,12582,
,,CHEMBL622258,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,9615.0,N,14285,1,,1,A,,,12582,
,,CHEMBL622259,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,9615.0,N,14286,1,,1,A,,,12582,
,,CHEMBL622927,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,9615.0,N,14287,1,,1,A,,,12582,
,,CHEMBL622928,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,9615.0,N,14288,1,,1,A,,,12582,
,,CHEMBL622929,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,9615.0,N,14289,1,,1,A,,,12582,
,,CHEMBL623182,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Intermediate,9615.0,N,14290,1,,1,A,,,12582,
,,CHEMBL623183,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,9615.0,N,14291,1,,1,A,,,12582,
,,CHEMBL623184,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,10116.0,N,14292,1,,1,A,,,12582,
,,CHEMBL623185,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,10116.0,N,14293,1,,1,A,,,12582,
,,CHEMBL877484,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,10116.0,N,14294,1,,1,A,,,12582,
,,CHEMBL627274,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,10116.0,N,14295,1,,1,A,,,12582,
,,CHEMBL623186,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,10116.0,N,14296,1,,1,A,,,12582,
,,CHEMBL623187,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,10116.0,N,14297,1,,1,A,,,12582,
,,CHEMBL623188,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,10116.0,N,14298,1,,1,A,,,12582,
,,CHEMBL628055,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,10116.0,N,14299,1,,1,A,,,12582,
,,CHEMBL628056,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,10116.0,N,14300,1,,1,A,,,12582,
,,CHEMBL628200,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,10116.0,N,14301,1,,1,A,,,12582,
,,CHEMBL628201,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,10116.0,N,14302,1,,1,A,,,12582,
,,CHEMBL628202,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,10116.0,N,14303,1,,1,A,,,12582,
,,CHEMBL628203,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,10116.0,N,14304,1,,1,A,,,12582,
,,CHEMBL628204,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,10116.0,N,14305,1,,1,A,,,12582,
,,CHEMBL628205,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,10116.0,N,14306,1,,1,A,,,12582,
,,CHEMBL628206,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,10116.0,N,14307,1,,1,A,,,12582,
In vivo,,CHEMBL628207,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),Autocuration,,U,14308,1,,0,A,,,13257,
In vivo,,CHEMBL627220,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,Autocuration,,U,14309,1,,0,A,,,13257,
In vivo,,CHEMBL627221,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,Autocuration,,U,14310,1,,0,A,,,13257,
In vivo,,CHEMBL627222,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),Autocuration,,U,14311,1,,0,A,,,13257,
In vivo,,CHEMBL627223,,22224,,BAO_0000218,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,Autocuration,,U,14312,1,,0,A,,,13257,
In vivo,,CHEMBL632062,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,Autocuration,,U,14313,1,,0,A,,,13257,
In vivo,,CHEMBL632063,,22224,Spleen,BAO_0000218,,2106.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,Autocuration,,U,14314,1,,0,A,,,13257,
In vivo,,CHEMBL632064,,22224,Urinary bladder,BAO_0000218,,1255.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,Autocuration,,U,14315,1,,0,A,,,13257,
In vivo,,CHEMBL632065,,22224,Blood,BAO_0000218,,178.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,Autocuration,,U,14316,1,,0,A,,,13257,
In vivo,,CHEMBL632066,,22224,Bone element,BAO_0000218,,1474.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,Autocuration,,U,14317,1,,0,A,,,13257,
In vivo,,CHEMBL632067,,22224,,BAO_0000218,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,Autocuration,,U,14318,1,,0,A,,,13257,
In vivo,,CHEMBL629188,,22224,Kidney,BAO_0000218,,2113.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,Autocuration,,U,14319,1,,0,A,,,13257,
In vivo,,CHEMBL629189,,22224,Liver,BAO_0000218,,2107.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,Autocuration,,U,14320,1,,0,A,,,13257,
In vivo,,CHEMBL629190,,22224,Lung,BAO_0000218,,2048.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,Autocuration,,U,14321,1,,0,A,,,13257,
In vivo,,CHEMBL629191,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,Autocuration,,U,14322,1,,0,A,,,13257,
In vivo,,CHEMBL629192,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),Autocuration,,U,14323,1,,0,A,,,13257,
In vivo,,CHEMBL629193,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,Autocuration,,U,14324,1,,0,A,,,13257,
In vivo,,CHEMBL629194,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),Autocuration,,U,14325,1,,0,A,,,13257,
In vivo,,CHEMBL629195,,22224,,BAO_0000218,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,Autocuration,,U,14326,1,,0,A,,,13257,
In vivo,,CHEMBL629373,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,Autocuration,,U,14327,1,,0,A,,,13257,
In vivo,,CHEMBL629374,,22224,Spleen,BAO_0000218,,2106.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,Autocuration,,U,14328,1,,0,A,,,13257,
In vivo,,CHEMBL629375,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,Autocuration,,U,14329,1,,0,A,,,13257,
In vivo,,CHEMBL629376,,22224,Urinary bladder,BAO_0000218,,1255.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,Autocuration,,U,14330,1,,0,A,,,13257,
In vivo,,CHEMBL629377,,22224,Blood,BAO_0000218,,178.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,Autocuration,,U,14331,1,,0,A,,,13257,
In vivo,,CHEMBL629378,,22224,Bone element,BAO_0000218,,1474.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,Autocuration,,U,14332,1,,0,A,,,13257,
In vivo,,CHEMBL629379,,22224,,BAO_0000218,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,Autocuration,,U,14333,1,,0,A,,,13257,
In vivo,,CHEMBL629151,,22224,Kidney,BAO_0000218,,2113.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,Autocuration,,U,14334,1,,0,A,,,13257,
In vivo,,CHEMBL629152,,22224,Liver,BAO_0000218,,2107.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,Autocuration,,U,14335,1,,0,A,,,13257,
In vivo,,CHEMBL629153,,22224,Lung,BAO_0000218,,2048.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,Autocuration,,U,14336,1,,0,A,,,13257,
In vivo,,CHEMBL629154,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,Autocuration,,U,14337,1,,0,A,,,13257,
In vivo,,CHEMBL629155,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),Autocuration,,U,14338,1,,0,A,,,13257,
In vivo,,CHEMBL629156,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,Autocuration,,U,14339,1,,0,A,,,13257,
In vivo,,CHEMBL629157,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,Autocuration,,U,14340,1,,0,A,,,13257,
In vivo,,CHEMBL629158,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),Autocuration,,U,14341,1,,0,A,,,13257,
In vivo,,CHEMBL629159,,22224,,BAO_0000218,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,Autocuration,,U,14342,1,,0,A,,,13257,
In vivo,,CHEMBL629160,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,Autocuration,,U,14343,1,,0,A,,,13257,
In vivo,,CHEMBL629161,,22224,Spleen,BAO_0000218,,2106.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,Autocuration,,U,14344,1,,0,A,,,13257,
In vivo,,CHEMBL629162,,22224,Urinary bladder,BAO_0000218,,1255.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,Autocuration,,U,14345,1,,0,A,,,13257,
In vivo,,CHEMBL629163,,22224,Blood,BAO_0000218,,178.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,Autocuration,,U,14346,1,,0,A,,,13257,
In vivo,,CHEMBL629164,,22224,Bone element,BAO_0000218,,1474.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,Autocuration,,U,14347,1,,0,A,,,13257,
In vivo,,CHEMBL629165,,22224,,BAO_0000218,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,Autocuration,,U,14348,1,,0,A,,,13257,
In vivo,,CHEMBL629166,,22224,Liver,BAO_0000218,,2107.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,Autocuration,,U,14349,1,,0,A,,,13257,
In vivo,,CHEMBL629167,,22224,Lung,BAO_0000218,,2048.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,Autocuration,,U,14350,1,,0,A,,,13257,
In vivo,,CHEMBL629168,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,Autocuration,,U,14351,1,,0,A,,,13257,
,,CHEMBL629169,,22224,,BAO_0000019,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,Autocuration,,U,14352,1,,0,A,,,2193,
,,CHEMBL629170,,22224,,BAO_0000019,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,Autocuration,,U,14353,1,,0,A,,,2193,
,,CHEMBL631153,,22224,,BAO_0000019,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,Autocuration,,U,14354,1,,0,A,,,2193,
,,CHEMBL875121,,22224,,BAO_0000019,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,Autocuration,,U,14355,1,,0,A,,,2193,
,,CHEMBL631154,,22224,,BAO_0000019,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,Autocuration,,U,14356,1,,0,A,,,2193,
,,CHEMBL631155,,22224,,BAO_0000019,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,Autocuration,,U,14357,1,,0,A,,,2193,
,,CHEMBL631156,,22224,,BAO_0000019,,,,Hydrolysis rate constant was determined,Autocuration,,U,14358,1,,0,A,,,568,
,,CHEMBL631157,,22224,,BAO_0000019,,,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",Autocuration,,U,14359,1,,0,A,,,9680,
,,CHEMBL631158,,22224,,BAO_0000019,,,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",Autocuration,,U,14360,1,,0,A,,,9680,
,,CHEMBL631159,,22224,,BAO_0000019,,,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",Autocuration,,U,14361,1,,0,A,,,9680,
,,CHEMBL631160,,22224,,BAO_0000019,,,,Observed second order rate constant,Autocuration,,U,14362,1,,0,A,,,10026,
,,CHEMBL631161,,22224,,BAO_0000019,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,,U,14363,1,,0,A,,,10281,
,,CHEMBL631162,,22224,,BAO_0000019,,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,Autocuration,,U,14364,1,,0,A,,,10014,
,,CHEMBL630313,,22224,,BAO_0000019,,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,Autocuration,,U,14365,1,,0,A,,,10014,
,,CHEMBL630314,,22224,,BAO_0000019,,,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",Autocuration,,U,14366,1,,0,A,,,9680,
,,CHEMBL630315,,22224,,BAO_0000019,,,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",Autocuration,,U,14367,1,,0,A,,,9680,
,,CHEMBL630316,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14368,1,,0,A,,,13028,
,,CHEMBL630986,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14369,1,,0,A,,,13028,
,,CHEMBL630987,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14370,1,,0,A,,,13028,
,,CHEMBL630988,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14371,1,,0,A,,,13028,
,,CHEMBL630989,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14372,1,,0,A,,,13028,
,,CHEMBL630990,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14373,1,,0,A,,,13028,
,,CHEMBL630991,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14374,1,,0,A,,,13028,
,,CHEMBL630992,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14375,1,,0,A,,,13028,
,,CHEMBL630993,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14376,1,,0,A,,,13028,
,,CHEMBL630994,,22224,,BAO_0000019,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,U,14377,1,,0,A,,,13028,
,,CHEMBL630995,,50597,,BAO_0000218,Rattus norvegicus,,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,Intermediate,10116.0,N,14378,1,,1,A,,,10014,
,,CHEMBL629252,,22224,,BAO_0000019,,,,Association constant for compound at 31 degree C was determined,Autocuration,,U,14379,1,,0,A,,,9962,
,,CHEMBL629253,,22224,,BAO_0000019,,,,Calculated antagonist equilibrium dissociation constant of the compound,Autocuration,,U,14380,1,,0,A,,,12029,
,,CHEMBL629944,,22224,,BAO_0000019,,,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,Autocuration,,U,14381,1,,0,A,,,12029,
,,CHEMBL629945,,50512,Trachea,BAO_0000218,Cavia porcellus,3126.0,,Dissociation constants vs LTE4 on guinea pig trachea,Intermediate,10141.0,N,14382,1,,1,A,,,10583,
,,CHEMBL629946,,22224,,BAO_0000019,,,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",Autocuration,,U,14383,1,,0,A,,,568,
,,CHEMBL629947,,22224,,BAO_0000019,,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",Autocuration,,U,14384,1,,0,A,,,568,
,,CHEMBL629948,,22224,,BAO_0000019,,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",Autocuration,,U,14385,1,,0,A,,,568,
,,CHEMBL856024,,22224,,BAO_0000019,,,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",Autocuration,,U,14386,1,,0,A,,,568,
,,CHEMBL629949,,22224,,BAO_0000019,,,,Affinity constant KD value was derived from TMP,Autocuration,,U,14387,1,,0,A,,,7493,
,,CHEMBL629950,,22224,,BAO_0000019,,,,Apparent dissociation (binding) rate constant was evaluated,Autocuration,,U,14388,1,,0,A,,,8371,
,,CHEMBL630127,,22224,,BAO_0000100,,,,Dissociation constant (KD) of the compound,Autocuration,,U,14389,1,,0,P,,,13114,
,,CHEMBL630128,,22224,,BAO_0000100,,,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,Autocuration,,U,14390,1,,0,P,,,15515,
,,CHEMBL630129,,22224,,BAO_0000100,,,,Dissociation constant from ESR titration experiments,Autocuration,,U,14391,1,,0,P,,,522,
,,CHEMBL630130,,22224,,BAO_0000019,,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),Autocuration,,U,14392,1,,0,,,,13888,
,,CHEMBL875234,,22224,,BAO_0000100,,,,Dissociation constant was evaluated.,Autocuration,,U,14393,1,,0,P,,,2616,
,,CHEMBL630131,,22224,,BAO_0000100,,,,Dissociation constant was reported,Autocuration,,U,14394,1,,0,P,,,3798,
,,CHEMBL630132,,50597,,BAO_0000218,Rattus norvegicus,,,Dissociation constant was determined in rat pituitary cells.,Intermediate,10116.0,N,14395,1,,1,A,,,8731,
,,CHEMBL630133,,22224,,BAO_0000019,,,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,Autocuration,,U,14396,1,,0,A,,,11892,
,,CHEMBL630134,,22224,,BAO_0000019,,,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,Autocuration,,U,14397,1,,0,A,,,11892,
,,CHEMBL630135,,22224,,BAO_0000019,,,,Equilibrium dissociation constant of the compound,Autocuration,,U,14398,1,,0,A,,,2582,
,,CHEMBL630136,,22224,,BAO_0000019,,,,Equilibrium dissociation constant was determined,Autocuration,,U,14399,1,,0,A,,,11892,
,,CHEMBL630137,,22224,,BAO_0000019,,,,Kinetic constant KD was evaluated,Autocuration,,U,14400,1,,0,A,,,13396,
,,CHEMBL630138,,22224,,BAO_0000019,,,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,Autocuration,,U,14401,1,,0,A,,,603,
,,CHEMBL630139,,22224,,BAO_0000019,,,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,Autocuration,,U,14402,1,,0,A,,,15673,
,,CHEMBL630140,,22224,,BAO_0000019,,,,Rate constant for hydrolysis in aqueous acetone.,Autocuration,,U,14403,1,,0,A,,,10368,
,,CHEMBL875235,,22224,,BAO_0000019,,,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,Autocuration,,U,14404,1,,0,A,,,14228,
,,CHEMBL876439,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,Intermediate,10116.0,N,14405,1,,1,A,,,11510,
,,CHEMBL630605,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,Intermediate,10116.0,N,14406,1,,1,A,,,11510,
,,CHEMBL630606,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,Intermediate,10116.0,N,14407,1,,1,A,,,11510,
,,CHEMBL630607,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,Intermediate,10116.0,N,14408,1,,1,A,,,11510,
,,CHEMBL630608,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,Intermediate,10116.0,N,14409,1,,1,A,,,11510,
,,CHEMBL630609,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,Intermediate,10116.0,N,14410,1,,1,A,,,11510,
,,CHEMBL630610,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,Intermediate,10116.0,N,14411,1,,1,A,,,11510,
,,CHEMBL630611,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,Intermediate,10116.0,N,14412,1,,1,A,,,11510,
,,CHEMBL629552,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,Intermediate,10116.0,N,14413,1,,1,A,,,11510,
,,CHEMBL629733,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,10116.0,N,14414,1,,1,A,,,11510,
,,CHEMBL629734,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,10116.0,N,14415,1,,1,A,,,11510,
,,CHEMBL629735,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,10116.0,N,14416,1,,1,A,,,11510,
,,CHEMBL629736,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,10116.0,N,14417,1,,1,A,,,11510,
,,CHEMBL629737,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,10116.0,N,14418,1,,1,A,,,11510,
,,CHEMBL629738,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,10116.0,N,14419,1,,1,A,,,11510,
,,CHEMBL629739,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,10116.0,N,14420,1,,1,A,,,11510,
,,CHEMBL629740,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,10116.0,N,14421,1,,1,A,,,11510,
,,CHEMBL629741,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,10116.0,N,14422,1,,1,A,,,11510,
,,CHEMBL629742,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,10116.0,N,14423,1,,1,A,,,11510,
,,CHEMBL629743,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,10116.0,N,14424,1,,1,A,,,11510,
,,CHEMBL629744,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,10116.0,N,14425,1,,1,A,,,11510,
,,CHEMBL629745,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,10116.0,N,14426,1,,1,A,,,11510,
,,CHEMBL629746,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,10116.0,N,14427,1,,1,A,,,11510,
,,CHEMBL629747,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,10116.0,N,14428,1,,1,A,,,11510,
,,CHEMBL629748,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,10116.0,N,14429,1,,1,A,,,11510,
,,CHEMBL629749,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,10116.0,N,14430,1,,1,A,,,11510,
,,CHEMBL629750,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,10116.0,N,14431,1,,1,A,,,11510,
,,CHEMBL629751,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,10116.0,N,14432,1,,1,A,,,11510,
,,CHEMBL629752,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,10116.0,N,14433,1,,1,A,,,11510,
,,CHEMBL629753,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,10116.0,N,14434,1,,1,A,,,11510,
,,CHEMBL629754,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,10116.0,N,14435,1,,1,A,,,11510,
,,CHEMBL629755,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,10116.0,N,14436,1,,1,A,,,11510,
,,CHEMBL629756,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,10116.0,N,14437,1,,1,A,,,11510,
,,CHEMBL629757,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,10116.0,N,14438,1,,1,A,,,11510,
,,CHEMBL629758,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,10116.0,N,14439,1,,1,A,,,11510,
,,CHEMBL629759,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,10116.0,N,14440,1,,1,A,,,11510,
,,CHEMBL629760,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,10116.0,N,14441,1,,1,A,,,11510,
,,CHEMBL876443,,50597,,BAO_0000218,Rattus norvegicus,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,10116.0,N,14442,1,,1,A,,,11510,
,,CHEMBL629761,,50588,,BAO_0000218,Canis lupus familiaris,,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,Intermediate,9615.0,N,14443,1,,1,A,,,8310,
,,CHEMBL629762,,50588,,BAO_0000218,Canis lupus familiaris,,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,Intermediate,9615.0,N,14444,1,,1,A,,,8310,
,,CHEMBL629763,,50594,,BAO_0000218,Mus musculus,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,10090.0,N,14445,1,,1,A,,,8310,
,,CHEMBL629764,,50594,,BAO_0000218,Mus musculus,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,10090.0,N,14446,1,,1,A,,,8310,
,,CHEMBL629765,,50594,,BAO_0000218,Mus musculus,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,10090.0,N,14447,1,,1,A,,,8310,
,,CHEMBL629766,,50594,,BAO_0000218,Mus musculus,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,Intermediate,10090.0,N,14448,1,,1,A,,,8310,
,,CHEMBL629767,,50594,,BAO_0000218,Mus musculus,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,10090.0,N,14449,1,,1,A,,,8310,
,,CHEMBL629768,,50588,,BAO_0000218,Canis lupus familiaris,,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,Intermediate,9615.0,N,14450,1,,1,A,,,8310,
,,CHEMBL629769,,50594,,BAO_0000218,Mus musculus,,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,Intermediate,10090.0,N,14451,1,,1,A,,,8310,
,,CHEMBL629770,,50588,,BAO_0000218,Canis lupus familiaris,,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,Intermediate,9615.0,N,14452,1,,1,A,,,8310,
,,CHEMBL629771,,50588,,BAO_0000218,Canis lupus familiaris,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,Intermediate,9615.0,N,14453,1,,1,A,,,8310,
,,CHEMBL629772,,50594,,BAO_0000218,Mus musculus,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,10090.0,N,14454,1,,1,A,,,8310,
,,CHEMBL629773,,50594,,BAO_0000218,Mus musculus,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,10090.0,N,14455,1,,1,A,,,8310,
,,CHEMBL625455,,50594,,BAO_0000218,Mus musculus,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,10090.0,N,14456,1,,1,A,,,8310,
,,CHEMBL625456,,50594,,BAO_0000218,Mus musculus,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,Intermediate,10090.0,N,14457,1,,1,A,,,8310,
,,CHEMBL625457,,50594,,BAO_0000218,Mus musculus,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,Intermediate,10090.0,N,14458,1,,1,A,,,8310,
,,CHEMBL625458,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,10116.0,N,14459,1,,1,A,,,12582,
,,CHEMBL625459,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,10116.0,N,14460,1,,1,A,,,12582,
,,CHEMBL875483,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,10116.0,N,14461,1,,1,A,,,12582,
,,CHEMBL634779,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,10116.0,N,14462,1,,1,A,,,12582,
,,CHEMBL625460,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,10116.0,N,14463,1,,1,A,,,12582,
,,CHEMBL626117,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,10116.0,N,14464,1,,1,A,,,12582,
,,CHEMBL626118,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,10116.0,N,14465,1,,1,A,,,12582,
,,CHEMBL628342,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,10116.0,N,14466,1,,1,A,,,12582,
,,CHEMBL628343,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,10116.0,N,14467,1,,1,A,,,12582,
,,CHEMBL628344,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,Intermediate,10116.0,N,14468,1,,1,A,,,12582,
,,CHEMBL628345,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,10116.0,N,14469,1,,1,A,,,12582,
,,CHEMBL628346,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,10116.0,N,14470,1,,1,A,,,12582,
,,CHEMBL628347,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,10116.0,N,14471,1,,1,A,,,12582,
,,CHEMBL628348,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,10116.0,N,14472,1,,1,A,,,12582,
,,CHEMBL628349,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,10116.0,N,14473,1,,1,A,,,12582,
,,CHEMBL875611,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,Intermediate,10116.0,N,14474,1,,1,A,,,12582,
,,CHEMBL628350,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,10116.0,N,14475,1,,1,A,,,12582,
,,CHEMBL628351,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,10116.0,N,14476,1,,1,A,,,12582,
,,CHEMBL628352,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,10116.0,N,14477,1,,1,A,,,12582,
,,CHEMBL628353,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,10116.0,N,14478,1,,1,A,,,12582,
,,CHEMBL628354,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,10116.0,N,14479,1,,1,A,,,12582,
,,CHEMBL626667,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,10116.0,N,14480,1,,1,A,,,12582,
,,CHEMBL626668,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,10116.0,N,14481,1,,1,A,,,12582,
,,CHEMBL626669,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,10116.0,N,14482,1,,1,A,,,12582,
,,CHEMBL626670,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,10116.0,N,14483,1,,1,A,,,12582,
,,CHEMBL626671,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,10116.0,N,14484,1,,1,A,,,12582,
,,CHEMBL626672,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,10116.0,N,14485,1,,1,A,,,12582,
,,CHEMBL626673,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,Intermediate,10116.0,N,14486,1,,1,A,,,12582,
,,CHEMBL626674,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,10116.0,N,14487,1,,1,A,,,12582,
,,CHEMBL626675,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,10116.0,N,14488,1,,1,A,,,12582,
,,CHEMBL626676,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,Intermediate,10116.0,N,14489,1,,1,A,,,12582,
,,CHEMBL626677,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,Intermediate,10116.0,N,14490,1,,1,A,,,12582,
,,CHEMBL626678,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,10116.0,N,14491,1,,1,A,,,12582,
,,CHEMBL626679,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,10116.0,N,14492,1,,1,A,,,12582,
,,CHEMBL875612,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,10116.0,N,14493,1,,1,A,,,12582,
,,CHEMBL626680,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,10116.0,N,14494,1,,1,A,,,12582,
,,CHEMBL626681,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,10116.0,N,14495,1,,1,A,,,12582,
,,CHEMBL626682,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,10116.0,N,14496,1,,1,A,,,12582,
,,CHEMBL626683,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,10116.0,N,14497,1,,1,A,,,12582,
,,CHEMBL626684,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,10116.0,N,14498,1,,1,A,,,12582,
,,CHEMBL626685,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,10116.0,N,14499,1,,1,A,,,12582,
,,CHEMBL626686,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,10116.0,N,14500,1,,1,A,,,12582,
,,CHEMBL626687,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,10116.0,N,14501,1,,1,A,,,12582,
,,CHEMBL624978,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,10116.0,N,14502,1,,1,A,,,12582,
,,CHEMBL624979,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,10116.0,N,14503,1,,1,A,,,12582,
,,CHEMBL624980,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,10116.0,N,14504,1,,1,A,,,12582,
,,CHEMBL624981,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,10116.0,N,14505,1,,1,A,,,12582,
,,CHEMBL624982,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,9615.0,N,14506,1,,1,A,,,12582,
In vivo,,CHEMBL627564,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),Autocuration,,U,14507,1,,0,A,,,13257,
In vivo,,CHEMBL627565,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),Autocuration,,U,14508,1,,0,A,,,13257,
In vivo,,CHEMBL627566,,22224,,BAO_0000218,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,Autocuration,,U,14509,1,,0,A,,,13257,
In vivo,,CHEMBL627567,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,Autocuration,,U,14510,1,,0,A,,,13257,
In vivo,,CHEMBL627568,,22224,Spleen,BAO_0000218,,2106.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,Autocuration,,U,14511,1,,0,A,,,13257,
In vivo,,CHEMBL627569,,22224,Kidney,BAO_0000218,,2113.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,Autocuration,,U,14512,1,,0,A,,,13257,
In vivo,,CHEMBL627570,,22224,Urinary bladder,BAO_0000218,,1255.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,Autocuration,,U,14513,1,,0,A,,,13257,
In vivo,,CHEMBL627571,,22224,Blood,BAO_0000218,,178.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,Autocuration,,U,14514,1,,0,A,,,13257,
In vivo,,CHEMBL627572,,22224,Bone element,BAO_0000218,,1474.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,Autocuration,,U,14515,1,,0,A,,,13257,
In vivo,,CHEMBL627573,,22224,,BAO_0000218,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,Autocuration,,U,14516,1,,0,A,,,13257,
In vivo,,CHEMBL627574,,22224,Kidney,BAO_0000218,,2113.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,Autocuration,,U,14517,1,,0,A,,,13257,
In vivo,,CHEMBL627575,,22224,Liver,BAO_0000218,,2107.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,Autocuration,,U,14518,1,,0,A,,,13257,
In vivo,,CHEMBL627576,,22224,Lung,BAO_0000218,,2048.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,Autocuration,,U,14519,1,,0,A,,,13257,
In vivo,,CHEMBL627577,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,Autocuration,,U,14520,1,,0,A,,,13257,
In vivo,,CHEMBL627578,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),Autocuration,,U,14521,1,,0,A,,,13257,
In vivo,,CHEMBL627579,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,Autocuration,,U,14522,1,,0,A,,,13257,
In vivo,,CHEMBL627580,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,Autocuration,,U,14523,1,,0,A,,,13257,
In vivo,,CHEMBL627581,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),Autocuration,,U,14524,1,,0,A,,,13257,
In vivo,,CHEMBL627582,,22224,,BAO_0000218,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,Autocuration,,U,14525,1,,0,A,,,13257,
In vivo,,CHEMBL627583,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,Autocuration,,U,14526,1,,0,A,,,13257,
In vivo,,CHEMBL627584,,22224,Spleen,BAO_0000218,,2106.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,Autocuration,,U,14527,1,,0,A,,,13257,
In vivo,,CHEMBL627585,,22224,Prostate gland,BAO_0000218,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,Autocuration,,U,14528,1,,0,A,,,13257,
In vivo,,CHEMBL627586,,22224,Muscle tissue,BAO_0000218,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,Autocuration,,U,14529,1,,0,A,,,13257,
In vivo,,CHEMBL627587,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,10116.0,N,14530,1,,1,A,,,15413,
In vivo,,CHEMBL627588,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,10116.0,N,14531,1,,1,A,,,15413,
In vivo,,CHEMBL628250,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,10116.0,N,14532,1,,1,A,,,15413,
In vivo,,CHEMBL628251,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,10116.0,N,14533,1,,1,A,,,15413,
In vivo,,CHEMBL628252,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,10116.0,N,14534,1,,1,A,,,15413,
In vivo,,CHEMBL628253,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,10116.0,N,14535,1,,1,A,,,15413,
In vivo,,CHEMBL628254,,50597,Hypothalamus,BAO_0000218,Rattus norvegicus,1898.0,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,10116.0,N,14536,1,,1,A,,,15413,
In vivo,,CHEMBL877493,,50597,Hypothalamus,BAO_0000218,Rattus norvegicus,1898.0,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,10116.0,N,14537,1,,1,A,,,15413,
In vivo,,CHEMBL628255,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,10116.0,N,14538,1,,1,A,,,15413,
In vivo,,CHEMBL628256,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,10116.0,N,14539,1,,1,A,,,15413,
In vivo,,CHEMBL628257,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,10116.0,N,14540,1,,1,A,,,15413,
In vivo,,CHEMBL628258,,50597,Hypothalamus,BAO_0000218,Rattus norvegicus,1898.0,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,10116.0,N,14541,1,,1,A,,,15413,
In vivo,,CHEMBL628259,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,10116.0,N,14542,1,,1,A,,,15413,
In vivo,,CHEMBL628429,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,10116.0,N,14543,1,,1,A,,,15413,
In vivo,,CHEMBL626862,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,10116.0,N,14544,1,,1,A,,,15413,
In vivo,,CHEMBL626863,,50597,Hypothalamus,BAO_0000218,Rattus norvegicus,1898.0,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,Intermediate,10116.0,N,14545,1,,1,A,,,15413,
In vivo,,CHEMBL625886,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,Intermediate,10116.0,N,14546,1,,1,A,,,15413,
In vivo,,CHEMBL625887,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,Intermediate,10116.0,N,14547,1,,1,A,,,15413,
In vivo,,CHEMBL625888,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,Intermediate,10116.0,N,14548,1,,1,A,,,15413,
In vivo,,CHEMBL625889,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,Intermediate,10116.0,N,14549,1,,1,A,,,15413,
In vivo,,CHEMBL625890,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,Intermediate,10116.0,N,14550,1,,1,A,,,15413,
In vivo,,CHEMBL625891,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,Intermediate,10116.0,N,14551,1,,1,A,,,15413,
In vivo,,CHEMBL625892,,50597,Hypothalamus,BAO_0000218,Rattus norvegicus,1898.0,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,Intermediate,10116.0,N,14552,1,,1,A,,,15413,
In vivo,,CHEMBL625893,,50597,Hypothalamus,BAO_0000218,Rattus norvegicus,1898.0,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,Intermediate,10116.0,N,14553,1,,1,A,,,15413,
In vivo,,CHEMBL625894,,50597,Cerebellum,BAO_0000218,Rattus norvegicus,2037.0,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,Intermediate,10116.0,N,14554,1,,1,A,,,15413,
In vivo,,CHEMBL625895,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,Intermediate,10116.0,N,14555,1,,1,A,,,15413,
,,CHEMBL625896,,22224,,BAO_0000019,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,,U,14556,1,,0,A,,,12404,
,,CHEMBL625897,,22224,,BAO_0000019,,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",Autocuration,,U,14557,1,,0,A,,,568,
,,CHEMBL625898,,22224,,BAO_0000019,,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",Autocuration,,U,14558,1,,0,A,,,568,
,,CHEMBL625899,,22224,,BAO_0000019,,,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",Autocuration,,U,14559,1,,0,A,,,568,
,,CHEMBL626124,,22224,,BAO_0000019,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,,U,14560,1,,0,A,,,12404,
,,CHEMBL628500,,50212,,BAO_0000218,Escherichia coli,,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,Intermediate,562.0,N,14561,1,,1,A,,,7624,
,,CHEMBL857856,,50597,,BAO_0000218,Rattus norvegicus,,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",Intermediate,10116.0,N,14562,1,,1,A,,,7624,
,,CHEMBL628501,,50597,,BAO_0000218,Rattus norvegicus,,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",Intermediate,10116.0,N,14563,1,,1,A,,,7624,
,,CHEMBL628502,,22224,,BAO_0000019,,,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",Autocuration,,U,14564,1,,0,A,,,4643,
,,CHEMBL628503,,22224,,BAO_0000019,,,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,Autocuration,,U,14565,1,,0,A,,,11532,
,,CHEMBL628504,,22224,,BAO_0000019,,,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,Autocuration,,U,14566,1,,0,A,,,11018,
,,CHEMBL628505,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",Autocuration,,U,14567,1,,0,A,,,2276,
,,CHEMBL874452,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",Autocuration,,U,14568,1,,0,A,,,2276,
,,CHEMBL628506,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",Autocuration,,U,14569,1,,0,A,,,2276,
,,CHEMBL628507,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",Autocuration,,U,14570,1,,0,A,,,2276,
,,CHEMBL628508,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",Autocuration,,U,14571,1,,0,A,,,2276,
,,CHEMBL628509,,22224,,BAO_0000019,,,,Michaelis constant (KM) was evaluated,Autocuration,,U,14572,1,,0,A,,,8949,
,,CHEMBL628510,,22224,,BAO_0000019,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,,U,14573,1,,0,A,,,12404,
,,CHEMBL628511,,22224,,BAO_0000019,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,Autocuration,,U,14574,1,,0,B,,,7625,
,,CHEMBL628512,,22224,,BAO_0000019,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,Autocuration,,U,14575,1,,0,B,,,7625,
,,CHEMBL628513,,22224,,BAO_0000019,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,Autocuration,,U,14576,1,,0,B,,,7625,
,,CHEMBL628514,,22224,,BAO_0000019,,,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,Autocuration,,U,14577,1,,0,B,,,7625,
,,CHEMBL628515,,22224,,BAO_0000019,,,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,Autocuration,,U,14578,1,,0,A,,,12908,
,,CHEMBL628516,,22224,,BAO_0000019,,,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,Autocuration,,U,14579,1,,0,A,,,10368,
,,CHEMBL628517,,22224,,BAO_0000019,,,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),Autocuration,,U,14580,1,,0,A,,,13108,
,,CHEMBL628518,,22224,,BAO_0000019,,,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),Autocuration,,U,14581,1,,0,A,,,13108,
,,CHEMBL628519,,22224,,BAO_0000019,,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,Autocuration,,U,14582,1,,0,A,,,15217,
,,CHEMBL628520,,22224,,BAO_0000019,,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,Autocuration,,U,14583,1,,0,A,,,15217,
,,CHEMBL628521,,22224,,BAO_0000019,,,,Binding constant was determined,Autocuration,,U,14584,1,,0,A,,,10933,
,,CHEMBL630443,,22224,,BAO_0000019,,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,Autocuration,,U,14585,1,,0,A,,,2363,
,,CHEMBL630444,,22224,,BAO_0000019,,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,Autocuration,,U,14586,1,,0,A,,,2363,
,,CHEMBL857732,,22224,,BAO_0000019,,,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,Autocuration,,U,14587,1,,0,A,,,2276,
,,CHEMBL630445,,22224,,BAO_0000100,,,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,Autocuration,,U,14588,1,,0,P,,,14915,
,,CHEMBL630446,,22224,,BAO_0000019,,,,Catalytic rate constant of the compound,Autocuration,,U,14589,1,,0,A,,,8847,
,,CHEMBL630447,,22224,,BAO_0000019,,,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,Autocuration,,U,14590,1,,0,B,,,15357,
,,CHEMBL630448,,22224,,BAO_0000019,,,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),Autocuration,,U,14591,1,,0,A,,,2869,
,,CHEMBL630449,,22224,,BAO_0000019,,,,Catalytic rate constant against phospholipase A2 was determined,Autocuration,,U,14592,1,,0,A,,,3484,
,,CHEMBL630450,,22224,,BAO_0000019,,,,"Compound was evaluated for catalytic constant, Kcat",Autocuration,,U,14593,1,,0,A,,,1373,
,,CHEMBL630451,,22224,,BAO_0000019,,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,Autocuration,,U,14594,1,,0,A,,,8142,
,,CHEMBL630452,,22224,,BAO_0000019,,,,Kcat calculated from 0.693/T1/2,Autocuration,,U,14595,1,,0,A,,,14131,
,,CHEMBL630453,,22224,,BAO_0000019,,,,Kcat was determined,Autocuration,,U,14596,1,,0,A,,,17269,
,,CHEMBL630454,,22224,,BAO_0000019,,,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,Autocuration,,U,14597,1,,0,A,,,3485,
,,CHEMBL630455,,22224,,BAO_0000019,,,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,Autocuration,,U,14598,1,,0,A,,,3485,
,,CHEMBL631487,,22224,,BAO_0000019,,,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,Autocuration,,U,14599,1,,0,A,,,3485,
,,CHEMBL631488,,22224,,BAO_0000019,,,,Kcat value was determined,Autocuration,,U,14600,1,,0,A,,,5962,
,,CHEMBL876440,,22224,,BAO_0000019,,,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,Autocuration,,U,14601,1,,0,A,,,3133,
,,CHEMBL631489,,22224,,BAO_0000019,,,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,Autocuration,,U,14602,1,,0,A,,,3133,
,,CHEMBL857742,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",Autocuration,,U,14603,1,,0,A,,,2276,
,,CHEMBL631490,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",Autocuration,,U,14604,1,,0,A,,,2276,
,,CHEMBL631491,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",Autocuration,,U,14605,1,,0,A,,,2276,
,,CHEMBL631492,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",Autocuration,,U,14606,1,,0,A,,,2276,
,,CHEMBL631493,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",Autocuration,,U,14607,1,,0,A,,,2276,
,,CHEMBL631494,,22224,,BAO_0000019,,,,Kinetic parameter for rate of conversion to PABA was determined,Autocuration,,U,14608,1,,0,A,,,4892,
,,CHEMBL631495,,22224,,BAO_0000019,,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,Autocuration,,U,14609,1,,0,A,,,3133,
,,CHEMBL631496,,50597,Feces,BAO_0000218,Rattus norvegicus,1988.0,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Intermediate,10116.0,N,14610,1,,1,A,,,11488,
,,CHEMBL631497,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,10116.0,N,14611,1,,1,A,,,11488,
,,CHEMBL631498,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,10116.0,N,14612,1,,1,A,,,11488,
,,CHEMBL629776,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,10116.0,N,14613,1,,1,A,,,11488,
,,CHEMBL629777,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,10116.0,N,14614,1,,1,A,,,11488,
,,CHEMBL629778,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Intermediate,10116.0,N,14615,1,,1,A,,,11488,
,,CHEMBL630456,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,Intermediate,10116.0,N,14616,1,,1,A,,,11488,
,,CHEMBL630457,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,Intermediate,10116.0,N,14617,1,,1,A,,,11488,
,,CHEMBL630458,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,Intermediate,10116.0,N,14618,1,,1,A,,,11488,
,,CHEMBL630459,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,Intermediate,10116.0,N,14619,1,,1,A,,,11488,
,,CHEMBL630460,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,Intermediate,10116.0,N,14620,1,,1,A,,,11488,
,,CHEMBL876550,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,Intermediate,10116.0,N,14621,1,,1,A,,,11488,
,,CHEMBL630461,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,Intermediate,10116.0,N,14622,1,,1,A,,,11488,
,,CHEMBL630462,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,Intermediate,10116.0,N,14623,1,,1,A,,,11488,
,,CHEMBL630463,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,Intermediate,10116.0,N,14624,1,,1,A,,,11488,
,,CHEMBL630464,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,Intermediate,10116.0,N,14625,1,,1,A,,,11488,
,,CHEMBL630465,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,Intermediate,10116.0,N,14626,1,,1,A,,,11488,
,,CHEMBL630466,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,Intermediate,10116.0,N,14627,1,,1,A,,,11488,
,,CHEMBL630467,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,Intermediate,10116.0,N,14628,1,,1,A,,,11488,
,,CHEMBL630633,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,Intermediate,10116.0,N,14629,1,,1,A,,,11488,
,,CHEMBL630634,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,Intermediate,10116.0,N,14630,1,,1,A,,,11488,
,,CHEMBL630635,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,Intermediate,10116.0,N,14631,1,,1,A,,,11488,
,,CHEMBL630636,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,Intermediate,10116.0,N,14632,1,,1,A,,,11488,
,,CHEMBL630637,,50597,,BAO_0000218,Rattus norvegicus,,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,Intermediate,10116.0,N,14633,1,,1,A,,,11488,
,,CHEMBL630638,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Intermediate,9986.0,N,14634,1,,1,A,,,7132,
,,CHEMBL630639,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Intermediate,9986.0,N,14635,1,,1,A,,,7132,
,,CHEMBL630640,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Intermediate,9986.0,N,14636,1,,1,A,,,7132,
,,CHEMBL876551,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Intermediate,9986.0,N,14637,1,,1,A,,,7132,
,,CHEMBL630641,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",Intermediate,9986.0,N,14638,1,,1,A,,,7132,
,,CHEMBL630642,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Intermediate,9986.0,N,14639,1,,1,A,,,7132,
,,CHEMBL630643,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Intermediate,9986.0,N,14640,1,,1,A,,,7132,
,,CHEMBL630644,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Intermediate,9986.0,N,14641,1,,1,A,,,7132,
,,CHEMBL630645,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Intermediate,9986.0,N,14642,1,,1,A,,,7132,
,,CHEMBL625599,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Intermediate,9986.0,N,14643,1,,1,A,,,7132,
,,CHEMBL625600,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Intermediate,9986.0,N,14644,1,,1,A,,,7132,
,,CHEMBL625601,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Intermediate,9986.0,N,14645,1,,1,A,,,7132,
,,CHEMBL625602,,50592,Feces,BAO_0000218,Oryctolagus cuniculus,1988.0,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Intermediate,9986.0,N,14646,1,,1,A,,,7132,
,,CHEMBL627470,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",Intermediate,9986.0,N,14647,1,,1,A,,,7132,
,,CHEMBL627471,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Intermediate,9986.0,N,14648,1,,1,A,,,7132,
,,CHEMBL627472,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Intermediate,9986.0,N,14649,1,,1,A,,,7132,
,,CHEMBL627473,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Intermediate,9986.0,N,14650,1,,1,A,,,7132,
,,CHEMBL627474,,50592,Urine,BAO_0000218,Oryctolagus cuniculus,1088.0,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Intermediate,9986.0,N,14651,1,,1,A,,,7132,
In vivo,,CHEMBL627475,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14652,1,,1,A,,,13925,
In vivo,,CHEMBL627476,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14653,1,,1,A,,,13925,
,,CHEMBL627477,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,9615.0,N,14654,1,,1,A,,,12582,
,,CHEMBL627478,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,9615.0,N,14655,1,,1,A,,,12582,
,,CHEMBL627479,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,9615.0,N,14656,1,,1,A,,,12582,
,,CHEMBL627480,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,9615.0,N,14657,1,,1,A,,,12582,
,,CHEMBL627481,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,9615.0,N,14658,1,,1,A,,,12582,
,,CHEMBL627482,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,9615.0,N,14659,1,,1,A,,,12582,
,,CHEMBL627483,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,9615.0,N,14660,1,,1,A,,,12582,
,,CHEMBL875636,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,9615.0,N,14661,1,,1,A,,,12582,
,,CHEMBL625764,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,9615.0,N,14662,1,,1,A,,,12582,
,,CHEMBL625765,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,9615.0,N,14663,1,,1,A,,,12582,
,,CHEMBL625766,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,Intermediate,9615.0,N,14664,1,,1,A,,,12582,
,,CHEMBL625767,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,9615.0,N,14665,1,,1,A,,,12582,
,,CHEMBL625768,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,9615.0,N,14666,1,,1,A,,,12582,
,,CHEMBL625769,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Intermediate,9615.0,N,14667,1,,1,A,,,12582,
,,CHEMBL625770,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Intermediate,9615.0,N,14668,1,,1,A,,,12582,
,,CHEMBL625771,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Intermediate,9615.0,N,14669,1,,1,A,,,12582,
,,CHEMBL625772,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,Intermediate,9615.0,N,14670,1,,1,A,,,12582,
,,CHEMBL625773,,50588,Urine,BAO_0000218,Canis lupus familiaris,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,9615.0,N,14671,1,,1,A,,,12582,
,,CHEMBL625774,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Intermediate,10116.0,N,14672,1,,1,A,,,12582,
,,CHEMBL625775,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,10116.0,N,14673,1,,1,A,,,12582,
,,CHEMBL625776,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,10116.0,N,14674,1,,1,A,,,12582,
,,CHEMBL625777,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,10116.0,N,14675,1,,1,A,,,12582,
,,CHEMBL625778,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,10116.0,N,14676,1,,1,A,,,12582,
,,CHEMBL625779,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,10116.0,N,14677,1,,1,A,,,12582,
,,CHEMBL625780,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,10116.0,N,14678,1,,1,A,,,12582,
,,CHEMBL625781,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,10116.0,N,14679,1,,1,A,,,12582,
,,CHEMBL875637,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,10116.0,N,14680,1,,1,A,,,12582,
,,CHEMBL626473,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,10116.0,N,14681,1,,1,A,,,12582,
,,CHEMBL626474,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,10116.0,N,14682,1,,1,A,,,12582,
,,CHEMBL626475,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,10116.0,N,14683,1,,1,A,,,12582,
,,CHEMBL626476,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,10116.0,N,14684,1,,1,A,,,12582,
,,CHEMBL634397,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,10116.0,N,14685,1,,1,A,,,12582,
,,CHEMBL626477,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,10116.0,N,14686,1,,1,A,,,12582,
,,CHEMBL631069,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,10116.0,N,14687,1,,1,A,,,12582,
,,CHEMBL631070,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,10116.0,N,14688,1,,1,A,,,12582,
,,CHEMBL631071,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,10116.0,N,14689,1,,1,A,,,12582,
,,CHEMBL631072,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,10116.0,N,14690,1,,1,A,,,12582,
,,CHEMBL631073,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,10116.0,N,14691,1,,1,A,,,12582,
,,CHEMBL631074,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,10116.0,N,14692,1,,1,A,,,12582,
,,CHEMBL631075,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,10116.0,N,14693,1,,1,A,,,12582,
,,CHEMBL631725,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,10116.0,N,14694,1,,1,A,,,12582,
,,CHEMBL631726,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,10116.0,N,14695,1,,1,A,,,12582,
,,CHEMBL631727,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,10116.0,N,14696,1,,1,A,,,12582,
,,CHEMBL631728,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,10116.0,N,14697,1,,1,A,,,12582,
,,CHEMBL631729,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,10116.0,N,14698,1,,1,A,,,12582,
,,CHEMBL631730,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,10116.0,N,14699,1,,1,A,,,12582,
,,CHEMBL631731,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,10116.0,N,14700,1,,1,A,,,12582,
,,CHEMBL631910,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,10116.0,N,14701,1,,1,A,,,12582,
In vivo,,CHEMBL631911,,50597,Hippocampus,BAO_0000218,Rattus norvegicus,10000000.0,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,Intermediate,10116.0,N,14702,1,,1,A,,,15413,
In vivo,,CHEMBL631912,,50597,Hypothalamus,BAO_0000218,Rattus norvegicus,1898.0,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,Intermediate,10116.0,N,14703,1,,1,A,,,15413,
In vivo,,CHEMBL631913,,50597,Hypothalamus,BAO_0000218,Rattus norvegicus,1898.0,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,Intermediate,10116.0,N,14704,1,,1,A,,,15413,
In vivo,,CHEMBL631914,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14705,1,,1,A,,,12017,
In vivo,,CHEMBL631915,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14706,1,,1,A,,,12017,
In vivo,,CHEMBL875778,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14707,1,,1,A,,,12017,
In vivo,,CHEMBL631916,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14708,1,,1,A,,,12017,
In vivo,,CHEMBL631917,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14709,1,,1,A,,,12017,
In vivo,,CHEMBL631918,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14710,1,,1,A,,,12017,
In vivo,,CHEMBL631919,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14711,1,,1,A,,,12017,
In vivo,,CHEMBL631920,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14712,1,,1,A,,,12017,
In vivo,,CHEMBL631921,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14713,1,,1,A,,,12017,
In vivo,,CHEMBL631922,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14714,1,,1,A,,,12017,
In vivo,,CHEMBL631923,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14715,1,,1,A,,,12017,
In vivo,,CHEMBL631924,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14716,1,,1,A,,,12017,
In vivo,,CHEMBL630234,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14717,1,,1,A,,,12017,
In vivo,,CHEMBL630235,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14718,1,,1,A,,,12017,
In vivo,,CHEMBL630236,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14719,1,,1,A,,,12017,
In vivo,,CHEMBL630237,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14720,1,,1,A,,,12017,
In vivo,,CHEMBL630238,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14721,1,,1,A,,,12017,
In vivo,,CHEMBL630239,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14722,1,,1,A,,,12017,
In vivo,,CHEMBL630303,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14723,1,,1,A,,,12017,
In vivo,,CHEMBL630304,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14724,1,,1,A,,,12017,
In vivo,,CHEMBL630305,,50597,,BAO_0000218,Rattus norvegicus,,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14725,1,,1,A,,,12017,
In vivo,,CHEMBL630306,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14726,1,,1,A,,,12017,
In vivo,,CHEMBL630307,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14727,1,,1,A,,,12017,
In vivo,,CHEMBL630308,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14728,1,,1,A,,,12017,
In vivo,,CHEMBL630309,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14729,1,,1,A,,,12017,
In vivo,,CHEMBL629309,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14730,1,,1,A,,,12017,
In vivo,,CHEMBL629993,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14731,1,,1,A,,,12017,
In vivo,,CHEMBL629994,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14732,1,,1,A,,,12017,
In vivo,,CHEMBL629995,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14733,1,,1,A,,,12017,
In vivo,,CHEMBL631993,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14734,1,,1,A,,,12017,
In vivo,,CHEMBL631994,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14735,1,,1,A,,,12017,
In vivo,,CHEMBL631995,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14736,1,,1,A,,,12017,
In vivo,,CHEMBL631996,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14737,1,,1,A,,,12017,
In vivo,,CHEMBL631997,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14738,1,,1,A,,,12017,
In vivo,,CHEMBL631998,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14739,1,,1,A,,,12017,
In vivo,,CHEMBL631999,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14740,1,,1,A,,,12017,
In vivo,,CHEMBL632000,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14741,1,,1,A,,,12017,
In vivo,,CHEMBL632001,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14742,1,,1,A,,,12017,
In vivo,,CHEMBL874424,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14743,1,,1,A,,,12017,
In vivo,,CHEMBL632002,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14744,1,,1,A,,,12017,
In vivo,,CHEMBL632003,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14745,1,,1,A,,,12017,
,,CHEMBL632004,,22224,,BAO_0000019,,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,Autocuration,,U,14746,1,,0,A,,,3133,
,,CHEMBL632005,,22224,,BAO_0000019,,,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,Autocuration,,U,14747,1,,0,A,,,2742,
,,CHEMBL632006,,22224,,BAO_0000019,,,,Compound was tested for amidase rate in the presence of N62C screen enzyme,Autocuration,,U,14748,1,,0,A,,,2742,
,,CHEMBL632007,,22224,,BAO_0000019,,,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,Autocuration,,U,14749,1,,0,A,,,2742,
,,CHEMBL632008,,22224,,BAO_0000019,,,,Compound was tested for amidase rate in the presence of S166C screen enzyme,Autocuration,,U,14750,1,,0,A,,,2742,
,,CHEMBL632009,,22224,,BAO_0000019,,,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,Autocuration,,U,14751,1,,0,A,,,2742,
,,CHEMBL632010,,22224,,BAO_0000019,,,,Compound was tested for esterase rate in the presence of N62C screen enzyme,Autocuration,,U,14752,1,,0,A,,,2742,
,,CHEMBL857750,,22224,,BAO_0000019,,,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,Autocuration,,U,14753,1,,0,A,,,2742,
,,CHEMBL632011,,22224,,BAO_0000019,,,,Compound was tested for esterase rate in the presence of S166C screen enzyme,Autocuration,,U,14754,1,,0,A,,,2742,
,,CHEMBL632012,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,U,14755,1,,0,A,,,2276,
,,CHEMBL632013,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,U,14756,1,,0,A,,,2276,
,,CHEMBL632014,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",Autocuration,,U,14757,1,,0,A,,,2276,
,,CHEMBL629622,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,U,14758,1,,0,A,,,2276,
,,CHEMBL629623,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,U,14759,1,,0,A,,,2276,
,,CHEMBL629624,,22224,,BAO_0000019,,,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",Autocuration,,U,14760,1,,0,A,,,2276,
,,CHEMBL629625,,22224,,BAO_0000019,,,,Ratio of Kcat to that of Km was determined,Autocuration,,U,14761,1,,0,A,,,17269,
,,CHEMBL629626,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",Autocuration,,U,14762,1,,0,A,,,2276,
,,CHEMBL629627,,22224,,BAO_0000019,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",Autocuration,,U,14763,1,,0,A,,,2276,
,,CHEMBL629628,,22224,,BAO_0000019,,,,"Compound was evaluated for constant, Kd",Autocuration,,U,14764,1,,0,A,,,15917,
,,CHEMBL629629,,22224,,BAO_0000019,,,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,Autocuration,,U,14765,1,,0,A,,,10933,
,,CHEMBL629630,,22224,,BAO_0000019,,,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,Autocuration,,U,14766,1,,0,A,,,10933,
,,CHEMBL856030,,22224,,BAO_0000019,,,,Dissociation Constant of compound determined,Autocuration,,U,14767,1,,0,A,,,14293,
,,CHEMBL629631,,22224,,BAO_0000019,,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,Autocuration,,U,14768,1,,0,B,,,6698,
,,CHEMBL629632,,22224,,BAO_0000019,,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,Autocuration,,U,14769,1,,0,B,,,6698,
,,CHEMBL629633,,22224,,BAO_0000100,,,,Dissociation constant of compound with Fructose was determined,Autocuration,,U,14770,1,,0,P,,,4318,
,,CHEMBL629634,,22224,,BAO_0000100,,,,Dissociation constant of compound with Fructose was determined; Not determined,Autocuration,,U,14771,1,,0,P,,,4318,
,,CHEMBL629635,,22224,,BAO_0000100,,,,Dissociation constant of compound with Lactulose was determined,Autocuration,,U,14772,1,,0,P,,,4318,
,,CHEMBL629636,,22224,,BAO_0000100,,,,Dissociation constant of compound with Lactulose was determined; Not determined,Autocuration,,U,14773,1,,0,P,,,4318,
,,CHEMBL629637,,22224,,BAO_0000100,,,,Dissociation constant of the Compound,Autocuration,,U,14774,1,,0,P,,,14959,
,,CHEMBL629638,,22224,,BAO_0000100,,,,Dissociation constant by non-linear regression analysis,Autocuration,,U,14775,1,,0,P,,,5913,
,,CHEMBL629639,,22224,,BAO_0000100,,,,Dissociation constant was determined,Autocuration,,U,14776,1,,0,P,,,14218,
,,CHEMBL629640,,22224,,BAO_0000100,,,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,Autocuration,,U,14777,1,,0,P,,,10689,
,,CHEMBL629641,,22224,,BAO_0000100,,,,Dissociation constant was determined,Autocuration,,U,14778,1,,0,P,,,13925,
,,CHEMBL631344,,22224,,BAO_0000100,,,,Dissociation constant was determined,Autocuration,,U,14779,1,,0,P,,,16359,
,,CHEMBL631345,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,Intermediate,10116.0,N,14780,1,,1,A,,,10944,
,,CHEMBL631346,,22224,,BAO_0000019,,,,The dissociation constant determined by fluorescence displacement assay,Autocuration,,U,14781,1,,0,A,,,11080,
,,CHEMBL631524,,22224,,BAO_0000019,,,,kd value surface plasmon resonance (SPR) method,Autocuration,,U,14782,1,,0,A,,,17805,
,,CHEMBL631525,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,Intermediate,10116.0,N,14783,1,,1,A,,,10944,
,,CHEMBL631526,,22224,,BAO_0000019,,,,First dissociation constant of the binding of compound to V30M TTR,Autocuration,,U,14784,1,,0,F,,,16645,
,,CHEMBL631527,,22224,,BAO_0000019,,,,Second dissociation constant of the binding of compound to V30M TTR,Autocuration,,U,14785,1,,0,F,,,16645,
,,CHEMBL631528,,22224,,BAO_0000019,,,,"Compound was evaluated for equilibrium constant, Ke",Autocuration,,U,14786,1,,0,A,,,7793,
,,CHEMBL631529,,22224,Hypothalamus,BAO_0000019,,1898.0,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,Autocuration,,U,14787,1,,0,A,,,12199,
,,CHEMBL631530,,22224,Hypothalamus,BAO_0000019,,1898.0,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,Autocuration,,U,14788,1,,0,A,,,12199,
,,CHEMBL631531,,22224,,BAO_0000019,,,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,,U,14789,1,,0,A,,,9680,
,,CHEMBL631532,,22224,,BAO_0000019,,,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,,U,14790,1,,0,A,,,9680,
,,CHEMBL631533,,22224,,BAO_0000019,,,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,,U,14791,1,,0,A,,,9680,
,,CHEMBL876552,,50594,,BAO_0000218,Mus musculus,,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,10090.0,N,14792,1,,1,A,,,13758,
,,CHEMBL631534,,50594,,BAO_0000218,Mus musculus,,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Intermediate,10090.0,N,14793,1,,1,A,,,13758,
,,CHEMBL631535,,50594,,BAO_0000218,Mus musculus,,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,10090.0,N,14794,1,,1,A,,,13758,
,,CHEMBL631536,,50594,,BAO_0000218,Mus musculus,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,10090.0,N,14795,1,,1,A,,,13758,
,,CHEMBL631537,,50594,,BAO_0000218,Mus musculus,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,Intermediate,10090.0,N,14796,1,,1,A,,,13758,
,,CHEMBL631538,,50594,,BAO_0000218,Mus musculus,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Intermediate,10090.0,N,14797,1,,1,A,,,13758,
,,CHEMBL631539,,50594,,BAO_0000218,Mus musculus,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,Intermediate,10090.0,N,14798,1,,1,A,,,13758,
,,CHEMBL631540,,50594,,BAO_0000218,Mus musculus,,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,10090.0,N,14799,1,,1,A,,,13758,
,,CHEMBL625637,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,10116.0,N,14800,1,,1,A,,,14393,
,,CHEMBL625638,,50597,,BAO_0000218,Rattus norvegicus,,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,10116.0,N,14801,1,,1,A,,,14393,
,,CHEMBL625639,,50597,,BAO_0000218,Rattus norvegicus,,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,10116.0,N,14802,1,,1,A,,,15078,
In vivo,,CHEMBL625640,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14803,1,,1,A,,,13925,
In vivo,,CHEMBL625641,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14804,1,,1,A,,,13925,
In vivo,,CHEMBL625642,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14805,1,,1,A,,,13925,
In vivo,,CHEMBL625643,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14806,1,,1,A,,,13925,
In vivo,,CHEMBL625644,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14807,1,,1,A,,,13925,
In vivo,,CHEMBL625645,,50597,Kidney,BAO_0000218,Rattus norvegicus,2113.0,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14808,1,,1,A,,,13925,
In vivo,,CHEMBL625646,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14809,1,,1,A,,,13925,
In vivo,,CHEMBL625647,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14810,1,,1,A,,,13925,
In vivo,,CHEMBL625648,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14811,1,,1,A,,,13925,
In vivo,,CHEMBL625649,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14812,1,,1,A,,,13925,
In vivo,,CHEMBL625650,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14813,1,,1,A,,,13925,
In vivo,,CHEMBL625651,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14814,1,,1,A,,,13925,
In vivo,,CHEMBL625652,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14815,1,,1,A,,,13925,
In vivo,,CHEMBL625653,,50597,Zone of skin,BAO_0000218,Rattus norvegicus,14.0,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14816,1,,1,A,,,13925,
In vivo,,CHEMBL625654,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14817,1,,1,A,,,13925,
In vivo,,CHEMBL625655,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,10116.0,N,14818,1,,1,A,,,13925,
In vivo,,CHEMBL625656,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of Compound in rat blood after 15 minutes of administration,Intermediate,10116.0,N,14819,1,,1,A,,,9712,
In vivo,,CHEMBL625657,,50597,Blood,BAO_0000218,Rattus norvegicus,178.0,,Biodistribution of Compound in rat blood after 2 minutes of administration,Intermediate,10116.0,N,14820,1,,1,A,,,9712,
In vivo,,CHEMBL625658,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of Compound in rat brain after 15 minutes of administration,Intermediate,10116.0,N,14821,1,,1,A,,,9712,
In vivo,,CHEMBL625659,,50597,Brain,BAO_0000218,Rattus norvegicus,955.0,,Biodistribution of Compound in rat brain after 2 minutes of administration,Intermediate,10116.0,N,14822,1,,1,A,,,9712,
In vivo,,CHEMBL625660,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of Compound in rat heart after 15 minutes of administration,Intermediate,10116.0,N,14823,1,,1,A,,,9712,
In vivo,,CHEMBL625661,,50597,Heart,BAO_0000218,Rattus norvegicus,948.0,,Biodistribution of Compound in rat heart after 2 minutes of administration,Intermediate,10116.0,N,14824,1,,1,A,,,9712,
In vivo,,CHEMBL625662,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of Compound in rat liver after 15 minutes of administration,Intermediate,10116.0,N,14825,1,,1,A,,,9712,
In vivo,,CHEMBL625663,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution of Compound in rat liver after 2 minutes of administration,Intermediate,10116.0,N,14826,1,,1,A,,,9712,
In vivo,,CHEMBL875621,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of Compound in rat lung after 15 minutes of administration,Intermediate,10116.0,N,14827,1,,1,A,,,9712,
In vivo,,CHEMBL628382,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution of Compound in rat lung after 2 minutes of administration,Intermediate,10116.0,N,14828,1,,1,A,,,9712,
In vivo,,CHEMBL628383,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of Compound in rat muscle after 15 minutes of administration,Intermediate,10116.0,N,14829,1,,1,A,,,9712,
In vivo,,CHEMBL628384,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution of Compound in rat muscle after 2 minutes of administration,Intermediate,10116.0,N,14830,1,,1,A,,,9712,
,,CHEMBL628385,,50597,,BAO_0000218,Rattus norvegicus,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,Intermediate,10116.0,N,14831,1,,1,A,,,13925,
,,CHEMBL875753,,50597,,BAO_0000218,Rattus norvegicus,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,Intermediate,10116.0,N,14832,1,,1,A,,,13925,
,,CHEMBL628386,,50597,,BAO_0000218,Rattus norvegicus,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,Intermediate,10116.0,N,14833,1,,1,A,,,13925,
,,CHEMBL628387,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat blood 2 minutes after intravenous injection,Intermediate,10116.0,N,14834,1,,1,A,,,6941,
,,CHEMBL628388,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat blood 2 hr after intravenous injection,Intermediate,10116.0,N,14835,1,,1,A,,,6941,
,,CHEMBL628389,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat blood 30 minutes after intravenous injection,Intermediate,10116.0,N,14836,1,,1,A,,,6941,
,,CHEMBL632756,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat blood 30 min after intravenous injection,Intermediate,10116.0,N,14837,1,,1,A,,,6941,
,,CHEMBL628390,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat brain 2 minutes after intravenous injection,Intermediate,10116.0,N,14838,1,,1,A,,,6941,
,,CHEMBL631811,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat brain 2 hr after intravenous injection,Intermediate,10116.0,N,14839,1,,1,A,,,6941,
,,CHEMBL631812,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat brain 30 minutes after intravenous injection,Intermediate,10116.0,N,14840,1,,1,A,,,6941,
,,CHEMBL631813,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat heart 2 minutes after intravenous injection,Intermediate,10116.0,N,14841,1,,1,A,,,6941,
,,CHEMBL631814,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat heart 2 hr after intravenous injection,Intermediate,10116.0,N,14842,1,,1,A,,,6941,
,,CHEMBL631815,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat heart 30 minutes after intravenous injection,Intermediate,10116.0,N,14843,1,,1,A,,,6941,
,,CHEMBL631816,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat kidney 2 minutes after intravenous injection,Intermediate,10116.0,N,14844,1,,1,A,,,6941,
,,CHEMBL875758,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat kidney 2 hr after intravenous injection,Intermediate,10116.0,N,14845,1,,1,A,,,6941,
,,CHEMBL631817,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat kidney 30 minutes after intravenous injection,Intermediate,10116.0,N,14846,1,,1,A,,,6941,
,,CHEMBL631818,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Organ distribution in rat liver 2 minutes after intravenous injection,Intermediate,10116.0,N,14847,1,,1,A,,,6941,
,,CHEMBL631819,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Organ distribution in rat liver 2 hr after intravenous injection,Intermediate,10116.0,N,14848,1,,1,A,,,6941,
,,CHEMBL631820,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Organ distribution in rat liver 30 minutes after intravenous injection,Intermediate,10116.0,N,14849,1,,1,A,,,6941,
,,CHEMBL631821,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat lung 2 minutes after intravenous injection,Intermediate,10116.0,N,14850,1,,1,A,,,6941,
,,CHEMBL631822,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat lung 2 hr after intravenous injection,Intermediate,10116.0,N,14851,1,,1,A,,,6941,
,,CHEMBL631823,,50597,,BAO_0000218,Rattus norvegicus,,,Organ distribution in rat lung 30 minutes after intravenous injection,Intermediate,10116.0,N,14852,1,,1,A,,,6941,
,,CHEMBL631824,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Organ distribution in rat muscle 2 minutes after intravenous injection,Intermediate,10116.0,N,14853,1,,1,A,,,6941,
,,CHEMBL631825,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Organ distribution in rat muscle 2 hr after intravenous injection,Intermediate,10116.0,N,14854,1,,1,A,,,6941,
,,CHEMBL631826,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Organ distribution in rat muscle 30 minutes after intravenous injection,Intermediate,10116.0,N,14855,1,,1,A,,,6941,
In vivo,,CHEMBL631827,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),Intermediate,10090.0,N,14856,1,,1,A,,,14439,
In vivo,,CHEMBL631828,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),Intermediate,10090.0,N,14857,1,,1,A,,,14439,
In vivo,,CHEMBL631829,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),Intermediate,10090.0,N,14858,1,,1,A,,,14439,
,,CHEMBL875759,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,10116.0,N,14859,1,,1,A,,,12582,
,,CHEMBL631830,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,Intermediate,10116.0,N,14860,1,,1,A,,,12582,
,,CHEMBL631831,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,10116.0,N,14861,1,,1,A,,,12582,
,,CHEMBL631832,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,10116.0,N,14862,1,,1,A,,,12582,
,,CHEMBL631833,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,10116.0,N,14863,1,,1,A,,,12582,
,,CHEMBL631834,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,10116.0,N,14864,1,,1,A,,,12582,
,,CHEMBL631835,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,10116.0,N,14865,1,,1,A,,,12582,
,,CHEMBL631836,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,10116.0,N,14866,1,,1,A,,,12582,
,,CHEMBL631837,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,10116.0,N,14867,1,,1,A,,,12582,
,,CHEMBL631838,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,10116.0,N,14868,1,,1,A,,,12582,
,,CHEMBL631839,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,10116.0,N,14869,1,,1,A,,,12582,
,,CHEMBL631840,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,10116.0,N,14870,1,,1,A,,,12582,
,,CHEMBL631841,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,10116.0,N,14871,1,,1,A,,,12582,
,,CHEMBL631842,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,10116.0,N,14872,1,,1,A,,,12582,
,,CHEMBL631843,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,10116.0,N,14873,1,,1,A,,,12582,
,,CHEMBL631844,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,10116.0,N,14874,1,,1,A,,,12582,
,,CHEMBL631845,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,10116.0,N,14875,1,,1,A,,,12582,
,,CHEMBL631846,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,10116.0,N,14876,1,,1,A,,,12582,
,,CHEMBL875760,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,10116.0,N,14877,1,,1,A,,,12582,
,,CHEMBL632199,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,10116.0,N,14878,1,,1,A,,,12582,
,,CHEMBL631847,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,10116.0,N,14879,1,,1,A,,,12582,
,,CHEMBL631848,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,10116.0,N,14880,1,,1,A,,,12582,
,,CHEMBL628707,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,10116.0,N,14881,1,,1,A,,,12582,
,,CHEMBL628708,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,10116.0,N,14882,1,,1,A,,,12582,
,,CHEMBL628709,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,10116.0,N,14883,1,,1,A,,,12582,
,,CHEMBL628710,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,10116.0,N,14884,1,,1,A,,,12582,
,,CHEMBL628711,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,10116.0,N,14885,1,,1,A,,,12582,
,,CHEMBL628712,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,10116.0,N,14886,1,,1,A,,,12582,
,,CHEMBL628713,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,10116.0,N,14887,1,,1,A,,,12582,
,,CHEMBL628714,,50597,Urine,BAO_0000218,Rattus norvegicus,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,10116.0,N,14888,1,,1,A,,,12582,
,,CHEMBL628715,,50597,,BAO_0000218,Rattus norvegicus,,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",Intermediate,10116.0,N,14889,1,,1,A,,,7415,
,,CHEMBL629179,,22224,,BAO_0000019,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,Autocuration,,U,14890,1,,0,A,,,7313,
,,CHEMBL629180,,22224,,BAO_0000019,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,Autocuration,,U,14891,1,,0,A,,,7313,
,,CHEMBL875108,,22224,,BAO_0000019,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,Autocuration,,U,14892,1,,0,A,,,7313,
,,CHEMBL629181,,22224,Adrenal cortex,BAO_0000019,,1235.0,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,,U,14893,1,,0,A,,,7570,
,,CHEMBL629182,,22224,Adrenal cortex,BAO_0000019,,1235.0,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,,U,14894,1,,0,A,,,7570,
,,CHEMBL629183,,22224,,BAO_0000019,,,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,Autocuration,,U,14895,1,,0,A,,,7570,
,,CHEMBL629184,,22224,,BAO_0000019,,,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,Autocuration,,U,14896,1,,0,A,,,7570,
,,CHEMBL629185,,22224,Adrenal cortex,BAO_0000019,,1235.0,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Autocuration,,U,14897,1,,0,A,,,7570,
,,CHEMBL629186,,22224,Adrenal cortex,BAO_0000019,,1235.0,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,,U,14898,1,,0,A,,,7570,
,,CHEMBL629187,,22224,,BAO_0000019,,,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,Autocuration,,U,14899,1,,0,A,,,7570,
,,CHEMBL629887,,22224,,BAO_0000019,,,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,Autocuration,,U,14900,1,,0,A,,,7570,
,,CHEMBL629888,,22224,,BAO_0000019,,,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,Autocuration,,U,14901,1,,0,A,,,7570,
,,CHEMBL629889,,22224,,BAO_0000019,,,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,Autocuration,,U,14902,1,,0,A,,,7570,
,,CHEMBL629890,,22224,Adrenal cortex,BAO_0000019,,1235.0,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,Autocuration,,U,14903,1,,0,A,,,7570,
,,CHEMBL629891,,22224,,BAO_0000019,,,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,Autocuration,,U,14904,1,,0,A,,,7570,
,,CHEMBL629892,,22224,,BAO_0000019,,,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,Autocuration,,U,14905,1,,0,A,,,7570,
,,CHEMBL629893,,22224,Adrenal cortex,BAO_0000019,,1235.0,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Autocuration,,U,14906,1,,0,A,,,7570,
,,CHEMBL629894,,22224,,BAO_0000019,,,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,Autocuration,,U,14907,1,,0,A,,,7570,
,,CHEMBL629895,,22224,,BAO_0000019,,,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,Autocuration,,U,14908,1,,0,A,,,7570,
In vivo,,CHEMBL875109,,22224,,BAO_0000218,Canis lupus familiaris,,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",Autocuration,9615.0,U,14909,1,,0,A,,,14122,
In vivo,,CHEMBL629896,,22224,,BAO_0000218,Macaca fascicularis,,,Absolute bioavailability in male cynomolgus monkeys,Autocuration,9541.0,U,14910,1,,0,A,,,16449,
In vivo,,CHEMBL629897,,22224,,BAO_0000218,Rattus norvegicus,,,Absolute bioavailability in maleSprague-Dawley rats,Autocuration,10116.0,U,14911,1,,0,A,,,16449,
In vivo,,CHEMBL629898,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14912,1,,1,A,,,12017,
In vivo,,CHEMBL630057,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14913,1,,1,A,,,12017,
In vivo,,CHEMBL630058,,50597,Liver,BAO_0000218,Rattus norvegicus,2107.0,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14914,1,,1,A,,,12017,
In vivo,,CHEMBL630059,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14915,1,,1,A,,,12017,
In vivo,,CHEMBL630060,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14916,1,,1,A,,,12017,
In vivo,,CHEMBL630061,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14917,1,,1,A,,,12017,
In vivo,,CHEMBL630062,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14918,1,,1,A,,,12017,
In vivo,,CHEMBL630063,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14919,1,,1,A,,,12017,
In vivo,,CHEMBL630064,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14920,1,,1,A,,,12017,
In vivo,,CHEMBL630065,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14921,1,,1,A,,,12017,
In vivo,,CHEMBL630066,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14922,1,,1,A,,,12017,
In vivo,,CHEMBL630067,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14923,1,,1,A,,,12017,
In vivo,,CHEMBL630068,,50597,Lung,BAO_0000218,Rattus norvegicus,2048.0,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14924,1,,1,A,,,12017,
In vivo,,CHEMBL631113,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14925,1,,1,A,,,12017,
In vivo,,CHEMBL631114,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14926,1,,1,A,,,12017,
In vivo,,CHEMBL631115,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14927,1,,1,A,,,12017,
In vivo,,CHEMBL631116,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14928,1,,1,A,,,12017,
In vivo,,CHEMBL630528,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14929,1,,1,A,,,12017,
In vivo,,CHEMBL630529,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14930,1,,1,A,,,12017,
In vivo,,CHEMBL630530,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14931,1,,1,A,,,12017,
In vivo,,CHEMBL630531,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14932,1,,1,A,,,12017,
In vivo,,CHEMBL630532,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14933,1,,1,A,,,12017,
In vivo,,CHEMBL630533,,50597,Muscle tissue,BAO_0000218,Rattus norvegicus,2385.0,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14934,1,,1,A,,,12017,
In vivo,,CHEMBL630534,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution in normal mice blood after 120 hr,Intermediate,10090.0,N,14935,1,,1,A,,,15045,
In vivo,,CHEMBL630535,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution in normal mice blood after 24 hr,Intermediate,10090.0,N,14936,1,,1,A,,,15045,
In vivo,,CHEMBL630536,,50594,Blood,BAO_0000218,Mus musculus,178.0,,Biodistribution in normal mice blood after 4 hr,Intermediate,10090.0,N,14937,1,,1,A,,,15045,
In vivo,,CHEMBL630537,,50594,Bone,BAO_0000218,Mus musculus,10000001.0,,Biodistribution in normal mice bone after 120 hr,Intermediate,10090.0,N,14938,1,,1,A,,,15045,
In vivo,,CHEMBL630538,,50594,Bone,BAO_0000218,Mus musculus,10000001.0,,Biodistribution in normal mice bone after 24 hr,Intermediate,10090.0,N,14939,1,,1,A,,,15045,
In vivo,,CHEMBL630539,,50594,Bone,BAO_0000218,Mus musculus,10000001.0,,Biodistribution in normal mice bone after 4 hr,Intermediate,10090.0,N,14940,1,,1,A,,,15045,
In vivo,,CHEMBL630540,,50594,Heart,BAO_0000218,Mus musculus,948.0,,Biodistribution in normal mice heart after 120 hr,Intermediate,10090.0,N,14941,1,,1,A,,,15045,
In vivo,,CHEMBL630541,,50594,Heart,BAO_0000218,Mus musculus,948.0,,Biodistribution in normal mice heart after 24 hr,Intermediate,10090.0,N,14942,1,,1,A,,,15045,
In vivo,,CHEMBL630542,,50594,Heart,BAO_0000218,Mus musculus,948.0,,Biodistribution in normal mice heart after 4 hr,Intermediate,10090.0,N,14943,1,,1,A,,,15045,
In vivo,,CHEMBL630543,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Biodistribution in normal mice kidney after 120 hr,Intermediate,10090.0,N,14944,1,,1,A,,,15045,
In vivo,,CHEMBL630544,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Biodistribution in normal mice kidney after 24 hr,Intermediate,10090.0,N,14945,1,,1,A,,,15045,
In vivo,,CHEMBL630545,,50594,Kidney,BAO_0000218,Mus musculus,2113.0,,Biodistribution in normal mice kidney after 4 hr,Intermediate,10090.0,N,14946,1,,1,A,,,15045,
In vivo,,CHEMBL630546,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution in normal mice liver after 120 hr,Intermediate,10090.0,N,14947,1,,1,A,,,15045,
In vivo,,CHEMBL630547,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution in normal mice liver after 24 hr,Intermediate,10090.0,N,14948,1,,1,A,,,15045,
In vivo,,CHEMBL630548,,50594,Liver,BAO_0000218,Mus musculus,2107.0,,Biodistribution in normal mice liver after 4 hr,Intermediate,10090.0,N,14949,1,,1,A,,,15045,
In vivo,,CHEMBL630549,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Biodistribution in normal mice spleen after 120 hr,Intermediate,10090.0,N,14950,1,,1,A,,,15045,
In vivo,,CHEMBL630550,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Biodistribution in normal mice spleen after 24 hr,Intermediate,10090.0,N,14951,1,,1,A,,,15045,
In vivo,,CHEMBL876426,,50594,Spleen,BAO_0000218,Mus musculus,2106.0,,Biodistribution in normal mice spleen after 4 hr,Intermediate,10090.0,N,14952,1,,1,A,,,15045,
In vivo,,CHEMBL630551,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14953,1,,1,A,,,12017,
In vivo,,CHEMBL630552,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14954,1,,1,A,,,12017,
In vivo,,CHEMBL630553,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14955,1,,1,A,,,12017,
In vivo,,CHEMBL630554,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14956,1,,1,A,,,12017,
In vivo,,CHEMBL630555,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14957,1,,1,A,,,12017,
In vivo,,CHEMBL630556,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14958,1,,1,A,,,12017,
In vivo,,CHEMBL630557,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14959,1,,1,A,,,12017,
In vivo,,CHEMBL630558,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,10116.0,N,14960,1,,1,A,,,12017,
In vivo,,CHEMBL630559,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14961,1,,1,A,,,12017,
In vivo,,CHEMBL630560,,50597,Spleen,BAO_0000218,Rattus norvegicus,2106.0,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14962,1,,1,A,,,12017,
In vivo,,CHEMBL876427,,50597,Thyroid gland,BAO_0000218,Rattus norvegicus,2046.0,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,10116.0,N,14963,1,,1,A,,,12017,
,,CHEMBL630561,,50597,,BAO_0000218,Rattus norvegicus,,,The Kel values in female wistar rats.,Intermediate,10116.0,N,14964,1,,1,A,,,14941,
,,CHEMBL630562,,22224,,BAO_0000019,,,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,Autocuration,,U,14965,1,,0,A,,,4646,
,,CHEMBL630563,,22224,,BAO_0000019,,,,Hydrolysis rate constant of the compound,Autocuration,,U,14966,1,,0,A,,,8847,
,,CHEMBL629673,,22229,,BAO_0000100,,,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,Autocuration,,U,14967,1,,0,P,,,11778,
,,CHEMBL629674,,22224,,BAO_0000019,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",Autocuration,,U,14968,1,,0,A,,,2363,
,,CHEMBL629675,,22224,,BAO_0000019,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",Autocuration,,U,14969,1,,0,A,,,2363,
,,CHEMBL629676,,22224,,BAO_0000019,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",Autocuration,,U,14970,1,,0,A,,,2363,
,,CHEMBL629677,,22224,,BAO_0000019,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",Autocuration,,U,14971,1,,0,A,,,2363,
,,CHEMBL629678,,22224,,BAO_0000019,,,,Apparent inactivation rate constant was evaluated,Autocuration,,U,14972,1,,0,A,,,8371,
,,CHEMBL629679,,22224,,BAO_0000019,,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,Autocuration,,U,14973,1,,0,A,,,14883,
,,CHEMBL629680,,22224,,BAO_0000019,,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,Autocuration,,U,14974,1,,0,A,,,14883,
,,CHEMBL629681,,22224,,BAO_0000019,,,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,Autocuration,,U,14975,1,,0,A,,,4643,
,,CHEMBL629682,,22224,,BAO_0000019,,,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,Autocuration,,U,14976,1,,0,A,,,3519,
,,CHEMBL629683,,22224,,BAO_0000019,,,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,Autocuration,,U,14977,1,,0,A,,,10600,
,,CHEMBL629684,,22224,,BAO_0000019,,,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,Autocuration,,U,14978,1,,0,F,,,8501,
,,CHEMBL629685,,22224,,BAO_0000100,,,,Dissociation constant was determined,Autocuration,,U,14979,1,,0,P,,,8505,
,,CHEMBL629686,,22224,,BAO_0000100,,,,Dissociation constant was determined,Autocuration,,U,14980,1,,0,P,,,9778,
,,CHEMBL872932,,22224,,BAO_0000100,,,,Dissociation constant at pH 7.4,Autocuration,,U,14981,1,,0,P,,,9778,
,,CHEMBL629687,,22224,,BAO_0000100,,,,Dissociation constant in presence of 1 mM dithiothreitol,Autocuration,,U,14982,1,,0,P,,,9778,
,,CHEMBL872931,,22224,,BAO_0000019,,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,Autocuration,,U,14983,1,,0,A,,,13007,
,,CHEMBL628151,,22224,,BAO_0000019,,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,Autocuration,,U,14984,1,,0,A,,,13007,
,,CHEMBL628152,,22224,,BAO_0000019,,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,Autocuration,,U,14985,1,,0,A,,,13007,
,,CHEMBL628153,,22224,,BAO_0000019,,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,Autocuration,,U,14986,1,,0,A,,,13007,
,,CHEMBL628154,,22224,,BAO_0000019,,,,Kinetic constant for aromatization of androstenedione,Autocuration,,U,14987,1,,0,A,,,11482,
,,CHEMBL628155,,22224,,BAO_0000019,,,,Kinetic constant for aromatization of testosterone,Autocuration,,U,14988,1,,0,A,,,11482,
,,CHEMBL628156,,22224,,BAO_0000019,,,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,Autocuration,,U,14989,1,,0,A,,,2303,
,,CHEMBL628157,,22224,,BAO_0000019,,,,Local inhibition constant was determined,Autocuration,,U,14990,1,,0,A,,,11964,
,,CHEMBL857533,,50347,,BAO_0000218,Saccharomyces cerevisiae,,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,Intermediate,4932.0,N,14991,1,,1,A,,,3140,
,,CHEMBL628158,,22224,,BAO_0000100,,,,Dissociation constant value of the compound,Autocuration,,U,14992,1,,0,P,,,10650,
,,CHEMBL628159,,22224,Cornea,BAO_0000019,,964.0,,In vitro permeability through cornea without epithelium,Autocuration,,U,14993,1,,0,A,,,4667,
,,CHEMBL875616,,22224,Cornea,BAO_0000019,,964.0,,In vitro permeability through intact cornea,Autocuration,,U,14994,1,,0,A,,,4667,
,,CHEMBL628160,,50592,Cornea,BAO_0000218,Oryctolagus cuniculus,964.0,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,Intermediate,9986.0,N,14995,1,,1,A,,,9199,
,,CHEMBL628161,,22224,,BAO_0000019,,,,Rate of enzyme inactivation for the compound was determined,Autocuration,,U,14996,1,,0,A,,,11966,
,,CHEMBL628162,,22224,Cornea,BAO_0000019,,964.0,,In vitro permeability through cornea without epithelium,Autocuration,,U,14997,1,,0,A,,,4667,
,,CHEMBL628163,,22224,Cornea,BAO_0000019,,964.0,,In vitro permeability through intact cornea,Autocuration,,U,14998,1,,0,A,,,4667,
,,CHEMBL628164,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,14999,1,,0,A,,,8354,
,,CHEMBL628165,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15000,1,,0,A,,,8354,
,,CHEMBL628166,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15001,1,,0,A,,,8354,
,,CHEMBL628167,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15002,1,,0,A,,,8354,
,,CHEMBL628168,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15003,1,,0,A,,,8354,
,,CHEMBL628169,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15004,1,,0,A,,,8354,
,,CHEMBL628170,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15005,1,,0,A,,,8354,
,,CHEMBL628171,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15006,1,,0,A,,,8354,
,,CHEMBL627434,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15007,1,,0,A,,,8354,
,,CHEMBL627435,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15008,1,,0,A,,,8354,
,,CHEMBL628110,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15009,1,,0,A,,,8354,
,,CHEMBL628111,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15010,1,,0,A,,,8354,
,,CHEMBL628112,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15011,1,,0,A,,,8354,
,,CHEMBL628260,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15012,1,,0,A,,,8354,
,,CHEMBL628261,,22224,,BAO_0000019,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,U,15013,1,,0,A,,,8354,
In vivo,,CHEMBL628262,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),Intermediate,10090.0,N,15014,1,,1,A,,,14439,
In vivo,,CHEMBL628263,,50587,,BAO_0000218,Homo sapiens,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,Intermediate,9606.0,N,15015,1,,1,A,,,14439,
In vivo,,CHEMBL628264,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),Intermediate,10090.0,N,15016,1,,1,A,,,14439,
In vivo,,CHEMBL628265,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),Intermediate,10090.0,N,15017,1,,1,A,,,14439,
In vivo,,CHEMBL628266,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),Intermediate,10090.0,N,15018,1,,1,A,,,14439,
In vivo,,CHEMBL628267,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),Intermediate,10090.0,N,15019,1,,1,A,,,14439,
In vivo,,CHEMBL628268,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,Intermediate,10090.0,N,15020,1,,1,A,,,14439,
In vivo,,CHEMBL628269,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),Intermediate,10090.0,N,15021,1,,1,A,,,14439,
In vivo,,CHEMBL628270,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),Intermediate,10090.0,N,15022,1,,1,A,,,14439,
In vivo,,CHEMBL628271,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),Intermediate,10090.0,N,15023,1,,1,A,,,14439,
In vivo,,CHEMBL628272,,50594,,BAO_0000218,Mus musculus,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),Intermediate,10090.0,N,15024,1,,1,A,,,14439,
